data_1fj7_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fj7 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.521 0.677 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.542 HG22 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -148.47 166.48 15.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.74 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -78.8 -42.91 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.233 1.649 . . . . 0.0 110.769 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CE2' ' C ' ' A' ' 67' ' ' SER . 96.3 m-85 -96.88 110.88 23.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 110.516 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -137.32 151.73 48.96 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 20' ' ' LEU . 4.5 pp -161.31 -178.03 6.41 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 110.391 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 62' ' ' TYR . 6.2 t80 -112.4 146.65 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.338 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mt -130.91 155.99 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.827 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 60' ' ' PHE . . . -136.51 -164.74 10.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.477 ' ND2' ' HG2' ' A' ' 86' ' ' GLU . 31.2 t-20 65.64 70.59 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.08 . . . . 0.0 110.092 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 25' ' ' LEU . 10.2 mp -119.16 130.25 55.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.845 . . . . 0.0 110.255 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 31.5 t30 -54.15 107.99 1.01 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.506 -0.746 . . . . 0.0 110.346 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.2 Cg_endo -74.49 -8.73 20.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.049 1.552 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.415 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 7.1 m120 -84.05 -14.54 50.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.578 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -117.57 -157.24 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.39 -0.819 . . . . 0.0 109.859 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.463 ' O ' HD11 ' A' ' 34' ' ' LEU . 1.6 m -100.14 146.92 26.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.529 ' O ' ' CD ' ' A' ' 35' ' ' LYS . 11.2 t -69.79 -30.37 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.319 -0.953 . . . . 0.0 109.059 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -63.72 -38.16 90.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.0 109.034 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 54.7 mm-40 -68.14 -36.31 79.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.524 HD23 ' CA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.42 -32.93 73.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.367 -0.833 . . . . 0.0 108.836 178.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 1.6 mptp? -65.82 -50.37 64.88 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.575 -0.703 . . . . 0.0 109.314 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.4 t -58.53 -35.64 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.842 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.57 -35.85 81.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.137 -0.977 . . . . 0.0 108.727 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.581 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 35.9 mt -80.15 -27.11 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.157 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -29.46 41.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.067 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.93 -38.37 27.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.361 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.55 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 5.2 tp -68.12 -32.17 72.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.585 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 6.0 m-85 -82.31 -23.19 35.27 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.54 65.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 109.362 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -89.37 -21.15 23.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.727 . . . . 0.0 109.456 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.635 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.1 m-80 -80.57 -20.52 43.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.474 -0.766 . . . . 0.0 109.743 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.635 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.2 t0 91.21 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.939 0.876 . . . . 0.0 108.759 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.585 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -84.11 -139.26 0.06 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -177.21 58.41 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.217 -0.927 . . . . 0.0 109.774 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 m -60.03 117.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.965 0.888 . . . . 0.0 109.94 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CB ' HG22 ' A' ' 16' ' ' THR . 2.6 t -95.29 -33.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.265 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.518 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 12.4 t0 -144.68 153.77 42.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.977 . . . . 0.0 110.676 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -155.91 99.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.87 . . . . 0.0 108.979 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -102.26 156.82 17.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.106 -0.996 . . . . 0.0 110.733 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.52 ' CG2' HG13 ' A' ' 31' ' ' VAL . 44.5 p -90.64 154.65 19.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.429 -0.795 . . . . 0.0 110.319 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.576 ' HA3' ' CD1' ' A' ' 60' ' ' PHE . . . -127.49 128.32 6.09 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.582 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 3.4 m 60.72 170.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.836 -0.802 . . . . 0.0 109.878 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.524 ' N ' ' CG2' ' A' ' 56' ' ' THR . 68.8 m-80 -38.6 -42.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.467 -0.77 . . . . 0.0 110.412 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.529 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 172.45 51.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.817 . . . . 0.0 109.802 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.408 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -110.54 -31.24 7.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.306 -0.871 . . . . 0.0 110.494 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . 5.9 p90 -159.39 149.33 18.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.026 -1.047 . . . . 0.0 110.424 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' N ' HD22 ' A' ' 25' ' ' LEU . . . -132.82 164.8 24.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.45 162.44 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -1.083 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.515 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 3.2 t -151.4 141.59 15.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.749 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 50.2 m-20 -112.06 147.54 35.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.501 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.6 m-85 -108.26 179.84 4.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.821 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.53 ' CG ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -114.08 13.42 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 111.496 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.54 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.4 p 178.88 179.42 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.381 1.086 . . . . 0.0 112.072 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.25 52.94 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -27.07 37.29 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.4 m-20 -83.43 -25.9 30.83 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 3.3 tm? -80.69 -34.79 34.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.477 0.656 . . . . 0.0 109.281 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.92 -36.13 67.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.806 . . . . 0.0 109.487 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -76.43 -27.45 56.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.89 -29.5 68.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.416 HD11 ' C ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -71.25 -45.99 62.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -75.92 -4.21 39.68 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.225 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.573 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -77.77 12.01 1.89 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 110.281 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -9.23 12.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.039 -1.038 . . . . 0.0 110.089 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.12 33.98 3.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.55 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -85.37 -170.15 2.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.125 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.562 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -179.1 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.257 1.027 . . . . 0.0 109.876 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.577 ' CG2' ' CG2' ' A' ' 87' ' ' ILE . 41.4 t -40.97 127.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.994 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.578 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 8.4 m-85 43.96 25.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.132 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 90.7 20.43 40.44 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' VAL . 23.4 m-20 -131.62 102.39 5.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -1.156 . . . . 0.0 109.521 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.562 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -53.47 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.272 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.577 ' CG2' ' CG2' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -47.46 142.57 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -108.11 163.88 12.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 109.163 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.518 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.53 -179.34 3.61 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 110.459 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 16' ' ' THR . 16.9 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.306 0.574 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.53 HG23 ' CB ' ' A' ' 50' ' ' VAL . 70.1 p -153.85 161.88 28.12 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.288 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.71 -23.88 14.03 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.025 1.539 . . . . 0.0 110.7 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.579 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 98.4 m-85 -106.37 112.67 25.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 110.562 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 18' ' ' PHE . 3.2 m120 -143.82 153.53 42.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.586 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.573 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 4.4 pp -166.49 -177.51 4.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -113.71 151.01 32.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.0 157.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 109.658 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.69 -168.47 11.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.0 t30 69.31 50.91 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -1.099 . . . . 0.0 110.214 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.6 mm? -100.13 123.08 43.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.511 ' N ' HD23 ' A' ' 34' ' ' LEU . 25.7 t-20 -42.92 102.18 0.27 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.59 -0.694 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.37 -14.21 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.02 1.537 . . . . 0.0 110.369 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 1.9 m-20 -80.25 -19.34 47.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.566 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -107.13 -156.31 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.414 -0.804 . . . . 0.0 109.832 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.1 m -103.2 143.14 33.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.57 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.5 t -66.58 -19.2 25.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.107 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . . . -71.54 -41.46 69.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 108.989 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.8 mm-40 -66.11 -37.49 85.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 109.288 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 30' ' ' SER . 5.0 mp -63.05 -34.58 77.89 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.315 -0.865 . . . . 0.0 108.745 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' CG ' ' CG2' ' A' ' 52' ' ' VAL . 2.8 mttt -60.14 -56.91 15.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 25.4 t -60.93 -34.59 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.588 -0.695 . . . . 0.0 109.468 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.35 -33.4 75.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 108.694 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.488 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.2 mt -81.11 -28.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.514 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -78.6 -30.29 46.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.084 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.22 -37.7 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.546 0.689 . . . . 0.0 109.458 179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.546 ' CD1' ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -68.56 -31.56 70.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.087 179.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 13.2 m-85 -88.16 -16.8 32.41 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.4 -29.38 19.11 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.995 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -91.82 -18.74 23.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.465 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.601 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -81.32 -58.73 2.92 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 0.0 109.719 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.1 m-20 148.26 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.27 0.557 . . . . 0.0 109.843 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 70' ' ' ASP . 4.1 mm? -106.1 -158.94 0.68 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.328 -0.857 . . . . 0.0 109.586 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.522 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -160.41 61.9 0.33 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.955 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 6.7 m -52.83 118.12 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.882 0.848 . . . . 0.0 109.856 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.53 ' CB ' HG23 ' A' ' 16' ' ' THR . 0.6 OUTLIER -87.43 -43.12 15.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 121.878 -0.514 . . . . 0.0 109.99 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 4.5 t0 -144.46 158.17 43.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.575 ' CG2' ' CG ' ' A' ' 35' ' ' LYS . 2.1 p -149.21 156.65 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 0.0 109.706 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -165.26 165.92 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.167 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.57 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 12.5 p -79.56 179.46 7.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.403 -0.811 . . . . 0.0 110.329 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -142.1 135.31 6.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.568 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 97.8 m 59.43 -83.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.903 . . . . 0.0 110.449 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 55' ' ' GLY . 1.6 m-20 -161.54 97.09 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.046 -1.034 . . . . 0.0 110.642 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 42.75 27.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.903 . . . . 0.0 110.655 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -119.58 -33.23 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 110.156 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.568 ' CD2' ' HB ' ' A' ' 56' ' ' THR . 3.2 m-85 -129.18 177.31 7.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.54 129.12 2.59 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.076 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 28.4 t80 -92.82 163.9 13.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 109.644 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.622 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 27.7 t -157.95 159.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.867 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -126.28 138.33 53.59 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.612 -0.68 . . . . 0.0 109.58 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 24.8 m-85 -102.7 175.26 5.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.676 -0.64 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.522 ' HG2' ' CB ' ' A' ' 48' ' ' ALA . 3.0 pt-20 -118.44 14.66 13.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 111.564 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.534 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.7 p -172.61 173.9 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.906 -1.121 . . . . 0.0 112.165 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.5 -23.91 42.63 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -25.43 30.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.572 ' OD1' ' CD1' ' A' ' 65' ' ' PHE . 5.4 t0 -82.14 -25.73 34.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 2.7 tm? -81.95 -33.64 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -34.37 71.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.756 . . . . 0.0 109.379 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.537 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -77.26 -28.75 53.67 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.12 -27.13 67.07 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -73.55 -48.85 29.8 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.82 -3.72 30.34 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.3 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -76.55 8.8 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.489 -0.757 . . . . 0.0 110.469 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 m -64.58 -8.72 15.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.198 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.97 17.8 48.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.546 ' CD2' ' CD1' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -72.31 -171.94 0.84 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.403 -1.057 . . . . 0.0 110.67 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.4 mttt -170.64 49.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.355 1.074 . . . . 0.0 109.655 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.586 ' CG2' ' CG2' ' A' ' 87' ' ' ILE . 23.7 t -40.06 124.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.027 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.566 ' CD1' ' HG3' ' A' ' 29' ' ' LYS . 4.9 m-85 42.72 29.38 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.188 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.12 25.14 38.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' VAL . 11.4 m120 -134.16 86.37 2.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.603 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.563 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 21.1 tt0 -41.92 100.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.586 ' CG2' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -60.18 140.22 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.489 -0.757 . . . . 0.0 110.42 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -111.63 156.3 22.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.153 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.39 169.73 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.043 -1.035 . . . . 0.0 110.608 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.014 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 16' ' ' THR . 4.1 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.194 0.521 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.567 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -167.4 158.24 9.95 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 110.477 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.86 -34.98 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.154 1.608 . . . . 0.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.522 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.1 m-85 -112.22 114.3 27.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' ND2' ' C ' ' A' ' 18' ' ' PHE . 2.8 m120 -132.87 148.98 52.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.578 ' O ' ' CD1' ' A' ' 62' ' ' TYR . 4.5 pp -165.4 -177.36 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 60' ' ' PHE . 3.3 t80 -115.2 150.01 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.97 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 2.2 mt -129.95 158.34 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.427 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.48 -173.45 13.04 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t30 72.54 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -1.012 . . . . 0.0 110.197 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.0 mm? -116.45 165.48 13.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 110.106 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 40.8 t30 -95.22 106.74 27.84 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 110.344 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -73.54 -13.92 24.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.042 1.548 . . . . 0.0 110.447 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.441 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 1.9 m-80 -78.67 -17.72 55.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.582 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -113.27 -155.27 0.56 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.44 -0.788 . . . . 0.0 109.862 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.496 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -100.65 142.53 32.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 110.498 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 54' ' ' THR . 2.9 t -67.37 -32.33 56.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.179 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.94 -39.01 92.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.319 -0.863 . . . . 0.0 108.965 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 70.2 mm-40 -63.79 -36.46 83.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.559 -0.713 . . . . 0.0 109.092 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 83' ' ' PHE . 92.2 mt -61.3 -38.81 88.14 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.37 -0.832 . . . . 0.0 108.908 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -58.96 -50.37 74.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -60.09 -37.72 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.477 -0.764 . . . . 0.0 109.668 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.35 -28.34 69.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.072 -1.017 . . . . 0.0 109.11 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.579 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 7.0 mt -87.84 -28.06 5.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.482 -0.761 . . . . 0.0 109.14 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.5 t -80.61 -24.71 38.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.167 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.52 -37.43 19.66 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.532 -0.73 . . . . 0.0 109.141 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.527 ' CD1' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -67.47 -34.72 77.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 77' ' ' LEU . 7.1 m-85 -83.47 -22.53 32.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB1' ' HA ' ' A' ' 40' ' ' GLU . . . -74.48 -33.72 62.92 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -18.21 25.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 0.0 109.345 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.21 -19.35 39.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.526 -0.734 . . . . 0.0 109.863 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 t70 91.69 29.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.008 0.909 . . . . 0.0 108.839 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.528 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -87.95 -140.68 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.526 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -178.28 59.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 m -56.01 117.08 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.075 0.941 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.567 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 0.9 OUTLIER -88.98 -36.51 8.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.67 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.507 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 24.2 t70 -143.69 147.31 34.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' CG1' HG21 ' A' ' 63' ' ' VAL . 2.6 t -153.23 139.63 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.609 -0.682 . . . . 0.0 109.462 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.435 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -158.08 -179.63 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.526 HG23 ' CG1' ' A' ' 31' ' ' VAL . 17.0 p -84.7 177.95 7.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.316 -0.865 . . . . 0.0 110.594 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -137.23 132.43 5.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.57 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 52.3 m 57.68 -91.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' N ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -153.02 98.1 2.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.073 -1.017 . . . . 0.0 110.434 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.461 ' NH2' ' HG2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER 41.92 26.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -116.35 -32.31 5.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 1.8 m-85 -135.97 -175.82 4.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.359 -0.838 . . . . 0.0 109.498 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.6 145.9 13.72 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.101 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -101.26 161.42 13.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -1.107 . . . . 0.0 109.528 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 4.7 t -161.46 159.86 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.552 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.1 m-20 -140.93 142.03 34.45 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.709 -0.619 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.643 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 61.2 m-85 -106.16 174.44 5.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.719 -0.613 . . . . 0.0 110.584 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 6.6 pt-20 -114.67 13.2 17.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 111.849 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.522 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.0 p -170.06 177.26 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.855 -1.153 . . . . 0.0 112.255 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.91 -23.56 48.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.51 -27.57 46.11 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.475 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.523 ' OD2' ' CG ' ' A' ' 66' ' ' GLU . 83.0 m-20 -83.14 -27.91 29.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 1.9 tm? -73.67 -38.67 64.85 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.274 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -37.25 71.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.42 -0.8 . . . . 0.0 109.348 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.11 -20.44 52.15 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.643 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -71.57 -31.94 67.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -76.8 -43.5 36.45 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.551 -0.718 . . . . 0.0 109.081 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -25.0 66.04 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.419 -0.8 . . . . 0.0 109.584 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.635 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 14.2 mt -66.82 -8.22 27.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 110.126 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.9 m -48.42 -19.81 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 110.654 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.23 34.78 3.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.33 -165.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 110.694 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.54 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.0 mtmt -169.64 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.193 0.997 . . . . 0.0 109.67 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.528 ' CG2' HD23 ' A' ' 34' ' ' LEU . 2.9 p -37.83 125.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.179 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.582 ' CD1' ' HG3' ' A' ' 29' ' ' LYS . 3.8 m-85 41.75 26.69 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.456 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 89.91 24.38 30.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 82' ' ' VAL . 12.3 m120 -135.04 89.82 2.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -1.137 . . . . 0.0 109.565 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.54 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.8 pt-20 -41.17 106.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 110.858 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.528 ' CG2' HG13 ' A' ' 82' ' ' VAL . 1.0 OUTLIER -72.54 135.54 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 110.285 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -112.04 159.76 18.15 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.506 -0.747 . . . . 0.0 109.156 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -117.31 172.7 7.13 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.864 -1.147 . . . . 0.0 110.574 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 110.201 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.443 HG21 ' OD2' ' A' ' 51' ' ' ASP . 1.9 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.514 0.673 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.545 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -134.85 157.65 76.67 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 110.496 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -79.57 -30.92 2.22 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 124.204 1.634 . . . . 0.0 110.821 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 67' ' ' SER . 56.7 m-85 -103.31 104.52 14.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 110.895 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 64' ' ' ASP . 3.3 m120 -137.85 149.06 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.436 -0.79 . . . . 0.0 109.344 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.574 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 3.3 pp -163.84 -175.58 4.16 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.453 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 41.5 t80 -108.86 167.54 10.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 14.8 mt -147.33 158.89 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.666 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -137.24 179.46 18.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.9 t30 70.16 92.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -1.127 . . . . 0.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 21.8 mt -145.02 130.92 19.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.978 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.475 ' HB3' HD21 ' A' ' 34' ' ' LEU . 37.5 t-20 -38.95 99.29 0.19 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.737 -0.602 . . . . 0.0 110.528 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -74.19 -19.28 20.13 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.081 1.569 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -78.5 -13.71 59.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -110.52 -155.65 0.57 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 109.97 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.473 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 6.5 m -104.73 152.7 22.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.315 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.529 HG12 ' CG2' ' A' ' 54' ' ' THR . 2.7 t -69.71 -46.01 76.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 109.452 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.52 -38.95 32.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.878 . . . . 0.0 109.279 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 28.5 mm-40 -67.97 -40.01 83.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.437 -0.789 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.534 ' CD2' HG12 ' A' ' 82' ' ' VAL . 25.6 mt -60.72 -36.59 79.23 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.298 -0.876 . . . . 0.0 108.742 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 10.3 mmtt -62.32 -57.64 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.2 t -52.22 -35.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.99 -34.48 78.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 4.5 mt -82.1 -27.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.2 m -77.86 -30.15 50.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.937 . . . . 0.0 109.023 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.59 -37.02 32.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.752 . . . . 0.0 109.456 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -69.08 -30.53 68.87 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.587 -0.696 . . . . 0.0 109.145 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.591 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.1 m-85 -84.7 -22.46 29.75 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.88 -32.42 61.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.437 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -12.44 28.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.0 109.735 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -92.41 -11.17 35.56 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.3 t70 85.12 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.917 0.865 . . . . 0.0 109.281 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.0 mm? -86.76 -131.15 0.06 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 47' ' ' LEU . . . 168.38 56.34 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.841 -1.162 . . . . 0.0 109.692 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 42' ' ' PHE . 12.6 m -58.16 120.5 4.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.067 0.937 . . . . 0.0 110.375 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.545 ' CB ' HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -90.37 -46.85 14.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.448 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 3.6 m-20 -148.1 118.88 7.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.173 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.51 HG12 ' CG1' ' A' ' 63' ' ' VAL . 16.6 m -101.24 171.55 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.295 -0.878 . . . . 0.0 109.692 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.82 164.48 16.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 0.0 110.431 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.529 ' CG2' HG12 ' A' ' 31' ' ' VAL . 23.4 p -92.03 162.32 14.42 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.456 -0.777 . . . . 0.0 110.549 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -117.5 121.47 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.549 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 2.1 m 72.0 -56.17 0.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.62 -0.929 . . . . 0.0 110.122 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER 173.74 -35.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.518 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 31.8 ttp180 -172.5 26.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.549 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.547 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 34.6 mttp -119.31 -33.74 4.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.549 ' CD2' ' OG1' ' A' ' 56' ' ' THR . 1.1 m-85 -131.26 -165.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.328 -0.858 . . . . 0.0 109.349 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -171.01 161.93 34.74 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.236 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.0 t80 -123.36 154.81 38.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.42 -1.047 . . . . 0.0 109.554 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.621 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.5 t -150.71 146.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.004 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 1.1 m-20 -118.27 135.06 54.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.529 -0.732 . . . . 0.0 109.507 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.643 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 51.4 m-85 -102.44 171.91 7.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.714 -0.616 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.53 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.58 15.77 16.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.89 . . . . 0.0 111.344 -178.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p -166.82 173.8 9.15 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.603 1.192 . . . . 0.0 112.281 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.453 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.24 -25.72 51.84 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.38 -26.79 58.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.571 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 89.1 m-20 -82.41 -30.63 30.05 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.15 -36.56 66.68 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.827 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -73.39 -38.72 65.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.813 . . . . 0.0 109.98 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.538 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -78.3 -29.64 47.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.643 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -64.39 -31.33 72.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.841 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 4.6 tt -72.82 -45.18 59.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -81.03 -1.13 42.76 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.41 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.588 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -77.91 7.83 5.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.282 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.4 m -70.29 -2.55 13.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 110.473 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.55 65.45 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' A' ' 87' ' ' ILE . 1.2 pp -71.69 129.4 38.59 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.388 -1.066 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -99.98 84.86 2.94 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.975 0.893 . . . . 0.0 109.518 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.556 ' HB ' ' CG2' ' A' ' 87' ' ' ILE . 4.2 p -43.85 118.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.727 -0.789 . . . . 0.0 108.998 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 2.1 m-85 46.01 22.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 110.306 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.03 12.26 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.319 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.6 m120 -126.49 89.67 3.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.31 . . . . 0.0 110.387 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.9 mp0 -40.33 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.63 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.556 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 12.5 pt -71.28 146.54 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.784 0.802 . . . . 0.0 110.581 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.474 ' O ' HG21 ' A' ' 22' ' ' ILE . 15.9 ttpt -116.06 158.64 22.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.485 ' CD1' ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -119.07 167.95 11.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.837 -1.164 . . . . 0.0 110.415 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.167 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.555 ' O ' ' OG1' ' A' ' 16' ' ' THR . 7.2 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.174 0.511 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 15' ' ' THR . 1.4 p 77.8 163.41 0.13 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.565 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.8 Cg_endo -77.85 -31.75 2.99 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.227 1.646 . . . . 0.0 110.91 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 74.4 m-85 -86.61 102.39 14.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.949 -1.094 . . . . 0.0 110.557 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 16' ' ' THR . 67.0 m-20 -139.52 157.74 45.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.219 -0.926 . . . . 0.0 109.623 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 20' ' ' LEU . 2.2 pp -167.02 -177.08 3.62 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.288 -0.882 . . . . 0.0 110.416 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 21' ' ' PHE . 1.5 t80 -117.29 146.58 43.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 87' ' ' ILE . 2.2 mt -129.93 160.5 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -136.63 -172.67 12.64 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 10.1 t-20 72.33 63.95 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.496 -1.002 . . . . 0.0 110.47 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.1 mm? -106.53 119.54 39.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.522 ' N ' HD13 ' A' ' 34' ' ' LEU . 11.6 t-20 -41.31 107.21 0.47 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.704 -0.622 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.79 -30.3 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.55 . . . . 0.0 110.042 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -78.83 -11.73 60.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.852 . . . . 0.0 109.63 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.439 ' HD2' ' CD ' ' A' ' 33' ' ' GLU . 4.4 mmtp -111.31 -156.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.342 -0.849 . . . . 0.0 109.74 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -111.96 150.71 30.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.335 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 58' ' ' ARG . 2.2 t -72.83 -19.97 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.376 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.38 -45.2 48.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.573 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -62.08 -38.03 87.29 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 26' ' ' ASN . 44.4 mt -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.226 -0.921 . . . . 0.0 108.912 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 1.7 mptp? -58.17 -48.88 78.92 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.547 0.689 . . . . 0.0 109.379 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 26.4 t -56.06 -35.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.723 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.547 ' HB1' ' CD1' ' A' ' 83' ' ' PHE . . . -63.3 -37.32 86.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 108.658 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.641 ' CG2' ' CE2' ' A' ' 42' ' ' PHE . 34.6 mt -81.41 -25.0 10.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 3.6 p -80.35 -26.95 38.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.066 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.92 -41.92 15.47 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.661 0.743 . . . . 0.0 109.31 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.574 ' CD1' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.0 -35.74 81.68 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.081 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.641 ' CE2' ' CG2' ' A' ' 38' ' ' ILE . 9.4 m-30 -85.34 -21.82 28.75 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.751 0.786 . . . . 0.0 108.943 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -75.57 -35.18 60.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.466 0.65 . . . . 0.0 109.509 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -84.11 -15.38 47.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 109.366 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.64 -10.94 44.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.859 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.3 t0 83.79 29.17 0.08 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.946 0.879 . . . . 0.0 108.832 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.567 HD21 ' CD1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -73.84 -130.84 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB3' ' CG ' ' A' ' 66' ' ' GLU . . . 173.27 57.45 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.447 -0.783 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 m -57.26 117.44 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.936 0.874 . . . . 0.0 110.836 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.543 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -93.42 -34.18 5.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.534 ' HB2' ' CG2' ' A' ' 15' ' ' THR . 0.7 OUTLIER -149.03 152.19 35.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.823 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.526 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -157.85 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.485 -0.76 . . . . 0.0 109.072 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' C ' ' CE ' ' A' ' 35' ' ' LYS . 7.1 mmm180 -106.96 168.23 9.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.772 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.47 ' CG2' HG11 ' A' ' 31' ' ' VAL . 4.4 p -80.17 170.94 15.74 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.438 -0.789 . . . . 0.0 110.279 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -128.88 114.1 1.7 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.469 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 1.4 m 67.66 -139.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 110.312 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.24 76.35 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.502 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.485 ' HA ' HG21 ' A' ' 31' ' ' VAL . 36.8 mtt180 57.8 42.12 23.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.486 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 21.2 mttt -119.46 -31.44 4.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 59' ' ' LYS . 2.8 m-85 -139.79 -169.26 2.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -166.8 140.59 6.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 2.3 m-30 -99.13 157.12 16.58 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.258 -1.143 . . . . 0.0 109.591 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.519 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.9 t -151.24 143.73 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.7 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.524 ' CB ' HG23 ' A' ' 15' ' ' THR . 0.8 OUTLIER -122.34 140.9 52.13 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.365 -0.835 . . . . 0.0 109.979 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CD1' HD21 ' A' ' 47' ' ' LEU . 14.2 m-85 -107.48 172.31 6.9 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.551 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -122.52 19.2 10.45 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.067 -1.021 . . . . 0.0 111.115 -178.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.2 p -165.06 176.22 8.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.588 1.185 . . . . 0.0 112.251 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.18 -25.81 42.73 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -32.06 63.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.036 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.527 ' CB ' ' HB3' ' A' ' 65' ' ' PHE . 90.4 m-20 -77.81 -29.57 50.76 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 1.9 tt -71.22 -39.73 71.54 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -62.16 -38.34 88.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' O ' HD11 ' A' ' 77' ' ' LEU . 23.9 mmtt -72.41 -24.62 61.26 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 89' ' ' LEU . . . -63.97 -34.92 79.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 tt -72.02 -44.64 63.09 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.4 9.72 14.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.094 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -75.89 -13.05 60.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.602 -0.686 . . . . 0.0 110.585 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.437 ' HA ' HD21 ' A' ' 89' ' ' LEU . 96.4 m -72.38 3.66 4.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.29 39.35 2.92 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.574 ' CD2' ' CD1' ' A' ' 41' ' ' LEU . 7.4 mt -100.14 -167.55 1.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -1.009 . . . . 0.0 111.017 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -167.61 51.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.069 0.937 . . . . 0.0 108.925 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.535 HG11 ' CB ' ' A' ' 85' ' ' ASN . 4.1 p -34.66 118.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.248 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.573 ' CE2' ' OE2' ' A' ' 33' ' ' GLU . 15.1 m-85 38.35 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 0.0 110.557 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 96.8 22.0 19.55 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.535 ' CB ' HG11 ' A' ' 82' ' ' VAL . 5.9 m-20 -134.01 84.34 2.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.093 -1.24 . . . . 0.0 109.853 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.527 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 23.4 tt0 -40.11 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.666 0.746 . . . . 0.0 110.44 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -59.55 123.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.607 -0.683 . . . . 0.0 110.499 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.5 mttp -95.25 127.88 41.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.003 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -109.34 169.67 8.55 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.399 -179.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.499 0.666 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.587 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.57 172.79 5.44 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.65 -0.656 . . . . 0.0 110.691 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.468 ' HD2' HG21 ' A' ' 16' ' ' THR . 49.5 Cg_endo -77.86 -47.0 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.136 1.598 . . . . 0.0 110.552 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.552 ' CE2' ' CA ' ' A' ' 67' ' ' SER . 55.6 m-85 -87.51 111.12 20.86 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 110.22 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.01 150.39 32.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.374 -0.828 . . . . 0.0 109.113 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.638 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 13.9 mt -146.42 170.2 17.32 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.361 -0.837 . . . . 0.0 111.22 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.656 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 5.8 t80 -126.06 140.76 52.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 8.6 mt -137.63 147.8 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 110.774 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.06 -167.66 11.59 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 21.4 t-20 70.92 36.87 1.38 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -1.093 . . . . 0.0 110.372 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 4.1 mm? -88.4 126.97 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.504 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 36.4 t-20 -40.9 107.76 0.5 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.661 -0.649 . . . . 0.0 110.378 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.41 -8.36 21.67 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.047 1.551 . . . . 0.0 110.289 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 28.1 m120 -96.71 -20.75 18.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.638 ' CD ' ' CE1' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -103.48 -158.9 0.69 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.449 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -103.8 148.27 26.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.286 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 2.1 t -69.71 -26.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.912 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -65.36 -41.16 94.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.416 -0.802 . . . . 0.0 109.031 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.572 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.6 mm-40 -64.27 -45.26 88.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.514 ' CD2' HG12 ' A' ' 82' ' ' VAL . 8.4 mt -60.09 -39.02 84.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.02 -57.17 14.25 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.539 0.685 . . . . 0.0 109.687 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.0 t -57.23 -31.52 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.852 . . . . 0.0 109.714 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.08 -39.06 92.66 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.183 -0.948 . . . . 0.0 108.822 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 19.3 mt -78.3 -24.72 13.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 109.362 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -80.83 -33.22 34.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.147 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.61 -37.04 43.27 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.581 0.705 . . . . 0.0 109.461 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.555 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.33 -31.94 69.46 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.102 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.648 ' CD2' ' CG1' ' A' ' 49' ' ' VAL . 3.3 m-85 -77.74 -26.28 49.82 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.89 -29.67 61.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.549 -0.719 . . . . 0.0 109.706 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.19 -22.42 17.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.703 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.8 m-80 -74.53 -42.15 59.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.703 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.6 t70 122.59 28.86 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.534 0 C-N-CA 123.682 0.793 . . . . 0.0 109.46 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.63 ' CD2' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -96.82 -153.87 0.43 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.463 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.72 61.45 0.2 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.648 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 6.0 m -55.23 115.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 122.08 0.943 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -91.28 -38.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.526 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -143.5 154.02 43.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.348 -0.845 . . . . 0.0 110.425 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -157.93 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.395 -0.816 . . . . 0.0 109.172 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.407 ' C ' ' HE2' ' A' ' 35' ' ' LYS . 6.1 mtp180 -121.3 165.66 15.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.006 -1.059 . . . . 0.0 111.055 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.533 ' CG2' ' HB ' ' A' ' 31' ' ' VAL . 13.0 p -88.37 156.74 18.99 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -124.9 118.1 3.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.579 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 3.5 m 66.77 -175.74 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -1.063 . . . . 0.0 110.757 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 58' ' ' ARG . 16.9 m120 -63.95 65.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.392 -0.817 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 2.1 mtt180 61.74 59.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 110.694 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -120.41 -34.8 3.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CZ ' ' OG1' ' A' ' 56' ' ' THR . 1.2 p90 -165.44 140.37 4.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.266 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -112.33 163.75 12.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.716 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 39.1 m-85 -114.26 163.42 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -1.003 . . . . 0.0 109.635 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.519 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 2.9 t -152.0 139.46 13.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.043 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 18' ' ' PHE . 3.6 m-20 -106.81 140.44 39.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.023 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 20' ' ' LEU . 13.1 m-85 -107.48 170.43 7.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 0.0 110.631 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -116.22 16.08 15.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 111.328 -178.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.552 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 3.1 t -163.44 175.32 10.9 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.748 1.261 . . . . 0.0 112.272 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.74 -24.67 22.62 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.35 -22.16 22.75 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.487 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 10.7 t0 -81.4 -34.02 31.87 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 18' ' ' PHE . 7.6 tt -76.28 -34.6 59.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -37.35 84.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.421 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.539 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 1.8 mtmt -72.3 -27.69 62.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.627 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -62.53 -34.07 76.18 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 5.5 tt -71.05 -44.49 65.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.29 1.18 22.57 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.488 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.59 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.75 12.64 2.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.855 . . . . 0.0 110.414 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -78.28 2.67 17.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.08 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.06 33.63 5.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.555 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 22.3 mt -98.44 -166.25 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.253 -1.145 . . . . 0.0 110.982 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.546 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.9 mttt -166.78 49.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.304 1.049 . . . . 0.0 109.416 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -38.25 126.94 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.288 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.638 ' CE1' ' CD ' ' A' ' 29' ' ' LYS . 9.0 m-85 42.46 26.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 110.414 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 90.55 21.67 36.63 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' VAL . 36.3 m-80 -136.19 99.51 4.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -1.136 . . . . 0.0 109.393 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.546 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -48.79 90.84 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 110.61 -179.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.533 HG22 ' CG1' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -48.83 135.24 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.85 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.2 ttpt -104.23 152.65 21.93 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -124.79 172.8 9.04 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.539 -0.726 . . . . 0.0 110.482 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 16' ' ' THR . 3.4 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.232 0.539 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.544 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 1.9 p -162.98 169.03 9.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 48.4 Cg_endo -76.58 -25.77 9.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.095 1.576 . . . . 0.0 110.734 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.541 ' CE2' ' C ' ' A' ' 67' ' ' SER . 87.6 m-85 -121.33 113.11 19.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.95 -1.094 . . . . 0.0 111.126 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -139.68 150.48 44.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 109.092 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.574 ' O ' ' CZ ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -161.99 178.61 8.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.443 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -97.93 162.87 13.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.671 . . . . 0.0 109.374 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 6.0 mt -153.82 152.08 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.922 -1.111 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -143.5 -166.29 11.17 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.112 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 6.7 t30 72.71 46.1 0.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.553 -0.969 . . . . 0.0 109.883 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.9 mm? -100.56 128.71 46.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 56.9 t-20 -44.89 103.48 0.34 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.255 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.4 Cg_endo -73.63 -20.9 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.977 1.514 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -14.7 60.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.861 . . . . 0.0 109.965 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.578 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 3.0 mmtt -110.91 -155.75 0.57 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -106.63 149.57 27.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 3.1 t -67.97 -40.93 84.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -52.72 -42.4 64.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.1 mm-40 -66.29 -35.39 80.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 109.308 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 55.6 mt -65.96 -36.31 82.98 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.367 -0.833 . . . . 0.0 109.081 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -60.89 -47.49 86.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.356 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 50.2 t -58.82 -41.51 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.611 -0.68 . . . . 0.0 110.072 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.49 -30.47 70.63 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.99 -1.069 . . . . 0.0 109.155 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.482 HD12 ' CD1' ' A' ' 87' ' ' ILE . 23.0 mm -86.34 -28.48 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.111 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.7 t -78.87 -26.27 43.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.334 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.09 -38.91 20.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.473 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 2.7 tp -63.98 -36.5 84.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.469 ' CD2' HG13 ' A' ' 49' ' ' VAL . 12.1 m-85 -83.25 -21.85 33.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 40' ' ' GLU . . . -81.33 -20.36 40.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -104.18 -16.43 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.553 -0.717 . . . . 0.0 109.625 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.72 -29.63 23.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 34.6 t70 111.99 28.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.531 ' CD1' HD22 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -101.08 -155.2 0.5 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -169.1 64.21 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.248 -0.908 . . . . 0.0 109.783 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.469 HG13 ' CD2' ' A' ' 42' ' ' PHE . 7.9 m -49.37 115.07 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.895 0.855 . . . . 0.0 110.096 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 10.6 t -82.83 -31.66 9.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.832 -0.543 . . . . 0.0 110.567 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.508 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 20.9 t0 -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.534 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 3.5 t -154.2 94.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.747 . . . . 0.0 109.276 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.526 ' CG ' ' HB3' ' A' ' 62' ' ' TYR . 10.7 ptp180 -108.95 170.21 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.762 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.582 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 4.9 p -80.63 164.43 22.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.392 -0.818 . . . . 0.0 110.363 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -134.58 124.0 3.35 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 25.3 m 44.12 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.495 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' THR . 10.9 m120 60.75 -141.05 0.54 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.375 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -116.0 32.46 6.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 -20.67 11.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 1.3 t80 -119.19 -171.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 110.24 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 175.88 154.93 12.04 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -118.78 159.76 23.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -1.036 . . . . 0.0 109.31 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.605 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.2 t -150.54 143.07 17.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.862 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -116.42 148.87 40.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.661 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 14.0 m-85 -110.72 177.9 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.35 13.54 16.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 111.516 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.4 p 179.17 175.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.958 -1.089 . . . . 0.0 112.135 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -78.54 -24.04 45.89 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 -26.49 32.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.999 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.0 t0 -80.7 -25.86 37.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD12 ' CD1' ' A' ' 18' ' ' PHE . 4.4 tt -80.19 -33.83 37.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.29 -33.74 70.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.6 -0.688 . . . . 0.0 109.518 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.47 ' O ' HD23 ' A' ' 77' ' ' LEU . 1.6 mmtt -77.22 -27.92 53.59 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.53 -24.54 61.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.429 ' C ' HD21 ' A' ' 75' ' ' LEU . 7.1 tt -74.11 -48.39 29.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -10.85 60.4 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.531 HD22 ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -67.22 -2.47 5.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.58 -0.7 . . . . 0.0 110.489 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.46 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 12.0 m -45.16 -24.8 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.034 . . . . 0.0 110.349 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' LEU . . . -63.32 -16.92 58.8 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.547 ' CD1' ' HA ' ' A' ' 86' ' ' GLU . 3.4 pp -45.07 175.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.622 -0.928 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 2.7 mttt -177.16 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.332 1.063 . . . . 0.0 109.362 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 82' ' ' VAL . 1.7 p -37.98 123.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.621 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.578 ' CE2' ' HG3' ' A' ' 29' ' ' LYS . 4.4 m-85 42.42 26.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.483 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 90.11 23.84 31.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 87' ' ' ILE . 3.9 m120 -135.41 84.43 2.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -1.194 . . . . 0.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -37.77 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.543 0.687 . . . . 0.0 110.744 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.533 HG13 ' CD2' ' A' ' 80' ' ' LEU . 4.9 pt -49.73 141.25 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.3 mmtm -107.57 155.9 19.6 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.082 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.25 172.76 7.56 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 110.573 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.509 ' CG2' HG23 ' A' ' 16' ' ' THR . 3.2 t . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.545 0.688 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.581 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 81.8 p -124.46 153.21 69.29 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.581 -0.7 . . . . 0.0 110.716 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.53 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.3 Cg_endo -80.06 -22.37 7.35 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.155 1.608 . . . . 0.0 110.538 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.7 m-85 -107.02 113.06 26.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 110.876 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.4 m120 -139.06 150.76 46.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.528 -0.733 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.577 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 4.4 pp -167.53 -179.63 4.47 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.481 ' HB3' ' CB ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -109.24 154.95 21.7 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.938 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.583 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 3.7 mt -141.89 148.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.58 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -134.1 -169.29 12.0 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.7 t30 72.8 30.31 1.77 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.961 . . . . 0.0 110.021 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.8 mm? -82.26 128.65 34.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 25' ' ' LEU . 30.3 t-20 -40.07 100.27 0.21 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.65 -0.656 . . . . 0.0 110.371 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.6 Cg_endo -74.18 -16.72 22.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.455 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -83.87 -13.43 53.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.74 -156.86 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.8 m -104.15 152.06 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.54 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.578 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 3.0 t -68.71 -28.38 39.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.454 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.25 -43.4 98.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 72.9 mm-40 -69.42 -31.1 69.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.737 . . . . 0.0 109.266 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 6.5 mt -68.01 -33.88 75.45 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.357 -0.839 . . . . 0.0 109.124 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' CE ' HG12 ' A' ' 31' ' ' VAL . 3.5 mtmt -66.08 -52.13 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.567 -0.708 . . . . 0.0 109.436 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.2 t -56.86 -39.71 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 110.059 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.565 ' HB3' ' CD1' ' A' ' 83' ' ' PHE . . . -61.91 -34.65 76.44 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 109.047 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.5 mt -82.3 -28.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.255 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -79.01 -27.36 43.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -83.81 -38.22 21.53 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 109.206 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -65.63 -34.51 78.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.548 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 8.0 m-85 -85.11 -20.41 30.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . -78.89 -33.19 45.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.457 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -23.28 25.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.8 OUTLIER -83.73 -20.53 33.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 11.4 m-20 89.44 28.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.256 1.027 . . . . 0.0 108.326 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -75.91 -143.71 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . . . -164.56 60.15 0.14 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.023 -1.048 . . . . 0.0 110.262 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.499 HG13 ' CB ' ' A' ' 42' ' ' PHE . 16.9 m -66.58 116.59 6.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.767 0.794 . . . . 0.0 109.859 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 1.4 t -99.26 -38.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.833 -0.542 . . . . 0.0 109.96 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.488 ' O ' HG11 ' A' ' 63' ' ' VAL . 15.2 t0 -143.51 154.53 43.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 110.447 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.523 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 20.5 t -154.74 105.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.747 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.03 167.98 9.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.578 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 16.3 p -81.11 160.0 24.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.367 -0.833 . . . . 0.0 110.233 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -130.91 120.13 2.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 70.46 -166.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.26 -1.141 . . . . 0.0 110.108 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.564 ' N ' ' CG2' ' A' ' 56' ' ' THR . 31.0 t-20 -42.99 -76.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.459 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.52 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 10.7 ttp180 -162.41 28.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.217 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.486 ' CE ' ' HA ' ' A' ' 24' ' ' ASN . 19.3 tptm -117.03 -6.27 11.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 109.858 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -121.84 -173.0 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.928 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.525 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 174.76 146.52 5.75 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.661 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.545 -0.974 . . . . 0.0 109.478 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.619 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 4.9 t -152.01 142.78 15.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.171 -0.955 . . . . 0.0 110.831 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -112.24 143.76 42.78 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.308 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 12.6 m-85 -107.53 177.09 4.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.529 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -117.28 12.36 14.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 111.427 -178.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.2 p -173.0 173.99 3.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.048 -1.032 . . . . 0.0 112.107 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.31 -23.86 43.23 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -25.05 31.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.576 ' OD1' ' CD1' ' A' ' 65' ' ' PHE . 3.9 t0 -81.99 -27.35 33.21 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.13 -33.74 33.0 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -72.88 -32.56 65.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.717 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -78.16 -29.89 48.88 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.74 -31.79 72.97 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.11 -45.75 59.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.87 -19.4 58.89 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.085 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -71.58 -4.0 24.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.582 -0.699 . . . . 0.0 109.977 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.471 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 87.4 m -74.4 3.98 6.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.337 -0.852 . . . . 0.0 111.039 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.84 -8.75 75.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 80' ' ' LEU . 3.5 mm? -79.36 -164.21 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.361 -1.082 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -149.26 50.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 81' ' ' LYS . 8.9 p 13.92 -132.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.06 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -69.28 -3.36 13.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.448 -1.408 . . . . 0.0 109.919 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 152.05 36.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' ILE . 11.7 t-20 -170.45 116.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -1.037 . . . . 0.0 109.346 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.567 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -52.03 89.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 0.0 110.385 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.541 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.4 135.08 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.629 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 26.5 mttt -103.88 170.95 7.62 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD2' HD21 ' A' ' 20' ' ' LEU . 4.9 mp -122.91 -175.28 3.13 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 110.492 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.481 ' CB ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.696 -0.627 . . . . 0.0 110.242 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 16' ' ' THR . 3.4 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.216 0.531 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.581 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER 179.15 162.37 0.73 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.563 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.43 -36.63 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.27 1.669 . . . . 0.0 110.832 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 95.6 m-85 -106.49 112.77 25.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.987 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 1.9 m120 -136.04 144.87 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.278 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.56 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 2.9 pp -155.52 -176.08 5.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 52.9 t80 -110.64 159.35 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.484 HG21 ' N ' ' A' ' 23' ' ' GLY . 24.9 mt -137.6 159.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.793 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.484 ' N ' HG21 ' A' ' 22' ' ' ILE . . . -147.44 176.77 26.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 88' ' ' LYS . 2.8 t30 62.62 57.73 1.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -1.137 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.516 ' HB3' ' CD1' ' A' ' 34' ' ' LEU . 4.2 mm? -90.32 -90.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.51 ' N ' HD11 ' A' ' 34' ' ' LEU . 37.2 t-20 -179.15 92.01 0.21 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.27 -13.86 28.27 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.966 1.508 . . . . 0.0 110.441 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -82.49 -14.36 55.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.973 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -116.57 -156.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.844 . . . . 0.0 109.882 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.43 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -99.57 147.98 24.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.569 ' CG2' ' CB ' ' A' ' 58' ' ' ARG . 21.9 t -68.92 -27.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.8 89.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.067 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 43.0 mm-40 -67.59 -33.0 74.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.499 -0.75 . . . . 0.0 109.325 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 20.2 mt -66.01 -37.85 86.97 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.417 -0.802 . . . . 0.0 109.017 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.463 ' HE3' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -60.83 -50.16 74.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.5 t -60.83 -35.12 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.526 -0.734 . . . . 0.0 109.247 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -59.68 -31.98 70.07 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.581 HG23 ' CE2' ' A' ' 42' ' ' PHE . 29.1 mm -80.71 -31.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.616 -0.677 . . . . 0.0 109.367 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -78.55 -23.59 46.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 108.914 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 6.3 tp -66.7 -32.98 74.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.603 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 10.4 m-85 -87.72 -20.75 25.8 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -80.98 -29.16 35.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.211 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HG3' ' OE1' ' A' ' 40' ' ' GLU . 17.2 mttt -87.34 -17.72 31.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 109.387 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.627 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.2 m-80 -92.27 -20.34 21.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.925 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.2 t0 90.21 29.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -74.8 -137.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HB1' ' OD2' ' A' ' 70' ' ' ASP . . . -173.63 58.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.188 -0.945 . . . . 0.0 109.604 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.553 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 12.8 m -58.42 117.51 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.942 0.877 . . . . 0.0 110.141 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.581 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 1.9 t -96.64 -33.54 4.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.909 -0.494 . . . . 0.0 109.866 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.524 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 6.9 t70 -144.27 149.34 36.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.067 -1.02 . . . . 0.0 110.884 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.516 ' CG1' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -138.16 150.66 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 0.0 109.776 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.456 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -154.96 164.26 39.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.938 . . . . 0.0 110.405 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.518 ' CG2' HG12 ' A' ' 31' ' ' VAL . 63.0 p -94.86 167.13 11.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.822 . . . . 0.0 110.571 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -126.5 117.33 2.77 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.449 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 1.1 m 55.43 -161.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -1.125 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 56' ' ' THR . 35.9 m120 -42.43 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.569 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 2.3 ptp180 -162.93 49.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.327 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -124.5 -23.13 4.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.398 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -128.14 -179.8 5.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -163.87 164.59 36.52 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 2.6 t80 -120.74 166.27 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.977 . . . . 0.0 109.291 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.516 HG21 ' CG1' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -165.48 168.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.818 -1.176 . . . . 0.0 111.543 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 76.5 m-20 -137.13 142.4 42.26 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 28.2 m-85 -104.6 -178.43 3.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.732 -0.605 . . . . 0.0 110.721 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.542 ' CG ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.69 17.99 13.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 0.0 111.05 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 18.9 p 177.95 176.63 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.463 1.125 . . . . 0.0 112.135 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.99 -24.26 55.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -28.6 49.68 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.363 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.537 ' HB3' ' CD1' ' A' ' 65' ' ' PHE . 88.3 m-20 -79.22 -28.02 42.51 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.54 -36.88 57.43 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.064 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.65 -32.78 72.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.419 -0.801 . . . . 0.0 109.576 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.528 ' CB ' HD22 ' A' ' 47' ' ' LEU . 5.3 mmtp -76.8 -29.4 55.98 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -64.83 -29.94 70.92 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.1 -44.03 60.96 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.14 -7.2 47.75 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.573 ' HG ' ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -73.07 4.93 3.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 110.63 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.431 ' O ' ' CD ' ' A' ' 86' ' ' GLU . 89.5 m -78.13 6.95 6.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 110.541 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.437 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . -118.32 19.55 10.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.503 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 2.8 mt -124.61 122.57 37.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.141 -1.211 . . . . 0.0 111.395 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 2.7 mttm -92.69 89.24 6.58 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.372 1.082 . . . . 0.0 108.517 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG2' HG23 ' A' ' 87' ' ' ILE . 3.0 m -36.93 -104.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.567 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -82.43 20.08 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.063 -1.023 . . . . 0.0 110.647 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' C ' ' ND2' ' A' ' 85' ' ' ASN . . . 122.71 10.33 5.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.5 m-80 -145.25 117.45 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.236 -1.155 . . . . 0.0 109.726 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 7.4 tp10 -56.68 83.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.419 -0.8 . . . . 0.0 109.982 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 85' ' ' ASN . 1.7 pt -43.57 126.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -102.22 131.86 48.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.746 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -108.44 173.07 6.48 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.926 -1.108 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 89' ' ' LEU . 3.8 mt-10 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.138 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 16' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 121.326 0.584 . . . . 0.0 109.917 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.592 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 45.9 p -130.24 153.4 81.2 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 110.309 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.56 -22.08 6.91 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.127 1.593 . . . . 0.0 110.742 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 75.3 m-85 -113.57 108.78 17.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.975 -1.078 . . . . 0.0 111.027 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.1 m120 -137.91 149.0 45.83 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 109.041 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -164.27 171.61 14.66 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 110.261 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.521 ' HB3' ' CG ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -89.99 160.14 16.53 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.47 -0.769 . . . . 0.0 109.207 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 mp -147.61 161.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.975 -1.078 . . . . 0.0 109.673 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.564 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -160.28 -160.07 10.32 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.084 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.3 t30 67.16 55.09 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -1.05 . . . . 0.0 110.141 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 3.7 mt -104.12 -133.67 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.321 -0.862 . . . . 0.0 110.066 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.438 ' N ' HD22 ' A' ' 34' ' ' LEU . 36.4 t-20 -143.0 109.78 5.49 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.111 -0.993 . . . . 0.0 110.235 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.59 2.66 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.993 1.522 . . . . 0.0 110.698 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 34.7 m-80 -113.59 18.3 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.968 . . . . 0.0 109.169 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.0 tptt -138.64 -158.34 0.85 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.717 -0.614 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -107.29 142.59 36.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.6 t -69.29 -32.07 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.386 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 36' ' ' VAL . . . -62.83 -27.81 69.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.003 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 11.3 mm-40 -77.59 -42.3 35.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 25' ' ' LEU . 3.8 mt -61.89 -37.93 86.43 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.259 -0.901 . . . . 0.0 109.092 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.529 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -63.17 -52.07 63.85 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.618 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 48.7 t -63.41 -28.14 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.252 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.43 -34.14 77.5 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 108.587 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 6.5 mt -83.89 -25.48 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 13.1 m -80.3 -28.86 38.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -82.43 -37.34 25.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.533 -0.73 . . . . 0.0 109.238 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.23 -30.44 67.51 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.555 -0.716 . . . . 0.0 109.18 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.574 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 3.2 m-85 -91.99 -14.63 29.13 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -0.82 . . . . 0.0 109.363 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -92.19 -28.57 16.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.697 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.51 -21.23 21.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.41 -0.806 . . . . 0.0 109.089 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -79.25 -60.01 2.54 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.388 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 147.37 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.186 0.517 . . . . 0.0 109.802 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.533 ' HG ' ' CD1' ' A' ' 77' ' ' LEU . 3.8 mm? -98.35 -157.72 0.62 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -156.93 63.82 0.51 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' HG21 ' A' ' 49' ' ' VAL . 12.7 m -58.28 117.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.929 0.871 . . . . 0.0 109.789 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.592 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 2.1 t -90.31 -44.26 14.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 O-C-N 121.735 -0.603 . . . . 0.0 110.188 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.501 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 34.3 t0 -141.04 152.74 45.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.07 -1.019 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.529 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 2.8 t -152.36 105.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 167.45 10.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.532 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 47.3 p -85.16 163.65 18.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.4 -0.812 . . . . 0.0 110.416 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.488 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -137.76 137.32 8.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 28.8 m 60.36 176.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -1.115 . . . . 0.0 109.961 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' THR . 20.0 m120 -40.98 -59.68 1.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.581 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -168.08 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.965 . . . . 0.0 110.193 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -127.14 -11.04 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.448 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' HA3' ' A' ' 23' ' ' GLY . 1.3 t80 -122.18 179.41 4.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.26 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.64 163.79 31.33 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.5 t80 -126.25 157.24 38.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.467 -1.019 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.604 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 4.2 t -151.72 145.2 16.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.813 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -116.35 144.01 44.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.405 -0.81 . . . . 0.0 109.705 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 19.6 m-85 -107.05 176.71 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.571 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.524 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -112.28 13.62 20.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 111.609 -178.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 25.0 p 177.66 178.16 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.401 1.096 . . . . 0.0 112.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.68 -22.65 53.69 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.59 -25.84 38.23 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.493 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 85.4 m-20 -83.3 -27.81 29.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 3.0 tm? -78.7 -34.06 46.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.772 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.03 -38.51 61.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 14.7 mtmt -79.55 -18.21 52.3 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -79.26 -28.1 42.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.379 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 78' ' ' THR . 5.6 tt -79.12 -44.32 22.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.435 -0.791 . . . . 0.0 109.105 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.463 ' N ' HD22 ' A' ' 75' ' ' LEU . 2.0 mt-10 -71.34 -24.26 62.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.308 -0.87 . . . . 0.0 109.29 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.574 HD12 ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -64.45 -15.05 60.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.0 109.972 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -37.93 -28.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.878 0.847 . . . . 0.0 110.891 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -51.73 -26.17 16.62 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.53 HD23 ' CG1' ' A' ' 87' ' ' ILE . 1.6 pt? -65.52 131.91 47.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -1.18 . . . . 0.0 110.896 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 3.5 mttm -109.9 80.76 1.35 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.08 0.943 . . . . 0.0 109.964 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -39.71 122.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.421 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.577 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.9 m-85 43.33 24.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 93.38 19.16 36.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.3 m-80 -133.31 91.7 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 110.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 9.2 tt0 -41.1 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 110.733 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 85' ' ' ASN . 0.7 OUTLIER -47.64 141.33 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.771 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -116.32 157.89 24.28 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.518 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -125.86 174.68 8.2 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.163 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.521 ' CG ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 110.166 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 16' ' ' THR . 5.3 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.561 0.696 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.525 HG21 ' CG1' ' A' ' 50' ' ' VAL . 32.0 p -119.64 163.29 28.19 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.579 -0.7 . . . . 0.0 110.417 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.67 -27.65 10.49 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.015 1.534 . . . . 0.0 110.661 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 68' ' ' ALA . 97.7 m-85 -102.63 112.52 25.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.374 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -143.05 151.97 41.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.748 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.569 ' O ' ' CZ ' ' A' ' 62' ' ' TYR . 3.0 pp -161.3 -176.41 5.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.408 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.557 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 16.3 t80 -108.75 161.5 15.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 mt -140.19 159.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -143.5 170.82 25.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 28.2 t30 67.81 71.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -1.118 . . . . 0.0 109.944 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -106.15 19.68 20.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' PHE . 2.8 t30 55.94 99.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.39 -19.57 21.92 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.02 1.537 . . . . 0.0 110.289 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.2 -19.83 56.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HG3' ' HB3' ' A' ' 83' ' ' PHE . 5.6 tmtt? -98.54 -154.29 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.855 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -113.56 139.56 48.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 110.384 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.583 ' CG2' ' CB ' ' A' ' 58' ' ' ARG . 2.6 t -67.98 -29.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.003 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.35 87.21 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 69.3 mm-40 -70.68 -27.53 64.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.516 ' CG ' HD11 ' A' ' 25' ' ' LEU . 3.2 mm? -64.43 -42.58 95.94 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.404 -0.81 . . . . 0.0 109.106 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.89 -54.65 27.55 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.981 -0.687 . . . . 0.0 109.8 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.9 t -62.66 -30.21 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.97 -40.01 90.9 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.758 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 34' ' ' LEU . 10.8 mm -78.58 -24.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.109 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 p -79.78 -32.94 40.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.26 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -80.34 -37.9 31.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.35 -30.91 69.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 0.0 109.167 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.569 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 5.5 m-85 -89.03 -16.0 32.7 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.499 -0.751 . . . . 0.0 109.328 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.8 -27.37 18.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.67 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -92.02 -21.1 20.69 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.694 0.759 . . . . 0.0 109.305 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -81.25 -59.16 2.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.2 m-20 144.61 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.204 0.601 . . . . 0.0 109.64 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 70' ' ' ASP . 2.7 mm? -99.26 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.205 -0.935 . . . . 0.0 109.842 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.82 61.87 0.47 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.527 HG13 ' CD2' ' A' ' 42' ' ' PHE . 11.7 m -58.28 116.14 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.814 0.816 . . . . 0.0 109.843 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 16' ' ' THR . 1.0 OUTLIER -88.95 -45.55 15.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 121.209 0.528 . . . . 0.0 109.779 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.458 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 12.6 t0 -143.37 159.22 42.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.637 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.525 HG13 ' CG ' ' A' ' 35' ' ' LYS . 6.2 p -158.81 100.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 110.068 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -96.58 164.72 12.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.523 ' CG2' HG11 ' A' ' 31' ' ' VAL . 1.3 p -87.32 159.15 18.87 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.167 -0.958 . . . . 0.0 110.14 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.506 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -121.04 120.37 4.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.576 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 10.0 m 50.42 102.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -1.124 . . . . 0.0 110.544 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' THR . 90.5 m-20 41.26 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.441 -0.787 . . . . 0.0 110.675 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.583 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -149.0 52.45 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 0.0 110.454 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 4.2 tmtt? -123.74 -24.31 4.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.926 . . . . 0.0 110.34 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 59' ' ' LYS . 1.6 m-85 -138.15 -158.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.371 -0.831 . . . . 0.0 109.37 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.506 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 168.83 165.77 26.77 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.267 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.569 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 10.2 t80 -122.84 158.53 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.564 -0.962 . . . . 0.0 109.38 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 22' ' ' ILE . 3.7 t -149.72 144.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.112 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 2.9 m-20 -114.31 139.18 49.65 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 17.8 m-85 -104.15 173.81 6.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.442 -0.786 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.469 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.16 13.48 15.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 111.577 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.535 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.7 p -171.82 173.87 4.39 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.207 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.576 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.51 -24.32 42.32 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.98 -25.2 32.5 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.989 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.566 ' OD1' ' CD1' ' A' ' 65' ' ' PHE . 4.8 t0 -83.12 -25.55 31.83 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 2.7 tm? -82.73 -31.24 28.56 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.69 -34.68 62.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.581 -0.699 . . . . 0.0 109.529 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.536 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 1.5 tppt? -78.56 -28.4 45.94 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -70.06 -25.99 63.8 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.452 ' O ' ' OG1' ' A' ' 78' ' ' THR . 0.5 OUTLIER -72.96 -48.65 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -5.77 45.12 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.176 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.569 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -75.85 6.31 5.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.491 -0.755 . . . . 0.0 110.446 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -65.27 -8.42 17.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.074 -1.016 . . . . 0.0 110.312 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.24 29.55 8.1 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD2' HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.31 117.1 30.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -1.057 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -112.47 93.39 4.42 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.944 1.354 . . . . 0.0 109.381 178.597 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 81' ' ' LYS . 23.5 t -46.66 -113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.269 -2.93 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.29 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 21.9 m-85 -80.31 47.57 0.93 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 120.705 -1.247 . . . . 0.0 109.673 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 81' ' ' LYS . . . 81.29 26.34 52.22 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 85' ' ' ASN . 7.9 p-10 -137.63 74.94 1.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -1.102 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.5 tm-20 -43.05 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -54.13 127.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.512 0.673 . . . . 0.0 110.402 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 23' ' ' GLY . 4.4 mttt -102.54 129.84 49.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.802 . . . . 0.0 109.577 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -111.18 172.99 6.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.964 -1.085 . . . . 0.0 110.685 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.751 . . . . 0.0 109.995 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.532 0.682 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.527 HG22 ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -135.34 164.95 40.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.1 Cg_endo -77.24 -38.49 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.167 1.614 . . . . 0.0 110.53 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.577 ' CE2' ' CA ' ' A' ' 67' ' ' SER . 97.3 m-85 -94.24 107.14 19.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.572 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' PHE . 6.8 m120 -136.41 154.3 50.83 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.356 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.646 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -170.51 -176.71 2.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 110.809 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.533 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 4.5 t80 -105.04 146.74 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.507 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.532 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 1.5 mt -141.09 149.76 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -149.36 -156.22 7.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.868 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.1 t30 67.52 41.59 2.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -1.022 . . . . 0.0 110.027 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.528 HD13 ' CD1' ' A' ' 34' ' ' LEU . 3.6 mm? -84.73 -167.82 1.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -119.98 107.3 40.09 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 58' ' ' ARG . 44.9 Cg_endo -73.25 -5.0 16.41 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.082 1.569 . . . . 0.0 110.324 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -79.78 -18.69 50.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.735 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 -155.51 0.58 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.554 -0.716 . . . . 0.0 109.709 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.47 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -99.21 141.28 32.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -0.999 . . . . 0.0 110.51 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 54' ' ' THR . 3.3 t -65.48 -29.86 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.178 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.67 89.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.849 . . . . 0.0 109.047 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 63.6 mm-40 -67.12 -30.73 70.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.528 ' CD1' HD13 ' A' ' 25' ' ' LEU . 3.9 mm? -66.53 -40.61 89.2 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.382 -0.824 . . . . 0.0 108.917 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -58.4 -53.3 59.83 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.362 -0.836 . . . . 0.0 108.911 178.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -65.27 -30.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.45 -29.63 70.88 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.534 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 34' ' ' LEU . 12.9 mm -84.04 -28.55 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.198 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.519 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 31.0 t -80.05 -27.83 39.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 108.893 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.526 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 2.8 tm-20 -81.88 -36.32 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.377 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.57 ' CD2' ' CD1' ' A' ' 80' ' ' LEU . 5.0 tp -70.96 -31.08 67.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.595 ' CE1' ' CD1' ' A' ' 77' ' ' LEU . 3.5 m-30 -90.98 -14.88 30.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.481 -0.762 . . . . 0.0 109.393 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -90.02 -27.27 19.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.405 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.43 -22.22 20.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.811 . . . . 0.0 109.225 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.4 m-80 -79.59 -58.99 2.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.684 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.2 m-20 148.03 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.143 0.497 . . . . 0.0 110.153 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.574 HD23 ' CD2' ' A' ' 42' ' ' PHE . 6.3 mp -103.4 -158.17 0.65 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.69 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.87 64.28 0.46 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 9.5 m -53.08 118.01 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.995 0.903 . . . . 0.0 109.761 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.527 ' CG1' HG22 ' A' ' 16' ' ' THR . 1.8 t -89.54 -39.12 12.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.064 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -150.22 158.12 43.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.698 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 35' ' ' LYS . 9.8 p -144.07 159.97 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.43 -0.794 . . . . 0.0 109.594 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -155.55 164.08 39.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 110.104 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.536 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -116.83 154.89 29.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 110.513 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -123.71 127.84 6.69 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.578 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 1.9 m 71.31 -171.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.384 -1.068 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 58' ' ' ARG . 3.7 p30 -48.67 -53.0 20.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.556 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.527 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -179.41 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.115 -0.991 . . . . 0.0 110.565 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -126.73 -22.87 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.561 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CD2' ' OG1' ' A' ' 56' ' ' THR . 1.6 m-85 -122.57 -177.18 3.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.937 . . . . 0.0 109.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 53' ' ' ARG . . . 176.54 135.43 2.16 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.235 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -98.09 169.53 9.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.989 . . . . 0.0 109.423 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 22' ' ' ILE . 17.6 t -158.82 162.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.139 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -130.99 140.6 50.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.697 -0.627 . . . . 0.0 109.479 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 16.8 m-85 -110.87 174.64 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.845 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.497 ' HG2' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.84 11.53 19.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.498 -0.751 . . . . 0.0 111.309 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.577 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 6.6 p -173.08 173.51 3.65 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.26 1.029 . . . . 0.0 112.185 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' N ' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.64 -23.56 45.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -84.44 -23.69 29.86 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.277 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.476 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 4.4 t0 -83.69 -26.94 29.39 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 18' ' ' PHE . 9.8 tt -81.4 -33.98 31.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.266 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -74.96 -32.96 61.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.456 -0.777 . . . . 0.0 109.621 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -81.47 -23.19 37.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.99 -29.94 63.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 3.1 tm? -75.96 -45.53 34.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -66.94 -23.39 65.96 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.435 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.595 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -67.57 -8.05 31.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.55 0.691 . . . . 0.0 110.391 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 78' ' ' THR . 22.2 m -67.4 0.37 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.646 -0.659 . . . . 0.0 111.556 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.1 16.93 54.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.57 ' CD1' ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -103.09 -159.12 0.71 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.988 . . . . 0.0 110.541 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.571 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -164.76 49.67 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.344 1.068 . . . . 0.0 108.914 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 81' ' ' LYS . 17.0 t 0.35 -115.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.769 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 4.0 m-30 -76.81 9.32 2.93 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 128.51 35.34 0.5 Allowed Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 87' ' ' ILE . 12.2 m120 -161.73 100.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 109.565 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.571 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -49.55 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.308 -0.87 . . . . 0.0 110.406 -179.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.528 ' CG2' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -42.71 143.13 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 5.5 mtpp -119.26 159.68 23.63 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.596 -0.69 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.516 ' CD2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -112.82 -179.2 3.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 110.226 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 21' ' ' PHE . 1.3 tt0 . . . . . 0 C--N 1.299 -1.63 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.744 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.513 ' CG2' HG23 ' A' ' 16' ' ' THR . 5.7 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.535 0.683 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.556 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 39.1 p -105.6 161.85 21.53 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.565 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.4 Cg_endo -74.85 -25.45 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.083 1.57 . . . . 0.0 110.762 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 68' ' ' ALA . 97.6 m-85 -102.2 110.16 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.973 -1.079 . . . . 0.0 110.567 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.47 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 2.0 m120 -140.88 149.75 42.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 20' ' ' LEU . 4.5 pp -163.72 -175.97 4.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 8.2 t80 -118.4 144.53 45.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 mt -127.46 157.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.196 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.96 -169.68 11.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 42.1 t30 72.67 71.8 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.562 -0.963 . . . . 0.0 110.132 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.9 mm? -110.59 157.78 19.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 110.268 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.519 ' ND2' ' OD1' ' A' ' 28' ' ' ASN . 39.4 t-20 -87.88 109.69 29.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.07 -28.33 12.98 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.967 1.509 . . . . 0.0 110.687 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' OD1' ' ND2' ' A' ' 26' ' ' ASN . 32.7 p30 -75.0 -13.68 60.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -110.49 -154.94 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.514 -0.741 . . . . 0.0 109.681 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.443 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 1.4 m -109.98 145.64 36.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.496 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.519 HG12 ' CG2' ' A' ' 54' ' ' THR . 2.9 t -69.97 -30.95 46.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.2 -0.937 . . . . 0.0 109.389 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.19 83.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.856 . . . . 0.0 109.26 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 63.2 mm-40 -68.71 -34.28 75.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.41 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.03 -35.57 81.59 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.403 -0.811 . . . . 0.0 109.104 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.509 ' CE ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -64.38 -48.2 76.35 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.472 -0.767 . . . . 0.0 109.25 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 9.9 t -61.26 -34.61 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.89 -34.05 76.6 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.214 -0.929 . . . . 0.0 108.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.57 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 22.4 mm -81.86 -28.04 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.5 t -79.02 -27.68 43.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.049 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.16 -39.15 23.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.601 0.715 . . . . 0.0 109.125 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.525 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -66.08 -32.73 74.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.633 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 9.3 m-85 -86.31 -19.16 30.26 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.393 -0.817 . . . . 0.0 109.212 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.48 -26.37 20.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.766 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -91.8 -19.14 22.87 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.485 -0.76 . . . . 0.0 109.051 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.617 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -81.89 -59.48 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.601 -0.687 . . . . 0.0 109.483 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.4 m-20 147.41 30.61 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.15 0.5 . . . . 0.0 110.002 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.633 ' CD2' ' CD2' ' A' ' 42' ' ' PHE . 3.4 mp -103.59 -157.06 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.41 65.29 0.44 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -53.17 117.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.935 0.874 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.556 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.24 -44.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.164 0.506 . . . . 0.0 109.943 -179.489 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.498 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 13.2 t70 -138.78 149.53 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.498 ' CG2' ' C ' ' A' ' 51' ' ' ASP . 2.4 t -152.3 102.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.78 . . . . 0.0 109.466 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 62' ' ' TYR . 64.1 mtm180 -114.37 168.83 9.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.089 -1.007 . . . . 0.0 110.466 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.519 ' CG2' HG12 ' A' ' 31' ' ' VAL . 16.3 p -76.35 179.02 6.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -138.73 131.63 5.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 53.5 m 57.32 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.518 ' OD1' ' CG2' ' A' ' 56' ' ' THR . 23.0 p-10 -161.0 90.54 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 110.489 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.482 ' CG ' ' O ' ' A' ' 58' ' ' ARG . 9.3 ttp180 53.27 19.84 1.68 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -113.01 -30.0 7.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CD2' ' HB ' ' A' ' 56' ' ' THR . 2.0 m-85 -138.6 -177.74 5.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -159.83 135.47 4.13 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.193 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.684 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 2.6 m-85 -91.47 154.78 18.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -1.15 . . . . 0.0 109.635 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.512 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 3.7 t -151.78 143.7 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.843 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.79 143.51 47.81 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.428 -0.795 . . . . 0.0 109.58 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 53.8 m-85 -108.2 173.48 6.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.946 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.529 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.25 16.68 14.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 111.622 -178.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 2.4 t -165.18 175.68 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.729 1.252 . . . . 0.0 112.216 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.571 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -88.23 -25.41 22.88 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.46 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.86 -21.65 26.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.468 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 9.4 t0 -84.0 -31.01 25.71 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 3.7 tp -75.16 -35.57 61.59 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.482 0.658 . . . . 0.0 109.336 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.86 -37.87 67.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.698 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.05 -26.74 56.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.33 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.05 -26.77 61.4 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.949 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -70.94 -47.16 60.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.73 -15.78 63.21 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.748 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.576 HD11 ' CE1' ' A' ' 42' ' ' PHE . 1.2 mm? -73.22 1.37 9.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.586 -0.696 . . . . 0.0 110.246 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.507 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 38.7 m -76.29 4.13 9.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.584 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.97 19.22 33.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 2.5 pp -100.33 122.65 43.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.217 -1.167 . . . . 0.0 110.56 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 85' ' ' ASN . 2.2 ttmt -82.9 81.55 8.56 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.905 1.336 . . . . 0.0 110.147 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.528 HG11 ' CG2' ' A' ' 87' ' ' ILE . 1.7 p -36.32 -98.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.27 -2.851 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.522 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 2.2 m-30 -91.29 20.67 4.96 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.026 -1.046 . . . . 0.0 110.533 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 81' ' ' LYS . . . 120.77 23.16 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.584 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 1.9 m-20 -155.58 100.04 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 0.0 109.745 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -42.69 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.085 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 85' ' ' ASN . 6.1 pt -42.89 154.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.278 -0.889 . . . . 0.0 110.575 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -121.66 157.92 29.8 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.76 -0.588 . . . . 0.0 109.457 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.533 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 7.7 mp -112.0 -179.04 3.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.058 -1.026 . . . . 0.0 110.488 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 21' ' ' PHE . 2.2 tt0 . . . . . 0 C--N 1.299 -1.6 0 O-C-N 121.659 -0.651 . . . . 0.0 110.159 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.448 ' O ' HG21 ' A' ' 16' ' ' THR . 7.9 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.237 0.541 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.523 HG23 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -171.15 164.32 4.99 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.402 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.7 Cg_endo -77.98 -27.21 5.93 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.201 1.632 . . . . 0.0 110.715 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 87.3 m-85 -110.24 116.73 32.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.6 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 5.9 m120 -142.8 157.01 45.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -0.809 . . . . 0.0 109.73 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.641 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -164.3 168.33 18.84 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.478 -0.763 . . . . 0.0 110.192 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 45.6 t80 -102.6 157.24 17.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 11.4 mt -126.68 165.89 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -160.01 106.59 0.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.625 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 7.9 t-20 147.5 66.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.521 ' CD1' HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -98.44 133.54 42.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 110.958 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.443 ' HB2' HD12 ' A' ' 34' ' ' LEU . 9.6 t-20 -58.36 113.11 5.9 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.706 -0.621 . . . . 0.0 109.946 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.76 -36.91 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.901 1.474 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -74.87 -16.27 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.623 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 4.1 mmtt -110.4 -155.2 0.56 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.694 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 34' ' ' LEU . 2.1 m -122.01 148.52 44.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 2.5 t -69.62 -35.52 66.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.244 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -54.98 -44.7 74.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 108.906 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 20.8 mm-40 -61.88 -44.77 96.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.519 ' CD2' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.26 -31.29 65.42 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.533 ' CD ' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.87 -60.71 3.41 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 83.7 t -58.47 -40.48 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.54 -0.725 . . . . 0.0 109.07 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.69 -33.03 73.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.571 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 23.8 mt -80.32 -30.23 12.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.562 -0.711 . . . . 0.0 109.138 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.446 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.4 t -77.42 -27.28 52.27 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.634 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -84.02 -40.92 17.81 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.534 0.683 . . . . 0.0 109.414 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 6.2 tp -61.75 -35.29 77.67 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.604 ' CE2' ' CD1' ' A' ' 77' ' ' LEU . 7.3 m-85 -84.62 -22.63 29.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . . . -72.23 -34.81 68.6 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.556 0.694 . . . . 0.0 109.285 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 40' ' ' GLU . 9.6 mtmt -78.08 -17.81 56.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.442 -0.787 . . . . 0.0 109.242 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.614 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -88.46 -16.26 33.25 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.583 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 88.86 30.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -82.1 -138.3 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.528 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -178.95 57.39 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 39' ' ' SER . 21.0 m -50.96 117.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.834 0.826 . . . . 0.0 110.033 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CB ' HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER -89.22 -45.31 15.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-O 121.226 0.536 . . . . 0.0 109.94 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -143.69 160.22 41.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.781 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.533 ' CG1' ' CD ' ' A' ' 35' ' ' LYS . 2.5 t -152.4 157.49 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.848 . . . . 0.0 109.494 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.09 164.25 33.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.206 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.53 ' CB ' HG13 ' A' ' 31' ' ' VAL . 16.9 p -91.83 156.18 17.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 110.847 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.57 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.57 129.51 9.34 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 56' ' ' THR . 2.6 m 59.61 13.59 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.99 . . . . 0.0 109.39 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER 70.66 15.75 6.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 111.328 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.532 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 168.19 -21.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.807 -1.183 . . . . 0.0 111.543 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 0.0 OUTLIER -89.06 -65.34 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.929 -1.107 . . . . 0.0 111.728 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 1.2 m-85 -103.66 -148.53 0.39 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.043 -1.035 . . . . 0.0 110.617 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.57 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 178.62 -179.85 48.63 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.583 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 40.9 t80 -151.96 150.44 30.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.515 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 4.0 t -150.69 153.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.219 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.583 ' OD1' ' CZ ' ' A' ' 62' ' ' TYR . 3.6 m-20 -122.27 138.03 54.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 66.4 m-85 -104.66 172.32 6.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 109.912 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.528 ' HG2' ' CB ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -117.52 17.11 14.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 111.254 -178.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 14.8 p -167.6 173.4 8.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.563 1.173 . . . . 0.0 112.314 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.459 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -76.33 -25.31 54.61 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -76.55 -27.73 56.01 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.518 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.538 ' HB3' ' CD1' ' A' ' 65' ' ' PHE . 87.8 m-20 -79.92 -30.35 39.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.82 -38.73 70.15 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.297 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -71.48 -30.88 66.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.741 . . . . 0.0 109.621 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.533 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 33.7 mmtt -83.49 -27.2 29.59 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.636 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.8 -30.93 71.64 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.06 -44.28 26.8 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -21.64 59.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.363 -0.836 . . . . 0.0 109.494 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.604 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.9 mt -72.19 -4.9 32.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.521 ' CG2' HD11 ' A' ' 89' ' ' LEU . 32.3 m -71.47 2.27 5.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 110.956 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.94 -3.15 56.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -91.34 135.59 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 110.346 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.51 76.06 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.998 0.904 . . . . 0.0 110.573 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.53 ' HB ' ' CG2' ' A' ' 87' ' ' ILE . 3.4 t -43.17 129.28 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER 46.34 22.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.518 -179.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 92.95 17.62 43.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 2.1 m-80 -133.89 110.35 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.052 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 29.2 tt0 -58.05 81.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.099 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.53 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 2.7 pt -43.84 123.69 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.454 -0.779 . . . . 0.0 110.406 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.6 mtpm? -106.72 132.75 52.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.46 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -121.69 179.25 4.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.944 -1.098 . . . . 0.0 111.329 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.641 -0.662 . . . . 0.0 109.616 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 16' ' ' THR . 3.4 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.202 0.525 . . . . 0.0 110.138 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 15' ' ' THR . 1.1 p -164.79 154.6 11.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 110.734 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 65' ' ' PHE . 51.3 Cg_endo -76.78 -39.82 0.62 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.205 1.634 . . . . 0.0 110.585 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.572 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 94.4 m-85 -121.57 119.92 33.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.796 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 18' ' ' PHE . 15.5 m-20 -139.94 152.39 46.32 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.33 -0.856 . . . . 0.0 109.411 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.567 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 3.0 pp -164.09 -175.0 3.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.503 ' CD1' ' C ' ' A' ' 21' ' ' PHE . 6.1 t80 -109.34 141.91 41.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.492 -0.755 . . . . 0.0 110.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -122.05 160.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.82 -175.87 14.08 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 11.9 t30 71.52 54.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.437 -1.037 . . . . 0.0 110.506 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 ' CD2' ' A' ' 34' ' ' LEU . 4.3 mm? -105.35 129.05 53.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.958 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 34.5 t-20 -40.54 100.6 0.22 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.72 -0.612 . . . . 0.0 110.502 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -73.73 -17.22 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.074 1.565 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.92 -14.8 40.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.721 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 8.5 mmtt -106.27 -157.79 0.63 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.496 -0.753 . . . . 0.0 109.554 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.467 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -106.25 142.88 35.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.765 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.578 ' CG2' ' CG ' ' A' ' 58' ' ' ARG . 2.7 t -66.1 -22.85 30.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.639 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -67.58 -38.96 84.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 1.8 pt-20 -65.67 -38.3 88.91 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.529 ' CD2' HD12 ' A' ' 25' ' ' LEU . 50.9 mt -60.98 -36.09 78.51 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.43 -60.49 3.71 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 28.7 t -60.51 -32.74 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.8 -38.07 89.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 108.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.572 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 24.5 mt -80.07 -24.46 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.413 -0.804 . . . . 0.0 108.995 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.403 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 7.8 p -80.13 -30.74 39.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 109.053 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -81.93 -40.73 21.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.562 0.696 . . . . 0.0 109.609 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.513 HD23 ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -65.53 -35.05 79.71 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 109.178 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.572 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 9.2 m-85 -83.0 -21.64 33.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.43 -24.7 57.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 40' ' ' GLU . 9.5 mttp -104.17 -17.23 14.97 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.587 -0.695 . . . . 0.0 109.519 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.674 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -81.3 -21.87 38.99 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.369 -0.832 . . . . 0.0 109.934 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.674 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.5 t0 99.34 29.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.462 HD13 ' CE2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -100.93 -149.85 0.38 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.44 61.23 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.45 HG13 ' CD2' ' A' ' 42' ' ' PHE . 6.5 m -50.9 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.001 0.905 . . . . 0.0 110.133 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.538 HG22 ' CG ' ' A' ' 66' ' ' GLU . 2.8 t -89.04 -35.68 7.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.264 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 8.4 t0 -146.85 156.18 42.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.116 -0.99 . . . . 0.0 111.229 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.593 ' CG1' ' CG ' ' A' ' 35' ' ' LYS . 14.8 p -153.17 146.59 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -149.59 166.54 28.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.562 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 15.7 p -87.75 160.45 18.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 110.528 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -125.63 126.0 5.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.489 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 1.8 m 59.34 -166.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -1.078 . . . . 0.0 110.073 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.461 ' O ' ' HD2' ' A' ' 58' ' ' ARG . 0.7 OUTLIER -41.76 -65.78 0.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.402 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.578 ' CG ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -173.89 51.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -124.47 -23.34 4.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.935 . . . . 0.0 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.493 ' HB2' ' HA3' ' A' ' 55' ' ' GLY . 1.0 OUTLIER -124.6 -177.05 3.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -168.0 141.75 7.03 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 48.2 t80 -94.62 169.07 10.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -1.151 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.571 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 2.4 t -163.64 163.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.469 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -137.07 144.63 43.25 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.8 m-85 -108.25 176.58 5.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.538 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -109.77 16.37 22.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 111.584 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p 178.17 178.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.139 . . . . 0.0 112.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.05 -23.28 52.04 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -26.2 41.06 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.361 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 85.9 m-20 -83.01 -28.0 29.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.49 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 2.6 tm? -77.96 -34.19 51.19 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.827 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.49 -40.05 62.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.849 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.03 -30.63 61.12 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.653 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.16 -28.48 67.33 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.475 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 5.7 tt -69.79 -45.18 68.54 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -12.47 60.68 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.164 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -76.07 4.62 8.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.54 -0.725 . . . . 0.0 109.939 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 89' ' ' LEU . 11.1 m -72.89 1.18 9.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.115 -0.991 . . . . 0.0 110.552 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.417 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -106.2 1.42 37.79 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' CD2' HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -84.8 124.0 31.07 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.151 -1.205 . . . . 0.0 111.257 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 32.2 mtpt -83.38 84.33 7.55 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.908 0.861 . . . . 0.0 109.189 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 83' ' ' PHE . 1.2 p -34.76 -94.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.577 ' CE2' ' HG3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -98.56 31.89 2.73 Favored 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.138 -0.976 . . . . 0.0 109.427 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.429 ' C ' ' HE3' ' A' ' 81' ' ' LYS . . . 108.35 15.51 13.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 87' ' ' ILE . 5.1 m120 -143.42 98.18 3.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -1.039 . . . . 0.0 109.528 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 78' ' ' THR . 35.1 tt0 -41.72 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.476 -0.765 . . . . 0.0 110.548 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -51.25 145.39 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.464 ' O ' HG23 ' A' ' 22' ' ' ILE . 18.5 tttt -120.87 155.77 33.42 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.566 -0.708 . . . . 0.0 109.904 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.571 ' CD2' ' N ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -120.38 171.35 8.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.468 HG23 ' OD2' ' A' ' 51' ' ' ASP . 4.3 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.258 0.551 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.55 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -172.2 162.53 4.35 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.525 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.0 Cg_endo -79.95 -25.96 4.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.187 1.625 . . . . 0.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.4 m-85 -116.25 119.7 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 0.0 110.951 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 30.2 m-20 -135.42 171.0 15.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.211 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 19' ' ' ASN . 11.2 mt -156.44 165.89 35.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 111.137 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -97.96 157.59 16.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 65.2 mt -149.39 146.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.323 -0.861 . . . . 0.0 110.121 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.92 179.91 22.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 48.1 t30 71.15 23.35 4.15 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.495 -1.003 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 4.1 mm? -68.37 122.93 19.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 28.1 t-20 -41.09 100.85 0.23 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.654 -0.653 . . . . 0.0 110.421 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.8 Cg_endo -75.69 -26.51 9.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.071 1.564 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -74.69 -24.1 58.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.966 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.7 mmtt -90.9 -154.45 0.35 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.603 -0.686 . . . . 0.0 109.72 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.1 m -101.9 143.83 31.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 3.7 t -69.0 -31.02 48.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 36' ' ' VAL . . . -66.7 -33.7 76.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.118 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 66.0 mm-40 -70.66 -36.58 73.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 109.359 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 42.3 mt -63.24 -34.57 77.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.442 -0.786 . . . . 0.0 109.061 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HE3' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -64.94 -55.84 16.78 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.213 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.5 t -58.3 -40.78 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 0.0 109.385 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 82' ' ' VAL . . . -59.32 -29.07 67.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.97 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.474 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 47.0 mt -83.95 -32.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.385 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.7 t -79.27 -23.14 43.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.97 -39.31 17.04 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 80' ' ' LEU . 4.9 tp -63.45 -36.89 85.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.551 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 10.2 m-85 -83.56 -22.02 32.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 40' ' ' GLU . . . -79.43 -21.76 45.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.97 -20.43 14.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.675 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -82.48 -21.12 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.459 -0.776 . . . . 0.0 109.788 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.675 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.3 t70 98.61 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.868 0.842 . . . . 0.0 108.891 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -91.33 -145.28 0.19 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.526 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -177.33 61.01 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 15.9 m -63.24 115.44 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 122.012 0.91 . . . . 0.0 110.317 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.574 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 19.6 t -82.0 -23.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.509 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.534 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -155.79 155.67 33.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 0.0 110.673 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.503 ' CG2' ' C ' ' A' ' 51' ' ' ASP . 3.4 t -152.87 128.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.805 . . . . 0.0 109.963 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -128.51 178.64 6.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.596 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -149.98 151.49 33.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 110.691 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' A' ' 56' ' ' THR . . . -173.0 -160.86 22.38 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 5.7 m 57.07 85.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -1.042 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.3 m-20 39.58 48.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.446 -0.784 . . . . 0.0 110.936 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 10.1 ptm180 37.44 35.51 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.577 -0.702 . . . . 0.0 111.004 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 20.0 tttt -121.92 -19.26 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 110.193 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -124.53 170.36 10.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' ' CG ' ' A' ' 60' ' ' PHE . . . -163.35 172.8 39.39 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.419 ' CE2' ' HD1' ' A' ' 21' ' ' PHE . 1.3 t80 -121.88 162.56 20.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.828 -0.807 . . . . 0.0 109.976 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.519 ' HB ' ' CD1' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -145.29 167.4 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.117 -0.989 . . . . 0.0 110.834 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 2.8 m-20 -141.69 144.1 33.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.56 -0.712 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.643 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 61.5 m-85 -118.3 -178.55 3.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.574 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 7.5 pt-20 -113.96 8.93 17.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.477 -0.764 . . . . 0.0 111.016 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 32.1 p -167.81 176.1 6.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.572 1.177 . . . . 0.0 112.423 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.566 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.34 -24.32 50.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -28.69 57.75 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.364 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 79.0 m-20 -82.54 -27.78 31.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -72.56 -37.34 68.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.876 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.02 -38.47 61.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 109.979 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 11.2 ttmm -76.68 -25.75 54.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.643 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -69.77 -31.75 69.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 89' ' ' LEU . 5.6 tt -70.86 -43.11 69.15 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -10.58 59.94 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.163 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -72.48 1.82 7.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.549 -0.72 . . . . 0.0 110.658 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.526 ' OG1' ' CG ' ' A' ' 89' ' ' LEU . 15.4 m -78.52 6.07 9.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.36 24.18 32.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.527 ' CD1' HD23 ' A' ' 41' ' ' LEU . 4.7 mt -127.11 128.14 45.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -1.188 . . . . 0.0 110.837 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 82' ' ' VAL . 21.3 mtmt -84.82 83.24 8.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.768 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.53 ' CG1' ' HB1' ' A' ' 37' ' ' ALA . 74.3 t -32.2 -98.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.063 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -85.38 23.06 1.38 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.665 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.94 20.44 5.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 87' ' ' ILE . 66.6 m-80 -154.71 116.12 4.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -1.102 . . . . 0.0 109.363 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 1.1 pt-20 -55.56 84.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 110.14 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 85' ' ' ASN . 24.4 pt -41.01 130.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.508 -0.745 . . . . 0.0 110.091 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 23' ' ' GLY . 3.4 mttt -98.15 122.58 41.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.373 -0.829 . . . . 0.0 109.774 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.532 ' CB ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -118.87 172.49 7.5 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.39 -0.819 . . . . 0.0 110.386 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 11.3 pt-20 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.469 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 16' ' ' THR . 4.6 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.205 0.526 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.518 HG22 ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.63 166.27 1.86 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.064 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.455 ' HD2' HG21 ' A' ' 16' ' ' THR . 48.0 Cg_endo -76.15 -31.95 4.47 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.95 1.5 . . . . 0.0 110.798 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.6 m-85 -111.62 106.93 15.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.026 -1.046 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 16' ' ' THR . 43.7 m-20 -139.79 156.06 46.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.352 -0.843 . . . . 0.0 109.814 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 3.5 pp -169.78 -168.55 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.288 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 22.0 t80 -111.95 158.46 19.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 110.265 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.507 HG21 ' N ' ' A' ' 23' ' ' GLY . 2.5 mt -140.73 160.11 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.104 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -141.76 -170.66 12.53 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.517 -1.325 . . . . 0.0 109.923 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 4.6 t30 73.85 34.31 0.91 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.622 -0.928 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 60' ' ' PHE . 7.9 mp -85.57 134.73 34.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.788 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.429 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 35.0 t-20 -60.2 109.89 2.39 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 110.464 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -74.55 -26.26 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.062 1.559 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.44 -25.11 57.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 109.897 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HE3' ' CE1' ' A' ' 83' ' ' PHE . 6.6 mmtt -91.23 -154.41 0.36 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.729 . . . . 0.0 109.665 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.61 140.79 44.62 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.534 ' O ' ' CD ' ' A' ' 35' ' ' LYS . 3.0 t -67.48 -35.36 73.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.096 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.23 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.181 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 65.7 mm-40 -73.45 -34.34 65.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.481 -0.762 . . . . 0.0 109.229 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -66.3 -30.37 70.77 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.375 -0.828 . . . . 0.0 109.068 179.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.549 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -68.74 -56.27 8.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -62.91 -37.44 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.55 -32.77 74.34 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.844 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 34' ' ' LEU . 13.5 mt -81.46 -28.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.475 -0.765 . . . . 0.0 109.107 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.533 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 3.6 m -77.82 -30.94 51.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.16 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.99 -37.63 33.87 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.59 ' CD1' ' CD2' ' A' ' 80' ' ' LEU . 1.1 tt -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.228 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 15.3 m-85 -87.55 -17.18 32.6 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.361 -0.837 . . . . 0.0 109.363 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.44 -28.97 20.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.799 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.2 mttt -91.44 -20.93 21.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.768 . . . . 0.0 109.395 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -79.08 -58.89 3.0 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.53 -0.731 . . . . 0.0 109.633 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 148.47 29.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.529 ' CD2' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -108.74 -158.86 0.66 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 109.593 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.529 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -160.33 65.37 0.33 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.018 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 11.0 m -54.59 115.44 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.811 0.815 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 11.5 t -82.51 -35.9 13.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 121.88 -0.513 . . . . 0.0 110.482 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.462 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -152.84 164.02 38.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 0.0 110.723 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.549 ' CG2' ' HG3' ' A' ' 35' ' ' LYS . 5.4 p -159.0 102.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.723 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -93.87 163.34 13.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.532 ' CG2' HG11 ' A' ' 31' ' ' VAL . 16.1 p -85.05 161.68 19.62 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.313 -0.867 . . . . 0.0 110.715 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -115.33 121.8 5.4 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 9.1 m -21.54 142.39 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.605 0.717 . . . . 0.0 112.445 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER 72.4 18.78 4.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.476 -0.765 . . . . 0.0 109.959 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.444 ' CZ ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 42.46 27.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.788 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.439 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -110.92 -17.93 13.19 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.523 ' HB2' ' HA3' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -130.08 -168.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.042 -1.036 . . . . 0.0 109.601 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 177.88 155.79 14.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.0 m-85 -108.9 162.18 14.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 3.2 t -150.13 143.17 17.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.891 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.13 144.97 42.28 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.547 -0.721 . . . . 0.0 109.717 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 13.1 m-85 -109.68 177.79 4.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.323 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.541 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 2.3 pp20? -114.21 8.4 16.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 111.285 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 10.0 p -175.41 177.15 1.87 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.278 1.037 . . . . 0.0 111.972 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.429 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -79.04 -22.87 44.75 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -82.22 -26.51 33.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.264 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.573 ' OD1' ' CD1' ' A' ' 65' ' ' PHE . 2.9 t0 -82.42 -26.61 32.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 tp -80.6 -33.71 35.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.62 -34.53 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.514 -0.741 . . . . 0.0 109.357 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.17 -29.08 60.32 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.51 -26.68 65.57 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 tt -72.98 -46.61 51.3 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -10.72 60.05 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.999 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -73.14 4.26 4.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.573 -0.705 . . . . 0.0 110.379 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 m -58.01 -14.27 6.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.54 37.69 3.33 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.59 ' CD2' ' CD1' ' A' ' 41' ' ' LEU . 4.2 mt -90.03 -168.56 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.535 -0.979 . . . . 0.0 111.159 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 17.7 mttt 170.89 53.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 108.927 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.51 ' C ' ' O ' ' A' ' 81' ' ' LYS . 90.7 t -24.96 -100.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.991 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 12.7 m-85 -89.64 39.99 0.97 Allowed 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.24 24.65 28.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 7.3 p-10 -138.52 86.21 2.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.538 -0.978 . . . . 0.0 109.016 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.581 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 1.1 pt-20 -41.74 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 110.686 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' ASN . 3.6 pt -51.27 146.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.554 0.692 . . . . 0.0 109.942 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.477 ' O ' HG21 ' A' ' 22' ' ' ILE . 20.9 tptt -119.43 156.29 30.43 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 109.845 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -119.87 171.95 8.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.069 -1.019 . . . . 0.0 110.304 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.365 -0.835 . . . . 0.0 110.127 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 16' ' ' THR . 3.3 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.433 0.635 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.558 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 69.5 p -139.78 164.28 39.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.583 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.3 Cg_endo -74.99 -21.65 15.66 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.088 1.573 . . . . 0.0 110.721 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 96.9 m-85 -106.67 113.44 26.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.037 -1.04 . . . . 0.0 110.56 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.531 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -144.76 140.59 28.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.53 -166.88 2.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.837 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.685 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 6.7 t80 -118.69 157.54 27.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.179 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.632 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.5 mt -145.85 151.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.44 -174.4 13.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 27.2 t30 69.84 55.28 0.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.163 -1.199 . . . . 0.0 109.998 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.9 mm? -93.78 123.75 37.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.541 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 58.5 t30 -42.25 101.71 0.25 Allowed Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' HG2' ' A' ' 58' ' ' ARG . 48.2 Cg_endo -75.39 -11.47 20.79 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.065 1.561 . . . . 0.0 110.498 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -81.96 -8.5 59.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 13.4 mttt -124.95 -154.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.971 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.542 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.9 m -100.09 147.59 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 2.6 t -64.53 -35.16 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.535 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -51.51 68.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 109.778 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 38.5 mm-40 -56.74 -31.61 64.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.83 . . . . 0.0 109.015 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 30' ' ' SER . 6.7 mp -66.27 -33.17 75.14 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.384 -0.822 . . . . 0.0 109.069 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HD2' ' CG1' ' A' ' 52' ' ' VAL . 29.1 mmtt -64.72 -55.47 19.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.974 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.8 t -57.26 -32.87 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.592 -0.693 . . . . 0.0 109.552 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.518 ' CB ' HG21 ' A' ' 82' ' ' VAL . . . -63.79 -35.62 81.21 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.822 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.514 ' CD1' ' HB ' ' A' ' 82' ' ' VAL . 15.6 mm -80.05 -26.75 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.535 -0.728 . . . . 0.0 109.311 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -79.58 -30.72 41.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.921 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.2 tm-20 -80.53 -39.69 27.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.583 0.706 . . . . 0.0 109.572 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.83 -33.54 75.84 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.132 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CE1' ' CG ' ' A' ' 77' ' ' LEU . 5.5 m-30 -81.82 -23.17 36.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 109.18 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.85 -27.53 44.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.027 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CD ' ' OE2' ' A' ' 40' ' ' GLU . 6.4 mtpt -87.8 -19.47 27.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.448 -0.783 . . . . 0.0 109.284 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -80.64 -60.04 2.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.562 -0.711 . . . . 0.0 109.423 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.0 m-20 149.68 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.571 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -106.58 -157.69 0.62 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.47 61.22 0.38 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.019 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 m -48.32 117.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.98 0.895 . . . . 0.0 110.068 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.558 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.94 -41.55 14.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' ' CG2' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -146.57 159.26 43.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.521 ' CG1' ' HD2' ' A' ' 35' ' ' LYS . 40.9 t -157.57 114.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.41 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -113.83 163.81 14.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 110.496 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 21.7 p -83.45 171.53 13.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.63 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -135.29 130.77 5.54 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.462 ' OG1' ' CE2' ' A' ' 60' ' ' PHE . 1.4 m 50.45 -140.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -1.16 . . . . 0.0 109.902 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 58' ' ' ARG . 41.0 p30 -100.75 79.82 2.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.075 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.533 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 7.7 ttp180 56.65 28.98 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 110.482 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.94 -31.23 10.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 109.889 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.685 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -150.93 177.52 10.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.566 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -154.2 150.52 22.16 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.298 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 20.7 t80 -103.85 160.6 14.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.365 -1.079 . . . . 0.0 109.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.626 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 88.7 t -154.5 154.42 7.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.435 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -124.13 139.88 53.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.708 -0.62 . . . . 0.0 109.865 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.637 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 21.7 m-85 -109.71 173.45 6.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.517 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.08 15.19 17.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.353 -0.842 . . . . 0.0 111.212 -178.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.56 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 2.3 t -166.24 175.49 8.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.718 1.247 . . . . 0.0 112.063 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.533 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -88.15 -25.39 22.98 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -20.95 26.21 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 8.7 t0 -84.14 -31.68 25.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 18' ' ' PHE . 8.4 tt -75.77 -34.59 60.24 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.485 0.66 . . . . 0.0 109.59 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.5 -35.19 60.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.992 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.537 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -76.65 -27.38 55.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.637 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.09 -28.7 64.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -68.95 -45.76 69.92 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.55 -15.55 63.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.963 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.629 ' CG ' ' CE1' ' A' ' 42' ' ' PHE . 1.2 mm? -72.86 0.01 12.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.225 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 88' ' ' LYS . 5.8 m -78.23 5.59 9.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 110.672 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -103.72 14.15 53.38 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.525 ' CD1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -115.3 131.21 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.843 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' A' ' 82' ' ' VAL . 14.1 mttt -75.95 83.85 2.86 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 109.62 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.575 ' CG1' ' CG2' ' A' ' 87' ' ' ILE . 1.2 p -31.34 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.81 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -100.84 28.79 4.94 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.61 15.93 3.89 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 87' ' ' ILE . 6.7 m-20 -158.64 116.62 2.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -1.2 . . . . 0.0 109.478 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 78' ' ' THR . 24.9 tt0 -52.72 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.575 ' CG2' ' CG1' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -42.77 154.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 110.215 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 78' ' ' THR . 7.1 mtpp -129.7 157.15 42.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.836 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 75' ' ' LEU . 3.7 mt -106.68 -179.54 3.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.11 -0.993 . . . . 0.0 110.119 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 2.5 tt0 . . . . . 0 C--N 1.299 -1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.53 ' O ' ' CG2' ' A' ' 16' ' ' THR . 5.6 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.311 0.577 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 15' ' ' THR . 16.2 p -159.89 159.11 27.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.838 . . . . 0.0 110.207 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.18 -18.2 14.46 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.149 1.605 . . . . 0.0 110.913 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.591 ' CE2' ' N ' ' A' ' 68' ' ' ALA . 79.9 m-85 -122.34 115.78 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.931 -1.106 . . . . 0.0 111.14 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 2.2 m120 -143.49 151.39 40.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.532 -0.73 . . . . 0.0 109.067 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.583 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 1.7 pp -160.22 179.59 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.425 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -103.66 158.12 16.59 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.631 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.567 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 6.6 mt -148.33 154.21 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.355 -0.841 . . . . 0.0 109.414 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -144.68 -164.87 10.79 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.7 t30 71.68 35.03 1.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.1 mm? -85.3 129.5 34.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.19 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 28.4 t-20 -50.06 106.17 0.6 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -74.42 -18.88 19.91 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.996 1.524 . . . . 0.0 110.486 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -79.45 -16.21 56.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.466 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -106.18 -155.88 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.372 -0.83 . . . . 0.0 109.817 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.52 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 2.6 m -103.6 149.39 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 110.181 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.568 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 3.0 t -69.85 -42.66 79.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -56.96 -34.81 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.503 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.93 -46.47 71.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.79 . . . . 0.0 109.581 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.577 ' HG ' ' CD2' ' A' ' 83' ' ' PHE . 2.0 mt -54.55 -32.44 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.177 -0.952 . . . . 0.0 108.837 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD3' ' HB ' ' A' ' 52' ' ' VAL . 13.2 mmtt -64.77 -58.43 6.27 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.131 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 21.9 t -53.24 -35.64 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.497 -0.752 . . . . 0.0 109.369 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.4 -39.01 93.35 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.574 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 70.8 mt -77.92 -26.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 m -79.16 -29.21 42.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.085 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.84 -38.56 22.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.456 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.511 ' HG ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.84 -31.49 71.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.645 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 6.9 m-85 -85.37 -22.22 28.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.97 -31.85 59.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.547 -0.721 . . . . 0.0 109.131 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -91.92 -15.41 28.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.59 -0.694 . . . . 0.0 109.134 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.671 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -82.71 -29.04 30.12 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.501 -0.75 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.671 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 36.6 t0 103.85 29.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.645 ' CD2' ' CD2' ' A' ' 42' ' ' PHE . 3.3 mp -97.73 -151.78 0.38 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.86 61.9 0.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.093 -1.004 . . . . 0.0 110.43 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -50.07 119.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.878 0.847 . . . . 0.0 109.396 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.542 HG21 ' CG ' ' A' ' 66' ' ' GLU . 2.5 t -89.28 -48.14 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.86 -0.525 . . . . 0.0 110.968 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.461 ' OD2' HG21 ' A' ' 15' ' ' THR . 5.1 m-20 -141.48 115.68 9.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.868 -1.145 . . . . 0.0 111.311 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HB ' ' HD3' ' A' ' 35' ' ' LYS . 16.0 m -103.64 143.49 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.437 -0.789 . . . . 0.0 109.679 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -150.32 167.79 25.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 110.532 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.568 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 13.7 p -88.9 164.31 15.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 110.578 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.558 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -132.63 127.35 4.8 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER 68.19 -143.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -1.112 . . . . 0.0 110.069 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.94 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.158 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.9 31.18 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 110.06 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HE3' ' HG3' ' A' ' 27' ' ' PRO . 19.3 tttt -123.76 -17.34 6.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -109.49 -176.57 3.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 110.156 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.524 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.4 152.26 10.9 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.5 t80 -125.12 158.85 32.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -1.049 . . . . 0.0 109.521 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.4 t -151.95 147.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.852 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.47 137.31 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.472 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 25.7 m-85 -100.04 177.46 5.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.665 -0.647 . . . . 0.0 111.101 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.542 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.19 12.02 15.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 111.611 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CD2' ' A' ' 18' ' ' PHE . 5.2 p -173.71 172.11 3.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 0.0 112.2 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.591 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -78.61 -25.76 45.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.25 -28.16 38.5 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.793 179.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 65' ' ' PHE . 5.5 t0 -79.77 -24.27 41.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 2.3 tm? -77.22 -35.65 55.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.48 -35.45 73.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.422 -0.799 . . . . 0.0 109.042 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.35 -25.36 57.69 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.7 -30.7 69.41 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 75' ' ' LEU . 7.9 tt -71.83 -45.54 61.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -77.79 -2.13 34.9 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.151 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.566 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -76.74 7.65 4.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 110.483 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -73.65 0.55 12.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.19 12.02 61.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.511 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -102.37 131.83 48.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.289 -1.124 . . . . 0.0 109.678 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -114.37 80.15 1.36 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.489 1.137 . . . . 0.0 110.11 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.535 ' CG1' HG22 ' A' ' 87' ' ' ILE . 3.5 m -51.17 127.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.68 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 8.2 m-30 38.17 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.477 -0.765 . . . . 0.0 111.331 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 85.44 26.88 34.54 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 82' ' ' VAL . 10.1 m120 -134.74 78.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.739 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.3 tm-20 -37.19 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.729 0.776 . . . . 0.0 110.747 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.535 HG22 ' CG1' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -47.7 144.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 89' ' ' LEU . 25.7 tttt -119.3 156.54 29.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.505 ' N ' ' HG2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -116.6 172.34 7.28 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 110.38 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.751 . . . . 0.0 110.133 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 16' ' ' THR . 5.8 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.555 0.693 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 74.6 p -139.27 164.76 36.66 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.565 -0.71 . . . . 0.0 110.265 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.4 Cg_endo -76.72 -22.62 11.77 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.022 1.538 . . . . 0.0 111.073 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 68' ' ' ALA . 91.5 m-85 -104.19 85.5 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.928 -1.107 . . . . 0.0 110.939 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.521 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.7 m-20 -122.61 146.87 47.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.09 -1.006 . . . . 0.0 109.374 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.55 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 1.8 pp -154.36 -176.97 6.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -103.18 166.46 10.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.617 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 9.0 mt -144.49 158.79 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -149.19 -178.67 24.41 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.031 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 20.5 t30 72.67 54.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.92 . . . . 0.0 110.233 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB3' ' CD1' ' A' ' 34' ' ' LEU . 21.0 mt -102.23 125.93 49.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.042 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 26.4 t-20 -41.25 110.08 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.733 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.01 -19.94 22.49 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.997 1.525 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -85.54 -7.56 58.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.953 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.578 ' HD3' ' CG ' ' A' ' 83' ' ' PHE . 10.1 mttt -114.15 -157.24 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.371 -0.83 . . . . 0.0 109.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.457 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.5 m -110.51 150.09 29.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 110.572 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 2.6 t -69.56 -38.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.337 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.408 ' O ' HG22 ' A' ' 36' ' ' VAL . . . -57.4 -34.66 69.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.422 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.448 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 5.6 mm-40 -74.82 -32.67 62.03 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.375 -0.828 . . . . 0.0 109.159 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 7.4 mt -66.21 -35.18 79.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.392 -0.818 . . . . 0.0 109.03 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 2.7 mptp? -67.11 -54.08 24.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 16.7 t -52.17 -35.97 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 109.581 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.34 -38.37 90.78 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.583 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 20.2 mm -78.02 -26.66 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.369 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -78.97 -31.92 45.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -79.8 -39.27 31.22 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.46 -0.775 . . . . 0.0 109.537 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD2' HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.6 -33.55 75.92 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.132 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.583 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.8 m-85 -82.17 -21.95 36.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.554 -0.716 . . . . 0.0 109.211 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.52 44.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.409 -0.807 . . . . 0.0 109.726 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 14.4 mtmm -104.67 -22.81 13.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -79.31 -30.92 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 35.7 t70 112.62 29.03 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.576 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 1.7 mm? -88.93 -153.16 0.25 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.478 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . -165.87 64.09 0.11 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 m -62.98 117.87 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.917 0.865 . . . . 0.0 110.079 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.525 HG23 ' CG ' ' A' ' 66' ' ' GLU . 2.3 t -92.36 -42.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -144.4 158.22 43.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.519 ' CG1' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -144.96 156.19 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 109.569 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.446 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -162.51 170.23 19.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.24 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.447 ' C ' ' HA2' ' A' ' 61' ' ' GLY . 13.8 p -90.48 164.62 14.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 110.243 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -120.5 131.78 8.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.491 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 99.0 m 58.72 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.937 . . . . 0.0 110.371 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 27.6 t-20 -173.25 84.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.627 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.542 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 66.25 22.18 10.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 110.729 179.43 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 4.0 tttm -120.59 -35.84 3.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' HG2' ' A' ' 59' ' ' LYS . 1.2 m-85 -135.27 -164.3 1.51 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -169.08 165.3 38.81 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.272 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 20' ' ' LEU . 36.8 t80 -128.73 153.1 47.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -1.02 . . . . 0.0 109.524 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.519 HG12 ' CG1' ' A' ' 52' ' ' VAL . 3.1 t -150.43 144.15 17.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.079 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -107.5 141.07 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 109.663 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.632 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 30.8 m-85 -104.3 177.79 4.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.876 . . . . 0.0 110.551 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.525 ' CG ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.12 15.91 14.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 111.02 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.7 p -179.38 178.28 0.7 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.368 1.08 . . . . 0.0 111.954 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.51 -22.57 50.99 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -27.99 38.77 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.43 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.525 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 85.8 m-20 -80.22 -29.27 38.5 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.526 ' CD2' HD22 ' A' ' 20' ' ' LEU . 3.4 tm? -81.41 -32.81 32.57 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.501 0.667 . . . . 0.0 109.314 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.68 -36.05 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.748 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.98 -30.14 50.09 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.632 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -63.82 -28.99 70.24 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.799 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.95 -47.15 31.0 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 5.01 16.21 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.612 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -79.39 11.66 2.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 110.422 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -6.44 19.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.41 25.03 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.557 ' CD1' ' CD1' ' A' ' 77' ' ' LEU . 1.3 mt -92.76 -171.16 2.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.468 -1.019 . . . . 0.0 110.9 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.574 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.4 mttt 176.55 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.869 0.842 . . . . 0.0 108.978 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.522 ' CG2' HG22 ' A' ' 87' ' ' ILE . 99.3 t -24.34 -101.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.169 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.578 ' CG ' ' HD3' ' A' ' 29' ' ' LYS . 10.2 m-85 -87.86 42.32 1.05 Allowed 'General case' 0 C--N 1.288 -2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 108.728 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.69 29.78 22.98 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 1.1 t-20 -145.91 88.12 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.449 -1.03 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.574 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -42.95 96.06 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.625 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.522 HG22 ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -48.56 125.73 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.606 -0.684 . . . . 0.0 110.144 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -100.89 129.9 46.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.733 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.524 ' C ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -113.58 176.34 5.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.013 -1.054 . . . . 0.0 111.222 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 3.2 pt-20 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.459 -0.776 . . . . 0.0 110.23 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 15' ' ' THR . 4.6 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.236 0.541 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.534 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -178.83 165.19 1.03 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 110.39 -179.928 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.557 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.8 Cg_endo -75.43 -44.16 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.101 1.579 . . . . 0.0 110.651 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 90.6 m-85 -96.15 106.33 18.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.119 -0.988 . . . . 0.0 110.594 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' ND2' ' C ' ' A' ' 18' ' ' PHE . 2.0 m120 -135.66 146.31 47.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -164.71 169.15 17.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.547 179.79 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 3.5 t80 -101.73 145.97 28.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.732 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' CE1' ' A' ' 21' ' ' PHE . 1.4 mt -127.78 158.53 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.68 179.84 17.21 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 45.8 t30 71.35 76.74 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.413 -1.051 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -118.88 126.44 51.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.021 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.475 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 46.0 t30 -40.43 100.36 0.22 Allowed Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.613 -0.68 . . . . 0.0 110.525 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.7 Cg_endo -75.75 -13.81 19.77 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.411 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -18.26 43.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -108.28 -156.52 0.58 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 0.0 109.753 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.524 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -101.63 147.19 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 57' ' ' ASN . 3.3 t -69.67 -32.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.486 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.74 85.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.183 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.584 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.72 -40.15 84.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.724 . . . . 0.0 109.33 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.534 HD21 ' CG1' ' A' ' 82' ' ' VAL . 40.2 mt -57.3 -37.04 71.84 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -61.45 -58.19 9.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.32 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -58.54 -33.7 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.414 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.61 -36.49 83.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.189 -0.945 . . . . 0.0 108.609 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 17.0 mt -79.66 -26.14 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.584 -0.697 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -79.79 -30.35 40.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 108.93 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.12 -38.06 27.86 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.514 0.673 . . . . 0.0 109.669 179.464 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.579 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 1.1 tt -69.9 -31.19 68.85 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.458 -0.776 . . . . 0.0 109.248 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 5.5 m-85 -82.87 -23.92 33.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.11 -32.01 61.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -90.02 -18.95 25.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.437 179.353 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.3 m-80 -85.49 -20.16 30.13 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.786 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.0 t0 89.42 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 -179.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -80.14 -138.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -176.52 57.44 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.953 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.549 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 9.9 m -63.32 117.45 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.047 0.927 . . . . 0.0 110.766 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.573 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -98.2 -34.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.524 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.51 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 56.7 t0 -144.78 148.49 34.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 3.8 t -152.87 100.28 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 169.23 8.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.124 -0.985 . . . . 0.0 110.388 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.45 ' HB ' HG11 ' A' ' 31' ' ' VAL . 17.4 p -83.52 168.21 16.66 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -122.04 122.02 4.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 60' ' ' PHE . 4.3 m 67.87 -57.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.755 -0.85 . . . . 0.0 110.368 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.475 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER 179.81 -43.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.69 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.461 ' HA ' HG21 ' A' ' 31' ' ' VAL . 12.4 ptt180 -168.39 25.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.721 . . . . 0.0 110.123 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.633 ' CB ' ' CE1' ' A' ' 60' ' ' PHE . 2.8 mttt -119.65 -24.83 6.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.803 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' CB ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -138.51 -172.38 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.195 -0.941 . . . . 0.0 109.449 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -172.93 151.69 14.55 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.147 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 38.0 m-85 -108.05 150.62 26.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.415 -1.05 . . . . 0.0 109.525 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.514 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 3.9 t -151.36 146.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.264 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.2 m-20 -122.56 146.6 47.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.573 ' C ' ' CG2' ' A' ' 50' ' ' VAL . 26.2 m-85 -114.86 -175.21 2.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.861 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.534 ' HG3' ' CG1' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -129.44 31.34 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.661 -1.274 . . . . 0.0 113.673 -176.623 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.776 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 22.6 p -172.88 172.76 3.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.902 -1.749 . . . . 0.0 113.167 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.77 -27.81 58.2 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -27.1 61.76 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 179.459 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.776 ' OD2' ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -78.23 -32.29 49.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.083 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -65.95 -41.55 91.14 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.284 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -70.09 -33.11 71.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 178.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 15.9 mmtt -81.49 -23.02 37.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 70' ' ' ASP . . . -69.19 -29.91 67.98 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -48.13 29.38 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.07 8.51 15.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.269 178.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 3.0 tt -66.32 -8.81 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 110.837 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 84.9 m -70.92 5.41 2.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.353 -0.842 . . . . 0.0 111.692 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.44 -6.48 56.52 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.579 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 6.8 mp -92.61 120.79 33.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -1.166 . . . . 0.0 110.723 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -95.07 80.69 3.63 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.965 0.888 . . . . 0.0 110.139 179.36 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.534 ' CG1' HD21 ' A' ' 34' ' ' LEU . 2.5 t -43.22 120.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 0.6 OUTLIER 48.73 20.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.965 -179.122 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.87 11.67 39.51 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.7 m120 -128.28 110.43 12.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -59.35 76.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.529 -0.732 . . . . 0.0 110.123 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 85' ' ' ASN . 4.9 pt -42.99 140.33 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 110.042 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.8 mttm -108.61 158.72 17.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.205 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.69 170.99 8.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 110.083 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 16' ' ' THR . 4.2 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.268 0.556 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.525 HG23 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -170.52 165.4 5.31 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.95 -34.06 2.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.097 1.577 . . . . 0.0 111.052 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.2 m-85 -109.78 115.62 30.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.737 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 3.5 m-80 -142.88 152.36 42.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.412 -0.805 . . . . 0.0 109.567 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.0 pt? -162.91 170.88 17.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 110.416 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -97.93 167.79 10.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' GLY . 14.2 mt -142.69 161.65 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -148.11 177.61 26.25 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 16.9 t30 71.73 43.75 0.55 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -1.095 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -92.73 127.63 38.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.932 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 63.8 t-20 -40.8 106.61 0.43 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 110.447 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.53 -24.4 16.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.085 1.571 . . . . 0.0 110.389 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -76.44 -10.93 59.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.902 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.8 mmtp -114.68 -155.6 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.959 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.8 m -115.22 153.39 30.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.369 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.571 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.8 t -69.52 -21.03 24.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.224 -0.922 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.27 89.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 109.308 179.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.1 mm-40 -71.49 -45.35 62.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.532 -0.73 . . . . 0.0 109.354 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.543 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -57.91 -31.07 66.42 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.542 ' CG ' ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -64.53 -62.09 1.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.513 0.673 . . . . 0.0 109.238 179.092 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 44.2 t -51.93 -38.99 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.716 . . . . 0.0 109.684 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.82 -28.54 70.08 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.036 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.477 ' CG1' HG21 ' A' ' 82' ' ' VAL . 39.9 mt -88.08 -27.63 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.006 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 8.9 m -79.97 -26.94 39.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.101 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.0 -38.99 20.23 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.25 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.545 ' CD2' ' CB ' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -65.99 -34.49 78.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 8.1 m-30 -86.45 -19.14 30.04 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -87.69 -28.12 21.99 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.831 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -90.41 -20.23 23.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.247 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.605 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -79.2 -59.63 2.69 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.658 -0.651 . . . . 0.0 109.56 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.605 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.8 m-20 149.01 30.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.275 0.56 . . . . 0.0 109.925 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.513 ' CD1' ' HB3' ' A' ' 73' ' ' LYS . 1.9 mp -99.94 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.836 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.6 63.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 m -49.89 117.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.909 0.862 . . . . 0.0 109.975 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.535 HG22 ' CG ' ' A' ' 66' ' ' GLU . 2.4 t -93.6 -44.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 121.165 0.507 . . . . 0.0 110.403 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.459 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 1.5 t70 -139.28 155.71 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.783 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.542 ' HB ' ' CG ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -136.86 174.44 11.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.318 -0.864 . . . . 0.0 110.101 -179.822 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 175.17 178.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.168 -0.957 . . . . 0.0 110.057 179.896 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.571 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 18.5 p -103.14 170.18 8.12 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.632 ' HA3' ' CB ' ' A' ' 60' ' ' PHE . . . -121.95 132.32 8.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 53.3 m 57.46 -92.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 110.448 179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.454 ' N ' HG22 ' A' ' 56' ' ' THR . 1.1 t-20 -154.53 99.32 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 110.744 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.53 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 42.1 mtm180 45.12 23.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -121.26 -32.88 3.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CB ' ' HA3' ' A' ' 55' ' ' GLY . 8.6 m-85 -119.88 -161.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 109.407 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 22' ' ' ILE . . . -167.92 167.65 40.22 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.58 ' CE1' ' OD1' ' A' ' 64' ' ' ASP . 14.6 t80 -142.01 153.58 44.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.394 -1.062 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 43.7 t -157.56 158.81 2.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.192 -178.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.58 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 11.4 m-20 -123.85 142.35 51.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.679 -0.638 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 49.6 m-85 -104.73 175.32 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 111.049 -179.215 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.535 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.37 11.76 20.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 111.524 -178.585 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.546 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.3 p -172.7 172.91 4.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 112.178 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.426 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -79.14 -23.96 43.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.43 -24.1 29.71 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.11 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CB ' ' OG ' ' A' ' 67' ' ' SER . 5.6 t0 -82.94 -26.58 31.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.58 HD23 ' CD2' ' A' ' 65' ' ' PHE . 2.8 tm? -79.58 -34.47 40.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.287 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.8 -33.86 62.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 109.779 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -80.62 -21.94 41.05 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.589 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -77.8 -28.23 50.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.198 179.059 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.517 HD22 ' CD1' ' A' ' 89' ' ' LEU . 2.0 tm? -75.72 -46.23 32.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.68 -26.31 66.97 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.218 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.493 HD13 ' CD1' ' A' ' 47' ' ' LEU . 6.9 mt -70.7 -20.58 62.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.839 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 75' ' ' LEU . 1.5 t -39.66 -31.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.306 1.05 . . . . 0.0 110.212 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.27 -20.31 9.75 Favored Glycine 0 C--N 1.281 -2.489 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.545 ' CB ' ' CD2' ' A' ' 41' ' ' LEU . 2.9 pp -66.99 125.84 27.26 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.319 -1.106 . . . . 0.0 110.655 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 11.0 mttt -93.88 78.67 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.301 1.048 . . . . 0.0 110.26 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.537 ' CG2' ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -43.8 131.09 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.146 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.573 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 3.0 m-85 44.32 24.25 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.467 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 91.21 25.03 25.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' ILE . 39.4 m-20 -140.35 104.8 4.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -1.184 . . . . 0.0 110.343 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 5.9 tt0 -56.35 84.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.289 -0.882 . . . . 0.0 109.933 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.526 ' CG2' HG22 ' A' ' 82' ' ' VAL . 2.7 pp -40.09 129.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.523 0.678 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.463 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -104.78 132.75 50.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.507 -0.745 . . . . 0.0 109.376 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.517 ' CD1' HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -105.64 174.07 6.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.888 -1.133 . . . . 0.0 110.737 -179.45 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 16' ' ' THR . 27.2 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.676 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.586 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 65.2 p -139.57 164.48 38.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.448 -0.782 . . . . 0.0 110.579 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.555 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 50.9 Cg_endo -78.21 -31.6 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.127 1.593 . . . . 0.0 110.695 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 89.9 m-85 -92.82 93.05 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.103 -0.998 . . . . 0.0 110.607 -179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.5 m120 -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.252 -0.905 . . . . 0.0 109.317 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.1 pt? -158.94 -176.63 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.714 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.2 t80 -101.37 156.61 17.35 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.592 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 2.4 mt -147.41 155.77 10.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.078 -1.014 . . . . 0.0 109.572 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -143.13 -162.7 9.42 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t30 71.38 14.09 6.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -1.107 . . . . 0.0 110.025 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 34' ' ' LEU . 3.4 mm? -66.5 124.81 23.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.704 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 32.6 t-20 -40.96 101.09 0.23 Allowed Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.623 -0.673 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 45.8 Cg_endo -72.37 -31.62 11.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.079 1.568 . . . . 0.0 110.433 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 26' ' ' ASN . 28.4 p30 -72.68 -14.8 61.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.2 tmtt? -96.79 -153.78 0.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.79 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -112.45 148.58 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.372 -0.83 . . . . 0.0 110.279 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.538 ' CG2' ' CB ' ' A' ' 58' ' ' ARG . 3.7 t -68.75 -25.25 30.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 36' ' ' VAL . . . -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 29.9 mm-40 -72.96 -31.67 64.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' A' ' 25' ' ' LEU . 23.5 mt -65.89 -31.83 72.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -72.1 -56.48 5.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.553 179.484 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 5.6 t -61.02 -33.69 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 179.134 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.72 -38.4 90.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.587 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 65.8 mt -75.52 -29.07 20.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.722 . . . . 0.0 109.584 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -77.46 -31.94 54.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.0 -1.063 . . . . 0.0 108.819 179.084 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.6 tm-20 -81.7 -42.23 20.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.507 0.67 . . . . 0.0 109.556 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' ' CD1' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -59.54 -37.58 78.76 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.748 -0.781 . . . . 0.0 108.966 179.167 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 9.7 m-85 -82.12 -22.65 36.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . -79.68 -17.2 54.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -109.24 -16.98 13.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 109.741 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.713 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -84.4 -31.29 24.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.713 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.9 t0 112.62 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-O 121.971 0.891 . . . . 0.0 108.765 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.506 HD12 ' CG ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -105.59 -155.01 0.53 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.769 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -168.98 63.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.282 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.579 HG13 ' CD2' ' A' ' 42' ' ' PHE . 4.9 m -49.62 116.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.85 0.833 . . . . 0.0 109.829 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 10.5 t -81.25 -38.0 16.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 52' ' ' VAL . 8.7 t0 -153.6 152.66 31.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.087 -1.008 . . . . 0.0 110.55 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 13.4 t -134.92 161.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 26.5 mtp180 -155.61 154.87 32.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.009 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.515 ' CG2' HG11 ' A' ' 31' ' ' VAL . 14.3 p -78.66 166.82 22.08 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.975 . . . . 0.0 110.398 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.538 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -141.06 122.3 2.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 55' ' ' GLY . 32.1 m 40.4 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.337 -1.096 . . . . 0.0 111.008 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' THR . 21.4 m120 60.11 -141.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.73 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.538 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 3.6 ptt85 -114.5 34.32 4.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 11.1 pttt -118.47 -19.14 8.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 109.959 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -119.89 174.16 6.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.547 179.637 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -176.59 148.66 9.19 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.815 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 8.4 t80 -111.51 157.57 20.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.883 . . . . 0.0 109.016 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.625 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -141.28 172.34 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.773 -1.204 . . . . 0.0 111.3 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 2.6 m-20 -136.43 135.94 39.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.769 -0.582 . . . . 0.0 109.457 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 16.8 m-85 -106.47 -178.66 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.562 -0.711 . . . . 0.0 110.988 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.563 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 2.1 pp20? -117.45 5.55 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 111.044 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.577 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.4 p -168.96 175.2 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.301 1.048 . . . . 0.0 112.21 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.99 -23.56 41.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.74 -26.46 31.9 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.013 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 65' ' ' PHE . 3.4 t0 -81.05 -27.76 35.63 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -75.5 -37.16 60.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -69.99 -33.9 72.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.753 . . . . 0.0 109.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.506 ' CG ' HD12 ' A' ' 47' ' ' LEU . 2.7 tppt? -73.4 -25.71 60.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.68 -26.99 61.82 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.943 0.878 . . . . 0.0 108.641 178.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 78' ' ' THR . 1.7 tm? -76.22 -34.47 59.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -16.76 48.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.729 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.527 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 1.1 pp -66.38 -17.83 65.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.98 -1.075 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -47.72 -16.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.569 -0.707 . . . . 0.0 111.751 -179.359 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -82.72 14.78 34.64 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.539 ' CD1' ' CD2' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -101.4 -163.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -1.195 . . . . 0.0 110.507 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.598 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -168.35 49.76 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 109.627 -179.758 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.581 ' CG2' ' CD1' ' A' ' 87' ' ' ILE . 5.0 t 5.67 -122.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.708 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 3.3 m-85 -72.31 -2.9 20.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.985 -1.072 . . . . 0.0 109.355 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 145.99 35.24 0.06 OUTLIER Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.1 m-20 -157.87 101.93 1.81 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -1.215 . . . . 0.0 109.996 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.598 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 2.8 pt-20 -52.58 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.581 ' CD1' ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -37.92 148.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.693 0.758 . . . . 0.0 110.75 -179.645 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 16.3 ttpt -121.87 156.81 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.578 ' CD2' ' CD1' ' A' ' 20' ' ' LEU . 1.8 mp -112.88 173.41 6.39 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.047 -1.033 . . . . 0.0 110.415 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 16' ' ' THR . 7.2 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.193 0.521 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -166.68 162.89 11.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.325 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.76 -32.87 5.4 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.115 1.587 . . . . 0.0 110.489 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 84.9 m-85 -108.47 107.36 17.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.927 . . . . 0.0 110.432 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -139.25 146.72 40.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.868 . . . . 0.0 109.339 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -163.17 175.1 11.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.12 -0.987 . . . . 0.0 110.924 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 60' ' ' PHE . 2.4 t80 -97.37 147.75 23.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.713 -0.617 . . . . 0.0 110.103 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.522 HD11 ' CG2' ' A' ' 63' ' ' VAL . 1.1 mp -133.85 148.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.946 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -135.56 -166.05 10.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 28.1 t30 67.15 58.16 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.099 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 61' ' ' GLY . 8.1 mt -105.95 123.99 48.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 110.366 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.494 ' N ' HD12 ' A' ' 34' ' ' LEU . 53.3 t-20 -41.45 104.13 0.33 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.774 . . . . 0.0 110.213 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.75 -15.48 26.85 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -78.13 -17.15 57.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.19 -156.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.742 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.517 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -100.33 146.85 26.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -70.85 -33.27 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.044 -1.063 . . . . 0.0 108.622 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.35 94.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 108.956 178.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 12.8 mm-40 -66.56 -33.54 75.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -64.26 -33.8 76.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.186 179.231 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 5.2 mmtt -66.29 -53.79 32.5 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.474 -0.766 . . . . 0.0 109.119 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -60.84 -40.94 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.376 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.8 -29.16 69.96 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 108.951 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.584 HG21 ' CE2' ' A' ' 42' ' ' PHE . 10.3 mt -85.86 -30.28 6.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.101 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 p -78.65 -25.77 45.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 109.283 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -84.43 -39.89 18.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.47 -0.768 . . . . 0.0 109.137 179.39 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -62.65 -36.83 84.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.739 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CZ ' ' CD2' ' A' ' 77' ' ' LEU . 9.1 m-30 -80.01 -25.19 40.35 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . . . -68.67 -40.15 80.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.488 179.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.51 -17.57 53.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.45 -0.781 . . . . 0.0 109.506 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.11 -8.73 58.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.521 -0.737 . . . . 0.0 110.009 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 9.1 t0 84.52 30.26 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.954 0.883 . . . . 0.0 108.848 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.582 HD22 ' CD1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -83.72 -132.34 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.321 0.581 . . . . 0.0 109.544 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' CG ' ' A' ' 66' ' ' GLU . . . 174.5 57.39 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.361 -0.837 . . . . 0.0 109.837 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.19 117.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.907 0.86 . . . . 0.0 110.472 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.526 ' CB ' HG22 ' A' ' 16' ' ' THR . 0.2 OUTLIER -92.42 -44.22 14.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.289 0.566 . . . . 0.0 109.651 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.499 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 35.2 t70 -136.76 145.8 45.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -0.902 . . . . 0.0 110.615 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 1.8 t -153.96 119.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.374 -0.829 . . . . 0.0 109.132 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.72 160.04 40.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.891 -1.13 . . . . 0.0 111.266 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.541 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 39.2 p -92.21 152.29 19.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.5 -0.75 . . . . 0.0 110.027 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -125.95 124.29 5.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.582 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER 67.97 -158.86 0.21 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.363 -1.081 . . . . 0.0 110.482 179.751 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.458 ' C ' ' CG ' ' A' ' 58' ' ' ARG . 10.3 t-20 -82.57 74.1 9.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.456 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.537 ' CG ' ' CG2' ' A' ' 31' ' ' VAL . 0.4 OUTLIER 60.64 14.54 5.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 179.663 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -69.27 -50.51 46.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.582 ' CZ ' ' OG1' ' A' ' 56' ' ' THR . 5.3 p90 -156.8 152.24 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.884 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.519 ' N ' HD13 ' A' ' 25' ' ' LEU . . . -124.04 167.95 16.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.1 t80 -119.75 155.3 32.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.406 -1.055 . . . . 0.0 109.721 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.59 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.2 t -151.2 143.43 16.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.746 -178.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -117.83 143.96 45.81 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CD1' HD22 ' A' ' 47' ' ' LEU . 37.6 m-85 -107.92 171.76 7.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.538 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 1.2 pp20? -118.55 16.38 13.74 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.29 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.505 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.0 p -164.37 176.13 9.37 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.466 1.127 . . . . 0.0 112.207 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.91 -25.09 43.74 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -31.07 59.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.093 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.528 ' CB ' ' HB3' ' A' ' 65' ' ' PHE . 91.3 m-20 -78.7 -28.4 45.12 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.569 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 1.8 tm? -74.64 -37.84 62.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -65.81 -34.53 78.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 0.0 109.025 178.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.528 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.02 -32.35 59.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.976 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.574 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -56.14 -33.57 65.32 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.47 -46.13 56.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.52 6.71 16.6 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.346 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.629 ' CD2' ' CZ ' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -77.15 -12.61 59.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.773 . . . . 0.0 110.367 -179.896 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 26.1 m -73.68 7.63 2.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.513 -0.742 . . . . 0.0 111.558 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' HG3' ' A' ' 86' ' ' GLU . . . -124.39 18.34 7.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.517 ' CD2' HD23 ' A' ' 41' ' ' LEU . 27.3 mt -107.66 111.16 23.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -1.143 . . . . 0.0 110.809 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 38.1 mttm -76.91 84.02 3.46 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.07 0.938 . . . . 0.0 109.741 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.55 ' CG2' ' N ' ' A' ' 83' ' ' PHE . 1.2 p -36.96 -94.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.415 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -96.81 29.05 3.17 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.159 -0.963 . . . . 0.0 109.681 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.46 9.54 12.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 87' ' ' ILE . 3.4 m-20 -139.95 106.28 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 78' ' ' THR . 1.6 tm-20 -47.67 88.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.692 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 85' ' ' ASN . 0.6 OUTLIER -45.73 145.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 179.777 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 89' ' ' LEU . 10.0 ttmt -117.58 155.7 29.36 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.647 -0.658 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -120.66 175.02 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.417 -0.802 . . . . 0.0 110.327 -179.769 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 O-C-N 121.542 -0.724 . . . . 0.0 109.663 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 15' ' ' THR . 23.8 m . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.055 0.455 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.584 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.42 168.78 1.59 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.817 -1.177 . . . . 0.0 110.854 -179.88 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD2' HG21 ' A' ' 16' ' ' THR . 50.6 Cg_endo -79.33 -48.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.218 1.641 . . . . 0.0 110.638 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CE2' ' CA ' ' A' ' 67' ' ' SER . 98.3 m-85 -85.84 110.03 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 5.6 m-80 -139.23 152.04 47.01 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.494 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 4.4 pp -162.54 -177.71 5.78 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.68 ' CD1' ' CE2' ' A' ' 62' ' ' TYR . 7.8 t80 -117.78 144.64 45.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.446 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.53 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.1 mt -133.49 155.4 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.333 -0.854 . . . . 0.0 109.132 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -128.18 -174.86 13.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.194 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.3 t30 74.86 13.69 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.906 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' LYS . 4.3 mm? -62.59 123.5 18.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.823 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.525 ' CB ' HD22 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -39.57 99.41 0.19 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.876 -0.515 . . . . 0.0 110.496 179.984 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.8 Cg_endo -78.16 -17.2 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.979 1.515 . . . . 0.0 110.619 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.11 -17.78 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.94 . . . . 0.0 110.071 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.571 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -110.5 -157.07 0.6 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 109.613 179.626 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.05 140.89 32.53 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 110.365 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.6 t -67.24 -34.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.732 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . . . -57.86 -34.53 69.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 44.6 mm-40 -68.23 -43.71 77.35 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.534 HD21 ' CG1' ' A' ' 82' ' ' VAL . 9.1 mt -61.15 -46.07 92.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.525 ' HG2' ' CG2' ' A' ' 52' ' ' VAL . 90.7 mttt -53.54 -51.05 64.14 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.314 0.578 . . . . 0.0 109.495 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.3 t -63.64 -38.56 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.474 179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.89 -35.64 81.31 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.733 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 93.4 mt -79.24 -28.14 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 109.171 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.524 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 6.9 t -78.0 -31.71 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 108.972 179.2 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.75 -38.85 32.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.603 -0.686 . . . . 0.0 109.765 179.589 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD2' ' HB3' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.67 -31.74 71.93 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.315 179.335 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.2 m-85 -82.18 -23.71 35.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 108.928 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.42 65.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.471 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -94.14 -17.26 22.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.684 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.665 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -81.77 -24.57 35.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.665 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 23.6 t70 101.57 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.472 HD13 ' CD2' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -97.5 -151.04 0.36 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.88 62.34 0.06 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.081 -1.012 . . . . 0.0 109.841 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 7.3 m -54.23 117.77 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.043 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 2.1 t -93.41 -39.13 10.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.981 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -146.75 163.65 35.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.072 -1.017 . . . . 0.0 110.572 179.864 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.525 ' CG2' ' HG2' ' A' ' 35' ' ' LYS . 14.4 p -165.61 114.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 109.909 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -119.59 165.3 14.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.596 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 3.8 p -79.56 171.24 15.41 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.43 -0.794 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 60' ' ' PHE . . . -140.45 98.48 0.23 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.634 -1.269 . . . . 0.0 110.479 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 85.6 m 58.78 130.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -1.089 . . . . 0.0 111.779 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' THR . 1.3 m-80 33.18 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.858 -0.526 . . . . 0.0 111.586 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.531 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 3.6 mtp-105 43.5 25.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.074 -1.016 . . . . 0.0 110.313 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.37 -33.27 18.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 55' ' ' GLY . 3.0 m-85 -112.68 -160.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 0.0 109.167 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 179.24 125.99 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.066 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 61.1 m-85 -90.2 158.57 17.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -1.124 . . . . 0.0 109.598 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 2.8 t -149.86 141.4 17.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.906 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 52.0 m-20 -112.67 146.46 38.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.0 109.53 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.606 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 50.3 m-85 -112.38 177.22 4.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.878 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HG2' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -113.79 18.86 17.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 111.475 -178.354 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.61 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 23.4 p -178.83 -179.3 0.6 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.643 1.211 . . . . 0.0 112.325 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.259 . . -81.0 -28.58 35.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.13 -24.92 59.5 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.229 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 79.1 m-20 -83.33 -33.34 25.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 71' ' ' LEU . 9.5 tp -70.67 -36.93 73.59 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.741 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -71.81 -41.17 68.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.689 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -74.25 -32.62 63.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.134 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.606 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -60.26 -29.92 69.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.18 -49.03 38.8 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.09 -0.46 28.2 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.31 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.582 HD12 ' CE1' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -82.56 17.08 1.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 110.367 -179.725 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.514 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 86.3 m -87.73 5.62 39.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.09 20.92 33.76 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -118.12 124.74 48.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.25 -1.147 . . . . 0.0 110.602 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 14.9 mttt -87.98 82.54 7.21 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.613 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.554 ' CG2' ' CG2' ' A' ' 87' ' ' ILE . 76.5 t -42.99 106.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.5 OUTLIER 60.09 22.67 11.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 110.397 -179.17 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.84 14.72 30.86 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' ILE . 19.5 m-20 -133.3 103.26 5.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.136 -1.214 . . . . 0.0 110.207 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.7 tt0 -57.52 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.554 ' CG2' ' CG2' ' A' ' 82' ' ' VAL . 13.0 pt -41.71 137.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.382 -0.824 . . . . 0.0 110.586 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -104.48 167.86 9.47 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.164 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.53 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 1.4 mp -109.7 179.0 4.25 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.04 -1.038 . . . . 0.0 110.641 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.949 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 15' ' ' THR . 5.1 m . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.193 0.52 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.524 HG23 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -173.52 161.98 3.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 110.516 -179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.77 -40.51 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.249 1.657 . . . . 0.0 110.675 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.482 ' CB ' ' HB2' ' A' ' 65' ' ' PHE . 81.6 m-85 -95.51 111.16 23.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 m120 -135.64 151.87 50.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.825 . . . . 0.0 109.687 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.637 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -160.01 166.89 29.12 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 110.512 -179.651 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 1.1 t80 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 110.002 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.529 ' CD1' HG22 ' A' ' 63' ' ' VAL . 7.8 mt -126.19 162.56 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -147.81 175.73 26.99 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 30.9 t30 72.71 64.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.582 -0.952 . . . . 0.0 110.07 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' A' ' 34' ' ' LEU . 18.9 mt -95.4 -167.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.463 ' HB3' HD12 ' A' ' 34' ' ' LEU . 54.0 t-20 -114.61 107.03 51.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.52 ' HA ' ' CD ' ' A' ' 58' ' ' ARG . 44.4 Cg_endo -72.27 -1.82 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.064 1.56 . . . . 0.0 110.579 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -113.97 20.52 15.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.671 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' CG ' ' OE2' ' A' ' 33' ' ' GLU . 2.2 tptm -148.12 -157.98 0.87 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.78 139.9 45.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.685 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 20.7 t -66.8 -28.42 43.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.08 179.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.79 85.18 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.568 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -64.4 -30.29 71.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.811 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.505 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.63 -37.42 84.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 108.932 178.921 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 13.3 mmtt -61.71 -54.07 47.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.459 -0.775 . . . . 0.0 109.306 179.251 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 42.7 t -49.21 -41.29 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.824 . . . . 0.0 109.88 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -62.39 -33.18 74.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.17 -0.956 . . . . 0.0 108.724 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 32.6 mt -82.03 -26.01 9.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.586 -0.696 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.75 -28.34 36.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 108.574 178.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -81.45 -41.13 22.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.57 0.7 . . . . 0.0 109.381 179.393 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.584 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.13 -34.43 78.02 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.096 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.636 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 5.9 m-85 -80.79 -23.56 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.04 -33.1 65.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 109.105 179.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.28 -17.3 24.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.402 179.278 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.17 -20.76 37.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.435 -0.791 . . . . 0.0 109.995 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.2 t70 95.76 29.17 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.992 0.901 . . . . 0.0 108.877 -179.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.636 ' CD1' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -91.68 -143.73 0.19 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.316 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.526 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -176.29 60.12 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 m -55.23 118.23 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.902 0.858 . . . . 0.0 110.214 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -92.03 -38.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.158 0.504 . . . . 0.0 109.82 -179.498 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.512 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 1.6 t70 -137.21 152.11 49.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 0.0 110.64 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.527 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -157.82 114.42 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.491 -0.755 . . . . 0.0 109.62 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG2' ' HB3' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -134.97 175.47 9.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.502 ' CG2' ' HB ' ' A' ' 31' ' ' VAL . 16.8 p -83.48 175.0 10.12 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.224 -0.923 . . . . 0.0 110.187 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -130.5 117.11 2.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.519 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.8 m 77.05 -64.81 0.31 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.117 -0.637 . . . . 0.0 109.829 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 56' ' ' THR . 18.9 p-10 179.91 -32.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.448 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.544 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -177.57 28.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -115.0 -33.61 5.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.205 -0.934 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.698 ' CD1' ' CE2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.91 -179.28 6.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.372 -0.83 . . . . 0.0 109.346 179.175 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.623 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -148.9 168.18 29.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.52 ' C ' ' CG2' ' A' ' 63' ' ' VAL . 5.9 t80 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -1.162 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 22' ' ' ILE . 3.7 t -151.63 158.35 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.531 -178.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.472 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 28.4 m-20 -130.96 142.68 50.37 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.111 -0.993 . . . . 0.0 109.951 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.639 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 64.3 m-85 -106.96 172.42 6.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.42 -0.8 . . . . 0.0 110.004 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.11 17.75 13.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -0.987 . . . . 0.0 111.462 -178.32 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.472 ' OG ' ' OD2' ' A' ' 70' ' ' ASP . 26.7 p -168.17 175.81 6.36 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.525 1.155 . . . . 0.0 112.437 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.83 -24.82 48.56 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -77.23 -26.6 52.83 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.576 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.53 ' CB ' ' HB3' ' A' ' 65' ' ' PHE . 90.2 m-20 -82.9 -30.04 28.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.6 -36.87 68.21 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.786 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.53 -36.91 63.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 109.973 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.532 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.22 -26.59 52.85 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.654 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.639 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -70.67 -29.37 65.68 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.912 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.464 ' HA ' HD11 ' A' ' 89' ' ' LEU . 4.7 tt -71.74 -46.96 56.87 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -4.22 44.05 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.257 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.586 ' CD1' ' CZ ' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -76.38 6.81 5.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.538 -0.726 . . . . 0.0 110.547 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.429 ' OG1' HD22 ' A' ' 89' ' ' LEU . 54.3 m -76.65 3.11 12.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 110.299 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.72 28.85 10.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.584 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.0 120.57 39.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -1.062 . . . . 0.0 110.236 -179.579 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 2.1 ttmt -91.58 87.97 6.57 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 123.017 1.389 . . . . 0.0 109.385 178.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 87' ' ' ILE . 98.5 t -43.24 -105.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.686 -179.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HB1' ' A' ' 37' ' ' ALA . 6.3 m-85 -90.13 40.37 1.0 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.014 -1.054 . . . . 0.0 109.964 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.54 19.57 24.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.525 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 12.4 m-80 -147.01 92.58 2.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 110.105 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.6 mt-10 -43.27 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.532 HG12 ' CG2' ' A' ' 82' ' ' VAL . 2.2 pp -58.67 129.21 20.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 110.203 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -104.63 133.22 49.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.466 179.701 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -110.72 174.16 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.936 -1.102 . . . . 0.0 111.122 -179.38 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.481 0 O-C-N 121.635 -0.666 . . . . 0.0 109.634 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.552 0.691 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.532 HG22 ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -119.04 163.9 23.97 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.553 -0.717 . . . . 0.0 110.567 -179.632 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.4 -29.56 6.0 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.201 1.632 . . . . 0.0 110.47 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.537 ' CE2' ' C ' ' A' ' 67' ' ' SER . 86.9 m-85 -108.54 113.2 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.667 -179.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 2.0 m120 -141.8 149.15 40.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.581 ' O ' ' CZ ' ' A' ' 62' ' ' TYR . 4.5 pp -164.62 -176.9 4.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.451 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.434 ' O ' HD13 ' A' ' 20' ' ' LEU . 7.7 t80 -108.94 153.35 23.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 110.169 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 23' ' ' GLY . 1.6 mt -138.92 155.27 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.915 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.24 -169.89 11.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.0 t30 72.0 51.32 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.498 -1.001 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.532 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 13.8 mt -102.51 120.97 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.915 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.51 ' N ' HD23 ' A' ' 34' ' ' LEU . 34.6 t30 -47.13 104.53 0.42 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.581 -0.699 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.6 Cg_endo -75.44 -5.02 16.1 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.045 1.55 . . . . 0.0 110.433 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.11 -20.35 45.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.99 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -107.95 -156.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.5 m -98.5 146.75 25.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 54' ' ' THR . 4.5 t -67.98 -34.1 65.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.722 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.449 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -64.52 -34.6 78.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.741 179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.519 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 59.0 mm-40 -71.44 -34.98 70.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.336 179.367 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 25' ' ' LEU . 6.7 mp -66.54 -29.02 69.0 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -70.94 -54.98 9.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.461 -0.775 . . . . 0.0 109.1 179.158 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.2 t -60.15 -35.03 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.817 . . . . 0.0 109.379 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.45 -38.03 88.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.9 mt -76.03 -29.37 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.493 179.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.491 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 1.9 t -78.66 -29.75 45.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.084 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.3 tm-20 -81.48 -36.95 28.7 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.522 ' CD1' HD11 ' A' ' 80' ' ' LEU . 1.1 tt -69.73 -30.2 67.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.502 -0.748 . . . . 0.0 109.093 179.038 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.571 ' CE1' HD11 ' A' ' 77' ' ' LEU . 3.9 m-85 -90.02 -16.71 29.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.492 -0.755 . . . . 0.0 109.388 179.278 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.88 -28.83 18.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.761 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.445 ' HE3' ' OE2' ' A' ' 40' ' ' GLU . 47.6 mttt -89.4 -24.6 21.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -77.41 -59.3 2.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.552 -0.717 . . . . 0.0 109.493 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 p30 148.02 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.489 0.661 . . . . 0.0 110.828 179.419 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -91.76 -154.35 0.37 Allowed 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.381 -0.824 . . . . 0.0 109.96 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.86 63.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 15.8 m -67.2 115.65 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.532 ' CG1' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -90.09 -39.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.223 0.535 . . . . 0.0 109.972 -179.602 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.521 ' CB ' ' OD2' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -140.78 156.31 46.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.0 110.566 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.5 ' CG2' ' C ' ' A' ' 51' ' ' ASP . 3.9 t -152.9 100.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.823 . . . . 0.0 110.017 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 2.3 ttp180 -99.69 167.44 10.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.527 ' CG2' HG11 ' A' ' 31' ' ' VAL . 12.7 p -88.25 169.7 11.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.243 -0.911 . . . . 0.0 110.475 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -128.75 115.46 2.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 1.0 OUTLIER 65.83 -150.58 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -1.064 . . . . 0.0 110.075 -179.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -63.76 -55.37 23.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.421 ' HA ' HG22 ' A' ' 31' ' ' VAL . 6.7 ptt-85 -176.39 49.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 110.254 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 16.5 mtpt -123.68 -23.93 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 110.293 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -132.48 178.37 6.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -164.63 142.99 8.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 13.5 t80 -97.03 157.77 15.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -1.179 . . . . 0.0 109.763 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.509 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 3.1 t -151.71 140.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.959 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' OD2' ' CB ' ' A' ' 51' ' ' ASP . 2.3 m-20 -108.09 140.82 40.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.473 -0.767 . . . . 0.0 109.056 178.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 8.5 m-85 -103.94 178.34 4.59 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.284 -0.885 . . . . 0.0 110.446 -179.026 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.466 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -108.15 -9.64 15.54 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.799 -178.447 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.558 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 17.3 p -168.12 -176.58 3.01 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.812 1.291 . . . . 0.0 113.061 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.79 -18.63 37.04 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.415 ' OE2' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -87.72 -27.09 22.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.069 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.564 ' OD2' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -82.5 -29.75 30.31 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.947 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.471 ' C ' ' CD2' ' A' ' 71' ' ' LEU . 2.0 tt -72.56 -37.65 68.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.47 -40.84 85.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.328 179.205 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 9.9 mttm -75.61 -27.33 58.45 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.289 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.03 -28.11 63.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.582 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 1.5 tm? -69.55 -46.3 66.76 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.88 -13.75 61.75 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.939 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -73.12 2.6 6.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 110.396 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.7 m -75.1 2.66 10.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.058 -1.026 . . . . 0.0 110.592 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.14 11.99 65.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' A' ' 77' ' ' LEU . 75.4 mt -89.55 -165.18 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.307 -1.113 . . . . 0.0 110.591 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.607 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -169.27 48.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.703 0.763 . . . . 0.0 109.867 179.796 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 81' ' ' LYS . 3.9 t 6.44 -123.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.636 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.564 ' CD2' ' HG3' ' A' ' 29' ' ' LYS . 16.6 m-85 -73.03 -3.16 24.43 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.149 178.743 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 146.89 35.32 0.06 OUTLIER Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.9 t30 -158.1 101.45 1.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -1.215 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.607 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -50.44 90.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.99 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.535 ' CG2' HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -39.84 137.27 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.568 0.699 . . . . 0.0 110.211 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 28.4 ttmt -112.78 156.44 22.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.522 -0.736 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.582 ' CD1' ' CD2' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -117.01 175.12 5.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 110.643 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.592 -0.692 . . . . 0.0 109.541 -179.503 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 15' ' ' THR . 19.6 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.29 0.567 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.528 HG23 ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -176.65 166.16 1.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.312 -179.876 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HD2' HG22 ' A' ' 16' ' ' THR . 51.2 Cg_endo -79.66 -25.93 5.07 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.107 1.583 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CZ ' ' CB ' ' A' ' 68' ' ' ALA . 79.1 m-85 -111.89 108.81 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.815 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -142.15 152.06 42.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 108.999 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.565 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 3.7 pp -162.65 -176.19 4.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.791 -179.686 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.3 t80 -104.39 154.48 19.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.548 -0.72 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.593 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 6.2 mt -143.83 152.73 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.54 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -140.7 -167.11 10.94 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.869 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.9 t30 70.7 38.29 1.27 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.339 -1.095 . . . . 0.0 109.888 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.8 mm? -88.97 127.97 35.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.297 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.444 ' ND2' ' HD2' ' A' ' 29' ' ' LYS . 34.5 t-20 -39.96 100.22 0.21 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.651 -0.656 . . . . 0.0 110.528 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -74.87 -13.14 21.79 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -87.68 -10.01 52.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG2' ' OE1' ' A' ' 33' ' ' GLU . 18.2 mttt -112.98 -159.0 0.67 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.772 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.5 m -97.2 146.0 25.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.516 HG12 ' CG2' ' A' ' 54' ' ' THR . 3.4 t -65.15 -38.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.185 179.38 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -59.6 -37.71 79.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.224 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.596 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.0 -29.86 68.97 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 7.7 mt -68.94 -31.56 70.52 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.328 -0.857 . . . . 0.0 109.437 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.533 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 9.7 mmpt? -69.13 -51.56 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.7 t -60.58 -39.53 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.566 -0.708 . . . . 0.0 109.892 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.598 ' CB ' ' CD2' ' A' ' 83' ' ' PHE . . . -62.26 -34.84 77.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 108.764 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 34' ' ' LEU . 44.7 mt -79.45 -29.79 13.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.597 -0.689 . . . . 0.0 109.193 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -77.81 -28.45 50.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.133 179.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -81.74 -39.03 24.79 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.534 0.683 . . . . 0.0 109.446 179.402 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 6.0 tp -66.08 -32.8 74.48 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.024 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 7.7 m-85 -85.52 -20.64 29.36 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.418 -0.801 . . . . 0.0 108.898 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.36 -31.66 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.514 -0.741 . . . . 0.0 109.508 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 8.9 mtpt -89.17 -23.39 22.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.639 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.503 -0.748 . . . . 0.0 109.829 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.7 t70 90.89 31.01 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.011 0.91 . . . . 0.0 108.851 -179.329 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.579 ' HG ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -77.96 -137.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.434 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.529 ' N ' HD11 ' A' ' 47' ' ' LEU . . . -171.16 58.05 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.546 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 15.6 m -66.82 113.14 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.772 0.796 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.586 ' CG2' ' CG ' ' A' ' 66' ' ' GLU . 71.3 t -91.07 -24.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 O-C-N 121.814 -0.554 . . . . 0.0 110.291 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.524 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -162.49 163.66 27.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 110.387 179.741 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.533 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.3 t -150.93 156.94 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -155.61 165.57 36.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.119 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.516 ' CG2' HG12 ' A' ' 31' ' ' VAL . 25.8 p -86.83 161.13 18.51 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -137.35 127.13 3.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 55' ' ' GLY . 6.3 m 49.77 100.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.169 . . . . 0.0 110.713 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' THR . 3.6 m-80 39.56 -98.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -141.13 30.53 1.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.007 -1.058 . . . . 0.0 110.636 -179.594 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -121.2 14.17 11.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.995 179.761 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CE2' ' CE2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -156.51 178.51 10.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.69 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -178.58 150.95 10.0 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.724 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.565 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 10.6 t80 -113.5 158.53 20.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.971 . . . . 0.0 109.013 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.554 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.4 t -151.09 144.36 16.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.881 -178.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 1.0 OUTLIER -102.75 146.56 28.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.527 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.576 ' CD1' ' OD2' ' A' ' 70' ' ' ASP . 3.7 m-85 -112.38 -172.23 2.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.937 -1.102 . . . . 0.0 111.165 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.586 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.21 -7.09 12.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.958 -179.421 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.578 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 24.1 p -176.18 175.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.58 1.181 . . . . 0.0 112.502 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.631 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -76.4 -25.81 54.9 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.108 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -29.47 58.22 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.964 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -76.6 -29.7 56.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.938 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -71.78 -38.78 70.25 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.606 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.19 -38.04 87.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.514 -0.741 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 2.5 mttp -81.56 -30.51 33.03 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.505 ' N ' HD23 ' A' ' 47' ' ' LEU . . . -74.95 -25.18 58.69 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.118 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 6.1 tt -73.35 -46.75 47.41 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.517 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.46 -14.81 62.25 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.875 178.218 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -71.82 -0.28 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.598 -0.689 . . . . 0.0 110.265 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 24.9 m -76.65 4.42 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.841 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.05 -8.66 86.27 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 3.5 mm? -80.46 -164.89 0.77 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -1.042 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.564 ' O ' ' C ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -148.45 51.41 1.0 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.624 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.564 ' C ' ' O ' ' A' ' 81' ' ' LYS . 8.7 p 17.04 -132.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.344 -179.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CD2' ' CB ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -78.6 11.47 2.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.447 -1.408 . . . . 0.0 109.666 178.579 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 143.57 36.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.6 t30 -174.07 115.76 0.21 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -1.19 . . . . 0.0 109.661 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.559 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 tt0 -52.5 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.104 -0.997 . . . . 0.0 110.346 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -44.75 143.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.802 179.668 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 9.3 mtmt -119.85 155.09 33.31 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -116.83 172.59 7.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.403 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.316 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 16' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 121.376 0.608 . . . . 0.0 109.934 . . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.59 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 20.3 p -140.64 160.99 56.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.417 -0.802 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.43 -22.53 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.013 1.533 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CE2' ' C ' ' A' ' 67' ' ' SER . 85.5 m-85 -123.36 115.38 21.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 111.159 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -138.72 150.84 46.59 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 21' ' ' PHE . 3.1 pp -165.22 -167.15 1.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.125 -0.984 . . . . 0.0 110.647 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.651 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 31.3 t80 -125.07 142.72 51.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.86 . . . . 0.0 110.019 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 23' ' ' GLY . 3.4 mt -119.99 170.12 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.03 -172.91 15.82 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t-20 73.26 48.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.61 -0.935 . . . . 0.0 110.177 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.7 mm? -93.3 123.04 36.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.429 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 22.5 t-20 -43.67 107.31 0.57 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.563 -0.711 . . . . 0.0 110.337 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.3 -27.94 15.79 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.104 1.581 . . . . 0.0 110.31 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -78.84 -17.03 56.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -106.19 -155.94 0.56 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 109.673 179.727 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 m -114.2 150.29 34.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.164 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG12 ' CG2' ' A' ' 54' ' ' THR . 2.8 t -69.38 -26.22 30.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.79 92.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.135 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.6 mm-40 -69.78 -46.17 66.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 109.148 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -55.37 -37.3 67.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.55 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HE2' HG21 ' A' ' 54' ' ' THR . 0.0 OUTLIER -56.85 -63.12 1.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.076 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.9 t -49.4 -35.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.49 -42.26 99.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 16.0 mm -73.11 -28.68 26.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.428 178.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.8 -29.44 50.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 0.0 109.044 179.351 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.46 -41.24 16.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.6 -0.687 . . . . 0.0 109.759 179.643 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -63.13 -34.91 78.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.49 -0.756 . . . . 0.0 109.187 179.177 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.634 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 8.6 m-85 -87.13 -21.15 26.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.079 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -77.19 -31.53 55.45 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.266 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -84.1 -19.46 34.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.52 -0.738 . . . . 0.0 109.138 179.25 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -87.31 -18.73 29.47 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.649 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.4 t70 87.84 29.62 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.634 ' CD1' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -76.89 -137.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.357 179.585 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . . . -176.27 57.55 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 49' ' ' VAL . 10.5 m -55.02 117.69 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.9 0.857 . . . . 0.0 109.87 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.59 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 2.2 t -90.95 -44.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.346 -179.382 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 17.5 t70 -143.9 148.03 34.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.105 -0.997 . . . . 0.0 110.926 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.501 ' CG1' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.13 158.31 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.427 -0.796 . . . . 0.0 109.577 179.907 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 62' ' ' TYR . 3.8 mtp180 -165.75 161.43 18.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.42 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.523 ' CG2' HG12 ' A' ' 31' ' ' VAL . 9.6 p -88.02 170.8 10.79 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 110.249 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -133.95 127.02 4.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 2.0 m 60.03 -135.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -1.138 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.528 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 14.8 t-20 -102.06 90.09 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.019 -1.051 . . . . 0.0 110.594 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.47 ' HA ' HG23 ' A' ' 31' ' ' VAL . 3.2 mtt180 43.34 45.57 5.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.61 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 18.9 mttt -124.32 -28.42 3.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.028 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 2.0 m-85 -138.82 -174.44 3.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 109.369 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -162.15 136.85 4.55 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.651 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 48.3 m-85 -94.48 159.98 14.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.137 . . . . 0.0 109.577 179.253 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 24.6 t -158.63 161.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.584 -178.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.4 m-20 -134.64 139.72 45.51 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.62 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 55.6 m-85 -103.66 175.34 5.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.905 -179.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.53 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.66 16.42 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 111.388 -178.543 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 20.7 p -178.38 176.71 1.03 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.434 1.111 . . . . 0.0 112.044 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.467 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.18 -23.52 51.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.91 -27.52 43.81 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.369 179.999 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 89.6 m-20 -80.37 -29.98 37.9 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.66 -36.78 60.05 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.323 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.33 -34.37 74.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.308 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -81.0 -26.29 36.57 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.326 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.62 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -64.77 -29.88 70.87 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.675 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -45.11 22.71 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.505 0.669 . . . . 0.0 109.246 179.12 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -23.28 66.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 110.019 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.588 HD11 ' CE2' ' A' ' 42' ' ' PHE . 20.8 mt -69.69 -5.17 23.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.465 ' OG1' HD12 ' A' ' 89' ' ' LEU . 25.9 m -67.39 -2.02 5.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.525 -0.734 . . . . 0.0 111.205 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.27 10.68 61.63 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 41' ' ' LEU . 6.1 mt -84.8 -161.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -1.051 . . . . 0.0 111.272 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 9.6 tttm -159.66 52.4 0.35 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.345 1.069 . . . . 0.0 109.821 -179.168 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' ' CG2' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -38.45 133.26 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.737 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 1.0 OUTLIER 40.97 34.74 0.3 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.313 -179.228 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 77.68 28.42 57.17 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 m-20 -144.42 107.77 4.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.291 179.643 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.553 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 mt-10 -59.03 92.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.005 -1.059 . . . . 0.0 110.3 -179.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.547 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -41.16 142.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.712 0.768 . . . . 0.0 110.505 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -121.44 125.15 46.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.516 -0.74 . . . . 0.0 109.217 179.513 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' CG1' ' A' ' 22' ' ' ILE . 1.3 mt -85.24 176.64 8.22 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.139 -0.975 . . . . 0.0 110.855 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--N 1.298 -1.631 0 O-C-N 121.701 -0.624 . . . . 0.0 109.715 -179.704 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.454 ' O ' HG21 ' A' ' 16' ' ' THR . 3.8 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.306 0.574 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.53 HG23 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -172.45 165.02 3.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.551 -179.876 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.5 Cg_endo -77.0 -40.49 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.175 1.619 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 95.5 m-85 -100.03 108.98 21.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.479 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 2.8 m120 -138.41 153.28 48.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.436 -0.79 . . . . 0.0 109.524 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.5 pt? -165.3 174.6 9.98 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 110.267 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.17 159.17 17.12 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.679 -0.638 . . . . 0.0 109.921 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 4.5 mt -142.61 149.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.403 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -132.1 -172.74 13.13 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.565 -1.303 . . . . 0.0 110.027 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 32.3 t30 72.1 49.88 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.527 -0.984 . . . . 0.0 109.858 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.9 mm? -95.46 123.54 39.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 110.082 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 25' ' ' LEU . 30.5 t-20 -42.47 101.78 0.25 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 110.287 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.3 Cg_endo -74.52 -16.68 21.4 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.973 1.512 . . . . 0.0 110.338 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.48 -15.97 59.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.032 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 -155.66 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 3.5 m -100.18 149.87 23.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 54' ' ' THR . 3.5 t -66.61 -45.87 87.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.817 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.54 83.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.527 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 80.6 mm-40 -58.84 -35.86 73.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.79 . . . . 0.0 109.278 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.532 HD22 ' CA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -65.68 -31.3 72.24 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.176 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HE2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -66.76 -50.84 61.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.538 -0.727 . . . . 0.0 109.335 179.228 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 22.0 t -59.66 -39.19 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.474 -0.766 . . . . 0.0 109.937 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.45 -33.45 73.76 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.135 -0.978 . . . . 0.0 108.682 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.509 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.5 mt -81.04 -30.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 46.4 t -77.22 -26.4 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.063 179.299 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -82.87 -43.26 16.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.707 0.765 . . . . 0.0 109.247 179.302 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 80' ' ' LEU . 1.1 tp -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.153 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 8.9 m-85 -83.71 -22.13 32.11 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.661 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . . . -78.57 -32.04 47.54 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.621 0.725 . . . . 0.0 109.286 179.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HE2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.73 -14.89 33.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.423 -0.798 . . . . 0.0 109.328 179.188 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.02 -18.09 28.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.656 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.1 t0 89.52 29.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.004 0.907 . . . . 0.0 108.765 -179.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.561 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.25 -137.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.517 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . 178.94 58.26 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.14 -0.975 . . . . 0.0 109.517 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 m -60.17 116.04 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.987 0.899 . . . . 0.0 110.148 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.548 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 17.1 t -81.44 -36.19 14.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.894 -0.504 . . . . 0.0 110.561 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.477 ' CB ' ' OD2' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -149.98 154.39 38.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 110.673 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.501 ' HA ' HG23 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -133.51 173.14 15.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.732 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 170.12 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.939 . . . . 0.0 110.47 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.521 ' CG2' HG12 ' A' ' 31' ' ' VAL . 28.5 p -100.7 164.74 11.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.225 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -134.53 136.6 8.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 63.47 -138.51 0.35 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -1.114 . . . . 0.0 110.293 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.0 m-20 -111.82 99.98 8.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 110.529 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 3.2 ptt85 38.37 27.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 111.02 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.3 ttpt -129.51 -5.33 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -138.58 -168.39 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.456 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -173.26 179.4 44.7 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.524 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.579 ' CE1' ' OD1' ' A' ' 64' ' ' ASP . 12.3 t80 -154.88 156.43 36.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.568 -0.96 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 25.5 t -158.66 164.28 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.009 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.579 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 7.9 m-20 -130.08 140.16 50.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.554 -0.716 . . . . 0.0 109.47 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.602 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 22.3 m-85 -103.09 179.56 4.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.286 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 10.9 pt-20 -113.11 2.54 15.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 110.954 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 56.8 p -165.44 177.68 7.31 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.585 1.183 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -78.27 -24.05 46.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.509 ' OE1' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -76.52 -26.85 55.67 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.562 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.543 ' OD2' ' CG ' ' A' ' 66' ' ' GLU . 77.6 m-20 -86.02 -27.37 24.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.13 -35.47 56.2 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.659 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.93 -32.43 40.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -80.85 -25.1 37.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.708 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.65 -26.74 45.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.998 178.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 tt -72.97 -46.05 54.51 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.39 -19.22 61.65 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -62.6 -11.06 14.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.761 -0.587 . . . . 0.0 109.949 179.569 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 18.7 m -39.23 -28.53 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.806 0.812 . . . . 0.0 110.966 -179.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.62 -20.55 12.25 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.431 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.555 ' CB ' ' CD2' ' A' ' 41' ' ' LEU . 1.5 pp -48.04 -178.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.441 -1.035 . . . . 0.0 111.82 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -167.7 51.41 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.556 ' C ' ' O ' ' A' ' 81' ' ' LYS . 11.0 p 5.73 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.091 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.477 ' H ' ' CG1' ' A' ' 82' ' ' VAL . 3.4 m-85 -81.58 13.79 2.91 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.437 -1.414 . . . . 0.0 108.985 178.447 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 133.73 34.77 0.29 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' ILE . 24.8 m-80 -158.86 103.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -1.022 . . . . 0.0 109.224 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 3.5 tt0 -49.91 90.52 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 110.371 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.531 ' CG1' HD11 ' A' ' 80' ' ' LEU . 16.7 pt -49.45 138.73 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.474 -0.766 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.21 175.19 6.37 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.522 ' CD2' ' CD1' ' A' ' 20' ' ' LEU . 7.1 mp -121.45 -176.66 3.35 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.372 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.648 -0.658 . . . . 0.0 110.184 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 16' ' ' THR . 30.2 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.21 0.529 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 15' ' ' THR . 24.8 p -158.93 153.36 20.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.94 -30.36 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.262 1.664 . . . . 0.0 110.339 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 96.4 m-85 -92.75 106.07 18.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.358 -179.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 4.8 m120 -139.52 152.69 47.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.604 ' N ' ' CZ ' ' A' ' 62' ' ' TYR . 1.6 pt? -165.33 164.73 19.78 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.514 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -91.08 160.75 15.43 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.379 -179.967 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 5.4 mt -150.03 146.93 16.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.951 -179.669 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -129.91 -171.47 12.94 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 26.2 t30 73.08 35.27 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.501 -0.999 . . . . 0.0 110.561 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.524 HD13 ' CD2' ' A' ' 34' ' ' LEU . 4.1 mm? -84.13 128.21 34.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.964 . . . . 0.0 109.824 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' LEU . 57.6 t-20 -39.8 102.89 0.27 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.663 -0.648 . . . . 0.0 110.61 -179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.02 7.0 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.045 1.55 . . . . 0.0 110.733 -179.729 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -106.07 -14.63 15.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.304 179.593 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -111.23 -156.3 0.58 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.624 -0.673 . . . . 0.0 109.629 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 2.3 m -105.49 148.53 27.11 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.735 179.283 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.8 t -63.97 -15.6 17.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.46 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -75.34 -38.38 60.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.432 -0.792 . . . . 0.0 109.05 178.828 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.8 mt-10 -72.13 -28.02 62.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.502 -0.749 . . . . 0.0 109.046 178.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.53 ' CD2' HG11 ' A' ' 82' ' ' VAL . 4.8 mt -70.79 -43.11 69.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 53.1 mttt -60.65 -43.81 97.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.66 -0.65 . . . . 0.0 110.018 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 8.5 t -63.67 -41.1 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.869 179.583 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.05 -38.16 90.09 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.635 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.638 ' CG2' ' CE2' ' A' ' 42' ' ' PHE . 17.6 mm -77.7 -28.87 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.234 178.973 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.465 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 14.9 t -76.96 -30.23 55.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.951 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.9 tm-20 -81.27 -45.92 15.53 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.567 0.699 . . . . 0.0 109.585 179.42 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.566 ' HG ' ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -56.76 -39.97 74.99 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.302 179.402 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.638 ' CE2' ' CG2' ' A' ' 38' ' ' ILE . 16.2 m-30 -78.43 -25.16 45.92 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.755 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 39' ' ' SER . . . -79.71 -33.12 41.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HG3' ' OE2' ' A' ' 40' ' ' GLU . 2.8 mttt -88.43 -13.07 41.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.534 -0.729 . . . . 0.0 109.432 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -92.36 -14.48 28.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.659 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.603 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.9 t0 86.38 28.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.578 HD21 ' CG ' ' A' ' 42' ' ' PHE . 2.5 tp -76.97 -136.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.401 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 70' ' ' ASP . . . -165.35 46.09 0.08 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.093 0.949 . . . . 0.0 108.67 178.923 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -55.29 150.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 122.241 1.02 . . . . 0.0 109.447 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.549 ' CG2' ' CG ' ' A' ' 66' ' ' GLU . 2.5 t -136.18 -34.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.356 -178.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 1.9 m-20 -152.61 -179.91 8.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 111.034 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 35' ' ' LYS . 14.6 p 179.84 113.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.764 -0.585 . . . . 0.0 109.8 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 172.18 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.698 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.586 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 18.9 p -82.34 162.4 22.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -134.21 122.58 3.01 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.734 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 55' ' ' GLY . 28.8 m 38.95 96.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.392 -1.064 . . . . 0.0 111.119 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' THR . 9.5 m120 64.13 -146.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.896 . . . . 0.0 110.622 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.405 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -112.91 31.71 6.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.572 -179.714 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.437 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 12.0 tttm -115.54 -20.25 10.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 110.07 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.52 -170.16 1.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.687 179.73 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 169.62 154.57 9.31 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.711 -179.876 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 21.6 t80 -115.13 163.04 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.555 -0.968 . . . . 0.0 109.514 179.537 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.618 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.4 t -148.88 148.22 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.019 -178.601 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -119.71 142.71 48.26 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.425 -0.797 . . . . 0.0 109.993 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.0 m-85 -110.91 178.97 4.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.753 . . . . 0.0 109.718 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.549 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -123.99 15.73 9.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.0 110.865 -179.124 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.547 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -165.81 174.94 9.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.835 1.302 . . . . 0.0 112.505 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.577 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -87.44 -25.73 23.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.484 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -83.72 -22.83 31.87 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.783 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 4.8 t0 -81.45 -33.91 31.76 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.809 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 48.5 tp -69.41 -39.4 77.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.04 -32.86 72.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.409 -0.807 . . . . 0.0 109.398 179.195 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 38.0 mttm -80.79 -24.21 38.73 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.22 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.34 -29.81 69.47 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.488 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -77.59 -45.44 25.19 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.152 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -17.43 64.48 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.451 -0.781 . . . . 0.0 109.676 179.46 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 42' ' ' PHE . 11.7 mt -67.43 -7.02 21.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 91.2 m -49.68 -15.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.432 -0.792 . . . . 0.0 111.217 -179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.31 18.19 19.53 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.487 . . . . . . . . 1 1 . 1 . 031 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.566 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -97.28 179.08 5.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -1.21 . . . . 0.0 109.146 179.843 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.572 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -162.22 53.62 0.22 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 109.752 179.942 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.56 ' C ' ' O ' ' A' ' 81' ' ' LYS . 3.5 t 8.5 -125.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.0 m-30 -75.04 -2.11 25.87 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.001 -1.062 . . . . 0.0 108.82 178.719 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 149.51 35.0 0.04 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' ILE . 58.1 m-20 -158.94 104.16 1.72 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.11 -1.229 . . . . 0.0 110.041 179.958 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.572 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -54.03 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 -179.616 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.535 ' CG2' HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -40.43 147.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.577 0.703 . . . . 0.0 110.186 179.722 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.6 mmmt -116.31 152.94 32.84 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.643 -0.661 . . . . 0.0 109.503 179.763 . . . . . . . . 2 2 . 1 . 031 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -115.82 173.91 6.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.852 . . . . . . . . 3 3 . 1 . 031 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.832 . . . . 0.0 110.213 179.961 . . . . . . . . 0 0 . 1 . 032 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.475 ' CG2' ' OD1' ' A' ' 51' ' ' ASP . 5.0 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.509 0.671 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.583 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 73.0 p -137.27 159.54 69.21 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.3 Cg_endo -76.51 -15.98 17.23 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.06 1.558 . . . . 0.0 110.896 -179.576 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 68' ' ' ALA . 92.1 m-85 -115.62 122.94 47.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 97.9 m-20 -139.43 170.21 16.35 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.644 -0.66 . . . . 0.0 109.271 179.603 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.656 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -169.25 163.55 10.87 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.29 -0.882 . . . . 0.0 110.47 -179.775 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.593 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -97.72 177.25 5.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.683 -0.636 . . . . 0.0 111.366 -177.72 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 21' ' ' PHE . 15.2 mt -157.28 133.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.98 166.61 23.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 35.8 t30 72.48 81.02 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.505 -0.997 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 4.2 mm? -119.92 128.79 53.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.531 ' CB ' HD21 ' A' ' 34' ' ' LEU . 31.1 t-20 -41.25 101.89 0.25 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.556 -0.715 . . . . 0.0 110.429 -179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 58' ' ' ARG . 45.8 Cg_endo -72.48 -23.7 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.036 1.545 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 1.7 m-20 -78.46 -16.16 57.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 110.048 179.866 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.2 mmtt -107.86 -155.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.3 m -102.97 145.03 30.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 54' ' ' THR . 2.6 t -68.18 -42.5 84.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.431 179.43 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.08 68.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.185 179.063 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 25.8 mm-40 -64.72 -43.54 93.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.0 109.092 179.109 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.531 HD21 ' CB ' ' A' ' 26' ' ' ASN . 18.6 mt -59.72 -38.88 82.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.365 -0.835 . . . . 0.0 108.802 179.033 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 9.8 mmpt? -59.98 -54.22 48.63 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.537 0.684 . . . . 0.0 109.366 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 18.3 t -54.21 -35.49 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 109.675 179.258 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.77 -32.3 73.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.169 -0.957 . . . . 0.0 108.798 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.545 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 14.1 mt -82.53 -28.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.853 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -78.75 -28.78 44.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 0.0 109.072 179.164 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.83 -41.12 23.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 109.162 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 1.1 tp -63.45 -34.42 77.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.604 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m-85 -79.9 -23.99 41.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.782 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.69 62.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 109.499 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -89.14 -17.97 28.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 179.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -87.85 -14.68 38.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 179.822 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.602 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.1 t70 83.96 30.91 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.916 0.865 . . . . 0.0 108.784 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -74.82 -129.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.464 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.465 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . 173.34 54.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.196 -0.94 . . . . 0.0 109.066 179.642 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.401 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 10.7 m -57.43 116.88 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.111 0.958 . . . . 0.0 110.392 -179.616 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 2.1 t -91.54 -39.14 11.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.475 ' OD1' ' CG2' ' A' ' 15' ' ' THR . 4.0 m-20 -152.65 125.35 8.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.162 -0.961 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 63' ' ' VAL . 3.2 m -115.09 153.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.256 -0.903 . . . . 0.0 110.001 179.526 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.44 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 1.4 tpt180 -148.98 168.78 22.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.431 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.523 ' CG2' HG11 ' A' ' 31' ' ' VAL . 75.6 p -99.51 159.61 14.9 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.55 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.28 115.74 4.19 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.902 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.66 -154.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -60.55 -51.94 67.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.09 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.515 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 2.1 ptp180 -177.3 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -125.12 -21.58 4.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.9 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -140.69 -154.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.105 -0.997 . . . . 0.0 109.995 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.55 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 172.23 175.61 40.45 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 20' ' ' LEU . 25.7 t80 -143.9 168.4 20.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.493 -1.004 . . . . 0.0 109.732 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 13.7 t -160.01 163.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.491 -178.89 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 1.3 m-20 -130.92 136.77 48.89 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.417 -0.802 . . . . 0.0 109.16 179.53 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 19.0 m-85 -103.24 176.81 5.03 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.495 0.664 . . . . 0.0 111.168 -179.247 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.533 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -115.26 17.1 16.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 111.247 -178.813 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.563 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 35.5 p 179.38 178.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.465 1.126 . . . . 0.0 112.338 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.585 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.95 -23.43 48.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -25.96 43.51 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.248 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.559 ' CA ' HD11 ' A' ' 47' ' ' LEU . 87.1 m-20 -83.42 -29.02 28.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.314 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.58 -29.42 36.98 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.821 179.655 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 3.6 mt-10 -79.89 -36.59 36.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.773 . . . . 0.0 110.36 -179.942 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.519 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -78.31 -29.58 47.82 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.91 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.657 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.0 -27.88 62.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.723 -0.791 . . . . 0.0 108.963 178.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.73 -43.35 69.08 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.542 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -13.54 60.73 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.083 178.472 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.581 ' HG ' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -72.73 5.03 3.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.604 -0.685 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.528 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 8.3 m -66.31 -5.64 11.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.94 -1.1 . . . . 0.0 110.56 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.06 32.26 4.98 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 179.131 . . . . . . . . 1 1 . 1 . 032 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -114.78 132.56 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.127 -179.732 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 1.5 mtmt -104.94 78.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.554 1.169 . . . . 0.0 109.976 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 87' ' ' ILE . 47.8 t -48.45 132.38 5.98 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.754 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.0 m-85 40.82 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.422 -0.799 . . . . 0.0 110.869 -179.757 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 86.72 28.78 25.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.561 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 87' ' ' ILE . 88.1 m-20 -143.12 91.77 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -1.175 . . . . 0.0 110.282 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 19.1 tt0 -42.27 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.171 179.821 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.574 ' CG2' ' CG2' ' A' ' 82' ' ' VAL . 2.2 pp -68.74 125.89 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 110.696 -179.806 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.8 mttt -83.85 118.49 23.99 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.645 . . . . . . . . 2 2 . 1 . 032 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -106.06 -171.19 1.85 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.988 -178.258 . . . . . . . . 3 3 . 1 . 032 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 21' ' ' PHE . 3.4 mt-10 . . . . . 0 N--CA 1.501 2.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.385 179.813 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 16' ' ' THR . 20.7 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.243 0.544 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.528 HG21 ' CG1' ' A' ' 50' ' ' VAL . 14.0 p -151.25 164.23 20.95 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.8 Cg_endo -75.17 -34.49 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.052 1.554 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.549 ' CE2' ' C ' ' A' ' 67' ' ' SER . 97.4 m-85 -100.64 102.39 13.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.067 -1.021 . . . . 0.0 110.489 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 2.0 m120 -137.99 153.2 49.43 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.321 -0.862 . . . . 0.0 109.527 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' HD23 ' A' ' 89' ' ' LEU . 4.6 pp -163.57 -171.78 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.5 t80 -116.54 151.22 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 2.8 mt -131.27 159.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.902 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -142.49 -176.24 16.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.628 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 47.8 t30 71.34 49.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 110.215 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.517 ' CB ' HD21 ' A' ' 34' ' ' LEU . 10.8 mp -97.26 132.94 42.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 39.1 t-20 -41.41 102.06 0.26 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.609 -0.682 . . . . 0.0 110.287 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.9 Cg_endo -77.06 8.06 3.37 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.046 1.55 . . . . 0.0 110.852 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -111.81 -17.67 12.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.986 -1.071 . . . . 0.0 108.948 179.55 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HB2' ' CG ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.72 -155.52 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.731 -0.605 . . . . 0.0 109.513 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.524 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -100.54 142.09 32.5 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.597 179.109 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.568 ' CG2' ' CB ' ' A' ' 58' ' ' ARG . 3.0 t -63.46 -42.88 97.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.114 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.49 -37.26 72.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 178.959 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.524 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 16.0 mm-40 -67.15 -30.22 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.62 179.529 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.517 HD21 ' CB ' ' A' ' 25' ' ' LEU . 3.0 mt -67.56 -38.4 84.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.594 ' CG ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -65.3 -47.31 77.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.839 . . . . 0.0 109.943 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 7.3 t -65.09 -34.57 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.131 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.53 -43.98 92.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.298 -0.876 . . . . 0.0 109.068 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.58 HG22 ' CE2' ' A' ' 42' ' ' PHE . 19.5 mm -76.96 -27.95 16.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.929 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -73.82 -32.75 63.87 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.437 -0.79 . . . . 0.0 109.395 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.9 tt0 -85.24 -43.11 14.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 110.009 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 3.7 tt -55.67 -40.8 72.78 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.569 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.58 ' CE2' HG22 ' A' ' 38' ' ' ILE . 11.6 m-30 -87.06 -23.62 24.88 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.447 179.542 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -75.93 -18.32 59.4 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -102.28 -39.27 7.28 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.588 179.632 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.615 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -51.03 -43.17 60.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.619 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 13.1 m-20 143.22 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.561 0.744 . . . . 0.0 110.151 179.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -112.0 -152.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 110.624 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 49' ' ' VAL . . . -164.31 55.83 0.15 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.674 0.749 . . . . 0.0 109.153 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -41.11 118.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.045 0.926 . . . . 0.0 110.151 -179.794 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.53 HG21 ' CG ' ' A' ' 66' ' ' GLU . 2.8 t -84.24 -44.11 17.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.283 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.466 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 5.4 t70 -147.72 160.73 42.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.873 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.594 ' CG2' ' CG ' ' A' ' 35' ' ' LYS . 7.6 p -150.96 111.15 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 2.2 mpp_? -99.71 165.53 11.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.966 . . . . 0.0 110.261 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.472 HG23 ' HD3' ' A' ' 35' ' ' LYS . 69.0 p -87.96 163.73 16.18 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.644 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -119.19 105.57 1.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.473 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.2 m 67.57 -134.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -1.145 . . . . 0.0 110.016 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -80.47 -48.58 12.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 110.482 -179.832 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.568 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -177.76 37.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 110.444 -179.877 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 21.5 mttt -113.93 -24.33 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 55' ' ' GLY . 1.2 m-85 -137.57 -174.99 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.04 154.01 18.37 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.7 m-85 -107.84 167.23 10.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.188 -1.183 . . . . 0.0 110.031 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 50.2 t -157.25 155.44 5.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.939 -178.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 51' ' ' ASP . 8.6 m-20 -125.22 139.5 53.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.703 -0.623 . . . . 0.0 109.498 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 17.7 m-85 -103.83 176.61 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.407 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.53 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -113.98 14.65 18.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 111.479 -178.395 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.9 p 176.94 178.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.371 1.081 . . . . 0.0 112.089 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . 0.47 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.5 -22.71 54.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.553 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -25.47 37.06 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.521 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 88.6 m-20 -82.79 -28.16 30.47 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.164 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 3.0 tm? -79.13 -33.7 43.97 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.566 179.389 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 1.4 tp10 -73.46 -39.22 65.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.805 . . . . 0.0 109.733 179.606 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -80.19 -18.04 50.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.524 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.47 -28.13 46.46 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.178 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 78' ' ' THR . 7.2 tt -79.69 -44.19 21.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -27.8 67.26 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.269 -0.894 . . . . 0.0 109.096 178.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.542 ' O ' ' CD2' ' A' ' 80' ' ' LEU . 15.4 mt -68.8 -7.97 39.08 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.536 0.684 . . . . 0.0 109.826 179.394 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 87.7 m -57.01 -9.14 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.658 -0.651 . . . . 0.0 111.506 -179.667 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.98 26.97 5.7 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -94.14 -161.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.218 -1.166 . . . . 0.0 110.695 -179.762 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.604 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -164.1 48.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.56 0.695 . . . . 0.0 109.817 179.643 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' A' ' 81' ' ' LYS . 7.9 p 8.49 -126.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.203 179.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 2.8 m-85 -72.44 -1.75 16.9 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.408 -1.432 . . . . 0.0 109.508 179.14 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 147.89 36.42 0.05 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 87' ' ' ILE . 15.3 m-20 -163.4 108.02 1.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -1.156 . . . . 0.0 109.418 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.604 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -51.27 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.61 -178.837 . . . . . . . . 3 3 . 1 . 033 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 85' ' ' ASN . 2.3 pp -46.38 144.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.651 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 8.1 mtmt -112.03 169.78 8.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.56 -0.712 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 7.7 mp -113.31 -177.56 3.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.302 -0.874 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.434 HG23 HG23 ' A' ' 16' ' ' THR . 1.8 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.511 0.672 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.547 HG22 ' CB ' ' A' ' 50' ' ' VAL . 17.6 p -138.6 158.08 70.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.689 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.7 Cg_endo -75.71 -29.07 7.51 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.136 1.598 . . . . 0.0 110.559 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 67' ' ' SER . 88.0 m-85 -106.35 101.89 11.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.774 -179.55 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.516 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.7 m120 -134.71 150.9 50.66 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.131 179.413 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 21' ' ' PHE . 4.3 pp -172.93 -175.69 1.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.861 -179.85 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.552 ' CD1' ' C ' ' A' ' 21' ' ' PHE . 3.2 t80 -110.29 154.65 23.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.024 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mt -140.15 153.55 22.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -121.04 -177.03 15.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.9 t30 70.46 71.41 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.297 -1.12 . . . . 0.0 110.012 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -114.1 27.43 9.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.307 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.501 ' ND2' ' ND2' ' A' ' 85' ' ' ASN . 0.7 OUTLIER 53.13 98.04 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 110.335 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.73 -9.9 22.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.96 1.505 . . . . 0.0 110.519 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -94.75 -12.94 26.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 109.83 179.917 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 12.4 mmtt -115.12 -160.01 0.72 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.449 -0.782 . . . . 0.0 109.536 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 2.0 m -112.69 148.09 35.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 2.6 t -67.44 -18.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.066 -1.021 . . . . 0.0 108.879 179.328 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 -41.98 80.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 178.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . 0.58 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 3.8 pt-20 -66.88 -45.96 76.42 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.041 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.544 ' N ' ' CG ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -62.7 -34.21 76.67 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.861 . . . . 0.0 108.72 178.957 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.79 -49.55 76.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.773 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.455 ' HA ' ' HB3' ' A' ' 39' ' ' SER . 91.1 t -64.39 -32.18 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.594 -0.691 . . . . 0.0 109.141 178.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.7 -43.0 90.51 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.854 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.609 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 24.7 mm -75.63 -24.62 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.568 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 39' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -77.66 -35.2 52.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 179.095 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.07 -38.76 26.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.491 0.662 . . . . 0.0 109.724 179.528 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . 0.526 HD21 ' CD2' ' A' ' 80' ' ' LEU . 10.4 tp -65.52 -32.43 74.02 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.406 179.356 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 42' ' ' PHE . . . . . 0.609 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.3 m-85 -87.51 -19.99 27.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.103 179.619 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.27 -26.96 20.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -92.39 -17.44 24.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.477 -0.764 . . . . 0.0 109.212 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 45' ' ' ASN . . . . . 0.608 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -83.23 -59.07 2.58 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.621 -0.674 . . . . 0.0 109.534 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.6 m-20 146.65 31.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.741 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -102.27 -156.27 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.192 -0.942 . . . . 0.0 109.874 -179.836 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . 0.53 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -162.39 56.51 0.23 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.784 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 10.4 m -45.53 118.79 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 50' ' ' VAL . . . . . 0.578 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -93.45 -33.89 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.514 ' O ' ' CG2' ' A' ' 52' ' ' VAL . 11.5 m-20 -149.35 148.24 29.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.322 -0.861 . . . . 0.0 110.686 -179.886 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.52 ' CG1' HG23 ' A' ' 63' ' ' VAL . 57.1 t -156.85 102.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.01 179.672 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -113.17 173.27 6.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 110.332 -179.814 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 54' ' ' THR . . . . . 0.516 HG22 ' CG1' ' A' ' 31' ' ' VAL . 2.0 p -82.33 -179.32 7.37 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.238 -0.914 . . . . 0.0 110.171 -179.665 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -140.91 132.5 5.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.513 HG21 ' ND2' ' A' ' 57' ' ' ASN . 63.4 m 58.34 -106.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.371 -1.076 . . . . 0.0 110.586 179.71 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.513 ' ND2' HG21 ' A' ' 56' ' ' THR . 7.9 p30 -130.17 90.56 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.861 -1.149 . . . . 0.0 110.48 -179.701 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.544 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 19.2 mtt85 41.77 29.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.533 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -112.39 -32.96 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.915 . . . . 0.0 110.177 179.943 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 2.3 m-85 -126.71 -162.59 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 109.361 179.733 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.58 132.12 2.15 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.575 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 21' ' ' PHE . 2.9 m-85 -86.33 158.35 19.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.404 -1.057 . . . . 0.0 109.116 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 63' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 25.2 t -158.68 156.32 3.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.947 -179.155 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 64' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 19' ' ' ASN . 80.3 m-20 -142.39 144.88 33.33 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 65' ' ' PHE . . . . . 0.578 ' C ' ' CG2' ' A' ' 50' ' ' VAL . 23.0 m-85 -114.97 -174.87 2.57 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.483 -0.761 . . . . 0.0 109.001 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.53 ' HG2' ' CB ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -132.67 29.61 4.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.494 -1.379 . . . . 0.0 113.44 -176.6 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.777 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p -169.09 173.5 6.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.319 -1.488 . . . . 0.0 113.119 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.3 -27.42 52.99 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.393 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 69' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -28.89 62.83 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.912 179.41 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.777 ' OD2' ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -76.5 -33.26 58.65 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.851 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 71' ' ' LEU . . . . . 0.553 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -62.28 -43.89 97.79 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.997 179.794 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.456 ' N ' HD23 ' A' ' 71' ' ' LEU . 3.9 tt0 -66.26 -35.52 80.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.034 178.806 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 4.8 mttm -78.59 -21.19 48.94 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.13 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 70' ' ' ASP . . . -69.33 -29.4 67.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 75' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 75' ' ' LEU . 4.3 tt -77.22 -45.74 25.52 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -71.66 -7.15 46.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.642 178.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.51 HD11 ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -57.63 -13.52 4.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 111.09 -179.996 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' HG21 ' A' ' 78' ' ' THR . 45.8 m -69.2 3.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.912 . . . . 0.0 111.801 -179.186 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.61 10.95 16.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.477 . . . . . . . . 1 1 . 1 . 034 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.526 ' CD2' HD21 ' A' ' 41' ' ' LEU . 45.6 mt -97.74 112.38 24.29 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.321 -1.105 . . . . 0.0 110.688 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 1.1 mttp -88.62 80.59 7.27 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.105 0.955 . . . . 0.0 110.295 179.589 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.559 ' CG2' ' CD1' ' A' ' 38' ' ' ILE . 1.1 p -46.16 126.84 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.697 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 33' ' ' GLU . 1.2 m-85 42.21 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.953 . . . . 0.0 110.653 -179.561 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 97.18 17.68 31.22 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 84.7 m-20 -133.54 110.52 9.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -1.142 . . . . 0.0 110.084 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.5 tm-20 -56.65 83.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 87' ' ' ILE . . . . . 0.541 ' CD1' ' O ' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -39.3 151.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 110.771 -179.479 . . . . . . . . 3 3 . 1 . 034 nuclear orig core ' A' A ' 88' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 31.9 ttpt -119.26 157.36 28.2 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . 0.537 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 5.1 mp -112.36 179.07 4.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.232 -0.917 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.662 -0.649 . . . . 0.0 109.924 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 p -145.19 65.41 1.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -1.147 . . . . 0.0 110.195 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.421 ' O ' ' C ' ' A' ' 4' ' ' MET . 0.1 OUTLIER -110.44 77.68 1.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.183 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' HIS . 2.7 tpp -43.19 -50.5 6.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.185 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.86 48.49 5.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 110.212 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -91.21 153.51 19.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.174 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.74 153.77 73.14 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.03 79.67 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.984 1.518 . . . . 0.0 110.384 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -160.21 135.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-O 121.315 0.579 . . . . 0.0 110.166 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.76 129.61 34.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 12' ' ' SER . . . -133.92 74.14 0.44 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 14' ' ' SER . 5.5 t 63.02 11.08 4.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.279 -1.13 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 46.53 26.06 0.47 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.133 0.968 . . . . 0.0 110.064 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.46 ' OG ' ' O ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -128.57 160.04 33.63 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.199 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.96 -13.24 10.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.961 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.542 HG22 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -148.47 166.48 15.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.74 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -78.8 -42.91 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.233 1.649 . . . . 0.0 110.769 -179.799 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CE2' ' C ' ' A' ' 67' ' ' SER . 96.3 m-85 -96.88 110.88 23.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 110.516 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -137.32 151.73 48.96 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.492 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 4.5 pp -161.31 -178.03 6.41 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 110.391 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 62' ' ' TYR . 6.2 t80 -112.4 146.65 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.338 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.518 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.3 mt -130.91 155.99 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.827 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' HA2' ' CB ' ' A' ' 60' ' ' PHE . . . -136.51 -164.74 10.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.477 ' ND2' ' HG2' ' A' ' 86' ' ' GLU . 31.2 t-20 65.64 70.59 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.08 . . . . 0.0 110.092 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.531 ' N ' ' CD1' ' A' ' 25' ' ' LEU . 10.2 mp -119.16 130.25 55.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.845 . . . . 0.0 110.255 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 31.5 t30 -54.15 107.99 1.01 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.506 -0.746 . . . . 0.0 110.346 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.2 Cg_endo -74.49 -8.73 20.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.049 1.552 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.415 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 7.1 m120 -84.05 -14.54 50.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.578 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -117.57 -157.24 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.39 -0.819 . . . . 0.0 109.859 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.463 ' O ' HD11 ' A' ' 34' ' ' LEU . 1.6 m -100.14 146.92 26.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 58' ' ' ARG . 11.2 t -69.79 -30.37 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.319 -0.953 . . . . 0.0 109.059 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.409 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -63.72 -38.16 90.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.0 109.034 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.442 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 54.7 mm-40 -68.14 -36.31 79.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.524 HD23 ' CA ' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.42 -32.93 73.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.367 -0.833 . . . . 0.0 108.836 178.863 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 1.6 mptp? -65.82 -50.37 64.88 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.575 -0.703 . . . . 0.0 109.314 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.4 t -58.53 -35.64 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.842 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.57 -35.85 81.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.137 -0.977 . . . . 0.0 108.727 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.581 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 35.9 mt -80.15 -27.11 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.157 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -29.46 41.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.067 179.164 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.93 -38.37 27.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.361 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.55 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 5.2 tp -68.12 -32.17 72.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.585 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 6.0 m-85 -82.31 -23.19 35.27 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.54 65.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 109.362 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -89.37 -21.15 23.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.727 . . . . 0.0 109.456 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.635 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.1 m-80 -80.57 -20.52 43.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.474 -0.766 . . . . 0.0 109.743 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.635 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.2 t0 91.21 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.939 0.876 . . . . 0.0 108.759 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.585 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -84.11 -139.26 0.06 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.469 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -177.21 58.41 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.217 -0.927 . . . . 0.0 109.774 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 12.2 m -60.03 117.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.965 0.888 . . . . 0.0 109.94 -179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.542 ' CB ' HG22 ' A' ' 16' ' ' THR . 2.6 t -95.29 -33.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.265 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.518 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 12.4 t0 -144.68 153.77 42.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.977 . . . . 0.0 110.676 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -155.91 99.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.87 . . . . 0.0 108.979 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -102.26 156.82 17.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.106 -0.996 . . . . 0.0 110.733 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.52 ' CG2' HG13 ' A' ' 31' ' ' VAL . 44.5 p -90.64 154.65 19.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.429 -0.795 . . . . 0.0 110.319 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.576 ' HA3' ' CD1' ' A' ' 60' ' ' PHE . . . -127.49 128.32 6.09 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.582 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 3.4 m 60.72 170.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.836 -0.802 . . . . 0.0 109.878 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.524 ' N ' ' CG2' ' A' ' 56' ' ' THR . 68.8 m-80 -38.6 -42.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.467 -0.77 . . . . 0.0 110.412 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.529 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 172.45 51.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.817 . . . . 0.0 109.802 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.408 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -110.54 -31.24 7.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.306 -0.871 . . . . 0.0 110.494 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' HB2' ' CE1' ' A' ' 21' ' ' PHE . 5.9 p90 -159.39 149.33 18.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.026 -1.047 . . . . 0.0 110.424 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' N ' HD22 ' A' ' 25' ' ' LEU . . . -132.82 164.8 24.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.45 162.44 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -1.083 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.515 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 3.2 t -151.4 141.59 15.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.749 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 50.2 m-20 -112.06 147.54 35.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.501 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.6 m-85 -108.26 179.84 4.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.821 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.53 ' CG ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -114.08 13.42 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 111.496 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.54 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.4 p 178.88 179.42 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.381 1.086 . . . . 0.0 112.072 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.25 52.94 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -27.07 37.29 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.478 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.4 m-20 -83.43 -25.9 30.83 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.3 tm? -80.69 -34.79 34.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.477 0.656 . . . . 0.0 109.281 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.92 -36.13 67.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.806 . . . . 0.0 109.487 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -76.43 -27.45 56.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.89 -29.5 68.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.416 HD11 ' C ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -71.25 -45.99 62.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -75.92 -4.21 39.68 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.225 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.573 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -77.77 12.01 1.89 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 110.281 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -9.23 12.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.039 -1.038 . . . . 0.0 110.089 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.12 33.98 3.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.55 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -85.37 -170.15 2.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.125 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.562 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -179.1 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.257 1.027 . . . . 0.0 109.876 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.577 ' CG2' ' CG2' ' A' ' 87' ' ' ILE . 41.4 t -40.97 127.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.994 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.578 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 8.4 m-85 43.96 25.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.132 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 90.7 20.43 40.44 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' VAL . 23.4 m-20 -131.62 102.39 5.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -1.156 . . . . 0.0 109.521 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.562 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -53.47 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.272 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.577 ' CG2' ' CG2' ' A' ' 82' ' ' VAL . 0.9 OUTLIER -47.46 142.57 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -108.11 163.88 12.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 109.163 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.518 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.53 -179.34 3.61 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 110.459 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -172.3 154.15 3.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 50.7 mttt -102.26 98.88 11.28 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.923 . . . . 0.0 110.248 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.7 Cg_endo -72.71 -174.16 1.41 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.021 1.537 . . . . 0.0 110.451 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -72.09 155.79 39.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 95' ' ' ARG . . . 88.95 25.18 30.08 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 94' ' ' GLY . 4.9 mpp_? -43.11 -45.22 5.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -1.171 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -80.55 -166.38 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 110.148 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.29 -15.82 2.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -83.74 -29.23 27.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -1.147 . . . . 0.0 110.248 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -131.77 -74.15 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.53 161.05 10.79 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.296 -1.12 . . . . 0.0 110.242 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 p -66.87 172.35 4.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -1.175 . . . . 0.0 110.199 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.35 43.82 30.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.7 ttp -118.79 85.48 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.204 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -129.1 71.86 1.44 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.173 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 1.1 tt0 47.73 93.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.231 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.565 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER 179.38 -59.41 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.209 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 43.7 Cg_endo -71.62 79.85 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.026 1.54 . . . . 0.0 110.427 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.431 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 12.1 p -126.87 70.33 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.219 0.533 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.34 -177.61 4.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.23 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.28 22.29 4.96 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.45 54.92 1.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -1.182 . . . . 0.0 110.181 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -168.15 28.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 110.126 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.99 141.46 29.48 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.32 0.581 . . . . 0.0 110.143 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.458 ' O ' HG22 ' A' ' 16' ' ' THR . 16.9 m -98.36 -7.07 29.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.53 HG23 ' CB ' ' A' ' 50' ' ' VAL . 70.1 p -153.85 161.88 28.12 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.288 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.579 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.71 -23.88 14.03 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.025 1.539 . . . . 0.0 110.7 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.579 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 98.4 m-85 -106.37 112.67 25.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 110.562 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 18' ' ' PHE . 3.2 m120 -143.82 153.53 42.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.586 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.573 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 4.4 pp -166.49 -177.51 4.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 35.0 t80 -113.71 151.01 32.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 110.134 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.49 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.0 157.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 109.658 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.69 -168.47 11.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.502 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.0 t30 69.31 50.91 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -1.099 . . . . 0.0 110.214 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.556 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.6 mm? -100.13 123.08 43.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.511 ' N ' HD23 ' A' ' 34' ' ' LEU . 25.7 t-20 -42.92 102.18 0.27 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.59 -0.694 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.37 -14.21 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.02 1.537 . . . . 0.0 110.369 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 1.9 m-20 -80.25 -19.34 47.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.566 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -107.13 -156.31 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.414 -0.804 . . . . 0.0 109.832 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.1 m -103.2 143.14 33.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.57 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.5 t -66.58 -19.2 25.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.107 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . . . -71.54 -41.46 69.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 108.989 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.559 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.8 mm-40 -66.11 -37.49 85.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 109.288 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 30' ' ' SER . 5.0 mp -63.05 -34.58 77.89 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.315 -0.865 . . . . 0.0 108.745 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' CG ' ' CG2' ' A' ' 52' ' ' VAL . 2.8 mttt -60.14 -56.91 15.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 25.4 t -60.93 -34.59 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.588 -0.695 . . . . 0.0 109.468 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.35 -33.4 75.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 108.694 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.488 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.2 mt -81.11 -28.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.514 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 0.3 OUTLIER -78.6 -30.29 46.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.084 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.481 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.22 -37.7 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.546 0.689 . . . . 0.0 109.458 179.482 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.546 ' CD1' ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -68.56 -31.56 70.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.087 179.143 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 13.2 m-85 -88.16 -16.8 32.41 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.4 -29.38 19.11 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.995 -179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -91.82 -18.74 23.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.465 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.601 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -81.32 -58.73 2.92 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 0.0 109.719 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.1 m-20 148.26 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.27 0.557 . . . . 0.0 109.843 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 70' ' ' ASP . 4.1 mm? -106.1 -158.94 0.68 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.328 -0.857 . . . . 0.0 109.586 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.522 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -160.41 61.9 0.33 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.955 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 6.7 m -52.83 118.12 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.882 0.848 . . . . 0.0 109.856 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.53 ' CB ' HG23 ' A' ' 16' ' ' THR . 0.6 OUTLIER -87.43 -43.12 15.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 121.878 -0.514 . . . . 0.0 109.99 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 4.5 t0 -144.46 158.17 43.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.575 ' CG2' ' CG ' ' A' ' 35' ' ' LYS . 2.1 p -149.21 156.65 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 0.0 109.706 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -165.26 165.92 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.167 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.57 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 12.5 p -79.56 179.46 7.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.403 -0.811 . . . . 0.0 110.329 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -142.1 135.31 6.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.568 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 97.8 m 59.43 -83.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.903 . . . . 0.0 110.449 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 55' ' ' GLY . 1.6 m-20 -161.54 97.09 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.046 -1.034 . . . . 0.0 110.642 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.505 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 42.75 27.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.903 . . . . 0.0 110.655 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.537 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -119.58 -33.23 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 110.156 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.568 ' CD2' ' HB ' ' A' ' 56' ' ' THR . 3.2 m-85 -129.18 177.31 7.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.54 129.12 2.59 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.076 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.622 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 28.4 t80 -92.82 163.9 13.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 109.644 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.622 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 27.7 t -157.95 159.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.867 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -126.28 138.33 53.59 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.612 -0.68 . . . . 0.0 109.58 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 24.8 m-85 -102.7 175.26 5.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.676 -0.64 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.522 ' HG2' ' CB ' ' A' ' 48' ' ' ALA . 3.0 pt-20 -118.44 14.66 13.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 111.564 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.534 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.7 p -172.61 173.9 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.906 -1.121 . . . . 0.0 112.165 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.5 -23.91 42.63 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -25.43 30.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.572 ' OD1' ' CD1' ' A' ' 65' ' ' PHE . 5.4 t0 -82.14 -25.73 34.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 2.7 tm? -81.95 -33.64 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -34.37 71.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.756 . . . . 0.0 109.379 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.537 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -77.26 -28.75 53.67 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.12 -27.13 67.07 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.451 HD22 ' CD1' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -73.55 -48.85 29.8 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.668 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.82 -3.72 30.34 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.3 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -76.55 8.8 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.489 -0.757 . . . . 0.0 110.469 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 m -64.58 -8.72 15.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.198 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.97 17.8 48.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.546 ' CD2' ' CD1' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -72.31 -171.94 0.84 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.403 -1.057 . . . . 0.0 110.67 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.4 mttt -170.64 49.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.355 1.074 . . . . 0.0 109.655 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.586 ' CG2' ' CG2' ' A' ' 87' ' ' ILE . 23.7 t -40.06 124.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.027 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.566 ' CD1' ' HG3' ' A' ' 29' ' ' LYS . 4.9 m-85 42.72 29.38 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.188 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.12 25.14 38.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' VAL . 11.4 m120 -134.16 86.37 2.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.603 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.563 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 21.1 tt0 -41.92 100.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.586 ' CG2' ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -60.18 140.22 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.489 -0.757 . . . . 0.0 110.42 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -111.63 156.3 22.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.153 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.39 169.73 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.043 -1.035 . . . . 0.0 110.608 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 2.9 tt0 -168.15 156.14 8.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.014 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -84.93 110.77 30.68 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.288 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.2 Cg_endo -73.39 -170.52 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.049 1.552 . . . . 0.0 110.436 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -133.64 -37.51 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.63 28.68 8.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -166.86 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -1.195 . . . . 0.0 110.191 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.96 -161.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 110.212 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 98' ' ' THR . . . 165.25 -157.6 30.12 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 97' ' ' GLY . 2.5 p 42.6 -163.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -1.13 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.98 154.97 39.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.896 . . . . 0.0 110.169 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.17 85.96 1.88 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.28 -1.13 . . . . 0.0 110.165 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.5 p -93.52 -8.98 39.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -1.177 . . . . 0.0 110.234 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -97.73 -149.65 0.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -0.914 . . . . 0.0 110.162 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.3 tpp -128.95 -54.68 1.21 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 51.48 67.15 1.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.208 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -74.99 -84.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.847 . . . . 0.0 110.152 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -141.85 159.93 57.71 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.214 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.37 -156.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.056 1.556 . . . . 0.0 110.089 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.409 ' CG1' ' N ' ' A' ' 10' ' ' GLU . 1.5 p -109.6 -157.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.284 0.564 . . . . 0.0 109.89 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.409 ' N ' ' CG1' ' A' ' 9' ' ' VAL . 1.7 pt-20 -68.26 170.95 7.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.51 69.43 2.01 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.24 17.59 14.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -1.143 . . . . 0.0 110.26 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 14' ' ' SER . 2.2 mt-10 -91.52 28.12 1.81 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 110.281 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -52.5 -173.09 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.183 0.516 . . . . 0.0 110.196 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.472 ' O ' ' CG2' ' A' ' 16' ' ' THR . 4.1 m -73.6 -5.83 42.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.567 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -167.4 158.24 9.95 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 110.477 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.86 -34.98 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.154 1.608 . . . . 0.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.522 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.1 m-85 -112.22 114.3 27.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' ND2' ' C ' ' A' ' 18' ' ' PHE . 2.8 m120 -132.87 148.98 52.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.578 ' O ' ' CD1' ' A' ' 62' ' ' TYR . 4.5 pp -165.4 -177.36 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 60' ' ' PHE . 3.3 t80 -115.2 150.01 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.97 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.498 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 2.2 mt -129.95 158.34 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.427 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.48 -173.45 13.04 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t30 72.54 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -1.012 . . . . 0.0 110.197 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.529 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.0 mm? -116.45 165.48 13.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 110.106 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.498 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 40.8 t30 -95.22 106.74 27.84 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 110.344 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -73.54 -13.92 24.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.042 1.548 . . . . 0.0 110.447 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.441 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 1.9 m-80 -78.67 -17.72 55.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.582 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -113.27 -155.27 0.56 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.44 -0.788 . . . . 0.0 109.862 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.496 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -100.65 142.53 32.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 110.498 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.526 ' CG1' HG23 ' A' ' 54' ' ' THR . 2.9 t -67.37 -32.33 56.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.179 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.94 -39.01 92.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.319 -0.863 . . . . 0.0 108.965 178.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 70.2 mm-40 -63.79 -36.46 83.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.559 -0.713 . . . . 0.0 109.092 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.531 HD22 ' CD2' ' A' ' 83' ' ' PHE . 92.2 mt -61.3 -38.81 88.14 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.37 -0.832 . . . . 0.0 108.908 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.516 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 0.8 OUTLIER -58.96 -50.37 74.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.536 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -60.09 -37.72 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.477 -0.764 . . . . 0.0 109.668 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.35 -28.34 69.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.072 -1.017 . . . . 0.0 109.11 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.579 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 7.0 mt -87.84 -28.06 5.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.482 -0.761 . . . . 0.0 109.14 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 7.5 t -80.61 -24.71 38.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.167 179.127 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.52 -37.43 19.66 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.532 -0.73 . . . . 0.0 109.141 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.527 ' CD1' HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -67.47 -34.72 77.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CE2' ' CD1' ' A' ' 77' ' ' LEU . 7.1 m-85 -83.47 -22.53 32.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB1' ' HA ' ' A' ' 40' ' ' GLU . . . -74.48 -33.72 62.92 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -18.21 25.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 0.0 109.345 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.21 -19.35 39.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.526 -0.734 . . . . 0.0 109.863 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 t70 91.69 29.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.008 0.909 . . . . 0.0 108.839 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.528 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -87.95 -140.68 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.526 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -178.28 59.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 m -56.01 117.08 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.075 0.941 . . . . 0.0 110.171 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.567 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 0.9 OUTLIER -88.98 -36.51 8.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.67 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.507 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 24.2 t70 -143.69 147.31 34.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' CG1' HG21 ' A' ' 63' ' ' VAL . 2.6 t -153.23 139.63 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.609 -0.682 . . . . 0.0 109.462 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.435 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -158.08 -179.63 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.526 HG23 ' CG1' ' A' ' 31' ' ' VAL . 17.0 p -84.7 177.95 7.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.316 -0.865 . . . . 0.0 110.594 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -137.23 132.43 5.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.57 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 52.3 m 57.68 -91.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' N ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -153.02 98.1 2.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.073 -1.017 . . . . 0.0 110.434 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.461 ' NH2' ' HG2' ' A' ' 58' ' ' ARG . 0.1 OUTLIER 41.92 26.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.491 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -116.35 -32.31 5.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 1.8 m-85 -135.97 -175.82 4.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.359 -0.838 . . . . 0.0 109.498 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.491 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.6 145.9 13.72 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.101 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.578 ' CD1' ' O ' ' A' ' 20' ' ' LEU . 0.3 OUTLIER -101.26 161.42 13.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -1.107 . . . . 0.0 109.528 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 4.7 t -161.46 159.86 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.552 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.1 m-20 -140.93 142.03 34.45 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.709 -0.619 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.643 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 61.2 m-85 -106.16 174.44 5.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.719 -0.613 . . . . 0.0 110.584 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.533 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 6.6 pt-20 -114.67 13.2 17.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 111.849 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.522 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.0 p -170.06 177.26 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.855 -1.153 . . . . 0.0 112.255 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.91 -23.56 48.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.51 -27.57 46.11 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.475 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' OD2' ' CG ' ' A' ' 66' ' ' GLU . 83.0 m-20 -83.14 -27.91 29.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 1.9 tm? -73.67 -38.67 64.85 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.274 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -37.25 71.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.42 -0.8 . . . . 0.0 109.348 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.468 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.11 -20.44 52.15 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.643 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -71.57 -31.94 67.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.9 tt -76.8 -43.5 36.45 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.551 -0.718 . . . . 0.0 109.081 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -25.0 66.04 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.419 -0.8 . . . . 0.0 109.584 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.635 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 14.2 mt -66.82 -8.22 27.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 110.126 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 5.9 m -48.42 -19.81 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 110.654 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.23 34.78 3.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.33 -165.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 110.694 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.54 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.0 mtmt -169.64 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.193 0.997 . . . . 0.0 109.67 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.528 ' CG2' HD23 ' A' ' 34' ' ' LEU . 2.9 p -37.83 125.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.179 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.582 ' CD1' ' HG3' ' A' ' 29' ' ' LYS . 3.8 m-85 41.75 26.69 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.456 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 89.91 24.38 30.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' N ' ' O ' ' A' ' 82' ' ' VAL . 12.3 m120 -135.04 89.82 2.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -1.137 . . . . 0.0 109.565 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.54 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.8 pt-20 -41.17 106.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 110.858 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.528 ' CG2' HG13 ' A' ' 82' ' ' VAL . 1.0 OUTLIER -72.54 135.54 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 110.285 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.498 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -112.04 159.76 18.15 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.506 -0.747 . . . . 0.0 109.156 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -117.31 172.7 7.13 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.864 -1.147 . . . . 0.0 110.574 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -173.85 125.12 0.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 110.201 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.3 111.25 4.68 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.8 Cg_endo -76.17 -175.31 2.47 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.988 1.52 . . . . 0.0 110.444 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.36 10.92 17.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.82 29.41 26.35 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.95 132.19 53.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.258 -1.142 . . . . 0.0 110.172 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -154.99 -173.21 4.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.212 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.98 25.99 6.24 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -130.96 109.44 10.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -1.175 . . . . 0.0 110.263 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -163.27 169.74 18.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 110.22 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.62 -101.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.297 -1.119 . . . . 0.0 110.152 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.18 -35.2 73.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -1.114 . . . . 0.0 110.194 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -83.52 62.81 7.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 5' ' ' LEU . 9.6 ttm -86.6 13.81 7.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 110.168 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.422 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.9 OUTLIER 61.07 144.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 110.233 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.42 150.19 15.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.219 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -149.16 132.55 8.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.255 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.6 -157.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.991 1.522 . . . . 0.0 110.099 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.5 t 53.06 97.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.298 0.571 . . . . 0.0 110.232 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -104.8 -173.86 2.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.95 . . . . 0.0 110.24 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.01 58.59 0.47 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 m -138.0 39.51 2.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.301 -1.117 . . . . 0.0 110.249 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -169.41 29.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.969 0.89 . . . . 0.0 110.134 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -49.16 -179.98 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.216 0.531 . . . . 0.0 110.237 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.443 HG21 ' OD2' ' A' ' 51' ' ' ASP . 1.9 t -83.4 -18.52 38.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.545 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.9 OUTLIER -134.85 157.65 76.67 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 110.496 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -79.57 -30.92 2.22 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 124.204 1.634 . . . . 0.0 110.821 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.566 ' CD2' ' O ' ' A' ' 67' ' ' SER . 56.7 m-85 -103.31 104.52 14.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 110.895 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.519 ' ND2' ' HB3' ' A' ' 64' ' ' ASP . 3.3 m120 -137.85 149.06 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.436 -0.79 . . . . 0.0 109.344 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.574 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 3.3 pp -163.84 -175.58 4.16 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.453 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 41.5 t80 -108.86 167.54 10.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.479 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 14.8 mt -147.33 158.89 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.666 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -137.24 179.46 18.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.9 t30 70.16 92.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -1.127 . . . . 0.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 21.8 mt -145.02 130.92 19.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.978 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.475 ' HB3' HD21 ' A' ' 34' ' ' LEU . 37.5 t-20 -38.95 99.29 0.19 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.737 -0.602 . . . . 0.0 110.528 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -74.19 -19.28 20.13 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.081 1.569 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -78.5 -13.71 59.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -110.52 -155.65 0.57 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 109.97 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.473 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 6.5 m -104.73 152.7 22.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.315 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.529 HG12 ' CG2' ' A' ' 54' ' ' THR . 2.7 t -69.71 -46.01 76.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 109.452 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -49.52 -38.95 32.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.878 . . . . 0.0 109.279 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.579 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 28.5 mm-40 -67.97 -40.01 83.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.437 -0.789 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.534 ' CD2' HG12 ' A' ' 82' ' ' VAL . 25.6 mt -60.72 -36.59 79.23 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.298 -0.876 . . . . 0.0 108.742 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.465 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 10.3 mmtt -62.32 -57.64 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.2 t -52.22 -35.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.5 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.99 -34.48 78.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 4.5 mt -82.1 -27.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 75.2 m -77.86 -30.15 50.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.937 . . . . 0.0 109.023 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.59 -37.02 32.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.752 . . . . 0.0 109.456 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.2 OUTLIER -69.08 -30.53 68.87 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.587 -0.696 . . . . 0.0 109.145 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.591 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.1 m-85 -84.7 -22.46 29.75 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.88 -32.42 61.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.437 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -12.44 28.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.0 109.735 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -92.41 -11.17 35.56 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.3 t70 85.12 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.917 0.865 . . . . 0.0 109.281 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.596 ' CD2' ' N ' ' A' ' 47' ' ' LEU . 3.0 mm? -86.76 -131.15 0.06 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 47' ' ' LEU . . . 168.38 56.34 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.841 -1.162 . . . . 0.0 109.692 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.411 HG12 ' CB ' ' A' ' 42' ' ' PHE . 12.6 m -58.16 120.5 4.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.067 0.937 . . . . 0.0 110.375 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.545 ' CB ' HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -90.37 -46.85 14.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.448 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.467 ' O ' ' OD1' ' A' ' 64' ' ' ASP . 3.6 m-20 -148.1 118.88 7.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.173 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.51 HG12 ' CG1' ' A' ' 63' ' ' VAL . 16.6 m -101.24 171.55 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.295 -0.878 . . . . 0.0 109.692 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.82 164.48 16.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 0.0 110.431 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.529 ' CG2' HG12 ' A' ' 31' ' ' VAL . 23.4 p -92.03 162.32 14.42 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.456 -0.777 . . . . 0.0 110.549 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -117.5 121.47 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.549 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 2.1 m 72.0 -56.17 0.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.62 -0.929 . . . . 0.0 110.122 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 31' ' ' VAL . 0.3 OUTLIER 173.74 -35.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.518 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 31.8 ttp180 -172.5 26.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.549 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.547 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 34.6 mttp -119.31 -33.74 4.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.549 ' CD2' ' OG1' ' A' ' 56' ' ' THR . 1.1 m-85 -131.26 -165.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.328 -0.858 . . . . 0.0 109.349 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -171.01 161.93 34.74 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.236 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.0 t80 -123.36 154.81 38.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.42 -1.047 . . . . 0.0 109.554 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.621 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.5 t -150.71 146.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.004 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 1.1 m-20 -118.27 135.06 54.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.529 -0.732 . . . . 0.0 109.507 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.643 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 51.4 m-85 -102.44 171.91 7.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.714 -0.616 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.53 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.58 15.77 16.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.89 . . . . 0.0 111.344 -178.218 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p -166.82 173.8 9.15 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.603 1.192 . . . . 0.0 112.281 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.453 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.24 -25.72 51.84 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.38 -26.79 58.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.571 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.538 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 89.1 m-20 -82.41 -30.63 30.05 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -73.15 -36.56 66.68 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.827 179.474 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -73.39 -38.72 65.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.813 . . . . 0.0 109.98 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.538 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -78.3 -29.64 47.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.643 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -64.39 -31.33 72.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.841 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.485 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 4.6 tt -72.82 -45.18 59.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -81.03 -1.13 42.76 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.41 178.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.588 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -77.91 7.83 5.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.282 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 92.4 m -70.29 -2.55 13.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 110.473 179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.55 65.45 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.536 ' CD1' HG12 ' A' ' 87' ' ' ILE . 1.2 pp -71.69 129.4 38.59 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.388 -1.066 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -99.98 84.86 2.94 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.975 0.893 . . . . 0.0 109.518 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.556 ' HB ' ' CG2' ' A' ' 87' ' ' ILE . 4.2 p -43.85 118.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.727 -0.789 . . . . 0.0 108.998 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.579 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 2.1 m-85 46.01 22.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 110.306 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.03 12.26 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.319 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.497 ' O ' HG13 ' A' ' 82' ' ' VAL . 9.6 m120 -126.49 89.67 3.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.31 . . . . 0.0 110.387 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.9 mp0 -40.33 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.63 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.556 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 12.5 pt -71.28 146.54 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.784 0.802 . . . . 0.0 110.581 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.474 ' O ' HG21 ' A' ' 22' ' ' ILE . 15.9 ttpt -116.06 158.64 22.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' CD1' ' HA ' ' A' ' 75' ' ' LEU . 0.1 OUTLIER -119.07 167.95 11.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.837 -1.164 . . . . 0.0 110.415 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.422 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.2 pt-20 -168.9 158.09 8.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.167 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 112.1 31.67 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.9 . . . . 0.0 110.24 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.435 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 45.9 Cg_endo -72.7 -170.93 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.949 1.499 . . . . 0.0 110.438 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -48.93 111.74 0.52 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.889 . . . . 0.0 110.253 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.79 -41.17 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.93 38.91 0.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 110.185 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -120.86 173.35 7.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.227 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -153.34 26.78 0.78 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.95 143.65 11.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.189 -1.183 . . . . 0.0 110.391 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -145.04 63.17 1.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.11 31.02 0.28 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.31 -1.112 . . . . 0.0 110.194 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.44 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.44 ' OG ' ' O ' ' A' ' 1' ' ' GLY . 53.5 p 45.95 28.74 0.65 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -1.146 . . . . 0.0 110.246 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' O ' ' CB ' ' A' ' 4' ' ' MET . 0.6 OUTLIER -82.22 50.43 1.59 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 110.182 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.45 ' CB ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 65.28 137.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 0.0 110.22 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.47 176.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.218 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.23 61.35 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.21 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 7' ' ' ASP . 11.9 p-10 -138.92 105.14 7.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.353 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 43.3 Cg_endo -71.26 81.71 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.963 1.507 . . . . 0.0 110.268 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 67.6 t 58.75 138.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.383 0.611 . . . . 0.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.67 177.98 4.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.43 ' C ' ' OG ' ' A' ' 12' ' ' SER . . . -122.82 99.02 0.63 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.43 ' OG ' ' C ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -165.01 97.28 0.73 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -1.171 . . . . 0.0 110.095 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -169.36 28.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.314 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.32 159.51 14.91 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.345 0.593 . . . . 0.0 110.397 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.555 ' O ' ' OG1' ' A' ' 16' ' ' THR . 7.2 m -90.37 42.19 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.848 . . . . 0.0 110.143 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.555 ' OG1' ' O ' ' A' ' 15' ' ' THR . 1.4 p 77.8 163.41 0.13 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.565 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.405 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.8 Cg_endo -77.85 -31.75 2.99 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.227 1.646 . . . . 0.0 110.91 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.561 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 74.4 m-85 -86.61 102.39 14.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.949 -1.094 . . . . 0.0 110.557 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 16' ' ' THR . 67.0 m-20 -139.52 157.74 45.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.219 -0.926 . . . . 0.0 109.623 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.491 ' CD1' ' C ' ' A' ' 20' ' ' LEU . 2.2 pp -167.02 -177.08 3.62 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.288 -0.882 . . . . 0.0 110.416 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.542 ' CD1' ' C ' ' A' ' 21' ' ' PHE . 1.5 t80 -117.29 146.58 43.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 87' ' ' ILE . 2.2 mt -129.93 160.5 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -136.63 -172.67 12.64 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.506 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 10.1 t-20 72.33 63.95 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.496 -1.002 . . . . 0.0 110.47 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.573 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.1 mm? -106.53 119.54 39.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.522 ' N ' HD13 ' A' ' 34' ' ' LEU . 11.6 t-20 -41.31 107.21 0.47 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.704 -0.622 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.79 -30.3 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.55 . . . . 0.0 110.042 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -78.83 -11.73 60.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.852 . . . . 0.0 109.63 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.439 ' HD2' ' CD ' ' A' ' 33' ' ' GLU . 4.4 mmtp -111.31 -156.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.342 -0.849 . . . . 0.0 109.74 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -111.96 150.71 30.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.335 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.485 HG21 ' HA ' ' A' ' 58' ' ' ARG . 2.2 t -72.83 -19.97 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.376 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -74.38 -45.2 48.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.573 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -62.08 -38.03 87.29 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.522 HD13 ' N ' ' A' ' 26' ' ' ASN . 44.4 mt -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.226 -0.921 . . . . 0.0 108.912 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 1.7 mptp? -58.17 -48.88 78.92 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.547 0.689 . . . . 0.0 109.379 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 26.4 t -56.06 -35.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.723 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.547 ' HB1' ' CD1' ' A' ' 83' ' ' PHE . . . -63.3 -37.32 86.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 108.658 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.641 ' CG2' ' CE2' ' A' ' 42' ' ' PHE . 34.6 mt -81.41 -25.0 10.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.526 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 3.6 p -80.35 -26.95 38.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.066 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.92 -41.92 15.47 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.661 0.743 . . . . 0.0 109.31 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.574 ' CD1' ' CD2' ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.0 -35.74 81.68 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.081 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.641 ' CE2' ' CG2' ' A' ' 38' ' ' ILE . 9.4 m-30 -85.34 -21.82 28.75 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.751 0.786 . . . . 0.0 108.943 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -75.57 -35.18 60.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.466 0.65 . . . . 0.0 109.509 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -84.11 -15.38 47.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 109.366 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.64 -10.94 44.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.859 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.3 t0 83.79 29.17 0.08 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.946 0.879 . . . . 0.0 108.832 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.567 HD21 ' CD1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -73.84 -130.84 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.551 ' HB3' ' CG ' ' A' ' 66' ' ' GLU . . . 173.27 57.45 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.447 -0.783 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.8 m -57.26 117.44 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.936 0.874 . . . . 0.0 110.836 -179.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.543 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 0.2 OUTLIER -93.42 -34.18 5.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.534 ' HB2' ' CG2' ' A' ' 15' ' ' THR . 0.7 OUTLIER -149.03 152.19 35.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.823 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.526 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -157.85 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.485 -0.76 . . . . 0.0 109.072 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' C ' ' CE ' ' A' ' 35' ' ' LYS . 7.1 mmm180 -106.96 168.23 9.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.772 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.47 ' CG2' HG11 ' A' ' 31' ' ' VAL . 4.4 p -80.17 170.94 15.74 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.438 -0.789 . . . . 0.0 110.279 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -128.88 114.1 1.7 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.469 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 1.4 m 67.66 -139.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 110.312 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -98.24 76.35 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.502 -179.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.485 ' HA ' HG21 ' A' ' 31' ' ' VAL . 36.8 mtt180 57.8 42.12 23.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.486 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 21.2 mttt -119.46 -31.44 4.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 59' ' ' LYS . 2.8 m-85 -139.79 -169.26 2.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -166.8 140.59 6.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 2.3 m-30 -99.13 157.12 16.58 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.258 -1.143 . . . . 0.0 109.591 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.519 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.9 t -151.24 143.73 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.7 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.524 ' CB ' HG23 ' A' ' 15' ' ' THR . 0.8 OUTLIER -122.34 140.9 52.13 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.365 -0.835 . . . . 0.0 109.979 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.567 ' CD1' HD21 ' A' ' 47' ' ' LEU . 14.2 m-85 -107.48 172.31 6.9 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.551 ' CG ' ' HB3' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -122.52 19.2 10.45 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.067 -1.021 . . . . 0.0 111.115 -178.506 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.2 p -165.06 176.22 8.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.588 1.185 . . . . 0.0 112.251 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.18 -25.81 42.73 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -32.06 63.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.036 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.527 ' CB ' ' HB3' ' A' ' 65' ' ' PHE . 90.4 m-20 -77.81 -29.57 50.76 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.561 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 1.9 tt -71.22 -39.73 71.54 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -62.16 -38.34 88.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' O ' HD11 ' A' ' 77' ' ' LEU . 23.9 mmtt -72.41 -24.62 61.26 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.527 ' O ' ' CD1' ' A' ' 89' ' ' LEU . . . -63.97 -34.92 79.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 tt -72.02 -44.64 63.09 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.4 9.72 14.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.094 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.571 HD12 ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -75.89 -13.05 60.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.602 -0.686 . . . . 0.0 110.585 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.437 ' HA ' HD21 ' A' ' 89' ' ' LEU . 96.4 m -72.38 3.66 4.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.29 39.35 2.92 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.574 ' CD2' ' CD1' ' A' ' 41' ' ' LEU . 7.4 mt -100.14 -167.55 1.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -1.009 . . . . 0.0 111.017 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.527 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -167.61 51.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.069 0.937 . . . . 0.0 108.925 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.535 HG11 ' CB ' ' A' ' 85' ' ' ASN . 4.1 p -34.66 118.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.248 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.573 ' CE2' ' OE2' ' A' ' 33' ' ' GLU . 15.1 m-85 38.35 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 0.0 110.557 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 96.8 22.0 19.55 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.535 ' CB ' HG11 ' A' ' 82' ' ' VAL . 5.9 m-20 -134.01 84.34 2.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.093 -1.24 . . . . 0.0 109.853 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.527 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 23.4 tt0 -40.11 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.666 0.746 . . . . 0.0 110.44 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.535 ' HB ' ' CG2' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -59.55 123.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.607 -0.683 . . . . 0.0 110.499 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.469 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.5 mttp -95.25 127.88 41.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.003 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -109.34 169.67 8.55 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.399 -179.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -166.85 173.98 8.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.28 106.26 25.02 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.379 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.8 Cg_endo -74.69 -168.93 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.956 1.503 . . . . 0.0 110.428 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 66.63 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.901 . . . . 0.0 110.209 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . -175.86 -43.28 0.06 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER 45.42 -171.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.174 . . . . 0.0 110.247 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.95 -173.55 4.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.922 . . . . 0.0 110.156 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.75 -156.26 44.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.02 151.83 31.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 110.468 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -170.52 42.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.36 -118.93 3.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.242 -1.152 . . . . 0.0 110.198 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.8 -24.15 19.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -1.148 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -110.55 26.88 10.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' LEU . 1.1 ttp -140.84 55.96 1.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 110.164 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.7 OUTLIER -51.88 -174.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.268 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -169.47 109.78 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.218 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.523 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 5.0 t70 -162.93 50.72 0.27 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.227 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 7' ' ' ASP . 48.4 Cg_endo -71.37 -156.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.075 1.566 . . . . 0.0 110.043 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.2 t 52.25 98.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.318 0.58 . . . . 0.0 110.235 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 11' ' ' GLY . 1.1 tt0 -51.46 177.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.146 -0.971 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' GLU . . . -44.03 -73.84 0.23 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.63 -68.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -1.15 . . . . 0.0 110.116 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.84 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 110.217 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.25 159.09 0.22 Allowed 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.403 0.62 . . . . 0.0 110.28 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t -119.88 -13.78 9.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.403 -0.81 . . . . 0.0 109.915 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.587 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.57 172.79 5.44 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.65 -0.656 . . . . 0.0 110.691 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.468 ' HD2' HG21 ' A' ' 16' ' ' THR . 49.5 Cg_endo -77.86 -47.0 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.136 1.598 . . . . 0.0 110.552 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.552 ' CE2' ' CA ' ' A' ' 67' ' ' SER . 55.6 m-85 -87.51 111.12 20.86 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 110.22 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.01 150.39 32.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.374 -0.828 . . . . 0.0 109.113 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.638 ' CD1' ' CE1' ' A' ' 65' ' ' PHE . 13.9 mt -146.42 170.2 17.32 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.361 -0.837 . . . . 0.0 111.22 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.656 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 5.8 t80 -126.06 140.76 52.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.545 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 8.6 mt -137.63 147.8 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 110.774 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.06 -167.66 11.59 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 21.4 t-20 70.92 36.87 1.38 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -1.093 . . . . 0.0 110.372 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.582 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 4.1 mm? -88.4 126.97 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.504 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 36.4 t-20 -40.9 107.76 0.5 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.661 -0.649 . . . . 0.0 110.378 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.41 -8.36 21.67 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.047 1.551 . . . . 0.0 110.289 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 28.1 m120 -96.71 -20.75 18.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.638 ' CD ' ' CE1' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -103.48 -158.9 0.69 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.449 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -103.8 148.27 26.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.286 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' HB ' ' CG2' ' A' ' 54' ' ' THR . 2.1 t -69.71 -26.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.912 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -65.36 -41.16 94.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.416 -0.802 . . . . 0.0 109.031 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.572 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.6 mm-40 -64.27 -45.26 88.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.514 ' CD2' HG12 ' A' ' 82' ' ' VAL . 8.4 mt -60.09 -39.02 84.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.02 -57.17 14.25 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.539 0.685 . . . . 0.0 109.687 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.0 t -57.23 -31.52 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.852 . . . . 0.0 109.714 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.08 -39.06 92.66 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.183 -0.948 . . . . 0.0 108.822 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 19.3 mt -78.3 -24.72 13.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 109.362 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 30.4 t -80.83 -33.22 34.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.147 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.61 -37.04 43.27 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.581 0.705 . . . . 0.0 109.461 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.555 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.33 -31.94 69.46 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.102 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.648 ' CD2' ' CG1' ' A' ' 49' ' ' VAL . 3.3 m-85 -77.74 -26.28 49.82 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.89 -29.67 61.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.549 -0.719 . . . . 0.0 109.706 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.19 -22.42 17.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.703 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.8 m-80 -74.53 -42.15 59.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.703 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.6 t70 122.59 28.86 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.534 0 C-N-CA 123.682 0.793 . . . . 0.0 109.46 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.63 ' CD2' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -96.82 -153.87 0.43 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.463 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.72 61.45 0.2 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.648 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 6.0 m -55.23 115.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 122.08 0.943 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.587 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -91.28 -38.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.526 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -143.5 154.02 43.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.348 -0.845 . . . . 0.0 110.425 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.54 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -157.93 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.395 -0.816 . . . . 0.0 109.172 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.407 ' C ' ' HE2' ' A' ' 35' ' ' LYS . 6.1 mtp180 -121.3 165.66 15.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.006 -1.059 . . . . 0.0 111.055 -179.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.533 ' CG2' ' HB ' ' A' ' 31' ' ' VAL . 13.0 p -88.37 156.74 18.99 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -124.9 118.1 3.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.579 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 3.5 m 66.77 -175.74 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -1.063 . . . . 0.0 110.757 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.421 ' O ' ' HB2' ' A' ' 58' ' ' ARG . 16.9 m120 -63.95 65.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.392 -0.817 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.516 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 2.1 mtt180 61.74 59.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 110.694 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.579 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -120.41 -34.8 3.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.579 ' CZ ' ' OG1' ' A' ' 56' ' ' THR . 1.2 p90 -165.44 140.37 4.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.266 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.471 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -112.33 163.75 12.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.716 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 39.1 m-85 -114.26 163.42 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -1.003 . . . . 0.0 109.635 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.519 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 2.9 t -152.0 139.46 13.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.043 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.47 ' HA ' ' O ' ' A' ' 18' ' ' PHE . 3.6 m-20 -106.81 140.44 39.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.023 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CE1' ' CD1' ' A' ' 20' ' ' LEU . 13.1 m-85 -107.48 170.43 7.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 0.0 110.631 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -116.22 16.08 15.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 111.328 -178.016 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.552 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 3.1 t -163.44 175.32 10.9 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.748 1.261 . . . . 0.0 112.272 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.74 -24.67 22.62 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -89.35 -22.16 22.75 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.487 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 10.7 t0 -81.4 -34.02 31.87 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.517 HD13 ' CD1' ' A' ' 18' ' ' PHE . 7.6 tt -76.28 -34.6 59.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -37.35 84.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.421 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.539 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 1.8 mtmt -72.3 -27.69 62.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.627 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -62.53 -34.07 76.18 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 5.5 tt -71.05 -44.49 65.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.29 1.18 22.57 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.488 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.59 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.75 12.64 2.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.855 . . . . 0.0 110.414 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -78.28 2.67 17.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.08 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.06 33.63 5.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.555 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 22.3 mt -98.44 -166.25 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.253 -1.145 . . . . 0.0 110.982 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.546 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.9 mttt -166.78 49.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.304 1.049 . . . . 0.0 109.416 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG1' HG22 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -38.25 126.94 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.288 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.638 ' CE1' ' CD ' ' A' ' 29' ' ' LYS . 9.0 m-85 42.46 26.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 110.414 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 90.55 21.67 36.63 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' VAL . 36.3 m-80 -136.19 99.51 4.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -1.136 . . . . 0.0 109.393 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.546 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -48.79 90.84 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 110.61 -179.099 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.533 HG22 ' CG1' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -48.83 135.24 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.85 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.2 ttpt -104.23 152.65 21.93 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -124.79 172.8 9.04 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.539 -0.726 . . . . 0.0 110.482 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.7 tt0 -164.16 174.0 11.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -100.48 101.02 13.56 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.244 179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.4 Cg_endo -72.71 -171.13 0.69 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.057 1.556 . . . . 0.0 110.437 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 6.4 ttmt 65.36 101.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.214 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . -44.58 123.01 5.06 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 94' ' ' GLY . 2.7 tmm_? 59.73 148.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.237 -1.155 . . . . 0.0 110.199 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.424 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 2.6 t70 -162.33 67.61 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 110.243 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 155.18 -84.32 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.46 155.0 38.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 110.396 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -71.84 -37.49 70.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.48 -111.81 3.84 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.214 -1.168 . . . . 0.0 110.222 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 m -127.46 -165.35 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -1.116 . . . . 0.0 110.178 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -119.54 23.22 11.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.879 . . . . 0.0 110.193 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -123.63 39.48 3.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.134 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tp 49.57 87.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.147 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 3.5 mt-10 -140.36 107.75 5.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.126 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.573 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 174.29 -60.44 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.942 . . . . 0.0 110.201 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 49.3 Cg_endo -71.45 -157.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.056 1.556 . . . . 0.0 110.062 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.516 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 9.8 p -164.28 120.6 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 O-C-N 121.81 -0.556 . . . . 0.0 110.191 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -76.54 -177.72 4.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.03 11.55 12.27 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.77 24.4 11.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -1.151 . . . . 0.0 110.231 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' HG3' ' N ' ' A' ' 14' ' ' SER . 3.0 pt-20 -117.92 -129.6 0.29 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.224 -0.923 . . . . 0.0 109.446 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.509 ' N ' ' HG3' ' A' ' 13' ' ' GLU . 0.1 OUTLIER 46.99 -175.44 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.128 0 O-C-N 121.662 -0.649 . . . . 0.0 110.257 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 16' ' ' THR . 3.4 m -105.01 -2.16 24.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.544 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 1.9 p -162.98 169.03 9.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 48.4 Cg_endo -76.58 -25.77 9.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.095 1.576 . . . . 0.0 110.734 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.541 ' CE2' ' C ' ' A' ' 67' ' ' SER . 87.6 m-85 -121.33 113.11 19.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.95 -1.094 . . . . 0.0 111.126 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -139.68 150.48 44.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 109.092 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.574 ' O ' ' CZ ' ' A' ' 62' ' ' TYR . 0.5 OUTLIER -161.99 178.61 8.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.443 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -97.93 162.87 13.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.671 . . . . 0.0 109.374 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.572 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 6.0 mt -153.82 152.08 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.922 -1.111 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.566 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -143.5 -166.29 11.17 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.112 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 6.7 t30 72.71 46.1 0.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.553 -0.969 . . . . 0.0 109.883 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.9 mm? -100.56 128.71 46.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.516 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 56.9 t-20 -44.89 103.48 0.34 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.255 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.4 Cg_endo -73.63 -20.9 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.977 1.514 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -14.7 60.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.861 . . . . 0.0 109.965 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.578 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 3.0 mmtt -110.91 -155.75 0.57 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -106.63 149.57 27.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.582 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 3.1 t -67.97 -40.93 84.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -52.72 -42.4 64.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.142 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.562 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.1 mm-40 -66.29 -35.39 80.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 109.308 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.514 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 55.6 mt -65.96 -36.31 82.98 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.367 -0.833 . . . . 0.0 109.081 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.534 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -60.89 -47.49 86.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.356 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.532 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 50.2 t -58.82 -41.51 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.611 -0.68 . . . . 0.0 110.072 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.49 -30.47 70.63 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.99 -1.069 . . . . 0.0 109.155 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.482 HD12 ' CD1' ' A' ' 87' ' ' ILE . 23.0 mm -86.34 -28.48 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.111 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 15.7 t -78.87 -26.27 43.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.334 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.09 -38.91 20.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.473 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 2.7 tp -63.98 -36.5 84.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.469 ' CD2' HG13 ' A' ' 49' ' ' VAL . 12.1 m-85 -83.25 -21.85 33.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.433 ' HB1' ' HA ' ' A' ' 40' ' ' GLU . . . -81.33 -20.36 40.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -104.18 -16.43 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.553 -0.717 . . . . 0.0 109.625 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.72 -29.63 23.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 34.6 t70 111.99 28.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.531 ' CD1' HD22 ' A' ' 77' ' ' LEU . 1.0 OUTLIER -101.08 -155.2 0.5 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -169.1 64.21 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.248 -0.908 . . . . 0.0 109.783 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.469 HG13 ' CD2' ' A' ' 42' ' ' PHE . 7.9 m -49.37 115.07 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.895 0.855 . . . . 0.0 110.096 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.546 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 10.6 t -82.83 -31.66 9.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.832 -0.543 . . . . 0.0 110.567 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.508 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 20.9 t0 -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.534 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 3.5 t -154.2 94.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.747 . . . . 0.0 109.276 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.526 ' CG ' ' HB3' ' A' ' 62' ' ' TYR . 10.7 ptp180 -108.95 170.21 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.762 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.582 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 4.9 p -80.63 164.43 22.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.392 -0.818 . . . . 0.0 110.363 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.484 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -134.58 124.0 3.35 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.468 ' O ' ' HB2' ' A' ' 57' ' ' ASN . 25.3 m 44.12 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.495 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' THR . 10.9 m120 60.75 -141.05 0.54 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.375 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -116.0 32.46 6.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 -20.67 11.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.572 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 1.3 t80 -119.19 -171.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 110.24 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.47 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 175.88 154.93 12.04 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -118.78 159.76 23.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -1.036 . . . . 0.0 109.31 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.605 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.2 t -150.54 143.07 17.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.862 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -116.42 148.87 40.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.661 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 14.0 m-85 -110.72 177.9 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.546 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.35 13.54 16.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 111.516 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.4 p 179.17 175.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.958 -1.089 . . . . 0.0 112.135 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -78.54 -24.04 45.89 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 -26.49 32.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.999 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.0 t0 -80.7 -25.86 37.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD12 ' CD1' ' A' ' 18' ' ' PHE . 4.4 tt -80.19 -33.83 37.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.29 -33.74 70.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.6 -0.688 . . . . 0.0 109.518 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.47 ' O ' HD23 ' A' ' 77' ' ' LEU . 1.6 mmtt -77.22 -27.92 53.59 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.53 -24.54 61.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.429 ' C ' HD21 ' A' ' 75' ' ' LEU . 7.1 tt -74.11 -48.39 29.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.516 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -10.85 60.4 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.531 HD22 ' CD1' ' A' ' 47' ' ' LEU . 0.2 OUTLIER -67.22 -2.47 5.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.58 -0.7 . . . . 0.0 110.489 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.46 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 12.0 m -45.16 -24.8 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.034 . . . . 0.0 110.349 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' LEU . . . -63.32 -16.92 58.8 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.547 ' CD1' ' HA ' ' A' ' 86' ' ' GLU . 3.4 pp -45.07 175.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.622 -0.928 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.563 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 2.7 mttt -177.16 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.332 1.063 . . . . 0.0 109.362 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.511 ' CG1' ' O ' ' A' ' 82' ' ' VAL . 1.7 p -37.98 123.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.621 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.578 ' CE2' ' HG3' ' A' ' 29' ' ' LYS . 4.4 m-85 42.42 26.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.483 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 90.11 23.84 31.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.532 ' O ' ' N ' ' A' ' 87' ' ' ILE . 3.9 m120 -135.41 84.43 2.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -1.194 . . . . 0.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.563 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 0.7 OUTLIER -37.77 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.543 0.687 . . . . 0.0 110.744 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.533 HG13 ' CD2' ' A' ' 80' ' ' LEU . 4.9 pt -49.73 141.25 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.3 mmtm -107.57 155.9 19.6 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.082 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.25 172.76 7.56 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 110.573 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -156.32 156.03 33.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.45 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 4.4 mtmp? -97.39 104.9 22.05 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.923 . . . . 0.0 110.374 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.3 Cg_endo -73.65 -170.35 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.953 1.501 . . . . 0.0 110.371 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.7 mttt 53.2 -170.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.89 -65.83 1.37 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 mtm-85 -71.49 109.04 5.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -1.145 . . . . 0.0 110.244 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -143.16 103.99 4.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.91 . . . . 0.0 110.125 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.93 -60.07 0.47 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.444 ' O ' ' HB3' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -129.67 -92.92 0.44 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -1.184 . . . . 0.0 110.465 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.444 ' HB3' ' O ' ' A' ' 98' ' ' THR . 0.9 OUTLIER 177.48 170.39 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.193 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 101' ' ' CYS . . . 66.79 145.85 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.474 ' C ' ' O ' ' A' ' 100' ' ' GLY . 14.5 p . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -156.47 69.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -1.182 . . . . 0.0 110.131 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -99.67 -71.42 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.8 mtp 47.03 -158.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.51 38.75 3.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 110.297 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.37 107.54 0.68 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -139.26 148.43 56.97 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.862 . . . . 0.0 110.275 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.92 80.41 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.107 1.583 . . . . 0.0 110.41 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' O ' HG12 ' A' ' 9' ' ' VAL . 14.0 p -96.64 47.35 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.249 0.547 . . . . 0.0 110.28 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.16 136.38 31.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.098 -1.001 . . . . 0.0 110.342 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 12' ' ' SER . . . -123.79 42.93 1.49 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 1.1 m 58.81 83.06 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.14 . . . . 0.0 110.185 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 14' ' ' SER . 0.8 OUTLIER -95.77 28.96 2.83 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.305 -0.872 . . . . 0.0 110.293 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -40.26 141.5 0.49 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.281 0.562 . . . . 0.0 110.293 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.509 ' CG2' HG23 ' A' ' 16' ' ' THR . 3.2 t -115.21 -19.99 10.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 110.267 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.581 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 81.8 p -124.46 153.21 69.29 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.581 -0.7 . . . . 0.0 110.716 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.53 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.3 Cg_endo -80.06 -22.37 7.35 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.155 1.608 . . . . 0.0 110.538 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.7 m-85 -107.02 113.06 26.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 110.876 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.4 m120 -139.06 150.76 46.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.528 -0.733 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.577 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 4.4 pp -167.53 -179.63 4.47 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.481 ' HB3' ' CB ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -109.24 154.95 21.7 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.938 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.583 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 3.7 mt -141.89 148.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.58 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -134.1 -169.29 12.0 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.7 t30 72.8 30.31 1.77 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.961 . . . . 0.0 110.021 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.556 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.8 mm? -82.26 128.65 34.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.432 ' C ' ' O ' ' A' ' 25' ' ' LEU . 30.3 t-20 -40.07 100.27 0.21 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.65 -0.656 . . . . 0.0 110.371 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.6 Cg_endo -74.18 -16.72 22.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.455 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -83.87 -13.43 53.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.74 -156.86 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.8 m -104.15 152.06 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.54 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.578 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 3.0 t -68.71 -28.38 39.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.454 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.25 -43.4 98.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.54 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 72.9 mm-40 -69.42 -31.1 69.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.737 . . . . 0.0 109.266 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.526 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 6.5 mt -68.01 -33.88 75.45 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.357 -0.839 . . . . 0.0 109.124 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' CE ' HG12 ' A' ' 31' ' ' VAL . 3.5 mtmt -66.08 -52.13 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.567 -0.708 . . . . 0.0 109.436 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.2 t -56.86 -39.71 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 110.059 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.565 ' HB3' ' CD1' ' A' ' 83' ' ' PHE . . . -61.91 -34.65 76.44 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 109.047 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.5 mt -82.3 -28.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.255 178.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.454 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -79.01 -27.36 43.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -83.81 -38.22 21.53 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 109.206 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 0.6 OUTLIER -65.63 -34.51 78.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.548 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 8.0 m-85 -85.11 -20.41 30.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.454 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . -78.89 -33.19 45.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.457 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -23.28 25.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.8 OUTLIER -83.73 -20.53 33.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 11.4 m-20 89.44 28.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.256 1.027 . . . . 0.0 108.326 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.548 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -75.91 -143.71 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.467 ' HB2' ' OD2' ' A' ' 70' ' ' ASP . . . -164.56 60.15 0.14 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.023 -1.048 . . . . 0.0 110.262 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.499 HG13 ' CB ' ' A' ' 42' ' ' PHE . 16.9 m -66.58 116.59 6.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.767 0.794 . . . . 0.0 109.859 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 1.4 t -99.26 -38.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.833 -0.542 . . . . 0.0 109.96 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.488 ' O ' HG11 ' A' ' 63' ' ' VAL . 15.2 t0 -143.51 154.53 43.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 110.447 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.523 ' CG1' ' HG2' ' A' ' 35' ' ' LYS . 20.5 t -154.74 105.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.747 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.03 167.98 9.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.578 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 16.3 p -81.11 160.0 24.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.367 -0.833 . . . . 0.0 110.233 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -130.91 120.13 2.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.564 ' CG2' ' N ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 70.46 -166.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.26 -1.141 . . . . 0.0 110.108 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.564 ' N ' ' CG2' ' A' ' 56' ' ' THR . 31.0 t-20 -42.99 -76.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.459 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.52 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 10.7 ttp180 -162.41 28.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.217 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.486 ' CE ' ' HA ' ' A' ' 24' ' ' ASN . 19.3 tptm -117.03 -6.27 11.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 109.858 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.583 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 0.6 OUTLIER -121.84 -173.0 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.928 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.525 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 174.76 146.52 5.75 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.661 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.545 -0.974 . . . . 0.0 109.478 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.619 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 4.9 t -152.01 142.78 15.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.171 -0.955 . . . . 0.0 110.831 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -112.24 143.76 42.78 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.308 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 12.6 m-85 -107.53 177.09 4.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.529 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -117.28 12.36 14.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 111.427 -178.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.2 p -173.0 173.99 3.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.048 -1.032 . . . . 0.0 112.107 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.478 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.31 -23.86 43.23 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -25.05 31.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.576 ' OD1' ' CD1' ' A' ' 65' ' ' PHE . 3.9 t0 -81.99 -27.35 33.21 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -81.13 -33.74 33.0 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -72.88 -32.56 65.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.717 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.533 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -78.16 -29.89 48.88 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.74 -31.79 72.97 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.9 tm? -72.11 -45.75 59.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.87 -19.4 58.89 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.085 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.53 ' CD2' HD22 ' A' ' 47' ' ' LEU . 0.6 OUTLIER -71.58 -4.0 24.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.582 -0.699 . . . . 0.0 109.977 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.471 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 87.4 m -74.4 3.98 6.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.337 -0.852 . . . . 0.0 111.039 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.84 -8.75 75.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.563 ' N ' ' CD2' ' A' ' 80' ' ' LEU . 3.5 mm? -79.36 -164.21 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.361 -1.082 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.567 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -149.26 50.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 81' ' ' LYS . 8.9 p 13.92 -132.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.06 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.565 ' CD1' ' HB3' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -69.28 -3.36 13.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.448 -1.408 . . . . 0.0 109.919 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 152.05 36.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 87' ' ' ILE . 11.7 t-20 -170.45 116.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -1.037 . . . . 0.0 109.346 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.567 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -52.03 89.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 0.0 110.385 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.541 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.4 135.08 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.629 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 26.5 mttt -103.88 170.95 7.62 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.527 ' CD2' HD21 ' A' ' 20' ' ' LEU . 4.9 mp -122.91 -175.28 3.13 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 110.492 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.481 ' CB ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -165.34 141.89 5.57 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.696 -0.627 . . . . 0.0 110.242 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.1 100.62 13.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 110.124 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.0 Cg_endo -72.84 -174.23 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.982 1.517 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.98 22.53 2.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 110.252 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.96 26.5 34.36 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -129.87 51.93 2.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -1.102 . . . . 0.0 110.258 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.45 160.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.54 -69.03 1.24 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 p -93.19 176.64 6.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -1.173 . . . . 0.0 110.268 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -124.13 160.42 27.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 110.171 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.87 -65.39 3.57 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.203 -1.175 . . . . 0.0 110.219 -179.959 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 t -135.57 114.58 12.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 110.253 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -138.72 51.85 1.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.865 . . . . 0.0 110.177 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.485 ' O ' ' N ' ' A' ' 6' ' ' GLU . 19.7 ptm -126.69 -162.27 1.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.446 ' CB ' ' O ' ' A' ' 4' ' ' MET . 0.2 OUTLIER 66.13 -64.09 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.485 ' N ' ' O ' ' A' ' 4' ' ' MET . 0.5 OUTLIER -143.04 -172.44 3.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.272 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.421 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 22.9 p30 -119.91 163.51 27.44 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.212 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 7' ' ' ASP . 49.1 Cg_endo -71.52 -157.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.973 1.512 . . . . 0.0 110.065 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.431 ' O ' HG13 ' A' ' 9' ' ' VAL . 8.4 p -167.92 141.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 O-C-N 121.791 -0.568 . . . . 0.0 110.218 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -159.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.452 ' O ' ' HB2' ' A' ' 12' ' ' SER . . . -97.76 -82.21 1.64 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.452 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 3.8 m 56.8 85.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -1.139 . . . . 0.0 110.216 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.72 27.96 8.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.265 -0.897 . . . . 0.0 110.243 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.11 167.52 6.38 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.171 0.51 . . . . 0.0 110.206 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 16' ' ' THR . 3.4 m -77.35 -6.46 53.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.072 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.581 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER 179.15 162.37 0.73 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.563 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.416 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.43 -36.63 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.27 1.669 . . . . 0.0 110.832 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 95.6 m-85 -106.49 112.77 25.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.987 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 1.9 m120 -136.04 144.87 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.278 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.56 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 2.9 pp -155.52 -176.08 5.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 52.9 t80 -110.64 159.35 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.484 HG21 ' N ' ' A' ' 23' ' ' GLY . 24.9 mt -137.6 159.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.793 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.484 ' N ' HG21 ' A' ' 22' ' ' ILE . . . -147.44 176.77 26.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.422 ' HB2' ' HG3' ' A' ' 88' ' ' LYS . 2.8 t30 62.62 57.73 1.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -1.137 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.516 ' HB3' ' CD1' ' A' ' 34' ' ' LEU . 4.2 mm? -90.32 -90.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.51 ' N ' HD11 ' A' ' 34' ' ' LEU . 37.2 t-20 -179.15 92.01 0.21 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.27 -13.86 28.27 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.966 1.508 . . . . 0.0 110.441 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -82.49 -14.36 55.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.973 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -116.57 -156.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.844 . . . . 0.0 109.882 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.43 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -99.57 147.98 24.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.569 ' CG2' ' CB ' ' A' ' 58' ' ' ARG . 21.9 t -68.92 -27.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.55 -40.8 89.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.067 179.042 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.43 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 43.0 mm-40 -67.59 -33.0 74.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.499 -0.75 . . . . 0.0 109.325 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 20.2 mt -66.01 -37.85 86.97 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.417 -0.802 . . . . 0.0 109.017 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.463 ' HE3' HG23 ' A' ' 54' ' ' THR . 0.0 OUTLIER -60.83 -50.16 74.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.5 t -60.83 -35.12 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.526 -0.734 . . . . 0.0 109.247 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.567 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -59.68 -31.98 70.07 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.581 HG23 ' CE2' ' A' ' 42' ' ' PHE . 29.1 mm -80.71 -31.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.616 -0.677 . . . . 0.0 109.367 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -78.55 -23.59 46.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 108.914 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.495 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 6.3 tp -66.7 -32.98 74.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.603 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 10.4 m-85 -87.72 -20.75 25.8 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -80.98 -29.16 35.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.211 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.457 ' HG3' ' OE1' ' A' ' 40' ' ' GLU . 17.2 mttt -87.34 -17.72 31.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 109.387 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.627 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.2 m-80 -92.27 -20.34 21.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.925 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.2 t0 90.21 29.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.603 ' HG ' ' CD1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -74.8 -137.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.464 ' HB1' ' OD2' ' A' ' 70' ' ' ASP . . . -173.63 58.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.188 -0.945 . . . . 0.0 109.604 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.553 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 12.8 m -58.42 117.51 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.942 0.877 . . . . 0.0 110.141 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.581 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 1.9 t -96.64 -33.54 4.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.909 -0.494 . . . . 0.0 109.866 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.524 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 6.9 t70 -144.27 149.34 36.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.067 -1.02 . . . . 0.0 110.884 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.516 ' CG1' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -138.16 150.66 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 0.0 109.776 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.456 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -154.96 164.26 39.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.938 . . . . 0.0 110.405 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.518 ' CG2' HG12 ' A' ' 31' ' ' VAL . 63.0 p -94.86 167.13 11.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.822 . . . . 0.0 110.571 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -126.5 117.33 2.77 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.449 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 1.1 m 55.43 -161.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -1.125 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' A' ' 56' ' ' THR . 35.9 m120 -42.43 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.569 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 2.3 ptp180 -162.93 49.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.327 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -124.5 -23.13 4.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.398 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -128.14 -179.8 5.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -163.87 164.59 36.52 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 2.6 t80 -120.74 166.27 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.977 . . . . 0.0 109.291 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.516 HG21 ' CG1' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -165.48 168.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.818 -1.176 . . . . 0.0 111.543 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 76.5 m-20 -137.13 142.4 42.26 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 28.2 m-85 -104.6 -178.43 3.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.732 -0.605 . . . . 0.0 110.721 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.542 ' CG ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.69 17.99 13.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 0.0 111.05 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 18.9 p 177.95 176.63 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.463 1.125 . . . . 0.0 112.135 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.99 -24.26 55.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -28.6 49.68 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.363 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' HB3' ' CD1' ' A' ' 65' ' ' PHE . 88.3 m-20 -79.22 -28.02 42.51 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.54 -36.88 57.43 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.064 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.65 -32.78 72.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.419 -0.801 . . . . 0.0 109.576 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' CB ' HD22 ' A' ' 47' ' ' LEU . 5.3 mmtp -76.8 -29.4 55.98 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.638 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -64.83 -29.94 70.92 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.449 ' O ' HD12 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.1 -44.03 60.96 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.548 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.14 -7.2 47.75 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.573 ' HG ' ' CE1' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -73.07 4.93 3.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 110.63 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.431 ' O ' ' CD ' ' A' ' 86' ' ' GLU . 89.5 m -78.13 6.95 6.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 110.541 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.437 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . -118.32 19.55 10.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.503 ' N ' ' OE2' ' A' ' 86' ' ' GLU . 2.8 mt -124.61 122.57 37.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.141 -1.211 . . . . 0.0 111.395 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.53 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 2.7 mttm -92.69 89.24 6.58 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.372 1.082 . . . . 0.0 108.517 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.533 ' CG2' HG23 ' A' ' 87' ' ' ILE . 3.0 m -36.93 -104.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.567 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -82.43 20.08 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.063 -1.023 . . . . 0.0 110.647 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' C ' ' ND2' ' A' ' 85' ' ' ASN . . . 122.71 10.33 5.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.5 m-80 -145.25 117.45 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.236 -1.155 . . . . 0.0 109.726 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 7.4 tp10 -56.68 83.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.419 -0.8 . . . . 0.0 109.982 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 85' ' ' ASN . 1.7 pt -43.57 126.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.454 ' HG2' ' O ' ' A' ' 86' ' ' GLU . 0.5 OUTLIER -102.22 131.86 48.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.746 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -108.44 173.07 6.48 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.926 -1.108 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.46 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 3.8 mt-10 -166.94 174.15 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.138 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -100.41 102.53 18.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.088 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' CG ' ' OH ' ' A' ' 62' ' ' TYR . 48.2 Cg_endo -74.57 169.33 22.77 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.023 1.539 . . . . 0.0 110.383 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 166.66 -78.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.548 -0.72 . . . . 0.0 110.05 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.34 40.2 0.13 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 52.63 -172.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 0.0 110.154 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER 42.56 85.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.32 -0.862 . . . . 0.0 110.251 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.08 68.63 0.09 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.458 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 2.7 p -112.23 -33.63 6.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -1.152 . . . . 0.0 110.204 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 98' ' ' THR . 0.0 OUTLIER 178.06 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 110.164 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.79 128.66 2.52 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.255 -1.144 . . . . 0.0 110.246 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 3' ' ' HIS . 10.3 t -93.75 23.3 4.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -1.16 . . . . 0.0 110.146 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' MET . 5.1 t-160 64.73 -156.18 0.3 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.142 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 3' ' ' HIS . 32.0 mtm 53.25 170.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.225 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.63 -34.1 3.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.187 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 1.5 mt-10 -178.64 -164.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.23 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.562 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.0 OUTLIER 172.89 -59.3 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.903 . . . . 0.0 110.142 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 43.6 Cg_endo -71.03 80.98 1.19 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.01 1.531 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 4.0 m -64.61 -151.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.611 0.72 . . . . 0.0 110.331 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.458 ' OE1' ' HB2' ' A' ' 14' ' ' SER . 10.6 pt-20 -132.03 -153.66 0.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 110.294 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' A' ' 12' ' ' SER . . . -91.74 48.33 2.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 11' ' ' GLY . 2.6 m -176.1 -98.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -1.186 . . . . 0.0 109.936 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER 173.69 31.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.086 -1.009 . . . . 0.0 110.517 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.579 ' O ' ' CB ' ' A' ' 15' ' ' THR . 15.2 m -61.89 -115.89 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.895 -0.503 . . . . 0.0 110.39 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.579 ' CB ' ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER 80.59 -7.31 1.6 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.326 0.584 . . . . 0.0 109.917 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.592 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 45.9 p -130.24 153.4 81.2 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 110.309 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.56 -22.08 6.91 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.127 1.593 . . . . 0.0 110.742 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 75.3 m-85 -113.57 108.78 17.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.975 -1.078 . . . . 0.0 111.027 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.1 m120 -137.91 149.0 45.83 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 109.041 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 0.8 OUTLIER -164.27 171.61 14.66 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 110.261 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.521 ' HB3' ' CG ' ' A' ' 90' ' ' GLU . 0.2 OUTLIER -89.99 160.14 16.53 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.47 -0.769 . . . . 0.0 109.207 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.483 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 mp -147.61 161.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.975 -1.078 . . . . 0.0 109.673 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.564 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -160.28 -160.07 10.32 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.084 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.47 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.3 t30 67.16 55.09 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -1.05 . . . . 0.0 110.141 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 60' ' ' PHE . 3.7 mt -104.12 -133.67 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.321 -0.862 . . . . 0.0 110.066 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.438 ' N ' HD22 ' A' ' 34' ' ' LEU . 36.4 t-20 -143.0 109.78 5.49 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.111 -0.993 . . . . 0.0 110.235 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.59 2.66 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.993 1.522 . . . . 0.0 110.698 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 34.7 m-80 -113.59 18.3 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.968 . . . . 0.0 109.169 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.0 tptt -138.64 -158.34 0.85 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.717 -0.614 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -107.29 142.59 36.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.6 t -69.29 -32.07 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.386 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.458 ' O ' HG22 ' A' ' 36' ' ' VAL . . . -62.83 -27.81 69.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.003 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 11.3 mm-40 -77.59 -42.3 35.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.465 HD21 HD23 ' A' ' 25' ' ' LEU . 3.8 mt -61.89 -37.93 86.43 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.259 -0.901 . . . . 0.0 109.092 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.529 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -63.17 -52.07 63.85 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.618 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.493 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 48.7 t -63.41 -28.14 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.252 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.43 -34.14 77.5 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 108.587 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 42' ' ' PHE . 6.5 mt -83.89 -25.48 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.5 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 13.1 m -80.3 -28.86 38.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -82.43 -37.34 25.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.533 -0.73 . . . . 0.0 109.238 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.525 HD23 ' CB ' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.23 -30.44 67.51 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.555 -0.716 . . . . 0.0 109.18 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.574 ' CZ ' HD12 ' A' ' 77' ' ' LEU . 3.2 m-85 -91.99 -14.63 29.13 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -0.82 . . . . 0.0 109.363 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.5 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -92.19 -28.57 16.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.697 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.51 -21.23 21.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.41 -0.806 . . . . 0.0 109.089 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -79.25 -60.01 2.54 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.388 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 147.37 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.186 0.517 . . . . 0.0 109.802 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.533 ' HG ' ' CD1' ' A' ' 77' ' ' LEU . 3.8 mm? -98.35 -157.72 0.62 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -156.93 63.82 0.51 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.426 ' O ' HG21 ' A' ' 49' ' ' VAL . 12.7 m -58.28 117.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.929 0.871 . . . . 0.0 109.789 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.592 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 2.1 t -90.31 -44.26 14.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 O-C-N 121.735 -0.603 . . . . 0.0 110.188 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.501 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 34.3 t0 -141.04 152.74 45.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.07 -1.019 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.529 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 2.8 t -152.36 105.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 167.45 10.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.532 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 47.3 p -85.16 163.65 18.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.4 -0.812 . . . . 0.0 110.416 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.488 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -137.76 137.32 8.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.48 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 28.8 m 60.36 176.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -1.115 . . . . 0.0 109.961 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' THR . 20.0 m120 -40.98 -59.68 1.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.581 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -168.08 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.965 . . . . 0.0 110.193 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tttt -127.14 -11.04 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.448 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' HA3' ' A' ' 23' ' ' GLY . 1.3 t80 -122.18 179.41 4.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.26 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.64 163.79 31.33 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.5 t80 -126.25 157.24 38.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.467 -1.019 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.604 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 4.2 t -151.72 145.2 16.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.813 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -116.35 144.01 44.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.405 -0.81 . . . . 0.0 109.705 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 19.6 m-85 -107.05 176.71 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.571 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.524 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -112.28 13.62 20.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 111.609 -178.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 25.0 p 177.66 178.16 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.401 1.096 . . . . 0.0 112.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.68 -22.65 53.69 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.426 ' OE2' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.59 -25.84 38.23 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.493 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 85.4 m-20 -83.3 -27.81 29.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.0 tm? -78.7 -34.06 46.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.772 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.03 -38.51 61.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' A' ' 77' ' ' LEU . 14.7 mtmt -79.55 -18.21 52.3 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -79.26 -28.1 42.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.379 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.464 ' O ' ' OG1' ' A' ' 78' ' ' THR . 5.6 tt -79.12 -44.32 22.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.435 -0.791 . . . . 0.0 109.105 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.463 ' N ' HD22 ' A' ' 75' ' ' LEU . 2.0 mt-10 -71.34 -24.26 62.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.308 -0.87 . . . . 0.0 109.29 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.574 HD12 ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -64.45 -15.05 60.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.0 109.972 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.464 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -37.93 -28.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.878 0.847 . . . . 0.0 110.891 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -51.73 -26.17 16.62 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.53 HD23 ' CG1' ' A' ' 87' ' ' ILE . 1.6 pt? -65.52 131.91 47.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -1.18 . . . . 0.0 110.896 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 3.5 mttm -109.9 80.76 1.35 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.08 0.943 . . . . 0.0 109.964 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.534 ' HB ' ' CG2' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -39.71 122.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.421 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.577 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.9 m-85 43.33 24.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 93.38 19.16 36.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.3 m-80 -133.31 91.7 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 110.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.565 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 9.2 tt0 -41.1 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 110.733 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 85' ' ' ASN . 0.7 OUTLIER -47.64 141.33 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.771 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.518 ' HG3' ' N ' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -116.32 157.89 24.28 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.518 ' N ' ' HG3' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -125.86 174.68 8.2 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.163 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.521 ' CG ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -173.87 113.87 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 110.166 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -55.2 121.19 35.22 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.198 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 93' ' ' LYS . 45.2 Cg_endo -73.47 -179.94 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.961 1.506 . . . . 0.0 110.286 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 92' ' ' PRO . 0.5 OUTLIER 177.23 31.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.414 -0.804 . . . . 0.0 110.254 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 95' ' ' ARG . . . -60.88 -28.79 69.07 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 94' ' ' GLY . 5.1 mtp180 41.94 42.59 2.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -1.096 . . . . 0.0 110.339 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.49 160.0 28.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.28 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.36 138.53 23.46 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.72 165.85 5.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -1.141 . . . . 0.0 110.407 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.34 -85.4 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.238 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 46.85 -134.27 11.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.268 -1.136 . . . . 0.0 110.177 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -116.47 175.23 5.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -1.186 . . . . 0.0 110.188 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.3 m170 46.97 64.18 1.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.7 ttm -104.51 -40.78 5.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.233 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.0 mt -142.87 -169.77 3.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.211 179.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -157.3 117.56 3.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.54 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 23.1 t70 44.64 49.49 5.9 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 7' ' ' ASP . 49.7 Cg_endo -71.51 -157.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.026 1.54 . . . . 0.0 110.158 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.436 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.3 p -140.57 77.19 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-O 121.242 0.544 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' OE2' ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER 64.55 149.79 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 110.234 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.96 58.99 0.52 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m 62.41 77.53 0.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.287 -1.125 . . . . 0.0 110.145 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.458 ' O ' ' O ' ' A' ' 14' ' ' SER . 1.3 mt-10 -91.65 28.44 1.76 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.563 ' CB ' ' ND2' ' A' ' 19' ' ' ASN . 0.5 OUTLIER -41.19 164.07 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.36 0.6 . . . . 0.0 110.199 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.51 HG22 ' N ' ' A' ' 16' ' ' THR . 5.3 t -75.82 -22.44 56.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.354 -0.842 . . . . 0.0 110.173 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.525 HG21 ' CG1' ' A' ' 50' ' ' VAL . 32.0 p -119.64 163.29 28.19 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.579 -0.7 . . . . 0.0 110.417 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.67 -27.65 10.49 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.015 1.534 . . . . 0.0 110.661 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CE1' ' HA ' ' A' ' 68' ' ' ALA . 97.7 m-85 -102.63 112.52 25.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.374 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.563 ' ND2' ' CB ' ' A' ' 14' ' ' SER . 3.7 m120 -143.05 151.97 41.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.748 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.569 ' O ' ' CZ ' ' A' ' 62' ' ' TYR . 3.0 pp -161.3 -176.41 5.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.408 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.557 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 16.3 t80 -108.75 161.5 15.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.544 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.1 mt -140.19 159.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -143.5 170.82 25.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.484 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 28.2 t30 67.81 71.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -1.118 . . . . 0.0 109.944 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.559 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -106.15 19.68 20.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' PHE . 2.8 t30 55.94 99.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.39 -19.57 21.92 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.02 1.537 . . . . 0.0 110.289 179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.2 -19.83 56.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.454 ' HG3' ' HB3' ' A' ' 83' ' ' PHE . 5.6 tmtt? -98.54 -154.29 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.855 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.471 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -113.56 139.56 48.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 110.384 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.583 ' CG2' ' CB ' ' A' ' 58' ' ' ARG . 2.6 t -67.98 -29.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.003 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.45 -37.35 87.21 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 69.3 mm-40 -70.68 -27.53 64.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.516 ' CG ' HD11 ' A' ' 25' ' ' LEU . 3.2 mm? -64.43 -42.58 95.94 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.404 -0.81 . . . . 0.0 109.106 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.526 ' CE ' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.89 -54.65 27.55 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.981 -0.687 . . . . 0.0 109.8 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.9 t -62.66 -30.21 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.494 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.97 -40.01 90.9 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.758 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 34' ' ' LEU . 10.8 mm -78.58 -24.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.109 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 1.4 p -79.78 -32.94 40.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.26 179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -80.34 -37.9 31.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.519 HD23 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.35 -30.91 69.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 0.0 109.167 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.569 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 5.5 m-85 -89.03 -16.0 32.7 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.499 -0.751 . . . . 0.0 109.328 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -90.8 -27.37 18.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.67 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.451 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -92.02 -21.1 20.69 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.694 0.759 . . . . 0.0 109.305 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -81.25 -59.16 2.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.2 m-20 144.61 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.204 0.601 . . . . 0.0 109.64 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.533 ' CD1' ' HA ' ' A' ' 70' ' ' ASP . 2.7 mm? -99.26 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.205 -0.935 . . . . 0.0 109.842 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.82 61.87 0.47 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.527 HG13 ' CD2' ' A' ' 42' ' ' PHE . 11.7 m -58.28 116.14 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.814 0.816 . . . . 0.0 109.843 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.525 ' CG1' HG21 ' A' ' 16' ' ' THR . 1.0 OUTLIER -88.95 -45.55 15.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 121.209 0.528 . . . . 0.0 109.779 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.458 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 12.6 t0 -143.37 159.22 42.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.637 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.525 HG13 ' CG ' ' A' ' 35' ' ' LYS . 6.2 p -158.81 100.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 110.068 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -96.58 164.72 12.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.523 ' CG2' HG11 ' A' ' 31' ' ' VAL . 1.3 p -87.32 159.15 18.87 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.167 -0.958 . . . . 0.0 110.14 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.506 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -121.04 120.37 4.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.576 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 10.0 m 50.42 102.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -1.124 . . . . 0.0 110.544 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' THR . 90.5 m-20 41.26 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.441 -0.787 . . . . 0.0 110.675 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.583 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -149.0 52.45 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 0.0 110.454 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.578 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 4.2 tmtt? -123.74 -24.31 4.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.926 . . . . 0.0 110.34 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CZ ' ' HB3' ' A' ' 59' ' ' LYS . 1.6 m-85 -138.15 -158.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.371 -0.831 . . . . 0.0 109.37 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.506 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 168.83 165.77 26.77 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.267 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.569 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 10.2 t80 -122.84 158.53 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.564 -0.962 . . . . 0.0 109.38 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.52 HG21 ' CD1' ' A' ' 22' ' ' ILE . 3.7 t -149.72 144.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.112 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 2.9 m-20 -114.31 139.18 49.65 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.65 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 17.8 m-85 -104.15 173.81 6.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.442 -0.786 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.469 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.16 13.48 15.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 111.577 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.535 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.7 p -171.82 173.87 4.39 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.207 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.576 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.51 -24.32 42.32 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.98 -25.2 32.5 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.989 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.566 ' OD1' ' CD1' ' A' ' 65' ' ' PHE . 4.8 t0 -83.12 -25.55 31.83 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 2.7 tm? -82.73 -31.24 28.56 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.69 -34.68 62.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.581 -0.699 . . . . 0.0 109.529 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.536 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 1.5 tppt? -78.56 -28.4 45.94 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.65 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -70.06 -25.99 63.8 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.452 ' O ' ' OG1' ' A' ' 78' ' ' THR . 0.5 OUTLIER -72.96 -48.65 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.604 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -5.77 45.12 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.176 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.569 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -75.85 6.31 5.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.491 -0.755 . . . . 0.0 110.446 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -65.27 -8.42 17.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.074 -1.016 . . . . 0.0 110.312 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.24 29.55 8.1 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.519 ' CD2' HD23 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.31 117.1 30.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -1.057 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.583 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -112.47 93.39 4.42 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.944 1.354 . . . . 0.0 109.381 178.597 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.55 ' O ' ' O ' ' A' ' 81' ' ' LYS . 23.5 t -46.66 -113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.269 -2.93 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.29 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.56 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 21.9 m-85 -80.31 47.57 0.93 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 120.705 -1.247 . . . . 0.0 109.673 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 81' ' ' LYS . . . 81.29 26.34 52.22 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 85' ' ' ASN . 7.9 p-10 -137.63 74.94 1.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -1.102 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.583 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.5 tm-20 -43.05 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.566 ' CD1' ' N ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -54.13 127.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.512 0.673 . . . . 0.0 110.402 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 23' ' ' GLY . 4.4 mttt -102.54 129.84 49.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.802 . . . . 0.0 109.577 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.5 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -111.18 172.99 6.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.964 -1.085 . . . . 0.0 110.685 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -168.23 166.81 12.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.751 . . . . 0.0 109.995 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -86.51 110.23 30.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.6 Cg_endo -73.33 -172.27 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.975 1.513 . . . . 0.0 110.471 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -84.48 168.17 15.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 110.176 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.55 -67.9 0.58 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -75.45 -17.95 60.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -1.165 . . . . 0.0 110.235 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 1.6 m-20 49.13 -170.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.885 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 98' ' ' THR . . . -71.57 97.96 0.73 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.459 ' O ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -41.99 -93.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -1.154 . . . . 0.0 110.459 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.42 ' N ' ' OG1' ' A' ' 98' ' ' THR . 0.0 OUTLIER -89.42 -46.11 8.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 110.229 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.25 177.89 30.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.394 -1.063 . . . . 0.0 110.219 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.12 64.77 1.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.281 -1.129 . . . . 0.0 110.167 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' CG ' ' O ' ' A' ' 3' ' ' HIS . 13.6 t-160 -151.84 44.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 tpp -122.15 11.92 10.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.186 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tp -84.44 137.84 33.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 110.213 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 3.0 pm0 -129.13 63.37 1.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 110.252 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.16 93.69 40.83 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.205 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.92 79.77 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.002 1.528 . . . . 0.0 110.398 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' O ' HG22 ' A' ' 9' ' ' VAL . 7.0 p -144.44 63.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.96 155.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.213 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.55 52.95 0.31 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 m -141.75 83.74 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -1.219 . . . . 0.0 110.239 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -170.72 29.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' GLU . 8.1 t 46.55 -175.14 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 121.23 0.538 . . . . 0.0 110.358 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t -74.69 -14.56 60.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.867 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.527 HG22 ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -135.34 164.95 40.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.1 Cg_endo -77.24 -38.49 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.167 1.614 . . . . 0.0 110.53 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.577 ' CE2' ' CA ' ' A' ' 67' ' ' SER . 97.3 m-85 -94.24 107.14 19.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.572 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' PHE . 6.8 m120 -136.41 154.3 50.83 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.356 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.646 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -170.51 -176.71 2.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 110.809 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.533 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 4.5 t80 -105.04 146.74 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.507 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.532 ' CD1' ' HB ' ' A' ' 63' ' ' VAL . 1.5 mt -141.09 149.76 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.514 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -149.36 -156.22 7.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.868 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.476 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.1 t30 67.52 41.59 2.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -1.022 . . . . 0.0 110.027 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.528 HD13 ' CD1' ' A' ' 34' ' ' LEU . 3.6 mm? -84.73 -167.82 1.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -119.98 107.3 40.09 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.466 ' HA ' ' HG3' ' A' ' 58' ' ' ARG . 44.9 Cg_endo -73.25 -5.0 16.41 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.082 1.569 . . . . 0.0 110.324 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -79.78 -18.69 50.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.735 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 -155.51 0.58 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.554 -0.716 . . . . 0.0 109.709 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.47 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -99.21 141.28 32.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -0.999 . . . . 0.0 110.51 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.536 ' CG1' ' HB ' ' A' ' 54' ' ' THR . 3.3 t -65.48 -29.86 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.178 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -65.84 -38.67 89.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.849 . . . . 0.0 109.047 178.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.533 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 63.6 mm-40 -67.12 -30.73 70.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.528 ' CD1' HD13 ' A' ' 25' ' ' LEU . 3.9 mm? -66.53 -40.61 89.2 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.382 -0.824 . . . . 0.0 108.917 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.508 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -58.4 -53.3 59.83 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.362 -0.836 . . . . 0.0 108.911 178.822 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.497 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -65.27 -30.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.45 -29.63 70.88 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.534 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 34' ' ' LEU . 12.9 mm -84.04 -28.55 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.198 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.519 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 31.0 t -80.05 -27.83 39.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 108.893 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.526 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 2.8 tm-20 -81.88 -36.32 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.377 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.57 ' CD2' ' CD1' ' A' ' 80' ' ' LEU . 5.0 tp -70.96 -31.08 67.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.595 ' CE1' ' CD1' ' A' ' 77' ' ' LEU . 3.5 m-30 -90.98 -14.88 30.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.481 -0.762 . . . . 0.0 109.393 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -90.02 -27.27 19.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.405 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.43 -22.22 20.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.811 . . . . 0.0 109.225 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.4 m-80 -79.59 -58.99 2.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.684 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.2 m-20 148.03 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.143 0.497 . . . . 0.0 110.153 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.574 HD23 ' CD2' ' A' ' 42' ' ' PHE . 6.3 mp -103.4 -158.17 0.65 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.69 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.87 64.28 0.46 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.519 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 9.5 m -53.08 118.01 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.995 0.903 . . . . 0.0 109.761 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.527 ' CG1' HG22 ' A' ' 16' ' ' THR . 1.8 t -89.54 -39.12 12.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.064 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -150.22 158.12 43.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.698 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.508 ' CG2' ' HG3' ' A' ' 35' ' ' LYS . 9.8 p -144.07 159.97 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.43 -0.794 . . . . 0.0 109.594 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -155.55 164.08 39.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 110.104 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.536 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -116.83 154.89 29.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 110.513 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -123.71 127.84 6.69 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.578 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 1.9 m 71.31 -171.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.384 -1.068 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.456 ' O ' ' HB3' ' A' ' 58' ' ' ARG . 3.7 p30 -48.67 -53.0 20.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.556 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.527 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -179.41 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.115 -0.991 . . . . 0.0 110.565 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -126.73 -22.87 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.561 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.578 ' CD2' ' OG1' ' A' ' 56' ' ' THR . 1.6 m-85 -122.57 -177.18 3.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.937 . . . . 0.0 109.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' CA ' ' O ' ' A' ' 53' ' ' ARG . . . 176.54 135.43 2.16 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.235 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.624 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -98.09 169.53 9.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.989 . . . . 0.0 109.423 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.532 ' HB ' ' CD1' ' A' ' 22' ' ' ILE . 17.6 t -158.82 162.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.139 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -130.99 140.6 50.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.697 -0.627 . . . . 0.0 109.479 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.645 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 16.8 m-85 -110.87 174.64 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.845 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.497 ' HG2' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.84 11.53 19.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.498 -0.751 . . . . 0.0 111.309 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.577 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 6.6 p -173.08 173.51 3.65 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.26 1.029 . . . . 0.0 112.185 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' N ' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.64 -23.56 45.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.463 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -84.44 -23.69 29.86 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.277 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.476 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 4.4 t0 -83.69 -26.94 29.39 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.414 HD13 ' HB3' ' A' ' 18' ' ' PHE . 9.8 tt -81.4 -33.98 31.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.266 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -74.96 -32.96 61.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.456 -0.777 . . . . 0.0 109.621 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -81.47 -23.19 37.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.645 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.99 -29.94 63.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.428 ' CD1' ' C ' ' A' ' 75' ' ' LEU . 3.1 tm? -75.96 -45.53 34.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -66.94 -23.39 65.96 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.435 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.595 ' CD1' ' CE1' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -67.57 -8.05 31.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.55 0.691 . . . . 0.0 110.391 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.459 ' O ' HG21 ' A' ' 78' ' ' THR . 22.2 m -67.4 0.37 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.646 -0.659 . . . . 0.0 111.556 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.1 16.93 54.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.57 ' CD1' ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -103.09 -159.12 0.71 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.988 . . . . 0.0 110.541 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.571 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -164.76 49.67 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.344 1.068 . . . . 0.0 108.914 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.542 ' C ' ' O ' ' A' ' 81' ' ' LYS . 17.0 t 0.35 -115.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.769 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.533 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 4.0 m-30 -76.81 9.32 2.93 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 128.51 35.34 0.5 Allowed Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.522 ' O ' ' N ' ' A' ' 87' ' ' ILE . 12.2 m120 -161.73 100.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 109.565 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.571 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -49.55 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.308 -0.87 . . . . 0.0 110.406 -179.212 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.528 ' CG2' HG23 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -42.71 143.13 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.466 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 5.5 mtpp -119.26 159.68 23.63 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.596 -0.69 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.516 ' CD2' HD23 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -112.82 -179.2 3.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 110.226 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 1.3 tt0 -168.89 148.56 4.22 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.744 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.488 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 17.3 mttm -99.8 102.19 16.38 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 110.311 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.4 Cg_endo -73.19 -171.92 0.9 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.98 1.516 . . . . 0.0 110.352 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -63.48 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.43 67.47 3.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.48 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -1.158 . . . . 0.0 110.118 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -68.99 157.26 37.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.227 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.86 -155.61 27.02 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 p -118.07 -147.67 0.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -1.089 . . . . 0.0 110.191 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.45 -16.3 14.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.194 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.99 98.88 0.23 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.41 103.07 4.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -1.164 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.95 38.53 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.206 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.45 112.46 10.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.927 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 pp -62.81 -170.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 0.0 110.16 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.6 pt-20 -150.53 -164.51 2.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.8 58.45 17.86 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.181 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.91 79.78 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.987 1.52 . . . . 0.0 110.428 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.6 p -153.69 128.7 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.263 0.554 . . . . 0.0 110.177 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.97 -172.61 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 0.0 110.219 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.47 62.7 0.38 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.39 37.06 2.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -1.125 . . . . 0.0 110.196 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -145.74 95.79 2.7 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.267 -0.896 . . . . 0.0 109.785 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.485 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -65.91 169.63 6.44 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 121.204 0.526 . . . . 0.0 110.222 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.513 ' CG2' HG23 ' A' ' 16' ' ' THR . 5.7 t -115.95 -23.73 8.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.115 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.556 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 39.1 p -105.6 161.85 21.53 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.565 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.4 Cg_endo -74.85 -25.45 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.083 1.57 . . . . 0.0 110.762 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CE1' ' HA ' ' A' ' 68' ' ' ALA . 97.6 m-85 -102.2 110.16 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.973 -1.079 . . . . 0.0 110.567 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' ND2' ' HB3' ' A' ' 14' ' ' SER . 2.0 m120 -140.88 149.75 42.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.451 ' CD1' ' C ' ' A' ' 20' ' ' LEU . 4.5 pp -163.72 -175.97 4.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 8.2 t80 -118.4 144.53 45.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.533 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 mt -127.46 157.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.196 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.96 -169.68 11.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.528 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 42.1 t30 72.67 71.8 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.562 -0.963 . . . . 0.0 110.132 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.9 mm? -110.59 157.78 19.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 110.268 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.519 ' ND2' ' OD1' ' A' ' 28' ' ' ASN . 39.4 t-20 -87.88 109.69 29.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.07 -28.33 12.98 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.967 1.509 . . . . 0.0 110.687 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' OD1' ' ND2' ' A' ' 26' ' ' ASN . 32.7 p30 -75.0 -13.68 60.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -110.49 -154.94 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.514 -0.741 . . . . 0.0 109.681 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.443 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 1.4 m -109.98 145.64 36.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.496 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.519 HG12 ' CG2' ' A' ' 54' ' ' THR . 2.9 t -69.97 -30.95 46.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.2 -0.937 . . . . 0.0 109.389 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.1 -37.19 83.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.856 . . . . 0.0 109.26 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.443 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 63.2 mm-40 -68.71 -34.28 75.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.41 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.486 HD21 ' CD1' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.03 -35.57 81.59 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.403 -0.811 . . . . 0.0 109.104 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.509 ' CE ' ' O ' ' A' ' 31' ' ' VAL . 0.1 OUTLIER -64.38 -48.2 76.35 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.472 -0.767 . . . . 0.0 109.25 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 9.9 t -61.26 -34.61 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.464 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.89 -34.05 76.6 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.214 -0.929 . . . . 0.0 108.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.57 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 22.4 mm -81.86 -28.04 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 11.5 t -79.02 -27.68 43.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.049 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.16 -39.15 23.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.601 0.715 . . . . 0.0 109.125 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.525 ' O ' ' ND2' ' A' ' 45' ' ' ASN . 0.3 OUTLIER -66.08 -32.73 74.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.633 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 9.3 m-85 -86.31 -19.16 30.26 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.393 -0.817 . . . . 0.0 109.212 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.48 -26.37 20.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.766 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -91.8 -19.14 22.87 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.485 -0.76 . . . . 0.0 109.051 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.617 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -81.89 -59.48 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.601 -0.687 . . . . 0.0 109.483 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.4 m-20 147.41 30.61 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.15 0.5 . . . . 0.0 110.002 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.633 ' CD2' ' CD2' ' A' ' 42' ' ' PHE . 3.4 mp -103.59 -157.06 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.41 65.29 0.44 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.8 m -53.17 117.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.935 0.874 . . . . 0.0 109.904 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.556 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.24 -44.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.164 0.506 . . . . 0.0 109.943 -179.489 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.498 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 13.2 t70 -138.78 149.53 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.498 ' CG2' ' C ' ' A' ' 51' ' ' ASP . 2.4 t -152.3 102.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.78 . . . . 0.0 109.466 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 62' ' ' TYR . 64.1 mtm180 -114.37 168.83 9.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.089 -1.007 . . . . 0.0 110.466 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.519 ' CG2' HG12 ' A' ' 31' ' ' VAL . 16.3 p -76.35 179.02 6.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -138.73 131.63 5.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 53.5 m 57.32 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.518 ' OD1' ' CG2' ' A' ' 56' ' ' THR . 23.0 p-10 -161.0 90.54 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 110.489 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.482 ' CG ' ' O ' ' A' ' 58' ' ' ARG . 9.3 ttp180 53.27 19.84 1.68 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -113.01 -30.0 7.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.575 ' CD2' ' HB ' ' A' ' 56' ' ' THR . 2.0 m-85 -138.6 -177.74 5.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -159.83 135.47 4.13 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.193 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.684 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 2.6 m-85 -91.47 154.78 18.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -1.15 . . . . 0.0 109.635 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.512 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 3.7 t -151.78 143.7 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.843 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.79 143.51 47.81 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.428 -0.795 . . . . 0.0 109.58 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 53.8 m-85 -108.2 173.48 6.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.946 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.529 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.25 16.68 14.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 111.622 -178.031 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 2.4 t -165.18 175.68 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.729 1.252 . . . . 0.0 112.216 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.571 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -88.23 -25.41 22.88 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.46 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.86 -21.65 26.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.468 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 9.4 t0 -84.0 -31.01 25.71 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.476 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 3.7 tp -75.16 -35.57 61.59 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.482 0.658 . . . . 0.0 109.336 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.86 -37.87 67.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.698 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.05 -26.74 56.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.33 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.05 -26.77 61.4 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.949 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -70.94 -47.16 60.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.73 -15.78 63.21 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.748 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.576 HD11 ' CE1' ' A' ' 42' ' ' PHE . 1.2 mm? -73.22 1.37 9.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.586 -0.696 . . . . 0.0 110.246 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.507 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 38.7 m -76.29 4.13 9.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.584 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.97 19.22 33.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.535 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 2.5 pp -100.33 122.65 43.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.217 -1.167 . . . . 0.0 110.56 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 85' ' ' ASN . 2.2 ttmt -82.9 81.55 8.56 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.905 1.336 . . . . 0.0 110.147 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.528 HG11 ' CG2' ' A' ' 87' ' ' ILE . 1.7 p -36.32 -98.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.27 -2.851 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.522 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 2.2 m-30 -91.29 20.67 4.96 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.026 -1.046 . . . . 0.0 110.533 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.539 ' CA ' ' HG2' ' A' ' 81' ' ' LYS . . . 120.77 23.16 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.584 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 1.9 m-20 -155.58 100.04 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 0.0 109.745 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -42.69 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.085 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 85' ' ' ASN . 6.1 pt -42.89 154.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.278 -0.889 . . . . 0.0 110.575 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.457 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -121.66 157.92 29.8 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.76 -0.588 . . . . 0.0 109.457 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.533 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 7.7 mp -112.0 -179.04 3.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.058 -1.026 . . . . 0.0 110.488 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 2.2 tt0 -166.25 153.52 9.78 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.659 -0.651 . . . . 0.0 110.159 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.28 97.6 10.4 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.227 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.9 Cg_endo -72.84 -171.57 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.931 1.49 . . . . 0.0 110.459 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt 44.74 27.73 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 110.166 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.99 -154.06 11.98 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.433 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -135.07 -81.82 0.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -1.148 . . . . 0.0 110.2 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 8.9 m-20 56.76 -163.63 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 110.248 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.01 -162.12 16.96 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.64 -34.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -1.136 . . . . 0.0 110.464 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -66.0 99.49 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.214 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.36 -70.42 0.12 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.164 . . . . 0.0 110.215 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 p -121.64 20.31 11.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.18 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.415 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.3 OUTLIER -175.0 164.08 3.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 110.19 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER 59.21 55.04 4.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.163 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.443 ' HG ' ' HB2' ' A' ' 95' ' ' ARG . 4.1 mm? -57.8 87.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.208 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 4' ' ' MET . 15.5 pt-20 -174.95 124.61 0.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.222 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.64 147.06 41.29 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.202 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.93 79.62 1.62 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.959 1.505 . . . . 0.0 110.299 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.407 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -170.63 140.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.221 0.534 . . . . 0.0 110.17 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.91 159.52 28.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.266 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.57 -24.14 11.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -96.76 38.71 1.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -1.137 . . . . 0.0 110.184 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.45 29.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -174.6 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.211 0.529 . . . . 0.0 110.239 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.448 ' O ' HG21 ' A' ' 16' ' ' THR . 7.9 m -111.55 1.54 16.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.523 HG23 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -171.15 164.32 4.99 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.402 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.7 Cg_endo -77.98 -27.21 5.93 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.201 1.632 . . . . 0.0 110.715 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 87.3 m-85 -110.24 116.73 32.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.6 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 5.9 m120 -142.8 157.01 45.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -0.809 . . . . 0.0 109.73 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.641 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -164.3 168.33 18.84 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.478 -0.763 . . . . 0.0 110.192 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.474 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 45.6 t80 -102.6 157.24 17.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.501 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 11.4 mt -126.68 165.89 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -160.01 106.59 0.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.625 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 7.9 t-20 147.5 66.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.521 ' CD1' HG11 ' A' ' 31' ' ' VAL . 4.6 mm? -98.44 133.54 42.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 110.958 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.443 ' HB2' HD12 ' A' ' 34' ' ' LEU . 9.6 t-20 -58.36 113.11 5.9 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.706 -0.621 . . . . 0.0 109.946 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.76 -36.91 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.901 1.474 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -74.87 -16.27 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.623 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 4.1 mmtt -110.4 -155.2 0.56 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.694 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.426 ' O ' HD11 ' A' ' 34' ' ' LEU . 2.1 m -122.01 148.52 44.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 179.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.532 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 2.5 t -69.62 -35.52 66.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.244 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -54.98 -44.7 74.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 108.906 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 20.8 mm-40 -61.88 -44.77 96.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.519 ' CD2' HD12 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.26 -31.29 65.42 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.533 ' CD ' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.87 -60.71 3.41 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.777 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 83.7 t -58.47 -40.48 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.54 -0.725 . . . . 0.0 109.07 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.69 -33.03 73.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.571 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 23.8 mt -80.32 -30.23 12.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.562 -0.711 . . . . 0.0 109.138 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.446 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.4 t -77.42 -27.28 52.27 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.634 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -84.02 -40.92 17.81 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.534 0.683 . . . . 0.0 109.414 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 6.2 tp -61.75 -35.29 77.67 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.604 ' CE2' ' CD1' ' A' ' 77' ' ' LEU . 7.3 m-85 -84.62 -22.63 29.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . . . -72.23 -34.81 68.6 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.556 0.694 . . . . 0.0 109.285 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.456 ' HE2' ' OE1' ' A' ' 40' ' ' GLU . 9.6 mtmt -78.08 -17.81 56.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.442 -0.787 . . . . 0.0 109.242 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.614 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -88.46 -16.26 33.25 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.583 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 88.86 30.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.589 ' CD1' ' CD1' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -82.1 -138.3 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.528 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -178.95 57.39 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.446 HG21 ' HA ' ' A' ' 39' ' ' SER . 21.0 m -50.96 117.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.834 0.826 . . . . 0.0 110.033 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.523 ' CB ' HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER -89.22 -45.31 15.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-O 121.226 0.536 . . . . 0.0 109.94 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -143.69 160.22 41.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.781 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.533 ' CG1' ' CD ' ' A' ' 35' ' ' LYS . 2.5 t -152.4 157.49 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.848 . . . . 0.0 109.494 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.09 164.25 33.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.206 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.53 ' CB ' HG13 ' A' ' 31' ' ' VAL . 16.9 p -91.83 156.18 17.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 110.847 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.57 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.57 129.51 9.34 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.553 ' CG2' ' O ' ' A' ' 56' ' ' THR . 2.6 m 59.61 13.59 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.99 . . . . 0.0 109.39 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER 70.66 15.75 6.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 111.328 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.532 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 168.19 -21.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.807 -1.183 . . . . 0.0 111.543 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.532 ' HB2' ' CG2' ' A' ' 56' ' ' THR . 0.0 OUTLIER -89.06 -65.34 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.929 -1.107 . . . . 0.0 111.728 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 1.2 m-85 -103.66 -148.53 0.39 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.043 -1.035 . . . . 0.0 110.617 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.57 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 178.62 -179.85 48.63 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.583 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 40.9 t80 -151.96 150.44 30.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.515 ' O ' ' CD1' ' A' ' 20' ' ' LEU . 4.0 t -150.69 153.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.219 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' OD1' ' CZ ' ' A' ' 62' ' ' TYR . 3.6 m-20 -122.27 138.03 54.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 66.4 m-85 -104.66 172.32 6.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 109.912 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.528 ' HG2' ' CB ' ' A' ' 48' ' ' ALA . 0.8 OUTLIER -117.52 17.11 14.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 111.254 -178.657 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 14.8 p -167.6 173.4 8.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.563 1.173 . . . . 0.0 112.314 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.459 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -76.33 -25.31 54.61 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -76.55 -27.73 56.01 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.518 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.538 ' HB3' ' CD1' ' A' ' 65' ' ' PHE . 87.8 m-20 -79.92 -30.35 39.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 12.6 tp -71.82 -38.73 70.15 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.297 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -71.48 -30.88 66.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.741 . . . . 0.0 109.621 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.533 ' O ' ' CD1' ' A' ' 77' ' ' LEU . 33.7 mmtt -83.49 -27.2 29.59 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.636 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.8 -30.93 71.64 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.06 -44.28 26.8 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -21.64 59.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.363 -0.836 . . . . 0.0 109.494 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.604 ' CD1' ' CE2' ' A' ' 42' ' ' PHE . 2.9 mt -72.19 -4.9 32.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.521 ' CG2' HD11 ' A' ' 89' ' ' LEU . 32.3 m -71.47 2.27 5.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 110.956 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.94 -3.15 56.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.539 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -91.34 135.59 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 110.346 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.51 76.06 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.998 0.904 . . . . 0.0 110.573 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.53 ' HB ' ' CG2' ' A' ' 87' ' ' ILE . 3.4 t -43.17 129.28 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.589 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER 46.34 22.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.518 -179.016 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 92.95 17.62 43.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 2.1 m-80 -133.89 110.35 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.052 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 29.2 tt0 -58.05 81.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.099 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.53 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 2.7 pt -43.84 123.69 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.454 -0.779 . . . . 0.0 110.406 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.6 mtpm? -106.72 132.75 52.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.46 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.583 ' CD1' ' N ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -121.69 179.25 4.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.944 -1.098 . . . . 0.0 111.329 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -176.89 148.82 0.68 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.641 -0.662 . . . . 0.0 109.616 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.489 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 1.5 mttp -59.27 112.98 5.91 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.277 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.418 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 46.1 Cg_endo -73.07 -174.31 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.988 1.52 . . . . 0.0 110.4 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER 42.78 77.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.168 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -130.17 7.96 6.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 21.7 ttt180 -114.57 56.26 0.73 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 0.0 110.257 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -54.81 154.38 5.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -146.2 63.21 0.45 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 97' ' ' GLY . 2.7 p 42.43 -155.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -1.112 . . . . 0.0 110.243 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -134.33 34.7 3.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.2 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.94 156.92 22.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.1 m . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.231 -1.158 . . . . 0.0 110.175 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 p -76.08 -45.08 35.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -1.108 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -139.87 128.0 22.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.93 8.57 30.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.203 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -70.86 159.3 34.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 110.194 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -135.49 -178.34 5.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.236 179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 31.7 p30 -144.14 138.58 15.04 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.18 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.1 79.8 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.975 1.513 . . . . 0.0 110.394 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.418 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 7.1 p -91.89 54.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.286 0.565 . . . . 0.0 110.226 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.48 173.5 6.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.27 81.28 0.4 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.49 51.75 1.35 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -1.141 . . . . 0.0 110.247 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -91.81 28.14 1.88 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.97 0.891 . . . . 0.0 110.325 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.09 -170.29 1.85 Allowed 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.828 -0.545 . . . . 0.0 110.208 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 16' ' ' THR . 3.4 m -80.59 -10.85 59.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.138 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 15' ' ' THR . 1.1 p -164.79 154.6 11.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 110.734 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD2' ' O ' ' A' ' 65' ' ' PHE . 51.3 Cg_endo -76.78 -39.82 0.62 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.205 1.634 . . . . 0.0 110.585 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.572 ' CE2' ' HA ' ' A' ' 68' ' ' ALA . 94.4 m-85 -121.57 119.92 33.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.796 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 18' ' ' PHE . 15.5 m-20 -139.94 152.39 46.32 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.33 -0.856 . . . . 0.0 109.411 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.567 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 3.0 pp -164.09 -175.0 3.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 6.1 t80 -109.34 141.91 41.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.492 -0.755 . . . . 0.0 110.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.51 HG23 ' N ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -122.05 160.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.82 -175.87 14.08 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 11.9 t30 71.52 54.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.437 -1.037 . . . . 0.0 110.506 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.529 HD12 ' CD2' ' A' ' 34' ' ' LEU . 4.3 mm? -105.35 129.05 53.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.958 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.428 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 34.5 t-20 -40.54 100.6 0.22 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.72 -0.612 . . . . 0.0 110.502 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -73.73 -17.22 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.074 1.565 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.92 -14.8 40.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.721 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.469 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 8.5 mmtt -106.27 -157.79 0.63 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.496 -0.753 . . . . 0.0 109.554 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.467 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -106.25 142.88 35.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.765 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.578 ' CG2' ' CG ' ' A' ' 58' ' ' ARG . 2.7 t -66.1 -22.85 30.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.639 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.456 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -67.58 -38.96 84.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.577 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 1.8 pt-20 -65.67 -38.3 88.91 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.529 ' CD2' HD12 ' A' ' 25' ' ' LEU . 50.9 mt -60.98 -36.09 78.51 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.43 -60.49 3.71 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 28.7 t -60.51 -32.74 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.8 -38.07 89.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 108.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.572 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 24.5 mt -80.07 -24.46 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.413 -0.804 . . . . 0.0 108.995 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.403 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 7.8 p -80.13 -30.74 39.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 109.053 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.503 ' OE1' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -81.93 -40.73 21.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.562 0.696 . . . . 0.0 109.609 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.513 HD23 ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -65.53 -35.05 79.71 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 109.178 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.572 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 9.2 m-85 -83.0 -21.64 33.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.43 -24.7 57.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.503 ' NZ ' ' OE1' ' A' ' 40' ' ' GLU . 9.5 mttp -104.17 -17.23 14.97 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.587 -0.695 . . . . 0.0 109.519 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.674 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -81.3 -21.87 38.99 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.369 -0.832 . . . . 0.0 109.934 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.674 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.5 t0 99.34 29.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.462 HD13 ' CE2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -100.93 -149.85 0.38 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.44 61.23 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.45 HG13 ' CD2' ' A' ' 42' ' ' PHE . 6.5 m -50.9 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.001 0.905 . . . . 0.0 110.133 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.538 HG22 ' CG ' ' A' ' 66' ' ' GLU . 2.8 t -89.04 -35.68 7.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.264 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.461 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 8.4 t0 -146.85 156.18 42.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.116 -0.99 . . . . 0.0 111.229 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.593 ' CG1' ' CG ' ' A' ' 35' ' ' LYS . 14.8 p -153.17 146.59 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -149.59 166.54 28.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.562 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 15.7 p -87.75 160.45 18.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 110.528 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.493 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -125.63 126.0 5.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.489 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 1.8 m 59.34 -166.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -1.078 . . . . 0.0 110.073 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.461 ' O ' ' HD2' ' A' ' 58' ' ' ARG . 0.7 OUTLIER -41.76 -65.78 0.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.402 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.578 ' CG ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -173.89 51.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.439 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -124.47 -23.34 4.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.935 . . . . 0.0 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.493 ' HB2' ' HA3' ' A' ' 55' ' ' GLY . 1.0 OUTLIER -124.6 -177.05 3.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -168.0 141.75 7.03 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.571 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 48.2 t80 -94.62 169.07 10.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -1.151 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.571 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 2.4 t -163.64 163.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.469 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -137.07 144.63 43.25 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.653 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.8 m-85 -108.25 176.58 5.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.538 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -109.77 16.37 22.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 111.584 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p 178.17 178.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.139 . . . . 0.0 112.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.05 -23.28 52.04 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -26.2 41.06 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.361 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.535 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 85.9 m-20 -83.01 -28.0 29.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.49 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 2.6 tm? -77.96 -34.19 51.19 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.827 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.49 -40.05 62.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.849 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.544 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.03 -30.63 61.12 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.653 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.16 -28.48 67.33 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.475 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 5.7 tt -69.79 -45.18 68.54 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -12.47 60.68 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.164 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.544 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -76.07 4.62 8.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.54 -0.725 . . . . 0.0 109.939 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.522 ' OG1' ' CD2' ' A' ' 89' ' ' LEU . 11.1 m -72.89 1.18 9.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.115 -0.991 . . . . 0.0 110.552 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.417 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -106.2 1.42 37.79 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' CD2' HD12 ' A' ' 77' ' ' LEU . 0.9 OUTLIER -84.8 124.0 31.07 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.151 -1.205 . . . . 0.0 111.257 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 32.2 mtpt -83.38 84.33 7.55 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.908 0.861 . . . . 0.0 109.189 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.543 ' CG2' ' N ' ' A' ' 83' ' ' PHE . 1.2 p -34.76 -94.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.577 ' CE2' ' HG3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER -98.56 31.89 2.73 Favored 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.138 -0.976 . . . . 0.0 109.427 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.429 ' C ' ' HE3' ' A' ' 81' ' ' LYS . . . 108.35 15.51 13.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.546 ' O ' ' N ' ' A' ' 87' ' ' ILE . 5.1 m120 -143.42 98.18 3.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -1.039 . . . . 0.0 109.528 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' CG ' ' O ' ' A' ' 78' ' ' THR . 35.1 tt0 -41.72 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.476 -0.765 . . . . 0.0 110.548 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 85' ' ' ASN . 0.5 OUTLIER -51.25 145.39 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.464 ' O ' HG23 ' A' ' 22' ' ' ILE . 18.5 tttt -120.87 155.77 33.42 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.566 -0.708 . . . . 0.0 109.904 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.571 ' N ' ' CD2' ' A' ' 89' ' ' LEU . 0.1 OUTLIER -120.38 171.35 8.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -171.95 127.82 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -61.33 110.58 3.2 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 49.4 Cg_endo -78.84 -170.05 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.927 1.488 . . . . 0.0 110.451 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 18.4 tptp 48.78 52.83 13.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.288 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . -94.21 -66.58 1.03 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER 48.77 -174.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -1.132 . . . . 0.0 110.241 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 41.8 p-10 -78.52 -157.34 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.24 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -131.38 63.44 0.63 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -42.63 -32.72 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -1.144 . . . . 0.0 110.406 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -172.02 81.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 110.248 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.64 -171.13 52.11 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.247 -1.149 . . . . 0.0 110.231 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.405 ' O ' ' OG ' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 4' ' ' MET . 1.4 p 59.57 -163.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -1.163 . . . . 0.0 110.217 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' O ' ' HB3' ' A' ' 4' ' ' MET . 47.8 m170 53.49 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 2' ' ' SER . 5.0 ptp -177.66 136.88 0.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.139 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.43 108.34 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.224 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.05 62.98 6.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.177 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.578 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -69.12 -60.52 4.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.166 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 49.4 Cg_endo -71.43 -157.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.996 1.524 . . . . 0.0 110.067 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' PRO . 95.9 t 51.7 104.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.781 -0.575 . . . . 0.0 110.196 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 54.59 -165.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.207 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.78 -4.97 63.02 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 1.1 p -117.76 5.58 12.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -1.198 . . . . 0.0 110.28 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.516 ' HB3' ' O ' ' A' ' 12' ' ' SER . 72.2 tt0 68.36 122.11 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 122.767 1.27 . . . . 0.0 110.386 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.62 178.6 6.46 Favored 'General case' 0 C--N 1.276 -2.603 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.177 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.468 HG23 ' OD2' ' A' ' 51' ' ' ASP . 4.3 m -88.42 -6.9 57.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.118 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.55 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -172.2 162.53 4.35 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.525 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.539 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.0 Cg_endo -79.95 -25.96 4.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.187 1.625 . . . . 0.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.4 m-85 -116.25 119.7 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 0.0 110.951 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.479 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 30.2 m-20 -135.42 171.0 15.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.211 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HG ' ' O ' ' A' ' 19' ' ' ASN . 11.2 mt -156.44 165.89 35.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 111.137 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -97.96 157.59 16.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 65.2 mt -149.39 146.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.323 -0.861 . . . . 0.0 110.121 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.92 179.91 22.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 48.1 t30 71.15 23.35 4.15 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.495 -1.003 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.576 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 4.1 mm? -68.37 122.93 19.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 28.1 t-20 -41.09 100.85 0.23 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.654 -0.653 . . . . 0.0 110.421 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.8 Cg_endo -75.69 -26.51 9.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.071 1.564 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -74.69 -24.1 58.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.966 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.7 mmtt -90.9 -154.45 0.35 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.603 -0.686 . . . . 0.0 109.72 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.1 m -101.9 143.83 31.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 3.7 t -69.0 -31.02 48.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.414 ' O ' HG22 ' A' ' 36' ' ' VAL . . . -66.7 -33.7 76.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.118 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.571 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 66.0 mm-40 -70.66 -36.58 73.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 109.359 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.523 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 42.3 mt -63.24 -34.57 77.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.442 -0.786 . . . . 0.0 109.061 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.54 ' HE3' ' CG2' ' A' ' 54' ' ' THR . 0.0 OUTLIER -64.94 -55.84 16.78 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.213 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.541 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.5 t -58.3 -40.78 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 0.0 109.385 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' HB1' ' CG1' ' A' ' 82' ' ' VAL . . . -59.32 -29.07 67.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.97 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.474 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 47.0 mt -83.95 -32.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.385 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.453 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.7 t -79.27 -23.14 43.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.97 -39.31 17.04 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.527 HD23 ' CD1' ' A' ' 80' ' ' LEU . 4.9 tp -63.45 -36.89 85.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.551 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 10.2 m-85 -83.56 -22.02 32.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.46 ' HB1' ' HA ' ' A' ' 40' ' ' GLU . . . -79.43 -21.76 45.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.97 -20.43 14.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.675 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -82.48 -21.12 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.459 -0.776 . . . . 0.0 109.788 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.675 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.3 t70 98.61 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.868 0.842 . . . . 0.0 108.891 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.551 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -91.33 -145.28 0.19 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.526 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -177.33 61.01 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.443 ' HA ' ' O ' ' A' ' 64' ' ' ASP . 15.9 m -63.24 115.44 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 122.012 0.91 . . . . 0.0 110.317 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.574 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 19.6 t -82.0 -23.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.509 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.534 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -155.79 155.67 33.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 0.0 110.673 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.503 ' CG2' ' C ' ' A' ' 51' ' ' ASP . 3.4 t -152.87 128.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.805 . . . . 0.0 109.963 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -128.51 178.64 6.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.596 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -149.98 151.49 33.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 110.691 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' A' ' 56' ' ' THR . . . -173.0 -160.86 22.38 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.472 ' HB ' ' HB3' ' A' ' 60' ' ' PHE . 5.7 m 57.07 85.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -1.042 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.3 m-20 39.58 48.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.446 -0.784 . . . . 0.0 110.936 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 10.1 ptm180 37.44 35.51 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.577 -0.702 . . . . 0.0 111.004 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.455 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 20.0 tttt -121.92 -19.26 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 110.193 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -124.53 170.36 10.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' N ' ' CG ' ' A' ' 60' ' ' PHE . . . -163.35 172.8 39.39 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.528 ' OH ' ' CB ' ' A' ' 92' ' ' PRO . 1.3 t80 -121.88 162.56 20.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.828 -0.807 . . . . 0.0 109.976 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.519 ' HB ' ' CD1' ' A' ' 22' ' ' ILE . 0.9 OUTLIER -145.29 167.4 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.117 -0.989 . . . . 0.0 110.834 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 2.8 m-20 -141.69 144.1 33.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.56 -0.712 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.643 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 61.5 m-85 -118.3 -178.55 3.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.574 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 7.5 pt-20 -113.96 8.93 17.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.477 -0.764 . . . . 0.0 111.016 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 32.1 p -167.81 176.1 6.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.572 1.177 . . . . 0.0 112.423 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.566 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.34 -24.32 50.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -28.69 57.75 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.364 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.533 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 79.0 m-20 -82.54 -27.78 31.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -72.56 -37.34 68.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.876 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.02 -38.47 61.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 109.979 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' HB3' ' CD2' ' A' ' 47' ' ' LEU . 11.2 ttmm -76.68 -25.75 54.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.643 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -69.77 -31.75 69.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.445 ' HA ' HD12 ' A' ' 89' ' ' LEU . 5.6 tt -70.86 -43.11 69.15 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -10.58 59.94 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.163 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.532 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -72.48 1.82 7.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.549 -0.72 . . . . 0.0 110.658 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.526 ' OG1' ' CG ' ' A' ' 89' ' ' LEU . 15.4 m -78.52 6.07 9.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.36 24.18 32.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.527 ' CD1' HD23 ' A' ' 41' ' ' LEU . 4.7 mt -127.11 128.14 45.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -1.188 . . . . 0.0 110.837 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 82' ' ' VAL . 21.3 mtmt -84.82 83.24 8.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.768 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.53 ' CG1' ' HB1' ' A' ' 37' ' ' ALA . 74.3 t -32.2 -98.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.063 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.571 ' CE1' ' HB3' ' A' ' 33' ' ' GLU . 0.2 OUTLIER -85.38 23.06 1.38 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.665 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.94 20.44 5.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 87' ' ' ILE . 66.6 m-80 -154.71 116.12 4.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -1.102 . . . . 0.0 109.363 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 1.1 pt-20 -55.56 84.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 110.14 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 85' ' ' ASN . 24.4 pt -41.01 130.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.508 -0.745 . . . . 0.0 110.091 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.489 ' O ' ' N ' ' A' ' 23' ' ' GLY . 3.4 mttt -98.15 122.58 41.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.373 -0.829 . . . . 0.0 109.774 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.532 ' CB ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -118.87 172.49 7.5 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.39 -0.819 . . . . 0.0 110.386 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 11.3 pt-20 -173.03 147.81 1.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.469 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -51.05 109.5 1.38 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.999 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 45.1 Cg_endo -72.18 -174.13 1.3 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.024 1.539 . . . . 0.0 110.603 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.41 -150.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 110.166 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.38 48.79 0.95 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 96' ' ' ASP . 0.9 OUTLIER 48.23 -144.48 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -1.135 . . . . 0.0 110.281 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -43.14 117.91 1.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.241 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.91 75.09 0.78 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 p -84.31 166.14 17.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -1.168 . . . . 0.0 110.272 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -127.57 34.26 4.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 110.194 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.25 18.37 56.39 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.205 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 p -114.13 137.01 52.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -1.142 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 49.67 52.19 15.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.209 -0.932 . . . . 0.0 110.183 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.412 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 26.5 mtm -64.05 -51.77 62.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.302 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.412 ' HG ' ' O ' ' A' ' 4' ' ' MET . 0.2 OUTLIER -166.89 -171.26 1.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -106.85 -88.82 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 110.161 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.5 m-20 -74.88 -58.86 1.53 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.148 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 44.1 Cg_endo -72.56 79.75 1.81 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.931 1.49 . . . . 0.0 110.427 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.498 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.9 p -101.37 57.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.821 -0.55 . . . . 0.0 110.168 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -128.41 135.2 49.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.856 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.99 57.13 0.92 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.518 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 27.2 m -123.76 -80.8 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -1.161 . . . . 0.0 110.213 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.518 ' HB2' ' O ' ' A' ' 12' ' ' SER . 12.2 tp10 170.87 124.41 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.08 0.943 . . . . 0.0 109.377 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.487 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER 28.8 -148.12 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.383 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.471 ' O ' HG23 ' A' ' 16' ' ' THR . 4.6 m -82.4 0.65 41.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.082 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.518 HG22 ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.63 166.27 1.86 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.064 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.455 ' HD2' HG21 ' A' ' 16' ' ' THR . 48.0 Cg_endo -76.15 -31.95 4.47 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.95 1.5 . . . . 0.0 110.798 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.6 m-85 -111.62 106.93 15.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.026 -1.046 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 16' ' ' THR . 43.7 m-20 -139.79 156.06 46.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.352 -0.843 . . . . 0.0 109.814 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.436 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 3.5 pp -169.78 -168.55 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.288 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.563 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 22.0 t80 -111.95 158.46 19.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 110.265 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.507 HG21 ' N ' ' A' ' 23' ' ' GLY . 2.5 mt -140.73 160.11 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.104 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -141.76 -170.66 12.53 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.517 -1.325 . . . . 0.0 109.923 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 4.6 t30 73.85 34.31 0.91 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.622 -0.928 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.523 ' CD2' ' O ' ' A' ' 60' ' ' PHE . 7.9 mp -85.57 134.73 34.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.788 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.429 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 35.0 t-20 -60.2 109.89 2.39 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 110.464 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -74.55 -26.26 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.062 1.559 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.44 -25.11 57.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 109.897 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.58 ' HE3' ' CE1' ' A' ' 83' ' ' PHE . 6.6 mmtt -91.23 -154.41 0.36 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.729 . . . . 0.0 109.665 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.61 140.79 44.62 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.534 ' O ' ' CD ' ' A' ' 35' ' ' LYS . 3.0 t -67.48 -35.36 73.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.096 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.08 -32.23 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.181 178.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 65.7 mm-40 -73.45 -34.34 65.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.481 -0.762 . . . . 0.0 109.229 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 38' ' ' ILE . 0.4 OUTLIER -66.3 -30.37 70.77 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.375 -0.828 . . . . 0.0 109.068 179.085 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.549 ' HG3' ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -68.74 -56.27 8.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.15 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -62.91 -37.44 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.499 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.55 -32.77 74.34 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.844 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.519 ' CD1' ' O ' ' A' ' 34' ' ' LEU . 13.5 mt -81.46 -28.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.475 -0.765 . . . . 0.0 109.107 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.533 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 3.6 m -77.82 -30.94 51.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.16 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.99 -37.63 33.87 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.59 ' CD1' ' CD2' ' A' ' 80' ' ' LEU . 1.1 tt -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.228 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.427 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 15.3 m-85 -87.55 -17.18 32.6 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.361 -0.837 . . . . 0.0 109.363 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -88.44 -28.97 20.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.799 179.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.422 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.2 mttt -91.44 -20.93 21.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.768 . . . . 0.0 109.395 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -79.08 -58.89 3.0 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.53 -0.731 . . . . 0.0 109.633 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 148.47 29.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.529 ' CD2' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -108.74 -158.86 0.66 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 109.593 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.529 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -160.33 65.37 0.33 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.018 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 11.0 m -54.59 115.44 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.811 0.815 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.541 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 11.5 t -82.51 -35.9 13.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 121.88 -0.513 . . . . 0.0 110.482 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.462 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -152.84 164.02 38.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 0.0 110.723 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.549 ' CG2' ' HG3' ' A' ' 35' ' ' LYS . 5.4 p -159.0 102.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.723 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.466 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -93.87 163.34 13.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.532 ' CG2' HG11 ' A' ' 31' ' ' VAL . 16.1 p -85.05 161.68 19.62 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.313 -0.867 . . . . 0.0 110.715 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.523 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -115.33 121.8 5.4 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 9.1 m -21.54 142.39 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.605 0.717 . . . . 0.0 112.445 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER 72.4 18.78 4.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.476 -0.765 . . . . 0.0 109.959 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.444 ' CZ ' HG22 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 42.46 27.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.788 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.439 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -110.92 -17.93 13.19 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.523 ' HB2' ' HA3' ' A' ' 55' ' ' GLY . 0.5 OUTLIER -130.08 -168.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.042 -1.036 . . . . 0.0 109.601 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 177.88 155.79 14.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.0 m-85 -108.9 162.18 14.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.505 ' HA ' ' HA ' ' A' ' 52' ' ' VAL . 3.2 t -150.13 143.17 17.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.891 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.13 144.97 42.28 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.547 -0.721 . . . . 0.0 109.717 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 13.1 m-85 -109.68 177.79 4.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.323 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.541 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 2.3 pp20? -114.21 8.4 16.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 111.285 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 10.0 p -175.41 177.15 1.87 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.278 1.037 . . . . 0.0 111.972 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.429 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -79.04 -22.87 44.75 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -82.22 -26.51 33.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.264 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.573 ' OD1' ' CD1' ' A' ' 65' ' ' PHE . 2.9 t0 -82.42 -26.61 32.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 3.1 tp -80.6 -33.71 35.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.62 -34.53 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.514 -0.741 . . . . 0.0 109.357 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.526 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.17 -29.08 60.32 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.51 -26.68 65.57 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.0 tt -72.98 -46.61 51.3 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -10.72 60.05 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.999 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.526 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -73.14 4.26 4.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.573 -0.705 . . . . 0.0 110.379 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 m -58.01 -14.27 6.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.54 37.69 3.33 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.59 ' CD2' ' CD1' ' A' ' 41' ' ' LEU . 4.2 mt -90.03 -168.56 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.535 -0.979 . . . . 0.0 111.159 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.581 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 17.7 mttt 170.89 53.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 108.927 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.51 ' C ' ' O ' ' A' ' 81' ' ' LYS . 90.7 t -24.96 -100.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.991 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 12.7 m-85 -89.64 39.99 0.97 Allowed 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.24 24.65 28.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 7.3 p-10 -138.52 86.21 2.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.538 -0.978 . . . . 0.0 109.016 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.581 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 1.1 pt-20 -41.74 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 110.686 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.511 ' N ' ' O ' ' A' ' 85' ' ' ASN . 3.6 pt -51.27 146.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.554 0.692 . . . . 0.0 109.942 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.477 ' O ' HG21 ' A' ' 22' ' ' ILE . 20.9 tptt -119.43 156.29 30.43 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 109.845 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -119.87 171.95 8.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.069 -1.019 . . . . 0.0 110.304 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.465 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -165.01 163.86 20.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.365 -0.835 . . . . 0.0 110.127 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.83 98.96 12.35 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.0 Cg_endo -73.54 -177.48 3.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.048 1.552 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 92' ' ' PRO . 17.2 ttpt 42.15 63.59 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.29 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 95' ' ' ARG . . . 156.5 -104.16 0.25 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 94' ' ' GLY . 2.1 mtt180 -42.91 155.35 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -1.121 . . . . 0.0 110.259 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.03 -157.62 0.63 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -54.02 -91.7 0.01 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -42.34 144.58 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -1.132 . . . . 0.0 110.456 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -64.87 -84.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.93 53.76 0.65 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 110.206 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -82.23 -30.11 30.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -1.152 . . . . 0.0 110.211 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -100.27 136.66 39.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 110.207 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.505 ' O ' ' N ' ' A' ' 6' ' ' GLU . 2.4 mtm -64.38 -17.15 63.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.464 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 1.1 mt 51.41 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.18 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' MET . 8.4 pt-20 176.52 50.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -131.71 69.98 81.24 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.96 79.64 1.63 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.955 1.502 . . . . 0.0 110.361 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.442 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 7.1 p -122.15 92.1 2.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 121.311 0.576 . . . . 0.0 110.257 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' CG ' ' OE2' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -94.44 -169.75 2.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 110.208 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 12' ' ' SER . . . -90.47 -26.63 22.58 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 2.1 p 171.33 106.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 110.147 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' OE2' ' CG ' ' A' ' 10' ' ' GLU . 15.4 mt-10 -115.4 -129.5 0.3 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.246 -0.909 . . . . 0.0 109.632 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.511 ' OG ' ' ND2' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -107.23 -170.43 1.7 Allowed 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.695 -0.628 . . . . 0.0 110.259 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.504 ' N ' ' OG ' ' A' ' 14' ' ' SER . 3.3 m -56.49 -18.99 13.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.074 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.558 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 69.5 p -139.78 164.28 39.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.583 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.3 Cg_endo -74.99 -21.65 15.66 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.088 1.573 . . . . 0.0 110.721 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 96.9 m-85 -106.67 113.44 26.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.037 -1.04 . . . . 0.0 110.56 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.531 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -144.76 140.59 28.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.595 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.53 -166.88 2.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.837 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.685 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 6.7 t80 -118.69 157.54 27.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.179 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.632 ' N ' ' CD1' ' A' ' 21' ' ' PHE . 5.5 mt -145.85 151.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.44 -174.4 13.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 27.2 t30 69.84 55.28 0.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.163 -1.199 . . . . 0.0 109.998 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.562 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.9 mm? -93.78 123.75 37.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.541 ' N ' ' CD2' ' A' ' 34' ' ' LEU . 58.5 t30 -42.25 101.71 0.25 Allowed Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' HA ' ' HG2' ' A' ' 58' ' ' ARG . 48.2 Cg_endo -75.39 -11.47 20.79 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.065 1.561 . . . . 0.0 110.498 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -81.96 -8.5 59.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.513 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 13.4 mttt -124.95 -154.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.971 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.542 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.9 m -100.09 147.59 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.533 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 2.6 t -64.53 -35.16 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.535 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -51.51 68.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 109.778 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.462 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 38.5 mm-40 -56.74 -31.61 64.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.83 . . . . 0.0 109.015 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.542 ' CD1' ' O ' ' A' ' 30' ' ' SER . 6.7 mp -66.27 -33.17 75.14 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.384 -0.822 . . . . 0.0 109.069 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.521 ' HD2' ' CG1' ' A' ' 52' ' ' VAL . 29.1 mmtt -64.72 -55.47 19.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.974 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.486 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.8 t -57.26 -32.87 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.592 -0.693 . . . . 0.0 109.552 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.518 ' CB ' HG21 ' A' ' 82' ' ' VAL . . . -63.79 -35.62 81.21 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.822 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.514 ' CD1' ' HB ' ' A' ' 82' ' ' VAL . 15.6 mm -80.05 -26.75 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.535 -0.728 . . . . 0.0 109.311 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 52.5 m -79.58 -30.72 41.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.921 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.2 tm-20 -80.53 -39.69 27.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.583 0.706 . . . . 0.0 109.572 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.525 HD21 ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.83 -33.54 75.84 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.132 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CE1' ' CG ' ' A' ' 77' ' ' LEU . 5.5 m-30 -81.82 -23.17 36.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 109.18 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.85 -27.53 44.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.027 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CD ' ' OE2' ' A' ' 40' ' ' GLU . 6.4 mtpt -87.8 -19.47 27.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.448 -0.783 . . . . 0.0 109.284 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -80.64 -60.04 2.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.562 -0.711 . . . . 0.0 109.423 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.0 m-20 149.68 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.571 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -106.58 -157.69 0.62 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.47 61.22 0.38 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.019 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.6 m -48.32 117.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.98 0.895 . . . . 0.0 110.068 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.558 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.94 -41.55 14.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.509 ' O ' ' CG2' ' A' ' 52' ' ' VAL . 0.1 OUTLIER -146.57 159.26 43.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.521 ' CG1' ' HD2' ' A' ' 35' ' ' LYS . 40.9 t -157.57 114.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.41 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -113.83 163.81 14.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 110.496 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.527 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 21.7 p -83.45 171.53 13.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.63 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -135.29 130.77 5.54 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.462 ' OG1' ' CE2' ' A' ' 60' ' ' PHE . 1.4 m 50.45 -140.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -1.16 . . . . 0.0 109.902 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.474 ' O ' ' HB3' ' A' ' 58' ' ' ARG . 41.0 p30 -100.75 79.82 2.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.075 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.533 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 7.7 ttp180 56.65 28.98 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 110.482 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.94 -31.23 10.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 109.889 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.685 ' CE1' ' CE2' ' A' ' 21' ' ' PHE . 0.9 OUTLIER -150.93 177.52 10.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.566 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -154.2 150.52 22.16 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.298 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 20.7 t80 -103.85 160.6 14.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.365 -1.079 . . . . 0.0 109.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.626 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 88.7 t -154.5 154.42 7.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.435 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -124.13 139.88 53.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.708 -0.62 . . . . 0.0 109.865 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.637 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 21.7 m-85 -109.71 173.45 6.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.517 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.08 15.19 17.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.353 -0.842 . . . . 0.0 111.212 -178.454 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.56 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 2.3 t -166.24 175.49 8.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.718 1.247 . . . . 0.0 112.063 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.533 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -88.15 -25.39 22.98 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -20.95 26.21 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.469 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 8.7 t0 -84.14 -31.68 25.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.449 HD13 ' HB3' ' A' ' 18' ' ' PHE . 8.4 tt -75.77 -34.59 60.24 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.485 0.66 . . . . 0.0 109.59 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.5 -35.19 60.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.992 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.537 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.5 OUTLIER -76.65 -27.38 55.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.637 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.09 -28.7 64.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.52 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 0.7 OUTLIER -68.95 -45.76 69.92 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.443 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.55 -15.55 63.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.963 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.629 ' CG ' ' CE1' ' A' ' 42' ' ' PHE . 1.2 mm? -72.86 0.01 12.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.225 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.531 ' CG2' ' HA ' ' A' ' 88' ' ' LYS . 5.8 m -78.23 5.59 9.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 110.672 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.406 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -103.72 14.15 53.38 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.525 ' CD1' HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -115.3 131.21 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.843 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' A' ' 82' ' ' VAL . 14.1 mttt -75.95 83.85 2.86 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 109.62 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.575 ' CG1' ' CG2' ' A' ' 87' ' ' ILE . 1.2 p -31.34 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.81 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.554 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -100.84 28.79 4.94 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.61 15.93 3.89 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.552 ' O ' ' N ' ' A' ' 87' ' ' ILE . 6.7 m-20 -158.64 116.62 2.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -1.2 . . . . 0.0 109.478 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 78' ' ' THR . 24.9 tt0 -52.72 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.575 ' CG2' ' CG1' ' A' ' 82' ' ' VAL . 0.4 OUTLIER -42.77 154.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 110.215 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' HA ' ' CG2' ' A' ' 78' ' ' THR . 7.1 mtpp -129.7 157.15 42.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.836 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.52 ' CD1' ' HA ' ' A' ' 75' ' ' LEU . 3.7 mt -106.68 -179.54 3.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.11 -0.993 . . . . 0.0 110.119 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 89' ' ' LEU . 2.5 tt0 175.18 -168.41 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 110.219 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -100.74 122.12 50.33 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.908 . . . . 0.0 110.373 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 43.4 Cg_endo -70.89 -160.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.938 1.494 . . . . 0.0 110.535 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.46 ' C ' ' O ' ' A' ' 92' ' ' PRO . 20.3 pttt -35.9 139.31 0.15 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.769 -0.582 . . . . 0.0 110.827 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . 151.74 -46.85 0.58 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.1 OUTLIER 42.55 -164.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -1.132 . . . . 0.0 110.317 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.9 t0 59.98 47.09 10.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -129.87 -167.54 12.1 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 97' ' ' GLY . 2.4 p 42.48 -162.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.258 -1.142 . . . . 0.0 110.243 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.91 -38.13 3.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 110.207 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.57 138.83 9.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.212 -1.169 . . . . 0.0 110.277 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 3' ' ' HIS . 24.3 m -134.1 143.55 48.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -1.118 . . . . 0.0 110.26 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 2' ' ' SER . 92.9 m-70 47.61 95.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.412 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -142.73 152.28 42.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.24 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.417 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.2 OUTLIER 63.29 29.28 15.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 110.231 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER 59.03 157.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.873 . . . . 0.0 110.167 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.73 135.49 24.73 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.47 -157.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.994 1.523 . . . . 0.0 110.059 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.444 ' O ' ' O ' ' A' ' 10' ' ' GLU . 9.7 p -111.98 46.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.269 0.557 . . . . 0.0 110.228 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 60.58 127.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 110.217 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.13 -59.76 8.06 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -155.42 -84.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -1.171 . . . . 0.0 110.135 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -134.47 -130.1 0.16 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.65 163.93 28.66 Favored 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.698 -0.626 . . . . 0.0 110.211 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.53 ' O ' ' CG2' ' A' ' 16' ' ' THR . 5.6 m -118.81 -8.77 10.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.146 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' A' ' 15' ' ' THR . 16.2 p -159.89 159.11 27.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.838 . . . . 0.0 110.207 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.18 -18.2 14.46 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.149 1.605 . . . . 0.0 110.913 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.591 ' CE2' ' N ' ' A' ' 68' ' ' ALA . 79.9 m-85 -122.34 115.78 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.931 -1.106 . . . . 0.0 111.14 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 2.2 m120 -143.49 151.39 40.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.532 -0.73 . . . . 0.0 109.067 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.583 ' O ' ' CE2' ' A' ' 62' ' ' TYR . 1.7 pp -160.22 179.59 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.425 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -103.66 158.12 16.59 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.631 -179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.567 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 6.6 mt -148.33 154.21 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.355 -0.841 . . . . 0.0 109.414 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.527 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -144.68 -164.87 10.79 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.7 t30 71.68 35.03 1.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.587 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.1 mm? -85.3 129.5 34.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.19 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.466 ' OD1' ' N ' ' A' ' 29' ' ' LYS . 28.4 t-20 -50.06 106.17 0.6 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -74.42 -18.88 19.91 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.996 1.524 . . . . 0.0 110.486 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -79.45 -16.21 56.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.466 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -106.18 -155.88 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.372 -0.83 . . . . 0.0 109.817 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.52 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 2.6 m -103.6 149.39 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 110.181 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.568 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 3.0 t -69.85 -42.66 79.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.422 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -56.96 -34.81 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.503 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.93 -46.47 71.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.79 . . . . 0.0 109.581 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.577 ' HG ' ' CD2' ' A' ' 83' ' ' PHE . 2.0 mt -54.55 -32.44 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.177 -0.952 . . . . 0.0 108.837 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.469 ' HD3' ' HB ' ' A' ' 52' ' ' VAL . 13.2 mmtt -64.77 -58.43 6.27 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.131 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 21.9 t -53.24 -35.64 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.497 -0.752 . . . . 0.0 109.369 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.504 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.4 -39.01 93.35 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.574 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 70.8 mt -77.92 -26.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 41.0 m -79.16 -29.21 42.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.085 179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.84 -38.56 22.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.456 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.511 ' HG ' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.84 -31.49 71.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.645 ' CD2' ' CD2' ' A' ' 47' ' ' LEU . 6.9 m-85 -85.37 -22.22 28.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.97 -31.85 59.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.547 -0.721 . . . . 0.0 109.131 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -91.92 -15.41 28.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.59 -0.694 . . . . 0.0 109.134 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.671 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -82.71 -29.04 30.12 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.501 -0.75 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.671 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 36.6 t0 103.85 29.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.645 ' CD2' ' CD2' ' A' ' 42' ' ' PHE . 3.3 mp -97.73 -151.78 0.38 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.86 61.9 0.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.093 -1.004 . . . . 0.0 110.43 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 5.9 m -50.07 119.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.878 0.847 . . . . 0.0 109.396 179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.542 HG21 ' CG ' ' A' ' 66' ' ' GLU . 2.5 t -89.28 -48.14 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.86 -0.525 . . . . 0.0 110.968 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.461 ' OD2' HG21 ' A' ' 15' ' ' THR . 5.1 m-20 -141.48 115.68 9.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.868 -1.145 . . . . 0.0 111.311 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.469 ' HB ' ' HD3' ' A' ' 35' ' ' LYS . 16.0 m -103.64 143.49 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.437 -0.789 . . . . 0.0 109.679 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -150.32 167.79 25.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 110.532 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.568 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 13.7 p -88.9 164.31 15.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 110.578 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.558 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -132.63 127.35 4.8 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER 68.19 -143.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -1.112 . . . . 0.0 110.069 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.94 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.158 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.9 31.18 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 110.06 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' HE3' ' HG3' ' A' ' 27' ' ' PRO . 19.3 tttt -123.76 -17.34 6.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.567 ' CD1' ' O ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -109.49 -176.57 3.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 110.156 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.524 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.4 152.26 10.9 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.5 t80 -125.12 158.85 32.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -1.049 . . . . 0.0 109.521 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.61 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.4 t -151.95 147.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.852 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.47 137.31 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.472 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.634 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 25.7 m-85 -100.04 177.46 5.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.665 -0.647 . . . . 0.0 111.101 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.542 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.19 12.02 15.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 111.611 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CD2' ' A' ' 18' ' ' PHE . 5.2 p -173.71 172.11 3.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 0.0 112.2 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.591 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -78.61 -25.76 45.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.482 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.25 -28.16 38.5 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.793 179.338 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' OD2' ' HB3' ' A' ' 65' ' ' PHE . 5.5 t0 -79.77 -24.27 41.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' CD1' ' C ' ' A' ' 71' ' ' LEU . 2.3 tm? -77.22 -35.65 55.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.48 -35.45 73.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.422 -0.799 . . . . 0.0 109.042 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.35 -25.36 57.69 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.027 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.634 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.7 -30.7 69.41 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.428 HD22 ' C ' ' A' ' 75' ' ' LEU . 7.9 tt -71.83 -45.54 61.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -77.79 -2.13 34.9 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.151 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.566 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -76.74 7.65 4.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 110.483 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -73.65 0.55 12.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.19 12.02 61.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.511 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -102.37 131.83 48.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.289 -1.124 . . . . 0.0 109.678 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -114.37 80.15 1.36 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.489 1.137 . . . . 0.0 110.11 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.535 ' CG1' HG22 ' A' ' 87' ' ' ILE . 3.5 m -51.17 127.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.68 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 8.2 m-30 38.17 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.477 -0.765 . . . . 0.0 111.331 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 85.44 26.88 34.54 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.533 ' N ' ' O ' ' A' ' 82' ' ' VAL . 10.1 m120 -134.74 78.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.739 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.3 tm-20 -37.19 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.729 0.776 . . . . 0.0 110.747 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.535 HG22 ' CG1' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -47.7 144.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.505 ' HG2' ' N ' ' A' ' 89' ' ' LEU . 25.7 tttt -119.3 156.54 29.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.505 ' N ' ' HG2' ' A' ' 88' ' ' LYS . 0.2 OUTLIER -116.6 172.34 7.28 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 110.38 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.5 tm-20 -161.02 146.05 14.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.751 . . . . 0.0 110.133 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.96 111.33 25.97 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 110.192 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.4 Cg_endo -72.97 -170.85 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.038 1.546 . . . . 0.0 110.435 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER 63.91 16.72 10.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.242 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . 63.78 -75.56 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 46.81 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -1.138 . . . . 0.0 110.229 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 95' ' ' ARG . 31.9 t70 -42.82 141.93 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 110.197 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -179.83 96.4 0.1 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.413 ' OG1' ' N ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -134.89 -92.86 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -1.121 . . . . 0.0 110.449 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.413 ' N ' ' OG1' ' A' ' 98' ' ' THR . 3.7 ttt180 -172.03 124.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.82 146.66 14.52 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.136 . . . . 0.0 110.29 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.08 35.06 4.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -1.178 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -140.21 126.24 19.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.07 175.4 5.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 110.273 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' A' ' 6' ' ' GLU . 2.2 mp -63.79 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 110.249 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 5' ' ' LEU . 26.2 tt0 62.39 161.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 110.271 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 51.04 79.8 0.33 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.66 -157.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.036 1.545 . . . . 0.0 110.024 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 10.9 p -164.73 58.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.212 0.53 . . . . 0.0 110.226 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 130.74 36.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.76 53.7 0.8 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.508 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 3.0 t -105.68 25.4 10.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -1.121 . . . . 0.0 110.188 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.508 ' HB2' ' O ' ' A' ' 12' ' ' SER . 46.5 tt0 169.89 125.6 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.423 1.106 . . . . 0.0 109.203 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -42.19 166.63 0.0 OUTLIER 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.221 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.5 HG22 ' N ' ' A' ' 16' ' ' THR . 5.8 t -105.58 -24.6 12.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.52 ' O ' ' ND2' ' A' ' 19' ' ' ASN . 74.6 p -139.27 164.76 36.66 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.565 -0.71 . . . . 0.0 110.265 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.4 Cg_endo -76.72 -22.62 11.77 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.022 1.538 . . . . 0.0 111.073 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE1' ' HA ' ' A' ' 68' ' ' ALA . 91.5 m-85 -104.19 85.5 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.928 -1.107 . . . . 0.0 110.939 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.521 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.7 m-20 -122.61 146.87 47.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.09 -1.006 . . . . 0.0 109.374 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.55 ' O ' ' CD2' ' A' ' 62' ' ' TYR . 1.8 pp -154.36 -176.97 6.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -103.18 166.46 10.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.617 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.505 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 9.0 mt -144.49 158.79 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -149.19 -178.67 24.41 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.031 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 20.5 t30 72.67 54.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.92 . . . . 0.0 110.233 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.509 ' HB3' ' CD1' ' A' ' 34' ' ' LEU . 21.0 mt -102.23 125.93 49.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.042 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.464 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 26.4 t-20 -41.25 110.08 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.733 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.01 -19.94 22.49 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.997 1.525 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -85.54 -7.56 58.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.953 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.578 ' HD3' ' CG ' ' A' ' 83' ' ' PHE . 10.1 mttt -114.15 -157.24 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.371 -0.83 . . . . 0.0 109.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.457 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.5 m -110.51 150.09 29.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 110.572 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 2.6 t -69.56 -38.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.337 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.408 ' O ' HG22 ' A' ' 36' ' ' VAL . . . -57.4 -34.66 69.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.422 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.448 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 5.6 mm-40 -74.82 -32.67 62.03 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.375 -0.828 . . . . 0.0 109.159 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.514 ' CD1' ' HA ' ' A' ' 31' ' ' VAL . 7.4 mt -66.21 -35.18 79.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.392 -0.818 . . . . 0.0 109.03 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.53 ' HD2' ' N ' ' A' ' 35' ' ' LYS . 2.7 mptp? -67.11 -54.08 24.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 16.7 t -52.17 -35.97 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 109.581 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.484 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.34 -38.37 90.78 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.583 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 20.2 mm -78.02 -26.66 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.369 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 37.6 m -78.97 -31.92 45.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -79.8 -39.27 31.22 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.46 -0.775 . . . . 0.0 109.537 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD2' HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.6 -33.55 75.92 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.132 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.583 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.8 m-85 -82.17 -21.95 36.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.554 -0.716 . . . . 0.0 109.211 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.52 44.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.409 -0.807 . . . . 0.0 109.726 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 14.4 mtmm -104.67 -22.81 13.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -79.31 -30.92 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 35.7 t70 112.62 29.03 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.576 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 1.7 mm? -88.93 -153.16 0.25 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.478 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . -165.87 64.09 0.11 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 15.6 m -62.98 117.87 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.917 0.865 . . . . 0.0 110.079 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.525 HG23 ' CG ' ' A' ' 66' ' ' GLU . 2.3 t -92.36 -42.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.465 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -144.4 158.22 43.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.519 ' CG1' HG12 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -144.96 156.19 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 109.569 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.446 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -162.51 170.23 19.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.24 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.447 ' C ' ' HA2' ' A' ' 61' ' ' GLY . 13.8 p -90.48 164.62 14.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 110.243 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -120.5 131.78 8.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.491 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 99.0 m 58.72 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.937 . . . . 0.0 110.371 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 27.6 t-20 -173.25 84.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.627 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.542 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 66.25 22.18 10.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 110.729 179.43 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.564 ' HG2' ' CE1' ' A' ' 60' ' ' PHE . 4.0 tttm -120.59 -35.84 3.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.564 ' CE1' ' HG2' ' A' ' 59' ' ' LYS . 1.2 m-85 -135.27 -164.3 1.51 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -169.08 165.3 38.81 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.272 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 20' ' ' LEU . 36.8 t80 -128.73 153.1 47.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -1.02 . . . . 0.0 109.524 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.519 HG12 ' CG1' ' A' ' 52' ' ' VAL . 3.1 t -150.43 144.15 17.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.079 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -107.5 141.07 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 109.663 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.632 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 30.8 m-85 -104.3 177.79 4.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.876 . . . . 0.0 110.551 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.525 ' CG ' HG23 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.12 15.91 14.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 111.02 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.7 p -179.38 178.28 0.7 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.368 1.08 . . . . 0.0 111.954 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.573 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.51 -22.57 50.99 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -27.99 38.77 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.43 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.525 ' HA ' ' CD1' ' A' ' 47' ' ' LEU . 85.8 m-20 -80.22 -29.27 38.5 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.526 ' CD2' HD22 ' A' ' 20' ' ' LEU . 3.4 tm? -81.41 -32.81 32.57 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.501 0.667 . . . . 0.0 109.314 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.68 -36.05 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.748 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.534 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.98 -30.14 50.09 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.632 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -63.82 -28.99 70.24 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.799 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.95 -47.15 31.0 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.843 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 5.01 16.21 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.612 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.576 ' HG ' ' CZ ' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -79.39 11.66 2.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 110.422 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -6.44 19.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.41 25.03 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.557 ' CD1' ' CD1' ' A' ' 77' ' ' LEU . 1.3 mt -92.76 -171.16 2.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.468 -1.019 . . . . 0.0 110.9 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.574 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.4 mttt 176.55 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.869 0.842 . . . . 0.0 108.978 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.522 ' CG2' HG22 ' A' ' 87' ' ' ILE . 99.3 t -24.34 -101.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.169 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.578 ' CG ' ' HD3' ' A' ' 29' ' ' LYS . 10.2 m-85 -87.86 42.32 1.05 Allowed 'General case' 0 C--N 1.288 -2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 108.728 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.69 29.78 22.98 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 1.1 t-20 -145.91 88.12 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.449 -1.03 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.574 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -42.95 96.06 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.625 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.522 HG22 ' CG2' ' A' ' 82' ' ' VAL . 0.8 OUTLIER -48.56 125.73 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.606 -0.684 . . . . 0.0 110.144 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.471 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.0 OUTLIER -100.89 129.9 46.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.733 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.524 ' C ' ' CD2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -113.58 176.34 5.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.013 -1.054 . . . . 0.0 111.222 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.42 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 3.2 pt-20 -178.39 131.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.459 -0.776 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.464 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 1.9 ptpt -60.22 115.34 12.82 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' CD ' ' HA ' ' A' ' 20' ' ' LEU . 46.1 Cg_endo -72.95 -171.6 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.84 1.442 . . . . 0.0 110.363 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -150.11 119.34 6.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 45.04 60.61 3.88 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.86 110.25 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -1.123 . . . . 0.0 110.293 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.01 133.83 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 110.246 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -67.34 -160.0 1.15 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER 177.73 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.263 -1.14 . . . . 0.0 110.47 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.37 9.2 14.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.215 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 112.52 -60.04 0.35 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.281 -1.129 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -152.72 179.83 8.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -1.136 . . . . 0.0 110.266 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -131.61 17.62 4.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 61.39 112.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 mt 62.44 55.76 2.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.274 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.75 -44.37 77.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -136.24 107.49 9.48 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 110.216 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.17 79.37 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.051 1.553 . . . . 0.0 110.416 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.445 ' CG1' ' O ' ' A' ' 9' ' ' VAL . 9.4 p -142.18 109.02 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.239 0.543 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 36.5 mp0 -93.3 163.26 13.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.19 71.7 1.0 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.06 -71.07 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -1.151 . . . . 0.0 110.16 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.29 27.75 8.77 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.26 -0.9 . . . . 0.0 110.066 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -173.66 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.256 0.55 . . . . 0.0 110.229 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.457 ' O ' HG23 ' A' ' 15' ' ' THR . 4.6 m -78.65 -2.15 37.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 110.16 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.534 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -178.83 165.19 1.03 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 110.39 -179.928 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.557 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.8 Cg_endo -75.43 -44.16 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.101 1.579 . . . . 0.0 110.651 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 90.6 m-85 -96.15 106.33 18.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.119 -0.988 . . . . 0.0 110.594 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' ND2' ' C ' ' A' ' 18' ' ' PHE . 2.0 m120 -135.66 146.31 47.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.569 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -164.71 169.15 17.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.547 179.79 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 3.5 t80 -101.73 145.97 28.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.732 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.561 ' O ' ' CE1' ' A' ' 21' ' ' PHE . 1.4 mt -127.78 158.53 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.68 179.84 17.21 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 45.8 t30 71.35 76.74 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.413 -1.051 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.4 mm? -118.88 126.44 51.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.021 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.475 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 46.0 t30 -40.43 100.36 0.22 Allowed Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.613 -0.68 . . . . 0.0 110.525 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.7 Cg_endo -75.75 -13.81 19.77 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.411 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -18.26 43.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.577 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -108.28 -156.52 0.58 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 0.0 109.753 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.524 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -101.63 147.19 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.475 HG21 ' O ' ' A' ' 57' ' ' ASN . 3.3 t -69.67 -32.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.486 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.74 85.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.183 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.584 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.72 -40.15 84.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.724 . . . . 0.0 109.33 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.534 HD21 ' CG1' ' A' ' 82' ' ' VAL . 40.2 mt -57.3 -37.04 71.84 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.522 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -61.45 -58.19 9.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.32 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.48 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -58.54 -33.7 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.414 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.61 -36.49 83.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.189 -0.945 . . . . 0.0 108.609 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 17.0 mt -79.66 -26.14 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.584 -0.697 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -79.79 -30.35 40.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 108.93 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.48 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.12 -38.06 27.86 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.514 0.673 . . . . 0.0 109.669 179.464 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.579 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 1.1 tt -69.9 -31.19 68.85 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.458 -0.776 . . . . 0.0 109.248 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 5.5 m-85 -82.87 -23.92 33.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.11 -32.01 61.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.455 ' HD3' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -90.02 -18.95 25.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.437 179.353 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.3 m-80 -85.49 -20.16 30.13 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.786 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.0 t0 89.42 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 -179.19 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.578 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -80.14 -138.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.424 ' HB3' ' HB2' ' A' ' 66' ' ' GLU . . . -176.52 57.44 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.953 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.549 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 9.9 m -63.32 117.45 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.047 0.927 . . . . 0.0 110.766 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.573 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -98.2 -34.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.524 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.51 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 56.7 t0 -144.78 148.49 34.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.522 ' CG1' ' HG3' ' A' ' 35' ' ' LYS . 3.8 t -152.87 100.28 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 169.23 8.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.124 -0.985 . . . . 0.0 110.388 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.45 ' HB ' HG11 ' A' ' 31' ' ' VAL . 17.4 p -83.52 168.21 16.66 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.515 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -122.04 122.02 4.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 60' ' ' PHE . 4.3 m 67.87 -57.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.755 -0.85 . . . . 0.0 110.368 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.475 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER 179.81 -43.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.69 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.461 ' HA ' HG21 ' A' ' 31' ' ' VAL . 12.4 ptt180 -168.39 25.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.721 . . . . 0.0 110.123 179.784 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.633 ' CB ' ' CE1' ' A' ' 60' ' ' PHE . 2.8 mttt -119.65 -24.83 6.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.803 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.633 ' CE1' ' CB ' ' A' ' 59' ' ' LYS . 0.2 OUTLIER -138.51 -172.38 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.195 -0.941 . . . . 0.0 109.449 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.488 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -172.93 151.69 14.55 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.147 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 38.0 m-85 -108.05 150.62 26.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.415 -1.05 . . . . 0.0 109.525 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.514 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 3.9 t -151.36 146.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.264 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.455 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.2 m-20 -122.56 146.6 47.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.573 ' C ' ' CG2' ' A' ' 50' ' ' VAL . 26.2 m-85 -114.86 -175.21 2.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.861 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.534 ' HG3' ' CG1' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -129.44 31.34 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.661 -1.274 . . . . 0.0 113.673 -176.623 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.776 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 22.6 p -172.88 172.76 3.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.902 -1.749 . . . . 0.0 113.167 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.77 -27.81 58.2 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -27.1 61.76 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 179.459 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.776 ' OD2' ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -78.23 -32.29 49.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.083 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.573 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -65.95 -41.55 91.14 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.284 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -70.09 -33.11 71.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 178.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.503 ' CG ' ' O ' ' A' ' 69' ' ' GLU . 15.9 mmtt -81.49 -23.02 37.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.468 ' N ' ' O ' ' A' ' 70' ' ' ASP . . . -69.19 -29.91 67.98 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.45 -48.13 29.38 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.261 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.07 8.51 15.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.269 178.567 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.525 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 3.0 tt -66.32 -8.81 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 110.837 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.465 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 84.9 m -70.92 5.41 2.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.353 -0.842 . . . . 0.0 111.692 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.44 -6.48 56.52 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.579 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 6.8 mp -92.61 120.79 33.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -1.166 . . . . 0.0 110.723 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.534 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -95.07 80.69 3.63 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.965 0.888 . . . . 0.0 110.139 179.36 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.534 ' CG1' HD21 ' A' ' 34' ' ' LEU . 2.5 t -43.22 120.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.584 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 0.6 OUTLIER 48.73 20.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.965 -179.122 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.87 11.67 39.51 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.7 m120 -128.28 110.43 12.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -59.35 76.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.529 -0.732 . . . . 0.0 110.123 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.545 ' N ' ' O ' ' A' ' 85' ' ' ASN . 4.9 pt -42.99 140.33 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 110.042 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.8 mttm -108.61 158.72 17.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.205 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -120.69 170.99 8.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -167.93 122.29 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 110.083 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -57.44 109.21 1.59 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.888 . . . . 0.0 110.376 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 49.7 Cg_endo -81.17 -169.79 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.978 1.515 . . . . 0.0 110.339 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -58.3 -178.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 110.08 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.57 -46.99 1.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.9 11.22 8.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -1.158 . . . . 0.0 110.173 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.15 131.05 42.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -126.74 14.49 6.73 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.97 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -176.58 135.45 0.24 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.198 -1.178 . . . . 0.0 110.428 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 98' ' ' THR . 0.6 OUTLIER 51.2 97.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 110.149 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 101' ' ' CYS . . . -75.15 81.48 0.92 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 100' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.277 -1.131 . . . . 0.0 110.241 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 65.26 -73.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -1.136 . . . . 0.0 110.272 -179.983 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 48.37 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 179.966 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -111.03 111.17 22.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.181 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.3 tp -139.59 -59.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.255 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.408 ' O ' ' HB2' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -96.39 -166.41 1.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 110.269 -179.983 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 17.0 t70 -176.06 55.78 0.13 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.143 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.529 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 48.4 Cg_endo -71.56 -157.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.054 1.555 . . . . 0.0 110.02 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.529 ' CG1' ' O ' ' A' ' 8' ' ' PRO . 11.9 p 37.51 46.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 121.233 0.539 . . . . 0.0 110.597 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' VAL . 16.3 mt-10 -42.93 165.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.876 . . . . 0.0 110.171 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.58 9.36 6.46 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 m -167.42 97.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -1.114 . . . . 0.0 110.247 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -126.87 -130.47 0.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -167.72 1.83 Allowed 'General case' 0 C--N 1.286 -2.173 0 O-C-N 121.679 -0.638 . . . . 0.0 110.204 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.441 ' O ' HG21 ' A' ' 16' ' ' THR . 4.2 m -89.51 -4.41 57.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 110.222 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.525 HG23 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -170.52 165.4 5.31 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.95 -34.06 2.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.097 1.577 . . . . 0.0 111.052 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.2 m-85 -109.78 115.62 30.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.737 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.472 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 3.5 m-80 -142.88 152.36 42.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.412 -0.805 . . . . 0.0 109.567 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.0 pt? -162.91 170.88 17.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 110.416 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -97.93 167.79 10.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' GLY . 14.2 mt -142.69 161.65 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -148.11 177.61 26.25 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 16.9 t30 71.73 43.75 0.55 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -1.095 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 4.2 mm? -92.73 127.63 38.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.932 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.512 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 63.8 t-20 -40.8 106.61 0.43 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 110.447 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.53 -24.4 16.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.085 1.571 . . . . 0.0 110.389 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -76.44 -10.93 59.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.902 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.573 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.8 mmtp -114.68 -155.6 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.959 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 6.8 m -115.22 153.39 30.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.369 179.885 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.571 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.8 t -69.52 -21.03 24.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.224 -0.922 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.27 89.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 109.308 179.134 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.527 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.1 mm-40 -71.49 -45.35 62.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.532 -0.73 . . . . 0.0 109.354 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.543 ' CD2' ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -57.91 -31.07 66.42 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.542 ' CG ' ' HB ' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -64.53 -62.09 1.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.513 0.673 . . . . 0.0 109.238 179.092 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.539 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 44.2 t -51.93 -38.99 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.716 . . . . 0.0 109.684 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.511 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.82 -28.54 70.08 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.036 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.477 ' CG1' HG21 ' A' ' 82' ' ' VAL . 39.9 mt -88.08 -27.63 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.006 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.465 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 8.9 m -79.97 -26.94 39.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.101 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.539 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.0 -38.99 20.23 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.25 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.545 ' CD2' ' CB ' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -65.99 -34.49 78.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.463 ' CD1' ' N ' ' A' ' 42' ' ' PHE . 8.1 m-30 -86.45 -19.14 30.04 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -87.69 -28.12 21.99 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.831 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -90.41 -20.23 23.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.247 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.605 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -79.2 -59.63 2.69 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.658 -0.651 . . . . 0.0 109.56 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.605 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.8 m-20 149.01 30.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.275 0.56 . . . . 0.0 109.925 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.513 ' CD1' ' HB3' ' A' ' 73' ' ' LYS . 1.9 mp -99.94 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.836 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.6 63.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 7.8 m -49.89 117.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.909 0.862 . . . . 0.0 109.975 179.829 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.535 HG22 ' CG ' ' A' ' 66' ' ' GLU . 2.4 t -93.6 -44.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 121.165 0.507 . . . . 0.0 110.403 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.459 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 1.5 t70 -139.28 155.71 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.783 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.542 ' HB ' ' CG ' ' A' ' 35' ' ' LYS . 0.5 OUTLIER -136.86 174.44 11.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.318 -0.864 . . . . 0.0 110.101 -179.822 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.438 ' HB2' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER 175.17 178.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.168 -0.957 . . . . 0.0 110.057 179.896 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.571 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 18.5 p -103.14 170.18 8.12 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.632 ' HA3' ' CB ' ' A' ' 60' ' ' PHE . . . -121.95 132.32 8.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.455 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 53.3 m 57.46 -92.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 110.448 179.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.454 ' N ' HG22 ' A' ' 56' ' ' THR . 1.1 t-20 -154.53 99.32 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 110.744 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.53 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 42.1 mtm180 45.12 23.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -121.26 -32.88 3.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.632 ' CB ' ' HA3' ' A' ' 55' ' ' GLY . 8.6 m-85 -119.88 -161.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 109.407 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' O ' ' N ' ' A' ' 22' ' ' ILE . . . -167.92 167.65 40.22 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.58 ' CE1' ' OD1' ' A' ' 64' ' ' ASP . 14.6 t80 -142.01 153.58 44.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.394 -1.062 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 43.7 t -157.56 158.81 2.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.192 -178.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.58 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 11.4 m-20 -123.85 142.35 51.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.679 -0.638 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 49.6 m-85 -104.73 175.32 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 111.049 -179.215 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.535 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.37 11.76 20.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 111.524 -178.585 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.546 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.3 p -172.7 172.91 4.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 112.178 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.426 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -79.14 -23.96 43.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.43 -24.1 29.71 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.11 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' CB ' ' OG ' ' A' ' 67' ' ' SER . 5.6 t0 -82.94 -26.58 31.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.58 HD23 ' CD2' ' A' ' 65' ' ' PHE . 2.8 tm? -79.58 -34.47 40.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.287 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.8 -33.86 62.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 109.779 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 0.1 OUTLIER -80.62 -21.94 41.05 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.589 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -77.8 -28.23 50.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.198 179.059 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.517 HD22 ' CD1' ' A' ' 89' ' ' LEU . 2.0 tm? -75.72 -46.23 32.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -66.68 -26.31 66.97 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.218 179.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.493 HD13 ' CD1' ' A' ' 47' ' ' LEU . 6.9 mt -70.7 -20.58 62.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.839 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.468 ' HB ' ' O ' ' A' ' 75' ' ' LEU . 1.5 t -39.66 -31.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.306 1.05 . . . . 0.0 110.212 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.27 -20.31 9.75 Favored Glycine 0 C--N 1.281 -2.489 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.545 ' CB ' ' CD2' ' A' ' 41' ' ' LEU . 2.9 pp -66.99 125.84 27.26 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.319 -1.106 . . . . 0.0 110.655 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.543 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 11.0 mttt -93.88 78.67 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.301 1.048 . . . . 0.0 110.26 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.537 ' CG2' ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -43.8 131.09 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.146 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.573 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 3.0 m-85 44.32 24.25 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.467 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 91.21 25.03 25.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' ILE . 39.4 m-20 -140.35 104.8 4.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -1.184 . . . . 0.0 110.343 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.543 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 5.9 tt0 -56.35 84.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.289 -0.882 . . . . 0.0 109.933 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.526 ' CG2' HG22 ' A' ' 82' ' ' VAL . 2.7 pp -40.09 129.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.523 0.678 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.463 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -104.78 132.75 50.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.507 -0.745 . . . . 0.0 109.376 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.517 ' CD1' HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -105.64 174.07 6.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.888 -1.133 . . . . 0.0 110.737 -179.45 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.41 135.91 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 110.109 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.27 113.29 5.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 110.167 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 46.0 Cg_endo -73.13 -169.64 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.017 1.535 . . . . 0.0 110.432 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 1.7 ttmt 67.55 105.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.62 -9.97 7.21 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.429 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 2.0 tmt_? -101.42 5.6 42.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -1.15 . . . . 0.0 110.224 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.29 157.92 32.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 110.235 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.12 57.49 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -123.44 115.94 22.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -1.152 . . . . 0.0 110.315 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.04 -23.72 9.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.74 87.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 110.242 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p 56.15 -161.31 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -1.178 . . . . 0.0 110.197 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -115.63 -177.76 3.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 30.2 ttp -85.39 -2.98 58.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 110.248 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.447 ' CB ' ' O ' ' A' ' 4' ' ' MET . 4.7 tp 65.58 137.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.18 59.55 4.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -146.18 100.53 4.18 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.51 79.42 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.99 1.521 . . . . 0.0 110.403 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' GLY . 52.6 t -144.05 128.16 13.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.18 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER -58.18 84.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.193 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 43.48 -97.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' GLU . 2.5 m 42.06 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.42 -1.047 . . . . 0.0 110.267 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -167.34 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 110.313 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.46 156.43 0.63 Allowed 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.798 -0.564 . . . . 0.0 109.718 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.467 ' O ' HG23 ' A' ' 16' ' ' THR . 27.2 m -124.29 -25.42 4.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 110.676 -179.781 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.586 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 65.2 p -139.57 164.48 38.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.448 -0.782 . . . . 0.0 110.579 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.555 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 50.9 Cg_endo -78.21 -31.6 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.127 1.593 . . . . 0.0 110.695 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.577 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 89.9 m-85 -92.82 93.05 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.103 -0.998 . . . . 0.0 110.607 -179.582 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.5 m120 -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.252 -0.905 . . . . 0.0 109.317 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.584 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.1 pt? -158.94 -176.63 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.714 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.2 t80 -101.37 156.61 17.35 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.592 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 2.4 mt -147.41 155.77 10.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.078 -1.014 . . . . 0.0 109.572 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.523 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -143.13 -162.7 9.42 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t30 71.38 14.09 6.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -1.107 . . . . 0.0 110.025 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.525 HD13 ' CD2' ' A' ' 34' ' ' LEU . 3.4 mm? -66.5 124.81 23.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.704 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.51 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 32.6 t-20 -40.96 101.09 0.23 Allowed Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.623 -0.673 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 45.8 Cg_endo -72.37 -31.62 11.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.079 1.568 . . . . 0.0 110.433 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 26' ' ' ASN . 28.4 p30 -72.68 -14.8 61.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.51 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.2 tmtt? -96.79 -153.78 0.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.79 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -112.45 148.58 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.372 -0.83 . . . . 0.0 110.279 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.538 ' CG2' ' CB ' ' A' ' 58' ' ' ARG . 3.7 t -68.75 -25.25 30.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.463 ' O ' HG22 ' A' ' 36' ' ' VAL . . . -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 29.9 mm-40 -72.96 -31.67 64.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.525 ' CD2' HD13 ' A' ' 25' ' ' LEU . 23.5 mt -65.89 -31.83 72.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.466 ' HE3' ' O ' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -72.1 -56.48 5.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.553 179.484 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.477 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 5.6 t -61.02 -33.69 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 179.134 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.72 -38.4 90.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.587 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 65.8 mt -75.52 -29.07 20.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.722 . . . . 0.0 109.584 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.45 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -77.46 -31.94 54.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.0 -1.063 . . . . 0.0 108.819 179.084 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.6 tm-20 -81.7 -42.23 20.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.507 0.67 . . . . 0.0 109.556 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.539 ' CD2' ' CD1' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -59.54 -37.58 78.76 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.748 -0.781 . . . . 0.0 108.966 179.167 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 9.7 m-85 -82.12 -22.65 36.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.45 ' HB3' ' O ' ' A' ' 39' ' ' SER . . . -79.68 -17.2 54.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -109.24 -16.98 13.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 109.741 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.713 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -84.4 -31.29 24.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.713 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.9 t0 112.62 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-O 121.971 0.891 . . . . 0.0 108.765 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.506 HD12 ' CG ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -105.59 -155.01 0.53 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.769 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.468 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -168.98 63.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.282 179.893 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.579 HG13 ' CD2' ' A' ' 42' ' ' PHE . 4.9 m -49.62 116.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.85 0.833 . . . . 0.0 109.829 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 10.5 t -81.25 -38.0 16.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.496 ' OD1' ' N ' ' A' ' 52' ' ' VAL . 8.7 t0 -153.6 152.66 31.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.087 -1.008 . . . . 0.0 110.55 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.496 ' N ' ' OD1' ' A' ' 51' ' ' ASP . 13.4 t -134.92 161.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 26.5 mtp180 -155.61 154.87 32.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.009 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.515 ' CG2' HG11 ' A' ' 31' ' ' VAL . 14.3 p -78.66 166.82 22.08 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.975 . . . . 0.0 110.398 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.538 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -141.06 122.3 2.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 55' ' ' GLY . 32.1 m 40.4 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.337 -1.096 . . . . 0.0 111.008 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.468 ' HB2' ' O ' ' A' ' 56' ' ' THR . 21.4 m120 60.11 -141.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.73 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.538 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 3.6 ptt85 -114.5 34.32 4.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 11.1 pttt -118.47 -19.14 8.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 109.959 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.592 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -119.89 174.16 6.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.547 179.637 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.452 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -176.59 148.66 9.19 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.815 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 8.4 t80 -111.51 157.57 20.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.883 . . . . 0.0 109.016 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.625 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -141.28 172.34 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.773 -1.204 . . . . 0.0 111.3 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.511 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 2.6 m-20 -136.43 135.94 39.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.769 -0.582 . . . . 0.0 109.457 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 16.8 m-85 -106.47 -178.66 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.562 -0.711 . . . . 0.0 110.988 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.563 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 2.1 pp20? -117.45 5.55 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 111.044 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.577 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.4 p -168.96 175.2 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.301 1.048 . . . . 0.0 112.21 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.572 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.99 -23.56 41.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.899 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.74 -26.46 31.9 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.013 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.487 ' OD2' ' HB3' ' A' ' 65' ' ' PHE . 3.4 t0 -81.05 -27.76 35.63 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.088 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -75.5 -37.16 60.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.667 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -69.99 -33.9 72.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.753 . . . . 0.0 109.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.506 ' CG ' HD12 ' A' ' 47' ' ' LEU . 2.7 tppt? -73.4 -25.71 60.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.193 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.638 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.68 -26.99 61.82 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.943 0.878 . . . . 0.0 108.641 178.599 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.453 ' O ' ' OG1' ' A' ' 78' ' ' THR . 1.7 tm? -76.22 -34.47 59.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.261 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -16.76 48.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.729 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.527 ' C ' ' CD1' ' A' ' 77' ' ' LEU . 1.1 pp -66.38 -17.83 65.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.98 -1.075 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.453 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -47.72 -16.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.569 -0.707 . . . . 0.0 111.751 -179.359 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -82.72 14.78 34.64 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.539 ' CD1' ' CD2' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -101.4 -163.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -1.195 . . . . 0.0 110.507 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.598 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -168.35 49.76 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 109.627 -179.758 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.581 ' CG2' ' CD1' ' A' ' 87' ' ' ILE . 5.0 t 5.67 -122.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.708 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.526 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 3.3 m-85 -72.31 -2.9 20.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.985 -1.072 . . . . 0.0 109.355 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 145.99 35.24 0.06 OUTLIER Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.1 m-20 -157.87 101.93 1.81 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -1.215 . . . . 0.0 109.996 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.598 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 2.8 pt-20 -52.58 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.581 ' CD1' ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -37.92 148.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.693 0.758 . . . . 0.0 110.75 -179.645 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 16.3 ttpt -121.87 156.81 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.578 ' CD2' ' CD1' ' A' ' 20' ' ' LEU . 1.8 mp -112.88 173.41 6.39 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.047 -1.033 . . . . 0.0 110.415 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -165.23 120.18 1.31 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.945 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 110.42 2.85 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.097 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.9 Cg_endo -75.71 -170.0 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.028 1.541 . . . . 0.0 110.235 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.52 21.93 6.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.94 15.97 39.85 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.53 97.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.227 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -114.23 -179.01 3.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.65 -91.4 0.08 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.46 167.05 23.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -1.151 . . . . 0.0 110.522 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -126.62 -176.04 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.27 45.07 0.95 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.203 -1.175 . . . . 0.0 110.225 179.962 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.409 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 2.5 m -148.03 31.14 0.86 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -1.127 . . . . 0.0 110.171 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 2' ' ' SER . 35.5 m170 54.62 68.47 0.86 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.231 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 ttp -106.13 110.54 22.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.219 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.8 pp -162.22 158.17 24.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 110.194 179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -121.71 -67.25 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 110.247 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -159.7 70.39 3.21 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -71.44 -157.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.959 1.505 . . . . 0.0 110.095 -179.974 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 41.1 t -146.35 101.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 O-C-N 121.762 -0.586 . . . . 0.0 110.176 -179.959 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 1.1 pm0 -148.41 39.92 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.57 20.81 47.9 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.524 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 93.0 p -102.5 -22.14 14.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -1.201 . . . . 0.0 110.191 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.524 ' HB3' ' O ' ' A' ' 12' ' ' SER . 33.3 tt0 68.46 122.71 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.85 1.31 . . . . 0.0 110.367 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -39.25 142.35 0.26 Allowed 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.208 -179.985 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.451 ' O ' HG23 ' A' ' 16' ' ' THR . 7.2 m -103.27 -5.18 23.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 0.0 110.282 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.526 HG22 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -166.68 162.89 11.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.325 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.76 -32.87 5.4 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.115 1.587 . . . . 0.0 110.489 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.569 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 84.9 m-85 -108.47 107.36 17.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.927 . . . . 0.0 110.432 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -139.25 146.72 40.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.868 . . . . 0.0 109.339 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -163.17 175.1 11.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.12 -0.987 . . . . 0.0 110.924 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.578 ' CZ ' ' HB2' ' A' ' 60' ' ' PHE . 2.4 t80 -97.37 147.75 23.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.713 -0.617 . . . . 0.0 110.103 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.522 HD11 ' CG2' ' A' ' 63' ' ' VAL . 1.1 mp -133.85 148.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.946 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.465 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -135.56 -166.05 10.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.441 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 28.1 t30 67.15 58.16 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.099 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.519 HD13 ' N ' ' A' ' 61' ' ' GLY . 8.1 mt -105.95 123.99 48.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 110.366 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.494 ' N ' HD12 ' A' ' 34' ' ' LEU . 53.3 t-20 -41.45 104.13 0.33 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.774 . . . . 0.0 110.213 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.75 -15.48 26.85 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -78.13 -17.15 57.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.19 -156.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.742 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.517 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -100.33 146.85 26.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.541 ' CG1' ' HB ' ' A' ' 54' ' ' THR . 0.8 OUTLIER -70.85 -33.27 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.044 -1.063 . . . . 0.0 108.622 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.35 94.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 108.956 178.819 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.517 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 12.8 mm-40 -66.56 -33.54 75.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.524 ' CD2' HG12 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -64.26 -33.8 76.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.186 179.231 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.536 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 5.2 mmtt -66.29 -53.79 32.5 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.474 -0.766 . . . . 0.0 109.119 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.543 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -60.84 -40.94 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.376 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.8 -29.16 69.96 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 108.951 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.584 HG21 ' CE2' ' A' ' 42' ' ' PHE . 10.3 mt -85.86 -30.28 6.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.101 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 34.2 p -78.65 -25.77 45.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 109.283 179.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.543 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -84.43 -39.89 18.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.47 -0.768 . . . . 0.0 109.137 179.39 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.517 HD23 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -62.65 -36.83 84.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.739 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.629 ' CZ ' ' CD2' ' A' ' 77' ' ' LEU . 9.1 m-30 -80.01 -25.19 40.35 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.402 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . . . -68.67 -40.15 80.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.488 179.379 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.51 -17.57 53.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.45 -0.781 . . . . 0.0 109.506 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.11 -8.73 58.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.521 -0.737 . . . . 0.0 110.009 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 9.1 t0 84.52 30.26 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.954 0.883 . . . . 0.0 108.848 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.582 HD22 ' CD1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -83.72 -132.34 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.321 0.581 . . . . 0.0 109.544 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.538 ' HB2' ' CG ' ' A' ' 66' ' ' GLU . . . 174.5 57.39 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.361 -0.837 . . . . 0.0 109.837 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 10.1 m -56.19 117.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.907 0.86 . . . . 0.0 110.472 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.526 ' CB ' HG22 ' A' ' 16' ' ' THR . 0.2 OUTLIER -92.42 -44.22 14.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.289 0.566 . . . . 0.0 109.651 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.499 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 35.2 t70 -136.76 145.8 45.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -0.902 . . . . 0.0 110.615 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.536 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 1.8 t -153.96 119.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.374 -0.829 . . . . 0.0 109.132 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.72 160.04 40.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.891 -1.13 . . . . 0.0 111.266 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.541 ' HB ' ' CG1' ' A' ' 31' ' ' VAL . 39.2 p -92.21 152.29 19.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.5 -0.75 . . . . 0.0 110.027 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.533 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -125.95 124.29 5.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.582 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 0.8 OUTLIER 67.97 -158.86 0.21 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.363 -1.081 . . . . 0.0 110.482 179.751 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.458 ' C ' ' CG ' ' A' ' 58' ' ' ARG . 10.3 t-20 -82.57 74.1 9.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.456 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.537 ' CG ' ' CG2' ' A' ' 31' ' ' VAL . 0.4 OUTLIER 60.64 14.54 5.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 179.663 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -69.27 -50.51 46.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.582 ' CZ ' ' OG1' ' A' ' 56' ' ' THR . 5.3 p90 -156.8 152.24 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.884 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.519 ' N ' HD13 ' A' ' 25' ' ' LEU . . . -124.04 167.95 16.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.1 t80 -119.75 155.3 32.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.406 -1.055 . . . . 0.0 109.721 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.59 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.2 t -151.2 143.43 16.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.746 -178.613 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -117.83 143.96 45.81 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CD1' HD22 ' A' ' 47' ' ' LEU . 37.6 m-85 -107.92 171.76 7.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.538 ' CG ' ' HB2' ' A' ' 48' ' ' ALA . 1.2 pp20? -118.55 16.38 13.74 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.29 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.505 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.0 p -164.37 176.13 9.37 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.466 1.127 . . . . 0.0 112.207 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.91 -25.09 43.74 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -31.07 59.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.093 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.528 ' CB ' ' HB3' ' A' ' 65' ' ' PHE . 91.3 m-20 -78.7 -28.4 45.12 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.569 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 1.8 tm? -74.64 -37.84 62.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -65.81 -34.53 78.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 0.0 109.025 178.948 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' CB ' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.02 -32.35 59.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.976 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.574 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -56.14 -33.57 65.32 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.459 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -72.47 -46.13 56.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.52 6.71 16.6 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.346 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.629 ' CD2' ' CZ ' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -77.15 -12.61 59.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.773 . . . . 0.0 110.367 -179.896 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.531 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 26.1 m -73.68 7.63 2.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.513 -0.742 . . . . 0.0 111.558 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' HA2' ' HG3' ' A' ' 86' ' ' GLU . . . -124.39 18.34 7.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.517 ' CD2' HD23 ' A' ' 41' ' ' LEU . 27.3 mt -107.66 111.16 23.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -1.143 . . . . 0.0 110.809 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.498 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 38.1 mttm -76.91 84.02 3.46 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.07 0.938 . . . . 0.0 109.741 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.55 ' CG2' ' N ' ' A' ' 83' ' ' PHE . 1.2 p -36.96 -94.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.415 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.55 ' N ' ' CG2' ' A' ' 82' ' ' VAL . 0.3 OUTLIER -96.81 29.05 3.17 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.159 -0.963 . . . . 0.0 109.681 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.46 9.54 12.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.539 ' O ' ' N ' ' A' ' 87' ' ' ILE . 3.4 m-20 -139.95 106.28 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 78' ' ' THR . 1.6 tm-20 -47.67 88.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.692 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.539 ' N ' ' O ' ' A' ' 85' ' ' ASN . 0.6 OUTLIER -45.73 145.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 179.777 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.508 ' HG2' ' N ' ' A' ' 89' ' ' LEU . 10.0 ttmt -117.58 155.7 29.36 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.647 -0.658 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -120.66 175.02 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.417 -0.802 . . . . 0.0 110.327 -179.769 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.512 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 0.8 OUTLIER -163.54 161.61 24.07 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.542 -0.724 . . . . 0.0 109.663 -179.592 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.512 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 7.3 mtpp -103.43 95.63 7.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.314 -0.866 . . . . 0.0 110.288 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.1 Cg_endo -72.24 -173.34 1.08 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.082 1.569 . . . . 0.0 110.5 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 95' ' ' ARG . 4.0 tttm 63.61 48.2 3.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.947 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.61 59.77 0.31 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER 52.17 -141.8 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -1.183 . . . . 0.0 110.167 179.955 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.58 120.63 13.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 110.177 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.45 -167.01 18.44 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 p -114.48 109.63 18.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.263 -1.139 . . . . 0.0 110.296 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -117.97 -46.78 2.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.49 158.55 0.13 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.289 -1.124 . . . . 0.0 110.209 -179.963 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.37 20.34 15.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -1.134 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.44 -171.32 1.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.47 139.24 47.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -131.32 130.55 42.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.262 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -91.31 150.14 21.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.418 ' OD1' ' HD2' ' A' ' 8' ' ' PRO . 9.5 t0 -68.24 136.16 91.35 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 110.189 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 10' ' ' GLU . 49.6 Cg_endo -71.52 -156.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.073 1.564 . . . . 0.0 110.148 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 8' ' ' PRO . 66.7 t -41.77 94.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 O-C-N 121.764 -0.585 . . . . 0.0 110.169 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 12' ' ' SER . 2.2 mt-10 -50.57 103.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.297 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 10' ' ' GLU . . . 44.28 -94.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.52 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 92.7 p -133.69 -66.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -1.198 . . . . 0.0 110.249 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.52 ' HB3' ' O ' ' A' ' 12' ' ' SER . 15.1 tt0 67.54 122.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.76 1.267 . . . . 0.0 110.28 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.468 ' O ' ' OG1' ' A' ' 16' ' ' THR . 0.1 OUTLIER -77.27 0.3 22.6 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.552 -179.859 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 15' ' ' THR . 23.8 m 47.79 19.74 0.18 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.564 -0.71 . . . . 0.0 110.873 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.584 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.42 168.78 1.59 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.817 -1.177 . . . . 0.0 110.854 -179.88 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD2' HG21 ' A' ' 16' ' ' THR . 50.6 Cg_endo -79.33 -48.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.218 1.641 . . . . 0.0 110.638 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CE2' ' CA ' ' A' ' 67' ' ' SER . 98.3 m-85 -85.84 110.03 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 5.6 m-80 -139.23 152.04 47.01 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.494 ' C ' ' CD1' ' A' ' 20' ' ' LEU . 4.4 pp -162.54 -177.71 5.78 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.68 ' CD1' ' CE2' ' A' ' 62' ' ' TYR . 7.8 t80 -117.78 144.64 45.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.446 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.53 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.1 mt -133.49 155.4 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.333 -0.854 . . . . 0.0 109.132 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -128.18 -174.86 13.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.194 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.3 t30 74.86 13.69 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.906 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.517 ' N ' ' O ' ' A' ' 59' ' ' LYS . 4.3 mm? -62.59 123.5 18.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.823 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.525 ' CB ' HD22 ' A' ' 34' ' ' LEU . 0.6 OUTLIER -39.57 99.41 0.19 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.876 -0.515 . . . . 0.0 110.496 179.984 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.8 Cg_endo -78.16 -17.2 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.979 1.515 . . . . 0.0 110.619 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.11 -17.78 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.94 . . . . 0.0 110.071 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.571 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -110.5 -157.07 0.6 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 109.613 179.626 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.471 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.05 140.89 32.53 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 110.365 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.596 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.6 t -67.24 -34.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.732 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.465 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . . . -57.86 -34.53 69.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.454 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 44.6 mm-40 -68.23 -43.71 77.35 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.534 HD21 ' CG1' ' A' ' 82' ' ' VAL . 9.1 mt -61.15 -46.07 92.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.609 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.525 ' HG2' ' CG2' ' A' ' 52' ' ' VAL . 90.7 mttt -53.54 -51.05 64.14 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.314 0.578 . . . . 0.0 109.495 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.466 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.3 t -63.64 -38.56 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.474 179.234 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.508 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.89 -35.64 81.31 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.733 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 93.4 mt -79.24 -28.14 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 109.171 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.524 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 6.9 t -78.0 -31.71 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 108.972 179.2 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.75 -38.85 32.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.603 -0.686 . . . . 0.0 109.765 179.589 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.529 ' CD2' ' HB3' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.67 -31.74 71.93 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.315 179.335 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.2 m-85 -82.18 -23.71 35.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 108.928 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.42 65.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.471 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -94.14 -17.26 22.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.684 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.665 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -81.77 -24.57 35.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.665 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 23.6 t70 101.57 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.472 HD13 ' CD2' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -97.5 -151.04 0.36 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.88 62.34 0.06 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.081 -1.012 . . . . 0.0 109.841 179.956 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.524 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 7.3 m -54.23 117.77 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.043 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.584 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 2.1 t -93.41 -39.13 10.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.981 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -146.75 163.65 35.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.072 -1.017 . . . . 0.0 110.572 179.864 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.525 ' CG2' ' HG2' ' A' ' 35' ' ' LYS . 14.4 p -165.61 114.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 109.909 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -119.59 165.3 14.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.596 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 3.8 p -79.56 171.24 15.41 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.43 -0.794 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 60' ' ' PHE . . . -140.45 98.48 0.23 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.634 -1.269 . . . . 0.0 110.479 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.457 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 85.6 m 58.78 130.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -1.089 . . . . 0.0 111.779 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' THR . 1.3 m-80 33.18 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.858 -0.526 . . . . 0.0 111.586 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.531 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 3.6 mtp-105 43.5 25.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.074 -1.016 . . . . 0.0 110.313 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.37 -33.27 18.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 55' ' ' GLY . 3.0 m-85 -112.68 -160.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 0.0 109.167 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.469 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 179.24 125.99 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.066 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 61.1 m-85 -90.2 158.57 17.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -1.124 . . . . 0.0 109.598 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.497 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 2.8 t -149.86 141.4 17.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.906 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.48 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 52.0 m-20 -112.67 146.46 38.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.0 109.53 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.606 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 50.3 m-85 -112.38 177.22 4.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.878 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.511 ' HG2' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -113.79 18.86 17.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 111.475 -178.354 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.61 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 23.4 p -178.83 -179.3 0.6 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.643 1.211 . . . . 0.0 112.325 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.259 . . -81.0 -28.58 35.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.484 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.13 -24.92 59.5 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.229 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 79.1 m-20 -83.33 -33.34 25.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.439 HD11 ' O ' ' A' ' 71' ' ' LEU . 9.5 tp -70.67 -36.93 73.59 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.741 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -71.81 -41.17 68.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.689 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -74.25 -32.62 63.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.134 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.606 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -60.26 -29.92 69.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.747 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -72.18 -49.03 38.8 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.724 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.09 -0.46 28.2 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.31 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.582 HD12 ' CE1' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -82.56 17.08 1.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 110.367 -179.725 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.514 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 86.3 m -87.73 5.62 39.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.09 20.92 33.76 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.533 ' O ' ' CD1' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -118.12 124.74 48.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.25 -1.147 . . . . 0.0 110.602 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.494 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 14.9 mttt -87.98 82.54 7.21 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.613 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.554 ' CG2' ' CG2' ' A' ' 87' ' ' ILE . 76.5 t -42.99 106.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.5 OUTLIER 60.09 22.67 11.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 110.397 -179.17 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.84 14.72 30.86 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' ILE . 19.5 m-20 -133.3 103.26 5.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.136 -1.214 . . . . 0.0 110.207 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.7 tt0 -57.52 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.554 ' CG2' ' CG2' ' A' ' 82' ' ' VAL . 13.0 pt -41.71 137.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.382 -0.824 . . . . 0.0 110.586 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -104.48 167.86 9.47 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.164 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.53 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 1.4 mp -109.7 179.0 4.25 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.04 -1.038 . . . . 0.0 110.641 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.472 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 179.42 137.62 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.949 179.957 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 112.07 22.88 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.5 Cg_endo -74.18 -170.26 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.997 1.525 . . . . 0.0 110.416 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.441 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 1.9 pttt -168.22 35.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.03 90.23 0.07 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 124.95 3.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -1.176 . . . . 0.0 110.219 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -175.14 -177.37 1.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.154 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.09 112.23 2.89 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.15 142.91 31.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -1.118 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.73 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.99 -37.45 1.04 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.236 -1.155 . . . . 0.0 110.182 -179.976 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.7 70.49 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -1.132 . . . . 0.0 110.192 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -86.09 47.57 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.202 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.0 mtm -82.43 121.7 27.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 110.197 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 mt -92.83 60.42 3.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.252 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.453 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 tp10 -90.51 117.54 29.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.935 . . . . 0.0 110.2 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.99 104.71 23.55 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.163 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 44.1 Cg_endo -73.55 79.61 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.072 1.564 . . . . 0.0 110.36 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.424 ' O ' ' C ' ' A' ' 10' ' ' GLU . 1.6 p -122.11 -159.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 121.758 -0.589 . . . . 0.0 109.925 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.424 ' C ' ' O ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 42.96 47.86 5.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 0.0 110.26 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.37 -80.57 1.0 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -156.04 -74.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -1.17 . . . . 0.0 110.035 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.456 ' N ' ' OG ' ' A' ' 12' ' ' SER . 2.4 mt-10 -175.17 30.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.352 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.65 137.67 57.41 Favored 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.764 -0.585 . . . . 0.0 110.107 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 15' ' ' THR . 5.1 m -123.79 8.14 8.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.243 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.524 HG23 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -173.52 161.98 3.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 110.516 -179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.77 -40.51 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.249 1.657 . . . . 0.0 110.675 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.482 ' CB ' ' HB2' ' A' ' 65' ' ' PHE . 81.6 m-85 -95.51 111.16 23.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 m120 -135.64 151.87 50.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.825 . . . . 0.0 109.687 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.637 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -160.01 166.89 29.12 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 110.512 -179.651 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 1.1 t80 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 110.002 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.529 ' CD1' HG22 ' A' ' 63' ' ' VAL . 7.8 mt -126.19 162.56 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -147.81 175.73 26.99 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 30.9 t30 72.71 64.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.582 -0.952 . . . . 0.0 110.07 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.505 HD23 ' CD2' ' A' ' 34' ' ' LEU . 18.9 mt -95.4 -167.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.463 ' HB3' HD12 ' A' ' 34' ' ' LEU . 54.0 t-20 -114.61 107.03 51.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.52 ' HA ' ' CD ' ' A' ' 58' ' ' ARG . 44.4 Cg_endo -72.27 -1.82 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.064 1.56 . . . . 0.0 110.579 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -113.97 20.52 15.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.671 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' CG ' ' OE2' ' A' ' 33' ' ' GLU . 2.2 tptm -148.12 -157.98 0.87 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.327 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.457 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.78 139.9 45.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.685 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 20.7 t -66.8 -28.42 43.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.08 179.504 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.79 85.18 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.679 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.568 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -64.4 -30.29 71.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.811 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.505 ' CD2' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.63 -37.42 84.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 108.932 178.921 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.527 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 13.3 mmtt -61.71 -54.07 47.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.459 -0.775 . . . . 0.0 109.306 179.251 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.46 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 42.7 t -49.21 -41.29 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.824 . . . . 0.0 109.88 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.576 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -62.39 -33.18 74.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.17 -0.956 . . . . 0.0 108.724 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 32.6 mt -82.03 -26.01 9.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.586 -0.696 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -80.75 -28.34 36.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 108.574 178.969 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -81.45 -41.13 22.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.57 0.7 . . . . 0.0 109.381 179.393 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.584 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.13 -34.43 78.02 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.096 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.636 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 5.9 m-85 -80.79 -23.56 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.04 -33.1 65.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 109.105 179.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.28 -17.3 24.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.402 179.278 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.17 -20.76 37.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.435 -0.791 . . . . 0.0 109.995 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.2 t70 95.76 29.17 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.992 0.901 . . . . 0.0 108.877 -179.396 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.636 ' CD1' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -91.68 -143.73 0.19 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.316 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.526 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -176.29 60.12 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 8.3 m -55.23 118.23 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.902 0.858 . . . . 0.0 110.214 179.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 0.3 OUTLIER -92.03 -38.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.158 0.504 . . . . 0.0 109.82 -179.498 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.512 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 1.6 t70 -137.21 152.11 49.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 0.0 110.64 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.527 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -157.82 114.42 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.491 -0.755 . . . . 0.0 109.62 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.459 ' HG2' ' HB3' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -134.97 175.47 9.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.502 ' CG2' ' HB ' ' A' ' 31' ' ' VAL . 16.8 p -83.48 175.0 10.12 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.224 -0.923 . . . . 0.0 110.187 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -130.5 117.11 2.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.519 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.8 m 77.05 -64.81 0.31 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.117 -0.637 . . . . 0.0 109.829 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.48 ' HB3' ' O ' ' A' ' 56' ' ' THR . 18.9 p-10 179.91 -32.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.448 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.544 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 1.0 OUTLIER -177.57 28.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -115.0 -33.61 5.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.205 -0.934 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.698 ' CD1' ' CE2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.91 -179.28 6.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.372 -0.83 . . . . 0.0 109.346 179.175 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.623 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -148.9 168.18 29.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.52 ' C ' ' CG2' ' A' ' 63' ' ' VAL . 5.9 t80 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -1.162 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.529 HG22 ' CD1' ' A' ' 22' ' ' ILE . 3.7 t -151.63 158.35 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.531 -178.922 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.472 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 28.4 m-20 -130.96 142.68 50.37 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.111 -0.993 . . . . 0.0 109.951 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.639 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 64.3 m-85 -106.96 172.42 6.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.42 -0.8 . . . . 0.0 110.004 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.529 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.11 17.75 13.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -0.987 . . . . 0.0 111.462 -178.32 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.472 ' OG ' ' OD2' ' A' ' 70' ' ' ASP . 26.7 p -168.17 175.81 6.36 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.525 1.155 . . . . 0.0 112.437 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.83 -24.82 48.56 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.698 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -77.23 -26.6 52.83 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.576 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.53 ' CB ' ' HB3' ' A' ' 65' ' ' PHE . 90.2 m-20 -82.9 -30.04 28.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.241 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.6 -36.87 68.21 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.786 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.53 -36.91 63.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 109.973 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.532 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.22 -26.59 52.85 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.654 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.639 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -70.67 -29.37 65.68 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.912 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.464 ' HA ' HD11 ' A' ' 89' ' ' LEU . 4.7 tt -71.74 -46.96 56.87 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -4.22 44.05 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.257 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.586 ' CD1' ' CZ ' ' A' ' 42' ' ' PHE . 0.4 OUTLIER -76.38 6.81 5.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.538 -0.726 . . . . 0.0 110.547 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.429 ' OG1' HD22 ' A' ' 89' ' ' LEU . 54.3 m -76.65 3.11 12.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 110.299 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.72 28.85 10.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.584 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.0 120.57 39.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -1.062 . . . . 0.0 110.236 -179.579 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.555 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 2.1 ttmt -91.58 87.97 6.57 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 123.017 1.389 . . . . 0.0 109.385 178.804 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.532 ' CG2' HG12 ' A' ' 87' ' ' ILE . 98.5 t -43.24 -105.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.686 -179.649 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HB1' ' A' ' 37' ' ' ALA . 6.3 m-85 -90.13 40.37 1.0 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.014 -1.054 . . . . 0.0 109.964 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 97.54 19.57 24.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.929 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.525 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 12.4 m-80 -147.01 92.58 2.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 110.105 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.555 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.6 mt-10 -43.27 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.532 HG12 ' CG2' ' A' ' 82' ' ' VAL . 2.2 pp -58.67 129.21 20.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 110.203 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -104.63 133.22 49.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.466 179.701 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -110.72 174.16 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.936 -1.102 . . . . 0.0 111.122 -179.38 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.464 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -173.22 132.18 0.49 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.635 -0.666 . . . . 0.0 109.634 -179.7 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -59.33 110.1 2.45 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.15 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.5 Cg_endo -79.22 -169.85 0.88 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.991 1.522 . . . . 0.0 110.451 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.69 47.34 20.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.196 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.54 22.94 18.05 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.78 140.06 55.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -1.131 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -165.03 158.02 16.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.4 -14.35 62.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.76 146.25 24.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -1.161 . . . . 0.0 110.375 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.9 168.99 18.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 110.221 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.17 60.77 0.15 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.925 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 2' ' ' SER . 1.0 OUTLIER -120.79 111.88 18.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -1.144 . . . . 0.0 110.25 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -102.78 82.23 2.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.276 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 ttm -151.03 66.56 0.91 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.166 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.92 118.61 9.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.12 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -101.99 16.04 27.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 0.0 110.198 179.977 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -43.35 -60.05 2.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.191 179.921 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 49.8 Cg_endo -71.47 -157.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.089 1.573 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' CG2' ' O ' ' A' ' 8' ' ' PRO . 88.9 t -155.5 125.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.847 -0.533 . . . . 0.0 110.275 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' VAL . 12.2 pt-20 -42.91 162.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 110.21 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.14 80.59 0.32 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -69.81 -6.15 30.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -1.193 . . . . 0.0 110.068 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -170.69 29.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.987 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.8 OUTLIER 41.42 -173.0 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.634 0.731 . . . . 0.0 111.399 179.205 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t -124.53 -16.44 6.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.08 -179.589 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.532 HG22 ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -119.04 163.9 23.97 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.553 -0.717 . . . . 0.0 110.567 -179.632 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -76.4 -29.56 6.0 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.201 1.632 . . . . 0.0 110.47 179.974 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.537 ' CE2' ' C ' ' A' ' 67' ' ' SER . 86.9 m-85 -108.54 113.2 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.667 -179.759 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 2.0 m120 -141.8 149.15 40.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.581 ' O ' ' CZ ' ' A' ' 62' ' ' TYR . 4.5 pp -164.62 -176.9 4.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.451 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.434 ' O ' HD13 ' A' ' 20' ' ' LEU . 7.7 t80 -108.94 153.35 23.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 110.169 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.517 HG23 ' N ' ' A' ' 23' ' ' GLY . 1.6 mt -138.92 155.27 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.915 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.24 -169.89 11.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.0 t30 72.0 51.32 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.498 -1.001 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.532 ' HB3' ' CD2' ' A' ' 34' ' ' LEU . 13.8 mt -102.51 120.97 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.915 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.51 ' N ' HD23 ' A' ' 34' ' ' LEU . 34.6 t30 -47.13 104.53 0.42 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.581 -0.699 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.6 Cg_endo -75.44 -5.02 16.1 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.045 1.55 . . . . 0.0 110.433 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.11 -20.35 45.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.99 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.564 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -107.95 -156.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.527 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.5 m -98.5 146.75 25.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 54' ' ' THR . 4.5 t -67.98 -34.1 65.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.722 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.449 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -64.52 -34.6 78.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.741 179.41 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.519 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 59.0 mm-40 -71.44 -34.98 70.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.336 179.367 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.532 ' CD2' ' HB3' ' A' ' 25' ' ' LEU . 6.7 mp -66.54 -29.02 69.0 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 53' ' ' ARG . 0.1 OUTLIER -70.94 -54.98 9.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.461 -0.775 . . . . 0.0 109.1 179.158 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.2 t -60.15 -35.03 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.817 . . . . 0.0 109.379 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.45 -38.03 88.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.9 mt -76.03 -29.37 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.493 179.042 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.491 ' HA ' ' CG2' ' A' ' 49' ' ' VAL . 1.9 t -78.66 -29.75 45.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.084 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.3 tm-20 -81.48 -36.95 28.7 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.522 ' CD1' HD11 ' A' ' 80' ' ' LEU . 1.1 tt -69.73 -30.2 67.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.502 -0.748 . . . . 0.0 109.093 179.038 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.571 ' CE1' HD11 ' A' ' 77' ' ' LEU . 3.9 m-85 -90.02 -16.71 29.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.492 -0.755 . . . . 0.0 109.388 179.278 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.88 -28.83 18.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.761 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.445 ' HE3' ' OE2' ' A' ' 40' ' ' GLU . 47.6 mttt -89.4 -24.6 21.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -77.41 -59.3 2.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.552 -0.717 . . . . 0.0 109.493 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 p30 148.02 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.489 0.661 . . . . 0.0 110.828 179.419 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.57 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -91.76 -154.35 0.37 Allowed 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.381 -0.824 . . . . 0.0 109.96 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.86 63.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.491 ' CG2' ' HA ' ' A' ' 39' ' ' SER . 15.8 m -67.2 115.65 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.532 ' CG1' HG22 ' A' ' 16' ' ' THR . 0.6 OUTLIER -90.09 -39.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.223 0.535 . . . . 0.0 109.972 -179.602 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.521 ' CB ' ' OD2' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -140.78 156.31 46.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.0 110.566 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.5 ' CG2' ' C ' ' A' ' 51' ' ' ASP . 3.9 t -152.9 100.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.823 . . . . 0.0 110.017 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 2.3 ttp180 -99.69 167.44 10.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.527 ' CG2' HG11 ' A' ' 31' ' ' VAL . 12.7 p -88.25 169.7 11.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.243 -0.911 . . . . 0.0 110.475 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.521 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -128.75 115.46 2.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.46 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 1.0 OUTLIER 65.83 -150.58 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -1.064 . . . . 0.0 110.075 -179.85 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 73.5 m-20 -63.76 -55.37 23.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.944 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.421 ' HA ' HG22 ' A' ' 31' ' ' VAL . 6.7 ptt-85 -176.39 49.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 110.254 -179.918 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 16.5 mtpt -123.68 -23.93 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 110.293 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.4 OUTLIER -132.48 178.37 6.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -164.63 142.99 8.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 13.5 t80 -97.03 157.77 15.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -1.179 . . . . 0.0 109.763 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.509 ' CG2' ' C ' ' A' ' 62' ' ' TYR . 3.1 t -151.71 140.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.959 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' OD2' ' CB ' ' A' ' 51' ' ' ASP . 2.3 m-20 -108.09 140.82 40.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.473 -0.767 . . . . 0.0 109.056 178.991 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 74' ' ' ALA . 8.5 m-85 -103.94 178.34 4.59 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.284 -0.885 . . . . 0.0 110.446 -179.026 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.466 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -108.15 -9.64 15.54 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.799 -178.447 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.558 ' O ' ' OD1' ' A' ' 70' ' ' ASP . 17.3 p -168.12 -176.58 3.01 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.812 1.291 . . . . 0.0 113.061 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -83.79 -18.63 37.04 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.567 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.415 ' OE2' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -87.72 -27.09 22.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.069 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.564 ' OD2' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -82.5 -29.75 30.31 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.947 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.471 ' C ' ' CD2' ' A' ' 71' ' ' LEU . 2.0 tt -72.56 -37.65 68.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.649 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.47 -40.84 85.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.328 179.205 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 9.9 mttm -75.61 -27.33 58.45 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.289 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.582 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.03 -28.11 63.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.737 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.582 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 1.5 tm? -69.55 -46.3 66.76 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.673 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.88 -13.75 61.75 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.939 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' A' ' 80' ' ' LEU . 1.0 OUTLIER -73.12 2.6 6.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 110.396 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 99.7 m -75.1 2.66 10.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.058 -1.026 . . . . 0.0 110.592 -179.969 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.14 11.99 65.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.574 ' CD1' ' CD1' ' A' ' 77' ' ' LEU . 75.4 mt -89.55 -165.18 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.307 -1.113 . . . . 0.0 110.591 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.607 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -169.27 48.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.703 0.763 . . . . 0.0 109.867 179.796 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.552 ' C ' ' O ' ' A' ' 81' ' ' LYS . 3.9 t 6.44 -123.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.636 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.564 ' CD2' ' HG3' ' A' ' 29' ' ' LYS . 16.6 m-85 -73.03 -3.16 24.43 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.149 178.743 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 146.89 35.32 0.06 OUTLIER Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.9 t30 -158.1 101.45 1.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -1.215 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.607 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -50.44 90.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.99 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.535 ' CG2' HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -39.84 137.27 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.568 0.699 . . . . 0.0 110.211 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 28.4 ttmt -112.78 156.44 22.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.522 -0.736 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.582 ' CD1' ' CD2' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -117.01 175.12 5.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 110.643 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.505 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 2.4 tt0 -169.04 159.3 9.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.592 -0.692 . . . . 0.0 109.541 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.505 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -92.0 108.65 31.81 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 0.0 110.442 -179.78 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.2 Cg_endo -75.3 -169.12 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.001 1.527 . . . . 0.0 110.388 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tttt 46.75 -150.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . 101.03 -48.55 1.13 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.457 ' HB3' ' O ' ' A' ' 94' ' ' GLY . 16.6 ptt85 -177.82 -139.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -1.159 . . . . 0.0 110.129 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -143.42 116.85 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 110.235 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 98' ' ' THR . . . -116.62 -85.99 1.2 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.455 ' OG1' ' O ' ' A' ' 98' ' ' THR . 3.4 p 42.82 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.132 . . . . 0.0 110.265 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.64 81.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.913 . . . . 0.0 110.328 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.81 -88.28 0.06 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.121 . . . . 0.0 110.262 179.951 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -101.41 107.58 18.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -1.141 . . . . 0.0 110.195 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 3' ' ' HIS . 0.5 OUTLIER -179.31 81.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.233 -179.938 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.416 ' HG3' ' O ' ' A' ' 4' ' ' MET . 2.3 ppp? -82.01 137.8 35.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 110.164 -179.971 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.0 mt -82.03 177.99 8.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 110.19 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.69 102.7 14.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -174.98 56.7 0.17 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.204 179.936 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 7' ' ' ASP . 49.4 Cg_endo -71.45 -157.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.114 1.586 . . . . 0.0 110.118 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 6.0 p -62.67 85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.774 -0.579 . . . . 0.0 110.23 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.59 -158.16 0.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.205 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.432 ' N ' ' OE2' ' A' ' 13' ' ' GLU . . . 138.13 -11.91 3.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.925 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.509 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 5.2 p -170.1 94.22 0.24 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.236 -1.155 . . . . 0.0 110.287 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' OE2' ' N ' ' A' ' 12' ' ' SER . 3.4 mp0 -141.52 93.65 2.59 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.159 -0.963 . . . . 0.0 109.687 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.82 164.94 18.93 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 121.361 0.601 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.518 ' O ' ' CG2' ' A' ' 15' ' ' THR . 19.6 m -151.01 16.05 0.75 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.166 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.528 HG23 ' CG1' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -176.65 166.16 1.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.312 -179.876 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.429 ' HD2' HG22 ' A' ' 16' ' ' THR . 51.2 Cg_endo -79.66 -25.93 5.07 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.107 1.583 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.631 ' CZ ' ' CB ' ' A' ' 68' ' ' ALA . 79.1 m-85 -111.89 108.81 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.815 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -142.15 152.06 42.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 108.999 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.565 ' O ' ' CE1' ' A' ' 62' ' ' TYR . 3.7 pp -162.65 -176.19 4.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.791 -179.686 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.3 t80 -104.39 154.48 19.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.548 -0.72 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.593 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 6.2 mt -143.83 152.73 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.54 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -140.7 -167.11 10.94 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.869 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.9 t30 70.7 38.29 1.27 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.339 -1.095 . . . . 0.0 109.888 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.577 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.8 mm? -88.97 127.97 35.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.297 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.444 ' ND2' ' HD2' ' A' ' 29' ' ' LYS . 34.5 t-20 -39.96 100.22 0.21 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.651 -0.656 . . . . 0.0 110.528 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.9 Cg_endo -74.87 -13.14 21.79 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -87.68 -10.01 52.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG2' ' OE1' ' A' ' 33' ' ' GLU . 18.2 mttt -112.98 -159.0 0.67 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.772 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.5 m -97.2 146.0 25.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.516 HG12 ' CG2' ' A' ' 54' ' ' THR . 3.4 t -65.15 -38.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.185 179.38 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -59.6 -37.71 79.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.224 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.596 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.0 -29.86 68.97 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.527 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 7.7 mt -68.94 -31.56 70.52 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.328 -0.857 . . . . 0.0 109.437 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.533 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 9.7 mmpt? -69.13 -51.56 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.472 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.7 t -60.58 -39.53 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.566 -0.708 . . . . 0.0 109.892 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.598 ' CB ' ' CD2' ' A' ' 83' ' ' PHE . . . -62.26 -34.84 77.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 108.764 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.515 ' CD1' ' O ' ' A' ' 34' ' ' LEU . 44.7 mt -79.45 -29.79 13.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.597 -0.689 . . . . 0.0 109.193 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 22.6 t -77.81 -28.45 50.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.133 179.196 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -81.74 -39.03 24.79 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.534 0.683 . . . . 0.0 109.446 179.402 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' 37' ' ' ALA . 6.0 tp -66.08 -32.8 74.48 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.024 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 7.7 m-85 -85.52 -20.64 29.36 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.418 -0.801 . . . . 0.0 108.898 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.36 -31.66 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.514 -0.741 . . . . 0.0 109.508 179.482 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 8.9 mtpt -89.17 -23.39 22.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.639 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.503 -0.748 . . . . 0.0 109.829 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.7 t70 90.89 31.01 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.011 0.91 . . . . 0.0 108.851 -179.329 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.579 ' HG ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -77.96 -137.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.434 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.529 ' N ' HD11 ' A' ' 47' ' ' LEU . . . -171.16 58.05 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.546 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 15.6 m -66.82 113.14 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.772 0.796 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.586 ' CG2' ' CG ' ' A' ' 66' ' ' GLU . 71.3 t -91.07 -24.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 O-C-N 121.814 -0.554 . . . . 0.0 110.291 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.524 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -162.49 163.66 27.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 110.387 179.741 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.533 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.3 t -150.93 156.94 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -155.61 165.57 36.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.119 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.516 ' CG2' HG12 ' A' ' 31' ' ' VAL . 25.8 p -86.83 161.13 18.51 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -137.35 127.13 3.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 55' ' ' GLY . 6.3 m 49.77 100.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.169 . . . . 0.0 110.713 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' THR . 3.6 m-80 39.56 -98.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -141.13 30.53 1.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.007 -1.058 . . . . 0.0 110.636 -179.594 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.457 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -121.2 14.17 11.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.995 179.761 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.631 ' CE2' ' CE2' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -156.51 178.51 10.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.69 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -178.58 150.95 10.0 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.724 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.565 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 10.6 t80 -113.5 158.53 20.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.971 . . . . 0.0 109.013 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.554 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.4 t -151.09 144.36 16.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.881 -178.249 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.524 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 1.0 OUTLIER -102.75 146.56 28.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.527 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.576 ' CD1' ' OD2' ' A' ' 70' ' ' ASP . 3.7 m-85 -112.38 -172.23 2.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.937 -1.102 . . . . 0.0 111.165 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.586 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.21 -7.09 12.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.958 -179.421 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.578 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 24.1 p -176.18 175.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.58 1.181 . . . . 0.0 112.502 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.631 ' CB ' ' CZ ' ' A' ' 18' ' ' PHE . . . -76.4 -25.81 54.9 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.108 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -29.47 58.22 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.964 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.576 ' OD2' ' CD1' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -76.6 -29.7 56.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.938 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -71.78 -38.78 70.25 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.606 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.19 -38.04 87.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.514 -0.741 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.529 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 2.5 mttp -81.56 -30.51 33.03 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.505 ' N ' HD23 ' A' ' 47' ' ' LEU . . . -74.95 -25.18 58.69 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.118 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.47 ' HB2' ' O ' ' A' ' 71' ' ' LEU . 6.1 tt -73.35 -46.75 47.41 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.517 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.46 -14.81 62.25 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.875 178.218 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -71.82 -0.28 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.598 -0.689 . . . . 0.0 110.265 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.455 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 24.9 m -76.65 4.42 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.841 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.05 -8.66 86.27 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.569 ' CD2' ' N ' ' A' ' 80' ' ' LEU . 3.5 mm? -80.46 -164.89 0.77 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -1.042 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.564 ' O ' ' C ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -148.45 51.41 1.0 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.624 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.564 ' C ' ' O ' ' A' ' 81' ' ' LYS . 8.7 p 17.04 -132.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.344 -179.711 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CD2' ' CB ' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -78.6 11.47 2.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.447 -1.408 . . . . 0.0 109.666 178.579 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 143.57 36.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.6 t30 -174.07 115.76 0.21 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -1.19 . . . . 0.0 109.661 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.559 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 tt0 -52.5 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.104 -0.997 . . . . 0.0 110.346 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.532 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -44.75 143.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.802 179.668 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 9.3 mtmt -119.85 155.09 33.31 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.497 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -116.83 172.59 7.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.462 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -163.74 105.16 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.316 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.466 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 6.4 ptpt -57.78 109.61 1.91 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 0.0 110.219 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.462 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.0 Cg_endo -74.9 -175.56 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.001 1.527 . . . . 0.0 110.445 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER 42.59 37.49 1.02 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.947 . . . . 0.0 110.214 179.906 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.436 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . -144.1 -156.58 6.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.448 ' O ' ' HB3' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -156.65 159.75 38.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -1.168 . . . . 0.0 110.242 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.448 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 19.1 t70 64.08 79.8 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.94 111.41 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.2 134.11 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -1.141 . . . . 0.0 110.469 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.38 43.78 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.252 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -60.25 -157.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.261 -1.141 . . . . 0.0 110.192 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 p -116.76 119.7 36.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 0.0 110.185 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 3' ' ' HIS . 0.9 OUTLIER -128.52 28.05 5.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.216 -179.944 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.458 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 1.5 mtp -77.27 -71.3 0.42 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 110.105 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.0 mt 47.83 36.45 5.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.22 -179.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.458 ' HG2' ' O ' ' A' ' 4' ' ' MET . 11.1 pt-20 -154.64 19.4 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -96.46 118.26 65.46 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.173 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.16 79.71 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.895 1.471 . . . . 0.0 110.371 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 9' ' ' VAL . 5.6 p -118.82 45.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 121.264 0.554 . . . . 0.0 110.299 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' ' CG ' ' A' ' 10' ' ' GLU . 1.9 pt-20 -115.71 102.27 9.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' SER . . . -44.36 -64.27 2.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.567 ' O ' ' CB ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER 71.96 107.09 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.31 -1.112 . . . . 0.0 109.199 -179.571 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 12' ' ' SER . 27.7 tt0 78.6 127.41 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.525 1.155 . . . . 0.0 110.309 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.573 ' O ' ' CB ' ' A' ' 15' ' ' THR . 0.8 OUTLIER 34.15 -136.14 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.01 179.326 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.573 ' CB ' ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER 78.99 -5.47 2.0 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.632 -0.667 . . . . 0.0 109.934 -179.417 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.59 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 20.3 p -140.64 160.99 56.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.417 -0.802 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.43 -22.53 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.013 1.533 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.539 ' CE2' ' C ' ' A' ' 67' ' ' SER . 85.5 m-85 -123.36 115.38 21.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 111.159 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -138.72 150.84 46.59 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.419 HD13 ' N ' ' A' ' 21' ' ' PHE . 3.1 pp -165.22 -167.15 1.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.125 -0.984 . . . . 0.0 110.647 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.651 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 31.3 t80 -125.07 142.72 51.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.86 . . . . 0.0 110.019 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.507 ' CG2' ' N ' ' A' ' 23' ' ' GLY . 3.4 mt -119.99 170.12 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.03 -172.91 15.82 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.695 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t-20 73.26 48.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.61 -0.935 . . . . 0.0 110.177 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.579 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 3.7 mm? -93.3 123.04 36.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.74 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.429 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 22.5 t-20 -43.67 107.31 0.57 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.563 -0.711 . . . . 0.0 110.337 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.3 -27.94 15.79 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.104 1.581 . . . . 0.0 110.31 179.814 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -78.84 -17.03 56.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -106.19 -155.94 0.56 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 109.673 179.727 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 m -114.2 150.29 34.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.164 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG12 ' CG2' ' A' ' 54' ' ' THR . 2.8 t -69.38 -26.22 30.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.79 92.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.135 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.6 mm-40 -69.78 -46.17 66.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 109.148 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.526 HD22 ' CD1' ' A' ' 25' ' ' LEU . 0.7 OUTLIER -55.37 -37.3 67.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.55 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.471 ' HE2' HG21 ' A' ' 54' ' ' THR . 0.0 OUTLIER -56.85 -63.12 1.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.076 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.49 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.9 t -49.4 -35.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.528 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.49 -42.26 99.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.827 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 16.0 mm -73.11 -28.68 26.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.428 178.863 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.483 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.8 -29.44 50.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 0.0 109.044 179.351 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.46 -41.24 16.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.6 -0.687 . . . . 0.0 109.759 179.643 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -63.13 -34.91 78.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.49 -0.756 . . . . 0.0 109.187 179.177 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.634 ' CD2' ' CD1' ' A' ' 47' ' ' LEU . 8.6 m-85 -87.13 -21.15 26.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.079 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.483 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -77.19 -31.53 55.45 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.266 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -84.1 -19.46 34.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.52 -0.738 . . . . 0.0 109.138 179.25 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -87.31 -18.73 29.47 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.649 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.4 t70 87.84 29.62 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.634 ' CD1' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -76.89 -137.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.357 179.585 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.455 ' HB2' ' HB2' ' A' ' 66' ' ' GLU . . . -176.27 57.55 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.457 HG22 ' O ' ' A' ' 49' ' ' VAL . 10.5 m -55.02 117.69 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.9 0.857 . . . . 0.0 109.87 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.59 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 2.2 t -90.95 -44.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.346 -179.382 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.476 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 17.5 t70 -143.9 148.03 34.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.105 -0.997 . . . . 0.0 110.926 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.501 ' CG1' HG21 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.13 158.31 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.427 -0.796 . . . . 0.0 109.577 179.907 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 62' ' ' TYR . 3.8 mtp180 -165.75 161.43 18.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.42 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.523 ' CG2' HG12 ' A' ' 31' ' ' VAL . 9.6 p -88.02 170.8 10.79 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 110.249 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.485 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -133.95 127.02 4.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.454 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 2.0 m 60.03 -135.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -1.138 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.528 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 14.8 t-20 -102.06 90.09 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.019 -1.051 . . . . 0.0 110.594 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.47 ' HA ' HG23 ' A' ' 31' ' ' VAL . 3.2 mtt180 43.34 45.57 5.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.61 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.57 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 18.9 mttt -124.32 -28.42 3.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.028 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 2.0 m-85 -138.82 -174.44 3.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 109.369 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -162.15 136.85 4.55 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.651 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 48.3 m-85 -94.48 159.98 14.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.137 . . . . 0.0 109.577 179.253 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.521 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 24.6 t -158.63 161.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.584 -178.876 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.477 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.4 m-20 -134.64 139.72 45.51 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.62 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 55.6 m-85 -103.66 175.34 5.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.905 -179.478 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.53 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.66 16.42 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 111.388 -178.543 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 20.7 p -178.38 176.71 1.03 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.434 1.111 . . . . 0.0 112.044 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.467 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.18 -23.52 51.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.802 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.457 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.91 -27.52 43.81 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.369 179.999 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.476 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 89.6 m-20 -80.37 -29.98 37.9 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.66 -36.78 60.05 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.323 179.165 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.33 -34.37 74.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.308 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.479 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -81.0 -26.29 36.57 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.326 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.62 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -64.77 -29.88 70.87 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.675 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -78.52 -45.11 22.71 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.505 0.669 . . . . 0.0 109.246 179.12 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -23.28 66.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 110.019 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.588 HD11 ' CE2' ' A' ' 42' ' ' PHE . 20.8 mt -69.69 -5.17 23.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.465 ' OG1' HD12 ' A' ' 89' ' ' LEU . 25.9 m -67.39 -2.02 5.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.525 -0.734 . . . . 0.0 111.205 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.27 10.68 61.63 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.594 ' CD1' ' CD1' ' A' ' 41' ' ' LEU . 6.1 mt -84.8 -161.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -1.051 . . . . 0.0 111.272 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 9.6 tttm -159.66 52.4 0.35 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.345 1.069 . . . . 0.0 109.821 -179.168 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.547 ' HB ' ' CG2' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -38.45 133.26 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.737 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 1.0 OUTLIER 40.97 34.74 0.3 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.313 -179.228 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 77.68 28.42 57.17 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 m-20 -144.42 107.77 4.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.291 179.643 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.553 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 mt-10 -59.03 92.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.005 -1.059 . . . . 0.0 110.3 -179.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.547 ' CG2' ' HB ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -41.16 142.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.712 0.768 . . . . 0.0 110.505 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.448 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -121.44 125.15 46.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.516 -0.74 . . . . 0.0 109.217 179.513 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.488 HD23 ' CG1' ' A' ' 22' ' ' ILE . 1.3 mt -85.24 176.64 8.22 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.139 -0.975 . . . . 0.0 110.855 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.1 tt0 -176.42 110.68 0.09 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.701 -0.624 . . . . 0.0 109.715 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -63.97 111.15 4.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 110.314 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.0 Cg_endo -74.71 -179.31 4.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.936 1.493 . . . . 0.0 110.385 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 92' ' ' PRO . 1.5 mttp 41.07 44.5 2.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.0 110.403 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.04 -157.39 14.69 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -109.55 -86.98 0.52 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -1.135 . . . . 0.0 110.219 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 5.1 p-10 -174.17 59.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.92 158.94 31.63 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.44 ' OG1' ' N ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.8 -93.25 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -1.128 . . . . 0.0 110.416 179.988 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . 0.44 ' N ' ' OG1' ' A' ' 98' ' ' THR . 1.0 OUTLIER -78.06 167.37 21.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 110.233 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.79 -175.54 13.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 97.9 m . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.158 . . . . 0.0 110.105 -179.983 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.59 -166.74 2.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -1.18 . . . . 0.0 110.117 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -132.12 73.11 1.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.2 mtm -117.74 33.12 5.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 110.224 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.26 30.78 6.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.94 -155.31 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.54 128.94 94.21 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.191 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.55 -157.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.973 1.512 . . . . 0.0 110.166 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.41 ' O ' ' C ' ' A' ' 10' ' ' GLU . 7.1 p -152.5 133.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 O-C-N 121.814 -0.554 . . . . 0.0 110.118 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' SER . 2.3 tt0 -43.16 134.53 3.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.14 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.73 61.5 0.32 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 10' ' ' GLU . 57.9 m -108.41 -6.11 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -1.161 . . . . 0.0 110.135 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -144.55 95.14 2.66 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.216 -0.927 . . . . 0.0 109.799 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.34 172.06 0.51 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.265 0.555 . . . . 0.0 110.136 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.454 ' O ' HG21 ' A' ' 16' ' ' THR . 3.8 m -87.83 -9.23 54.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.53 HG23 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -172.45 165.02 3.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.551 -179.876 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.431 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.5 Cg_endo -77.0 -40.49 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.175 1.619 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 95.5 m-85 -100.03 108.98 21.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.664 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.479 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 2.8 m120 -138.41 153.28 48.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.436 -0.79 . . . . 0.0 109.524 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.574 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 2.5 pt? -165.3 174.6 9.98 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 110.267 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -109.17 159.17 17.12 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.679 -0.638 . . . . 0.0 109.921 -179.662 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 4.5 mt -142.61 149.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.403 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.578 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -132.1 -172.74 13.13 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.565 -1.303 . . . . 0.0 110.027 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.509 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 32.3 t30 72.1 49.88 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.527 -0.984 . . . . 0.0 109.858 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.588 ' CD2' ' N ' ' A' ' 25' ' ' LEU . 3.9 mm? -95.46 123.54 39.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 110.082 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.418 ' C ' ' O ' ' A' ' 25' ' ' LEU . 30.5 t-20 -42.47 101.78 0.25 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 110.287 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.3 Cg_endo -74.52 -16.68 21.4 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.973 1.512 . . . . 0.0 110.338 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.48 -15.97 59.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.032 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 -155.66 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.527 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 3.5 m -100.18 149.87 23.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.521 HG12 ' CG2' ' A' ' 54' ' ' THR . 3.5 t -66.61 -45.87 87.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.817 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.54 83.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.527 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 80.6 mm-40 -58.84 -35.86 73.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.79 . . . . 0.0 109.278 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.532 HD22 ' CA ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -65.68 -31.3 72.24 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.176 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.481 ' HE2' ' N ' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -66.76 -50.84 61.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.538 -0.727 . . . . 0.0 109.335 179.228 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 22.0 t -59.66 -39.19 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.474 -0.766 . . . . 0.0 109.937 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.45 -33.45 73.76 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.135 -0.978 . . . . 0.0 108.682 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.509 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.5 mt -81.04 -30.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 46.4 t -77.22 -26.4 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.063 179.299 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -82.87 -43.26 16.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.707 0.765 . . . . 0.0 109.247 179.302 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 80' ' ' LEU . 1.1 tp -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.153 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.561 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 8.9 m-85 -83.71 -22.13 32.11 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.661 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB2' ' HA ' ' A' ' 40' ' ' GLU . . . -78.57 -32.04 47.54 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.621 0.725 . . . . 0.0 109.286 179.518 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.452 ' HE2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.73 -14.89 33.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.423 -0.798 . . . . 0.0 109.328 179.188 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.02 -18.09 28.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.656 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.1 t0 89.52 29.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.004 0.907 . . . . 0.0 108.765 -179.234 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.561 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.25 -137.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.517 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . 178.94 58.26 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.14 -0.975 . . . . 0.0 109.517 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . . . . . . . . . 13.0 m -60.17 116.04 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.987 0.899 . . . . 0.0 110.148 -179.783 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.548 ' CG2' ' HB3' ' A' ' 66' ' ' GLU . 17.1 t -81.44 -36.19 14.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.894 -0.504 . . . . 0.0 110.561 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.477 ' CB ' ' OD2' ' A' ' 64' ' ' ASP . 0.3 OUTLIER -149.98 154.39 38.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 110.673 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.501 ' HA ' HG23 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -133.51 173.14 15.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.732 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 170.12 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.939 . . . . 0.0 110.47 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.521 ' CG2' HG12 ' A' ' 31' ' ' VAL . 28.5 p -100.7 164.74 11.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.225 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.567 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -134.53 136.6 8.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.454 ' OG1' ' HB2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 63.47 -138.51 0.35 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -1.114 . . . . 0.0 110.293 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.0 m-20 -111.82 99.98 8.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 110.529 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 3.2 ptt85 38.37 27.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 111.02 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.3 ttpt -129.51 -5.33 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 0.3 OUTLIER -138.58 -168.39 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.456 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -173.26 179.4 44.7 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.524 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.579 ' CE1' ' OD1' ' A' ' 64' ' ' ASP . 12.3 t80 -154.88 156.43 36.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.568 -0.96 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 25.5 t -158.66 164.28 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.009 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.579 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 7.9 m-20 -130.08 140.16 50.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.554 -0.716 . . . . 0.0 109.47 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.602 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 22.3 m-85 -103.09 179.56 4.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.286 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.548 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 10.9 pt-20 -113.11 2.54 15.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 110.954 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 56.8 p -165.44 177.68 7.31 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.585 1.183 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.5 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -78.27 -24.05 46.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.767 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.509 ' OE1' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -76.52 -26.85 55.67 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.562 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.543 ' OD2' ' CG ' ' A' ' 66' ' ' GLU . 77.6 m-20 -86.02 -27.37 24.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.308 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -77.13 -35.47 56.2 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.659 179.288 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.93 -32.43 40.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.528 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.4 OUTLIER -80.85 -25.1 37.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.708 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.602 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.65 -26.74 45.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.998 178.936 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 6.9 tt -72.97 -46.05 54.51 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.735 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.39 -19.22 61.65 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.528 ' CD2' ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -62.6 -11.06 14.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.761 -0.587 . . . . 0.0 109.949 179.569 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.461 ' O ' ' HG3' ' A' ' 86' ' ' GLU . 18.7 m -39.23 -28.53 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.806 0.812 . . . . 0.0 110.966 -179.463 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.62 -20.55 12.25 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.431 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.555 ' CB ' ' CD2' ' A' ' 41' ' ' LEU . 1.5 pp -48.04 -178.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.441 -1.035 . . . . 0.0 111.82 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.556 ' O ' ' C ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -167.7 51.41 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.556 ' C ' ' O ' ' A' ' 81' ' ' LYS . 11.0 p 5.73 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.091 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.477 ' H ' ' CG1' ' A' ' 82' ' ' VAL . 3.4 m-85 -81.58 13.79 2.91 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.437 -1.414 . . . . 0.0 108.985 178.447 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 133.73 34.77 0.29 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.774 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.527 ' O ' ' N ' ' A' ' 87' ' ' ILE . 24.8 m-80 -158.86 103.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -1.022 . . . . 0.0 109.224 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.553 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 3.5 tt0 -49.91 90.52 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 110.371 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.531 ' CG1' HD11 ' A' ' 80' ' ' LEU . 16.7 pt -49.45 138.73 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.474 -0.766 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.491 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.21 175.19 6.37 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.522 ' CD2' ' CD1' ' A' ' 20' ' ' LEU . 7.1 mp -121.45 -176.66 3.35 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.372 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.72 96.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.648 -0.658 . . . . 0.0 110.184 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.33 115.49 12.53 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.918 . . . . 0.0 110.152 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 20' ' ' LEU . 46.4 Cg_endo -72.94 -174.15 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.943 1.497 . . . . 0.0 110.441 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER 50.58 73.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 179.998 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.15 72.76 0.05 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -128.18 73.75 1.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -1.124 . . . . 0.0 110.252 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -68.29 169.14 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 98' ' ' THR . . . 98.3 -18.62 56.79 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.6 p 42.44 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -1.11 . . . . 0.0 110.327 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -79.32 52.54 1.36 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.25 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.91 -40.59 5.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.183 -1.186 . . . . 0.0 110.236 -179.995 . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 031 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 p -156.18 77.65 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -1.159 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.87 55.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.95 59.95 1.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.178 -179.983 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 mt -55.64 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.76 85.37 3.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 110.209 179.965 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -150.71 75.92 8.32 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.88 . . . . 0.0 110.256 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.74 80.5 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.022 1.538 . . . . 0.0 110.421 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.457 ' O ' ' O ' ' A' ' 10' ' ' GLU . 11.8 p -136.8 124.18 31.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 121.78 -0.575 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -57.95 -154.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.862 . . . . 0.0 110.212 179.903 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.07 73.14 0.11 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.987 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 13' ' ' GLU . 20.8 m -76.2 -91.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -1.147 . . . . 0.0 110.029 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 12' ' ' SER . 4.7 mt-10 38.0 97.92 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.992 0.901 . . . . 0.0 110.883 179.463 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -38.21 146.48 0.06 Allowed 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.242 179.728 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.527 ' O ' ' CG2' ' A' ' 16' ' ' THR . 30.2 m -89.37 -12.14 41.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 110.666 -179.557 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.527 ' CG2' ' O ' ' A' ' 15' ' ' THR . 24.8 p -158.93 153.36 20.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.586 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.94 -30.36 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.262 1.664 . . . . 0.0 110.339 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.586 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 96.4 m-85 -92.75 106.07 18.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.358 -179.799 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 4.8 m120 -139.52 152.69 47.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.604 ' N ' ' CZ ' ' A' ' 62' ' ' TYR . 1.6 pt? -165.33 164.73 19.78 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.514 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -91.08 160.75 15.43 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.379 -179.967 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.581 ' O ' ' CD2' ' A' ' 60' ' ' PHE . 5.4 mt -150.03 146.93 16.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.951 -179.669 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.539 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -129.91 -171.47 12.94 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 26.2 t30 73.08 35.27 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.501 -0.999 . . . . 0.0 110.561 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.524 HD13 ' CD2' ' A' ' 34' ' ' LEU . 4.1 mm? -84.13 128.21 34.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.964 . . . . 0.0 109.824 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.414 ' C ' ' O ' ' A' ' 25' ' ' LEU . 57.6 t-20 -39.8 102.89 0.27 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.663 -0.648 . . . . 0.0 110.61 -179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.02 7.0 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.045 1.55 . . . . 0.0 110.733 -179.729 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -106.07 -14.63 15.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.304 179.593 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -111.23 -156.3 0.58 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.624 -0.673 . . . . 0.0 109.629 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 2.3 m -105.49 148.53 27.11 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.735 179.283 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 54' ' ' THR . 2.8 t -63.97 -15.6 17.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.46 ' O ' HG21 ' A' ' 36' ' ' VAL . . . -75.34 -38.38 60.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.432 -0.792 . . . . 0.0 109.05 178.828 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.55 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 3.8 mt-10 -72.13 -28.02 62.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.502 -0.749 . . . . 0.0 109.046 178.955 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.53 ' CD2' HG11 ' A' ' 82' ' ' VAL . 4.8 mt -70.79 -43.11 69.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HB3' ' CG1' ' A' ' 52' ' ' VAL . 53.1 mttt -60.65 -43.81 97.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.66 -0.65 . . . . 0.0 110.018 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.469 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 8.5 t -63.67 -41.1 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.869 179.583 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.05 -38.16 90.09 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.635 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.638 ' CG2' ' CE2' ' A' ' 42' ' ' PHE . 17.6 mm -77.7 -28.87 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.234 178.973 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.465 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 14.9 t -76.96 -30.23 55.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.951 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.9 tm-20 -81.27 -45.92 15.53 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.567 0.699 . . . . 0.0 109.585 179.42 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.566 ' HG ' ' CD1' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -56.76 -39.97 74.99 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.302 179.402 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.638 ' CE2' ' CG2' ' A' ' 38' ' ' ILE . 16.2 m-30 -78.43 -25.16 45.92 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.755 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB1' ' O ' ' A' ' 39' ' ' SER . . . -79.71 -33.12 41.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.465 ' HG3' ' OE2' ' A' ' 40' ' ' GLU . 2.8 mttt -88.43 -13.07 41.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.534 -0.729 . . . . 0.0 109.432 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -92.36 -14.48 28.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.659 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.603 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.9 t0 86.38 28.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.936 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.578 HD21 ' CG ' ' A' ' 42' ' ' PHE . 2.5 tp -76.97 -136.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.401 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.54 ' CB ' ' HB2' ' A' ' 70' ' ' ASP . . . -165.35 46.09 0.08 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.093 0.949 . . . . 0.0 108.67 178.923 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.414 HG22 ' N ' ' A' ' 50' ' ' VAL . 0.5 OUTLIER -55.29 150.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 122.241 1.02 . . . . 0.0 109.447 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.549 ' CG2' ' CG ' ' A' ' 66' ' ' GLU . 2.5 t -136.18 -34.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.356 -178.984 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 1.9 m-20 -152.61 -179.91 8.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 111.034 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.537 ' CG1' ' HB3' ' A' ' 35' ' ' LYS . 14.6 p 179.84 113.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.764 -0.585 . . . . 0.0 109.8 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 172.18 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.698 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.586 ' CG2' ' CG1' ' A' ' 31' ' ' VAL . 18.9 p -82.34 162.4 22.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -134.21 122.58 3.01 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.734 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.469 ' O ' ' O ' ' A' ' 55' ' ' GLY . 28.8 m 38.95 96.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.392 -1.064 . . . . 0.0 111.119 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.464 ' HB2' ' O ' ' A' ' 56' ' ' THR . 9.5 m120 64.13 -146.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.896 . . . . 0.0 110.622 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.405 ' HA ' HG23 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -112.91 31.71 6.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.572 -179.714 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.437 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 12.0 tttm -115.54 -20.25 10.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 110.07 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.581 ' CD2' ' O ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -115.52 -170.16 1.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.687 179.73 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 169.62 154.57 9.31 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.711 -179.876 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 21.6 t80 -115.13 163.04 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.555 -0.968 . . . . 0.0 109.514 179.537 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.618 ' N ' ' CD1' ' A' ' 62' ' ' TYR . 3.4 t -148.88 148.22 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.019 -178.601 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.475 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -119.71 142.71 48.26 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.425 -0.797 . . . . 0.0 109.993 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.639 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.0 m-85 -110.91 178.97 4.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.753 . . . . 0.0 109.718 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.549 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -123.99 15.73 9.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.0 110.865 -179.124 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.547 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -165.81 174.94 9.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.835 1.302 . . . . 0.0 112.505 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.577 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -87.44 -25.73 23.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.484 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.459 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -83.72 -22.83 31.87 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.783 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.54 ' HB2' ' CB ' ' A' ' 48' ' ' ALA . 4.8 t0 -81.45 -33.91 31.76 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.809 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.458 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 48.5 tp -69.41 -39.4 77.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.04 -32.86 72.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.409 -0.807 . . . . 0.0 109.398 179.195 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.531 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 38.0 mttm -80.79 -24.21 38.73 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.22 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.639 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.34 -29.81 69.47 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.488 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.532 ' CD2' ' CD1' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -77.59 -45.44 25.19 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.152 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -17.43 64.48 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.451 -0.781 . . . . 0.0 109.676 179.46 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.569 HD13 ' CD1' ' A' ' 42' ' ' PHE . 11.7 mt -67.43 -7.02 21.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.405 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 91.2 m -49.68 -15.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.432 -0.792 . . . . 0.0 111.217 -179.956 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.31 18.19 19.53 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.487 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.566 ' CD1' ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -97.28 179.08 5.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -1.21 . . . . 0.0 109.146 179.843 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.572 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.1 OUTLIER -162.22 53.62 0.22 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 109.752 179.942 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.56 ' C ' ' O ' ' A' ' 81' ' ' LYS . 3.5 t 8.5 -125.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.55 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.0 m-30 -75.04 -2.11 25.87 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.001 -1.062 . . . . 0.0 108.82 178.719 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 149.51 35.0 0.04 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' ILE . 58.1 m-20 -158.94 104.16 1.72 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.11 -1.229 . . . . 0.0 110.041 179.958 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.572 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -54.03 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 -179.616 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.535 ' CG2' HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -40.43 147.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.577 0.703 . . . . 0.0 110.186 179.722 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.516 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.6 mmmt -116.31 152.94 32.84 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.643 -0.661 . . . . 0.0 109.503 179.763 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.532 ' CD1' ' CD2' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -115.82 173.91 6.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.852 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -165.36 145.25 6.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.832 . . . . 0.0 110.213 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -76.29 115.23 45.35 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.2 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.461 ' HD2' ' HG3' ' A' ' 95' ' ' ARG . 46.2 Cg_endo -73.15 -173.17 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.906 1.477 . . . . 0.0 110.398 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.31 121.33 22.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 110.252 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.29 32.73 5.67 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.461 ' HG3' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -119.0 133.29 55.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -1.093 . . . . 0.0 110.233 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -118.45 -156.44 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 0.0 110.266 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.22 97.73 0.48 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.421 ' O ' ' OG1' ' A' ' 98' ' ' THR . 2.8 p -97.05 106.76 19.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.19 -1.182 . . . . 0.0 110.287 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -140.83 -155.66 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 -179.92 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.54 153.26 19.9 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.231 -1.159 . . . . 0.0 110.216 179.931 . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 032 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -117.31 41.05 2.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -1.121 . . . . 0.0 110.203 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 -81.78 0.46 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 8.4 ptm -134.12 -166.82 1.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.883 . . . . 0.0 110.208 -179.95 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.443 ' O ' ' CB ' ' A' ' 6' ' ' GLU . 1.0 OUTLIER 63.04 -153.67 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 -179.985 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' LEU . 3.1 tt0 64.97 47.03 2.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.88 144.74 98.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.172 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.08 79.92 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.995 1.524 . . . . 0.0 110.4 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.32 93.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.305 0.574 . . . . 0.0 110.223 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -99.71 -168.97 1.68 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.215 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.07 -14.72 11.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.4 m -101.95 49.61 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -1.129 . . . . 0.0 110.168 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -91.54 27.73 1.92 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 110.21 -179.881 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.93 173.79 0.41 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.223 0.535 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.475 ' CG2' ' OD1' ' A' ' 51' ' ' ASP . 5.0 t -121.41 -24.18 5.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.265 -179.923 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.583 ' CG2' ' CG1' ' A' ' 50' ' ' VAL . 73.0 p -137.27 159.54 69.21 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.509 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.3 Cg_endo -76.51 -15.98 17.23 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.06 1.558 . . . . 0.0 110.896 -179.576 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.585 ' CE1' ' HA ' ' A' ' 68' ' ' ALA . 92.1 m-85 -115.62 122.94 47.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 97.9 m-20 -139.43 170.21 16.35 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.644 -0.66 . . . . 0.0 109.271 179.603 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.656 ' N ' ' CD1' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -169.25 163.55 10.87 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.29 -0.882 . . . . 0.0 110.47 -179.775 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.593 ' CB ' ' O ' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -97.72 177.25 5.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.683 -0.636 . . . . 0.0 111.366 -177.72 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 21' ' ' PHE . 15.2 mt -157.28 133.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.98 166.61 23.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 35.8 t30 72.48 81.02 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.505 -0.997 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.523 ' N ' ' CD2' ' A' ' 25' ' ' LEU . 4.2 mm? -119.92 128.79 53.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.531 ' CB ' HD21 ' A' ' 34' ' ' LEU . 31.1 t-20 -41.25 101.89 0.25 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.556 -0.715 . . . . 0.0 110.429 -179.883 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.464 ' HA ' ' HD3' ' A' ' 58' ' ' ARG . 45.8 Cg_endo -72.48 -23.7 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.036 1.545 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 1.7 m-20 -78.46 -16.16 57.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 110.048 179.866 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.2 mmtt -107.86 -155.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.3 m -102.97 145.03 30.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.523 HG11 ' CG2' ' A' ' 54' ' ' THR . 2.6 t -68.18 -42.5 84.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.431 179.43 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -56.44 -36.08 68.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.185 179.063 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 25.8 mm-40 -64.72 -43.54 93.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.0 109.092 179.109 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.531 HD21 ' CB ' ' A' ' 26' ' ' ASN . 18.6 mt -59.72 -38.88 82.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.365 -0.835 . . . . 0.0 108.802 179.033 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 9.8 mmpt? -59.98 -54.22 48.63 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.537 0.684 . . . . 0.0 109.366 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 18.3 t -54.21 -35.49 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 109.675 179.258 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.77 -32.3 73.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.169 -0.957 . . . . 0.0 108.798 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.545 ' O ' ' CD2' ' A' ' 42' ' ' PHE . 14.1 mt -82.53 -28.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.853 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -78.75 -28.78 44.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 0.0 109.072 179.164 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.479 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.83 -41.12 23.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 109.162 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 80' ' ' LEU . 1.1 tp -63.45 -34.42 77.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.919 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.604 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m-85 -79.9 -23.99 41.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.782 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.69 62.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 109.499 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -89.14 -17.97 28.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 179.465 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -87.85 -14.68 38.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 179.822 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.602 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.1 t70 83.96 30.91 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.916 0.865 . . . . 0.0 108.784 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.604 ' HG ' ' CD1' ' A' ' 42' ' ' PHE . 0.0 OUTLIER -74.82 -129.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.464 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.465 ' CB ' ' OD2' ' A' ' 70' ' ' ASP . . . 173.34 54.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.196 -0.94 . . . . 0.0 109.066 179.642 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.401 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 10.7 m -57.43 116.88 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.111 0.958 . . . . 0.0 110.392 -179.616 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.583 ' CG1' ' CG2' ' A' ' 16' ' ' THR . 2.1 t -91.54 -39.14 11.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.475 ' OD1' ' CG2' ' A' ' 15' ' ' THR . 4.0 m-20 -152.65 125.35 8.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.162 -0.961 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.481 ' HA ' HG23 ' A' ' 63' ' ' VAL . 3.2 m -115.09 153.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.256 -0.903 . . . . 0.0 110.001 179.526 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.44 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 1.4 tpt180 -148.98 168.78 22.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.431 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.523 ' CG2' HG11 ' A' ' 31' ' ' VAL . 75.6 p -99.51 159.61 14.9 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.55 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.28 115.74 4.19 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.902 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 58.66 -154.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 179.953 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 81.5 m-20 -60.55 -51.94 67.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.09 179.966 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.515 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 2.1 ptp180 -177.3 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.523 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -125.12 -21.58 4.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.9 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.523 ' CE1' ' HB3' ' A' ' 59' ' ' LYS . 0.5 OUTLIER -140.69 -154.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.105 -0.997 . . . . 0.0 109.995 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.55 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 172.23 175.61 40.45 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.538 ' CD1' ' O ' ' A' ' 20' ' ' LEU . 25.7 t80 -143.9 168.4 20.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.493 -1.004 . . . . 0.0 109.732 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 13.7 t -160.01 163.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.491 -178.89 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.471 ' HA ' ' HA ' ' A' ' 19' ' ' ASN . 1.3 m-20 -130.92 136.77 48.89 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.417 -0.802 . . . . 0.0 109.16 179.53 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.657 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 19.0 m-85 -103.24 176.81 5.03 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.495 0.664 . . . . 0.0 111.168 -179.247 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.533 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -115.26 17.1 16.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 111.247 -178.813 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.563 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 35.5 p 179.38 178.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.465 1.126 . . . . 0.0 112.338 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.585 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.95 -23.43 48.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.811 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -25.96 43.51 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.248 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.559 ' CA ' HD11 ' A' ' 47' ' ' LEU . 87.1 m-20 -83.42 -29.02 28.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.314 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.58 -29.42 36.98 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.821 179.655 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.464 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 3.6 mt-10 -79.89 -36.59 36.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.773 . . . . 0.0 110.36 -179.942 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.519 ' O ' ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -78.31 -29.58 47.82 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.91 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.657 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.0 -27.88 62.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.723 -0.791 . . . . 0.0 108.963 178.895 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.73 -43.35 69.08 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.542 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -13.54 60.73 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.083 178.472 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.581 ' HG ' ' CE1' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -72.73 5.03 3.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.604 -0.685 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.528 ' HA ' ' CD2' ' A' ' 89' ' ' LEU . 8.3 m -66.31 -5.64 11.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.94 -1.1 . . . . 0.0 110.56 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.06 32.26 4.98 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 179.131 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.589 ' CD2' ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -114.78 132.56 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.127 -179.732 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.546 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 1.5 mtmt -104.94 78.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.554 1.169 . . . . 0.0 109.976 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.574 ' CG2' ' CG2' ' A' ' 87' ' ' ILE . 47.8 t -48.45 132.38 5.98 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.754 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.0 m-85 40.82 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.422 -0.799 . . . . 0.0 110.869 -179.757 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 86.72 28.78 25.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.561 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 87' ' ' ILE . 88.1 m-20 -143.12 91.77 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -1.175 . . . . 0.0 110.282 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 19.1 tt0 -42.27 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.171 179.821 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.574 ' CG2' ' CG2' ' A' ' 82' ' ' VAL . 2.2 pp -68.74 125.89 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 110.696 -179.806 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.8 mttt -83.85 118.49 23.99 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.645 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.568 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -106.06 -171.19 1.85 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.988 -178.258 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 21' ' ' PHE . 3.4 mt-10 78.51 177.73 0.14 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.385 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.595 ' N ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 67.95 43.89 0.29 Allowed Pre-proline 0 N--CA 1.493 1.691 0 CA-C-O 121.294 0.569 . . . . 0.0 112.02 178.771 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.601 ' CG ' ' HA ' ' A' ' 20' ' ' LEU . 49.7 Cg_endo -68.78 -162.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.608 1.32 . . . . 0.0 110.425 178.421 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER 172.21 -60.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.603 -0.686 . . . . 0.0 109.671 179.809 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' LYS . . . 43.13 26.41 0.52 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.831 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 93' ' ' LYS . 72.7 ttt180 -146.67 120.67 9.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -1.098 . . . . 0.0 110.436 -179.577 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 42.39 -156.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.313 179.868 . . . . . . . . 3 3 . 1 . 032 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -135.65 -98.03 0.54 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 97' ' ' GLY . 2.5 p 42.44 -147.87 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -1.146 . . . . 0.0 110.261 179.876 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.06 39.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.36 -0.837 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 032 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.73 125.53 1.27 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.315 -1.109 . . . . 0.0 110.205 179.982 . . . . . . . . 0 0 . 1 . 033 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 1.1 p 179.73 -179.55 0.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -1.149 . . . . 0.0 110.19 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.549 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 51.3 p-80 -175.53 107.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 46.9 -157.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 110.201 179.896 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -165.93 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.0 -87.09 0.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 110.203 180.0 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -155.53 113.16 2.23 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.084 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.41 -157.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.945 1.497 . . . . 0.0 110.053 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 10' ' ' GLU . 3.8 p -151.96 112.79 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 121.248 0.547 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 12' ' ' SER . 3.8 mt-10 53.34 179.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 110.168 -179.937 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.3 83.86 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 10' ' ' GLU . 60.5 p -158.37 93.7 1.23 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -1.127 . . . . 0.0 110.248 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -120.84 -128.8 0.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.232 -0.917 . . . . 0.0 109.495 179.994 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -41.42 132.44 2.71 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.238 0.542 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 16' ' ' THR . 20.7 m -81.0 -11.62 59.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 110.33 -179.76 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.528 HG21 ' CG1' ' A' ' 50' ' ' VAL . 14.0 p -151.25 164.23 20.95 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.8 Cg_endo -75.17 -34.49 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.052 1.554 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.549 ' CE2' ' C ' ' A' ' 67' ' ' SER . 97.4 m-85 -100.64 102.39 13.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.067 -1.021 . . . . 0.0 110.489 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.0 m120 -137.99 153.2 49.43 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.321 -0.862 . . . . 0.0 109.527 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.504 ' CD2' HD23 ' A' ' 89' ' ' LEU . 4.6 pp -163.57 -171.78 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.5 t80 -116.54 151.22 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.516 ' HA ' ' HA ' ' A' ' 89' ' ' LEU . 2.8 mt -131.27 159.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.902 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -142.49 -176.24 16.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.628 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 47.8 t30 71.34 49.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 110.215 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.517 ' CB ' HD21 ' A' ' 34' ' ' LEU . 10.8 mp -97.26 132.94 42.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.415 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 39.1 t-20 -41.41 102.06 0.26 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.609 -0.682 . . . . 0.0 110.287 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.9 Cg_endo -77.06 8.06 3.37 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.046 1.55 . . . . 0.0 110.852 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -111.81 -17.67 12.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.986 -1.071 . . . . 0.0 108.948 179.55 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.415 ' HB2' ' CG ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.72 -155.52 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.731 -0.605 . . . . 0.0 109.513 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.524 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -100.54 142.09 32.5 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.597 179.109 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.568 ' CG2' ' CB ' ' A' ' 58' ' ' ARG . 3.0 t -63.46 -42.88 97.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.114 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . 0.446 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.49 -37.26 72.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 178.959 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.524 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 16.0 mm-40 -67.15 -30.22 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.62 179.529 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.517 HD21 ' CB ' ' A' ' 25' ' ' LEU . 3.0 mt -67.56 -38.4 84.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.594 ' CG ' ' CG2' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -65.3 -47.31 77.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.839 . . . . 0.0 109.943 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.513 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 7.3 t -65.09 -34.57 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.131 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.53 -43.98 92.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.298 -0.876 . . . . 0.0 109.068 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.58 HG22 ' CE2' ' A' ' 42' ' ' PHE . 19.5 mm -76.96 -27.95 16.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.929 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.543 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -73.82 -32.75 63.87 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.437 -0.79 . . . . 0.0 109.395 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.9 tt0 -85.24 -43.11 14.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 110.009 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.549 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 3.7 tt -55.67 -40.8 72.78 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.569 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.58 ' CE2' HG22 ' A' ' 38' ' ' ILE . 11.6 m-30 -87.06 -23.62 24.88 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.447 179.542 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 39' ' ' SER . . . -75.93 -18.32 59.4 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -102.28 -39.27 7.28 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.588 179.632 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.615 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -51.03 -43.17 60.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.619 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 13.1 m-20 143.22 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.561 0.744 . . . . 0.0 110.151 179.587 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.525 ' CD1' ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -112.0 -152.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 110.624 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 49' ' ' VAL . . . -164.31 55.83 0.15 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.674 0.749 . . . . 0.0 109.153 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 42' ' ' PHE . 0.9 OUTLIER -41.11 118.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.045 0.926 . . . . 0.0 110.151 -179.794 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.53 HG21 ' CG ' ' A' ' 66' ' ' GLU . 2.8 t -84.24 -44.11 17.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.283 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.466 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 5.4 t70 -147.72 160.73 42.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.873 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.594 ' CG2' ' CG ' ' A' ' 35' ' ' LYS . 7.6 p -150.96 111.15 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 2.2 mpp_? -99.71 165.53 11.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.966 . . . . 0.0 110.261 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.472 HG23 ' HD3' ' A' ' 35' ' ' LYS . 69.0 p -87.96 163.73 16.18 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.644 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -119.19 105.57 1.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.473 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.2 m 67.57 -134.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -1.145 . . . . 0.0 110.016 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.461 ' O ' ' HB3' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -80.47 -48.58 12.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 110.482 -179.832 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.568 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -177.76 37.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 110.444 -179.877 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.466 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 21.5 mttt -113.93 -24.33 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.52 ' O ' ' N ' ' A' ' 55' ' ' GLY . 1.2 m-85 -137.57 -174.99 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.489 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.04 154.01 18.37 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.898 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.7 m-85 -107.84 167.23 10.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.188 -1.183 . . . . 0.0 110.031 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 50.2 t -157.25 155.44 5.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.939 -178.99 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.466 ' OD2' ' HB3' ' A' ' 51' ' ' ASP . 8.6 m-20 -125.22 139.5 53.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.703 -0.623 . . . . 0.0 109.498 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.651 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 17.7 m-85 -103.83 176.61 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.407 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.53 ' CG ' HG21 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -113.98 14.65 18.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 111.479 -178.395 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.9 p 176.94 178.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.371 1.081 . . . . 0.0 112.089 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.47 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.5 -22.71 54.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.553 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -25.47 37.06 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.521 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' O ' ' CB ' ' A' ' 74' ' ' ALA . 88.6 m-20 -82.79 -28.16 30.47 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.164 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.495 ' C ' ' CD1' ' A' ' 71' ' ' LEU . 3.0 tm? -79.13 -33.7 43.97 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.566 179.389 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 1.4 tp10 -73.46 -39.22 65.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.805 . . . . 0.0 109.733 179.606 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.525 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 0.0 OUTLIER -80.19 -18.04 50.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.524 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.651 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.47 -28.13 46.46 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.178 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.458 ' O ' ' OG1' ' A' ' 78' ' ' THR . 7.2 tt -79.69 -44.19 21.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -27.8 67.26 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.269 -0.894 . . . . 0.0 109.096 178.9 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.542 ' O ' ' CD2' ' A' ' 80' ' ' LEU . 15.4 mt -68.8 -7.97 39.08 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.536 0.684 . . . . 0.0 109.826 179.394 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.458 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 87.7 m -57.01 -9.14 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.658 -0.651 . . . . 0.0 111.506 -179.667 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.98 26.97 5.7 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.283 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.542 ' CD2' ' O ' ' A' ' 77' ' ' LEU . 0.6 OUTLIER -94.14 -161.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.218 -1.166 . . . . 0.0 110.695 -179.762 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.604 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -164.1 48.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.56 0.695 . . . . 0.0 109.817 179.643 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.555 ' C ' ' O ' ' A' ' 81' ' ' LYS . 7.9 p 8.49 -126.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.203 179.708 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 2.8 m-85 -72.44 -1.75 16.9 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.408 -1.432 . . . . 0.0 109.508 179.14 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 147.89 36.42 0.05 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.537 ' O ' ' N ' ' A' ' 87' ' ' ILE . 15.3 m-20 -163.4 108.02 1.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -1.156 . . . . 0.0 109.418 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.604 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -51.27 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.61 -178.837 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 85' ' ' ASN . 2.3 pp -46.38 144.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.651 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.481 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 8.1 mtmt -112.03 169.78 8.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.56 -0.712 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.516 ' HA ' ' HA ' ' A' ' 22' ' ' ILE . 7.7 mp -113.31 -177.56 3.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.302 -0.874 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -174.64 -174.67 0.85 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 110.243 179.974 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -116.29 106.12 49.5 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.226 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 45.5 Cg_endo -73.41 -170.44 0.66 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.997 1.525 . . . . 0.0 110.43 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.4 OUTLIER 67.66 94.14 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 -179.89 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 138.79 -56.12 0.65 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.446 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -102.52 113.4 26.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -1.132 . . . . 0.0 110.239 -179.983 . . . . . . . . 3 3 . 1 . 033 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.5 134.17 48.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.194 179.94 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.52 162.03 25.76 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.92 135.79 34.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.321 -1.105 . . . . 0.0 110.366 -179.987 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.1 46.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.12 -125.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.992 . . . . . . . . 1 1 . 1 . 033 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.222 -1.164 . . . . 0.0 110.195 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 034 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.481 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 0.1 OUTLIER -112.5 -16.54 12.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -1.136 . . . . 0.0 110.183 179.981 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 2' ' ' SER . 98.9 m-70 -153.65 175.39 13.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.26 39.48 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.275 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.81 153.43 49.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 57.63 24.1 10.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 179.973 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.68 146.69 32.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.4 -157.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.077 1.567 . . . . 0.0 110.099 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.522 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 77.6 t 50.41 51.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.223 0.535 . . . . 0.0 110.147 179.965 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.88 121.54 14.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.293 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.03 46.45 2.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.927 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.514 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -70.31 -6.07 32.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.334 -1.098 . . . . 0.0 110.156 179.985 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.514 ' HB2' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER 170.12 125.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.451 1.119 . . . . 0.0 109.276 179.593 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.73 178.04 0.66 Allowed 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.135 179.981 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.434 HG23 HG23 ' A' ' 16' ' ' THR . 1.8 t -109.59 -17.46 13.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 110.11 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.547 HG22 ' CB ' ' A' ' 50' ' ' VAL . 17.6 p -138.6 158.08 70.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.689 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.7 Cg_endo -75.71 -29.07 7.51 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.136 1.598 . . . . 0.0 110.559 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CE2' ' O ' ' A' ' 67' ' ' SER . 88.0 m-85 -106.35 101.89 11.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.774 -179.55 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.516 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.7 m120 -134.71 150.9 50.66 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.131 179.413 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.458 HD13 ' O ' ' A' ' 21' ' ' PHE . 4.3 pp -172.93 -175.69 1.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.861 -179.85 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.552 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 3.2 t80 -110.29 154.65 23.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.024 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.537 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mt -140.15 153.55 22.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -121.04 -177.03 15.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.9 t30 70.46 71.41 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.297 -1.12 . . . . 0.0 110.012 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.478 ' HA ' HD23 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -114.1 27.43 9.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.307 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.501 ' ND2' ' ND2' ' A' ' 85' ' ' ASN . 0.7 OUTLIER 53.13 98.04 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 110.335 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.73 -9.9 22.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.96 1.505 . . . . 0.0 110.519 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -94.75 -12.94 26.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 109.83 179.917 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.474 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 12.4 mmtt -115.12 -160.01 0.72 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.449 -0.782 . . . . 0.0 109.536 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.487 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 2.0 m -112.69 148.09 35.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.544 ' CG2' ' HA ' ' A' ' 58' ' ' ARG . 2.6 t -67.44 -18.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.066 -1.021 . . . . 0.0 108.879 179.328 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 -41.98 80.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 178.861 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . 0.58 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 3.8 pt-20 -66.88 -45.96 76.42 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.041 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.544 ' N ' ' CG ' ' A' ' 33' ' ' GLU . 0.5 OUTLIER -62.7 -34.21 76.67 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.861 . . . . 0.0 108.72 178.957 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.464 ' HB2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -57.79 -49.55 76.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.773 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.455 ' HA ' ' HB3' ' A' ' 39' ' ' SER . 91.1 t -64.39 -32.18 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.594 -0.691 . . . . 0.0 109.141 178.584 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.7 -43.0 90.51 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.854 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.609 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 24.7 mm -75.63 -24.62 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.568 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 39' ' ' SER . . . . . 0.455 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -77.66 -35.2 52.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 179.095 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.07 -38.76 26.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.491 0.662 . . . . 0.0 109.724 179.528 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.526 HD21 ' CD2' ' A' ' 80' ' ' LEU . 10.4 tp -65.52 -32.43 74.02 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.406 179.356 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 42' ' ' PHE . . . . . 0.609 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.3 m-85 -87.51 -19.99 27.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.103 179.619 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.27 -26.96 20.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -92.39 -17.44 24.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.477 -0.764 . . . . 0.0 109.212 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 45' ' ' ASN . . . . . 0.608 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -83.23 -59.07 2.58 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.621 -0.674 . . . . 0.0 109.534 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.6 m-20 146.65 31.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.741 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.527 ' CD2' ' HB2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -102.27 -156.27 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.192 -0.942 . . . . 0.0 109.874 -179.836 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . 0.53 ' CB ' ' HG2' ' A' ' 66' ' ' GLU . . . -162.39 56.51 0.23 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.784 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.434 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 10.4 m -45.53 118.79 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 50' ' ' VAL . . . . . 0.578 ' CG2' ' C ' ' A' ' 65' ' ' PHE . 0.0 OUTLIER -93.45 -33.89 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.514 ' O ' ' CG2' ' A' ' 52' ' ' VAL . 11.5 m-20 -149.35 148.24 29.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.322 -0.861 . . . . 0.0 110.686 -179.886 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.52 ' CG1' HG23 ' A' ' 63' ' ' VAL . 57.1 t -156.85 102.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.01 179.672 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -113.17 173.27 6.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 110.332 -179.814 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.516 HG22 ' CG1' ' A' ' 31' ' ' VAL . 2.0 p -82.33 -179.32 7.37 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.238 -0.914 . . . . 0.0 110.171 -179.665 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.474 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -140.91 132.5 5.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.513 HG21 ' ND2' ' A' ' 57' ' ' ASN . 63.4 m 58.34 -106.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.371 -1.076 . . . . 0.0 110.586 179.71 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.513 ' ND2' HG21 ' A' ' 56' ' ' THR . 7.9 p30 -130.17 90.56 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.861 -1.149 . . . . 0.0 110.48 -179.701 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.544 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 19.2 mtt85 41.77 29.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.533 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -112.39 -32.96 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.915 . . . . 0.0 110.177 179.943 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 60' ' ' PHE . . . . . 0.486 ' HB3' ' CZ ' ' A' ' 21' ' ' PHE . 2.3 m-85 -126.71 -162.59 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 109.361 179.733 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.479 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.58 132.12 2.15 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.575 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CE1' ' HB2' ' A' ' 21' ' ' PHE . 2.9 m-85 -86.33 158.35 19.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.404 -1.057 . . . . 0.0 109.116 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 63' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 62' ' ' TYR . 25.2 t -158.68 156.32 3.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.947 -179.155 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 64' ' ' ASP . . . . . 0.479 ' OD1' ' HB3' ' A' ' 19' ' ' ASN . 80.3 m-20 -142.39 144.88 33.33 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 65' ' ' PHE . . . . . 0.578 ' C ' ' CG2' ' A' ' 50' ' ' VAL . 23.0 m-85 -114.97 -174.87 2.57 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.483 -0.761 . . . . 0.0 109.001 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.53 ' HG2' ' CB ' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -132.67 29.61 4.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.494 -1.379 . . . . 0.0 113.44 -176.6 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.777 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p -169.09 173.5 6.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.319 -1.488 . . . . 0.0 113.119 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.3 -27.42 52.99 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.393 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 69' ' ' GLU . . . . . 0.456 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -28.89 62.83 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.912 179.41 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.777 ' OD2' ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -76.5 -33.26 58.65 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.851 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.553 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -62.28 -43.89 97.79 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.997 179.794 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.456 ' N ' HD23 ' A' ' 71' ' ' LEU . 3.9 tt0 -66.26 -35.52 80.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.034 178.806 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 69' ' ' GLU . 4.8 mttm -78.59 -21.19 48.94 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.13 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.49 ' N ' ' O ' ' A' ' 70' ' ' ASP . . . -69.33 -29.4 67.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.767 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 75' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 75' ' ' LEU . 4.3 tt -77.22 -45.74 25.52 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.496 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 8.5 tt0 -71.66 -7.15 46.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.642 178.93 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.51 HD11 ' CE2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -57.63 -13.52 4.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 111.09 -179.996 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 78' ' ' THR . . . . . 0.454 ' O ' HG21 ' A' ' 78' ' ' THR . 45.8 m -69.2 3.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.912 . . . . 0.0 111.801 -179.186 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.61 10.95 16.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.477 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.526 ' CD2' HD21 ' A' ' 41' ' ' LEU . 45.6 mt -97.74 112.38 24.29 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.321 -1.105 . . . . 0.0 110.688 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 81' ' ' LYS . . . . . 0.509 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 1.1 mttp -88.62 80.59 7.27 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.105 0.955 . . . . 0.0 110.295 179.589 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.559 ' CG2' ' CD1' ' A' ' 38' ' ' ILE . 1.1 p -46.16 126.84 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.697 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.58 ' CE1' ' HG3' ' A' ' 33' ' ' GLU . 1.2 m-85 42.21 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.953 . . . . 0.0 110.653 -179.561 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 97.18 17.68 31.22 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 84.7 m-20 -133.54 110.52 9.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -1.142 . . . . 0.0 110.084 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.5 tm-20 -56.65 83.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 87' ' ' ILE . . . . . 0.541 ' O ' ' CD1' ' A' ' 87' ' ' ILE . 0.5 OUTLIER -39.3 151.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 110.771 -179.479 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 88' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 31.9 ttpt -119.26 157.36 28.2 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . 0.537 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 5.1 mp -112.36 179.07 4.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.232 -0.917 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.5 ' OE1' ' N ' ' A' ' 91' ' ' LYS . 0.0 OUTLIER -170.48 161.34 7.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.662 -0.649 . . . . 0.0 109.924 179.856 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.5 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -102.12 100.36 15.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.462 -179.708 . . . . . . . . 3 3 . 1 . 034 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.1 Cg_endo -75.07 -169.16 0.6 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.081 1.569 . . . . 0.0 110.408 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 92' ' ' PRO . 13.2 tttm 42.38 45.42 3.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.23 139.5 3.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.96 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -178.19 2.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 0.0 110.221 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.28 61.37 6.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.201 -179.972 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 98' ' ' THR . . . 74.5 -110.75 3.17 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.92 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 98' ' ' THR . . . . . 0.466 ' O ' ' OG1' ' A' ' 98' ' ' THR . 3.4 p 42.31 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -1.164 . . . . 0.0 110.354 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 166.55 13.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.903 . . . . 0.0 110.148 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear orig full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.24 65.34 3.46 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear orig full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.268 -1.137 . . . . 0.0 110.249 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.521 0.677 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.822 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -148.47 166.48 15.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.74 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.2 Cg_endo -78.8 -42.91 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.233 1.649 . . . . 0.0 110.769 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CE2' ' C ' ' A' ' 67' ' ' SER . 96.3 m-85 -96.88 110.88 23.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 110.516 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.528 ' N ' ' ND2' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -137.32 151.73 48.96 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -161.31 -178.03 6.41 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 110.391 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 62' ' ' TYR . 6.2 t80 -112.4 146.65 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.338 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.3 mt -130.91 155.99 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.827 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 60' ' ' PHE . . . -136.51 -164.74 10.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.912 ' C ' HD12 ' A' ' 25' ' ' LEU . 31.2 t-20 65.64 70.59 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.08 . . . . 0.0 110.092 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.912 HD12 ' C ' ' A' ' 24' ' ' ASN . 10.2 mp -119.16 130.25 55.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.845 . . . . 0.0 110.255 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.779 ' H ' HD21 ' A' ' 34' ' ' LEU . 31.5 t30 -54.15 107.99 1.01 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.506 -0.746 . . . . 0.0 110.346 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.2 Cg_endo -74.49 -8.73 20.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.049 1.552 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 7.1 m120 -84.05 -14.54 50.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -117.57 -157.24 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.39 -0.819 . . . . 0.0 109.859 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.659 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.6 m -100.14 146.92 26.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 54' ' ' THR . 11.2 t -69.79 -30.37 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.319 -0.953 . . . . 0.0 109.059 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -63.72 -38.16 90.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.0 109.034 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 54.7 mm-40 -68.14 -36.31 79.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.854 HD23 HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -62.42 -32.93 73.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.367 -0.833 . . . . 0.0 108.836 178.863 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.618 ' HG3' HG12 ' A' ' 52' ' ' VAL . 1.6 mptp? -65.82 -50.37 64.88 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.575 -0.703 . . . . 0.0 109.314 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.4 t -58.53 -35.64 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.842 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.57 -35.85 81.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.137 -0.977 . . . . 0.0 108.727 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.581 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 35.9 mt -80.15 -27.11 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.157 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.53 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -79.43 -29.46 41.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.067 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.93 -38.37 27.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.361 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.676 HD22 HD23 ' A' ' 80' ' ' LEU . 5.2 tp -68.12 -32.17 72.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 6.0 m-85 -82.31 -23.19 35.27 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.54 65.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 109.362 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -89.37 -21.15 23.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.727 . . . . 0.0 109.456 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.635 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.1 m-80 -80.57 -20.52 43.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.474 -0.766 . . . . 0.0 109.743 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.635 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.2 t0 91.21 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.939 0.876 . . . . 0.0 108.759 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.882 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -84.11 -139.26 0.06 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -177.21 58.41 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.217 -0.927 . . . . 0.0 109.774 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.2 m -60.03 117.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.965 0.888 . . . . 0.0 109.94 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.6 t -95.29 -33.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.265 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.518 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 12.4 t0 -144.68 153.77 42.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.977 . . . . 0.0 110.676 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.618 HG12 ' HG3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -155.91 99.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.87 . . . . 0.0 108.979 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -102.26 156.82 17.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.106 -0.996 . . . . 0.0 110.733 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.931 HG22 HG12 ' A' ' 31' ' ' VAL . 44.5 p -90.64 154.65 19.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.429 -0.795 . . . . 0.0 110.319 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' A' ' 60' ' ' PHE . . . -127.49 128.32 6.09 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.578 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 3.4 m 60.72 170.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.836 -0.802 . . . . 0.0 109.878 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.54 ' N ' HG22 ' A' ' 56' ' ' THR . 68.8 m-80 -38.6 -42.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.467 -0.77 . . . . 0.0 110.412 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.543 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 172.45 51.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.817 . . . . 0.0 109.802 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -110.54 -31.24 7.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.306 -0.871 . . . . 0.0 110.494 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.825 ' HA ' HD13 ' A' ' 25' ' ' LEU . 5.9 p90 -159.39 149.33 18.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.026 -1.047 . . . . 0.0 110.424 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -132.82 164.8 24.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.45 162.44 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -1.083 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 52' ' ' VAL . 3.2 t -151.4 141.59 15.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.749 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 50.2 m-20 -112.06 147.54 35.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.501 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.6 m-85 -108.26 179.84 4.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.821 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.586 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -114.08 13.42 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 111.496 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.54 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.4 p 178.88 179.42 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.381 1.086 . . . . 0.0 112.072 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.25 52.94 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -27.07 37.29 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.727 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 79.4 m-20 -83.43 -25.9 30.83 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.765 ' O ' HD13 ' A' ' 71' ' ' LEU . 3.3 tm? -80.69 -34.79 34.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.477 0.656 . . . . 0.0 109.281 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.92 -36.13 67.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.806 . . . . 0.0 109.487 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.882 ' HB2' HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -76.43 -27.45 56.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.89 -29.5 68.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -71.25 -45.99 62.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -75.92 -4.21 39.68 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.225 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.964 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -77.77 12.01 1.89 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 110.281 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -9.23 12.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.039 -1.038 . . . . 0.0 110.089 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.12 33.98 3.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.009 HD13 ' CD1' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -85.37 -170.15 2.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.125 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -179.1 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.257 1.027 . . . . 0.0 109.876 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HD23 ' A' ' 34' ' ' LEU . 41.4 t -40.97 127.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.994 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 8.4 m-85 43.96 25.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.132 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . 90.7 20.43 40.44 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' VAL . 23.4 m-20 -131.62 102.39 5.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -1.156 . . . . 0.0 109.521 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.582 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -53.47 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.272 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.009 ' CD1' HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -47.46 142.57 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -108.11 163.88 12.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 109.163 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.604 HD23 ' CD1' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -115.53 -179.34 3.61 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 110.459 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.562 ' C ' HG23 ' A' ' 16' ' ' THR . 16.9 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.306 0.574 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.678 ' CG2' HG11 ' A' ' 50' ' ' VAL . 70.1 p -153.85 161.88 28.12 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.288 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.58 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.71 -23.88 14.03 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.025 1.539 . . . . 0.0 110.7 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.58 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 98.4 m-85 -106.37 112.67 25.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 110.562 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 18' ' ' PHE . 3.2 m120 -143.82 153.53 42.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.586 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -166.49 -177.51 4.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.673 ' N ' HD12 ' A' ' 20' ' ' LEU . 35.0 t80 -113.71 151.01 32.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 110.134 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.0 157.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 109.658 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.69 -168.47 11.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.562 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER 69.31 50.91 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -1.099 . . . . 0.0 110.214 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.97 HD23 ' HA ' ' A' ' 60' ' ' PHE . 3.6 mm? -100.13 123.08 43.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.735 ' N ' HD21 ' A' ' 34' ' ' LEU . 25.7 t-20 -42.92 102.18 0.27 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.59 -0.694 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.37 -14.21 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.02 1.537 . . . . 0.0 110.369 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 1.9 m-20 -80.25 -19.34 47.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -107.13 -156.31 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.414 -0.804 . . . . 0.0 109.832 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.1 m -103.2 143.14 33.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.967 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.5 t -66.58 -19.2 25.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.107 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . . . -71.54 -41.46 69.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 108.989 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.8 mm-40 -66.11 -37.49 85.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 109.288 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.735 HD21 ' N ' ' A' ' 26' ' ' ASN . 5.0 mp -63.05 -34.58 77.89 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.315 -0.865 . . . . 0.0 108.745 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.614 ' CG ' HG22 ' A' ' 52' ' ' VAL . 2.8 mttt -60.14 -56.91 15.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 25.4 t -60.93 -34.59 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.588 -0.695 . . . . 0.0 109.468 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.35 -33.4 75.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 108.694 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.488 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.2 mt -81.11 -28.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.99 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -78.6 -30.29 46.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.084 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.22 -37.7 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.546 0.689 . . . . 0.0 109.458 179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.912 HD13 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -68.56 -31.56 70.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.087 179.143 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.681 ' CE1' HD11 ' A' ' 80' ' ' LEU . 13.2 m-85 -88.16 -16.8 32.41 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.4 -29.38 19.11 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.995 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -91.82 -18.74 23.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.465 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.601 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 3.0 m120 -81.32 -58.73 2.92 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 0.0 109.719 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.1 m-20 148.26 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.27 0.557 . . . . 0.0 109.843 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.74 HD11 ' CB ' ' A' ' 73' ' ' LYS . 4.1 mm? -106.1 -158.94 0.68 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.328 -0.857 . . . . 0.0 109.586 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.813 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -160.41 61.9 0.33 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.955 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.99 HG21 ' HA ' ' A' ' 39' ' ' SER . 6.7 m -52.83 118.12 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.882 0.848 . . . . 0.0 109.856 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.751 HG22 ' HB3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -87.43 -43.12 15.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 121.878 -0.514 . . . . 0.0 109.99 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 4.5 t0 -144.46 158.17 43.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.614 HG22 ' CG ' ' A' ' 35' ' ' LYS . 2.1 p -149.21 156.65 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 0.0 109.706 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -165.26 165.92 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.167 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.967 HG22 ' CG1' ' A' ' 31' ' ' VAL . 12.5 p -79.56 179.46 7.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.403 -0.811 . . . . 0.0 110.329 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -142.1 135.31 6.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 97.8 m 59.43 -83.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.903 . . . . 0.0 110.449 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 55' ' ' GLY . 1.6 m-20 -161.54 97.09 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.046 -1.034 . . . . 0.0 110.642 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.53 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 42.75 27.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.903 . . . . 0.0 110.655 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -119.58 -33.23 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 110.156 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.97 ' HA ' HD23 ' A' ' 25' ' ' LEU . 3.2 m-85 -129.18 177.31 7.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.54 129.12 2.59 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.076 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 63' ' ' VAL . 28.4 t80 -92.82 163.9 13.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 109.644 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 62' ' ' TYR . 27.7 t -157.95 159.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.867 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -126.28 138.33 53.59 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.612 -0.68 . . . . 0.0 109.58 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 24.8 m-85 -102.7 175.26 5.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.676 -0.64 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.813 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 3.0 pt-20 -118.44 14.66 13.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 111.564 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.534 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.7 p -172.61 173.9 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.906 -1.121 . . . . 0.0 112.165 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.542 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.5 -23.91 42.63 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -25.43 30.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.642 ' OD1' HD12 ' A' ' 47' ' ' LEU . 5.4 t0 -82.14 -25.73 34.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 71' ' ' LEU . 2.7 tm? -81.95 -33.64 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -34.37 71.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.756 . . . . 0.0 109.379 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.74 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -77.26 -28.75 53.67 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.12 -27.13 67.07 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -73.55 -48.85 29.8 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.668 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.82 -3.72 30.34 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.3 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.968 HD12 ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -76.55 8.8 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.489 -0.757 . . . . 0.0 110.469 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 m -64.58 -8.72 15.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.198 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.97 17.8 48.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.09 HD13 HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -72.31 -171.94 0.84 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.403 -1.057 . . . . 0.0 110.67 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.4 mttt -170.64 49.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.355 1.074 . . . . 0.0 109.655 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.795 HG21 HG21 ' A' ' 87' ' ' ILE . 23.7 t -40.06 124.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.027 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.9 m-85 42.72 29.38 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.188 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.12 25.14 38.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' VAL . 11.4 m120 -134.16 86.37 2.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.603 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.589 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 21.1 tt0 -41.92 100.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.09 HD11 HD13 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -60.18 140.22 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.489 -0.757 . . . . 0.0 110.42 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -111.63 156.3 22.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.153 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.606 ' CD1' HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -120.39 169.73 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.043 -1.035 . . . . 0.0 110.608 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.014 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 16' ' ' THR . 4.1 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.194 0.521 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.967 HG21 ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -167.4 158.24 9.95 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 110.477 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.86 -34.98 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.154 1.608 . . . . 0.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.522 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.1 m-85 -112.22 114.3 27.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -132.87 148.98 52.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -165.4 -177.36 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.618 ' N ' HD12 ' A' ' 20' ' ' LEU . 3.3 t80 -115.2 150.01 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.97 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 88' ' ' LYS . 2.2 mt -129.95 158.34 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.427 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.48 -173.45 13.04 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.84 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER 72.54 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -1.012 . . . . 0.0 110.197 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.0 mm? -116.45 165.48 13.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 110.106 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 40.8 t30 -95.22 106.74 27.84 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 110.344 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -73.54 -13.92 24.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.042 1.548 . . . . 0.0 110.447 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.439 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 3.3 m120 -78.67 -17.72 55.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.581 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -113.27 -155.27 0.56 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.44 -0.788 . . . . 0.0 109.862 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.499 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -100.65 142.53 32.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 110.498 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.799 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.9 t -67.37 -32.33 56.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.179 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.94 -39.01 92.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.319 -0.863 . . . . 0.0 108.965 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 70.2 mm-40 -63.79 -36.46 83.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.559 -0.713 . . . . 0.0 109.092 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 31' ' ' VAL . 92.2 mt -61.3 -38.81 88.14 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.37 -0.832 . . . . 0.0 108.908 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.868 ' HD3' HG12 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -58.96 -50.37 74.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -60.09 -37.72 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.477 -0.764 . . . . 0.0 109.668 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -61.35 -28.34 69.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.072 -1.017 . . . . 0.0 109.11 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.579 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 7.0 mt -87.84 -28.06 5.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.482 -0.761 . . . . 0.0 109.14 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 7.5 t -80.61 -24.71 38.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.167 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.52 -37.43 19.66 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.532 -0.73 . . . . 0.0 109.141 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.084 HD22 HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -67.47 -34.72 77.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.092 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 7.1 m-85 -83.47 -22.53 32.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -74.48 -33.72 62.92 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -18.21 25.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 0.0 109.345 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.2 m120 -82.21 -19.35 39.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.526 -0.734 . . . . 0.0 109.863 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 t70 91.69 29.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.008 0.909 . . . . 0.0 108.839 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -87.95 -140.68 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.717 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -178.28 59.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.6 m -56.01 117.08 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.075 0.941 . . . . 0.0 110.171 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.967 ' HB ' HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -88.98 -36.51 8.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.67 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.2 t70 -143.69 147.31 34.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.056 HG13 HG22 ' A' ' 63' ' ' VAL . 2.6 t -153.23 139.63 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.609 -0.682 . . . . 0.0 109.462 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -158.08 -179.63 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.798 HG22 HG12 ' A' ' 31' ' ' VAL . 17.0 p -84.7 177.95 7.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.316 -0.865 . . . . 0.0 110.594 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -137.23 132.43 5.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.576 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 52.3 m 57.68 -91.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.484 ' N ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -153.02 98.1 2.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.073 -1.017 . . . . 0.0 110.434 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.551 ' HG3' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 41.92 26.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -116.35 -32.31 5.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.8 m-85 -135.97 -175.82 4.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.359 -0.838 . . . . 0.0 109.498 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.6 145.9 13.72 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.101 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.808 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -101.26 161.42 13.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -1.107 . . . . 0.0 109.528 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.056 HG22 HG13 ' A' ' 52' ' ' VAL . 4.7 t -161.46 159.86 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.552 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.1 m-20 -140.93 142.03 34.45 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.709 -0.619 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.714 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 61.2 m-85 -106.16 174.44 5.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.719 -0.613 . . . . 0.0 110.584 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.717 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 6.6 pt-20 -114.67 13.2 17.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 111.849 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.522 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.0 p -170.06 177.26 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.855 -1.153 . . . . 0.0 112.255 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.91 -23.56 48.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.51 -27.57 46.11 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.475 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 83.0 m-20 -83.14 -27.91 29.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.783 HD13 ' C ' ' A' ' 71' ' ' LEU . 1.9 tm? -73.67 -38.67 64.85 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.274 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -37.25 71.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.42 -0.8 . . . . 0.0 109.348 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.792 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.11 -20.44 52.15 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.738 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -71.57 -31.94 67.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.9 tt -76.8 -43.5 36.45 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.551 -0.718 . . . . 0.0 109.081 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -25.0 66.04 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.419 -0.8 . . . . 0.0 109.584 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.092 HD13 ' CZ ' ' A' ' 42' ' ' PHE . 14.2 mt -66.82 -8.22 27.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 110.126 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.898 ' OG1' HD21 ' A' ' 89' ' ' LEU . 5.9 m -48.42 -19.81 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 110.654 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.23 34.78 3.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.084 HD21 HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.33 -165.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 110.694 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.0 mtmt -169.64 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.193 0.997 . . . . 0.0 109.67 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 85' ' ' ASN . 2.9 p -37.83 125.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.179 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.8 m-85 41.75 26.69 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.456 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 89.91 24.38 30.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.751 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.3 m120 -135.04 89.82 2.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -1.137 . . . . 0.0 109.565 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.565 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.8 pt-20 -41.17 106.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 110.858 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.082 HD11 HD13 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -72.54 135.54 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 110.285 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -112.04 159.76 18.15 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.506 -0.747 . . . . 0.0 109.156 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.898 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.2 OUTLIER -117.31 172.7 7.13 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.864 -1.147 . . . . 0.0 110.574 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 110.201 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 16' ' ' THR . 1.9 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.514 0.673 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.828 HG21 HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -134.85 157.65 76.67 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 110.496 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -79.57 -30.92 2.22 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 124.204 1.634 . . . . 0.0 110.821 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.869 ' HD1' HD13 ' A' ' 71' ' ' LEU . 56.7 m-85 -103.31 104.52 14.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 110.895 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 7.6 m-20 -137.85 149.06 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.436 -0.79 . . . . 0.0 109.344 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.3 pp -163.84 -175.58 4.16 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.453 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 41.5 t80 -108.86 167.54 10.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.64 HD12 ' CG2' ' A' ' 63' ' ' VAL . 14.8 mt -147.33 158.89 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.666 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -137.24 179.46 18.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 1.6 t-20 70.16 92.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -1.127 . . . . 0.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.954 ' HB3' HD13 ' A' ' 34' ' ' LEU . 21.8 mt -145.02 130.92 19.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.978 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.624 ' HB3' HD21 ' A' ' 34' ' ' LEU . 37.5 t-20 -38.95 99.29 0.19 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.737 -0.602 . . . . 0.0 110.528 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -74.19 -19.28 20.13 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.081 1.569 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -78.5 -13.71 59.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -110.52 -155.65 0.57 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 109.97 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 6.5 m -104.73 152.7 22.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.315 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.949 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.7 t -69.71 -46.01 76.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 109.452 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -49.52 -38.95 32.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.878 . . . . 0.0 109.279 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 28.5 mm-40 -67.97 -40.01 83.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.437 -0.789 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.954 HD13 ' HB3' ' A' ' 25' ' ' LEU . 25.6 mt -60.72 -36.59 79.23 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.298 -0.876 . . . . 0.0 108.742 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 10.3 mmtt -62.32 -57.64 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 32' ' ' ALA . 17.2 t -52.22 -35.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.99 -34.48 78.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 34' ' ' LEU . 4.5 mt -82.1 -27.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.501 ' HA ' HG21 ' A' ' 49' ' ' VAL . 75.2 m -77.86 -30.15 50.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.937 . . . . 0.0 109.023 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.59 -37.02 32.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.752 . . . . 0.0 109.456 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.08 -30.53 68.87 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.587 -0.696 . . . . 0.0 109.145 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.687 ' HE1' HD22 ' A' ' 80' ' ' LEU . 7.1 m-85 -84.7 -22.46 29.75 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.88 -32.42 61.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.437 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -12.44 28.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.0 109.735 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.6 m120 -92.41 -11.17 35.56 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.3 t70 85.12 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.917 0.865 . . . . 0.0 109.281 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.976 HD11 ' HB3' ' A' ' 73' ' ' LYS . 3.0 mm? -86.76 -131.15 0.06 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.863 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 168.38 56.34 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.841 -1.162 . . . . 0.0 109.692 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.6 m -58.16 120.5 4.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.067 0.937 . . . . 0.0 110.375 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -90.37 -46.85 14.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.448 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.472 ' OD2' HG21 ' A' ' 15' ' ' THR . 3.6 m-20 -148.1 118.88 7.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.173 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.871 HG12 HG13 ' A' ' 63' ' ' VAL . 16.6 m -101.24 171.55 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.295 -0.878 . . . . 0.0 109.692 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.82 164.48 16.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 0.0 110.431 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.725 ' HB ' HG11 ' A' ' 31' ' ' VAL . 23.4 p -92.03 162.32 14.42 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.456 -0.777 . . . . 0.0 110.549 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -117.5 121.47 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.549 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 2.1 m 72.0 -56.17 0.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.62 -0.929 . . . . 0.0 110.122 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.545 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.3 OUTLIER 173.74 -35.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.596 ' HA ' HG22 ' A' ' 31' ' ' VAL . 31.8 ttp180 -172.5 26.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.549 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.547 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 34.6 mttp -119.31 -33.74 4.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.654 ' C ' HD12 ' A' ' 25' ' ' LEU . 1.1 m-85 -131.26 -165.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.328 -0.858 . . . . 0.0 109.349 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -171.01 161.93 34.74 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.236 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.0 t80 -123.36 154.81 38.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.42 -1.047 . . . . 0.0 109.554 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.871 HG13 HG12 ' A' ' 52' ' ' VAL . 3.5 t -150.71 146.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.004 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.1 m-20 -118.27 135.06 54.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.529 -0.732 . . . . 0.0 109.507 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.681 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 51.4 m-85 -102.44 171.91 7.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.714 -0.616 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.771 ' HB3' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.58 15.77 16.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.89 . . . . 0.0 111.344 -178.218 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p -166.82 173.8 9.15 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.603 1.192 . . . . 0.0 112.281 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.453 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.24 -25.72 51.84 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.478 ' OE1' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.38 -26.79 58.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.571 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.863 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 89.1 m-20 -82.41 -30.63 30.05 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.869 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -73.15 -36.56 66.68 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.827 179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -73.39 -38.72 65.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.813 . . . . 0.0 109.98 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.976 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.3 -29.64 47.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 70' ' ' ASP . . . -64.39 -31.33 72.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.841 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 4.6 tt -72.82 -45.18 59.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.1 mt-10 -81.03 -1.13 42.76 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.41 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -77.91 7.83 5.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.282 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.792 ' OG1' HD21 ' A' ' 89' ' ' LEU . 92.4 m -70.29 -2.55 13.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 110.473 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.55 65.45 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.9 HD21 HD11 ' A' ' 87' ' ' ILE . 1.2 pp -71.69 129.4 38.59 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.388 -1.066 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -99.98 84.86 2.94 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.975 0.893 . . . . 0.0 109.518 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.901 HG11 HD23 ' A' ' 25' ' ' LEU . 4.2 p -43.85 118.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.727 -0.789 . . . . 0.0 108.998 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 2.1 m-85 46.01 22.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 110.306 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.03 12.26 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.319 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.801 ' O ' HG12 ' A' ' 82' ' ' VAL . 9.6 m120 -126.49 89.67 3.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.31 . . . . 0.0 110.387 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.9 mp0 -40.33 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.63 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.9 HD11 HD21 ' A' ' 80' ' ' LEU . 12.5 pt -71.28 146.54 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.784 0.802 . . . . 0.0 110.581 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.53 ' O ' HG23 ' A' ' 22' ' ' ILE . 15.9 ttpt -116.06 158.64 22.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -119.07 167.95 11.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.837 -1.164 . . . . 0.0 110.415 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.167 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.793 ' C ' HG23 ' A' ' 16' ' ' THR . 7.2 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.174 0.511 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.94 ' CG2' HG11 ' A' ' 50' ' ' VAL . 1.4 p 77.8 163.41 0.13 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.565 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.8 Cg_endo -77.85 -31.75 2.99 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.227 1.646 . . . . 0.0 110.91 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 74.4 m-85 -86.61 102.39 14.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.949 -1.094 . . . . 0.0 110.557 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 16' ' ' THR . 67.0 m-20 -139.52 157.74 45.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.219 -0.926 . . . . 0.0 109.623 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 20' ' ' LEU . 2.2 pp -167.02 -177.08 3.62 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.288 -0.882 . . . . 0.0 110.416 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 t80 -117.29 146.58 43.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.574 HD12 ' CG2' ' A' ' 63' ' ' VAL . 2.2 mt -129.93 160.5 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -136.63 -172.67 12.64 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.704 ' C ' HD22 ' A' ' 25' ' ' LEU . 10.1 t-20 72.33 63.95 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.496 -1.002 . . . . 0.0 110.47 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.863 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.1 mm? -106.53 119.54 39.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.762 ' HB2' HD21 ' A' ' 34' ' ' LEU . 11.6 t-20 -41.31 107.21 0.47 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.704 -0.622 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.79 -30.3 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.55 . . . . 0.0 110.042 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.83 -11.73 60.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.852 . . . . 0.0 109.63 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' CD ' ' A' ' 33' ' ' GLU . 4.4 mmtp -111.31 -156.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.342 -0.849 . . . . 0.0 109.74 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -111.96 150.71 30.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.335 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.956 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.2 t -72.83 -19.97 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.376 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -74.38 -45.2 48.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.573 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -62.08 -38.03 87.29 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 31' ' ' VAL . 44.4 mt -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.226 -0.921 . . . . 0.0 108.912 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 1.7 mptp? -58.17 -48.88 78.92 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.547 0.689 . . . . 0.0 109.379 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 32' ' ' ALA . 26.4 t -56.06 -35.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.723 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -63.3 -37.32 86.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 108.658 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 42' ' ' PHE . 34.6 mt -81.41 -25.0 10.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.79 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 3.6 p -80.35 -26.95 38.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.066 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.92 -41.92 15.47 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.661 0.743 . . . . 0.0 109.31 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.937 HD22 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.0 -35.74 81.68 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.081 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.783 ' CE1' HD11 ' A' ' 80' ' ' LEU . 9.4 m-30 -85.34 -21.82 28.75 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.751 0.786 . . . . 0.0 108.943 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.57 -35.18 60.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.466 0.65 . . . . 0.0 109.509 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -84.11 -15.38 47.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 109.366 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.64 -10.94 44.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.859 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.3 t0 83.79 29.17 0.08 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.946 0.879 . . . . 0.0 108.832 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.94 HD21 ' CE1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -73.84 -130.84 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.052 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 173.27 57.45 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.447 -0.783 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 49' ' ' VAL . 15.8 m -57.26 117.44 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.936 0.874 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.94 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -93.42 -34.18 5.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.554 ' HB2' ' CG2' ' A' ' 15' ' ' THR . 0.7 OUTLIER -149.03 152.19 35.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.823 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.698 HG13 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -157.85 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.485 -0.76 . . . . 0.0 109.072 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' C ' ' CE ' ' A' ' 35' ' ' LYS . 7.1 mmm180 -106.96 168.23 9.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.772 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.956 ' HB ' HG11 ' A' ' 31' ' ' VAL . 4.4 p -80.17 170.94 15.74 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.438 -0.789 . . . . 0.0 110.279 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -128.88 114.1 1.7 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.4 m 67.66 -139.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 110.312 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.476 ' H ' HG22 ' A' ' 56' ' ' THR . 80.8 m-20 -98.24 76.35 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 36.8 mtt180 57.8 42.12 23.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.486 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 21.2 mttt -119.46 -31.44 4.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.863 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.8 m-85 -139.79 -169.26 2.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -166.8 140.59 6.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 2.3 m-30 -99.13 157.12 16.58 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.258 -1.143 . . . . 0.0 109.591 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.698 HG13 HG13 ' A' ' 52' ' ' VAL . 3.9 t -151.24 143.73 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.7 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' OD2' ' CG2' ' A' ' 15' ' ' THR . 0.8 OUTLIER -122.34 140.9 52.13 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.365 -0.835 . . . . 0.0 109.979 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.94 ' CE1' HD21 ' A' ' 47' ' ' LEU . 14.2 m-85 -107.48 172.31 6.9 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.877 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -122.52 19.2 10.45 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.067 -1.021 . . . . 0.0 111.115 -178.506 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.2 p -165.06 176.22 8.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.588 1.185 . . . . 0.0 112.251 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.18 -25.81 42.73 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -32.06 63.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.036 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 1.052 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 90.4 m-20 -77.81 -29.57 50.76 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.783 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tt -71.22 -39.73 71.54 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.63 ' N ' HD23 ' A' ' 71' ' ' LEU . 5.9 tt0 -62.16 -38.34 88.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' LEU . 23.9 mmtt -72.41 -24.62 61.26 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 71' ' ' LEU . . . -63.97 -34.92 79.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.0 tt -72.02 -44.64 63.09 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.4 9.72 14.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.094 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -75.89 -13.05 60.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.602 -0.686 . . . . 0.0 110.585 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.625 ' CA ' HD21 ' A' ' 89' ' ' LEU . 96.4 m -72.38 3.66 4.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.29 39.35 2.92 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 87' ' ' ILE . 7.4 mt -100.14 -167.55 1.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -1.009 . . . . 0.0 111.017 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -167.61 51.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.069 0.937 . . . . 0.0 108.925 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 85' ' ' ASN . 4.1 p -34.66 118.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.248 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 15.1 m-85 38.35 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 0.0 110.557 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 96.8 22.0 19.55 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.853 ' O ' HG12 ' A' ' 82' ' ' VAL . 1.2 m120 -134.01 84.34 2.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.093 -1.24 . . . . 0.0 109.853 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.553 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 23.4 tt0 -40.11 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.666 0.746 . . . . 0.0 110.44 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -59.55 123.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.607 -0.683 . . . . 0.0 110.499 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.5 mttp -95.25 127.88 41.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.003 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.625 HD21 ' CA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -109.34 169.67 8.55 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.399 -179.012 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.499 0.666 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.946 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.57 172.79 5.44 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.65 -0.656 . . . . 0.0 110.691 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.5 Cg_endo -77.86 -47.0 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.136 1.598 . . . . 0.0 110.552 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.647 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.6 m-85 -87.51 111.12 20.86 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 110.22 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.01 150.39 32.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.374 -0.828 . . . . 0.0 109.113 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.184 HD12 ' CE1' ' A' ' 65' ' ' PHE . 13.9 mt -146.42 170.2 17.32 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.361 -0.837 . . . . 0.0 111.22 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.656 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 5.8 t80 -126.06 140.76 52.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.79 HD12 HG21 ' A' ' 63' ' ' VAL . 8.6 mt -137.63 147.8 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 110.774 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.06 -167.66 11.59 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 21.4 t-20 70.92 36.87 1.38 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -1.093 . . . . 0.0 110.372 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.1 mm? -88.4 126.97 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.504 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 36.4 t-20 -40.9 107.76 0.5 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.661 -0.649 . . . . 0.0 110.378 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.41 -8.36 21.67 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.047 1.551 . . . . 0.0 110.289 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 28.1 m120 -96.71 -20.75 18.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.638 ' CD ' ' CE1' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -103.48 -158.9 0.69 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -103.8 148.27 26.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.286 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.86 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.1 t -69.71 -26.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.912 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -65.36 -41.16 94.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.416 -0.802 . . . . 0.0 109.031 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.6 mm-40 -64.27 -45.26 88.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 31' ' ' VAL . 8.4 mt -60.09 -39.02 84.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.02 -57.17 14.25 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.539 0.685 . . . . 0.0 109.687 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 32' ' ' ALA . 15.0 t -57.23 -31.52 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.852 . . . . 0.0 109.714 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.08 -39.06 92.66 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.183 -0.948 . . . . 0.0 108.822 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 19.3 mt -78.3 -24.72 13.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 109.362 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.517 ' HA ' HG21 ' A' ' 49' ' ' VAL . 30.4 t -80.83 -33.22 34.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.147 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.61 -37.04 43.27 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.581 0.705 . . . . 0.0 109.461 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.616 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.33 -31.94 69.46 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.102 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.913 ' CD2' HD22 ' A' ' 47' ' ' LEU . 3.3 m-85 -77.74 -26.28 49.82 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.89 -29.67 61.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.549 -0.719 . . . . 0.0 109.706 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.19 -22.42 17.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.703 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.6 m120 -74.53 -42.15 59.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.703 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.6 t70 122.59 28.86 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.534 0 C-N-CA 123.682 0.793 . . . . 0.0 109.46 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.015 HD11 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -96.82 -153.87 0.43 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.463 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.72 61.45 0.2 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 ' CD2' ' A' ' 42' ' ' PHE . 6.0 m -55.23 115.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 122.08 0.943 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.946 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -91.28 -38.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -143.5 154.02 43.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.348 -0.845 . . . . 0.0 110.425 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -157.93 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.395 -0.816 . . . . 0.0 109.172 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -121.3 165.66 15.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.006 -1.059 . . . . 0.0 111.055 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.694 ' HB ' HG11 ' A' ' 31' ' ' VAL . 13.0 p -88.37 156.74 18.99 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -124.9 118.1 3.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 57' ' ' ASN . 3.5 m 66.77 -175.74 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -1.063 . . . . 0.0 110.757 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.69 ' H ' HG22 ' A' ' 56' ' ' THR . 16.9 m120 -63.95 65.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.392 -0.817 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' THR . 2.1 mtt180 61.74 59.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 110.694 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -120.41 -34.8 3.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.808 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.2 p90 -165.44 140.37 4.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.266 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -112.33 163.75 12.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.716 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 39.1 m-85 -114.26 163.42 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -1.003 . . . . 0.0 109.635 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.79 HG21 HD12 ' A' ' 22' ' ' ILE . 2.9 t -152.0 139.46 13.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.043 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' PHE . 3.6 m-20 -106.81 140.44 39.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.023 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 1.184 ' CE1' HD12 ' A' ' 20' ' ' LEU . 13.1 m-85 -107.48 170.43 7.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 0.0 110.631 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.727 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -116.22 16.08 15.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 111.328 -178.016 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.552 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 3.1 t -163.44 175.32 10.9 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.748 1.261 . . . . 0.0 112.272 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.74 -24.67 22.62 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -89.35 -22.16 22.75 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.831 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 10.7 t0 -81.4 -34.02 31.87 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.681 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 7.6 tt -76.28 -34.6 59.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -37.35 84.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.421 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 1.015 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.8 mtmt -72.3 -27.69 62.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.914 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -62.53 -34.07 76.18 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 5.5 tt -71.05 -44.49 65.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.29 1.18 22.57 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.488 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.045 HD12 HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -79.75 12.64 2.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.855 . . . . 0.0 110.414 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -78.28 2.67 17.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.08 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.06 33.63 5.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.045 HD11 HD12 ' A' ' 77' ' ' LEU . 22.3 mt -98.44 -166.25 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.253 -1.145 . . . . 0.0 110.982 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.9 mttt -166.78 49.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.304 1.049 . . . . 0.0 109.416 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.794 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -38.25 126.94 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.288 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.638 ' CE1' ' CD ' ' A' ' 29' ' ' LYS . 9.0 m-85 42.46 26.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 110.414 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 90.55 21.67 36.63 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' VAL . 22.9 m120 -136.19 99.51 4.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -1.136 . . . . 0.0 109.393 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.569 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -48.79 90.84 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 110.61 -179.099 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -48.83 135.24 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.85 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.2 ttpt -104.23 152.65 21.93 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -124.79 172.8 9.04 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.539 -0.726 . . . . 0.0 110.482 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.232 0.539 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 1.014 ' CG2' HG11 ' A' ' 50' ' ' VAL . 1.9 p -162.98 169.03 9.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 48.4 Cg_endo -76.58 -25.77 9.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.095 1.576 . . . . 0.0 110.734 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.721 ' CD1' HD13 ' A' ' 71' ' ' LEU . 87.6 m-85 -121.33 113.11 19.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.95 -1.094 . . . . 0.0 111.126 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -139.68 150.48 44.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 109.092 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -161.99 178.61 8.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.464 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -97.93 162.87 13.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.671 . . . . 0.0 109.374 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.062 HD12 ' CG2' ' A' ' 63' ' ' VAL . 6.0 mt -153.82 152.08 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.922 -1.111 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -143.5 -166.29 11.17 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.112 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.575 ' C ' HD22 ' A' ' 25' ' ' LEU . 2.7 t-20 72.71 46.1 0.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.553 -0.969 . . . . 0.0 109.883 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.928 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.9 mm? -100.56 128.71 46.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' HB3' HD21 ' A' ' 34' ' ' LEU . 56.9 t-20 -44.89 103.48 0.34 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.255 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.4 Cg_endo -73.63 -20.9 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.977 1.514 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -76.29 -14.7 60.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.861 . . . . 0.0 109.965 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 3.0 mmtt -110.91 -155.75 0.57 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -106.63 149.57 27.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.975 HG11 HG22 ' A' ' 54' ' ' THR . 3.1 t -67.97 -40.93 84.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.4 64.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.1 mm-40 -66.29 -35.39 80.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 109.308 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.928 HD13 ' HB3' ' A' ' 25' ' ' LEU . 55.6 mt -65.96 -36.31 82.98 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.367 -0.833 . . . . 0.0 109.081 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.533 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -60.89 -47.49 86.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.356 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 50.2 t -58.82 -41.51 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.611 -0.68 . . . . 0.0 110.072 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -61.49 -30.47 70.63 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.99 -1.069 . . . . 0.0 109.155 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.625 HD12 HD13 ' A' ' 87' ' ' ILE . 23.0 mm -86.34 -28.48 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.111 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.715 ' HA ' HG21 ' A' ' 49' ' ' VAL . 15.7 t -78.87 -26.27 43.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.334 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.09 -38.91 20.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.85 HD23 ' CD1' ' A' ' 77' ' ' LEU . 2.7 tp -63.98 -36.5 84.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CD2' HD13 ' A' ' 47' ' ' LEU . 12.1 m-85 -83.25 -21.85 33.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -81.33 -20.36 40.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -104.18 -16.43 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.553 -0.717 . . . . 0.0 109.625 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.72 -29.63 23.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 34.6 t70 111.99 28.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -101.08 -155.2 0.5 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.891 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -169.1 64.21 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.248 -0.908 . . . . 0.0 109.783 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.715 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.9 m -49.37 115.07 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.895 0.855 . . . . 0.0 110.096 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.014 HG11 ' CG2' ' A' ' 16' ' ' THR . 10.6 t -82.83 -31.66 9.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.832 -0.543 . . . . 0.0 110.567 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 20.9 t0 -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.752 HG22 HG13 ' A' ' 63' ' ' VAL . 3.5 t -154.2 94.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.747 . . . . 0.0 109.276 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.541 ' CG ' ' HB3' ' A' ' 62' ' ' TYR . 10.7 ptp180 -108.95 170.21 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.762 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.975 HG22 HG11 ' A' ' 31' ' ' VAL . 4.9 p -80.63 164.43 22.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.392 -0.818 . . . . 0.0 110.363 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 60' ' ' PHE . . . -134.58 124.0 3.35 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.496 HG22 ' OD1' ' A' ' 57' ' ' ASN . 25.3 m 44.12 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.495 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.496 ' OD1' HG22 ' A' ' 56' ' ' THR . 10.9 m120 60.75 -141.05 0.54 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.375 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -116.0 32.46 6.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 -20.67 11.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.605 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.3 t80 -119.19 -171.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 110.24 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 175.88 154.93 12.04 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -118.78 159.76 23.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -1.036 . . . . 0.0 109.31 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.062 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.2 t -150.54 143.07 17.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.862 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -116.42 148.87 40.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.661 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.679 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 14.0 m-85 -110.72 177.9 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.891 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -115.35 13.54 16.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 111.516 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.4 p 179.17 175.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.958 -1.089 . . . . 0.0 112.135 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -78.54 -24.04 45.89 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 -26.49 32.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.999 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.0 t0 -80.7 -25.86 37.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.721 HD13 ' CD1' ' A' ' 18' ' ' PHE . 4.4 tt -80.19 -33.83 37.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.29 -33.74 70.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.6 -0.688 . . . . 0.0 109.518 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HB2' HD21 ' A' ' 47' ' ' LEU . 1.6 mmtt -77.22 -27.92 53.59 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.679 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.53 -24.54 61.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.11 -48.39 29.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -10.85 60.4 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.85 ' CD1' HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -67.22 -2.47 5.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.58 -0.7 . . . . 0.0 110.489 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.46 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 12.0 m -45.16 -24.8 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.034 . . . . 0.0 110.349 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' LEU . . . -63.32 -16.92 58.8 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.801 HD11 ' HG3' ' A' ' 86' ' ' GLU . 3.4 pp -45.07 175.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.622 -0.928 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HA ' ' CA ' ' A' ' 86' ' ' GLU . 2.7 mttt -177.16 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.332 1.063 . . . . 0.0 109.362 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.808 HG22 HD23 ' A' ' 34' ' ' LEU . 1.7 p -37.98 123.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.621 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.4 m-85 42.42 26.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.483 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 90.11 23.84 31.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.674 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 m120 -135.41 84.43 2.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -1.194 . . . . 0.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.801 ' HG3' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -37.77 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.543 0.687 . . . . 0.0 110.744 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.776 ' CG1' HD13 ' A' ' 80' ' ' LEU . 4.9 pt -49.73 141.25 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.3 mmtm -107.57 155.9 19.6 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.082 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -120.25 172.76 7.56 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 110.573 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 1.027 HG23 HG23 ' A' ' 16' ' ' THR . 3.2 t . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.545 0.688 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 1.027 HG23 HG23 ' A' ' 15' ' ' THR . 81.8 p -124.46 153.21 69.29 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.581 -0.7 . . . . 0.0 110.716 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.3 Cg_endo -80.06 -22.37 7.35 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.155 1.608 . . . . 0.0 110.538 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.7 m-85 -107.02 113.06 26.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 110.876 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.4 m120 -139.06 150.76 46.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.528 -0.733 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.756 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -167.53 -179.63 4.47 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.646 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -109.24 154.95 21.7 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.938 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.67 HD12 ' CG2' ' A' ' 63' ' ' VAL . 3.7 mt -141.89 148.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.597 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -134.1 -169.29 12.0 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.7 t30 72.8 30.31 1.77 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.961 . . . . 0.0 110.021 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.99 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.8 mm? -82.26 128.65 34.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.745 ' H ' HD21 ' A' ' 34' ' ' LEU . 30.3 t-20 -40.07 100.27 0.21 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.65 -0.656 . . . . 0.0 110.371 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.6 Cg_endo -74.18 -16.72 22.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.455 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -83.87 -13.43 53.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.74 -156.86 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.8 m -104.15 152.06 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.54 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.023 HG11 HG22 ' A' ' 54' ' ' THR . 3.0 t -68.71 -28.38 39.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.454 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -62.25 -43.4 98.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 72.9 mm-40 -69.42 -31.1 69.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.737 . . . . 0.0 109.266 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.99 HD13 ' HB3' ' A' ' 25' ' ' LEU . 6.5 mt -68.01 -33.88 75.45 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.357 -0.839 . . . . 0.0 109.124 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HE3' HG12 ' A' ' 31' ' ' VAL . 3.5 mtmt -66.08 -52.13 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.567 -0.708 . . . . 0.0 109.436 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.2 t -56.86 -39.71 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 110.059 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -61.91 -34.65 76.44 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 109.047 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 34' ' ' LEU . 10.5 mt -82.3 -28.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.255 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -79.01 -27.36 43.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -83.81 -38.22 21.53 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 109.206 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.686 HD21 ' HG ' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -65.63 -34.51 78.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.63 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 8.0 m-85 -85.11 -20.41 30.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.89 -33.19 45.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.457 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -23.28 25.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.8 OUTLIER -83.73 -20.53 33.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 11.4 m-20 89.44 28.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.256 1.027 . . . . 0.0 108.326 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.03 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -75.91 -143.71 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -164.56 60.15 0.14 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.023 -1.048 . . . . 0.0 110.262 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.495 HG13 ' CB ' ' A' ' 42' ' ' PHE . 16.9 m -66.58 116.59 6.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.767 0.794 . . . . 0.0 109.859 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.909 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.4 t -99.26 -38.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.833 -0.542 . . . . 0.0 109.96 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.553 ' C ' HG23 ' A' ' 52' ' ' VAL . 15.2 t0 -143.51 154.53 43.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 110.447 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.0 HG22 HG13 ' A' ' 63' ' ' VAL . 20.5 t -154.74 105.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.747 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.03 167.98 9.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' THR . . . . . 1.023 HG22 HG11 ' A' ' 31' ' ' VAL . 16.3 p -81.11 160.0 24.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.367 -0.833 . . . . 0.0 110.233 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 56' ' ' THR . . . -130.91 120.13 2.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.764 HG23 ' N ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 70.46 -166.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.26 -1.141 . . . . 0.0 110.108 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.764 ' N ' HG23 ' A' ' 56' ' ' THR . 31.0 t-20 -42.99 -76.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.459 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.572 ' HG3' HG22 ' A' ' 31' ' ' VAL . 10.7 ttp180 -162.41 28.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.217 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' A' ' 24' ' ' ASN . 19.3 tptm -117.03 -6.27 11.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 109.858 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.669 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -121.84 -173.0 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.928 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 174.76 146.52 5.75 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.661 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.545 -0.974 . . . . 0.0 109.478 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.0 HG13 HG22 ' A' ' 52' ' ' VAL . 4.9 t -152.01 142.78 15.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.171 -0.955 . . . . 0.0 110.831 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -112.24 143.76 42.78 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.308 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 12.6 m-85 -107.53 177.09 4.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.601 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -117.28 12.36 14.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 111.427 -178.53 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.2 p -173.0 173.99 3.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.048 -1.032 . . . . 0.0 112.107 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.31 -23.86 43.23 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -25.05 31.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.936 ' OD1' HD12 ' A' ' 47' ' ' LEU . 3.9 t0 -81.99 -27.35 33.21 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD12 ' HD2' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -81.13 -33.74 33.0 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -72.88 -32.56 65.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.717 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 1.03 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -78.16 -29.89 48.88 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.512 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.74 -31.79 72.97 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.626 HD13 ' C ' ' A' ' 75' ' ' LEU . 2.9 tm? -72.11 -45.75 59.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.87 -19.4 58.89 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.085 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -71.58 -4.0 24.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.582 -0.699 . . . . 0.0 109.977 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 78' ' ' THR . 87.4 m -74.4 3.98 6.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.337 -0.852 . . . . 0.0 111.039 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.84 -8.75 75.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.686 ' HG ' HD21 ' A' ' 41' ' ' LEU . 3.5 mm? -79.36 -164.21 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.361 -1.082 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -149.26 50.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.801 ' HB ' HG23 ' A' ' 87' ' ' ILE . 8.9 p 13.92 -132.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.06 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.781 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -69.28 -3.36 13.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.448 -1.408 . . . . 0.0 109.919 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 152.05 36.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.768 ' O ' HG12 ' A' ' 82' ' ' VAL . 11.7 t-20 -170.45 116.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -1.037 . . . . 0.0 109.346 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.592 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -52.03 89.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 0.0 110.385 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.801 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.4 135.08 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.629 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 26.5 mttt -103.88 170.95 7.62 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 20' ' ' LEU . 4.9 mp -122.91 -175.28 3.13 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 110.492 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.498 ' CB ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.696 -0.627 . . . . 0.0 110.242 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.837 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.216 0.531 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.911 HG21 ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER 179.15 162.37 0.73 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.563 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.43 -36.63 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.27 1.669 . . . . 0.0 110.832 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 95.6 m-85 -106.49 112.77 25.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.987 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.6 m-20 -136.04 144.87 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.278 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 20' ' ' LEU . 2.9 pp -155.52 -176.08 5.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 52.9 t80 -110.64 159.35 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.599 HG22 HD21 ' A' ' 25' ' ' LEU . 24.9 mt -137.6 159.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.793 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' ILE . . . -147.44 176.77 26.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 88' ' ' LYS . 2.8 t30 62.62 57.73 1.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -1.137 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.905 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.2 mm? -90.32 -90.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.782 ' CB ' HD21 ' A' ' 34' ' ' LEU . 37.2 t-20 -179.15 92.01 0.21 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.27 -13.86 28.27 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.966 1.508 . . . . 0.0 110.441 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -82.49 -14.36 55.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.973 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -116.57 -156.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.844 . . . . 0.0 109.882 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -99.57 147.98 24.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 54' ' ' THR . 21.9 t -68.92 -27.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.55 -40.8 89.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.067 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 43.0 mm-40 -67.59 -33.0 74.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.499 -0.75 . . . . 0.0 109.325 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.905 HD13 ' HB3' ' A' ' 25' ' ' LEU . 20.2 mt -66.01 -37.85 86.97 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.417 -0.802 . . . . 0.0 109.017 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' CG ' ' HB ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -60.83 -50.16 74.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 32' ' ' ALA . 10.5 t -60.83 -35.12 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.526 -0.734 . . . . 0.0 109.247 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.714 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -59.68 -31.98 70.07 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.849 ' CD1' HD13 ' A' ' 87' ' ' ILE . 29.1 mm -80.71 -31.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.616 -0.677 . . . . 0.0 109.367 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -78.55 -23.59 46.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 108.914 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.939 HD21 ' HB3' ' A' ' 80' ' ' LEU . 6.3 tp -66.7 -32.98 74.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.617 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 10.4 m-85 -87.72 -20.75 25.8 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -80.98 -29.16 35.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.211 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HG3' ' OE1' ' A' ' 40' ' ' GLU . 17.2 mttt -87.34 -17.72 31.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 109.387 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.627 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.2 m-80 -92.27 -20.34 21.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.925 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.2 t0 90.21 29.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.939 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -74.8 -137.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.76 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -173.63 58.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.188 -0.945 . . . . 0.0 109.604 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.553 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 12.8 m -58.42 117.51 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.942 0.877 . . . . 0.0 110.141 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.911 ' HB ' HG21 ' A' ' 16' ' ' THR . 1.9 t -96.64 -33.54 4.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.909 -0.494 . . . . 0.0 109.866 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.536 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 6.9 t70 -144.27 149.34 36.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.067 -1.02 . . . . 0.0 110.884 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.6 HG12 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -138.16 150.66 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 0.0 109.776 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -154.96 164.26 39.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.938 . . . . 0.0 110.405 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.73 HG22 HG12 ' A' ' 31' ' ' VAL . 63.0 p -94.86 167.13 11.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.822 . . . . 0.0 110.571 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -126.5 117.33 2.77 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.1 m 55.43 -161.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -1.125 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.647 ' H ' HG22 ' A' ' 56' ' ' THR . 35.9 m120 -42.43 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.569 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 2.3 ptp180 -162.93 49.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.327 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -124.5 -23.13 4.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.398 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -128.14 -179.8 5.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -163.87 164.59 36.52 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 2.6 t80 -120.74 166.27 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.977 . . . . 0.0 109.291 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.606 HG12 HD11 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -165.48 168.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.818 -1.176 . . . . 0.0 111.543 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 76.5 m-20 -137.13 142.4 42.26 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.772 ' CE2' ' HB2' ' A' ' 74' ' ' ALA . 28.2 m-85 -104.6 -178.43 3.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.732 -0.605 . . . . 0.0 110.721 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.579 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.69 17.99 13.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 0.0 111.05 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 18.9 p 177.95 176.63 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.463 1.125 . . . . 0.0 112.135 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.99 -24.26 55.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -28.6 49.68 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.363 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.76 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 88.3 m-20 -79.22 -28.02 42.51 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.54 -36.88 57.43 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.064 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.65 -32.78 72.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.419 -0.801 . . . . 0.0 109.576 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.939 ' HB2' HD21 ' A' ' 47' ' ' LEU . 5.3 mmtp -76.8 -29.4 55.98 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.772 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -64.83 -29.94 70.92 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.483 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.1 -44.03 60.96 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.548 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.14 -7.2 47.75 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -73.07 4.93 3.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 110.63 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.542 ' O ' HG22 ' A' ' 78' ' ' THR . 89.5 m -78.13 6.95 6.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 110.541 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.437 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . -118.32 19.55 10.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.939 ' HB3' HD21 ' A' ' 41' ' ' LEU . 2.8 mt -124.61 122.57 37.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.141 -1.211 . . . . 0.0 111.395 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.7 mttm -92.69 89.24 6.58 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.372 1.082 . . . . 0.0 108.517 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.989 HG21 HG23 ' A' ' 87' ' ' ILE . 3.0 m -36.93 -104.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -82.43 20.08 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.063 -1.023 . . . . 0.0 110.647 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.71 10.33 5.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 82' ' ' VAL . 4.4 m120 -145.25 117.45 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.236 -1.155 . . . . 0.0 109.726 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 80' ' ' LEU . 7.4 tp10 -56.68 83.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.419 -0.8 . . . . 0.0 109.982 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.989 HG23 HG21 ' A' ' 82' ' ' VAL . 1.7 pt -43.57 126.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -102.22 131.86 48.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.746 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -108.44 173.07 6.48 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.926 -1.108 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 89' ' ' LEU . 3.8 mt-10 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.138 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.646 HG22 HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 121.326 0.584 . . . . 0.0 109.917 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.972 ' CG2' HG11 ' A' ' 50' ' ' VAL . 45.9 p -130.24 153.4 81.2 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 110.309 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.56 -22.08 6.91 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.127 1.593 . . . . 0.0 110.742 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 75.3 m-85 -113.57 108.78 17.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.975 -1.078 . . . . 0.0 111.027 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.1 m120 -137.91 149.0 45.83 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 109.041 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -164.27 171.61 14.66 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 110.261 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.651 ' C ' HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.99 160.14 16.53 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.47 -0.769 . . . . 0.0 109.207 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.778 HD13 HG23 ' A' ' 63' ' ' VAL . 1.6 mp -147.61 161.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.975 -1.078 . . . . 0.0 109.673 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -160.28 -160.07 10.32 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.084 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 1.0 OUTLIER 67.16 55.09 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -1.05 . . . . 0.0 110.141 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.648 ' HB3' HD22 ' A' ' 34' ' ' LEU . 3.7 mt -104.12 -133.67 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.321 -0.862 . . . . 0.0 110.066 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 36.4 t-20 -143.0 109.78 5.49 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.111 -0.993 . . . . 0.0 110.235 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.59 2.66 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.993 1.522 . . . . 0.0 110.698 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 34.7 m-80 -113.59 18.3 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.968 . . . . 0.0 109.169 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.6 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.0 tptt -138.64 -158.34 0.85 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.717 -0.614 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -107.29 142.59 36.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.778 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.6 t -69.29 -32.07 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.386 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -62.83 -27.81 69.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.003 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 11.3 mm-40 -77.59 -42.3 35.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' A' ' 31' ' ' VAL . 3.8 mt -61.89 -37.93 86.43 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.259 -0.901 . . . . 0.0 109.092 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.744 ' HG3' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -63.17 -52.07 63.85 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.618 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 32' ' ' ALA . 48.7 t -63.41 -28.14 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.252 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.43 -34.14 77.5 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 108.587 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.655 HD11 HG21 ' A' ' 87' ' ' ILE . 6.5 mt -83.89 -25.48 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.589 ' HA ' HG21 ' A' ' 49' ' ' VAL . 13.1 m -80.3 -28.86 38.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -82.43 -37.34 25.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.533 -0.73 . . . . 0.0 109.238 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.646 HD23 ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -70.23 -30.44 67.51 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.555 -0.716 . . . . 0.0 109.18 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.844 ' CE1' HD22 ' A' ' 77' ' ' LEU . 3.2 m-85 -91.99 -14.63 29.13 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -0.82 . . . . 0.0 109.363 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -92.19 -28.57 16.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.697 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.51 -21.23 21.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.41 -0.806 . . . . 0.0 109.089 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 3.1 m120 -79.25 -60.01 2.54 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.388 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 147.37 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.186 0.517 . . . . 0.0 109.802 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.885 HD21 ' HB3' ' A' ' 73' ' ' LYS . 3.8 mm? -98.35 -157.72 0.62 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.558 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -156.93 63.82 0.51 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.7 m -58.28 117.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.929 0.871 . . . . 0.0 109.789 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.972 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -90.31 -44.26 14.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 O-C-N 121.735 -0.603 . . . . 0.0 110.188 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.501 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 34.3 t0 -141.04 152.74 45.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.07 -1.019 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.809 HG22 HG13 ' A' ' 63' ' ' VAL . 2.8 t -152.36 105.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 167.45 10.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.778 HG22 ' CG1' ' A' ' 31' ' ' VAL . 47.3 p -85.16 163.65 18.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.4 -0.812 . . . . 0.0 110.416 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.497 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -137.76 137.32 8.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.553 HG22 ' N ' ' A' ' 57' ' ' ASN . 28.8 m 60.36 176.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -1.115 . . . . 0.0 109.961 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.553 ' N ' HG22 ' A' ' 56' ' ' THR . 20.0 m120 -40.98 -59.68 1.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.581 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -168.08 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.965 . . . . 0.0 110.193 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.623 ' C ' HD12 ' A' ' 25' ' ' LEU . 12.0 tttt -127.14 -11.04 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.448 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.3 t80 -122.18 179.41 4.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.26 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.64 163.79 31.33 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.5 t80 -126.25 157.24 38.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.467 -1.019 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.809 HG13 HG22 ' A' ' 52' ' ' VAL . 4.2 t -151.72 145.2 16.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.813 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.1 m-20 -116.35 144.01 44.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.405 -0.81 . . . . 0.0 109.705 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.838 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 19.6 m-85 -107.05 176.71 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.571 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.622 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -112.28 13.62 20.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 111.609 -178.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 25.0 p 177.66 178.16 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.401 1.096 . . . . 0.0 112.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.68 -22.65 53.69 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' OE2' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.59 -25.84 38.23 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.493 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.759 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 85.4 m-20 -83.3 -27.81 29.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD13 ' C ' ' A' ' 71' ' ' LEU . 3.0 tm? -78.7 -34.06 46.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.772 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.03 -38.51 61.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.885 ' HB3' HD21 ' A' ' 47' ' ' LEU . 14.7 mtmt -79.55 -18.21 52.3 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.838 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -79.26 -28.1 42.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.379 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.6 tt -79.12 -44.32 22.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.435 -0.791 . . . . 0.0 109.105 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.0 mt-10 -71.34 -24.26 62.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.308 -0.87 . . . . 0.0 109.29 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -64.45 -15.05 60.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.0 109.972 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -37.93 -28.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.878 0.847 . . . . 0.0 110.891 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -51.73 -26.17 16.62 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 87' ' ' ILE . 1.6 pt? -65.52 131.91 47.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -1.18 . . . . 0.0 110.896 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 3.5 mttm -109.9 80.76 1.35 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.08 0.943 . . . . 0.0 109.964 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -39.71 122.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.421 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.6 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.9 m-85 43.33 24.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 93.38 19.16 36.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.56 ' O ' HG12 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -133.31 91.7 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 110.173 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 9.2 tt0 -41.1 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 110.733 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -47.64 141.33 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.771 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -116.32 157.89 24.28 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.86 174.68 8.2 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.163 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 110.166 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 1.015 HG23 HG23 ' A' ' 16' ' ' THR . 5.3 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.561 0.696 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . 1.015 HG23 HG23 ' A' ' 15' ' ' THR . 32.0 p -119.64 163.29 28.19 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.579 -0.7 . . . . 0.0 110.417 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.67 -27.65 10.49 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.015 1.534 . . . . 0.0 110.661 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 97.7 m-85 -102.63 112.52 25.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.374 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 19' ' ' ASN . 1.2 m-80 -143.05 151.97 41.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.748 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.0 pp -161.3 -176.41 5.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.408 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 16.3 t80 -108.75 161.5 15.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.897 HD12 HG21 ' A' ' 63' ' ' VAL . 5.1 mt -140.19 159.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -143.5 170.82 25.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.659 ' C ' HD22 ' A' ' 25' ' ' LEU . 28.2 t30 67.81 71.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -1.118 . . . . 0.0 109.944 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.773 HD13 HD12 ' A' ' 34' ' ' LEU . 4.2 mm? -106.15 19.68 20.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' PHE . 2.8 t30 55.94 99.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 47.2 Cg_endo -73.39 -19.57 21.92 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.02 1.537 . . . . 0.0 110.289 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.2 -19.83 56.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 83' ' ' PHE . 5.6 tmtt? -98.54 -154.29 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.855 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.724 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -113.56 139.56 48.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 110.384 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.897 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.6 t -67.98 -29.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.003 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.45 -37.35 87.21 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 69.3 mm-40 -70.68 -27.53 64.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.773 HD12 HD13 ' A' ' 25' ' ' LEU . 3.2 mm? -64.43 -42.58 95.94 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.404 -0.81 . . . . 0.0 109.106 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.829 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.89 -54.65 27.55 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.981 -0.687 . . . . 0.0 109.8 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 32' ' ' ALA . 4.9 t -62.66 -30.21 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.747 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -65.97 -40.01 90.9 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.758 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 34' ' ' LEU . 10.8 mm -78.58 -24.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.109 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.861 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.4 p -79.78 -32.94 40.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.26 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -80.34 -37.9 31.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.148 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.35 -30.91 69.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 0.0 109.167 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 5.5 m-85 -89.03 -16.0 32.7 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.499 -0.751 . . . . 0.0 109.328 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -90.8 -27.37 18.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.67 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.474 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -92.02 -21.1 20.69 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.694 0.759 . . . . 0.0 109.305 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -81.25 -59.16 2.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.2 m-20 144.61 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.204 0.601 . . . . 0.0 109.64 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' OD1' ' A' ' 70' ' ' ASP . 2.7 mm? -99.26 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.205 -0.935 . . . . 0.0 109.842 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.82 61.87 0.47 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 39' ' ' SER . 11.7 m -58.28 116.14 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.814 0.816 . . . . 0.0 109.843 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.853 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.0 OUTLIER -88.95 -45.55 15.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 121.209 0.528 . . . . 0.0 109.779 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 12.6 t0 -143.37 159.22 42.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.637 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 35' ' ' LYS . 6.2 p -158.81 100.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 110.068 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -96.58 164.72 12.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.897 ' HB ' HG11 ' A' ' 31' ' ' VAL . 1.3 p -87.32 159.15 18.87 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.167 -0.958 . . . . 0.0 110.14 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -121.04 120.37 4.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.583 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 10.0 m 50.42 102.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -1.124 . . . . 0.0 110.544 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' THR . 90.5 m-20 41.26 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.441 -0.787 . . . . 0.0 110.675 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.583 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -149.0 52.45 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 0.0 110.454 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 4.2 tmtt? -123.74 -24.31 4.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.926 . . . . 0.0 110.34 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.762 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.6 m-85 -138.15 -158.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.371 -0.831 . . . . 0.0 109.37 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 168.83 165.77 26.77 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.267 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.569 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 10.2 t80 -122.84 158.53 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.564 -0.962 . . . . 0.0 109.38 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.897 HG21 HD12 ' A' ' 22' ' ' ILE . 3.7 t -149.72 144.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.112 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 2.9 m-20 -114.31 139.18 49.65 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.696 ' HE2' HD21 ' A' ' 20' ' ' LEU . 17.8 m-85 -104.15 173.81 6.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.442 -0.786 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.695 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.16 13.48 15.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 111.577 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.535 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.7 p -171.82 173.87 4.39 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.207 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.51 -24.32 42.32 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.98 -25.2 32.5 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.989 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.866 ' OD1' HD12 ' A' ' 47' ' ' LEU . 4.8 t0 -83.12 -25.55 31.83 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.784 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.7 tm? -82.73 -31.24 28.56 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.69 -34.68 62.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.581 -0.699 . . . . 0.0 109.529 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.833 ' HG2' HD21 ' A' ' 47' ' ' LEU . 1.5 tppt? -78.56 -28.4 45.94 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.686 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -70.06 -25.99 63.8 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.473 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -72.96 -48.65 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.604 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -5.77 45.12 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.176 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -75.85 6.31 5.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.491 -0.755 . . . . 0.0 110.446 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -65.27 -8.42 17.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.074 -1.016 . . . . 0.0 110.312 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.24 29.55 8.1 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.148 HD22 HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.31 117.1 30.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -1.057 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -112.47 93.39 4.42 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.944 1.354 . . . . 0.0 109.381 178.597 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.747 HG13 ' HB1' ' A' ' 37' ' ' ALA . 23.5 t -46.66 -113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.269 -2.93 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.29 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 21.9 m-85 -80.31 47.57 0.93 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 120.705 -1.247 . . . . 0.0 109.673 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 81' ' ' LYS . . . 81.29 26.34 52.22 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.517 ' O ' ' ND2' ' A' ' 85' ' ' ASN . 7.9 p-10 -137.63 74.94 1.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -1.102 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.5 tm-20 -43.05 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.666 HD13 ' N ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -54.13 127.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.512 0.673 . . . . 0.0 110.402 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 23' ' ' GLY . 4.4 mttt -102.54 129.84 49.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.802 . . . . 0.0 109.577 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -111.18 172.99 6.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.964 -1.085 . . . . 0.0 110.685 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.751 . . . . 0.0 109.995 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.532 0.682 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.819 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -135.34 164.95 40.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.1 Cg_endo -77.24 -38.49 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.167 1.614 . . . . 0.0 110.53 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.3 m-85 -94.24 107.14 19.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.572 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 24.8 m-20 -136.41 154.3 50.83 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.356 179.467 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.866 HD22 ' N ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -170.51 -176.71 2.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 110.809 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.866 ' N ' HD22 ' A' ' 20' ' ' LEU . 4.5 t80 -105.04 146.74 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.507 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 20' ' ' LEU . 1.5 mt -141.09 149.76 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -149.36 -156.22 7.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.868 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 1.5 t-20 67.52 41.59 2.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -1.022 . . . . 0.0 110.027 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 34' ' ' LEU . 3.6 mm? -84.73 -167.82 1.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -119.98 107.3 40.09 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HG3' ' A' ' 58' ' ' ARG . 44.9 Cg_endo -73.25 -5.0 16.41 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.082 1.569 . . . . 0.0 110.324 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.78 -18.69 50.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.735 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 -155.51 0.58 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.554 -0.716 . . . . 0.0 109.709 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.607 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.21 141.28 32.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -0.999 . . . . 0.0 110.51 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 58' ' ' ARG . 3.3 t -65.48 -29.86 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.178 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -65.84 -38.67 89.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.849 . . . . 0.0 109.047 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 63.6 mm-40 -67.12 -30.73 70.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 25' ' ' LEU . 3.9 mm? -66.53 -40.61 89.2 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.382 -0.824 . . . . 0.0 108.917 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.614 ' HG2' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -58.4 -53.3 59.83 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.362 -0.836 . . . . 0.0 108.911 178.822 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -65.27 -30.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.45 -29.63 70.88 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.534 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.658 HD11 HG21 ' A' ' 87' ' ' ILE . 12.9 mm -84.04 -28.55 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.198 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.966 ' HA ' HG21 ' A' ' 49' ' ' VAL . 31.0 t -80.05 -27.83 39.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 108.893 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.526 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 2.8 tm-20 -81.88 -36.32 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.377 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.107 ' CD2' HD13 ' A' ' 80' ' ' LEU . 5.0 tp -70.96 -31.08 67.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.077 ' CE1' HD13 ' A' ' 77' ' ' LEU . 3.5 m-30 -90.98 -14.88 30.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.481 -0.762 . . . . 0.0 109.393 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -90.02 -27.27 19.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.405 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.43 -22.22 20.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.811 . . . . 0.0 109.225 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.4 m-80 -79.59 -58.99 2.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.684 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.2 m-20 148.03 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.143 0.497 . . . . 0.0 110.153 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.901 HD11 ' HB3' ' A' ' 73' ' ' LYS . 6.3 mp -103.4 -158.17 0.65 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.69 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.87 64.28 0.46 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.966 HG21 ' HA ' ' A' ' 39' ' ' SER . 9.5 m -53.08 118.01 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.995 0.903 . . . . 0.0 109.761 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.8 t -89.54 -39.12 12.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.064 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.488 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -150.22 158.12 43.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.698 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.739 HG23 HG22 ' A' ' 63' ' ' VAL . 9.8 p -144.07 159.97 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.43 -0.794 . . . . 0.0 109.594 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -155.55 164.08 39.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 110.104 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.549 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -116.83 154.89 29.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 110.513 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -123.71 127.84 6.69 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.9 m 71.31 -171.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.384 -1.068 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.696 ' H ' HG22 ' A' ' 56' ' ' THR . 3.7 p30 -48.67 -53.0 20.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.556 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.656 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -179.41 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.115 -0.991 . . . . 0.0 110.565 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -126.73 -22.87 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.561 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.576 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.6 m-85 -122.57 -177.18 3.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.937 . . . . 0.0 109.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . 176.54 135.43 2.16 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.235 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.731 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -98.09 169.53 9.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.989 . . . . 0.0 109.423 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.739 HG22 HG23 ' A' ' 52' ' ' VAL . 17.6 t -158.82 162.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.139 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -130.99 140.6 50.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.697 -0.627 . . . . 0.0 109.479 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.789 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 16.8 m-85 -110.87 174.64 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.845 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.668 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.84 11.53 19.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.498 -0.751 . . . . 0.0 111.309 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.645 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.6 p -173.08 173.51 3.65 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.26 1.029 . . . . 0.0 112.185 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' N ' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.64 -23.56 45.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -84.44 -23.69 29.86 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.277 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 4.4 t0 -83.69 -26.94 29.39 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 71' ' ' LEU . 9.8 tt -81.4 -33.98 31.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.266 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -74.96 -32.96 61.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.456 -0.777 . . . . 0.0 109.621 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.901 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -81.47 -23.19 37.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.789 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.99 -29.94 63.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.66 HD13 ' C ' ' A' ' 75' ' ' LEU . 3.1 tm? -75.96 -45.53 34.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -66.94 -23.39 65.96 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.435 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.077 HD13 ' CE1' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -67.57 -8.05 31.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.55 0.691 . . . . 0.0 110.391 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 87' ' ' ILE . 22.2 m -67.4 0.37 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.646 -0.659 . . . . 0.0 111.556 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.1 16.93 54.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.107 HD13 ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -103.09 -159.12 0.71 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.988 . . . . 0.0 110.541 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -164.76 49.67 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.344 1.068 . . . . 0.0 108.914 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.749 HG21 HG23 ' A' ' 87' ' ' ILE . 17.0 t 0.35 -115.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.769 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 4.0 m-30 -76.81 9.32 2.93 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 128.51 35.34 0.5 Allowed Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.522 ' CA ' ' HG3' ' A' ' 81' ' ' LYS . 12.2 m120 -161.73 100.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 109.565 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.586 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -49.55 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.308 -0.87 . . . . 0.0 110.406 -179.212 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.749 HG23 HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -42.71 143.13 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 5.5 mtpp -119.26 159.68 23.63 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.596 -0.69 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -112.82 -179.2 3.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 110.226 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 21' ' ' PHE . 1.3 tt0 . . . . . 0 C--N 1.299 -1.63 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.744 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 16' ' ' THR . 5.7 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.535 0.683 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.928 ' CG2' HG11 ' A' ' 50' ' ' VAL . 39.1 p -105.6 161.85 21.53 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.4 Cg_endo -74.85 -25.45 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.083 1.57 . . . . 0.0 110.762 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.711 ' CD1' HD22 ' A' ' 71' ' ' LEU . 97.6 m-85 -102.2 110.16 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.973 -1.079 . . . . 0.0 110.567 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 2.0 m120 -140.88 149.75 42.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.712 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -163.72 -175.97 4.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 8.2 t80 -118.4 144.53 45.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.542 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 mt -127.46 157.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.196 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.96 -169.68 11.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.714 ' C ' HD22 ' A' ' 25' ' ' LEU . 42.1 t30 72.67 71.8 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.562 -0.963 . . . . 0.0 110.132 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.983 HD13 HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -110.59 157.78 19.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 110.268 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.519 ' ND2' ' OD1' ' A' ' 28' ' ' ASN . 39.4 t-20 -87.88 109.69 29.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.07 -28.33 12.98 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.967 1.509 . . . . 0.0 110.687 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' OD1' ' ND2' ' A' ' 26' ' ' ASN . 32.7 p30 -75.0 -13.68 60.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -110.49 -154.94 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.514 -0.741 . . . . 0.0 109.681 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.555 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.4 m -109.98 145.64 36.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.496 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.655 HG12 ' HE3' ' A' ' 35' ' ' LYS . 2.9 t -69.97 -30.95 46.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.2 -0.937 . . . . 0.0 109.389 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -67.1 -37.19 83.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.856 . . . . 0.0 109.26 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 63.2 mm-40 -68.71 -34.28 75.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.41 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.983 HD22 HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.03 -35.57 81.59 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.403 -0.811 . . . . 0.0 109.104 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.707 ' HG3' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -64.38 -48.2 76.35 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.472 -0.767 . . . . 0.0 109.25 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 32' ' ' ALA . 9.9 t -61.26 -34.61 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.703 ' CB ' HG23 ' A' ' 82' ' ' VAL . . . -62.89 -34.05 76.6 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.214 -0.929 . . . . 0.0 108.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.791 ' CD1' HD13 ' A' ' 87' ' ' ILE . 22.4 mm -81.86 -28.04 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.736 ' HA ' HG21 ' A' ' 49' ' ' VAL . 11.5 t -79.02 -27.68 43.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.049 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.16 -39.15 23.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.601 0.715 . . . . 0.0 109.125 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.714 HD22 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.08 -32.73 74.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.923 ' CD2' HD23 ' A' ' 47' ' ' LEU . 9.3 m-85 -86.31 -19.16 30.26 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.393 -0.817 . . . . 0.0 109.212 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.48 -26.37 20.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.766 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -91.8 -19.14 22.87 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.485 -0.76 . . . . 0.0 109.051 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.617 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -81.89 -59.48 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.601 -0.687 . . . . 0.0 109.483 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.4 m-20 147.41 30.61 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.15 0.5 . . . . 0.0 110.002 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.923 HD23 ' CD2' ' A' ' 42' ' ' PHE . 3.4 mp -103.59 -157.06 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.41 65.29 0.44 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 39' ' ' SER . 5.8 m -53.17 117.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.935 0.874 . . . . 0.0 109.904 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.928 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.24 -44.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.164 0.506 . . . . 0.0 109.943 -179.489 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 13.2 t70 -138.78 149.53 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 35' ' ' LYS . 2.4 t -152.3 102.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.78 . . . . 0.0 109.466 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 62' ' ' TYR . 64.1 mtm180 -114.37 168.83 9.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.089 -1.007 . . . . 0.0 110.466 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.629 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.3 p -76.35 179.02 6.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -138.73 131.63 5.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.9 HG22 ' OD1' ' A' ' 57' ' ' ASN . 53.5 m 57.32 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.9 ' OD1' HG22 ' A' ' 56' ' ' THR . 23.0 p-10 -161.0 90.54 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 110.489 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.3 ttp180 53.27 19.84 1.68 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -113.01 -30.0 7.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.689 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.0 m-85 -138.6 -177.74 5.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -159.83 135.47 4.13 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.193 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.684 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 2.6 m-85 -91.47 154.78 18.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -1.15 . . . . 0.0 109.635 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 52' ' ' VAL . 3.7 t -151.78 143.7 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.843 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.79 143.51 47.81 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.428 -0.795 . . . . 0.0 109.58 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.946 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 53.8 m-85 -108.2 173.48 6.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.946 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.722 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.25 16.68 14.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 111.622 -178.031 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 2.4 t -165.18 175.68 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.729 1.252 . . . . 0.0 112.216 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.544 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -88.23 -25.41 22.88 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.451 ' OE1' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.86 -21.65 26.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 9.4 t0 -84.0 -31.01 25.71 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.711 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.7 tp -75.16 -35.57 61.59 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.482 0.658 . . . . 0.0 109.336 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.86 -37.87 67.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.698 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 1.039 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.05 -26.74 56.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.33 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.946 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.05 -26.77 61.4 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.949 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -70.94 -47.16 60.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.73 -15.78 63.21 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.748 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.2 mm? -73.22 1.37 9.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.586 -0.696 . . . . 0.0 110.246 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.99 ' OG1' HD13 ' A' ' 89' ' ' LEU . 38.7 m -76.29 4.13 9.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.584 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.97 19.22 33.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.006 HD21 HD11 ' A' ' 87' ' ' ILE . 2.5 pp -100.33 122.65 43.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.217 -1.167 . . . . 0.0 110.56 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 85' ' ' ASN . 2.2 ttmt -82.9 81.55 8.56 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.905 1.336 . . . . 0.0 110.147 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.774 HG22 ' N ' ' A' ' 83' ' ' PHE . 1.7 p -36.32 -98.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.27 -2.851 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.774 ' N ' HG22 ' A' ' 82' ' ' VAL . 2.2 m-30 -91.29 20.67 4.96 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.026 -1.046 . . . . 0.0 110.533 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.554 ' CA ' ' HG2' ' A' ' 81' ' ' LYS . . . 120.77 23.16 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.584 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 1.9 m-20 -155.58 100.04 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 0.0 109.745 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -42.69 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.085 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.006 HD11 HD21 ' A' ' 80' ' ' LEU . 6.1 pt -42.89 154.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.278 -0.889 . . . . 0.0 110.575 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -121.66 157.92 29.8 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.76 -0.588 . . . . 0.0 109.457 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.99 HD13 ' OG1' ' A' ' 78' ' ' THR . 7.7 mp -112.0 -179.04 3.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.058 -1.026 . . . . 0.0 110.488 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 21' ' ' PHE . 2.2 tt0 . . . . . 0 C--N 1.299 -1.6 0 O-C-N 121.659 -0.651 . . . . 0.0 110.159 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 15' ' ' THR . 7.9 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.237 0.541 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.785 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -171.15 164.32 4.99 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.41 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.7 Cg_endo -77.98 -27.21 5.93 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.201 1.632 . . . . 0.0 110.715 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 87.3 m-85 -110.24 116.73 32.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.6 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 5.9 m120 -142.8 157.01 45.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -0.809 . . . . 0.0 109.73 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.824 HD23 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -164.3 168.33 18.84 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.478 -0.763 . . . . 0.0 110.192 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.565 ' N ' HD22 ' A' ' 20' ' ' LEU . 45.6 t80 -102.6 157.24 17.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 11.4 mt -126.68 165.89 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -160.01 106.59 0.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.625 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 7.9 t-20 147.5 66.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.092 HD13 HD22 ' A' ' 34' ' ' LEU . 4.6 mm? -98.44 133.54 42.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 110.958 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.585 ' HB2' HD11 ' A' ' 34' ' ' LEU . 9.6 t-20 -58.36 113.11 5.9 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.706 -0.621 . . . . 0.0 109.946 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.76 -36.91 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.901 1.474 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -74.87 -16.27 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.623 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.574 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 4.1 mmtt -110.4 -155.2 0.56 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.694 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -122.01 148.52 44.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.986 HG13 ' CD1' ' A' ' 25' ' ' LEU . 2.5 t -69.62 -35.52 66.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.244 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -54.98 -44.7 74.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 108.906 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 20.8 mm-40 -61.88 -44.77 96.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.092 HD22 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.26 -31.29 65.42 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.828 ' HD2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.87 -60.71 3.41 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.777 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 83.7 t -58.47 -40.48 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.54 -0.725 . . . . 0.0 109.07 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.69 -33.03 73.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 34' ' ' LEU . 23.8 mt -80.32 -30.23 12.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.562 -0.711 . . . . 0.0 109.138 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 1.4 t -77.42 -27.28 52.27 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.634 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -84.02 -40.92 17.81 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.534 0.683 . . . . 0.0 109.414 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.109 HD21 HD22 ' A' ' 80' ' ' LEU . 6.2 tp -61.75 -35.29 77.67 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.142 ' CE2' HD13 ' A' ' 77' ' ' LEU . 7.3 m-85 -84.62 -22.63 29.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -72.23 -34.81 68.6 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.556 0.694 . . . . 0.0 109.285 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HE2' ' OE1' ' A' ' 40' ' ' GLU . 9.6 mtmt -78.08 -17.81 56.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.442 -0.787 . . . . 0.0 109.242 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.614 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -88.46 -16.26 33.25 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.583 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 88.86 30.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.884 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -82.1 -138.3 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -178.95 57.39 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 49' ' ' VAL . 21.0 m -50.96 117.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.834 0.826 . . . . 0.0 110.033 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.785 HG21 HG21 ' A' ' 16' ' ' THR . 0.5 OUTLIER -89.22 -45.31 15.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-O 121.226 0.536 . . . . 0.0 109.94 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -143.69 160.22 41.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.781 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.828 HG12 ' HD2' ' A' ' 35' ' ' LYS . 2.5 t -152.4 157.49 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.848 . . . . 0.0 109.494 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.09 164.25 33.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.206 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.474 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.9 p -91.83 156.18 17.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 110.847 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.579 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.57 129.51 9.34 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.752 HG21 ' HD2' ' A' ' 59' ' ' LYS . 2.6 m 59.61 13.59 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.99 . . . . 0.0 109.39 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER 70.66 15.75 6.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 111.328 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 168.19 -21.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.807 -1.183 . . . . 0.0 111.543 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HD2' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -89.06 -65.34 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.929 -1.107 . . . . 0.0 111.728 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 1.2 m-85 -103.66 -148.53 0.39 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.043 -1.035 . . . . 0.0 110.617 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 178.62 -179.85 48.63 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.583 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 40.9 t80 -151.96 150.44 30.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.801 HG22 HG13 ' A' ' 52' ' ' VAL . 4.0 t -150.69 153.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.219 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.583 ' OD1' ' CZ ' ' A' ' 62' ' ' TYR . 3.6 m-20 -122.27 138.03 54.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 66.4 m-85 -104.66 172.32 6.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 109.912 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.765 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -117.52 17.11 14.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 111.254 -178.657 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 14.8 p -167.6 173.4 8.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.563 1.173 . . . . 0.0 112.314 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -76.33 -25.31 54.61 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -76.55 -27.73 56.01 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.518 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.605 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 87.8 m-20 -79.92 -30.35 39.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 12.6 tp -71.82 -38.73 70.15 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.297 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -71.48 -30.88 66.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.741 . . . . 0.0 109.621 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . 33.7 mmtt -83.49 -27.2 29.59 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.636 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.8 -30.93 71.64 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -78.06 -44.28 26.8 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -21.64 59.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.363 -0.836 . . . . 0.0 109.494 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.142 HD13 ' CE2' ' A' ' 42' ' ' PHE . 2.9 mt -72.19 -4.9 32.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' THR . . . . . 1.027 ' OG1' HD11 ' A' ' 89' ' ' LEU . 32.3 m -71.47 2.27 5.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 110.956 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.94 -3.15 56.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.109 HD22 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -91.34 135.59 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 110.346 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.51 76.06 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.998 0.904 . . . . 0.0 110.573 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.885 ' HB ' HG23 ' A' ' 87' ' ' ILE . 3.4 t -43.17 129.28 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER 46.34 22.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.518 -179.016 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.95 17.62 43.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.3 m120 -133.89 110.35 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.052 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 29.2 tt0 -58.05 81.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.099 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 82' ' ' VAL . 2.7 pt -43.84 123.69 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.454 -0.779 . . . . 0.0 110.406 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.6 mtpm? -106.72 132.75 52.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.46 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.027 HD11 ' OG1' ' A' ' 78' ' ' THR . 0.0 OUTLIER -121.69 179.25 4.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.944 -1.098 . . . . 0.0 111.329 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.641 -0.662 . . . . 0.0 109.616 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.838 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.202 0.525 . . . . 0.0 110.138 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 15' ' ' THR . 1.1 p -164.79 154.6 11.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 110.734 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 65' ' ' PHE . 51.3 Cg_endo -76.78 -39.82 0.62 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.205 1.634 . . . . 0.0 110.585 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.568 ' CE2' ' CA ' ' A' ' 68' ' ' ALA . 94.4 m-85 -121.57 119.92 33.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.796 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 18' ' ' PHE . 15.5 m-20 -139.94 152.39 46.32 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.33 -0.856 . . . . 0.0 109.411 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.0 pp -164.09 -175.0 3.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 6.1 t80 -109.34 141.91 41.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.492 -0.755 . . . . 0.0 110.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 88' ' ' LYS . 1.0 OUTLIER -122.05 160.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.82 -175.87 14.08 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.58 ' C ' HD22 ' A' ' 25' ' ' LEU . 11.9 t30 71.52 54.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.437 -1.037 . . . . 0.0 110.506 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.3 mm? -105.35 129.05 53.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.958 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.431 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 34.5 t-20 -40.54 100.6 0.22 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.72 -0.612 . . . . 0.0 110.502 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -73.73 -17.22 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.074 1.565 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.92 -14.8 40.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.721 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 8.5 mmtt -106.27 -157.79 0.63 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.496 -0.753 . . . . 0.0 109.554 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -106.25 142.88 35.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.765 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.908 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.7 t -66.1 -22.85 30.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.639 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -67.58 -38.96 84.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' OE2' ' CD1' ' A' ' 83' ' ' PHE . 1.8 pt-20 -65.67 -38.3 88.91 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 31' ' ' VAL . 50.9 mt -60.98 -36.09 78.51 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.43 -60.49 3.71 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 28.7 t -60.51 -32.74 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -64.8 -38.07 89.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 108.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.572 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 24.5 mt -80.07 -24.46 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.413 -0.804 . . . . 0.0 108.995 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.801 ' HA ' HG21 ' A' ' 49' ' ' VAL . 7.8 p -80.13 -30.74 39.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 109.053 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.93 -40.73 21.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.562 0.696 . . . . 0.0 109.609 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.87 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -65.53 -35.05 79.71 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 109.178 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.733 ' HD2' HD22 ' A' ' 47' ' ' LEU . 9.2 m-85 -83.0 -21.64 33.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.43 -24.7 57.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.494 ' NZ ' ' OE1' ' A' ' 40' ' ' GLU . 9.5 mttp -104.17 -17.23 14.97 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.587 -0.695 . . . . 0.0 109.519 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.674 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -81.3 -21.87 38.99 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.369 -0.832 . . . . 0.0 109.934 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.674 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.5 t0 99.34 29.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.733 HD22 ' HD2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -100.93 -149.85 0.38 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.44 61.23 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.801 HG21 ' HA ' ' A' ' 39' ' ' SER . 6.5 m -50.9 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.001 0.905 . . . . 0.0 110.133 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.692 ' HB ' HG21 ' A' ' 16' ' ' THR . 2.8 t -89.04 -35.68 7.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.264 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 8.4 t0 -146.85 156.18 42.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.116 -0.99 . . . . 0.0 111.229 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.593 ' CG1' ' CG ' ' A' ' 35' ' ' LYS . 14.8 p -153.17 146.59 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -149.59 166.54 28.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.908 HG22 ' CG1' ' A' ' 31' ' ' VAL . 15.7 p -87.75 160.45 18.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 110.528 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -125.63 126.0 5.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.8 m 59.34 -166.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -1.078 . . . . 0.0 110.073 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.706 ' H ' HG22 ' A' ' 56' ' ' THR . 0.7 OUTLIER -41.76 -65.78 0.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.402 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.642 ' HG3' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -173.89 51.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -124.47 -23.34 4.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.935 . . . . 0.0 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.925 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -124.6 -177.05 3.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -168.0 141.75 7.03 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.866 ' O ' HG23 ' A' ' 63' ' ' VAL . 48.2 t80 -94.62 169.07 10.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -1.151 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 62' ' ' TYR . 2.4 t -163.64 163.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.482 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -137.07 144.63 43.25 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.802 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 31.8 m-85 -108.25 176.58 5.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.608 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -109.77 16.37 22.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 111.584 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p 178.17 178.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.139 . . . . 0.0 112.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.568 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.05 -23.28 52.04 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -26.2 41.06 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.361 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.693 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 85.9 m-20 -83.01 -28.0 29.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.6 tm? -77.96 -34.19 51.19 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.827 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.49 -40.05 62.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.849 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.788 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.03 -30.63 61.12 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.802 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.16 -28.48 67.33 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 89' ' ' LEU . 5.7 tt -69.79 -45.18 68.54 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -12.47 60.68 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.164 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.993 HD12 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -76.07 4.62 8.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.54 -0.725 . . . . 0.0 109.939 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' THR . . . . . 1.025 ' OG1' HD21 ' A' ' 89' ' ' LEU . 11.1 m -72.89 1.18 9.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.115 -0.991 . . . . 0.0 110.552 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -106.2 1.42 37.79 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.039 HD21 HD11 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -84.8 124.0 31.07 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.151 -1.205 . . . . 0.0 111.257 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 82' ' ' VAL . 32.2 mtpt -83.38 84.33 7.55 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.908 0.861 . . . . 0.0 109.189 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.972 ' CG1' HG23 ' A' ' 87' ' ' ILE . 1.2 p -34.76 -94.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.798 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -98.56 31.89 2.73 Favored 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.138 -0.976 . . . . 0.0 109.427 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' C ' ' HE3' ' A' ' 81' ' ' LYS . . . 108.35 15.51 13.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.647 ' O ' HG12 ' A' ' 82' ' ' VAL . 5.1 m120 -143.42 98.18 3.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -1.039 . . . . 0.0 109.528 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 35.1 tt0 -41.72 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.476 -0.765 . . . . 0.0 110.548 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.039 HD11 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.25 145.39 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.697 ' HA ' HG23 ' A' ' 78' ' ' THR . 18.5 tttt -120.87 155.77 33.42 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.566 -0.708 . . . . 0.0 109.904 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.025 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -120.38 171.35 8.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.798 ' O ' HG23 ' A' ' 16' ' ' THR . 4.3 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.258 0.551 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.812 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -172.2 162.53 4.35 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.525 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.0 Cg_endo -79.95 -25.96 4.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.187 1.625 . . . . 0.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.4 m-85 -116.25 119.7 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 0.0 110.951 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 30.2 m-20 -135.42 171.0 15.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.211 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.655 HD12 ' CE2' ' A' ' 65' ' ' PHE . 11.2 mt -156.44 165.89 35.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 111.137 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -97.96 157.59 16.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.977 HG22 HD21 ' A' ' 25' ' ' LEU . 65.2 mt -149.39 146.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.323 -0.861 . . . . 0.0 110.121 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.92 179.91 22.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 48.1 t30 71.15 23.35 4.15 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.495 -1.003 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.005 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.1 mm? -68.37 122.93 19.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.567 ' O ' HD11 ' A' ' 34' ' ' LEU . 28.1 t-20 -41.09 100.85 0.23 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.654 -0.653 . . . . 0.0 110.421 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.8 Cg_endo -75.69 -26.51 9.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.071 1.564 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -74.69 -24.1 58.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.966 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.7 mmtt -90.9 -154.45 0.35 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.603 -0.686 . . . . 0.0 109.72 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.1 m -101.9 143.83 31.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.764 ' CG1' HG21 ' A' ' 54' ' ' THR . 3.7 t -69.0 -31.02 48.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.7 -33.7 76.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.118 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 66.0 mm-40 -70.66 -36.58 73.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 109.359 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.005 HD13 ' HB3' ' A' ' 25' ' ' LEU . 42.3 mt -63.24 -34.57 77.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.442 -0.786 . . . . 0.0 109.061 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.715 ' HZ2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -64.94 -55.84 16.78 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.213 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.5 t -58.3 -40.78 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 0.0 109.385 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.727 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -59.32 -29.07 67.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.97 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.474 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 47.0 mt -83.95 -32.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.385 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.7 t -79.27 -23.14 43.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.97 -39.31 17.04 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.947 HD21 ' HB3' ' A' ' 80' ' ' LEU . 4.9 tp -63.45 -36.89 85.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.56 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 10.2 m-85 -83.56 -22.02 32.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.43 -21.76 45.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.97 -20.43 14.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.675 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -82.48 -21.12 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.459 -0.776 . . . . 0.0 109.788 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.675 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.3 t70 98.61 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.868 0.842 . . . . 0.0 108.891 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.937 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -91.33 -145.28 0.19 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -177.33 61.01 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.9 m -63.24 115.44 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 122.012 0.91 . . . . 0.0 110.317 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.812 ' CB ' HG21 ' A' ' 16' ' ' THR . 19.6 t -82.0 -23.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.509 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.783 ' CG ' HG21 ' A' ' 15' ' ' THR . 0.2 OUTLIER -155.79 155.67 33.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 0.0 110.673 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.715 HG12 ' HZ2' ' A' ' 35' ' ' LYS . 3.4 t -152.87 128.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.805 . . . . 0.0 109.963 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -128.51 178.64 6.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.764 HG21 ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -149.98 151.49 33.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 110.691 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 56' ' ' THR . . . -173.0 -160.86 22.38 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 56' ' ' THR . 5.7 m 57.07 85.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -1.042 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.3 m-20 39.58 48.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.446 -0.784 . . . . 0.0 110.936 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 10.1 ptm180 37.44 35.51 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.577 -0.702 . . . . 0.0 111.004 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 25' ' ' LEU . 20.0 tttt -121.92 -19.26 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 110.193 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -124.53 170.36 10.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -163.35 172.8 39.39 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.422 ' CE2' ' HD1' ' A' ' 21' ' ' PHE . 1.3 t80 -121.88 162.56 20.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.828 -0.807 . . . . 0.0 109.976 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.559 HG23 HG13 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -145.29 167.4 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.117 -0.989 . . . . 0.0 110.834 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.545 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 2.8 m-20 -141.69 144.1 33.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.56 -0.712 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.843 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 61.5 m-85 -118.3 -178.55 3.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 7.5 pt-20 -113.96 8.93 17.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.477 -0.764 . . . . 0.0 111.016 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.653 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 32.1 p -167.81 176.1 6.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.572 1.177 . . . . 0.0 112.423 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.34 -24.32 50.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -28.69 57.75 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.364 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.697 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.0 m-20 -82.54 -27.78 31.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -72.56 -37.34 68.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.876 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.02 -38.47 61.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 109.979 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.955 ' O ' HD23 ' A' ' 77' ' ' LEU . 11.2 ttmm -76.68 -25.75 54.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.843 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -69.77 -31.75 69.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.6 tt -70.86 -43.11 69.15 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -10.58 59.94 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.163 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.955 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -72.48 1.82 7.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.549 -0.72 . . . . 0.0 110.658 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.565 ' CA ' HD21 ' A' ' 89' ' ' LEU . 15.4 m -78.52 6.07 9.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.36 24.18 32.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.947 ' HB3' HD21 ' A' ' 41' ' ' LEU . 4.7 mt -127.11 128.14 45.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -1.188 . . . . 0.0 110.837 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 82' ' ' VAL . 21.3 mtmt -84.82 83.24 8.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.768 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.82 HG21 HG21 ' A' ' 87' ' ' ILE . 74.3 t -32.2 -98.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.063 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.667 ' N ' HG12 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -85.38 23.06 1.38 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.665 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.94 20.44 5.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 87' ' ' ILE . 66.6 m-80 -154.71 116.12 4.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -1.102 . . . . 0.0 109.363 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 1.1 pt-20 -55.56 84.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 110.14 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.82 HG21 HG21 ' A' ' 82' ' ' VAL . 24.4 pt -41.01 130.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.508 -0.745 . . . . 0.0 110.091 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.504 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 3.4 mttt -98.15 122.58 41.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.373 -0.829 . . . . 0.0 109.774 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -118.87 172.49 7.5 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.39 -0.819 . . . . 0.0 110.386 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 11.3 pt-20 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.469 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 15' ' ' THR . 4.6 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.205 0.526 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.815 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.63 166.27 1.86 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.064 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 16' ' ' THR . 48.0 Cg_endo -76.15 -31.95 4.47 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.95 1.5 . . . . 0.0 110.798 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.6 m-85 -111.62 106.93 15.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.026 -1.046 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 16' ' ' THR . 43.7 m-20 -139.79 156.06 46.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.352 -0.843 . . . . 0.0 109.814 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 21' ' ' PHE . 3.5 pp -169.78 -168.55 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.288 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.627 ' N ' HD12 ' A' ' 20' ' ' LEU . 22.0 t80 -111.95 158.46 19.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 110.265 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.966 HD12 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -140.73 160.11 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.104 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -141.76 -170.66 12.53 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.517 -1.325 . . . . 0.0 109.923 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.6 t-20 73.85 34.31 0.91 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.622 -0.928 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.049 HD22 ' O ' ' A' ' 60' ' ' PHE . 7.9 mp -85.57 134.73 34.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.788 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 35.0 t-20 -60.2 109.89 2.39 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 110.464 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -74.55 -26.26 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.062 1.559 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.44 -25.11 57.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 109.897 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HE3' ' CE1' ' A' ' 83' ' ' PHE . 6.6 mmtt -91.23 -154.41 0.36 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.729 . . . . 0.0 109.665 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.61 140.79 44.62 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.682 HG12 ' HE2' ' A' ' 35' ' ' LYS . 3.0 t -67.48 -35.36 73.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.096 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -61.08 -32.23 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.181 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 65.7 mm-40 -73.45 -34.34 65.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.481 -0.762 . . . . 0.0 109.229 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.966 HD22 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -66.3 -30.37 70.77 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.375 -0.828 . . . . 0.0 109.068 179.085 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.682 ' HE2' HG12 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -68.74 -56.27 8.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.15 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -62.91 -37.44 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.55 -32.77 74.34 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.844 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 34' ' ' LEU . 13.5 mt -81.46 -28.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.475 -0.765 . . . . 0.0 109.107 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' SER . . . . . 1.024 ' HA ' HG21 ' A' ' 49' ' ' VAL . 3.6 m -77.82 -30.94 51.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.16 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.99 -37.63 33.87 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.986 HD22 HD21 ' A' ' 80' ' ' LEU . 1.1 tt -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.228 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 47' ' ' LEU . 15.3 m-85 -87.55 -17.18 32.6 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.361 -0.837 . . . . 0.0 109.363 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -88.44 -28.97 20.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.2 mttt -91.44 -20.93 21.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.768 . . . . 0.0 109.395 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.9 m120 -79.08 -58.89 3.0 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.53 -0.731 . . . . 0.0 109.633 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 148.47 29.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -108.74 -158.86 0.66 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 109.593 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -160.33 65.37 0.33 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.018 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.024 HG21 ' HA ' ' A' ' 39' ' ' SER . 11.0 m -54.59 115.44 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.811 0.815 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.815 HG11 ' CG2' ' A' ' 16' ' ' THR . 11.5 t -82.51 -35.9 13.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 121.88 -0.513 . . . . 0.0 110.482 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -152.84 164.02 38.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 0.0 110.723 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.61 HG22 ' HG3' ' A' ' 35' ' ' LYS . 5.4 p -159.0 102.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.723 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -93.87 163.34 13.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.626 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.1 p -85.05 161.68 19.62 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.313 -0.867 . . . . 0.0 110.715 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -115.33 121.8 5.4 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 9.1 m -21.54 142.39 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.605 0.717 . . . . 0.0 112.445 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.2 t-20 72.4 18.78 4.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.476 -0.765 . . . . 0.0 109.959 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.589 ' HD2' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 42.46 27.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.788 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.456 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -110.92 -17.93 13.19 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 1.049 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -130.08 -168.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.042 -1.036 . . . . 0.0 109.601 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 177.88 155.79 14.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.0 m-85 -108.9 162.18 14.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.966 HG21 HD12 ' A' ' 22' ' ' ILE . 3.2 t -150.13 143.17 17.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.891 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.13 144.97 42.28 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.547 -0.721 . . . . 0.0 109.717 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 13.1 m-85 -109.68 177.79 4.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.323 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.589 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 2.3 pp20? -114.21 8.4 16.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 111.285 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 10.0 p -175.41 177.15 1.87 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.278 1.037 . . . . 0.0 111.972 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.429 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -79.04 -22.87 44.75 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -82.22 -26.51 33.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.264 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.595 ' OD1' HD23 ' A' ' 47' ' ' LEU . 2.9 t0 -82.42 -26.61 32.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.422 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.1 tp -80.6 -33.71 35.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.62 -34.53 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.514 -0.741 . . . . 0.0 109.357 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.17 -29.08 60.32 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.51 -26.68 65.57 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.0 tt -72.98 -46.61 51.3 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -10.72 60.05 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.999 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.916 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -73.14 4.26 4.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.573 -0.705 . . . . 0.0 110.379 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 m -58.01 -14.27 6.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.54 37.69 3.33 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.011 HD13 HD11 ' A' ' 87' ' ' ILE . 4.2 mt -90.03 -168.56 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.535 -0.979 . . . . 0.0 111.159 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.587 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 17.7 mttt 170.89 53.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 108.927 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.787 HG11 HD23 ' A' ' 34' ' ' LEU . 90.7 t -24.96 -100.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.991 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.626 ' N ' HG12 ' A' ' 82' ' ' VAL . 12.7 m-85 -89.64 39.99 0.97 Allowed 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.24 24.65 28.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 7.3 p-10 -138.52 86.21 2.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.538 -0.978 . . . . 0.0 109.016 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.587 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 1.1 pt-20 -41.74 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 110.686 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 80' ' ' LEU . 3.6 pt -51.27 146.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.554 0.692 . . . . 0.0 109.942 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 22' ' ' ILE . 20.9 tptt -119.43 156.29 30.43 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 109.845 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -119.87 171.95 8.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.069 -1.019 . . . . 0.0 110.304 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.365 -0.835 . . . . 0.0 110.127 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 HG23 ' A' ' 16' ' ' THR . 3.3 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.433 0.635 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.919 ' CG2' HG11 ' A' ' 50' ' ' VAL . 69.5 p -139.78 164.28 39.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.583 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.3 Cg_endo -74.99 -21.65 15.66 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.088 1.573 . . . . 0.0 110.721 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 96.9 m-85 -106.67 113.44 26.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.037 -1.04 . . . . 0.0 110.56 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.531 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -144.76 140.59 28.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.815 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.53 -166.88 2.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.837 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.685 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 6.7 t80 -118.69 157.54 27.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.179 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.799 HG13 HD23 ' A' ' 89' ' ' LEU . 5.5 mt -145.85 151.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.44 -174.4 13.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 27.2 t30 69.84 55.28 0.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.163 -1.199 . . . . 0.0 109.998 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 60' ' ' PHE . 3.9 mm? -93.78 123.75 37.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.924 ' N ' HD21 ' A' ' 34' ' ' LEU . 58.5 t30 -42.25 101.71 0.25 Allowed Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HA ' ' HG2' ' A' ' 58' ' ' ARG . 48.2 Cg_endo -75.39 -11.47 20.79 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.065 1.561 . . . . 0.0 110.498 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -81.96 -8.5 59.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 13.4 mttt -124.95 -154.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.971 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.877 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.9 m -100.09 147.59 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.876 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.6 t -64.53 -35.16 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.535 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -51.51 68.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 109.778 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 38.5 mm-40 -56.74 -31.61 64.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.83 . . . . 0.0 109.015 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.924 HD21 ' N ' ' A' ' 26' ' ' ASN . 6.7 mp -66.27 -33.17 75.14 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.384 -0.822 . . . . 0.0 109.069 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.939 ' HD2' HG12 ' A' ' 52' ' ' VAL . 29.1 mmtt -64.72 -55.47 19.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.974 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.8 t -57.26 -32.87 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.592 -0.693 . . . . 0.0 109.552 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 82' ' ' VAL . . . -63.79 -35.62 81.21 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.822 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 82' ' ' VAL . 15.6 mm -80.05 -26.75 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.535 -0.728 . . . . 0.0 109.311 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.823 ' HA ' HG21 ' A' ' 49' ' ' VAL . 52.5 m -79.58 -30.72 41.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.921 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.2 tm-20 -80.53 -39.69 27.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.583 0.706 . . . . 0.0 109.572 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.83 -33.54 75.84 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.132 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.733 ' HE1' HD12 ' A' ' 77' ' ' LEU . 5.5 m-30 -81.82 -23.17 36.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 109.18 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.85 -27.53 44.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.027 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CD ' ' OE2' ' A' ' 40' ' ' GLU . 6.4 mtpt -87.8 -19.47 27.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.448 -0.783 . . . . 0.0 109.284 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -80.64 -60.04 2.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.562 -0.711 . . . . 0.0 109.423 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.0 m-20 149.68 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.571 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.906 HD11 ' HB3' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -106.58 -157.69 0.62 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.47 61.22 0.38 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.019 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.6 m -48.32 117.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.98 0.895 . . . . 0.0 110.068 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.919 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.94 -41.55 14.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.581 ' C ' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -146.57 159.26 43.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.939 HG12 ' HD2' ' A' ' 35' ' ' LYS . 40.9 t -157.57 114.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -113.83 163.81 14.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 110.496 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.876 ' HB ' HG11 ' A' ' 31' ' ' VAL . 21.7 p -83.45 171.53 13.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.63 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -135.29 130.77 5.54 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.4 m 50.45 -140.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -1.16 . . . . 0.0 109.902 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.485 ' H ' HG22 ' A' ' 56' ' ' THR . 41.0 p30 -100.75 79.82 2.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.075 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HA ' HG22 ' A' ' 31' ' ' VAL . 7.7 ttp180 56.65 28.98 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 110.482 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.94 -31.23 10.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 109.889 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.789 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.93 177.52 10.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.566 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -154.2 150.52 22.16 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.298 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 20.7 t80 -103.85 160.6 14.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.365 -1.079 . . . . 0.0 109.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.924 HG22 HG13 ' A' ' 52' ' ' VAL . 88.7 t -154.5 154.42 7.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.435 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -124.13 139.88 53.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.708 -0.62 . . . . 0.0 109.865 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.861 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 21.7 m-85 -109.71 173.45 6.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.718 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.08 15.19 17.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.353 -0.842 . . . . 0.0 111.212 -178.454 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.56 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 2.3 t -166.24 175.49 8.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.718 1.247 . . . . 0.0 112.063 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.15 -25.39 22.98 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -20.95 26.21 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' OD2' ' HB3' ' A' ' 65' ' ' PHE . 8.7 t0 -84.14 -31.68 25.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 71' ' ' LEU . 8.4 tt -75.77 -34.59 60.24 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.485 0.66 . . . . 0.0 109.59 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.5 -35.19 60.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.992 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 1.018 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -76.65 -27.38 55.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.861 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.09 -28.7 64.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.728 HD22 HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -68.95 -45.76 69.92 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.443 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.55 -15.55 63.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.963 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.018 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.2 mm? -72.86 0.01 12.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.225 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.854 HG23 ' HA ' ' A' ' 88' ' ' LYS . 5.8 m -78.23 5.59 9.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 110.672 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.408 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -103.72 14.15 53.38 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.713 HD22 HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -115.3 131.21 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.843 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' A' ' 82' ' ' VAL . 14.1 mttt -75.95 83.85 2.86 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 109.62 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.106 HG11 HG23 ' A' ' 87' ' ' ILE . 1.2 p -31.34 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.81 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.811 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -100.84 28.79 4.94 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.61 15.93 3.89 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.762 ' O ' HG12 ' A' ' 82' ' ' VAL . 6.7 m-20 -158.64 116.62 2.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -1.2 . . . . 0.0 109.478 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 78' ' ' THR . 24.9 tt0 -52.72 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.106 HG23 HG11 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -42.77 154.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 110.215 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.854 ' HA ' HG23 ' A' ' 78' ' ' THR . 7.1 mtpp -129.7 157.15 42.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.836 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 22' ' ' ILE . 3.7 mt -106.68 -179.54 3.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.11 -0.993 . . . . 0.0 110.119 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--N 1.299 -1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 110.219 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 16' ' ' THR . 5.6 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.311 0.577 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.882 ' CG2' HG11 ' A' ' 50' ' ' VAL . 16.2 p -159.89 159.11 27.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.838 . . . . 0.0 110.207 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.18 -18.2 14.46 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.149 1.605 . . . . 0.0 110.913 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 79.9 m-85 -122.34 115.78 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.931 -1.106 . . . . 0.0 111.14 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 2.2 m120 -143.49 151.39 40.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.532 -0.73 . . . . 0.0 109.067 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.806 HD21 ' HE2' ' A' ' 65' ' ' PHE . 1.7 pp -160.22 179.59 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.66 158.12 16.59 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.631 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 88' ' ' LYS . 6.6 mt -148.33 154.21 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.355 -0.841 . . . . 0.0 109.414 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -144.68 -164.87 10.79 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t-20 71.68 35.03 1.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.749 ' CD1' HD22 ' A' ' 34' ' ' LEU . 4.1 mm? -85.3 129.5 34.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.19 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.704 ' H ' HD21 ' A' ' 34' ' ' LEU . 28.4 t-20 -50.06 106.17 0.6 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HG3' ' HE3' ' A' ' 59' ' ' LYS . 47.9 Cg_endo -74.42 -18.88 19.91 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.996 1.524 . . . . 0.0 110.486 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -79.45 -16.21 56.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -106.18 -155.88 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.372 -0.83 . . . . 0.0 109.817 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 2.6 m -103.6 149.39 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 110.181 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.777 ' CG1' HG22 ' A' ' 54' ' ' THR . 3.0 t -69.85 -42.66 79.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -56.96 -34.81 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.503 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.93 -46.47 71.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.79 . . . . 0.0 109.581 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.749 HD22 ' CD1' ' A' ' 25' ' ' LEU . 2.0 mt -54.55 -32.44 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.177 -0.952 . . . . 0.0 108.837 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HD3' ' HB ' ' A' ' 52' ' ' VAL . 13.2 mmtt -64.77 -58.43 6.27 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.131 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 21.9 t -53.24 -35.64 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.497 -0.752 . . . . 0.0 109.369 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.4 -39.01 93.35 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.574 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 70.8 mt -77.92 -26.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.615 ' HA ' HG21 ' A' ' 49' ' ' VAL . 41.0 m -79.16 -29.21 42.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.085 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.84 -38.56 22.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.456 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.862 ' HG ' HD13 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.84 -31.49 71.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.735 ' CE1' HD12 ' A' ' 77' ' ' LEU . 6.9 m-85 -85.37 -22.22 28.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.97 -31.85 59.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.547 -0.721 . . . . 0.0 109.131 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -91.92 -15.41 28.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.59 -0.694 . . . . 0.0 109.134 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.671 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m120 -82.71 -29.04 30.12 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.501 -0.75 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.671 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 36.6 t0 103.85 29.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.011 HD11 ' CB ' ' A' ' 73' ' ' LYS . 3.3 mp -97.73 -151.78 0.38 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.86 61.9 0.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.093 -1.004 . . . . 0.0 110.43 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 39' ' ' SER . 5.9 m -50.07 119.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.878 0.847 . . . . 0.0 109.396 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.882 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.5 t -89.28 -48.14 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.86 -0.525 . . . . 0.0 110.968 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 5.1 m-20 -141.48 115.68 9.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.868 -1.145 . . . . 0.0 111.311 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 63' ' ' VAL . 16.0 m -103.64 143.49 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.437 -0.789 . . . . 0.0 109.679 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -150.32 167.79 25.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 110.532 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.777 HG22 ' CG1' ' A' ' 31' ' ' VAL . 13.7 p -88.9 164.31 15.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 110.578 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -132.63 127.35 4.8 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER 68.19 -143.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -1.112 . . . . 0.0 110.069 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.94 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.158 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.9 31.18 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 110.06 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HE3' ' HG3' ' A' ' 27' ' ' PRO . 19.3 tttt -123.76 -17.34 6.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -109.49 -176.57 3.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 110.156 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.4 152.26 10.9 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.5 t80 -125.12 158.85 32.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -1.049 . . . . 0.0 109.521 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 52' ' ' VAL . 3.4 t -151.95 147.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.852 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.47 137.31 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.472 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.806 ' HE2' HD21 ' A' ' 20' ' ' LEU . 25.7 m-85 -100.04 177.46 5.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.665 -0.647 . . . . 0.0 111.101 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.64 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.19 12.02 15.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 111.611 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CD2' ' A' ' 18' ' ' PHE . 5.2 p -173.71 172.11 3.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 0.0 112.2 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.61 -25.76 45.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.25 -28.16 38.5 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.793 179.338 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.495 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 5.5 t0 -79.77 -24.27 41.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.788 HD13 ' C ' ' A' ' 71' ' ' LEU . 2.3 tm? -77.22 -35.65 55.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.48 -35.45 73.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.422 -0.799 . . . . 0.0 109.042 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 1.011 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -75.35 -25.36 57.69 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.027 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.7 -30.7 69.41 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.9 tt -71.83 -45.54 61.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -77.79 -2.13 34.9 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.151 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.924 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -76.74 7.65 4.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 110.483 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -73.65 0.55 12.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.19 12.02 61.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.862 HD13 ' HG ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -102.37 131.83 48.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.289 -1.124 . . . . 0.0 109.678 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.742 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -114.37 80.15 1.36 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.489 1.137 . . . . 0.0 110.11 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.036 ' CG2' HG23 ' A' ' 87' ' ' ILE . 3.5 m -51.17 127.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.68 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 8.2 m-30 38.17 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.477 -0.765 . . . . 0.0 111.331 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 85.44 26.88 34.54 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.541 ' HB2' HG23 ' A' ' 82' ' ' VAL . 10.1 m120 -134.74 78.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.739 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.3 tm-20 -37.19 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.729 0.776 . . . . 0.0 110.747 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.036 HG23 ' CG2' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -47.7 144.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' HG23 ' A' ' 22' ' ' ILE . 25.7 tttt -119.3 156.54 29.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.6 172.34 7.28 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 110.38 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.751 . . . . 0.0 110.133 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 16' ' ' THR . 5.8 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.555 0.693 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 15' ' ' THR . 74.6 p -139.27 164.76 36.66 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.565 -0.71 . . . . 0.0 110.265 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.72 -22.62 11.77 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.022 1.538 . . . . 0.0 111.073 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.541 ' CE2' ' C ' ' A' ' 67' ' ' SER . 91.5 m-85 -104.19 85.5 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.928 -1.107 . . . . 0.0 110.939 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.521 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.7 m-20 -122.61 146.87 47.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.09 -1.006 . . . . 0.0 109.374 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.831 HD21 ' HE2' ' A' ' 65' ' ' PHE . 1.8 pp -154.36 -176.97 6.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -103.18 166.46 10.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.617 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.774 HD12 ' CG2' ' A' ' 63' ' ' VAL . 9.0 mt -144.49 158.79 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -149.19 -178.67 24.41 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.031 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.1 t-20 72.67 54.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.92 . . . . 0.0 110.233 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.923 ' HB3' HD13 ' A' ' 34' ' ' LEU . 21.0 mt -102.23 125.93 49.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.042 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 26.4 t-20 -41.25 110.08 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.733 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.01 -19.94 22.49 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.997 1.525 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -85.54 -7.56 58.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.953 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.583 ' HD3' ' CG ' ' A' ' 83' ' ' PHE . 10.1 mttt -114.15 -157.24 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.371 -0.83 . . . . 0.0 109.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.454 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 3.5 m -110.51 150.09 29.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 110.572 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.911 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.6 t -69.56 -38.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.337 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.4 -34.66 69.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.422 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 5.6 mm-40 -74.82 -32.67 62.03 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.375 -0.828 . . . . 0.0 109.159 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.923 HD13 ' HB3' ' A' ' 25' ' ' LEU . 7.4 mt -66.21 -35.18 79.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.392 -0.818 . . . . 0.0 109.03 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.755 ' HE2' HG12 ' A' ' 31' ' ' VAL . 2.7 mptp? -67.11 -54.08 24.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 32' ' ' ALA . 16.7 t -52.17 -35.97 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 109.581 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.742 ' CB ' HG13 ' A' ' 82' ' ' VAL . . . -64.34 -38.37 90.78 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.841 HD11 ' CG2' ' A' ' 82' ' ' VAL . 20.2 mm -78.02 -26.66 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.369 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.559 ' HA ' HG21 ' A' ' 49' ' ' VAL . 37.6 m -78.97 -31.92 45.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -79.8 -39.27 31.22 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.46 -0.775 . . . . 0.0 109.537 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.859 HD22 HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.6 -33.55 75.92 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.132 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.586 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 7.8 m-85 -82.17 -21.95 36.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.554 -0.716 . . . . 0.0 109.211 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.52 44.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.409 -0.807 . . . . 0.0 109.726 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 14.4 mtmm -104.67 -22.81 13.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -79.31 -30.92 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 35.7 t70 112.62 29.03 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.583 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 1.7 mm? -88.93 -153.16 0.25 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.923 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -165.87 64.09 0.11 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.6 m -62.98 117.87 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.917 0.865 . . . . 0.0 110.079 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.92 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.3 t -92.36 -42.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -144.4 158.22 43.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.949 HG13 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -144.96 156.19 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 109.569 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.449 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -162.51 170.23 19.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.24 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.586 HG22 ' CG1' ' A' ' 31' ' ' VAL . 13.8 p -90.48 164.62 14.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 110.243 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -120.5 131.78 8.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.494 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 99.0 m 58.72 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.937 . . . . 0.0 110.371 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 27.6 t-20 -173.25 84.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.627 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER 66.25 22.18 10.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 110.729 179.43 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.566 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.0 tttm -120.59 -35.84 3.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.852 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.2 m-85 -135.27 -164.3 1.51 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -169.08 165.3 38.81 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.272 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 20' ' ' LEU . 36.8 t80 -128.73 153.1 47.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -1.02 . . . . 0.0 109.524 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.949 HG13 HG13 ' A' ' 52' ' ' VAL . 3.1 t -150.43 144.15 17.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.079 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -107.5 141.07 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 109.663 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.831 ' HE2' HD21 ' A' ' 20' ' ' LEU . 30.8 m-85 -104.3 177.79 4.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.876 . . . . 0.0 110.551 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.626 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.12 15.91 14.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 111.02 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.7 p -179.38 178.28 0.7 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.368 1.08 . . . . 0.0 111.954 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.51 -22.57 50.99 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -27.99 38.77 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.43 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.923 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 85.8 m-20 -80.22 -29.27 38.5 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 71' ' ' LEU . 3.4 tm? -81.41 -32.81 32.57 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.501 0.667 . . . . 0.0 109.314 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.68 -36.05 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.748 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.633 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.98 -30.14 50.09 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . . . -63.82 -28.99 70.24 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.799 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.486 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -74.95 -47.15 31.0 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.843 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 5.01 16.21 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.612 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -79.39 11.66 2.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 110.422 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -6.44 19.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.41 25.03 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 77' ' ' LEU . 1.3 mt -92.76 -171.16 2.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.468 -1.019 . . . . 0.0 110.9 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.578 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.4 mttt 176.55 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.869 0.842 . . . . 0.0 108.978 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.841 ' CG2' HD11 ' A' ' 38' ' ' ILE . 99.3 t -24.34 -101.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.169 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.625 ' N ' HG12 ' A' ' 82' ' ' VAL . 10.2 m-85 -87.86 42.32 1.05 Allowed 'General case' 0 C--N 1.288 -2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 108.728 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.69 29.78 22.98 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.1 t-20 -145.91 88.12 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.449 -1.03 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.578 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -42.95 96.06 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.625 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -48.56 125.73 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.606 -0.684 . . . . 0.0 110.144 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -100.89 129.9 46.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.733 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.754 ' H ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -113.58 176.34 5.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.013 -1.054 . . . . 0.0 111.222 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 3.2 pt-20 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.459 -0.776 . . . . 0.0 110.23 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 16' ' ' THR . 4.6 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.236 0.541 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . 1.026 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -178.83 165.19 1.03 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 110.39 -179.928 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.561 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.8 Cg_endo -75.43 -44.16 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.101 1.579 . . . . 0.0 110.651 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 90.6 m-85 -96.15 106.33 18.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.119 -0.988 . . . . 0.0 110.594 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -135.66 146.31 47.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -164.71 169.15 17.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.547 179.79 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 3.5 t80 -101.73 145.97 28.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.732 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 mt -127.78 158.53 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.68 179.84 17.21 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.834 ' C ' HD22 ' A' ' 25' ' ' LEU . 45.8 t30 71.35 76.74 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.413 -1.051 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.834 HD22 ' C ' ' A' ' 24' ' ' ASN . 4.4 mm? -118.88 126.44 51.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.021 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.515 ' HB3' HD21 ' A' ' 34' ' ' LEU . 46.0 t30 -40.43 100.36 0.22 Allowed Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.613 -0.68 . . . . 0.0 110.525 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.7 Cg_endo -75.75 -13.81 19.77 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.411 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -18.26 43.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -108.28 -156.52 0.58 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 0.0 109.753 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.525 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -101.63 147.19 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.987 ' HA ' HD12 ' A' ' 34' ' ' LEU . 3.3 t -69.67 -32.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.486 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.74 85.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.183 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.72 -40.15 84.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.724 . . . . 0.0 109.33 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.987 HD12 ' HA ' ' A' ' 31' ' ' VAL . 40.2 mt -57.3 -37.04 71.84 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -61.45 -58.19 9.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.32 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -58.54 -33.7 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.414 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.61 -36.49 83.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.189 -0.945 . . . . 0.0 108.609 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.604 HG13 HG22 ' A' ' 82' ' ' VAL . 17.0 mt -79.66 -26.14 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.584 -0.697 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -79.79 -30.35 40.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 108.93 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.12 -38.06 27.86 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.514 0.673 . . . . 0.0 109.669 179.464 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.066 HD22 ' CD2' ' A' ' 80' ' ' LEU . 1.1 tt -69.9 -31.19 68.85 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.458 -0.776 . . . . 0.0 109.248 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.888 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 5.5 m-85 -82.87 -23.92 33.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.11 -32.01 61.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -90.02 -18.95 25.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.437 179.353 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m120 -85.49 -20.16 30.13 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.786 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.0 t0 89.42 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 -179.19 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.773 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -80.14 -138.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 47' ' ' LEU . . . -176.52 57.44 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.953 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 49' ' ' VAL . 9.9 m -63.32 117.45 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.047 0.927 . . . . 0.0 110.766 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 1.026 HG21 HG21 ' A' ' 16' ' ' THR . 0.0 OUTLIER -98.2 -34.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.524 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.51 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 56.7 t0 -144.78 148.49 34.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.894 HG22 HG13 ' A' ' 63' ' ' VAL . 3.8 t -152.87 100.28 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 169.23 8.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.124 -0.985 . . . . 0.0 110.388 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.482 ' HB ' HG11 ' A' ' 31' ' ' VAL . 17.4 p -83.52 168.21 16.66 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -122.04 122.02 4.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 60' ' ' PHE . 4.3 m 67.87 -57.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.755 -0.85 . . . . 0.0 110.368 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.504 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER 179.81 -43.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.69 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -168.39 25.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.721 . . . . 0.0 110.123 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.633 ' CB ' ' CE1' ' A' ' 60' ' ' PHE . 2.8 mttt -119.65 -24.83 6.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.803 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.827 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -138.51 -172.38 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.195 -0.941 . . . . 0.0 109.449 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -172.93 151.69 14.55 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.147 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 38.0 m-85 -108.05 150.62 26.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.415 -1.05 . . . . 0.0 109.525 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.894 HG13 HG22 ' A' ' 52' ' ' VAL . 3.9 t -151.36 146.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.264 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 m-20 -122.56 146.6 47.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.646 ' O ' HG21 ' A' ' 50' ' ' VAL . 26.2 m-85 -114.86 -175.21 2.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.861 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.709 ' HG3' HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -129.44 31.34 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.661 -1.274 . . . . 0.0 113.673 -176.623 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.776 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 22.6 p -172.88 172.76 3.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.902 -1.749 . . . . 0.0 113.167 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.77 -27.81 58.2 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -27.1 61.76 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 179.459 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.776 ' OD2' ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -78.23 -32.29 49.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.083 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -65.95 -41.55 91.14 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.284 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' HD23 ' A' ' 71' ' ' LEU . 2.4 tt0 -70.09 -33.11 71.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 178.931 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.773 ' HB2' HD21 ' A' ' 47' ' ' LEU . 15.9 mmtt -81.49 -23.02 37.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.362 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -69.19 -29.91 67.98 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.456 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.45 -48.13 29.38 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.261 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.07 8.51 15.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.269 178.567 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.897 HD23 ' O ' ' A' ' 77' ' ' LEU . 3.0 tt -66.32 -8.81 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 110.837 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.533 ' O ' HG22 ' A' ' 78' ' ' THR . 84.9 m -70.92 5.41 2.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.353 -0.842 . . . . 0.0 111.692 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.44 -6.48 56.52 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.066 ' CD2' HD22 ' A' ' 41' ' ' LEU . 6.8 mp -92.61 120.79 33.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -1.166 . . . . 0.0 110.723 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -95.07 80.69 3.63 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.965 0.888 . . . . 0.0 110.139 179.36 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 87' ' ' ILE . 2.5 t -43.22 120.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.611 ' HB2' HD23 ' A' ' 34' ' ' LEU . 0.6 OUTLIER 48.73 20.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.965 -179.122 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.87 11.67 39.51 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.7 m120 -128.28 110.43 12.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -59.35 76.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.529 -0.732 . . . . 0.0 110.123 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 82' ' ' VAL . 4.9 pt -42.99 140.33 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 110.042 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.8 mttm -108.61 158.72 17.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.205 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -120.69 170.99 8.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 110.083 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.497 HG21 ' OD2' ' A' ' 51' ' ' ASP . 4.2 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.268 0.556 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.831 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -170.52 165.4 5.31 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.95 -34.06 2.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.097 1.577 . . . . 0.0 111.052 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.2 m-85 -109.78 115.62 30.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.737 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.492 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 3.5 m-80 -142.88 152.36 42.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.412 -0.805 . . . . 0.0 109.567 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.735 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.0 pt? -162.91 170.88 17.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 110.416 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -97.93 167.79 10.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' GLY . 14.2 mt -142.69 161.65 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -148.11 177.61 26.25 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 16.9 t30 71.73 43.75 0.55 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -1.095 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.933 ' CD1' HD22 ' A' ' 34' ' ' LEU . 4.2 mm? -92.73 127.63 38.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.932 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.783 ' H ' HD21 ' A' ' 34' ' ' LEU . 63.8 t-20 -40.8 106.61 0.43 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 110.447 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.53 -24.4 16.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.085 1.571 . . . . 0.0 110.389 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -76.44 -10.93 59.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.902 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.8 mmtp -114.68 -155.6 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.959 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.823 ' O ' HD12 ' A' ' 34' ' ' LEU . 6.8 m -115.22 153.39 30.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.082 HG11 HG22 ' A' ' 54' ' ' THR . 2.8 t -69.52 -21.03 24.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.224 -0.922 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.27 89.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 109.308 179.134 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.1 mm-40 -71.49 -45.35 62.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.532 -0.73 . . . . 0.0 109.354 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.933 HD22 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -57.91 -31.07 66.42 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -64.53 -62.09 1.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.513 0.673 . . . . 0.0 109.238 179.092 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 44.2 t -51.93 -38.99 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.716 . . . . 0.0 109.684 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.82 -28.54 70.08 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.036 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 34' ' ' LEU . 39.9 mt -88.08 -27.63 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.006 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 8.9 m -79.97 -26.94 39.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.101 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.0 -38.99 20.23 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.25 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.809 HD22 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -65.99 -34.49 78.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.697 ' CD1' HD13 ' A' ' 77' ' ' LEU . 8.1 m-30 -86.45 -19.14 30.04 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -87.69 -28.12 21.99 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.831 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -90.41 -20.23 23.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.247 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.877 ' OD1' HD21 ' A' ' 77' ' ' LEU . 1.9 m-80 -79.2 -59.63 2.69 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.658 -0.651 . . . . 0.0 109.56 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.605 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.8 m-20 149.01 30.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.275 0.56 . . . . 0.0 109.925 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' ' 73' ' ' LYS . 1.9 mp -99.94 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.836 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.6 63.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 49' ' ' VAL . 7.8 m -49.89 117.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.909 0.862 . . . . 0.0 109.975 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.831 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.4 t -93.6 -44.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 121.165 0.507 . . . . 0.0 110.403 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.497 ' OD2' HG21 ' A' ' 15' ' ' THR . 1.5 t70 -139.28 155.71 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.783 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -136.86 174.44 11.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.318 -0.864 . . . . 0.0 110.101 -179.822 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER 175.17 178.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.168 -0.957 . . . . 0.0 110.057 179.896 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 54' ' ' THR . . . . . 1.082 HG22 HG11 ' A' ' 31' ' ' VAL . 18.5 p -103.14 170.18 8.12 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.626 ' HA3' ' CB ' ' A' ' 60' ' ' PHE . . . -121.95 132.32 8.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 57' ' ' ASN . 53.3 m 57.46 -92.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 110.448 179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.485 ' N ' HG22 ' A' ' 56' ' ' THR . 1.1 t-20 -154.53 99.32 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 110.744 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 42.1 mtm180 45.12 23.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -121.26 -32.88 3.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.771 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.6 m-85 -119.88 -161.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 109.407 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -167.92 167.65 40.22 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.636 ' O ' HG23 ' A' ' 63' ' ' VAL . 14.6 t80 -142.01 153.58 44.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.394 -1.062 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.728 HG22 HG12 ' A' ' 52' ' ' VAL . 43.7 t -157.56 158.81 2.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.192 -178.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.58 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 11.4 m-20 -123.85 142.35 51.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.679 -0.638 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.836 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 49.6 m-85 -104.73 175.32 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 111.049 -179.215 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.635 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.37 11.76 20.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 111.524 -178.585 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.546 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.3 p -172.7 172.91 4.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 112.178 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -79.14 -23.96 43.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.43 -24.1 29.71 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.11 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 5.6 t0 -82.94 -26.58 31.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.774 HD13 ' C ' ' A' ' 71' ' ' LEU . 2.8 tm? -79.58 -34.47 40.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.287 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.8 -33.86 62.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 109.779 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.769 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -80.62 -21.94 41.05 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.589 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.836 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -77.8 -28.23 50.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.198 179.059 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.979 HD23 HD11 ' A' ' 89' ' ' LEU . 2.0 tm? -75.72 -46.23 32.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.478 ' N ' HD13 ' A' ' 75' ' ' LEU . 1.8 mt-10 -66.68 -26.31 66.97 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.218 179.057 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.877 HD21 ' OD1' ' A' ' 45' ' ' ASN . 6.9 mt -70.7 -20.58 62.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.839 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 75' ' ' LEU . 1.5 t -39.66 -31.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.306 1.05 . . . . 0.0 110.212 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.27 -20.31 9.75 Favored Glycine 0 C--N 1.281 -2.489 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.017 ' CD1' HG23 ' A' ' 82' ' ' VAL . 2.9 pp -66.99 125.84 27.26 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.319 -1.106 . . . . 0.0 110.655 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 11.0 mttt -93.88 78.67 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.301 1.048 . . . . 0.0 110.26 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.017 HG23 ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -43.8 131.09 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.146 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.575 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 3.0 m-85 44.32 24.25 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.467 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 91.21 25.03 25.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' ILE . 39.4 m-20 -140.35 104.8 4.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -1.184 . . . . 0.0 110.343 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 5.9 tt0 -56.35 84.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.289 -0.882 . . . . 0.0 109.933 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.798 HD12 ' O ' ' A' ' 87' ' ' ILE . 2.7 pp -40.09 129.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.523 0.678 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -104.78 132.75 50.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.507 -0.745 . . . . 0.0 109.376 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.979 HD11 HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -105.64 174.07 6.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.888 -1.133 . . . . 0.0 110.737 -179.45 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.976 ' CG2' HG11 ' A' ' 50' ' ' VAL . 65.2 p -139.57 164.48 38.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.448 -0.782 . . . . 0.0 110.579 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 50.9 Cg_endo -78.21 -31.6 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.127 1.593 . . . . 0.0 110.695 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 89.9 m-85 -92.82 93.05 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.103 -0.998 . . . . 0.0 110.607 -179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.5 m120 -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.252 -0.905 . . . . 0.0 109.317 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.029 HD11 HD23 ' A' ' 89' ' ' LEU . 2.1 pt? -158.94 -176.63 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.714 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.2 t80 -101.37 156.61 17.35 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.646 HG22 HD21 ' A' ' 25' ' ' LEU . 2.4 mt -147.41 155.77 10.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.078 -1.014 . . . . 0.0 109.572 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.545 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -143.13 -162.7 9.42 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t30 71.38 14.09 6.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -1.107 . . . . 0.0 110.025 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.938 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.4 mm? -66.5 124.81 23.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.704 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 32.6 t-20 -40.96 101.09 0.23 Allowed Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.623 -0.673 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 45.8 Cg_endo -72.37 -31.62 11.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.079 1.568 . . . . 0.0 110.433 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 26' ' ' ASN . 28.4 p30 -72.68 -14.8 61.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.2 tmtt? -96.79 -153.78 0.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.79 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -112.45 148.58 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.372 -0.83 . . . . 0.0 110.279 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.56 HG12 ' CE ' ' A' ' 35' ' ' LYS . 3.7 t -68.75 -25.25 30.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 29.9 mm-40 -72.96 -31.67 64.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.938 HD13 ' HB3' ' A' ' 25' ' ' LEU . 23.5 mt -65.89 -31.83 72.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' CE ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -72.1 -56.48 5.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.553 179.484 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 32' ' ' ALA . 5.6 t -61.02 -33.69 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 179.134 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.72 -38.4 90.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.587 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 65.8 mt -75.52 -29.07 20.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.722 . . . . 0.0 109.584 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.855 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -77.46 -31.94 54.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.0 -1.063 . . . . 0.0 108.819 179.084 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.6 tm-20 -81.7 -42.23 20.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.507 0.67 . . . . 0.0 109.556 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.067 HD21 ' CD1' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -59.54 -37.58 78.76 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.748 -0.781 . . . . 0.0 108.966 179.167 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.79 ' CD2' HG13 ' A' ' 49' ' ' VAL . 9.7 m-85 -82.12 -22.65 36.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.68 -17.2 54.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -109.24 -16.98 13.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 109.741 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.713 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -84.4 -31.29 24.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.713 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.9 t0 112.62 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-O 121.971 0.891 . . . . 0.0 108.765 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.761 HD11 ' CG ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -105.59 -155.01 0.53 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.769 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.98 63.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 39' ' ' SER . 4.9 m -49.62 116.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.85 0.833 . . . . 0.0 109.829 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.976 HG11 ' CG2' ' A' ' 16' ' ' THR . 10.5 t -81.25 -38.0 16.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 8.7 t0 -153.6 152.66 31.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.087 -1.008 . . . . 0.0 110.55 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.648 HG13 HG23 ' A' ' 63' ' ' VAL . 13.4 t -134.92 161.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 26.5 mtp180 -155.61 154.87 32.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.009 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.462 ' C ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 p -78.66 166.82 22.08 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.975 . . . . 0.0 110.398 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -141.06 122.3 2.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 55' ' ' GLY . 32.1 m 40.4 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.337 -1.096 . . . . 0.0 111.008 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 56' ' ' THR . 21.4 m120 60.11 -141.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.73 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.538 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 3.6 ptt85 -114.5 34.32 4.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 11.1 pttt -118.47 -19.14 8.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 109.959 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.594 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -119.89 174.16 6.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.547 179.637 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -176.59 148.66 9.19 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.815 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 8.4 t80 -111.51 157.57 20.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.883 . . . . 0.0 109.016 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -141.28 172.34 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.773 -1.204 . . . . 0.0 111.3 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 2.6 m-20 -136.43 135.94 39.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.769 -0.582 . . . . 0.0 109.457 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 16.8 m-85 -106.47 -178.66 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.562 -0.711 . . . . 0.0 110.988 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.576 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 2.1 pp20? -117.45 5.55 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 111.044 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.657 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.4 p -168.96 175.2 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.301 1.048 . . . . 0.0 112.21 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.99 -23.56 41.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.899 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.74 -26.46 31.9 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.013 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.75 ' OD1' HD23 ' A' ' 47' ' ' LEU . 3.4 t0 -81.05 -27.76 35.63 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.088 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -75.5 -37.16 60.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.667 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -69.99 -33.9 72.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.753 . . . . 0.0 109.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.761 ' CG ' HD11 ' A' ' 47' ' ' LEU . 2.7 tppt? -73.4 -25.71 60.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.193 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 1.014 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -72.68 -26.99 61.82 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.943 0.878 . . . . 0.0 108.641 178.599 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.757 ' O ' HD13 ' A' ' 75' ' ' LEU . 1.7 tm? -76.22 -34.47 59.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.261 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -16.76 48.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.729 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.014 HD23 ' HA ' ' A' ' 74' ' ' ALA . 1.1 pp -66.38 -17.83 65.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.98 -1.075 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -47.72 -16.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.569 -0.707 . . . . 0.0 111.751 -179.359 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -82.72 14.78 34.64 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.067 ' CD1' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -101.4 -163.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -1.195 . . . . 0.0 110.507 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.611 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -168.35 49.76 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 109.627 -179.758 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.848 ' CG2' HG23 ' A' ' 87' ' ' ILE . 5.0 t 5.67 -122.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.708 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 3.3 m-85 -72.31 -2.9 20.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.985 -1.072 . . . . 0.0 109.355 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 145.99 35.24 0.06 OUTLIER Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -157.87 101.93 1.81 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -1.215 . . . . 0.0 109.996 179.991 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.611 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 2.8 pt-20 -52.58 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.848 HG23 ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -37.92 148.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.693 0.758 . . . . 0.0 110.75 -179.645 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 16.3 ttpt -121.87 156.81 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 1.029 HD23 HD11 ' A' ' 20' ' ' LEU . 1.8 mp -112.88 173.41 6.39 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.047 -1.033 . . . . 0.0 110.415 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 16' ' ' THR . 7.2 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.193 0.521 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.764 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -166.68 162.89 11.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.325 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.76 -32.87 5.4 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.115 1.587 . . . . 0.0 110.489 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 84.9 m-85 -108.47 107.36 17.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.927 . . . . 0.0 110.432 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -139.25 146.72 40.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.868 . . . . 0.0 109.339 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -163.17 175.1 11.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.12 -0.987 . . . . 0.0 110.924 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 60' ' ' PHE . 2.4 t80 -97.37 147.75 23.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.713 -0.617 . . . . 0.0 110.103 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 63' ' ' VAL . 1.1 mp -133.85 148.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.946 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -135.56 -166.05 10.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' C ' HD23 ' A' ' 25' ' ' LEU . 28.1 t30 67.15 58.16 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.099 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.878 HD11 ' N ' ' A' ' 61' ' ' GLY . 8.1 mt -105.95 123.99 48.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 110.366 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' LEU . 53.3 t-20 -41.45 104.13 0.33 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.774 . . . . 0.0 110.213 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.75 -15.48 26.85 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -78.13 -17.15 57.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.19 -156.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.742 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.526 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -100.33 146.85 26.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.736 HG22 ' CB ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -70.85 -33.27 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.044 -1.063 . . . . 0.0 108.622 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.35 94.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 108.956 178.819 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.526 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 12.8 mm-40 -66.56 -33.54 75.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.894 ' O ' HD12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -64.26 -33.8 76.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.186 179.231 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 1.045 ' HD3' HG12 ' A' ' 52' ' ' VAL . 5.2 mmtt -66.29 -53.79 32.5 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.474 -0.766 . . . . 0.0 109.119 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -60.84 -40.94 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.376 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.8 -29.16 69.96 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 108.951 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 34' ' ' LEU . 10.3 mt -85.86 -30.28 6.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.101 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.684 ' HA ' HG11 ' A' ' 49' ' ' VAL . 34.2 p -78.65 -25.77 45.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 109.283 179.202 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -84.43 -39.89 18.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.47 -0.768 . . . . 0.0 109.137 179.39 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.063 HD21 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -62.65 -36.83 84.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.739 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.071 ' CE2' HD21 ' A' ' 77' ' ' LEU . 9.1 m-30 -80.01 -25.19 40.35 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -68.67 -40.15 80.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.488 179.379 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.51 -17.57 53.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.45 -0.781 . . . . 0.0 109.506 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.11 -8.73 58.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.521 -0.737 . . . . 0.0 110.009 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 9.1 t0 84.52 30.26 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.954 0.883 . . . . 0.0 108.848 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.846 HD21 ' CE1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -83.72 -132.34 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.321 0.581 . . . . 0.0 109.544 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 1.022 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 174.5 57.39 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.361 -0.837 . . . . 0.0 109.837 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.684 HG11 ' HA ' ' A' ' 39' ' ' SER . 10.1 m -56.19 117.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.907 0.86 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.765 HG22 ' HB3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -92.42 -44.22 14.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.289 0.566 . . . . 0.0 109.651 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 35.2 t70 -136.76 145.8 45.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -0.902 . . . . 0.0 110.615 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.045 HG12 ' HD3' ' A' ' 35' ' ' LYS . 1.8 t -153.96 119.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.374 -0.829 . . . . 0.0 109.132 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.72 160.04 40.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.891 -1.13 . . . . 0.0 111.266 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.578 ' HB ' HG11 ' A' ' 31' ' ' VAL . 39.2 p -92.21 152.29 19.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.5 -0.75 . . . . 0.0 110.027 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -125.95 124.29 5.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 67.97 -158.86 0.21 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.363 -1.081 . . . . 0.0 110.482 179.751 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.625 ' H ' HG22 ' A' ' 56' ' ' THR . 10.3 t-20 -82.57 74.1 9.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.456 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.736 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER 60.64 14.54 5.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 179.663 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -69.27 -50.51 46.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . 5.3 p90 -156.8 152.24 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.884 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.878 ' N ' HD11 ' A' ' 25' ' ' LEU . . . -124.04 167.95 16.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.1 t80 -119.75 155.3 32.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.406 -1.055 . . . . 0.0 109.721 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.841 HG23 HD13 ' A' ' 22' ' ' ILE . 3.2 t -151.2 143.43 16.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.746 -178.613 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -117.83 143.96 45.81 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.846 ' CE1' HD21 ' A' ' 47' ' ' LEU . 37.6 m-85 -107.92 171.76 7.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.838 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp20? -118.55 16.38 13.74 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.29 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.505 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.0 p -164.37 176.13 9.37 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.466 1.127 . . . . 0.0 112.207 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.91 -25.09 43.74 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -31.07 59.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.093 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 1.022 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 91.3 m-20 -78.7 -28.4 45.12 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.77 HD13 ' C ' ' A' ' 71' ' ' LEU . 1.8 tm? -74.64 -37.84 62.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -65.81 -34.53 78.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 0.0 109.025 178.948 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.707 ' C ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.02 -32.35 59.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.976 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -56.14 -33.57 65.32 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.459 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.588 HD13 ' C ' ' A' ' 75' ' ' LEU . 2.5 tm? -72.47 -46.13 56.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.486 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.52 6.71 16.6 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.346 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.071 HD21 ' CE2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -77.15 -12.61 59.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.773 . . . . 0.0 110.367 -179.896 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.932 ' OG1' HD21 ' A' ' 89' ' ' LEU . 26.1 m -73.68 7.63 2.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.513 -0.742 . . . . 0.0 111.558 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.474 ' HA2' ' HG3' ' A' ' 86' ' ' GLU . . . -124.39 18.34 7.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.063 HD22 HD21 ' A' ' 41' ' ' LEU . 27.3 mt -107.66 111.16 23.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -1.143 . . . . 0.0 110.809 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 82' ' ' VAL . 38.1 mttm -76.91 84.02 3.46 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.07 0.938 . . . . 0.0 109.741 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.886 ' CG1' HG23 ' A' ' 87' ' ' ILE . 1.2 p -36.96 -94.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.415 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.792 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -96.81 29.05 3.17 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.159 -0.963 . . . . 0.0 109.681 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.46 9.54 12.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.722 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.4 m-20 -139.95 106.28 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 78' ' ' THR . 1.6 tm-20 -47.67 88.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.692 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.886 HG23 ' CG1' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.73 145.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 179.777 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 10.0 ttmt -117.58 155.7 29.36 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.647 -0.658 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.932 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.2 OUTLIER -120.66 175.02 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.417 -0.802 . . . . 0.0 110.327 -179.769 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 O-C-N 121.542 -0.724 . . . . 0.0 109.663 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 15' ' ' THR . 23.8 m . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.055 0.455 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.967 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.42 168.78 1.59 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.817 -1.177 . . . . 0.0 110.854 -179.88 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.6 Cg_endo -79.33 -48.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.218 1.641 . . . . 0.0 110.638 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 98.3 m-85 -85.84 110.03 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 5.6 m-80 -139.23 152.04 47.01 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -162.54 -177.71 5.78 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.716 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.8 t80 -117.78 144.64 45.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.446 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD21 ' A' ' 25' ' ' LEU . 1.1 mt -133.49 155.4 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.333 -0.854 . . . . 0.0 109.132 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -128.18 -174.86 13.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.194 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.3 t30 74.86 13.69 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.906 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.63 HD21 HG22 ' A' ' 22' ' ' ILE . 4.3 mm? -62.59 123.5 18.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.823 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -39.57 99.41 0.19 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.876 -0.515 . . . . 0.0 110.496 179.984 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.8 Cg_endo -78.16 -17.2 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.979 1.515 . . . . 0.0 110.619 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.11 -17.78 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.94 . . . . 0.0 110.071 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.566 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -110.5 -157.07 0.6 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 109.613 179.626 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.483 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.05 140.89 32.53 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 110.365 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.008 HG11 HG22 ' A' ' 54' ' ' THR . 2.6 t -67.24 -34.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.732 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.897 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.86 -34.53 69.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.454 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 44.6 mm-40 -68.23 -43.71 77.35 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.882 HD22 HG12 ' A' ' 82' ' ' VAL . 9.1 mt -61.15 -46.07 92.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.609 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.68 ' HG2' HG22 ' A' ' 52' ' ' VAL . 90.7 mttt -53.54 -51.05 64.14 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.314 0.578 . . . . 0.0 109.495 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 32' ' ' ALA . 11.3 t -63.64 -38.56 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.474 179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.89 -35.64 81.31 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.733 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 93.4 mt -79.24 -28.14 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 109.171 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' SER . . . . . 1.046 ' HA ' HG21 ' A' ' 49' ' ' VAL . 6.9 t -78.0 -31.71 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 108.972 179.2 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.75 -38.85 32.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.603 -0.686 . . . . 0.0 109.765 179.589 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.67 -31.74 71.93 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.315 179.335 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.2 m-85 -82.18 -23.71 35.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 108.928 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.42 65.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.471 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -94.14 -17.26 22.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.684 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.665 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.2 m120 -81.77 -24.57 35.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.665 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 23.6 t70 101.57 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.124 HD11 HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -97.5 -151.04 0.36 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.54 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -168.88 62.34 0.06 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.081 -1.012 . . . . 0.0 109.841 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.046 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.3 m -54.23 117.77 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.043 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.967 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -93.41 -39.13 10.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.981 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -146.75 163.65 35.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.072 -1.017 . . . . 0.0 110.572 179.864 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.68 HG22 ' HG2' ' A' ' 35' ' ' LYS . 14.4 p -165.61 114.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 109.909 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -119.59 165.3 14.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 54' ' ' THR . . . . . 1.008 HG22 HG11 ' A' ' 31' ' ' VAL . 3.8 p -79.56 171.24 15.41 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.43 -0.794 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 60' ' ' PHE . . . -140.45 98.48 0.23 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.634 -1.269 . . . . 0.0 110.479 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 85.6 m 58.78 130.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -1.089 . . . . 0.0 111.779 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' THR . 1.3 m-80 33.18 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.858 -0.526 . . . . 0.0 111.586 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.517 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 3.6 mtp-105 43.5 25.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.074 -1.016 . . . . 0.0 110.313 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.37 -33.27 18.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 55' ' ' GLY . 3.0 m-85 -112.68 -160.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 0.0 109.167 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 179.24 125.99 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.066 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 61.1 m-85 -90.2 158.57 17.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -1.124 . . . . 0.0 109.598 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 52' ' ' VAL . 2.8 t -149.86 141.4 17.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.906 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 52.0 m-20 -112.67 146.46 38.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.0 109.53 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.73 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 50.3 m-85 -112.38 177.22 4.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.878 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -113.79 18.86 17.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 111.475 -178.354 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.63 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 23.4 p -178.83 -179.3 0.6 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.643 1.211 . . . . 0.0 112.325 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.259 . . -81.0 -28.58 35.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.484 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.13 -24.92 59.5 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.229 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.709 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.1 m-20 -83.33 -33.34 25.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 71' ' ' LEU . 9.5 tp -70.67 -36.93 73.59 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.741 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -71.81 -41.17 68.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.689 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.885 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -74.25 -32.62 63.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.134 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 65' ' ' PHE . . . -60.26 -29.92 69.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.747 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.492 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -72.18 -49.03 38.8 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.724 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.09 -0.46 28.2 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.31 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.124 HD21 HD11 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -82.56 17.08 1.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 110.367 -179.725 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.514 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 86.3 m -87.73 5.62 39.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.09 20.92 33.76 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.879 ' CD2' HD12 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -118.12 124.74 48.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.25 -1.147 . . . . 0.0 110.602 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 14.9 mttt -87.98 82.54 7.21 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.613 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.882 HG12 HD22 ' A' ' 34' ' ' LEU . 76.5 t -42.99 106.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.5 OUTLIER 60.09 22.67 11.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 110.397 -179.17 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.84 14.72 30.86 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' ILE . 19.5 m-20 -133.3 103.26 5.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.136 -1.214 . . . . 0.0 110.207 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.7 tt0 -57.52 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.864 HG21 HG21 ' A' ' 82' ' ' VAL . 13.0 pt -41.71 137.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.382 -0.824 . . . . 0.0 110.586 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -104.48 167.86 9.47 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.164 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.54 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 1.4 mp -109.7 179.0 4.25 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.04 -1.038 . . . . 0.0 110.641 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.949 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 16' ' ' THR . 5.1 m . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.193 0.52 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.8 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -173.52 161.98 3.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 110.516 -179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.77 -40.51 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.249 1.657 . . . . 0.0 110.675 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 65' ' ' PHE . 81.6 m-85 -95.51 111.16 23.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.6 m120 -135.64 151.87 50.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.825 . . . . 0.0 109.687 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -160.01 166.89 29.12 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 110.512 -179.651 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 1.1 t80 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 110.002 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.663 HD12 ' CG2' ' A' ' 63' ' ' VAL . 7.8 mt -126.19 162.56 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -147.81 175.73 26.99 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 30.9 t30 72.71 64.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.582 -0.952 . . . . 0.0 110.07 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.938 HD13 HG13 ' A' ' 31' ' ' VAL . 18.9 mt -95.4 -167.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.507 ' H ' HD11 ' A' ' 34' ' ' LEU . 54.0 t-20 -114.61 107.03 51.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HA ' ' CD ' ' A' ' 58' ' ' ARG . 44.4 Cg_endo -72.27 -1.82 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.064 1.56 . . . . 0.0 110.579 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -113.97 20.52 15.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.671 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' CG ' ' OE2' ' A' ' 33' ' ' GLU . 2.2 tptm -148.12 -157.98 0.87 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.327 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.78 139.9 45.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.685 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.938 HG13 HD13 ' A' ' 25' ' ' LEU . 20.7 t -66.8 -28.42 43.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.08 179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.79 85.18 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.679 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.568 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -64.4 -30.29 71.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.811 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.885 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.63 -37.42 84.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 108.932 178.921 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.921 ' HD3' HG12 ' A' ' 52' ' ' VAL . 13.3 mmtt -61.71 -54.07 47.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.459 -0.775 . . . . 0.0 109.306 179.251 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 42.7 t -49.21 -41.29 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.824 . . . . 0.0 109.88 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.035 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.39 -33.18 74.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.17 -0.956 . . . . 0.0 108.724 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 32.6 mt -82.03 -26.01 9.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.586 -0.696 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.689 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -80.75 -28.34 36.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 108.574 178.969 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -81.45 -41.13 22.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.57 0.7 . . . . 0.0 109.381 179.393 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.12 HD22 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.13 -34.43 78.02 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.096 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.129 ' CD2' HD13 ' A' ' 47' ' ' LEU . 5.9 m-85 -80.79 -23.56 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -73.04 -33.1 65.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 109.105 179.25 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.28 -17.3 24.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.402 179.278 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.17 -20.76 37.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.435 -0.791 . . . . 0.0 109.995 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.2 t70 95.76 29.17 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.992 0.901 . . . . 0.0 108.877 -179.396 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.129 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -91.68 -143.73 0.19 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.316 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' A' ' 66' ' ' GLU . . . -176.29 60.12 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 39' ' ' SER . 8.3 m -55.23 118.23 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.902 0.858 . . . . 0.0 110.214 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.8 ' CB ' HG21 ' A' ' 16' ' ' THR . 0.3 OUTLIER -92.03 -38.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.158 0.504 . . . . 0.0 109.82 -179.498 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.512 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 1.6 t70 -137.21 152.11 49.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 0.0 110.64 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.921 HG12 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -157.82 114.42 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.491 -0.755 . . . . 0.0 109.62 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -134.97 175.47 9.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.656 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.8 p -83.48 175.0 10.12 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.224 -0.923 . . . . 0.0 110.187 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -130.5 117.11 2.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.567 ' HG1' ' HD2' ' A' ' 60' ' ' PHE . 2.8 m 77.05 -64.81 0.31 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.117 -0.637 . . . . 0.0 109.829 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 56' ' ' THR . 18.9 p-10 179.91 -32.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.448 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -177.57 28.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -115.0 -33.61 5.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.205 -0.934 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.698 ' CD1' ' CE2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.91 -179.28 6.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.372 -0.83 . . . . 0.0 109.346 179.175 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.623 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -148.9 168.18 29.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.52 ' C ' ' CG2' ' A' ' 63' ' ' VAL . 5.9 t80 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -1.162 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.817 HG13 HG13 ' A' ' 52' ' ' VAL . 3.7 t -151.63 158.35 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.531 -178.922 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 28.4 m-20 -130.96 142.68 50.37 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.111 -0.993 . . . . 0.0 109.951 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 64.3 m-85 -106.96 172.42 6.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.42 -0.8 . . . . 0.0 110.004 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.742 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.11 17.75 13.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -0.987 . . . . 0.0 111.462 -178.32 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.472 ' OG ' ' OD2' ' A' ' 70' ' ' ASP . 26.7 p -168.17 175.81 6.36 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.525 1.155 . . . . 0.0 112.437 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.83 -24.82 48.56 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.698 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -77.23 -26.6 52.83 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.576 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.617 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 90.2 m-20 -82.9 -30.04 28.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.241 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.6 -36.87 68.21 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.786 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.53 -36.91 63.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 109.973 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.971 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.22 -26.59 52.85 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.654 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 65' ' ' PHE . . . -70.67 -29.37 65.68 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.912 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 75' ' ' LEU . 4.7 tt -71.74 -46.96 56.87 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -4.22 44.05 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.257 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -76.38 6.81 5.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.538 -0.726 . . . . 0.0 110.547 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 78' ' ' THR . 54.3 m -76.65 3.11 12.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 110.299 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.72 28.85 10.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.12 ' CD2' HD22 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.0 120.57 39.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -1.062 . . . . 0.0 110.236 -179.579 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.629 ' N ' HD12 ' A' ' 80' ' ' LEU . 2.1 ttmt -91.58 87.97 6.57 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 123.017 1.389 . . . . 0.0 109.385 178.804 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 37' ' ' ALA . 98.5 t -43.24 -105.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.686 -179.649 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 1.035 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 6.3 m-85 -90.13 40.37 1.0 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.014 -1.054 . . . . 0.0 109.964 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.416 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . 97.54 19.57 24.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.547 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 10.4 m120 -147.01 92.58 2.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 110.105 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.6 mt-10 -43.27 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.75 HG21 HG21 ' A' ' 82' ' ' VAL . 2.2 pp -58.67 129.21 20.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 110.203 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -104.63 133.22 49.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.466 179.701 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.554 ' HB2' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -110.72 174.16 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.936 -1.102 . . . . 0.0 111.122 -179.38 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.481 0 O-C-N 121.635 -0.666 . . . . 0.0 109.634 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.552 0.691 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.974 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -119.04 163.9 23.97 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.553 -0.717 . . . . 0.0 110.567 -179.632 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.4 -29.56 6.0 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.201 1.632 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 86.9 m-85 -108.54 113.2 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.667 -179.759 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 2.0 m120 -141.8 149.15 40.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.769 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -164.62 -176.9 4.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.451 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.579 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.7 t80 -108.94 153.35 23.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 110.169 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.92 155.27 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.915 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.24 -169.89 11.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.8 OUTLIER 72.0 51.32 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.498 -1.001 . . . . 0.0 110.422 179.935 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 60' ' ' PHE . 13.8 mt -102.51 120.97 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.915 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 34' ' ' LEU . 34.6 t30 -47.13 104.53 0.42 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.581 -0.699 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.6 Cg_endo -75.44 -5.02 16.1 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.045 1.55 . . . . 0.0 110.433 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -80.11 -20.35 45.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.99 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -107.95 -156.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.737 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.5 m -98.5 146.75 25.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.767 HG11 ' HB ' ' A' ' 54' ' ' THR . 4.5 t -67.98 -34.1 65.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.722 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.52 -34.6 78.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.741 179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 59.0 mm-40 -71.44 -34.98 70.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.336 179.367 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 30' ' ' SER . 6.7 mp -66.54 -29.02 69.0 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 1.076 ' HZ2' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.94 -54.98 9.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.461 -0.775 . . . . 0.0 109.1 179.158 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 32' ' ' ALA . 12.2 t -60.15 -35.03 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.817 . . . . 0.0 109.379 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.45 -38.03 88.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.9 mt -76.03 -29.37 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.493 179.042 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' SER . . . . . 1.012 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.9 t -78.66 -29.75 45.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.084 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.3 tm-20 -81.48 -36.95 28.7 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 80' ' ' LEU . 1.1 tt -69.73 -30.2 67.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.502 -0.748 . . . . 0.0 109.093 179.038 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 3.9 m-85 -90.02 -16.71 29.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.492 -0.755 . . . . 0.0 109.388 179.278 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.88 -28.83 18.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HE3' ' OE2' ' A' ' 40' ' ' GLU . 47.6 mttt -89.4 -24.6 21.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.4 m120 -77.41 -59.3 2.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.552 -0.717 . . . . 0.0 109.493 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 p30 148.02 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.489 0.661 . . . . 0.0 110.828 179.419 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.847 HD11 ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -91.76 -154.35 0.37 Allowed 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.381 -0.824 . . . . 0.0 109.96 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.86 63.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 1.012 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.8 m -67.2 115.65 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.974 HG21 HG21 ' A' ' 16' ' ' THR . 0.6 OUTLIER -90.09 -39.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.223 0.535 . . . . 0.0 109.972 -179.602 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.521 ' CB ' ' OD2' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -140.78 156.31 46.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.0 110.566 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.076 HG12 ' HZ2' ' A' ' 35' ' ' LYS . 3.9 t -152.9 100.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.823 . . . . 0.0 110.017 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 2.3 ttp180 -99.69 167.44 10.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.767 ' HB ' HG11 ' A' ' 31' ' ' VAL . 12.7 p -88.25 169.7 11.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.243 -0.911 . . . . 0.0 110.475 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -128.75 115.46 2.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER 65.83 -150.58 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -1.064 . . . . 0.0 110.075 -179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.575 ' H ' HG22 ' A' ' 56' ' ' THR . 73.5 m-20 -63.76 -55.37 23.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -176.39 49.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 110.254 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 16.5 mtpt -123.68 -23.93 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 110.293 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.777 ' O ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -132.48 178.37 6.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -164.63 142.99 8.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 13.5 t80 -97.03 157.77 15.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -1.179 . . . . 0.0 109.763 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.816 HG13 HG22 ' A' ' 52' ' ' VAL . 3.1 t -151.71 140.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.959 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.523 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 2.3 m-20 -108.09 140.82 40.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.473 -0.767 . . . . 0.0 109.056 178.991 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.806 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 8.5 m-85 -103.94 178.34 4.59 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.284 -0.885 . . . . 0.0 110.446 -179.026 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.634 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -108.15 -9.64 15.54 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.799 -178.447 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 17.3 p -168.12 -176.58 3.01 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.812 1.291 . . . . 0.0 113.061 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -83.79 -18.63 37.04 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.567 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.437 ' OE2' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -87.72 -27.09 22.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.069 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.847 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -82.5 -29.75 30.31 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.947 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.706 HD23 ' C ' ' A' ' 71' ' ' LEU . 2.0 tt -72.56 -37.65 68.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.649 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.593 ' N ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -67.47 -40.84 85.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.328 179.205 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 1.044 ' O ' HD23 ' A' ' 77' ' ' LEU . 9.9 mttm -75.61 -27.33 58.45 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.289 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.806 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.03 -28.11 63.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.737 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 89' ' ' LEU . 1.5 tm? -69.55 -46.3 66.76 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.673 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.88 -13.75 61.75 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.939 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -73.12 2.6 6.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 110.396 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.678 ' OG1' HD21 ' A' ' 89' ' ' LEU . 99.7 m -75.1 2.66 10.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.058 -1.026 . . . . 0.0 110.592 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.14 11.99 65.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 41' ' ' LEU . 75.4 mt -89.55 -165.18 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.307 -1.113 . . . . 0.0 110.591 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.617 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -169.27 48.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.703 0.763 . . . . 0.0 109.867 179.796 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.046 HG21 HG23 ' A' ' 87' ' ' ILE . 3.9 t 6.44 -123.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.636 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CD2' ' HG3' ' A' ' 29' ' ' LYS . 16.6 m-85 -73.03 -3.16 24.43 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.149 178.743 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 146.89 35.32 0.06 OUTLIER Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.9 t30 -158.1 101.45 1.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -1.215 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.617 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -50.44 90.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.99 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.046 HG23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -39.84 137.27 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.568 0.699 . . . . 0.0 110.211 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.643 ' O ' HG23 ' A' ' 22' ' ' ILE . 28.4 ttmt -112.78 156.44 22.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.522 -0.736 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -117.01 175.12 5.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 110.643 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.592 -0.692 . . . . 0.0 109.541 -179.503 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 15' ' ' THR . 19.6 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.29 0.567 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.754 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -176.65 166.16 1.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.312 -179.876 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 16' ' ' THR . 51.2 Cg_endo -79.66 -25.93 5.07 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.107 1.583 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.963 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 79.1 m-85 -111.89 108.81 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.815 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -142.15 152.06 42.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 108.999 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.752 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.7 pp -162.65 -176.19 4.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.791 -179.686 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.3 t80 -104.39 154.48 19.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.548 -0.72 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.625 HD12 ' CG2' ' A' ' 63' ' ' VAL . 6.2 mt -143.83 152.73 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.54 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -140.7 -167.11 10.94 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.869 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.9 t30 70.7 38.29 1.27 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.339 -1.095 . . . . 0.0 109.888 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.944 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.8 mm? -88.97 127.97 35.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.297 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.741 ' H ' HD21 ' A' ' 34' ' ' LEU . 34.5 t-20 -39.96 100.22 0.21 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.651 -0.656 . . . . 0.0 110.528 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HB3' ' CG ' ' A' ' 59' ' ' LYS . 47.9 Cg_endo -74.87 -13.14 21.79 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -87.68 -10.01 52.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HZ3' ' HD1' ' A' ' 83' ' ' PHE . 18.2 mttt -112.98 -159.0 0.67 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.772 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.5 m -97.2 146.0 25.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.668 ' HA ' HD12 ' A' ' 34' ' ' LEU . 3.4 t -65.15 -38.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.185 179.38 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -59.6 -37.71 79.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.224 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.602 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.0 -29.86 68.97 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.944 HD13 ' HB3' ' A' ' 25' ' ' LEU . 7.7 mt -68.94 -31.56 70.52 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.328 -0.857 . . . . 0.0 109.437 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.556 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 9.7 mmpt? -69.13 -51.56 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.7 t -60.58 -39.53 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.566 -0.708 . . . . 0.0 109.892 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.984 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . . . -62.26 -34.84 77.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 108.764 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 34' ' ' LEU . 44.7 mt -79.45 -29.79 13.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.597 -0.689 . . . . 0.0 109.193 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 22.6 t -77.81 -28.45 50.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.133 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -81.74 -39.03 24.79 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.534 0.683 . . . . 0.0 109.446 179.402 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.692 HD21 ' CB ' ' A' ' 80' ' ' LEU . 6.0 tp -66.08 -32.8 74.48 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.024 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 7.7 m-85 -85.52 -20.64 29.36 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.418 -0.801 . . . . 0.0 108.898 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.36 -31.66 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.514 -0.741 . . . . 0.0 109.508 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 8.9 mtpt -89.17 -23.39 22.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.77 ' OD1' HD11 ' A' ' 77' ' ' LEU . 1.7 m-80 -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.503 -0.748 . . . . 0.0 109.829 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.7 t70 90.89 31.01 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.011 0.91 . . . . 0.0 108.851 -179.329 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.986 HD11 ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -77.96 -137.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.434 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.772 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -171.16 58.05 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.567 HG11 ' HD2' ' A' ' 42' ' ' PHE . 15.6 m -66.82 113.14 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.772 0.796 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.754 HG11 ' CG2' ' A' ' 16' ' ' THR . 71.3 t -91.07 -24.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 O-C-N 121.814 -0.554 . . . . 0.0 110.291 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -162.49 163.66 27.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 110.387 179.741 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.3 t -150.93 156.94 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -155.61 165.57 36.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.119 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.641 ' HB ' HG11 ' A' ' 31' ' ' VAL . 25.8 p -86.83 161.13 18.51 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -137.35 127.13 3.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 55' ' ' GLY . 6.3 m 49.77 100.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.169 . . . . 0.0 110.713 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' THR . 6.8 m120 39.56 -98.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -141.13 30.53 1.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.007 -1.058 . . . . 0.0 110.636 -179.594 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -121.2 14.17 11.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.995 179.761 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -156.51 178.51 10.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.69 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -178.58 150.95 10.0 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.724 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.565 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 10.6 t80 -113.5 158.53 20.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.971 . . . . 0.0 109.013 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.625 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.4 t -151.09 144.36 16.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.881 -178.249 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HB3' ' HG1' ' A' ' 16' ' ' THR . 1.0 OUTLIER -102.75 146.56 28.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.527 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.7 ' O ' HG21 ' A' ' 16' ' ' THR . 3.7 m-85 -112.38 -172.23 2.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.937 -1.102 . . . . 0.0 111.165 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.772 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -115.21 -7.09 12.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.958 -179.421 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.645 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 24.1 p -176.18 175.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.58 1.181 . . . . 0.0 112.502 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.963 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -76.4 -25.81 54.9 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.108 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -29.47 58.22 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.964 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.986 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.6 -29.7 56.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.938 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -71.78 -38.78 70.25 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.606 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.19 -38.04 87.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.514 -0.741 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.796 ' O ' HD23 ' A' ' 77' ' ' LEU . 2.5 mttp -81.56 -30.51 33.03 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' A' ' 47' ' ' LEU . . . -74.95 -25.18 58.69 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.118 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.1 tt -73.35 -46.75 47.41 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.517 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.46 -14.81 62.25 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.875 178.218 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -71.82 -0.28 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.598 -0.689 . . . . 0.0 110.265 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.54 ' OG1' HD21 ' A' ' 89' ' ' LEU . 24.9 m -76.65 4.42 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.841 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.05 -8.66 86.27 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.692 ' CB ' HD21 ' A' ' 41' ' ' LEU . 3.5 mm? -80.46 -164.89 0.77 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -1.042 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -148.45 51.41 1.0 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.624 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.868 ' HB ' HG23 ' A' ' 87' ' ' ILE . 8.7 p 17.04 -132.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.344 -179.711 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.984 ' CD2' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -78.6 11.47 2.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.447 -1.408 . . . . 0.0 109.666 178.579 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 143.57 36.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.696 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.6 t30 -174.07 115.76 0.21 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -1.19 . . . . 0.0 109.661 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 tt0 -52.5 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.104 -0.997 . . . . 0.0 110.346 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.868 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -44.75 143.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.802 179.668 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 22' ' ' ILE . 9.3 mtmt -119.85 155.09 33.31 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.83 172.59 7.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.316 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.551 ' CG2' HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 121.376 0.608 . . . . 0.0 109.934 . . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.984 ' CG2' HG11 ' A' ' 50' ' ' VAL . 20.3 p -140.64 160.99 56.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.417 -0.802 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.43 -22.53 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.013 1.533 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.706 ' HD1' HD13 ' A' ' 71' ' ' LEU . 85.5 m-85 -123.36 115.38 21.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 111.159 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -138.72 150.84 46.59 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.647 HD21 ' HE2' ' A' ' 65' ' ' PHE . 3.1 pp -165.22 -167.15 1.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.125 -0.984 . . . . 0.0 110.647 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.651 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 31.3 t80 -125.07 142.72 51.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.86 . . . . 0.0 110.019 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 3.4 mt -119.99 170.12 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.03 -172.91 15.82 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.695 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t-20 73.26 48.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.61 -0.935 . . . . 0.0 110.177 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 1.061 HD13 HD22 ' A' ' 34' ' ' LEU . 3.7 mm? -93.3 123.04 36.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.74 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.557 ' N ' HD11 ' A' ' 34' ' ' LEU . 22.5 t-20 -43.67 107.31 0.57 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.563 -0.711 . . . . 0.0 110.337 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 45.8 Cg_endo -72.3 -27.94 15.79 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.104 1.581 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -78.84 -17.03 56.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.565 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -106.19 -155.94 0.56 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 109.673 179.727 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 m -114.2 150.29 34.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.164 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.816 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.8 t -69.38 -26.22 30.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.79 92.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.135 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.6 mm-40 -69.78 -46.17 66.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 109.148 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.061 HD22 HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -55.37 -37.3 67.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.55 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.85 -63.12 1.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.076 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.9 t -49.4 -35.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 34' ' ' LEU . . . -62.49 -42.26 99.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.827 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.767 HD11 HG21 ' A' ' 87' ' ' ILE . 16.0 mm -73.11 -28.68 26.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.428 178.863 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.8 -29.44 50.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 0.0 109.044 179.351 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.46 -41.24 16.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.6 -0.687 . . . . 0.0 109.759 179.643 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.73 HD11 HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -63.13 -34.91 78.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.49 -0.756 . . . . 0.0 109.187 179.177 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.133 ' CD2' HD13 ' A' ' 47' ' ' LEU . 8.6 m-85 -87.13 -21.15 26.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.079 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -77.19 -31.53 55.45 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.266 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -84.1 -19.46 34.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.52 -0.738 . . . . 0.0 109.138 179.25 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -87.31 -18.73 29.47 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.649 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.4 t70 87.84 29.62 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 1.133 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -76.89 -137.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.357 179.585 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -176.27 57.55 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 49' ' ' VAL . 10.5 m -55.02 117.69 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.9 0.857 . . . . 0.0 109.87 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.984 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.2 t -90.95 -44.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.346 -179.382 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 17.5 t70 -143.9 148.03 34.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.105 -0.997 . . . . 0.0 110.926 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.94 HG12 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.13 158.31 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.427 -0.796 . . . . 0.0 109.577 179.907 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 62' ' ' TYR . 3.8 mtp180 -165.75 161.43 18.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.42 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.816 HG22 ' CG1' ' A' ' 31' ' ' VAL . 9.6 p -88.02 170.8 10.79 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 110.249 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -133.95 127.02 4.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 57' ' ' ASN . 2.0 m 60.03 -135.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -1.138 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.528 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 14.8 t-20 -102.06 90.09 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.019 -1.051 . . . . 0.0 110.594 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 3.2 mtt180 43.34 45.57 5.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.61 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 18.9 mttt -124.32 -28.42 3.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.028 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.737 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.0 m-85 -138.82 -174.44 3.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 109.369 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -162.15 136.85 4.55 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 63' ' ' VAL . 48.3 m-85 -94.48 159.98 14.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.137 . . . . 0.0 109.577 179.253 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.94 HG22 HG12 ' A' ' 52' ' ' VAL . 24.6 t -158.63 161.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.584 -178.876 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.499 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -134.64 139.72 45.51 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.647 ' HE2' HD21 ' A' ' 20' ' ' LEU . 55.6 m-85 -103.66 175.34 5.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.905 -179.478 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.638 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.66 16.42 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 111.388 -178.543 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 20.7 p -178.38 176.71 1.03 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.434 1.111 . . . . 0.0 112.044 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.467 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.18 -23.52 51.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.802 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.91 -27.52 43.81 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.369 179.999 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.663 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 89.6 m-20 -80.37 -29.98 37.9 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.706 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -75.66 -36.78 60.05 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.323 179.165 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.33 -34.37 74.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.308 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.481 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -81.0 -26.29 36.57 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.326 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.837 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -64.77 -29.88 70.87 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.675 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.52 -45.11 22.71 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.505 0.669 . . . . 0.0 109.246 179.12 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -23.28 66.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 110.019 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.926 HD11 ' CD1' ' A' ' 47' ' ' LEU . 20.8 mt -69.69 -5.17 23.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.466 ' OG1' HD12 ' A' ' 89' ' ' LEU . 25.9 m -67.39 -2.02 5.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.525 -0.734 . . . . 0.0 111.205 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.27 10.68 61.63 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 41' ' ' LEU . 6.1 mt -84.8 -161.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -1.051 . . . . 0.0 111.272 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.575 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 9.6 tttm -159.66 52.4 0.35 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.345 1.069 . . . . 0.0 109.821 -179.168 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.739 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -38.45 133.26 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.737 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 1.0 OUTLIER 40.97 34.74 0.3 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.313 -179.228 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 77.68 28.42 57.17 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 m-20 -144.42 107.77 4.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.291 179.643 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.575 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 mt-10 -59.03 92.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.005 -1.059 . . . . 0.0 110.3 -179.161 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.767 HG21 HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -41.16 142.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.712 0.768 . . . . 0.0 110.505 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -121.44 125.15 46.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.516 -0.74 . . . . 0.0 109.217 179.513 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 20' ' ' LEU . 1.3 mt -85.24 176.64 8.22 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.139 -0.975 . . . . 0.0 110.855 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--N 1.298 -1.631 0 O-C-N 121.701 -0.624 . . . . 0.0 109.715 -179.704 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.778 HG21 ' CG ' ' A' ' 51' ' ' ASP . 3.8 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.306 0.574 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.957 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -172.45 165.02 3.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.551 -179.876 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.5 Cg_endo -77.0 -40.49 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.175 1.619 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.672 ' HD1' HD13 ' A' ' 71' ' ' LEU . 95.5 m-85 -100.03 108.98 21.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.664 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.493 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 2.8 m120 -138.41 153.28 48.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.436 -0.79 . . . . 0.0 109.524 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.792 HD12 HD23 ' A' ' 89' ' ' LEU . 2.5 pt? -165.3 174.6 9.98 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 110.267 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -109.17 159.17 17.12 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.679 -0.638 . . . . 0.0 109.921 -179.662 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 88' ' ' LYS . 4.5 mt -142.61 149.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.403 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.6 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -132.1 -172.74 13.13 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.565 -1.303 . . . . 0.0 110.027 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.514 ' C ' HD22 ' A' ' 25' ' ' LEU . 32.3 t30 72.1 49.88 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.527 -0.984 . . . . 0.0 109.858 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.784 ' CD1' HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -95.46 123.54 39.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 110.082 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.654 ' N ' HD21 ' A' ' 34' ' ' LEU . 30.5 t-20 -42.47 101.78 0.25 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 110.287 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.3 Cg_endo -74.52 -16.68 21.4 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.973 1.512 . . . . 0.0 110.338 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.48 -15.97 59.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.032 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 -155.66 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.71 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.5 m -100.18 149.87 23.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.502 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 3.5 t -66.61 -45.87 87.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.817 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.54 83.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 80.6 mm-40 -58.84 -35.86 73.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.79 . . . . 0.0 109.278 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.942 HD23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -65.68 -31.3 72.24 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.176 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HE2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.76 -50.84 61.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.538 -0.727 . . . . 0.0 109.335 179.228 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 22.0 t -59.66 -39.19 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.474 -0.766 . . . . 0.0 109.937 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.931 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -61.45 -33.45 73.76 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.135 -0.978 . . . . 0.0 108.682 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.665 HG12 HD13 ' A' ' 87' ' ' ILE . 42.5 mt -81.04 -30.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 46.4 t -77.22 -26.4 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.063 179.299 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -82.87 -43.26 16.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.707 0.765 . . . . 0.0 109.247 179.302 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 80' ' ' LEU . 1.1 tp -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.153 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.568 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 8.9 m-85 -83.71 -22.13 32.11 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.661 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.57 -32.04 47.54 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.621 0.725 . . . . 0.0 109.286 179.518 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.47 ' HE2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.73 -14.89 33.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.423 -0.798 . . . . 0.0 109.328 179.188 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.02 -18.09 28.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.656 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.1 t0 89.52 29.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.004 0.907 . . . . 0.0 108.765 -179.234 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.568 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.25 -137.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.655 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . 178.94 58.26 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.14 -0.975 . . . . 0.0 109.517 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 49' ' ' VAL . 13.0 m -60.17 116.04 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.987 0.899 . . . . 0.0 110.148 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.957 HG11 ' CG2' ' A' ' 16' ' ' THR . 17.1 t -81.44 -36.19 14.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.894 -0.504 . . . . 0.0 110.561 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.778 ' CG ' HG21 ' A' ' 15' ' ' THR . 0.3 OUTLIER -149.98 154.39 38.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 110.673 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -133.51 173.14 15.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.732 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 170.12 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.939 . . . . 0.0 110.47 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.523 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 28.5 p -100.7 164.74 11.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.225 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.565 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -134.53 136.6 8.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 63.47 -138.51 0.35 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -1.114 . . . . 0.0 110.293 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.0 m-20 -111.82 99.98 8.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 110.529 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 3.2 ptt85 38.37 27.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 111.02 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.3 ttpt -129.51 -5.33 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.736 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -138.58 -168.39 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -173.26 179.4 44.7 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.524 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.687 ' O ' HG23 ' A' ' 63' ' ' VAL . 12.3 t80 -154.88 156.43 36.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.568 -0.96 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.808 HG22 HG12 ' A' ' 52' ' ' VAL . 25.5 t -158.66 164.28 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.009 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.579 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 7.9 m-20 -130.08 140.16 50.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.554 -0.716 . . . . 0.0 109.47 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.67 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 22.3 m-85 -103.09 179.56 4.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.286 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 10.9 pt-20 -113.11 2.54 15.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 110.954 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 56.8 p -165.44 177.68 7.31 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.585 1.183 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -78.27 -24.05 46.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -76.52 -26.85 55.67 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.562 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 77.6 m-20 -86.02 -27.37 24.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.308 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.672 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -77.13 -35.47 56.2 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.659 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.93 -32.43 40.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.755 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -80.85 -25.1 37.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.708 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.65 -26.74 45.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.998 178.936 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.597 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.9 tt -72.97 -46.05 54.51 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.735 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.39 -19.22 61.65 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -62.6 -11.06 14.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.761 -0.587 . . . . 0.0 109.949 179.569 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.525 HG22 ' OE2' ' A' ' 86' ' ' GLU . 18.7 m -39.23 -28.53 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.806 0.812 . . . . 0.0 110.966 -179.463 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.62 -20.55 12.25 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.431 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.839 HD13 HG12 ' A' ' 87' ' ' ILE . 1.5 pp -48.04 -178.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.441 -1.035 . . . . 0.0 111.82 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -167.7 51.41 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.942 HG21 HD23 ' A' ' 34' ' ' LEU . 11.0 p 5.73 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.091 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.931 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 3.4 m-85 -81.58 13.79 2.91 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.437 -1.414 . . . . 0.0 108.985 178.447 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 133.73 34.77 0.29 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.774 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.632 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.8 m120 -158.86 103.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -1.022 . . . . 0.0 109.224 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.728 ' HA ' HD12 ' A' ' 80' ' ' LEU . 3.5 tt0 -49.91 90.52 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 110.371 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.839 HG12 HD13 ' A' ' 80' ' ' LEU . 16.7 pt -49.45 138.73 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.474 -0.766 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.21 175.19 6.37 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD23 HD12 ' A' ' 20' ' ' LEU . 7.1 mp -121.45 -176.66 3.35 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.372 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.648 -0.658 . . . . 0.0 110.184 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 16' ' ' THR . 30.2 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.21 0.529 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.941 ' CG2' HG11 ' A' ' 50' ' ' VAL . 24.8 p -158.93 153.36 20.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.94 -30.36 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.262 1.664 . . . . 0.0 110.339 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.62 ' HD1' HD22 ' A' ' 71' ' ' LEU . 96.4 m-85 -92.75 106.07 18.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.358 -179.799 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 4.8 m-80 -139.52 152.69 47.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.6 pt? -165.33 164.73 19.78 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.461 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -91.08 160.75 15.43 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.379 -179.967 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 1.05 HD12 ' CG2' ' A' ' 63' ' ' VAL . 5.4 mt -150.03 146.93 16.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.951 -179.669 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -129.91 -171.47 12.94 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 26.2 t30 73.08 35.27 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.501 -0.999 . . . . 0.0 110.561 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.792 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.1 mm? -84.13 128.21 34.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.964 . . . . 0.0 109.824 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.79 ' H ' HD21 ' A' ' 34' ' ' LEU . 57.6 t-20 -39.8 102.89 0.27 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.663 -0.648 . . . . 0.0 110.61 -179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.02 7.0 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.045 1.55 . . . . 0.0 110.733 -179.729 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -106.07 -14.63 15.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.304 179.593 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -111.23 -156.3 0.58 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.624 -0.673 . . . . 0.0 109.629 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.477 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 2.3 m -105.49 148.53 27.11 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.735 179.283 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 1.018 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.8 t -63.97 -15.6 17.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.849 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -75.34 -38.38 60.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.432 -0.792 . . . . 0.0 109.05 178.828 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 3.8 mt-10 -72.13 -28.02 62.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.502 -0.749 . . . . 0.0 109.046 178.955 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.968 HD23 HG11 ' A' ' 82' ' ' VAL . 4.8 mt -70.79 -43.11 69.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.718 ' HG2' HG22 ' A' ' 52' ' ' VAL . 53.1 mttt -60.65 -43.81 97.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.66 -0.65 . . . . 0.0 110.018 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 32' ' ' ALA . 8.5 t -63.67 -41.1 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.869 179.583 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.717 ' HB2' ' HE1' ' A' ' 83' ' ' PHE . . . -63.05 -38.16 90.09 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.635 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.895 HD11 HG22 ' A' ' 82' ' ' VAL . 17.6 mm -77.7 -28.87 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.234 178.973 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.9 t -76.96 -30.23 55.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.951 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.9 tm-20 -81.27 -45.92 15.53 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.567 0.699 . . . . 0.0 109.585 179.42 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.043 ' HG ' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -56.76 -39.97 74.99 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.302 179.402 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 1.029 ' CE1' HD13 ' A' ' 77' ' ' LEU . 16.2 m-30 -78.43 -25.16 45.92 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.755 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.71 -33.12 41.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.472 ' HG3' ' OE2' ' A' ' 40' ' ' GLU . 2.8 mttt -88.43 -13.07 41.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.534 -0.729 . . . . 0.0 109.432 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -92.36 -14.48 28.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.659 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.603 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.9 t0 86.38 28.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.936 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 77' ' ' LEU . 2.5 tp -76.97 -136.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.401 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . . . -165.35 46.09 0.08 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.093 0.949 . . . . 0.0 108.67 178.923 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -55.29 150.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 122.241 1.02 . . . . 0.0 109.447 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.941 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.5 t -136.18 -34.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.356 -178.984 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' O ' ' HB ' ' A' ' 52' ' ' VAL . 1.9 m-20 -152.61 -179.91 8.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 111.034 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.718 HG22 ' HG2' ' A' ' 35' ' ' LYS . 14.6 p 179.84 113.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.764 -0.585 . . . . 0.0 109.8 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 172.18 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.698 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 54' ' ' THR . . . . . 1.018 HG22 ' CG1' ' A' ' 31' ' ' VAL . 18.9 p -82.34 162.4 22.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -134.21 122.58 3.01 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.734 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.545 HG22 ' OD1' ' A' ' 57' ' ' ASN . 28.8 m 38.95 96.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.392 -1.064 . . . . 0.0 111.119 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.545 ' OD1' HG22 ' A' ' 56' ' ' THR . 9.5 m120 64.13 -146.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.896 . . . . 0.0 110.622 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 31.71 6.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.572 -179.714 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 12.0 tttm -115.54 -20.25 10.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 110.07 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.597 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.52 -170.16 1.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.687 179.73 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 169.62 154.57 9.31 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.711 -179.876 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 21.6 t80 -115.13 163.04 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.555 -0.968 . . . . 0.0 109.514 179.537 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 1.05 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.4 t -148.88 148.22 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.019 -178.601 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -119.71 142.71 48.26 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.425 -0.797 . . . . 0.0 109.993 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 31.0 m-85 -110.91 178.97 4.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.753 . . . . 0.0 109.718 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.549 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -123.99 15.73 9.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.0 110.865 -179.124 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.547 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -165.81 174.94 9.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.835 1.302 . . . . 0.0 112.505 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -87.44 -25.73 23.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.484 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -83.72 -22.83 31.87 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.783 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.78 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t0 -81.45 -33.91 31.76 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.809 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.62 HD22 ' HD1' ' A' ' 18' ' ' PHE . 48.5 tp -69.41 -39.4 77.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.04 -32.86 72.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.409 -0.807 . . . . 0.0 109.398 179.195 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.558 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 38.0 mttm -80.79 -24.21 38.73 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.22 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.987 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -67.34 -29.81 69.47 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.488 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.743 HD22 HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -77.59 -45.44 25.19 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.152 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -17.43 64.48 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.451 -0.781 . . . . 0.0 109.676 179.46 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 1.029 HD13 ' CE1' ' A' ' 42' ' ' PHE . 11.7 mt -67.43 -7.02 21.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.2 m -49.68 -15.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.432 -0.792 . . . . 0.0 111.217 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.31 18.19 19.53 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.487 . . . . . . . . 1 1 . 1 . 031 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.043 HD13 ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -97.28 179.08 5.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -1.21 . . . . 0.0 109.146 179.843 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.672 ' H ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -162.22 53.62 0.22 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 109.752 179.942 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 87' ' ' ILE . 3.5 t 8.5 -125.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.717 ' HE1' ' HB2' ' A' ' 37' ' ' ALA . 4.0 m-30 -75.04 -2.11 25.87 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.001 -1.062 . . . . 0.0 108.82 178.719 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 149.51 35.0 0.04 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' ILE . 58.1 m-20 -158.94 104.16 1.72 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.11 -1.229 . . . . 0.0 110.041 179.958 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.581 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -54.03 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 -179.616 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 1.019 HG23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -40.43 147.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.577 0.703 . . . . 0.0 110.186 179.722 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.6 mmmt -116.31 152.94 32.84 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.643 -0.661 . . . . 0.0 109.503 179.763 . . . . . . . . 2 2 . 1 . 031 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.743 HD11 HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -115.82 173.91 6.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.852 . . . . . . . . 3 3 . 1 . 031 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.832 . . . . 0.0 110.213 179.961 . . . . . . . . 0 0 . 1 . 032 nuclear build core ' A' A ' 15' ' ' THR . . . . . 1.042 HG23 HG23 ' A' ' 16' ' ' THR . 5.0 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.509 0.671 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 16' ' ' THR . . . . . 1.042 HG23 HG23 ' A' ' 15' ' ' THR . 73.0 p -137.27 159.54 69.21 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.3 Cg_endo -76.51 -15.98 17.23 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.06 1.558 . . . . 0.0 110.896 -179.576 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.643 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 92.1 m-85 -115.62 122.94 47.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 97.9 m-20 -139.43 170.21 16.35 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.644 -0.66 . . . . 0.0 109.271 179.603 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.809 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -169.25 163.55 10.87 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.29 -0.882 . . . . 0.0 110.47 -179.775 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.596 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.72 177.25 5.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.683 -0.636 . . . . 0.0 111.366 -177.72 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 21' ' ' PHE . 15.2 mt -157.28 133.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.98 166.61 23.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.909 ' C ' HD22 ' A' ' 25' ' ' LEU . 35.8 t30 72.48 81.02 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.505 -0.997 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.909 HD22 ' C ' ' A' ' 24' ' ' ASN . 4.2 mm? -119.92 128.79 53.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.532 ' CB ' HD21 ' A' ' 34' ' ' LEU . 31.1 t-20 -41.25 101.89 0.25 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.556 -0.715 . . . . 0.0 110.429 -179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.564 ' HA ' ' HD3' ' A' ' 58' ' ' ARG . 45.8 Cg_endo -72.48 -23.7 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.036 1.545 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 1.7 m-20 -78.46 -16.16 57.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 110.048 179.866 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.2 mmtt -107.86 -155.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.536 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.3 m -102.97 145.03 30.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.918 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.6 t -68.18 -42.5 84.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.431 179.43 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -56.44 -36.08 68.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.185 179.063 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 25.8 mm-40 -64.72 -43.54 93.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.0 109.092 179.109 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.918 HD12 ' HA ' ' A' ' 31' ' ' VAL . 18.6 mt -59.72 -38.88 82.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.365 -0.835 . . . . 0.0 108.802 179.033 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.789 ' HA ' HD12 ' A' ' 38' ' ' ILE . 9.8 mmpt? -59.98 -54.22 48.63 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.537 0.684 . . . . 0.0 109.366 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 32' ' ' ALA . 18.3 t -54.21 -35.49 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 109.675 179.258 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.77 -32.3 73.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.169 -0.957 . . . . 0.0 108.798 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.789 HD12 ' HA ' ' A' ' 35' ' ' LYS . 14.1 mt -82.53 -28.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.853 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -78.75 -28.78 44.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 0.0 109.072 179.164 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.83 -41.12 23.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 109.162 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.073 ' CD2' HD22 ' A' ' 80' ' ' LEU . 1.1 tp -63.45 -34.42 77.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.919 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m-85 -79.9 -23.99 41.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.782 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.69 62.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 109.499 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -89.14 -17.97 28.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 179.465 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -87.85 -14.68 38.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 179.822 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.602 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.1 t70 83.96 30.91 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.916 0.865 . . . . 0.0 108.784 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.618 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -74.82 -129.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.464 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.81 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 173.34 54.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.196 -0.94 . . . . 0.0 109.066 179.642 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 49' ' ' VAL . 10.7 m -57.43 116.88 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.111 0.958 . . . . 0.0 110.392 -179.616 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.95 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -91.54 -39.14 11.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.758 ' CG ' HG21 ' A' ' 15' ' ' THR . 4.0 m-20 -152.65 125.35 8.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.162 -0.961 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.946 HG12 HG22 ' A' ' 63' ' ' VAL . 3.2 m -115.09 153.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.256 -0.903 . . . . 0.0 110.001 179.526 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 1.4 tpt180 -148.98 168.78 22.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.431 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.706 ' HB ' HG11 ' A' ' 31' ' ' VAL . 75.6 p -99.51 159.61 14.9 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.559 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.28 115.74 4.19 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.902 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 58.66 -154.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.498 ' H ' HG22 ' A' ' 56' ' ' THR . 81.5 m-20 -60.55 -51.94 67.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.09 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.582 ' CB ' HG22 ' A' ' 31' ' ' VAL . 2.1 ptp180 -177.3 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -125.12 -21.58 4.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.9 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.878 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -140.69 -154.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.105 -0.997 . . . . 0.0 109.995 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.559 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 172.23 175.61 40.45 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.743 ' O ' HG23 ' A' ' 63' ' ' VAL . 25.7 t80 -143.9 168.4 20.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.493 -1.004 . . . . 0.0 109.732 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.946 HG22 HG12 ' A' ' 52' ' ' VAL . 13.7 t -160.01 163.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.491 -178.89 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.3 m-20 -130.92 136.77 48.89 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.417 -0.802 . . . . 0.0 109.16 179.53 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.677 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 19.0 m-85 -103.24 176.81 5.03 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.495 0.664 . . . . 0.0 111.168 -179.247 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.612 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -115.26 17.1 16.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 111.247 -178.813 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.643 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 35.5 p 179.38 178.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.465 1.126 . . . . 0.0 112.338 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.95 -23.43 48.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.811 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -25.96 43.51 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.248 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.81 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 87.1 m-20 -83.42 -29.02 28.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.314 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.58 -29.42 36.98 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.821 179.655 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 3.6 mt-10 -79.89 -36.59 36.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.773 . . . . 0.0 110.36 -179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.753 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -78.31 -29.58 47.82 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.91 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.0 -27.88 62.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.723 -0.791 . . . . 0.0 108.963 178.895 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.73 -43.35 69.08 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.542 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -13.54 60.73 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.083 178.472 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -72.73 5.03 3.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.604 -0.685 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.801 ' HA ' HD21 ' A' ' 89' ' ' LEU . 8.3 m -66.31 -5.64 11.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.94 -1.1 . . . . 0.0 110.56 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.06 32.26 4.98 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 179.131 . . . . . . . . 1 1 . 1 . 032 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.073 HD22 ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -114.78 132.56 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.127 -179.732 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.614 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.5 mtmt -104.94 78.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.554 1.169 . . . . 0.0 109.976 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.796 HG12 HD23 ' A' ' 34' ' ' LEU . 47.8 t -48.45 132.38 5.98 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.754 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.0 m-85 40.82 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.422 -0.799 . . . . 0.0 110.869 -179.757 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.591 ' O ' ' ND2' ' A' ' 85' ' ' ASN . . . 86.72 28.78 25.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.561 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 18.9 m120 -143.12 91.77 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -1.175 . . . . 0.0 110.282 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 19.1 tt0 -42.27 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.171 179.821 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 82' ' ' VAL . 2.2 pp -68.74 125.89 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 110.696 -179.806 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.8 mttt -83.85 118.49 23.99 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.645 . . . . . . . . 2 2 . 1 . 032 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 ' HA ' ' A' ' 78' ' ' THR . 0.4 OUTLIER -106.06 -171.19 1.85 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.988 -178.258 . . . . . . . . 3 3 . 1 . 032 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 3.4 mt-10 . . . . . 0 N--CA 1.501 2.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.385 179.813 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 16' ' ' THR . 20.7 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.243 0.544 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.759 ' CG2' HG11 ' A' ' 50' ' ' VAL . 14.0 p -151.25 164.23 20.95 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.8 Cg_endo -75.17 -34.49 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.052 1.554 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.549 ' CE2' ' C ' ' A' ' 67' ' ' SER . 97.4 m-85 -100.64 102.39 13.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.067 -1.021 . . . . 0.0 110.489 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 2.0 m120 -137.99 153.2 49.43 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.321 -0.862 . . . . 0.0 109.527 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.786 HD22 HD23 ' A' ' 89' ' ' LEU . 4.6 pp -163.57 -171.78 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.5 t80 -116.54 151.22 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG22 HD11 ' A' ' 25' ' ' LEU . 2.8 mt -131.27 159.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.902 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -142.49 -176.24 16.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.628 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 47.8 t30 71.34 49.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 110.215 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' HA ' ' A' ' 60' ' ' PHE . 10.8 mp -97.26 132.94 42.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.658 ' H ' HD21 ' A' ' 34' ' ' LEU . 39.1 t-20 -41.41 102.06 0.26 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.609 -0.682 . . . . 0.0 110.287 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.9 Cg_endo -77.06 8.06 3.37 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.046 1.55 . . . . 0.0 110.852 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -111.81 -17.67 12.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.986 -1.071 . . . . 0.0 108.948 179.55 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' CG ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.72 -155.52 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.731 -0.605 . . . . 0.0 109.513 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -100.54 142.09 32.5 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.597 179.109 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.929 HG12 ' HE3' ' A' ' 35' ' ' LYS . 3.0 t -63.46 -42.88 97.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.114 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.49 -37.26 72.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 178.959 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 16.0 mm-40 -67.15 -30.22 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.62 179.529 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.111 HD23 HG21 ' A' ' 82' ' ' VAL . 3.0 mt -67.56 -38.4 84.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.929 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.3 -47.31 77.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.839 . . . . 0.0 109.943 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 32' ' ' ALA . 7.3 t -65.09 -34.57 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.131 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.53 -43.98 92.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.298 -0.876 . . . . 0.0 109.068 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.555 HG23 ' CE2' ' A' ' 42' ' ' PHE . 19.5 mm -76.96 -27.95 16.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.929 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.725 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -73.82 -32.75 63.87 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.437 -0.79 . . . . 0.0 109.395 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.9 tt0 -85.24 -43.11 14.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 110.009 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 3.7 tt -55.67 -40.8 72.78 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.569 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.555 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.6 m-30 -87.06 -23.62 24.88 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.447 179.542 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.93 -18.32 59.4 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -102.28 -39.27 7.28 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.588 179.632 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.615 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -51.03 -43.17 60.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.619 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 13.1 m-20 143.22 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.561 0.744 . . . . 0.0 110.151 179.587 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -112.0 -152.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 110.624 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 49' ' ' VAL . . . -164.31 55.83 0.15 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.674 0.749 . . . . 0.0 109.153 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -41.11 118.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.045 0.926 . . . . 0.0 110.151 -179.794 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.8 t -84.24 -44.11 17.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.283 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 5.4 t70 -147.72 160.73 42.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.873 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.813 HG22 ' CG ' ' A' ' 35' ' ' LYS . 7.6 p -150.96 111.15 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 2.2 mpp_? -99.71 165.53 11.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.966 . . . . 0.0 110.261 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.472 HG22 ' HD3' ' A' ' 35' ' ' LYS . 69.0 p -87.96 163.73 16.18 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.644 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -119.19 105.57 1.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.473 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.2 m 67.57 -134.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -1.145 . . . . 0.0 110.016 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.509 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -80.47 -48.58 12.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 110.482 -179.832 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.823 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -177.76 37.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 110.444 -179.877 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 21.5 mttt -113.93 -24.33 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.996 ' HA ' HD13 ' A' ' 25' ' ' LEU . 1.2 m-85 -137.57 -174.99 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.04 154.01 18.37 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.898 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.7 m-85 -107.84 167.23 10.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.188 -1.183 . . . . 0.0 110.031 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 62' ' ' TYR . 50.2 t -157.25 155.44 5.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.939 -178.99 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 51' ' ' ASP . 8.6 m-20 -125.22 139.5 53.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.703 -0.623 . . . . 0.0 109.498 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.873 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 17.7 m-85 -103.83 176.61 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.407 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.645 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -113.98 14.65 18.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 111.479 -178.395 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.9 p 176.94 178.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.371 1.081 . . . . 0.0 112.089 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.47 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.5 -22.71 54.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.553 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -25.47 37.06 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.521 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 88.6 m-20 -82.79 -28.16 30.47 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.164 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.78 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.0 tm? -79.13 -33.7 43.97 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.566 179.389 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 1.4 tp10 -73.46 -39.22 65.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.805 . . . . 0.0 109.733 179.606 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.703 ' HB3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -80.19 -18.04 50.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.524 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.873 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.47 -28.13 46.46 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.178 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.2 tt -79.69 -44.19 21.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -27.8 67.26 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.269 -0.894 . . . . 0.0 109.096 178.9 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.803 ' O ' HD23 ' A' ' 80' ' ' LEU . 15.4 mt -68.8 -7.97 39.08 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.536 0.684 . . . . 0.0 109.826 179.394 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 87.7 m -57.01 -9.14 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.658 -0.651 . . . . 0.0 111.506 -179.667 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.98 26.97 5.7 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.283 . . . . . . . . 1 1 . 1 . 033 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.958 HD11 HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -94.14 -161.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.218 -1.166 . . . . 0.0 110.695 -179.762 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.62 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -164.1 48.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.56 0.695 . . . . 0.0 109.817 179.643 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 1.111 HG21 HD23 ' A' ' 34' ' ' LEU . 7.9 p 8.49 -126.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.203 179.708 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.708 ' N ' HG13 ' A' ' 82' ' ' VAL . 2.8 m-85 -72.44 -1.75 16.9 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.408 -1.432 . . . . 0.0 109.508 179.14 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 147.89 36.42 0.05 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' HG12 ' A' ' 82' ' ' VAL . 15.3 m-20 -163.4 108.02 1.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -1.156 . . . . 0.0 109.418 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.62 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -51.27 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.61 -178.837 . . . . . . . . 3 3 . 1 . 033 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.958 HG12 HD11 ' A' ' 80' ' ' LEU . 2.3 pp -46.38 144.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.651 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 8.1 mtmt -112.03 169.78 8.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.56 -0.712 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.786 HD23 HD22 ' A' ' 20' ' ' LEU . 7.7 mp -113.31 -177.56 3.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.302 -0.874 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.921 HG23 HG23 ' A' ' 16' ' ' THR . 1.8 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.511 0.672 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.973 HG21 HG21 ' A' ' 50' ' ' VAL . 17.6 p -138.6 158.08 70.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.689 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.571 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.7 Cg_endo -75.71 -29.07 7.51 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.136 1.598 . . . . 0.0 110.559 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 88.0 m-85 -106.35 101.89 11.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.774 -179.55 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.516 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.7 m120 -134.71 150.9 50.66 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.131 179.413 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 21' ' ' PHE . 4.3 pp -172.93 -175.69 1.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.861 -179.85 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.716 ' N ' HD12 ' A' ' 20' ' ' LEU . 3.2 t80 -110.29 154.65 23.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.024 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mt -140.15 153.55 22.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -121.04 -177.03 15.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.9 t30 70.46 71.41 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.297 -1.12 . . . . 0.0 110.012 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.91 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -114.1 27.43 9.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.307 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.537 ' HB2' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER 53.13 98.04 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 110.335 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.73 -9.9 22.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.96 1.505 . . . . 0.0 110.519 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -94.75 -12.94 26.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 109.83 179.917 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 12.4 mmtt -115.12 -160.01 0.72 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.449 -0.782 . . . . 0.0 109.536 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.728 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.0 m -112.69 148.09 35.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.795 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.6 t -67.44 -18.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.066 -1.021 . . . . 0.0 108.879 179.328 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 -41.98 80.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 178.861 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 3.8 pt-20 -66.88 -45.96 76.42 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.041 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.91 HD22 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -62.7 -34.21 76.67 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.861 . . . . 0.0 108.72 178.957 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 35' ' ' LYS . . . . . 0.94 ' HD2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -57.79 -49.55 76.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.773 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' A' ' 39' ' ' SER . 91.1 t -64.39 -32.18 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.594 -0.691 . . . . 0.0 109.141 178.584 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.561 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -65.7 -43.0 90.51 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.854 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.821 ' CD1' HG23 ' A' ' 82' ' ' VAL . 24.7 mm -75.63 -24.62 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.568 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 39' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -77.66 -35.2 52.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 179.095 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.07 -38.76 26.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.491 0.662 . . . . 0.0 109.724 179.528 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 1.044 HD21 HD22 ' A' ' 80' ' ' LEU . 10.4 tp -65.52 -32.43 74.02 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.406 179.356 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 42' ' ' PHE . . . . . 0.899 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 7.3 m-85 -87.51 -19.99 27.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.103 179.619 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.27 -26.96 20.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -92.39 -17.44 24.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.477 -0.764 . . . . 0.0 109.212 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 45' ' ' ASN . . . . . 0.608 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.8 m120 -83.23 -59.07 2.58 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.621 -0.674 . . . . 0.0 109.534 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 46' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.6 m-20 146.65 31.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.741 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.799 HD23 ' HB2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -102.27 -156.27 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.192 -0.942 . . . . 0.0 109.874 -179.836 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' ' HG2' ' A' ' 66' ' ' GLU . . . -162.39 56.51 0.23 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.784 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 39' ' ' SER . 10.4 m -45.53 118.79 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 50' ' ' VAL . . . . . 0.973 HG21 HG21 ' A' ' 16' ' ' THR . 0.0 OUTLIER -93.45 -33.89 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.586 ' C ' HG23 ' A' ' 52' ' ' VAL . 11.5 m-20 -149.35 148.24 29.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.322 -0.861 . . . . 0.0 110.686 -179.886 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.94 HG12 ' HD2' ' A' ' 35' ' ' LYS . 57.1 t -156.85 102.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.01 179.672 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -113.17 173.27 6.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 110.332 -179.814 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 54' ' ' THR . . . . . 0.795 HG22 ' CG1' ' A' ' 31' ' ' VAL . 2.0 p -82.33 -179.32 7.37 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.238 -0.914 . . . . 0.0 110.171 -179.665 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -140.91 132.5 5.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.659 HG22 ' OD1' ' A' ' 57' ' ' ASN . 63.4 m 58.34 -106.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.371 -1.076 . . . . 0.0 110.586 179.71 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.659 ' OD1' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -130.17 90.56 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.861 -1.149 . . . . 0.0 110.48 -179.701 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.543 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 19.2 mtt85 41.77 29.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.533 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HD3' ' ND2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -112.39 -32.96 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.915 . . . . 0.0 110.177 179.943 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 60' ' ' PHE . . . . . 0.606 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 m-85 -126.71 -162.59 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 109.361 179.733 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.58 132.12 2.15 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.575 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.712 ' O ' HG23 ' A' ' 63' ' ' VAL . 2.9 m-85 -86.33 158.35 19.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.404 -1.057 . . . . 0.0 109.116 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 63' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 52' ' ' VAL . 25.2 t -158.68 156.32 3.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.947 -179.155 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 64' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 50' ' ' VAL . 80.3 m-20 -142.39 144.88 33.33 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' O ' HG21 ' A' ' 50' ' ' VAL . 23.0 m-85 -114.97 -174.87 2.57 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.483 -0.761 . . . . 0.0 109.001 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.579 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -132.67 29.61 4.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.494 -1.379 . . . . 0.0 113.44 -176.6 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.777 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p -169.09 173.5 6.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.319 -1.488 . . . . 0.0 113.119 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.3 -27.42 52.99 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.393 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -28.89 62.83 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.912 179.41 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.799 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -76.5 -33.26 58.65 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.851 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -62.28 -43.89 97.79 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.997 179.794 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.485 ' N ' HD23 ' A' ' 71' ' ' LEU . 3.9 tt0 -66.26 -35.52 80.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.034 178.806 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.729 ' HB3' HD11 ' A' ' 47' ' ' LEU . 4.8 mttm -78.59 -21.19 48.94 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.13 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.771 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -69.33 -29.4 67.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.767 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 75' ' ' LEU . . . . . 0.67 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.3 tt -77.22 -45.74 25.52 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.496 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.582 ' N ' HD23 ' A' ' 75' ' ' LEU . 8.5 tt0 -71.66 -7.15 46.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.642 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.899 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -57.63 -13.52 4.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 111.09 -179.996 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 78' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 78' ' ' THR . 45.8 m -69.2 3.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.912 . . . . 0.0 111.801 -179.186 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.61 10.95 16.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.477 . . . . . . . . 1 1 . 1 . 034 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 1.044 HD22 HD21 ' A' ' 41' ' ' LEU . 45.6 mt -97.74 112.38 24.29 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.321 -1.105 . . . . 0.0 110.688 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 81' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 1.1 mttp -88.62 80.59 7.27 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.105 0.955 . . . . 0.0 110.295 179.589 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.821 HG23 ' CD1' ' A' ' 38' ' ' ILE . 1.1 p -46.16 126.84 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.697 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 33' ' ' GLU . 1.2 m-85 42.21 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.953 . . . . 0.0 110.653 -179.561 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.51 ' O ' ' ND2' ' A' ' 85' ' ' ASN . . . 97.18 17.68 31.22 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 5.5 m120 -133.54 110.52 9.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -1.142 . . . . 0.0 110.084 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.5 tm-20 -56.65 83.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 87' ' ' ILE . . . . . 0.792 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -39.3 151.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 110.771 -179.479 . . . . . . . . 3 3 . 1 . 034 nuclear build core ' A' A ' 88' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 22' ' ' ILE . 31.9 ttpt -119.26 157.36 28.2 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.548 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 5.1 mp -112.36 179.07 4.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.232 -0.917 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.662 -0.649 . . . . 0.0 109.924 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 p -145.19 65.41 1.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -1.147 . . . . 0.0 110.195 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.421 ' O ' ' C ' ' A' ' 4' ' ' MET . 0.1 OUTLIER -110.44 77.68 1.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.183 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' HIS . 2.7 tpp -43.19 -50.5 6.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.185 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.86 48.49 5.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 110.212 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -91.21 153.51 19.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.174 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.74 153.77 73.14 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.03 79.67 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.984 1.518 . . . . 0.0 110.384 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -160.21 135.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-O 121.315 0.579 . . . . 0.0 110.166 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.76 129.61 34.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 12' ' ' SER . . . -133.92 74.14 0.44 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 11' ' ' GLY . 5.5 t 63.02 11.08 4.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.279 -1.13 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 46.53 26.06 0.47 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.133 0.968 . . . . 0.0 110.064 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 12' ' ' SER . 0.0 OUTLIER -128.57 160.04 33.63 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.199 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.96 -13.24 10.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.961 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.822 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -148.47 166.48 15.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.74 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.2 Cg_endo -78.8 -42.91 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.233 1.649 . . . . 0.0 110.769 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CE2' ' C ' ' A' ' 67' ' ' SER . 96.3 m-85 -96.88 110.88 23.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 110.516 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -137.32 151.73 48.96 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -161.31 -178.03 6.41 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 110.391 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 62' ' ' TYR . 6.2 t80 -112.4 146.65 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.338 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.3 mt -130.91 155.99 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.827 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 60' ' ' PHE . . . -136.51 -164.74 10.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.912 ' C ' HD12 ' A' ' 25' ' ' LEU . 31.2 t-20 65.64 70.59 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.08 . . . . 0.0 110.092 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.912 HD12 ' C ' ' A' ' 24' ' ' ASN . 10.2 mp -119.16 130.25 55.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.845 . . . . 0.0 110.255 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.779 ' H ' HD21 ' A' ' 34' ' ' LEU . 31.5 t30 -54.15 107.99 1.01 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.506 -0.746 . . . . 0.0 110.346 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.2 Cg_endo -74.49 -8.73 20.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.049 1.552 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 7.1 m120 -84.05 -14.54 50.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -117.57 -157.24 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.39 -0.819 . . . . 0.0 109.859 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.659 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.6 m -100.14 146.92 26.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 54' ' ' THR . 11.2 t -69.79 -30.37 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.319 -0.953 . . . . 0.0 109.059 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -63.72 -38.16 90.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.0 109.034 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 54.7 mm-40 -68.14 -36.31 79.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.854 HD23 HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -62.42 -32.93 73.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.367 -0.833 . . . . 0.0 108.836 178.863 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.618 ' HG3' HG12 ' A' ' 52' ' ' VAL . 1.6 mptp? -65.82 -50.37 64.88 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.575 -0.703 . . . . 0.0 109.314 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.4 t -58.53 -35.64 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.842 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.57 -35.85 81.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.137 -0.977 . . . . 0.0 108.727 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.581 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 35.9 mt -80.15 -27.11 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.157 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.53 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -79.43 -29.46 41.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.067 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.93 -38.37 27.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.361 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.676 HD22 HD23 ' A' ' 80' ' ' LEU . 5.2 tp -68.12 -32.17 72.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 6.0 m-85 -82.31 -23.19 35.27 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.54 65.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 109.362 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -89.37 -21.15 23.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.727 . . . . 0.0 109.456 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.635 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.1 m-80 -80.57 -20.52 43.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.474 -0.766 . . . . 0.0 109.743 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.635 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.2 t0 91.21 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.939 0.876 . . . . 0.0 108.759 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.882 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -84.11 -139.26 0.06 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -177.21 58.41 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.217 -0.927 . . . . 0.0 109.774 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.2 m -60.03 117.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.965 0.888 . . . . 0.0 109.94 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.6 t -95.29 -33.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.265 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.518 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 12.4 t0 -144.68 153.77 42.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.977 . . . . 0.0 110.676 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.618 HG12 ' HG3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -155.91 99.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.87 . . . . 0.0 108.979 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -102.26 156.82 17.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.106 -0.996 . . . . 0.0 110.733 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.931 HG22 HG12 ' A' ' 31' ' ' VAL . 44.5 p -90.64 154.65 19.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.429 -0.795 . . . . 0.0 110.319 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' A' ' 60' ' ' PHE . . . -127.49 128.32 6.09 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.578 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 3.4 m 60.72 170.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.836 -0.802 . . . . 0.0 109.878 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.54 ' N ' HG22 ' A' ' 56' ' ' THR . 68.8 m-80 -38.6 -42.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.467 -0.77 . . . . 0.0 110.412 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.543 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 172.45 51.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.817 . . . . 0.0 109.802 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -110.54 -31.24 7.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.306 -0.871 . . . . 0.0 110.494 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.825 ' HA ' HD13 ' A' ' 25' ' ' LEU . 5.9 p90 -159.39 149.33 18.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.026 -1.047 . . . . 0.0 110.424 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -132.82 164.8 24.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.45 162.44 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -1.083 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 52' ' ' VAL . 3.2 t -151.4 141.59 15.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.749 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 50.2 m-20 -112.06 147.54 35.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.501 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.6 m-85 -108.26 179.84 4.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.821 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.586 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -114.08 13.42 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 111.496 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.54 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.4 p 178.88 179.42 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.381 1.086 . . . . 0.0 112.072 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.25 52.94 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -27.07 37.29 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.727 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 79.4 m-20 -83.43 -25.9 30.83 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.765 HD13 ' O ' ' A' ' 71' ' ' LEU . 3.3 tm? -80.69 -34.79 34.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.477 0.656 . . . . 0.0 109.281 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.92 -36.13 67.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.806 . . . . 0.0 109.487 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.882 ' HB2' HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -76.43 -27.45 56.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.89 -29.5 68.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -71.25 -45.99 62.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -75.92 -4.21 39.68 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.225 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.964 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -77.77 12.01 1.89 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 110.281 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -9.23 12.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.039 -1.038 . . . . 0.0 110.089 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.12 33.98 3.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.009 HD13 ' CD1' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -85.37 -170.15 2.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.125 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -179.1 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.257 1.027 . . . . 0.0 109.876 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HD23 ' A' ' 34' ' ' LEU . 41.4 t -40.97 127.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.994 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 8.4 m-85 43.96 25.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.132 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . 90.7 20.43 40.44 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' VAL . 23.4 m-20 -131.62 102.39 5.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -1.156 . . . . 0.0 109.521 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.582 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -53.47 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.272 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.009 ' CD1' HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -47.46 142.57 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -108.11 163.88 12.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 109.163 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.604 HD23 ' CD1' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -115.53 -179.34 3.61 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 110.459 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -172.3 154.15 3.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 50.7 mttt -102.26 98.88 11.28 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.923 . . . . 0.0 110.248 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.7 Cg_endo -72.71 -174.16 1.41 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.021 1.537 . . . . 0.0 110.451 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -72.09 155.79 39.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 95' ' ' ARG . . . 88.95 25.18 30.08 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 94' ' ' GLY . 4.9 mpp_? -43.11 -45.22 5.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -1.171 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -80.55 -166.38 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 110.148 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.29 -15.82 2.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -83.74 -29.23 27.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -1.147 . . . . 0.0 110.248 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -131.77 -74.15 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.53 161.05 10.79 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.296 -1.12 . . . . 0.0 110.242 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 p -66.87 172.35 4.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -1.175 . . . . 0.0 110.199 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.35 43.82 30.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.7 ttp -118.79 85.48 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.204 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -129.1 71.86 1.44 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.173 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 1.1 tt0 47.73 93.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.231 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.565 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER 179.38 -59.41 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.209 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 43.7 Cg_endo -71.62 79.85 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.026 1.54 . . . . 0.0 110.427 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.677 HG13 ' O ' ' A' ' 9' ' ' VAL . 12.1 p -126.87 70.33 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.219 0.533 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.34 -177.61 4.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.23 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.28 22.29 4.96 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.45 54.92 1.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -1.182 . . . . 0.0 110.181 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -168.15 28.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 110.126 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.99 141.46 29.48 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.32 0.581 . . . . 0.0 110.143 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.562 ' C ' HG23 ' A' ' 16' ' ' THR . 16.9 m -98.36 -7.07 29.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.678 ' CG2' HG11 ' A' ' 50' ' ' VAL . 70.1 p -153.85 161.88 28.12 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.288 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.58 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.71 -23.88 14.03 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.025 1.539 . . . . 0.0 110.7 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.58 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 98.4 m-85 -106.37 112.67 25.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 110.562 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 18' ' ' PHE . 3.2 m120 -143.82 153.53 42.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.586 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -166.49 -177.51 4.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.673 ' N ' HD12 ' A' ' 20' ' ' LEU . 35.0 t80 -113.71 151.01 32.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 110.134 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.0 157.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 109.658 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.69 -168.47 11.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.562 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.7 OUTLIER 69.31 50.91 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -1.099 . . . . 0.0 110.214 179.998 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.97 HD23 ' HA ' ' A' ' 60' ' ' PHE . 3.6 mm? -100.13 123.08 43.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.735 ' N ' HD21 ' A' ' 34' ' ' LEU . 25.7 t-20 -42.92 102.18 0.27 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.59 -0.694 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.37 -14.21 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.02 1.537 . . . . 0.0 110.369 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 1.9 m-20 -80.25 -19.34 47.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -107.13 -156.31 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.414 -0.804 . . . . 0.0 109.832 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.1 m -103.2 143.14 33.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.967 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.5 t -66.58 -19.2 25.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.107 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . . . -71.54 -41.46 69.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 108.989 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.8 mm-40 -66.11 -37.49 85.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 109.288 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.735 HD21 ' N ' ' A' ' 26' ' ' ASN . 5.0 mp -63.05 -34.58 77.89 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.315 -0.865 . . . . 0.0 108.745 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.614 ' CG ' HG22 ' A' ' 52' ' ' VAL . 2.8 mttt -60.14 -56.91 15.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 25.4 t -60.93 -34.59 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.588 -0.695 . . . . 0.0 109.468 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.35 -33.4 75.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 108.694 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.488 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.2 mt -81.11 -28.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.99 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -78.6 -30.29 46.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.084 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.22 -37.7 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.546 0.689 . . . . 0.0 109.458 179.482 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.912 HD13 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -68.56 -31.56 70.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.087 179.143 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.681 ' CE1' HD11 ' A' ' 80' ' ' LEU . 13.2 m-85 -88.16 -16.8 32.41 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.4 -29.38 19.11 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.995 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -91.82 -18.74 23.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.465 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.601 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 3.0 m120 -81.32 -58.73 2.92 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 0.0 109.719 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.1 m-20 148.26 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.27 0.557 . . . . 0.0 109.843 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.74 HD11 ' CB ' ' A' ' 73' ' ' LYS . 4.1 mm? -106.1 -158.94 0.68 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.328 -0.857 . . . . 0.0 109.586 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.813 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -160.41 61.9 0.33 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.955 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.99 HG21 ' HA ' ' A' ' 39' ' ' SER . 6.7 m -52.83 118.12 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.882 0.848 . . . . 0.0 109.856 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.751 HG22 ' HB3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -87.43 -43.12 15.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 121.878 -0.514 . . . . 0.0 109.99 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 4.5 t0 -144.46 158.17 43.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.614 HG22 ' CG ' ' A' ' 35' ' ' LYS . 2.1 p -149.21 156.65 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 0.0 109.706 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -165.26 165.92 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.167 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.967 HG22 ' CG1' ' A' ' 31' ' ' VAL . 12.5 p -79.56 179.46 7.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.403 -0.811 . . . . 0.0 110.329 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -142.1 135.31 6.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 97.8 m 59.43 -83.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.903 . . . . 0.0 110.449 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 55' ' ' GLY . 1.6 m-20 -161.54 97.09 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.046 -1.034 . . . . 0.0 110.642 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.53 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 42.75 27.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.903 . . . . 0.0 110.655 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -119.58 -33.23 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 110.156 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.97 ' HA ' HD23 ' A' ' 25' ' ' LEU . 3.2 m-85 -129.18 177.31 7.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.54 129.12 2.59 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.076 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 63' ' ' VAL . 28.4 t80 -92.82 163.9 13.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 109.644 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 62' ' ' TYR . 27.7 t -157.95 159.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.867 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -126.28 138.33 53.59 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.612 -0.68 . . . . 0.0 109.58 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 24.8 m-85 -102.7 175.26 5.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.676 -0.64 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.813 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 3.0 pt-20 -118.44 14.66 13.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 111.564 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.534 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.7 p -172.61 173.9 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.906 -1.121 . . . . 0.0 112.165 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.542 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.5 -23.91 42.63 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -25.43 30.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.642 ' OD1' HD12 ' A' ' 47' ' ' LEU . 5.4 t0 -82.14 -25.73 34.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.781 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.7 tm? -81.95 -33.64 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -34.37 71.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.756 . . . . 0.0 109.379 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.74 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -77.26 -28.75 53.67 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.12 -27.13 67.07 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -73.55 -48.85 29.8 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.668 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.82 -3.72 30.34 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.3 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.968 HD12 ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -76.55 8.8 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.489 -0.757 . . . . 0.0 110.469 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 m -64.58 -8.72 15.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.198 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.97 17.8 48.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.09 HD13 HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -72.31 -171.94 0.84 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.403 -1.057 . . . . 0.0 110.67 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.4 mttt -170.64 49.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.355 1.074 . . . . 0.0 109.655 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.795 HG21 HG21 ' A' ' 87' ' ' ILE . 23.7 t -40.06 124.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.027 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.9 m-85 42.72 29.38 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.188 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.12 25.14 38.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' VAL . 11.4 m120 -134.16 86.37 2.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.603 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.589 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 21.1 tt0 -41.92 100.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.09 HD11 HD13 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -60.18 140.22 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.489 -0.757 . . . . 0.0 110.42 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -111.63 156.3 22.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.153 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.606 ' CD1' HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -120.39 169.73 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.043 -1.035 . . . . 0.0 110.608 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 2.9 tt0 -168.15 156.14 8.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.014 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -84.93 110.77 30.68 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.288 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.2 Cg_endo -73.39 -170.52 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.049 1.552 . . . . 0.0 110.436 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -133.64 -37.51 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.63 28.68 8.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -166.86 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -1.195 . . . . 0.0 110.191 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.96 -161.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 110.212 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 98' ' ' THR . . . 165.25 -157.6 30.12 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 97' ' ' GLY . 2.5 p 42.6 -163.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -1.13 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.98 154.97 39.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.896 . . . . 0.0 110.169 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.17 85.96 1.88 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.28 -1.13 . . . . 0.0 110.165 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.5 p -93.52 -8.98 39.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -1.177 . . . . 0.0 110.234 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -97.73 -149.65 0.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -0.914 . . . . 0.0 110.162 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.3 tpp -128.95 -54.68 1.21 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 51.48 67.15 1.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.208 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -74.99 -84.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.847 . . . . 0.0 110.152 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -141.85 159.93 57.71 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.214 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.37 -156.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.056 1.556 . . . . 0.0 110.089 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.663 HG22 ' H ' ' A' ' 10' ' ' GLU . 1.5 p -109.6 -157.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.284 0.564 . . . . 0.0 109.89 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 9' ' ' VAL . 1.7 pt-20 -68.26 170.95 7.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.51 69.43 2.01 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.24 17.59 14.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -1.143 . . . . 0.0 110.26 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 14' ' ' SER . 2.2 mt-10 -91.52 28.12 1.81 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 110.281 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -52.5 -173.09 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.183 0.516 . . . . 0.0 110.196 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 16' ' ' THR . 4.1 m -73.6 -5.83 42.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.967 HG21 ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -167.4 158.24 9.95 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 110.477 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.86 -34.98 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.154 1.608 . . . . 0.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.522 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.1 m-85 -112.22 114.3 27.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -132.87 148.98 52.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 179.487 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -165.4 -177.36 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.618 ' N ' HD12 ' A' ' 20' ' ' LEU . 3.3 t80 -115.2 150.01 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.97 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 88' ' ' LYS . 2.2 mt -129.95 158.34 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.427 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.48 -173.45 13.04 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.84 ' C ' HD22 ' A' ' 25' ' ' LEU . 0.9 OUTLIER 72.54 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -1.012 . . . . 0.0 110.197 -179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.0 mm? -116.45 165.48 13.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 110.106 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 40.8 t30 -95.22 106.74 27.84 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 110.344 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -73.54 -13.92 24.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.042 1.548 . . . . 0.0 110.447 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 3.3 m120 -78.67 -17.72 55.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.581 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -113.27 -155.27 0.56 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.44 -0.788 . . . . 0.0 109.862 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.499 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -100.65 142.53 32.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 110.498 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.799 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.9 t -67.37 -32.33 56.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.179 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.94 -39.01 92.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.319 -0.863 . . . . 0.0 108.965 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 70.2 mm-40 -63.79 -36.46 83.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.559 -0.713 . . . . 0.0 109.092 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 31' ' ' VAL . 92.2 mt -61.3 -38.81 88.14 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.37 -0.832 . . . . 0.0 108.908 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.868 ' HD3' HG12 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -58.96 -50.37 74.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -60.09 -37.72 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.477 -0.764 . . . . 0.0 109.668 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -61.35 -28.34 69.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.072 -1.017 . . . . 0.0 109.11 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.579 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 7.0 mt -87.84 -28.06 5.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.482 -0.761 . . . . 0.0 109.14 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 7.5 t -80.61 -24.71 38.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.167 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.52 -37.43 19.66 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.532 -0.73 . . . . 0.0 109.141 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.084 HD22 HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -67.47 -34.72 77.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.092 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 7.1 m-85 -83.47 -22.53 32.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -74.48 -33.72 62.92 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -18.21 25.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 0.0 109.345 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.2 m120 -82.21 -19.35 39.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.526 -0.734 . . . . 0.0 109.863 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 t70 91.69 29.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.008 0.909 . . . . 0.0 108.839 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -87.95 -140.68 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.717 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -178.28 59.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.6 m -56.01 117.08 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.075 0.941 . . . . 0.0 110.171 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.967 ' HB ' HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -88.98 -36.51 8.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.67 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.2 t70 -143.69 147.31 34.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.056 HG13 HG22 ' A' ' 63' ' ' VAL . 2.6 t -153.23 139.63 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.609 -0.682 . . . . 0.0 109.462 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -158.08 -179.63 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.798 HG22 HG12 ' A' ' 31' ' ' VAL . 17.0 p -84.7 177.95 7.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.316 -0.865 . . . . 0.0 110.594 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -137.23 132.43 5.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.576 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 52.3 m 57.68 -91.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.484 ' N ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -153.02 98.1 2.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.073 -1.017 . . . . 0.0 110.434 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.551 ' HG3' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 41.92 26.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -116.35 -32.31 5.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.8 m-85 -135.97 -175.82 4.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.359 -0.838 . . . . 0.0 109.498 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.6 145.9 13.72 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.101 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.808 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -101.26 161.42 13.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -1.107 . . . . 0.0 109.528 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.056 HG22 HG13 ' A' ' 52' ' ' VAL . 4.7 t -161.46 159.86 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.552 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.1 m-20 -140.93 142.03 34.45 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.709 -0.619 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.714 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 61.2 m-85 -106.16 174.44 5.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.719 -0.613 . . . . 0.0 110.584 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.717 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 6.6 pt-20 -114.67 13.2 17.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 111.849 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.522 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.0 p -170.06 177.26 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.855 -1.153 . . . . 0.0 112.255 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.91 -23.56 48.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.51 -27.57 46.11 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.475 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 83.0 m-20 -83.14 -27.91 29.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.783 HD13 ' C ' ' A' ' 71' ' ' LEU . 1.9 tm? -73.67 -38.67 64.85 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.274 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -37.25 71.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.42 -0.8 . . . . 0.0 109.348 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.792 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.11 -20.44 52.15 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.738 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -71.57 -31.94 67.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.9 tt -76.8 -43.5 36.45 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.551 -0.718 . . . . 0.0 109.081 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -25.0 66.04 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.419 -0.8 . . . . 0.0 109.584 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.092 HD13 ' CZ ' ' A' ' 42' ' ' PHE . 14.2 mt -66.82 -8.22 27.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 110.126 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.898 ' OG1' HD21 ' A' ' 89' ' ' LEU . 5.9 m -48.42 -19.81 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 110.654 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.23 34.78 3.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.084 HD21 HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.33 -165.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 110.694 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.0 mtmt -169.64 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.193 0.997 . . . . 0.0 109.67 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 85' ' ' ASN . 2.9 p -37.83 125.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.179 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.8 m-85 41.75 26.69 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.456 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 89.91 24.38 30.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.751 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.3 m120 -135.04 89.82 2.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -1.137 . . . . 0.0 109.565 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.565 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.8 pt-20 -41.17 106.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 110.858 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.082 HD11 HD13 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -72.54 135.54 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 110.285 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -112.04 159.76 18.15 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.506 -0.747 . . . . 0.0 109.156 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.898 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.2 OUTLIER -117.31 172.7 7.13 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.864 -1.147 . . . . 0.0 110.574 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -173.85 125.12 0.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 110.201 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.3 111.25 4.68 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.8 Cg_endo -76.17 -175.31 2.47 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.988 1.52 . . . . 0.0 110.444 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.36 10.92 17.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.82 29.41 26.35 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.95 132.19 53.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.258 -1.142 . . . . 0.0 110.172 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -154.99 -173.21 4.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.212 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.98 25.99 6.24 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -130.96 109.44 10.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -1.175 . . . . 0.0 110.263 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -163.27 169.74 18.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 110.22 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.62 -101.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.297 -1.119 . . . . 0.0 110.152 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.18 -35.2 73.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -1.114 . . . . 0.0 110.194 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -83.52 62.81 7.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 5' ' ' LEU . 9.6 ttm -86.6 13.81 7.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 110.168 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.448 ' HA ' HD13 ' A' ' 5' ' ' LEU . 0.9 OUTLIER 61.07 144.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 110.233 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.42 150.19 15.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.219 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -149.16 132.55 8.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.255 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.6 -157.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.991 1.522 . . . . 0.0 110.099 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.5 t 53.06 97.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.298 0.571 . . . . 0.0 110.232 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -104.8 -173.86 2.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.95 . . . . 0.0 110.24 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.01 58.59 0.47 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 m -138.0 39.51 2.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.301 -1.117 . . . . 0.0 110.249 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -169.41 29.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.969 0.89 . . . . 0.0 110.134 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -49.16 -179.98 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.216 0.531 . . . . 0.0 110.237 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 16' ' ' THR . 1.9 t -83.4 -18.52 38.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.828 HG21 HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -134.85 157.65 76.67 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 110.496 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -79.57 -30.92 2.22 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 124.204 1.634 . . . . 0.0 110.821 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.869 ' HD1' HD13 ' A' ' 71' ' ' LEU . 56.7 m-85 -103.31 104.52 14.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 110.895 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 7.6 m-20 -137.85 149.06 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.436 -0.79 . . . . 0.0 109.344 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.3 pp -163.84 -175.58 4.16 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.453 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 41.5 t80 -108.86 167.54 10.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.64 HD12 ' CG2' ' A' ' 63' ' ' VAL . 14.8 mt -147.33 158.89 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.666 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -137.24 179.46 18.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 1.6 t-20 70.16 92.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -1.127 . . . . 0.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.954 ' HB3' HD13 ' A' ' 34' ' ' LEU . 21.8 mt -145.02 130.92 19.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.978 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.624 ' HB3' HD21 ' A' ' 34' ' ' LEU . 37.5 t-20 -38.95 99.29 0.19 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.737 -0.602 . . . . 0.0 110.528 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -74.19 -19.28 20.13 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.081 1.569 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -78.5 -13.71 59.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -110.52 -155.65 0.57 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 109.97 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 6.5 m -104.73 152.7 22.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.315 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.949 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.7 t -69.71 -46.01 76.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 109.452 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -49.52 -38.95 32.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.878 . . . . 0.0 109.279 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 28.5 mm-40 -67.97 -40.01 83.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.437 -0.789 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.954 HD13 ' HB3' ' A' ' 25' ' ' LEU . 25.6 mt -60.72 -36.59 79.23 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.298 -0.876 . . . . 0.0 108.742 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 10.3 mmtt -62.32 -57.64 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 32' ' ' ALA . 17.2 t -52.22 -35.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.99 -34.48 78.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 34' ' ' LEU . 4.5 mt -82.1 -27.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.501 ' HA ' HG21 ' A' ' 49' ' ' VAL . 75.2 m -77.86 -30.15 50.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.937 . . . . 0.0 109.023 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.59 -37.02 32.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.752 . . . . 0.0 109.456 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.08 -30.53 68.87 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.587 -0.696 . . . . 0.0 109.145 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.687 ' HE1' HD22 ' A' ' 80' ' ' LEU . 7.1 m-85 -84.7 -22.46 29.75 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.88 -32.42 61.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.437 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -12.44 28.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.0 109.735 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.6 m120 -92.41 -11.17 35.56 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.3 t70 85.12 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.917 0.865 . . . . 0.0 109.281 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.976 HD11 ' HB3' ' A' ' 73' ' ' LYS . 3.0 mm? -86.76 -131.15 0.06 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.863 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 168.38 56.34 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.841 -1.162 . . . . 0.0 109.692 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.6 m -58.16 120.5 4.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.067 0.937 . . . . 0.0 110.375 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -90.37 -46.85 14.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.448 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.472 ' OD2' HG21 ' A' ' 15' ' ' THR . 3.6 m-20 -148.1 118.88 7.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.173 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.871 HG12 HG13 ' A' ' 63' ' ' VAL . 16.6 m -101.24 171.55 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.295 -0.878 . . . . 0.0 109.692 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.82 164.48 16.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 0.0 110.431 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.725 ' HB ' HG11 ' A' ' 31' ' ' VAL . 23.4 p -92.03 162.32 14.42 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.456 -0.777 . . . . 0.0 110.549 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -117.5 121.47 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.549 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 2.1 m 72.0 -56.17 0.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.62 -0.929 . . . . 0.0 110.122 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.545 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.3 OUTLIER 173.74 -35.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.596 ' HA ' HG22 ' A' ' 31' ' ' VAL . 31.8 ttp180 -172.5 26.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.549 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.547 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 34.6 mttp -119.31 -33.74 4.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.654 ' C ' HD12 ' A' ' 25' ' ' LEU . 1.1 m-85 -131.26 -165.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.328 -0.858 . . . . 0.0 109.349 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -171.01 161.93 34.74 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.236 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.0 t80 -123.36 154.81 38.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.42 -1.047 . . . . 0.0 109.554 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.871 HG13 HG12 ' A' ' 52' ' ' VAL . 3.5 t -150.71 146.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.004 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.1 m-20 -118.27 135.06 54.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.529 -0.732 . . . . 0.0 109.507 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.681 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 51.4 m-85 -102.44 171.91 7.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.714 -0.616 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.771 ' HB3' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.58 15.77 16.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.89 . . . . 0.0 111.344 -178.218 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p -166.82 173.8 9.15 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.603 1.192 . . . . 0.0 112.281 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.453 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.24 -25.72 51.84 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.478 ' OE1' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.38 -26.79 58.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.571 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.863 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 89.1 m-20 -82.41 -30.63 30.05 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.869 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -73.15 -36.56 66.68 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.827 179.474 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -73.39 -38.72 65.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.813 . . . . 0.0 109.98 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.976 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.3 -29.64 47.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 70' ' ' ASP . . . -64.39 -31.33 72.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.841 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 4.6 tt -72.82 -45.18 59.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.1 mt-10 -81.03 -1.13 42.76 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.41 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -77.91 7.83 5.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.282 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.792 ' OG1' HD21 ' A' ' 89' ' ' LEU . 92.4 m -70.29 -2.55 13.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 110.473 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.55 65.45 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.9 HD21 HD11 ' A' ' 87' ' ' ILE . 1.2 pp -71.69 129.4 38.59 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.388 -1.066 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -99.98 84.86 2.94 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.975 0.893 . . . . 0.0 109.518 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.901 HG11 HD23 ' A' ' 25' ' ' LEU . 4.2 p -43.85 118.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.727 -0.789 . . . . 0.0 108.998 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 2.1 m-85 46.01 22.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 110.306 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.03 12.26 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.319 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.801 ' O ' HG12 ' A' ' 82' ' ' VAL . 9.6 m120 -126.49 89.67 3.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.31 . . . . 0.0 110.387 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.9 mp0 -40.33 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.63 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.9 HD11 HD21 ' A' ' 80' ' ' LEU . 12.5 pt -71.28 146.54 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.784 0.802 . . . . 0.0 110.581 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.53 ' O ' HG23 ' A' ' 22' ' ' ILE . 15.9 ttpt -116.06 158.64 22.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -119.07 167.95 11.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.837 -1.164 . . . . 0.0 110.415 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.43 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.2 pt-20 -168.9 158.09 8.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.167 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 112.1 31.67 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.9 . . . . 0.0 110.24 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.434 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 45.9 Cg_endo -72.7 -170.93 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.949 1.499 . . . . 0.0 110.438 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -48.93 111.74 0.52 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.889 . . . . 0.0 110.253 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.79 -41.17 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.93 38.91 0.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 110.185 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -120.86 173.35 7.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.227 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -153.34 26.78 0.78 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.95 143.65 11.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.189 -1.183 . . . . 0.0 110.391 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -145.04 63.17 1.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.11 31.02 0.28 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.31 -1.112 . . . . 0.0 110.194 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p 45.95 28.74 0.65 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -1.146 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' O ' ' CB ' ' A' ' 4' ' ' MET . 0.6 OUTLIER -82.22 50.43 1.59 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 110.182 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.45 ' CB ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 65.28 137.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 0.0 110.22 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.47 176.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.218 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.23 61.35 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.21 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 11.9 p-10 -138.92 105.14 7.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.353 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 43.3 Cg_endo -71.26 81.71 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.963 1.507 . . . . 0.0 110.268 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 67.6 t 58.75 138.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.383 0.611 . . . . 0.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.67 177.98 4.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.43 ' C ' ' OG ' ' A' ' 12' ' ' SER . . . -122.82 99.02 0.63 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.43 ' OG ' ' C ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -165.01 97.28 0.73 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -1.171 . . . . 0.0 110.095 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -169.36 28.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.314 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.32 159.51 14.91 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.345 0.593 . . . . 0.0 110.397 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.793 ' C ' HG23 ' A' ' 16' ' ' THR . 7.2 m -90.37 42.19 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.848 . . . . 0.0 110.143 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.94 ' CG2' HG11 ' A' ' 50' ' ' VAL . 1.4 p 77.8 163.41 0.13 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.565 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.8 Cg_endo -77.85 -31.75 2.99 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.227 1.646 . . . . 0.0 110.91 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 74.4 m-85 -86.61 102.39 14.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.949 -1.094 . . . . 0.0 110.557 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 16' ' ' THR . 67.0 m-20 -139.52 157.74 45.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.219 -0.926 . . . . 0.0 109.623 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 20' ' ' LEU . 2.2 pp -167.02 -177.08 3.62 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.288 -0.882 . . . . 0.0 110.416 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 t80 -117.29 146.58 43.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.574 HD12 ' CG2' ' A' ' 63' ' ' VAL . 2.2 mt -129.93 160.5 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -136.63 -172.67 12.64 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.704 ' C ' HD22 ' A' ' 25' ' ' LEU . 10.1 t-20 72.33 63.95 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.496 -1.002 . . . . 0.0 110.47 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.863 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.1 mm? -106.53 119.54 39.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.762 ' HB2' HD21 ' A' ' 34' ' ' LEU . 11.6 t-20 -41.31 107.21 0.47 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.704 -0.622 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.79 -30.3 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.55 . . . . 0.0 110.042 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -78.83 -11.73 60.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.852 . . . . 0.0 109.63 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' CD ' ' A' ' 33' ' ' GLU . 4.4 mmtp -111.31 -156.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.342 -0.849 . . . . 0.0 109.74 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -111.96 150.71 30.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.335 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.956 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.2 t -72.83 -19.97 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.376 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -74.38 -45.2 48.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.573 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -62.08 -38.03 87.29 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 31' ' ' VAL . 44.4 mt -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.226 -0.921 . . . . 0.0 108.912 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 1.7 mptp? -58.17 -48.88 78.92 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.547 0.689 . . . . 0.0 109.379 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 32' ' ' ALA . 26.4 t -56.06 -35.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.723 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -63.3 -37.32 86.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 108.658 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 42' ' ' PHE . 34.6 mt -81.41 -25.0 10.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.79 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 3.6 p -80.35 -26.95 38.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.066 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.92 -41.92 15.47 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.661 0.743 . . . . 0.0 109.31 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.937 HD22 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.0 -35.74 81.68 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.081 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.783 ' CE1' HD11 ' A' ' 80' ' ' LEU . 9.4 m-30 -85.34 -21.82 28.75 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.751 0.786 . . . . 0.0 108.943 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.57 -35.18 60.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.466 0.65 . . . . 0.0 109.509 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -84.11 -15.38 47.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 109.366 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.64 -10.94 44.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.859 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.3 t0 83.79 29.17 0.08 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.946 0.879 . . . . 0.0 108.832 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.94 HD21 ' CE1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -73.84 -130.84 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.052 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 173.27 57.45 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.447 -0.783 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 49' ' ' VAL . 15.8 m -57.26 117.44 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.936 0.874 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.94 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -93.42 -34.18 5.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.554 ' HB2' ' CG2' ' A' ' 15' ' ' THR . 0.7 OUTLIER -149.03 152.19 35.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.823 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.698 HG13 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -157.85 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.485 -0.76 . . . . 0.0 109.072 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' C ' ' CE ' ' A' ' 35' ' ' LYS . 7.1 mmm180 -106.96 168.23 9.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.772 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.956 ' HB ' HG11 ' A' ' 31' ' ' VAL . 4.4 p -80.17 170.94 15.74 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.438 -0.789 . . . . 0.0 110.279 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -128.88 114.1 1.7 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.4 m 67.66 -139.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 110.312 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.476 ' H ' HG22 ' A' ' 56' ' ' THR . 80.8 m-20 -98.24 76.35 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 36.8 mtt180 57.8 42.12 23.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.486 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 21.2 mttt -119.46 -31.44 4.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.863 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.8 m-85 -139.79 -169.26 2.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -166.8 140.59 6.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 2.3 m-30 -99.13 157.12 16.58 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.258 -1.143 . . . . 0.0 109.591 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.698 HG13 HG13 ' A' ' 52' ' ' VAL . 3.9 t -151.24 143.73 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.7 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' OD2' ' CG2' ' A' ' 15' ' ' THR . 0.8 OUTLIER -122.34 140.9 52.13 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.365 -0.835 . . . . 0.0 109.979 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.94 ' CE1' HD21 ' A' ' 47' ' ' LEU . 14.2 m-85 -107.48 172.31 6.9 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.877 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -122.52 19.2 10.45 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.067 -1.021 . . . . 0.0 111.115 -178.506 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.2 p -165.06 176.22 8.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.588 1.185 . . . . 0.0 112.251 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.18 -25.81 42.73 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -32.06 63.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.036 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 1.052 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 90.4 m-20 -77.81 -29.57 50.76 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.783 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tt -71.22 -39.73 71.54 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.63 ' N ' HD23 ' A' ' 71' ' ' LEU . 5.9 tt0 -62.16 -38.34 88.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' LEU . 23.9 mmtt -72.41 -24.62 61.26 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 71' ' ' LEU . . . -63.97 -34.92 79.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.42 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.0 tt -72.02 -44.64 63.09 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.4 9.72 14.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.094 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -75.89 -13.05 60.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.602 -0.686 . . . . 0.0 110.585 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.625 ' CA ' HD21 ' A' ' 89' ' ' LEU . 96.4 m -72.38 3.66 4.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.29 39.35 2.92 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 87' ' ' ILE . 7.4 mt -100.14 -167.55 1.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -1.009 . . . . 0.0 111.017 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -167.61 51.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.069 0.937 . . . . 0.0 108.925 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 85' ' ' ASN . 4.1 p -34.66 118.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.248 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 15.1 m-85 38.35 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 0.0 110.557 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 96.8 22.0 19.55 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.853 ' O ' HG12 ' A' ' 82' ' ' VAL . 1.2 m120 -134.01 84.34 2.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.093 -1.24 . . . . 0.0 109.853 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.553 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 23.4 tt0 -40.11 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.666 0.746 . . . . 0.0 110.44 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -59.55 123.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.607 -0.683 . . . . 0.0 110.499 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.5 mttp -95.25 127.88 41.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.003 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.625 HD21 ' CA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -109.34 169.67 8.55 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.399 -179.012 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -166.85 173.98 8.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.28 106.26 25.02 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.379 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.8 Cg_endo -74.69 -168.93 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.956 1.503 . . . . 0.0 110.428 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 66.63 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.901 . . . . 0.0 110.209 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . -175.86 -43.28 0.06 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER 45.42 -171.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.174 . . . . 0.0 110.247 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.95 -173.55 4.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.922 . . . . 0.0 110.156 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.75 -156.26 44.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.02 151.83 31.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 110.468 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -170.52 42.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.36 -118.93 3.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.242 -1.152 . . . . 0.0 110.198 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.8 -24.15 19.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -1.148 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -110.55 26.88 10.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' LEU . 1.1 ttp -140.84 55.96 1.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 110.164 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.7 OUTLIER -51.88 -174.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.268 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -169.47 109.78 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.218 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.523 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 5.0 t70 -162.93 50.72 0.27 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.227 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 7' ' ' ASP . 48.4 Cg_endo -71.37 -156.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.075 1.566 . . . . 0.0 110.043 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.2 t 52.25 98.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.318 0.58 . . . . 0.0 110.235 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 11' ' ' GLY . 1.1 tt0 -51.46 177.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.146 -0.971 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' GLU . . . -44.03 -73.84 0.23 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.63 -68.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -1.15 . . . . 0.0 110.116 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.84 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 110.217 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.25 159.09 0.22 Allowed 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.403 0.62 . . . . 0.0 110.28 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t -119.88 -13.78 9.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.403 -0.81 . . . . 0.0 109.915 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.946 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.57 172.79 5.44 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.65 -0.656 . . . . 0.0 110.691 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.5 Cg_endo -77.86 -47.0 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.136 1.598 . . . . 0.0 110.552 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.647 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.6 m-85 -87.51 111.12 20.86 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 110.22 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.01 150.39 32.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.374 -0.828 . . . . 0.0 109.113 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.184 HD12 ' CE1' ' A' ' 65' ' ' PHE . 13.9 mt -146.42 170.2 17.32 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.361 -0.837 . . . . 0.0 111.22 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.656 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 5.8 t80 -126.06 140.76 52.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.79 HD12 HG21 ' A' ' 63' ' ' VAL . 8.6 mt -137.63 147.8 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 110.774 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.06 -167.66 11.59 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 21.4 t-20 70.92 36.87 1.38 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -1.093 . . . . 0.0 110.372 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.1 mm? -88.4 126.97 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.504 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 36.4 t-20 -40.9 107.76 0.5 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.661 -0.649 . . . . 0.0 110.378 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.41 -8.36 21.67 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.047 1.551 . . . . 0.0 110.289 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 28.1 m120 -96.71 -20.75 18.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.638 ' CD ' ' CE1' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -103.48 -158.9 0.69 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -103.8 148.27 26.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.286 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.86 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.1 t -69.71 -26.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.912 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -65.36 -41.16 94.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.416 -0.802 . . . . 0.0 109.031 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.6 mm-40 -64.27 -45.26 88.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 31' ' ' VAL . 8.4 mt -60.09 -39.02 84.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.02 -57.17 14.25 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.539 0.685 . . . . 0.0 109.687 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 32' ' ' ALA . 15.0 t -57.23 -31.52 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.852 . . . . 0.0 109.714 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.08 -39.06 92.66 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.183 -0.948 . . . . 0.0 108.822 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 19.3 mt -78.3 -24.72 13.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 109.362 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.517 ' HA ' HG21 ' A' ' 49' ' ' VAL . 30.4 t -80.83 -33.22 34.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.147 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.61 -37.04 43.27 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.581 0.705 . . . . 0.0 109.461 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.616 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.33 -31.94 69.46 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.102 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.913 ' CD2' HD22 ' A' ' 47' ' ' LEU . 3.3 m-85 -77.74 -26.28 49.82 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.89 -29.67 61.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.549 -0.719 . . . . 0.0 109.706 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.19 -22.42 17.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.703 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.6 m120 -74.53 -42.15 59.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.703 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.6 t70 122.59 28.86 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.534 0 C-N-CA 123.682 0.793 . . . . 0.0 109.46 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.015 HD11 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -96.82 -153.87 0.43 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.463 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.72 61.45 0.2 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 ' CD2' ' A' ' 42' ' ' PHE . 6.0 m -55.23 115.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 122.08 0.943 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.946 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -91.28 -38.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -143.5 154.02 43.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.348 -0.845 . . . . 0.0 110.425 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -157.93 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.395 -0.816 . . . . 0.0 109.172 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -121.3 165.66 15.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.006 -1.059 . . . . 0.0 111.055 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.694 ' HB ' HG11 ' A' ' 31' ' ' VAL . 13.0 p -88.37 156.74 18.99 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -124.9 118.1 3.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 57' ' ' ASN . 3.5 m 66.77 -175.74 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -1.063 . . . . 0.0 110.757 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.69 ' H ' HG22 ' A' ' 56' ' ' THR . 16.9 m120 -63.95 65.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.392 -0.817 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' THR . 2.1 mtt180 61.74 59.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 110.694 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -120.41 -34.8 3.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.808 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.2 p90 -165.44 140.37 4.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.266 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -112.33 163.75 12.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.716 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 39.1 m-85 -114.26 163.42 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -1.003 . . . . 0.0 109.635 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.79 HG21 HD12 ' A' ' 22' ' ' ILE . 2.9 t -152.0 139.46 13.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.043 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' PHE . 3.6 m-20 -106.81 140.44 39.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.023 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 1.184 ' CE1' HD12 ' A' ' 20' ' ' LEU . 13.1 m-85 -107.48 170.43 7.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 0.0 110.631 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.727 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -116.22 16.08 15.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 111.328 -178.016 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.552 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 3.1 t -163.44 175.32 10.9 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.748 1.261 . . . . 0.0 112.272 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.74 -24.67 22.62 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -89.35 -22.16 22.75 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.831 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 10.7 t0 -81.4 -34.02 31.87 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.681 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 7.6 tt -76.28 -34.6 59.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -37.35 84.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.421 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 1.015 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.8 mtmt -72.3 -27.69 62.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.914 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -62.53 -34.07 76.18 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 5.5 tt -71.05 -44.49 65.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.29 1.18 22.57 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.488 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.045 HD12 HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -79.75 12.64 2.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.855 . . . . 0.0 110.414 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -78.28 2.67 17.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.08 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.06 33.63 5.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.045 HD11 HD12 ' A' ' 77' ' ' LEU . 22.3 mt -98.44 -166.25 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.253 -1.145 . . . . 0.0 110.982 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.9 mttt -166.78 49.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.304 1.049 . . . . 0.0 109.416 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.794 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -38.25 126.94 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.288 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.638 ' CE1' ' CD ' ' A' ' 29' ' ' LYS . 9.0 m-85 42.46 26.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 110.414 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 90.55 21.67 36.63 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' VAL . 22.9 m120 -136.19 99.51 4.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -1.136 . . . . 0.0 109.393 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.569 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -48.79 90.84 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 110.61 -179.099 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -48.83 135.24 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.85 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.2 ttpt -104.23 152.65 21.93 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -124.79 172.8 9.04 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.539 -0.726 . . . . 0.0 110.482 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.7 tt0 -164.16 174.0 11.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -100.48 101.02 13.56 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.244 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.4 Cg_endo -72.71 -171.13 0.69 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.057 1.556 . . . . 0.0 110.437 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 6.4 ttmt 65.36 101.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.214 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . -44.58 123.01 5.06 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 94' ' ' GLY . 2.7 tmm_? 59.73 148.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.237 -1.155 . . . . 0.0 110.199 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.434 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 2.6 t70 -162.33 67.61 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 110.243 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 155.18 -84.32 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.46 155.0 38.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 110.396 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -71.84 -37.49 70.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.48 -111.81 3.84 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.214 -1.168 . . . . 0.0 110.222 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 m -127.46 -165.35 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -1.116 . . . . 0.0 110.178 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -119.54 23.22 11.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.879 . . . . 0.0 110.193 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -123.63 39.48 3.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.134 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tp 49.57 87.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.147 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 3.5 mt-10 -140.36 107.75 5.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.126 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.573 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 174.29 -60.44 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.942 . . . . 0.0 110.201 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 49.3 Cg_endo -71.45 -157.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.056 1.556 . . . . 0.0 110.062 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 9' ' ' VAL . 9.8 p -164.28 120.6 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 O-C-N 121.81 -0.556 . . . . 0.0 110.191 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -76.54 -177.72 4.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.03 11.55 12.27 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.77 24.4 11.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -1.151 . . . . 0.0 110.231 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 14' ' ' SER . 3.0 pt-20 -117.92 -129.6 0.29 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.224 -0.923 . . . . 0.0 109.446 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.497 ' N ' ' HG3' ' A' ' 13' ' ' GLU . 0.1 OUTLIER 46.99 -175.44 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.128 0 O-C-N 121.662 -0.649 . . . . 0.0 110.257 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m -105.01 -2.16 24.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 1.014 ' CG2' HG11 ' A' ' 50' ' ' VAL . 1.9 p -162.98 169.03 9.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 48.4 Cg_endo -76.58 -25.77 9.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.095 1.576 . . . . 0.0 110.734 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.721 ' CD1' HD13 ' A' ' 71' ' ' LEU . 87.6 m-85 -121.33 113.11 19.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.95 -1.094 . . . . 0.0 111.126 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -139.68 150.48 44.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 109.092 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -161.99 178.61 8.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.464 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -97.93 162.87 13.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.671 . . . . 0.0 109.374 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.062 HD12 ' CG2' ' A' ' 63' ' ' VAL . 6.0 mt -153.82 152.08 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.922 -1.111 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -143.5 -166.29 11.17 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.112 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.575 ' C ' HD22 ' A' ' 25' ' ' LEU . 2.7 t-20 72.71 46.1 0.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.553 -0.969 . . . . 0.0 109.883 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.928 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.9 mm? -100.56 128.71 46.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' HB3' HD21 ' A' ' 34' ' ' LEU . 56.9 t-20 -44.89 103.48 0.34 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.255 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.4 Cg_endo -73.63 -20.9 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.977 1.514 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -76.29 -14.7 60.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.861 . . . . 0.0 109.965 179.873 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 3.0 mmtt -110.91 -155.75 0.57 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -106.63 149.57 27.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.975 HG11 HG22 ' A' ' 54' ' ' THR . 3.1 t -67.97 -40.93 84.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.4 64.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.1 mm-40 -66.29 -35.39 80.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 109.308 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.928 HD13 ' HB3' ' A' ' 25' ' ' LEU . 55.6 mt -65.96 -36.31 82.98 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.367 -0.833 . . . . 0.0 109.081 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.533 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -60.89 -47.49 86.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.356 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 50.2 t -58.82 -41.51 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.611 -0.68 . . . . 0.0 110.072 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -61.49 -30.47 70.63 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.99 -1.069 . . . . 0.0 109.155 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.625 HD12 HD13 ' A' ' 87' ' ' ILE . 23.0 mm -86.34 -28.48 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.111 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.715 ' HA ' HG21 ' A' ' 49' ' ' VAL . 15.7 t -78.87 -26.27 43.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.334 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.09 -38.91 20.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.85 HD23 ' CD1' ' A' ' 77' ' ' LEU . 2.7 tp -63.98 -36.5 84.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CD2' HD13 ' A' ' 47' ' ' LEU . 12.1 m-85 -83.25 -21.85 33.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -81.33 -20.36 40.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -104.18 -16.43 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.553 -0.717 . . . . 0.0 109.625 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.72 -29.63 23.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 34.6 t70 111.99 28.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -101.08 -155.2 0.5 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.891 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -169.1 64.21 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.248 -0.908 . . . . 0.0 109.783 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.715 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.9 m -49.37 115.07 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.895 0.855 . . . . 0.0 110.096 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.014 HG11 ' CG2' ' A' ' 16' ' ' THR . 10.6 t -82.83 -31.66 9.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.832 -0.543 . . . . 0.0 110.567 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 20.9 t0 -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.752 HG22 HG13 ' A' ' 63' ' ' VAL . 3.5 t -154.2 94.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.747 . . . . 0.0 109.276 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.541 ' CG ' ' HB3' ' A' ' 62' ' ' TYR . 10.7 ptp180 -108.95 170.21 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.762 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.975 HG22 HG11 ' A' ' 31' ' ' VAL . 4.9 p -80.63 164.43 22.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.392 -0.818 . . . . 0.0 110.363 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 60' ' ' PHE . . . -134.58 124.0 3.35 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.496 HG22 ' OD1' ' A' ' 57' ' ' ASN . 25.3 m 44.12 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.495 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.496 ' OD1' HG22 ' A' ' 56' ' ' THR . 10.9 m120 60.75 -141.05 0.54 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.375 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -116.0 32.46 6.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 -20.67 11.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.605 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.3 t80 -119.19 -171.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 110.24 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 175.88 154.93 12.04 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -118.78 159.76 23.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -1.036 . . . . 0.0 109.31 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.062 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.2 t -150.54 143.07 17.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.862 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -116.42 148.87 40.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.661 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.679 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 14.0 m-85 -110.72 177.9 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.891 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -115.35 13.54 16.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 111.516 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.4 p 179.17 175.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.958 -1.089 . . . . 0.0 112.135 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -78.54 -24.04 45.89 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 -26.49 32.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.999 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.0 t0 -80.7 -25.86 37.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.721 HD13 ' CD1' ' A' ' 18' ' ' PHE . 4.4 tt -80.19 -33.83 37.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.29 -33.74 70.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.6 -0.688 . . . . 0.0 109.518 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HB2' HD21 ' A' ' 47' ' ' LEU . 1.6 mmtt -77.22 -27.92 53.59 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.679 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.53 -24.54 61.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.11 -48.39 29.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -10.85 60.4 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.85 ' CD1' HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -67.22 -2.47 5.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.58 -0.7 . . . . 0.0 110.489 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.46 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 12.0 m -45.16 -24.8 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.034 . . . . 0.0 110.349 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' LEU . . . -63.32 -16.92 58.8 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.801 HD11 ' HG3' ' A' ' 86' ' ' GLU . 3.4 pp -45.07 175.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.622 -0.928 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HA ' ' CA ' ' A' ' 86' ' ' GLU . 2.7 mttt -177.16 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.332 1.063 . . . . 0.0 109.362 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.808 HG22 HD23 ' A' ' 34' ' ' LEU . 1.7 p -37.98 123.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.621 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.4 m-85 42.42 26.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.483 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 90.11 23.84 31.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.674 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 m120 -135.41 84.43 2.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -1.194 . . . . 0.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.801 ' HG3' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -37.77 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.543 0.687 . . . . 0.0 110.744 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.776 ' CG1' HD13 ' A' ' 80' ' ' LEU . 4.9 pt -49.73 141.25 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.3 mmtm -107.57 155.9 19.6 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.082 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.574 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -120.25 172.76 7.56 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 110.573 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -156.32 156.03 33.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.45 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 4.4 mtmp? -97.39 104.9 22.05 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.923 . . . . 0.0 110.374 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.3 Cg_endo -73.65 -170.35 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.953 1.501 . . . . 0.0 110.371 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.7 mttt 53.2 -170.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.89 -65.83 1.37 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 mtm-85 -71.49 109.04 5.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -1.145 . . . . 0.0 110.244 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -143.16 103.99 4.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.91 . . . . 0.0 110.125 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.93 -60.07 0.47 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -129.67 -92.92 0.44 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -1.184 . . . . 0.0 110.465 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.498 ' H ' HG23 ' A' ' 98' ' ' THR . 0.9 OUTLIER 177.48 170.39 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.193 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 101' ' ' CYS . . . 66.79 145.85 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.474 ' C ' ' O ' ' A' ' 100' ' ' GLY . 14.5 p . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -156.47 69.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -1.182 . . . . 0.0 110.131 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -99.67 -71.42 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.8 mtp 47.03 -158.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.51 38.75 3.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 110.297 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.37 107.54 0.68 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -139.26 148.43 56.97 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.862 . . . . 0.0 110.275 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.92 80.41 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.107 1.583 . . . . 0.0 110.41 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 9' ' ' VAL . 14.0 p -96.64 47.35 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.249 0.547 . . . . 0.0 110.28 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.16 136.38 31.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.098 -1.001 . . . . 0.0 110.342 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 12' ' ' SER . . . -123.79 42.93 1.49 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 1.1 m 58.81 83.06 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.14 . . . . 0.0 110.185 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 14' ' ' SER . 0.8 OUTLIER -95.77 28.96 2.83 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.305 -0.872 . . . . 0.0 110.293 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -40.26 141.5 0.49 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.281 0.562 . . . . 0.0 110.293 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 1.027 HG23 HG23 ' A' ' 16' ' ' THR . 3.2 t -115.21 -19.99 10.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 110.267 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 1.027 HG23 HG23 ' A' ' 15' ' ' THR . 81.8 p -124.46 153.21 69.29 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.581 -0.7 . . . . 0.0 110.716 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.3 Cg_endo -80.06 -22.37 7.35 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.155 1.608 . . . . 0.0 110.538 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.7 m-85 -107.02 113.06 26.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 110.876 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.4 m120 -139.06 150.76 46.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.528 -0.733 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.756 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -167.53 -179.63 4.47 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.646 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -109.24 154.95 21.7 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.938 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.67 HD12 ' CG2' ' A' ' 63' ' ' VAL . 3.7 mt -141.89 148.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.597 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -134.1 -169.29 12.0 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.7 t30 72.8 30.31 1.77 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.961 . . . . 0.0 110.021 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.99 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.8 mm? -82.26 128.65 34.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.745 ' H ' HD21 ' A' ' 34' ' ' LEU . 30.3 t-20 -40.07 100.27 0.21 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.65 -0.656 . . . . 0.0 110.371 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.6 Cg_endo -74.18 -16.72 22.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.455 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -83.87 -13.43 53.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.74 -156.86 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.8 m -104.15 152.06 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.54 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.023 HG11 HG22 ' A' ' 54' ' ' THR . 3.0 t -68.71 -28.38 39.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.454 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -62.25 -43.4 98.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 72.9 mm-40 -69.42 -31.1 69.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.737 . . . . 0.0 109.266 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.99 HD13 ' HB3' ' A' ' 25' ' ' LEU . 6.5 mt -68.01 -33.88 75.45 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.357 -0.839 . . . . 0.0 109.124 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HE3' HG12 ' A' ' 31' ' ' VAL . 3.5 mtmt -66.08 -52.13 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.567 -0.708 . . . . 0.0 109.436 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.2 t -56.86 -39.71 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 110.059 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -61.91 -34.65 76.44 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 109.047 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 34' ' ' LEU . 10.5 mt -82.3 -28.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.255 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -79.01 -27.36 43.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -83.81 -38.22 21.53 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 109.206 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.686 HD21 ' HG ' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -65.63 -34.51 78.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.63 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 8.0 m-85 -85.11 -20.41 30.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.89 -33.19 45.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.457 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -23.28 25.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.8 OUTLIER -83.73 -20.53 33.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 11.4 m-20 89.44 28.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.256 1.027 . . . . 0.0 108.326 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.03 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -75.91 -143.71 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -164.56 60.15 0.14 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.023 -1.048 . . . . 0.0 110.262 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.495 HG13 ' CB ' ' A' ' 42' ' ' PHE . 16.9 m -66.58 116.59 6.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.767 0.794 . . . . 0.0 109.859 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.909 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.4 t -99.26 -38.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.833 -0.542 . . . . 0.0 109.96 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.553 ' C ' HG23 ' A' ' 52' ' ' VAL . 15.2 t0 -143.51 154.53 43.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 110.447 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.0 HG22 HG13 ' A' ' 63' ' ' VAL . 20.5 t -154.74 105.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.747 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.03 167.98 9.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . 1.023 HG22 HG11 ' A' ' 31' ' ' VAL . 16.3 p -81.11 160.0 24.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.367 -0.833 . . . . 0.0 110.233 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 56' ' ' THR . . . -130.91 120.13 2.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.764 HG23 ' N ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 70.46 -166.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.26 -1.141 . . . . 0.0 110.108 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.764 ' N ' HG23 ' A' ' 56' ' ' THR . 31.0 t-20 -42.99 -76.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.459 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.572 ' HG3' HG22 ' A' ' 31' ' ' VAL . 10.7 ttp180 -162.41 28.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.217 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' A' ' 24' ' ' ASN . 19.3 tptm -117.03 -6.27 11.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 109.858 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.669 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -121.84 -173.0 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.928 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 174.76 146.52 5.75 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.661 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.545 -0.974 . . . . 0.0 109.478 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.0 HG13 HG22 ' A' ' 52' ' ' VAL . 4.9 t -152.01 142.78 15.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.171 -0.955 . . . . 0.0 110.831 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -112.24 143.76 42.78 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.308 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 12.6 m-85 -107.53 177.09 4.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.601 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -117.28 12.36 14.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 111.427 -178.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.2 p -173.0 173.99 3.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.048 -1.032 . . . . 0.0 112.107 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.31 -23.86 43.23 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -25.05 31.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.936 ' OD1' HD12 ' A' ' 47' ' ' LEU . 3.9 t0 -81.99 -27.35 33.21 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD12 ' HD2' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -81.13 -33.74 33.0 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -72.88 -32.56 65.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.717 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 1.03 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -78.16 -29.89 48.88 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.74 -31.79 72.97 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.626 HD13 ' C ' ' A' ' 75' ' ' LEU . 2.9 tm? -72.11 -45.75 59.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.87 -19.4 58.89 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.085 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -71.58 -4.0 24.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.582 -0.699 . . . . 0.0 109.977 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 78' ' ' THR . 87.4 m -74.4 3.98 6.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.337 -0.852 . . . . 0.0 111.039 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.84 -8.75 75.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.686 ' HG ' HD21 ' A' ' 41' ' ' LEU . 3.5 mm? -79.36 -164.21 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.361 -1.082 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -149.26 50.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.801 ' HB ' HG23 ' A' ' 87' ' ' ILE . 8.9 p 13.92 -132.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.06 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.781 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -69.28 -3.36 13.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.448 -1.408 . . . . 0.0 109.919 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 152.05 36.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.768 ' O ' HG12 ' A' ' 82' ' ' VAL . 11.7 t-20 -170.45 116.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -1.037 . . . . 0.0 109.346 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.592 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -52.03 89.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 0.0 110.385 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.801 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.4 135.08 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.629 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 26.5 mttt -103.88 170.95 7.62 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 20' ' ' LEU . 4.9 mp -122.91 -175.28 3.13 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 110.492 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.498 ' CB ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -165.34 141.89 5.57 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.696 -0.627 . . . . 0.0 110.242 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.1 100.62 13.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 110.124 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.0 Cg_endo -72.84 -174.23 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.982 1.517 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.98 22.53 2.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 110.252 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.96 26.5 34.36 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -129.87 51.93 2.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -1.102 . . . . 0.0 110.258 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.45 160.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.54 -69.03 1.24 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 p -93.19 176.64 6.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -1.173 . . . . 0.0 110.268 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -124.13 160.42 27.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 110.171 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.87 -65.39 3.57 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.203 -1.175 . . . . 0.0 110.219 -179.959 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 t -135.57 114.58 12.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 110.253 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -138.72 51.85 1.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.865 . . . . 0.0 110.177 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.495 ' O ' ' N ' ' A' ' 6' ' ' GLU . 19.7 ptm -126.69 -162.27 1.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.511 ' HA ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 66.13 -64.09 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 4' ' ' MET . 0.5 OUTLIER -143.04 -172.44 3.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.272 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 22.9 p30 -119.91 163.51 27.44 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.212 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 7' ' ' ASP . 49.1 Cg_endo -71.52 -157.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.973 1.512 . . . . 0.0 110.065 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -167.92 141.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 O-C-N 121.791 -0.568 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -159.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 12' ' ' SER . . . -97.76 -82.21 1.64 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 3.8 m 56.8 85.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -1.139 . . . . 0.0 110.216 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.72 27.96 8.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.265 -0.897 . . . . 0.0 110.243 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.11 167.52 6.38 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.171 0.51 . . . . 0.0 110.206 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.837 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m -77.35 -6.46 53.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.072 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.911 HG21 ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER 179.15 162.37 0.73 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.563 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.43 -36.63 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.27 1.669 . . . . 0.0 110.832 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 95.6 m-85 -106.49 112.77 25.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.987 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.6 m-20 -136.04 144.87 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.278 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 20' ' ' LEU . 2.9 pp -155.52 -176.08 5.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 52.9 t80 -110.64 159.35 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.599 HG22 HD21 ' A' ' 25' ' ' LEU . 24.9 mt -137.6 159.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.793 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' ILE . . . -147.44 176.77 26.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 88' ' ' LYS . 2.8 t30 62.62 57.73 1.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -1.137 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.905 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.2 mm? -90.32 -90.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.782 ' CB ' HD21 ' A' ' 34' ' ' LEU . 37.2 t-20 -179.15 92.01 0.21 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.27 -13.86 28.27 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.966 1.508 . . . . 0.0 110.441 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -82.49 -14.36 55.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.973 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -116.57 -156.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.844 . . . . 0.0 109.882 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -99.57 147.98 24.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 54' ' ' THR . 21.9 t -68.92 -27.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.55 -40.8 89.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.067 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 43.0 mm-40 -67.59 -33.0 74.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.499 -0.75 . . . . 0.0 109.325 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.905 HD13 ' HB3' ' A' ' 25' ' ' LEU . 20.2 mt -66.01 -37.85 86.97 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.417 -0.802 . . . . 0.0 109.017 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' CG ' ' HB ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -60.83 -50.16 74.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 32' ' ' ALA . 10.5 t -60.83 -35.12 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.526 -0.734 . . . . 0.0 109.247 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.714 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -59.68 -31.98 70.07 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.849 ' CD1' HD13 ' A' ' 87' ' ' ILE . 29.1 mm -80.71 -31.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.616 -0.677 . . . . 0.0 109.367 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -78.55 -23.59 46.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 108.914 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.939 HD21 ' HB3' ' A' ' 80' ' ' LEU . 6.3 tp -66.7 -32.98 74.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.617 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 10.4 m-85 -87.72 -20.75 25.8 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -80.98 -29.16 35.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.211 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HG3' ' OE1' ' A' ' 40' ' ' GLU . 17.2 mttt -87.34 -17.72 31.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 109.387 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.627 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.2 m-80 -92.27 -20.34 21.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.925 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.2 t0 90.21 29.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.939 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -74.8 -137.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.76 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -173.63 58.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.188 -0.945 . . . . 0.0 109.604 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.553 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 12.8 m -58.42 117.51 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.942 0.877 . . . . 0.0 110.141 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.911 ' HB ' HG21 ' A' ' 16' ' ' THR . 1.9 t -96.64 -33.54 4.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.909 -0.494 . . . . 0.0 109.866 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.536 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 6.9 t70 -144.27 149.34 36.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.067 -1.02 . . . . 0.0 110.884 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.6 HG12 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -138.16 150.66 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 0.0 109.776 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -154.96 164.26 39.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.938 . . . . 0.0 110.405 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.73 HG22 HG12 ' A' ' 31' ' ' VAL . 63.0 p -94.86 167.13 11.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.822 . . . . 0.0 110.571 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -126.5 117.33 2.77 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.1 m 55.43 -161.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -1.125 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.647 ' H ' HG22 ' A' ' 56' ' ' THR . 35.9 m120 -42.43 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.569 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 2.3 ptp180 -162.93 49.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.327 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -124.5 -23.13 4.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.398 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -128.14 -179.8 5.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -163.87 164.59 36.52 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 2.6 t80 -120.74 166.27 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.977 . . . . 0.0 109.291 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.606 HG12 HD11 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -165.48 168.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.818 -1.176 . . . . 0.0 111.543 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 76.5 m-20 -137.13 142.4 42.26 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.772 ' CE2' ' HB2' ' A' ' 74' ' ' ALA . 28.2 m-85 -104.6 -178.43 3.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.732 -0.605 . . . . 0.0 110.721 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.579 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.69 17.99 13.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 0.0 111.05 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 18.9 p 177.95 176.63 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.463 1.125 . . . . 0.0 112.135 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.99 -24.26 55.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -28.6 49.68 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.363 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.76 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 88.3 m-20 -79.22 -28.02 42.51 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.54 -36.88 57.43 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.064 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.65 -32.78 72.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.419 -0.801 . . . . 0.0 109.576 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.939 ' HB2' HD21 ' A' ' 47' ' ' LEU . 5.3 mmtp -76.8 -29.4 55.98 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.772 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -64.83 -29.94 70.92 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.483 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.1 -44.03 60.96 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.548 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.14 -7.2 47.75 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -73.07 4.93 3.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 110.63 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.542 ' O ' HG22 ' A' ' 78' ' ' THR . 89.5 m -78.13 6.95 6.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 110.541 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.437 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . -118.32 19.55 10.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.939 ' HB3' HD21 ' A' ' 41' ' ' LEU . 2.8 mt -124.61 122.57 37.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.141 -1.211 . . . . 0.0 111.395 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.7 mttm -92.69 89.24 6.58 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.372 1.082 . . . . 0.0 108.517 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.989 HG21 HG23 ' A' ' 87' ' ' ILE . 3.0 m -36.93 -104.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -82.43 20.08 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.063 -1.023 . . . . 0.0 110.647 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.71 10.33 5.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 82' ' ' VAL . 4.4 m120 -145.25 117.45 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.236 -1.155 . . . . 0.0 109.726 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 80' ' ' LEU . 7.4 tp10 -56.68 83.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.419 -0.8 . . . . 0.0 109.982 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.989 HG23 HG21 ' A' ' 82' ' ' VAL . 1.7 pt -43.57 126.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -102.22 131.86 48.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.746 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -108.44 173.07 6.48 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.926 -1.108 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 3.8 mt-10 -166.94 174.15 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.138 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -100.41 102.53 18.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.088 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' CG ' ' OH ' ' A' ' 62' ' ' TYR . 48.2 Cg_endo -74.57 169.33 22.77 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.023 1.539 . . . . 0.0 110.383 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 166.66 -78.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.548 -0.72 . . . . 0.0 110.05 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.34 40.2 0.13 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 52.63 -172.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 0.0 110.154 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER 42.56 85.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.32 -0.862 . . . . 0.0 110.251 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.08 68.63 0.09 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 2.7 p -112.23 -33.63 6.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -1.152 . . . . 0.0 110.204 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 98' ' ' THR . 0.0 OUTLIER 178.06 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 110.164 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.79 128.66 2.52 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.255 -1.144 . . . . 0.0 110.246 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 3' ' ' HIS . 10.3 t -93.75 23.3 4.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -1.16 . . . . 0.0 110.146 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' MET . 5.1 t-160 64.73 -156.18 0.3 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.142 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 3' ' ' HIS . 32.0 mtm 53.25 170.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.225 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.453 ' HA ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -122.63 -34.1 3.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.187 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 1.5 mt-10 -178.64 -164.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.23 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.562 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.0 OUTLIER 172.89 -59.3 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.903 . . . . 0.0 110.142 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 43.6 Cg_endo -71.03 80.98 1.19 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.01 1.531 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.551 HG23 ' N ' ' A' ' 10' ' ' GLU . 4.0 m -64.61 -151.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.611 0.72 . . . . 0.0 110.331 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 9' ' ' VAL . 10.6 pt-20 -132.03 -153.66 0.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 110.294 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' A' ' 12' ' ' SER . . . -91.74 48.33 2.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 11' ' ' GLY . 2.6 m -176.1 -98.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -1.186 . . . . 0.0 109.936 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER 173.69 31.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.086 -1.009 . . . . 0.0 110.517 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.673 ' O ' HG22 ' A' ' 15' ' ' THR . 15.2 m -61.89 -115.89 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.895 -0.503 . . . . 0.0 110.39 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER 80.59 -7.31 1.6 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.326 0.584 . . . . 0.0 109.917 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.972 ' CG2' HG11 ' A' ' 50' ' ' VAL . 45.9 p -130.24 153.4 81.2 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 110.309 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.56 -22.08 6.91 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.127 1.593 . . . . 0.0 110.742 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 75.3 m-85 -113.57 108.78 17.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.975 -1.078 . . . . 0.0 111.027 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.1 m120 -137.91 149.0 45.83 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 109.041 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -164.27 171.61 14.66 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 110.261 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.651 ' C ' HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.99 160.14 16.53 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.47 -0.769 . . . . 0.0 109.207 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.778 HD13 HG23 ' A' ' 63' ' ' VAL . 1.6 mp -147.61 161.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.975 -1.078 . . . . 0.0 109.673 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -160.28 -160.07 10.32 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.084 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 1.0 OUTLIER 67.16 55.09 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -1.05 . . . . 0.0 110.141 -179.793 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.648 ' HB3' HD22 ' A' ' 34' ' ' LEU . 3.7 mt -104.12 -133.67 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.321 -0.862 . . . . 0.0 110.066 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 36.4 t-20 -143.0 109.78 5.49 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.111 -0.993 . . . . 0.0 110.235 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.59 2.66 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.993 1.522 . . . . 0.0 110.698 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 34.7 m-80 -113.59 18.3 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.968 . . . . 0.0 109.169 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.6 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.0 tptt -138.64 -158.34 0.85 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.717 -0.614 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -107.29 142.59 36.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.778 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.6 t -69.29 -32.07 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.386 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -62.83 -27.81 69.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.003 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 11.3 mm-40 -77.59 -42.3 35.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' A' ' 31' ' ' VAL . 3.8 mt -61.89 -37.93 86.43 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.259 -0.901 . . . . 0.0 109.092 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.744 ' HG3' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -63.17 -52.07 63.85 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.618 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 32' ' ' ALA . 48.7 t -63.41 -28.14 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.252 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.43 -34.14 77.5 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 108.587 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.655 HD11 HG21 ' A' ' 87' ' ' ILE . 6.5 mt -83.89 -25.48 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.589 ' HA ' HG21 ' A' ' 49' ' ' VAL . 13.1 m -80.3 -28.86 38.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -82.43 -37.34 25.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.533 -0.73 . . . . 0.0 109.238 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.646 HD23 ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -70.23 -30.44 67.51 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.555 -0.716 . . . . 0.0 109.18 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.844 ' CE1' HD22 ' A' ' 77' ' ' LEU . 3.2 m-85 -91.99 -14.63 29.13 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -0.82 . . . . 0.0 109.363 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -92.19 -28.57 16.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.697 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.51 -21.23 21.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.41 -0.806 . . . . 0.0 109.089 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 3.1 m120 -79.25 -60.01 2.54 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.388 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 147.37 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.186 0.517 . . . . 0.0 109.802 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.885 HD21 ' HB3' ' A' ' 73' ' ' LYS . 3.8 mm? -98.35 -157.72 0.62 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.558 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -156.93 63.82 0.51 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.7 m -58.28 117.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.929 0.871 . . . . 0.0 109.789 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.972 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -90.31 -44.26 14.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 O-C-N 121.735 -0.603 . . . . 0.0 110.188 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.501 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 34.3 t0 -141.04 152.74 45.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.07 -1.019 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.809 HG22 HG13 ' A' ' 63' ' ' VAL . 2.8 t -152.36 105.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 167.45 10.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.778 HG22 ' CG1' ' A' ' 31' ' ' VAL . 47.3 p -85.16 163.65 18.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.4 -0.812 . . . . 0.0 110.416 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.497 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -137.76 137.32 8.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.553 HG22 ' N ' ' A' ' 57' ' ' ASN . 28.8 m 60.36 176.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -1.115 . . . . 0.0 109.961 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.553 ' N ' HG22 ' A' ' 56' ' ' THR . 20.0 m120 -40.98 -59.68 1.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.581 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -168.08 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.965 . . . . 0.0 110.193 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.623 ' C ' HD12 ' A' ' 25' ' ' LEU . 12.0 tttt -127.14 -11.04 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.448 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.3 t80 -122.18 179.41 4.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.26 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.64 163.79 31.33 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.5 t80 -126.25 157.24 38.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.467 -1.019 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.809 HG13 HG22 ' A' ' 52' ' ' VAL . 4.2 t -151.72 145.2 16.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.813 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -116.35 144.01 44.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.405 -0.81 . . . . 0.0 109.705 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.838 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 19.6 m-85 -107.05 176.71 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.571 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.622 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -112.28 13.62 20.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 111.609 -178.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 25.0 p 177.66 178.16 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.401 1.096 . . . . 0.0 112.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.68 -22.65 53.69 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' OE2' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.59 -25.84 38.23 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.493 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.759 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 85.4 m-20 -83.3 -27.81 29.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.777 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.0 tm? -78.7 -34.06 46.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.772 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.03 -38.51 61.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.885 ' HB3' HD21 ' A' ' 47' ' ' LEU . 14.7 mtmt -79.55 -18.21 52.3 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.838 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -79.26 -28.1 42.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.379 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.6 tt -79.12 -44.32 22.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.435 -0.791 . . . . 0.0 109.105 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.0 mt-10 -71.34 -24.26 62.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.308 -0.87 . . . . 0.0 109.29 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -64.45 -15.05 60.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.0 109.972 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -37.93 -28.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.878 0.847 . . . . 0.0 110.891 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -51.73 -26.17 16.62 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 87' ' ' ILE . 1.6 pt? -65.52 131.91 47.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -1.18 . . . . 0.0 110.896 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 3.5 mttm -109.9 80.76 1.35 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.08 0.943 . . . . 0.0 109.964 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -39.71 122.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.421 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.6 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.9 m-85 43.33 24.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 93.38 19.16 36.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.56 ' O ' HG12 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -133.31 91.7 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 110.173 179.845 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 9.2 tt0 -41.1 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 110.733 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -47.64 141.33 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.771 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -116.32 157.89 24.28 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.584 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.86 174.68 8.2 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.163 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -173.87 113.87 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 110.166 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -55.2 121.19 35.22 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.198 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 20' ' ' LEU . 45.2 Cg_endo -73.47 -179.94 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.961 1.506 . . . . 0.0 110.286 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 92' ' ' PRO . 0.5 OUTLIER 177.23 31.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.414 -0.804 . . . . 0.0 110.254 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 95' ' ' ARG . . . -60.88 -28.79 69.07 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 94' ' ' GLY . 5.1 mtp180 41.94 42.59 2.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -1.096 . . . . 0.0 110.339 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.49 160.0 28.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.28 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.36 138.53 23.46 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.72 165.85 5.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -1.141 . . . . 0.0 110.407 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.34 -85.4 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.238 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 46.85 -134.27 11.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.268 -1.136 . . . . 0.0 110.177 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -116.47 175.23 5.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -1.186 . . . . 0.0 110.188 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.3 m170 46.97 64.18 1.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.7 ttm -104.51 -40.78 5.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.233 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD13 ' HB3' ' A' ' 8' ' ' PRO . 2.0 mt -142.87 -169.77 3.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.211 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' C ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -157.3 117.56 3.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.54 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 23.1 t70 44.64 49.49 5.9 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HB3' HD13 ' A' ' 5' ' ' LEU . 49.7 Cg_endo -71.51 -157.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.026 1.54 . . . . 0.0 110.158 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 9' ' ' VAL . 9.3 p -140.57 77.19 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-O 121.242 0.544 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER 64.55 149.79 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 110.234 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.96 58.99 0.52 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m 62.41 77.53 0.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.287 -1.125 . . . . 0.0 110.145 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' HB2' ' OE2' ' A' ' 10' ' ' GLU . 1.3 mt-10 -91.65 28.44 1.76 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.458 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -41.19 164.07 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.36 0.6 . . . . 0.0 110.199 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 1.015 HG23 HG23 ' A' ' 16' ' ' THR . 5.3 t -75.82 -22.44 56.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.354 -0.842 . . . . 0.0 110.173 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . 1.015 HG23 HG23 ' A' ' 15' ' ' THR . 32.0 p -119.64 163.29 28.19 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.579 -0.7 . . . . 0.0 110.417 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.67 -27.65 10.49 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.015 1.534 . . . . 0.0 110.661 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 97.7 m-85 -102.63 112.52 25.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.374 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.473 ' ND2' ' N ' ' A' ' 19' ' ' ASN . 1.2 m-80 -143.05 151.97 41.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.748 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.0 pp -161.3 -176.41 5.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.408 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 16.3 t80 -108.75 161.5 15.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.897 HD12 HG21 ' A' ' 63' ' ' VAL . 5.1 mt -140.19 159.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -143.5 170.82 25.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.659 ' C ' HD22 ' A' ' 25' ' ' LEU . 28.2 t30 67.81 71.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -1.118 . . . . 0.0 109.944 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.773 HD13 HD12 ' A' ' 34' ' ' LEU . 4.2 mm? -106.15 19.68 20.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' PHE . 2.8 t30 55.94 99.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 47.2 Cg_endo -73.39 -19.57 21.92 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.02 1.537 . . . . 0.0 110.289 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.2 -19.83 56.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 83' ' ' PHE . 5.6 tmtt? -98.54 -154.29 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.855 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.724 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -113.56 139.56 48.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 110.384 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.897 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.6 t -67.98 -29.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.003 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.45 -37.35 87.21 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 69.3 mm-40 -70.68 -27.53 64.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.773 HD12 HD13 ' A' ' 25' ' ' LEU . 3.2 mm? -64.43 -42.58 95.94 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.404 -0.81 . . . . 0.0 109.106 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.829 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.89 -54.65 27.55 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.981 -0.687 . . . . 0.0 109.8 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 32' ' ' ALA . 4.9 t -62.66 -30.21 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.747 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -65.97 -40.01 90.9 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.758 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 34' ' ' LEU . 10.8 mm -78.58 -24.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.109 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.861 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.4 p -79.78 -32.94 40.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.26 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -80.34 -37.9 31.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.148 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.35 -30.91 69.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 0.0 109.167 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 5.5 m-85 -89.03 -16.0 32.7 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.499 -0.751 . . . . 0.0 109.328 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -90.8 -27.37 18.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.67 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.474 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -92.02 -21.1 20.69 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.694 0.759 . . . . 0.0 109.305 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -81.25 -59.16 2.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.2 m-20 144.61 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.204 0.601 . . . . 0.0 109.64 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' OD1' ' A' ' 70' ' ' ASP . 2.7 mm? -99.26 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.205 -0.935 . . . . 0.0 109.842 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.82 61.87 0.47 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 39' ' ' SER . 11.7 m -58.28 116.14 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.814 0.816 . . . . 0.0 109.843 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.853 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.0 OUTLIER -88.95 -45.55 15.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 121.209 0.528 . . . . 0.0 109.779 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 12.6 t0 -143.37 159.22 42.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.637 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 35' ' ' LYS . 6.2 p -158.81 100.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 110.068 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -96.58 164.72 12.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.897 ' HB ' HG11 ' A' ' 31' ' ' VAL . 1.3 p -87.32 159.15 18.87 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.167 -0.958 . . . . 0.0 110.14 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -121.04 120.37 4.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.583 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 10.0 m 50.42 102.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -1.124 . . . . 0.0 110.544 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' THR . 90.5 m-20 41.26 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.441 -0.787 . . . . 0.0 110.675 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.583 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -149.0 52.45 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 0.0 110.454 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 4.2 tmtt? -123.74 -24.31 4.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.926 . . . . 0.0 110.34 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.762 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.6 m-85 -138.15 -158.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.371 -0.831 . . . . 0.0 109.37 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 168.83 165.77 26.77 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.267 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.569 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 10.2 t80 -122.84 158.53 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.564 -0.962 . . . . 0.0 109.38 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.897 HG21 HD12 ' A' ' 22' ' ' ILE . 3.7 t -149.72 144.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.112 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 2.9 m-20 -114.31 139.18 49.65 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.696 ' HE2' HD21 ' A' ' 20' ' ' LEU . 17.8 m-85 -104.15 173.81 6.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.442 -0.786 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.695 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.16 13.48 15.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 111.577 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.535 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.7 p -171.82 173.87 4.39 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.207 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.51 -24.32 42.32 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.98 -25.2 32.5 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.989 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.866 ' OD1' HD12 ' A' ' 47' ' ' LEU . 4.8 t0 -83.12 -25.55 31.83 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.784 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.7 tm? -82.73 -31.24 28.56 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.69 -34.68 62.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.581 -0.699 . . . . 0.0 109.529 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.833 ' HG2' HD21 ' A' ' 47' ' ' LEU . 1.5 tppt? -78.56 -28.4 45.94 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.686 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -70.06 -25.99 63.8 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.473 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -72.96 -48.65 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.604 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -5.77 45.12 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.176 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -75.85 6.31 5.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.491 -0.755 . . . . 0.0 110.446 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -65.27 -8.42 17.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.074 -1.016 . . . . 0.0 110.312 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.24 29.55 8.1 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.148 HD22 HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.31 117.1 30.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -1.057 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -112.47 93.39 4.42 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.944 1.354 . . . . 0.0 109.381 178.597 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.747 HG13 ' HB1' ' A' ' 37' ' ' ALA . 23.5 t -46.66 -113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.269 -2.93 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.29 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 21.9 m-85 -80.31 47.57 0.93 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 120.705 -1.247 . . . . 0.0 109.673 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 81' ' ' LYS . . . 81.29 26.34 52.22 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.517 ' O ' ' ND2' ' A' ' 85' ' ' ASN . 7.9 p-10 -137.63 74.94 1.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -1.102 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.5 tm-20 -43.05 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.666 HD13 ' N ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -54.13 127.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.512 0.673 . . . . 0.0 110.402 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 23' ' ' GLY . 4.4 mttt -102.54 129.84 49.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.802 . . . . 0.0 109.577 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.487 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -111.18 172.99 6.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.964 -1.085 . . . . 0.0 110.685 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -168.23 166.81 12.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.751 . . . . 0.0 109.995 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -86.51 110.23 30.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HG3' ' OH ' ' A' ' 62' ' ' TYR . 46.6 Cg_endo -73.33 -172.27 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.975 1.513 . . . . 0.0 110.471 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -84.48 168.17 15.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 110.176 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.55 -67.9 0.58 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -75.45 -17.95 60.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -1.165 . . . . 0.0 110.235 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 1.6 m-20 49.13 -170.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.885 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 98' ' ' THR . . . -71.57 97.96 0.73 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -41.99 -93.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -1.154 . . . . 0.0 110.459 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.498 ' H ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER -89.42 -46.11 8.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 110.229 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.25 177.89 30.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.394 -1.063 . . . . 0.0 110.219 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.12 64.77 1.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.281 -1.129 . . . . 0.0 110.167 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 13.6 t-160 -151.84 44.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 tpp -122.15 11.92 10.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.186 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tp -84.44 137.84 33.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 110.213 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' OE1' ' N ' ' A' ' 6' ' ' GLU . 3.0 pm0 -129.13 63.37 1.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 110.252 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.16 93.69 40.83 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.205 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.92 79.77 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.002 1.528 . . . . 0.0 110.398 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.0 p -144.44 63.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.96 155.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.213 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.55 52.95 0.31 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 m -141.75 83.74 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -1.219 . . . . 0.0 110.239 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -170.72 29.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.574 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 8.1 t 46.55 -175.14 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 121.23 0.538 . . . . 0.0 110.358 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t -74.69 -14.56 60.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.867 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.819 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -135.34 164.95 40.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.1 Cg_endo -77.24 -38.49 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.167 1.614 . . . . 0.0 110.53 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.3 m-85 -94.24 107.14 19.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.572 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.574 ' ND2' ' HB3' ' A' ' 14' ' ' SER . 24.8 m-20 -136.41 154.3 50.83 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.356 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.866 HD22 ' N ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -170.51 -176.71 2.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 110.809 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.866 ' N ' HD22 ' A' ' 20' ' ' LEU . 4.5 t80 -105.04 146.74 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.507 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 20' ' ' LEU . 1.5 mt -141.09 149.76 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -149.36 -156.22 7.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.868 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 1.5 t-20 67.52 41.59 2.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -1.022 . . . . 0.0 110.027 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 34' ' ' LEU . 3.6 mm? -84.73 -167.82 1.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -119.98 107.3 40.09 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HG3' ' A' ' 58' ' ' ARG . 44.9 Cg_endo -73.25 -5.0 16.41 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.082 1.569 . . . . 0.0 110.324 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.78 -18.69 50.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.735 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 -155.51 0.58 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.554 -0.716 . . . . 0.0 109.709 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.607 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.21 141.28 32.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -0.999 . . . . 0.0 110.51 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 58' ' ' ARG . 3.3 t -65.48 -29.86 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.178 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -65.84 -38.67 89.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.849 . . . . 0.0 109.047 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 63.6 mm-40 -67.12 -30.73 70.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 25' ' ' LEU . 3.9 mm? -66.53 -40.61 89.2 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.382 -0.824 . . . . 0.0 108.917 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.614 ' HG2' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -58.4 -53.3 59.83 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.362 -0.836 . . . . 0.0 108.911 178.822 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -65.27 -30.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.45 -29.63 70.88 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.534 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.658 HD11 HG21 ' A' ' 87' ' ' ILE . 12.9 mm -84.04 -28.55 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.198 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.966 ' HA ' HG21 ' A' ' 49' ' ' VAL . 31.0 t -80.05 -27.83 39.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 108.893 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.526 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 2.8 tm-20 -81.88 -36.32 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.377 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.107 ' CD2' HD13 ' A' ' 80' ' ' LEU . 5.0 tp -70.96 -31.08 67.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.077 ' CE1' HD13 ' A' ' 77' ' ' LEU . 3.5 m-30 -90.98 -14.88 30.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.481 -0.762 . . . . 0.0 109.393 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -90.02 -27.27 19.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.405 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.43 -22.22 20.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.811 . . . . 0.0 109.225 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.4 m-80 -79.59 -58.99 2.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.684 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.2 m-20 148.03 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.143 0.497 . . . . 0.0 110.153 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.901 HD11 ' HB3' ' A' ' 73' ' ' LYS . 6.3 mp -103.4 -158.17 0.65 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.69 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.87 64.28 0.46 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.966 HG21 ' HA ' ' A' ' 39' ' ' SER . 9.5 m -53.08 118.01 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.995 0.903 . . . . 0.0 109.761 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.8 t -89.54 -39.12 12.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.064 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.488 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -150.22 158.12 43.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.698 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.739 HG23 HG22 ' A' ' 63' ' ' VAL . 9.8 p -144.07 159.97 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.43 -0.794 . . . . 0.0 109.594 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -155.55 164.08 39.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 110.104 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.549 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -116.83 154.89 29.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 110.513 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -123.71 127.84 6.69 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.9 m 71.31 -171.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.384 -1.068 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.696 ' H ' HG22 ' A' ' 56' ' ' THR . 3.7 p30 -48.67 -53.0 20.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.556 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.656 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -179.41 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.115 -0.991 . . . . 0.0 110.565 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -126.73 -22.87 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.561 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.576 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.6 m-85 -122.57 -177.18 3.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.937 . . . . 0.0 109.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . 176.54 135.43 2.16 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.235 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.731 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -98.09 169.53 9.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.989 . . . . 0.0 109.423 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.739 HG22 HG23 ' A' ' 52' ' ' VAL . 17.6 t -158.82 162.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.139 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -130.99 140.6 50.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.697 -0.627 . . . . 0.0 109.479 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.789 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 16.8 m-85 -110.87 174.64 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.845 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.668 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.84 11.53 19.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.498 -0.751 . . . . 0.0 111.309 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.645 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.6 p -173.08 173.51 3.65 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.26 1.029 . . . . 0.0 112.185 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' N ' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.64 -23.56 45.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -84.44 -23.69 29.86 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.277 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 4.4 t0 -83.69 -26.94 29.39 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 71' ' ' LEU . 9.8 tt -81.4 -33.98 31.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.266 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -74.96 -32.96 61.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.456 -0.777 . . . . 0.0 109.621 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.901 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -81.47 -23.19 37.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.789 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.99 -29.94 63.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.66 HD13 ' C ' ' A' ' 75' ' ' LEU . 3.1 tm? -75.96 -45.53 34.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -66.94 -23.39 65.96 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.435 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.077 HD13 ' CE1' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -67.57 -8.05 31.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.55 0.691 . . . . 0.0 110.391 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 87' ' ' ILE . 22.2 m -67.4 0.37 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.646 -0.659 . . . . 0.0 111.556 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.1 16.93 54.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.107 HD13 ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -103.09 -159.12 0.71 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.988 . . . . 0.0 110.541 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -164.76 49.67 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.344 1.068 . . . . 0.0 108.914 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG21 HG23 ' A' ' 87' ' ' ILE . 17.0 t 0.35 -115.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.769 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 4.0 m-30 -76.81 9.32 2.93 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 128.51 35.34 0.5 Allowed Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.522 ' CA ' ' HG3' ' A' ' 81' ' ' LYS . 12.2 m120 -161.73 100.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 109.565 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.586 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -49.55 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.308 -0.87 . . . . 0.0 110.406 -179.212 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.749 HG23 HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -42.71 143.13 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 5.5 mtpp -119.26 159.68 23.63 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.596 -0.69 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -112.82 -179.2 3.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 110.226 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 1.3 tt0 -168.89 148.56 4.22 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.744 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 17.3 mttm -99.8 102.19 16.38 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 110.311 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.4 Cg_endo -73.19 -171.92 0.9 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.98 1.516 . . . . 0.0 110.352 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -63.48 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.43 67.47 3.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.48 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -1.158 . . . . 0.0 110.118 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -68.99 157.26 37.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.227 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.86 -155.61 27.02 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 p -118.07 -147.67 0.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -1.089 . . . . 0.0 110.191 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.45 -16.3 14.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.194 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.99 98.88 0.23 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.41 103.07 4.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -1.164 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.95 38.53 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.206 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.45 112.46 10.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.927 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 6' ' ' GLU . 2.3 pp -62.81 -170.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 0.0 110.16 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.704 ' N ' HD12 ' A' ' 5' ' ' LEU . 2.6 pt-20 -150.53 -164.51 2.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.8 58.45 17.86 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.181 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.91 79.78 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.987 1.52 . . . . 0.0 110.428 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.6 p -153.69 128.7 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.263 0.554 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.97 -172.61 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 0.0 110.219 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.47 62.7 0.38 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.39 37.06 2.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -1.125 . . . . 0.0 110.196 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -145.74 95.79 2.7 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.267 -0.896 . . . . 0.0 109.785 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.505 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -65.91 169.63 6.44 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 121.204 0.526 . . . . 0.0 110.222 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 16' ' ' THR . 5.7 t -115.95 -23.73 8.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.115 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.928 ' CG2' HG11 ' A' ' 50' ' ' VAL . 39.1 p -105.6 161.85 21.53 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.4 Cg_endo -74.85 -25.45 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.083 1.57 . . . . 0.0 110.762 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.711 ' CD1' HD22 ' A' ' 71' ' ' LEU . 97.6 m-85 -102.2 110.16 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.973 -1.079 . . . . 0.0 110.567 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' ' 14' ' ' SER . 2.0 m120 -140.88 149.75 42.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.712 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -163.72 -175.97 4.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 8.2 t80 -118.4 144.53 45.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.542 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 mt -127.46 157.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.196 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.96 -169.68 11.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.714 ' C ' HD22 ' A' ' 25' ' ' LEU . 42.1 t30 72.67 71.8 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.562 -0.963 . . . . 0.0 110.132 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.983 HD13 HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -110.59 157.78 19.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 110.268 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.519 ' ND2' ' OD1' ' A' ' 28' ' ' ASN . 39.4 t-20 -87.88 109.69 29.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.07 -28.33 12.98 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.967 1.509 . . . . 0.0 110.687 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' OD1' ' ND2' ' A' ' 26' ' ' ASN . 32.7 p30 -75.0 -13.68 60.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -110.49 -154.94 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.514 -0.741 . . . . 0.0 109.681 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.555 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.4 m -109.98 145.64 36.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.496 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.655 HG12 ' HE3' ' A' ' 35' ' ' LYS . 2.9 t -69.97 -30.95 46.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.2 -0.937 . . . . 0.0 109.389 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -67.1 -37.19 83.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.856 . . . . 0.0 109.26 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 63.2 mm-40 -68.71 -34.28 75.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.41 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.983 HD22 HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.03 -35.57 81.59 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.403 -0.811 . . . . 0.0 109.104 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.707 ' HG3' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -64.38 -48.2 76.35 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.472 -0.767 . . . . 0.0 109.25 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 32' ' ' ALA . 9.9 t -61.26 -34.61 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.703 ' CB ' HG23 ' A' ' 82' ' ' VAL . . . -62.89 -34.05 76.6 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.214 -0.929 . . . . 0.0 108.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.791 ' CD1' HD13 ' A' ' 87' ' ' ILE . 22.4 mm -81.86 -28.04 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.736 ' HA ' HG21 ' A' ' 49' ' ' VAL . 11.5 t -79.02 -27.68 43.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.049 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.16 -39.15 23.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.601 0.715 . . . . 0.0 109.125 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.714 HD22 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.08 -32.73 74.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.923 ' CD2' HD23 ' A' ' 47' ' ' LEU . 9.3 m-85 -86.31 -19.16 30.26 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.393 -0.817 . . . . 0.0 109.212 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.48 -26.37 20.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.766 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -91.8 -19.14 22.87 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.485 -0.76 . . . . 0.0 109.051 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.617 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -81.89 -59.48 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.601 -0.687 . . . . 0.0 109.483 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.4 m-20 147.41 30.61 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.15 0.5 . . . . 0.0 110.002 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.923 HD23 ' CD2' ' A' ' 42' ' ' PHE . 3.4 mp -103.59 -157.06 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.41 65.29 0.44 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 39' ' ' SER . 5.8 m -53.17 117.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.935 0.874 . . . . 0.0 109.904 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.928 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.24 -44.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.164 0.506 . . . . 0.0 109.943 -179.489 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 13.2 t70 -138.78 149.53 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 35' ' ' LYS . 2.4 t -152.3 102.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.78 . . . . 0.0 109.466 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 62' ' ' TYR . 64.1 mtm180 -114.37 168.83 9.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.089 -1.007 . . . . 0.0 110.466 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.629 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.3 p -76.35 179.02 6.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -138.73 131.63 5.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.9 HG22 ' OD1' ' A' ' 57' ' ' ASN . 53.5 m 57.32 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.9 ' OD1' HG22 ' A' ' 56' ' ' THR . 23.0 p-10 -161.0 90.54 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 110.489 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.3 ttp180 53.27 19.84 1.68 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -113.01 -30.0 7.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.689 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.0 m-85 -138.6 -177.74 5.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -159.83 135.47 4.13 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.193 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.684 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 2.6 m-85 -91.47 154.78 18.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -1.15 . . . . 0.0 109.635 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 52' ' ' VAL . 3.7 t -151.78 143.7 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.843 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.79 143.51 47.81 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.428 -0.795 . . . . 0.0 109.58 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.946 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 53.8 m-85 -108.2 173.48 6.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.946 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.722 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.25 16.68 14.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 111.622 -178.031 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 2.4 t -165.18 175.68 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.729 1.252 . . . . 0.0 112.216 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.544 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -88.23 -25.41 22.88 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.451 ' OE1' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.86 -21.65 26.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 9.4 t0 -84.0 -31.01 25.71 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.711 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.7 tp -75.16 -35.57 61.59 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.482 0.658 . . . . 0.0 109.336 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.86 -37.87 67.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.698 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 1.039 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.05 -26.74 56.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.33 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.946 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.05 -26.77 61.4 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.949 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -70.94 -47.16 60.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.73 -15.78 63.21 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.748 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.2 mm? -73.22 1.37 9.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.586 -0.696 . . . . 0.0 110.246 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.99 ' OG1' HD13 ' A' ' 89' ' ' LEU . 38.7 m -76.29 4.13 9.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.584 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.97 19.22 33.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.006 HD21 HD11 ' A' ' 87' ' ' ILE . 2.5 pp -100.33 122.65 43.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.217 -1.167 . . . . 0.0 110.56 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 85' ' ' ASN . 2.2 ttmt -82.9 81.55 8.56 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.905 1.336 . . . . 0.0 110.147 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.774 HG22 ' N ' ' A' ' 83' ' ' PHE . 1.7 p -36.32 -98.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.27 -2.851 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.774 ' N ' HG22 ' A' ' 82' ' ' VAL . 2.2 m-30 -91.29 20.67 4.96 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.026 -1.046 . . . . 0.0 110.533 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.554 ' CA ' ' HG2' ' A' ' 81' ' ' LYS . . . 120.77 23.16 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.584 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 1.9 m-20 -155.58 100.04 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 0.0 109.745 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -42.69 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.085 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.006 HD11 HD21 ' A' ' 80' ' ' LEU . 6.1 pt -42.89 154.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.278 -0.889 . . . . 0.0 110.575 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -121.66 157.92 29.8 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.76 -0.588 . . . . 0.0 109.457 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.99 HD13 ' OG1' ' A' ' 78' ' ' THR . 7.7 mp -112.0 -179.04 3.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.058 -1.026 . . . . 0.0 110.488 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 2.2 tt0 -166.25 153.52 9.78 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.659 -0.651 . . . . 0.0 110.159 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.28 97.6 10.4 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.227 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.9 Cg_endo -72.84 -171.57 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.931 1.49 . . . . 0.0 110.459 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt 44.74 27.73 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 110.166 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.99 -154.06 11.98 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -135.07 -81.82 0.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -1.148 . . . . 0.0 110.2 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 8.9 m-20 56.76 -163.63 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 110.248 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.01 -162.12 16.96 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.64 -34.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -1.136 . . . . 0.0 110.464 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -66.0 99.49 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.214 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.36 -70.42 0.12 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.164 . . . . 0.0 110.215 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 p -121.64 20.31 11.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.18 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.419 ' O ' ' HB2' ' A' ' 4' ' ' MET . 2.8 p-80 -175.0 164.08 3.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 110.19 -179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER 59.21 55.04 4.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.163 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.1 mm? -57.8 87.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.208 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 4' ' ' MET . 15.5 pt-20 -174.95 124.61 0.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.222 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.64 147.06 41.29 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.202 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.93 79.62 1.62 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.959 1.505 . . . . 0.0 110.299 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -170.63 140.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.221 0.534 . . . . 0.0 110.17 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.91 159.52 28.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.266 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.57 -24.14 11.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -96.76 38.71 1.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -1.137 . . . . 0.0 110.184 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.45 29.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -174.6 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.211 0.529 . . . . 0.0 110.239 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 15' ' ' THR . 7.9 m -111.55 1.54 16.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.785 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -171.15 164.32 4.99 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.41 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.7 Cg_endo -77.98 -27.21 5.93 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.201 1.632 . . . . 0.0 110.715 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 87.3 m-85 -110.24 116.73 32.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.6 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 5.9 m120 -142.8 157.01 45.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -0.809 . . . . 0.0 109.73 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.824 HD23 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -164.3 168.33 18.84 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.478 -0.763 . . . . 0.0 110.192 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.565 ' N ' HD22 ' A' ' 20' ' ' LEU . 45.6 t80 -102.6 157.24 17.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 11.4 mt -126.68 165.89 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -160.01 106.59 0.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.625 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 7.9 t-20 147.5 66.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.092 HD13 HD22 ' A' ' 34' ' ' LEU . 4.6 mm? -98.44 133.54 42.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 110.958 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.585 ' HB2' HD11 ' A' ' 34' ' ' LEU . 9.6 t-20 -58.36 113.11 5.9 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.706 -0.621 . . . . 0.0 109.946 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.76 -36.91 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.901 1.474 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -74.87 -16.27 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.623 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.574 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 4.1 mmtt -110.4 -155.2 0.56 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.694 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -122.01 148.52 44.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.986 HG13 ' CD1' ' A' ' 25' ' ' LEU . 2.5 t -69.62 -35.52 66.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.244 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -54.98 -44.7 74.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 108.906 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 20.8 mm-40 -61.88 -44.77 96.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.092 HD22 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.26 -31.29 65.42 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.828 ' HD2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.87 -60.71 3.41 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.777 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 83.7 t -58.47 -40.48 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.54 -0.725 . . . . 0.0 109.07 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.69 -33.03 73.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 34' ' ' LEU . 23.8 mt -80.32 -30.23 12.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.562 -0.711 . . . . 0.0 109.138 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 1.4 t -77.42 -27.28 52.27 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.634 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -84.02 -40.92 17.81 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.534 0.683 . . . . 0.0 109.414 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.109 HD21 HD22 ' A' ' 80' ' ' LEU . 6.2 tp -61.75 -35.29 77.67 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.142 ' CE2' HD13 ' A' ' 77' ' ' LEU . 7.3 m-85 -84.62 -22.63 29.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -72.23 -34.81 68.6 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.556 0.694 . . . . 0.0 109.285 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HE2' ' OE1' ' A' ' 40' ' ' GLU . 9.6 mtmt -78.08 -17.81 56.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.442 -0.787 . . . . 0.0 109.242 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.614 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -88.46 -16.26 33.25 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.583 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 88.86 30.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.884 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -82.1 -138.3 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -178.95 57.39 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 49' ' ' VAL . 21.0 m -50.96 117.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.834 0.826 . . . . 0.0 110.033 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.785 HG21 HG21 ' A' ' 16' ' ' THR . 0.5 OUTLIER -89.22 -45.31 15.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-O 121.226 0.536 . . . . 0.0 109.94 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -143.69 160.22 41.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.781 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.828 HG12 ' HD2' ' A' ' 35' ' ' LYS . 2.5 t -152.4 157.49 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.848 . . . . 0.0 109.494 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.09 164.25 33.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.206 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.474 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.9 p -91.83 156.18 17.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 110.847 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.579 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.57 129.51 9.34 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.752 HG21 ' HD2' ' A' ' 59' ' ' LYS . 2.6 m 59.61 13.59 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.99 . . . . 0.0 109.39 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER 70.66 15.75 6.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 111.328 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 168.19 -21.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.807 -1.183 . . . . 0.0 111.543 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HD2' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -89.06 -65.34 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.929 -1.107 . . . . 0.0 111.728 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 1.2 m-85 -103.66 -148.53 0.39 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.043 -1.035 . . . . 0.0 110.617 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 178.62 -179.85 48.63 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.583 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 40.9 t80 -151.96 150.44 30.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.801 HG22 HG13 ' A' ' 52' ' ' VAL . 4.0 t -150.69 153.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.219 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' OD1' ' CZ ' ' A' ' 62' ' ' TYR . 3.6 m-20 -122.27 138.03 54.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 66.4 m-85 -104.66 172.32 6.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 109.912 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.765 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -117.52 17.11 14.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 111.254 -178.657 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 14.8 p -167.6 173.4 8.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.563 1.173 . . . . 0.0 112.314 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -76.33 -25.31 54.61 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -76.55 -27.73 56.01 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.518 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.605 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 87.8 m-20 -79.92 -30.35 39.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 12.6 tp -71.82 -38.73 70.15 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.297 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -71.48 -30.88 66.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.741 . . . . 0.0 109.621 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . 33.7 mmtt -83.49 -27.2 29.59 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.636 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.8 -30.93 71.64 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.507 ' O ' HD13 ' A' ' 75' ' ' LEU . 0.7 OUTLIER -78.06 -44.28 26.8 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -21.64 59.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.363 -0.836 . . . . 0.0 109.494 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.142 HD13 ' CE2' ' A' ' 42' ' ' PHE . 2.9 mt -72.19 -4.9 32.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' THR . . . . . 1.027 ' OG1' HD11 ' A' ' 89' ' ' LEU . 32.3 m -71.47 2.27 5.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 110.956 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.94 -3.15 56.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.109 HD22 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -91.34 135.59 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 110.346 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.51 76.06 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.998 0.904 . . . . 0.0 110.573 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.885 ' HB ' HG23 ' A' ' 87' ' ' ILE . 3.4 t -43.17 129.28 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER 46.34 22.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.518 -179.016 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.95 17.62 43.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.3 m120 -133.89 110.35 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.052 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 29.2 tt0 -58.05 81.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.099 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 82' ' ' VAL . 2.7 pt -43.84 123.69 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.454 -0.779 . . . . 0.0 110.406 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.6 mtpm? -106.72 132.75 52.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.46 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.027 HD11 ' OG1' ' A' ' 78' ' ' THR . 0.0 OUTLIER -121.69 179.25 4.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.944 -1.098 . . . . 0.0 111.329 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -176.89 148.82 0.68 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.641 -0.662 . . . . 0.0 109.616 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 1.5 mttp -59.27 112.98 5.91 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.277 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 46.1 Cg_endo -73.07 -174.31 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.988 1.52 . . . . 0.0 110.4 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER 42.78 77.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.168 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -130.17 7.96 6.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 21.7 ttt180 -114.57 56.26 0.73 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 0.0 110.257 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -54.81 154.38 5.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -146.2 63.21 0.45 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 97' ' ' GLY . 2.7 p 42.43 -155.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -1.112 . . . . 0.0 110.243 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -134.33 34.7 3.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.2 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.94 156.92 22.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.1 m . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.231 -1.158 . . . . 0.0 110.175 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 p -76.08 -45.08 35.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -1.108 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -139.87 128.0 22.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.93 8.57 30.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.203 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -70.86 159.3 34.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 110.194 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.611 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.5 mm-40 -135.49 -178.34 5.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 31.7 p30 -144.14 138.58 15.04 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.18 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.1 79.8 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.975 1.513 . . . . 0.0 110.394 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.1 p -91.89 54.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.286 0.565 . . . . 0.0 110.226 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.48 173.5 6.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.27 81.28 0.4 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.49 51.75 1.35 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -1.141 . . . . 0.0 110.247 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -91.81 28.14 1.88 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.97 0.891 . . . . 0.0 110.325 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.09 -170.29 1.85 Allowed 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.828 -0.545 . . . . 0.0 110.208 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.838 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m -80.59 -10.85 59.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.138 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 15' ' ' THR . 1.1 p -164.79 154.6 11.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 110.734 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 65' ' ' PHE . 51.3 Cg_endo -76.78 -39.82 0.62 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.205 1.634 . . . . 0.0 110.585 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.568 ' CE2' ' CA ' ' A' ' 68' ' ' ALA . 94.4 m-85 -121.57 119.92 33.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.796 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 18' ' ' PHE . 15.5 m-20 -139.94 152.39 46.32 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.33 -0.856 . . . . 0.0 109.411 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.0 pp -164.09 -175.0 3.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 6.1 t80 -109.34 141.91 41.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.492 -0.755 . . . . 0.0 110.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 88' ' ' LYS . 1.0 OUTLIER -122.05 160.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.82 -175.87 14.08 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.58 ' C ' HD22 ' A' ' 25' ' ' LEU . 11.9 t30 71.52 54.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.437 -1.037 . . . . 0.0 110.506 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.3 mm? -105.35 129.05 53.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.958 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 34.5 t-20 -40.54 100.6 0.22 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.72 -0.612 . . . . 0.0 110.502 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -73.73 -17.22 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.074 1.565 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.92 -14.8 40.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.721 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 8.5 mmtt -106.27 -157.79 0.63 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.496 -0.753 . . . . 0.0 109.554 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -106.25 142.88 35.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.765 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.908 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.7 t -66.1 -22.85 30.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.639 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -67.58 -38.96 84.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' OE2' ' CD1' ' A' ' 83' ' ' PHE . 1.8 pt-20 -65.67 -38.3 88.91 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 31' ' ' VAL . 50.9 mt -60.98 -36.09 78.51 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.43 -60.49 3.71 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 28.7 t -60.51 -32.74 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -64.8 -38.07 89.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 108.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.572 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 24.5 mt -80.07 -24.46 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.413 -0.804 . . . . 0.0 108.995 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.801 ' HA ' HG21 ' A' ' 49' ' ' VAL . 7.8 p -80.13 -30.74 39.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 109.053 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.93 -40.73 21.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.562 0.696 . . . . 0.0 109.609 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.87 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -65.53 -35.05 79.71 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 109.178 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.733 ' HD2' HD22 ' A' ' 47' ' ' LEU . 9.2 m-85 -83.0 -21.64 33.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.43 -24.7 57.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' NZ ' ' OE1' ' A' ' 40' ' ' GLU . 9.5 mttp -104.17 -17.23 14.97 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.587 -0.695 . . . . 0.0 109.519 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.674 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -81.3 -21.87 38.99 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.369 -0.832 . . . . 0.0 109.934 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.674 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.5 t0 99.34 29.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.733 HD22 ' HD2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -100.93 -149.85 0.38 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.44 61.23 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.801 HG21 ' HA ' ' A' ' 39' ' ' SER . 6.5 m -50.9 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.001 0.905 . . . . 0.0 110.133 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.692 ' HB ' HG21 ' A' ' 16' ' ' THR . 2.8 t -89.04 -35.68 7.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.264 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 8.4 t0 -146.85 156.18 42.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.116 -0.99 . . . . 0.0 111.229 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.593 ' CG1' ' CG ' ' A' ' 35' ' ' LYS . 14.8 p -153.17 146.59 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -149.59 166.54 28.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.908 HG22 ' CG1' ' A' ' 31' ' ' VAL . 15.7 p -87.75 160.45 18.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 110.528 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -125.63 126.0 5.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.8 m 59.34 -166.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -1.078 . . . . 0.0 110.073 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.706 ' H ' HG22 ' A' ' 56' ' ' THR . 0.7 OUTLIER -41.76 -65.78 0.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.402 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.642 ' HG3' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -173.89 51.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -124.47 -23.34 4.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.935 . . . . 0.0 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.925 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -124.6 -177.05 3.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -168.0 141.75 7.03 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.866 ' O ' HG23 ' A' ' 63' ' ' VAL . 48.2 t80 -94.62 169.07 10.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -1.151 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 62' ' ' TYR . 2.4 t -163.64 163.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.482 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -137.07 144.63 43.25 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.802 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 31.8 m-85 -108.25 176.58 5.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.608 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -109.77 16.37 22.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 111.584 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p 178.17 178.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.139 . . . . 0.0 112.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.568 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.05 -23.28 52.04 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -26.2 41.06 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.361 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.693 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 85.9 m-20 -83.01 -28.0 29.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.6 tm? -77.96 -34.19 51.19 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.827 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.49 -40.05 62.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.849 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.788 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.03 -30.63 61.12 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.802 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.16 -28.48 67.33 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 89' ' ' LEU . 5.7 tt -69.79 -45.18 68.54 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -12.47 60.68 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.164 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.993 HD12 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -76.07 4.62 8.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.54 -0.725 . . . . 0.0 109.939 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' THR . . . . . 1.025 ' OG1' HD21 ' A' ' 89' ' ' LEU . 11.1 m -72.89 1.18 9.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.115 -0.991 . . . . 0.0 110.552 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -106.2 1.42 37.79 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.039 HD21 HD11 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -84.8 124.0 31.07 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.151 -1.205 . . . . 0.0 111.257 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 82' ' ' VAL . 32.2 mtpt -83.38 84.33 7.55 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.908 0.861 . . . . 0.0 109.189 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.972 ' CG1' HG23 ' A' ' 87' ' ' ILE . 1.2 p -34.76 -94.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.798 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -98.56 31.89 2.73 Favored 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.138 -0.976 . . . . 0.0 109.427 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' C ' ' HE3' ' A' ' 81' ' ' LYS . . . 108.35 15.51 13.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.647 ' O ' HG12 ' A' ' 82' ' ' VAL . 5.1 m120 -143.42 98.18 3.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -1.039 . . . . 0.0 109.528 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 35.1 tt0 -41.72 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.476 -0.765 . . . . 0.0 110.548 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.039 HD11 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.25 145.39 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.697 ' HA ' HG23 ' A' ' 78' ' ' THR . 18.5 tttt -120.87 155.77 33.42 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.566 -0.708 . . . . 0.0 109.904 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.025 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -120.38 171.35 8.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -171.95 127.82 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -61.33 110.58 3.2 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 49.4 Cg_endo -78.84 -170.05 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.927 1.488 . . . . 0.0 110.451 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 18.4 tptp 48.78 52.83 13.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.288 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . -94.21 -66.58 1.03 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER 48.77 -174.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -1.132 . . . . 0.0 110.241 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 41.8 p-10 -78.52 -157.34 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.24 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -131.38 63.44 0.63 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -42.63 -32.72 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -1.144 . . . . 0.0 110.406 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -172.02 81.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 110.248 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.64 -171.13 52.11 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.247 -1.149 . . . . 0.0 110.231 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 4' ' ' MET . 1.4 p 59.57 -163.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -1.163 . . . . 0.0 110.217 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 4' ' ' MET . 47.8 m170 53.49 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 2' ' ' SER . 5.0 ptp -177.66 136.88 0.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.139 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.43 108.34 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.224 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.05 62.98 6.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.177 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.578 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -69.12 -60.52 4.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.166 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 49.4 Cg_endo -71.43 -157.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.996 1.524 . . . . 0.0 110.067 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' PRO . 95.9 t 51.7 104.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.781 -0.575 . . . . 0.0 110.196 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 54.59 -165.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.207 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.78 -4.97 63.02 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 1.1 p -117.76 5.58 12.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -1.198 . . . . 0.0 110.28 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.527 ' HB3' ' O ' ' A' ' 12' ' ' SER . 72.2 tt0 68.36 122.11 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 122.767 1.27 . . . . 0.0 110.386 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.62 178.6 6.46 Favored 'General case' 0 C--N 1.276 -2.603 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.177 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.798 ' O ' HG23 ' A' ' 16' ' ' THR . 4.3 m -88.42 -6.9 57.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.118 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.812 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -172.2 162.53 4.35 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.525 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.0 Cg_endo -79.95 -25.96 4.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.187 1.625 . . . . 0.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.4 m-85 -116.25 119.7 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 0.0 110.951 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 30.2 m-20 -135.42 171.0 15.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.211 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.655 HD12 ' CE2' ' A' ' 65' ' ' PHE . 11.2 mt -156.44 165.89 35.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 111.137 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -97.96 157.59 16.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.977 HG22 HD21 ' A' ' 25' ' ' LEU . 65.2 mt -149.39 146.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.323 -0.861 . . . . 0.0 110.121 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.92 179.91 22.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 48.1 t30 71.15 23.35 4.15 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.495 -1.003 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.005 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.1 mm? -68.37 122.93 19.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.567 ' O ' HD11 ' A' ' 34' ' ' LEU . 28.1 t-20 -41.09 100.85 0.23 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.654 -0.653 . . . . 0.0 110.421 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.8 Cg_endo -75.69 -26.51 9.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.071 1.564 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -74.69 -24.1 58.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.966 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.7 mmtt -90.9 -154.45 0.35 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.603 -0.686 . . . . 0.0 109.72 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.1 m -101.9 143.83 31.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.764 ' CG1' HG21 ' A' ' 54' ' ' THR . 3.7 t -69.0 -31.02 48.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.7 -33.7 76.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.118 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 66.0 mm-40 -70.66 -36.58 73.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 109.359 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.005 HD13 ' HB3' ' A' ' 25' ' ' LEU . 42.3 mt -63.24 -34.57 77.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.442 -0.786 . . . . 0.0 109.061 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.715 ' HZ2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -64.94 -55.84 16.78 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.213 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.5 t -58.3 -40.78 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 0.0 109.385 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.727 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -59.32 -29.07 67.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.97 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.474 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 47.0 mt -83.95 -32.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.385 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.7 t -79.27 -23.14 43.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.97 -39.31 17.04 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.947 HD21 ' HB3' ' A' ' 80' ' ' LEU . 4.9 tp -63.45 -36.89 85.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.56 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 10.2 m-85 -83.56 -22.02 32.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.43 -21.76 45.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.97 -20.43 14.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.675 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -82.48 -21.12 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.459 -0.776 . . . . 0.0 109.788 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.675 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.3 t70 98.61 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.868 0.842 . . . . 0.0 108.891 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.937 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -91.33 -145.28 0.19 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -177.33 61.01 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.9 m -63.24 115.44 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 122.012 0.91 . . . . 0.0 110.317 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.812 ' CB ' HG21 ' A' ' 16' ' ' THR . 19.6 t -82.0 -23.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.509 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.783 ' CG ' HG21 ' A' ' 15' ' ' THR . 0.2 OUTLIER -155.79 155.67 33.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 0.0 110.673 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.715 HG12 ' HZ2' ' A' ' 35' ' ' LYS . 3.4 t -152.87 128.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.805 . . . . 0.0 109.963 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -128.51 178.64 6.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.764 HG21 ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -149.98 151.49 33.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 110.691 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 56' ' ' THR . . . -173.0 -160.86 22.38 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 56' ' ' THR . 5.7 m 57.07 85.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -1.042 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.3 m-20 39.58 48.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.446 -0.784 . . . . 0.0 110.936 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 10.1 ptm180 37.44 35.51 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.577 -0.702 . . . . 0.0 111.004 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 25' ' ' LEU . 20.0 tttt -121.92 -19.26 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 110.193 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -124.53 170.36 10.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -163.35 172.8 39.39 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.528 ' OH ' ' CB ' ' A' ' 92' ' ' PRO . 1.3 t80 -121.88 162.56 20.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.828 -0.807 . . . . 0.0 109.976 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.559 HG23 HG13 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -145.29 167.4 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.117 -0.989 . . . . 0.0 110.834 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.545 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 2.8 m-20 -141.69 144.1 33.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.56 -0.712 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.843 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 61.5 m-85 -118.3 -178.55 3.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 7.5 pt-20 -113.96 8.93 17.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.477 -0.764 . . . . 0.0 111.016 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.653 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 32.1 p -167.81 176.1 6.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.572 1.177 . . . . 0.0 112.423 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.34 -24.32 50.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -28.69 57.75 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.364 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.697 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.0 m-20 -82.54 -27.78 31.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -72.56 -37.34 68.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.876 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.02 -38.47 61.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 109.979 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.955 ' O ' HD23 ' A' ' 77' ' ' LEU . 11.2 ttmm -76.68 -25.75 54.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.843 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -69.77 -31.75 69.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.461 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.6 tt -70.86 -43.11 69.15 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -10.58 59.94 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.163 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.955 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -72.48 1.82 7.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.549 -0.72 . . . . 0.0 110.658 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.565 ' CA ' HD21 ' A' ' 89' ' ' LEU . 15.4 m -78.52 6.07 9.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.36 24.18 32.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.947 ' HB3' HD21 ' A' ' 41' ' ' LEU . 4.7 mt -127.11 128.14 45.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -1.188 . . . . 0.0 110.837 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 82' ' ' VAL . 21.3 mtmt -84.82 83.24 8.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.768 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.82 HG21 HG21 ' A' ' 87' ' ' ILE . 74.3 t -32.2 -98.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.063 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.667 ' N ' HG12 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -85.38 23.06 1.38 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.665 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.94 20.44 5.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 87' ' ' ILE . 66.6 m-80 -154.71 116.12 4.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -1.102 . . . . 0.0 109.363 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 1.1 pt-20 -55.56 84.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 110.14 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.82 HG21 HG21 ' A' ' 82' ' ' VAL . 24.4 pt -41.01 130.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.508 -0.745 . . . . 0.0 110.091 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 3.4 mttt -98.15 122.58 41.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.373 -0.829 . . . . 0.0 109.774 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.582 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -118.87 172.49 7.5 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.39 -0.819 . . . . 0.0 110.386 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 11.3 pt-20 -173.03 147.81 1.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.469 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -51.05 109.5 1.38 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.999 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 45.1 Cg_endo -72.18 -174.13 1.3 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.024 1.539 . . . . 0.0 110.603 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.41 -150.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 110.166 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.38 48.79 0.95 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 96' ' ' ASP . 0.9 OUTLIER 48.23 -144.48 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -1.135 . . . . 0.0 110.281 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -43.14 117.91 1.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.241 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.91 75.09 0.78 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 p -84.31 166.14 17.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -1.168 . . . . 0.0 110.272 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -127.57 34.26 4.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 110.194 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.25 18.37 56.39 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.205 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 p -114.13 137.01 52.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -1.142 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 49.67 52.19 15.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.209 -0.932 . . . . 0.0 110.183 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.413 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 26.5 mtm -64.05 -51.77 62.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.302 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 4' ' ' MET . 0.2 OUTLIER -166.89 -171.26 1.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -106.85 -88.82 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 110.161 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.5 m-20 -74.88 -58.86 1.53 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.148 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 44.1 Cg_endo -72.56 79.75 1.81 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.931 1.49 . . . . 0.0 110.427 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.74 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -101.37 57.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.821 -0.55 . . . . 0.0 110.168 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -128.41 135.2 49.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.856 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.99 57.13 0.92 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 27.2 m -123.76 -80.8 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -1.161 . . . . 0.0 110.213 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 12' ' ' SER . 12.2 tp10 170.87 124.41 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.08 0.943 . . . . 0.0 109.377 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.487 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER 28.8 -148.12 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.383 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.545 HG22 ' O ' ' A' ' 15' ' ' THR . 4.6 m -82.4 0.65 41.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.082 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.815 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.63 166.27 1.86 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.064 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 16' ' ' THR . 48.0 Cg_endo -76.15 -31.95 4.47 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.95 1.5 . . . . 0.0 110.798 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.6 m-85 -111.62 106.93 15.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.026 -1.046 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 16' ' ' THR . 43.7 m-20 -139.79 156.06 46.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.352 -0.843 . . . . 0.0 109.814 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 21' ' ' PHE . 3.5 pp -169.78 -168.55 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.288 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.627 ' N ' HD12 ' A' ' 20' ' ' LEU . 22.0 t80 -111.95 158.46 19.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 110.265 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.966 HD12 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -140.73 160.11 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.104 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -141.76 -170.66 12.53 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.517 -1.325 . . . . 0.0 109.923 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.6 t-20 73.85 34.31 0.91 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.622 -0.928 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.049 HD22 ' O ' ' A' ' 60' ' ' PHE . 7.9 mp -85.57 134.73 34.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.788 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 35.0 t-20 -60.2 109.89 2.39 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 110.464 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -74.55 -26.26 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.062 1.559 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.44 -25.11 57.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 109.897 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HE3' ' CE1' ' A' ' 83' ' ' PHE . 6.6 mmtt -91.23 -154.41 0.36 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.729 . . . . 0.0 109.665 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.61 140.79 44.62 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.682 HG12 ' HE2' ' A' ' 35' ' ' LYS . 3.0 t -67.48 -35.36 73.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.096 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -61.08 -32.23 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.181 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 65.7 mm-40 -73.45 -34.34 65.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.481 -0.762 . . . . 0.0 109.229 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.966 HD22 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -66.3 -30.37 70.77 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.375 -0.828 . . . . 0.0 109.068 179.085 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.682 ' HE2' HG12 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -68.74 -56.27 8.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.15 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -62.91 -37.44 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.55 -32.77 74.34 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.844 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 34' ' ' LEU . 13.5 mt -81.46 -28.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.475 -0.765 . . . . 0.0 109.107 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' SER . . . . . 1.024 ' HA ' HG21 ' A' ' 49' ' ' VAL . 3.6 m -77.82 -30.94 51.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.16 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.99 -37.63 33.87 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.986 HD22 HD21 ' A' ' 80' ' ' LEU . 1.1 tt -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.228 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 47' ' ' LEU . 15.3 m-85 -87.55 -17.18 32.6 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.361 -0.837 . . . . 0.0 109.363 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -88.44 -28.97 20.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.2 mttt -91.44 -20.93 21.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.768 . . . . 0.0 109.395 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.9 m120 -79.08 -58.89 3.0 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.53 -0.731 . . . . 0.0 109.633 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 148.47 29.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -108.74 -158.86 0.66 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 109.593 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -160.33 65.37 0.33 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.018 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.024 HG21 ' HA ' ' A' ' 39' ' ' SER . 11.0 m -54.59 115.44 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.811 0.815 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.815 HG11 ' CG2' ' A' ' 16' ' ' THR . 11.5 t -82.51 -35.9 13.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 121.88 -0.513 . . . . 0.0 110.482 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -152.84 164.02 38.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 0.0 110.723 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.61 HG22 ' HG3' ' A' ' 35' ' ' LYS . 5.4 p -159.0 102.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.723 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -93.87 163.34 13.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.626 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.1 p -85.05 161.68 19.62 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.313 -0.867 . . . . 0.0 110.715 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -115.33 121.8 5.4 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 9.1 m -21.54 142.39 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.605 0.717 . . . . 0.0 112.445 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 56' ' ' THR . 1.2 t-20 72.4 18.78 4.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.476 -0.765 . . . . 0.0 109.959 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.589 ' HD2' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 42.46 27.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.788 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.456 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -110.92 -17.93 13.19 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 1.049 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -130.08 -168.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.042 -1.036 . . . . 0.0 109.601 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 177.88 155.79 14.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.0 m-85 -108.9 162.18 14.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.966 HG21 HD12 ' A' ' 22' ' ' ILE . 3.2 t -150.13 143.17 17.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.891 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.13 144.97 42.28 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.547 -0.721 . . . . 0.0 109.717 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 13.1 m-85 -109.68 177.79 4.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.323 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.589 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 2.3 pp20? -114.21 8.4 16.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 111.285 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 10.0 p -175.41 177.15 1.87 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.278 1.037 . . . . 0.0 111.972 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.429 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -79.04 -22.87 44.75 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -82.22 -26.51 33.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.264 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.595 ' OD1' HD23 ' A' ' 47' ' ' LEU . 2.9 t0 -82.42 -26.61 32.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.422 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.1 tp -80.6 -33.71 35.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.62 -34.53 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.514 -0.741 . . . . 0.0 109.357 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.17 -29.08 60.32 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.51 -26.68 65.57 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.0 tt -72.98 -46.61 51.3 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -10.72 60.05 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.999 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.916 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -73.14 4.26 4.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.573 -0.705 . . . . 0.0 110.379 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 m -58.01 -14.27 6.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.54 37.69 3.33 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.011 HD13 HD11 ' A' ' 87' ' ' ILE . 4.2 mt -90.03 -168.56 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.535 -0.979 . . . . 0.0 111.159 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.587 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 17.7 mttt 170.89 53.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 108.927 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.787 HG11 HD23 ' A' ' 34' ' ' LEU . 90.7 t -24.96 -100.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.991 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.626 ' N ' HG12 ' A' ' 82' ' ' VAL . 12.7 m-85 -89.64 39.99 0.97 Allowed 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.24 24.65 28.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 7.3 p-10 -138.52 86.21 2.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.538 -0.978 . . . . 0.0 109.016 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.587 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 1.1 pt-20 -41.74 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 110.686 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 80' ' ' LEU . 3.6 pt -51.27 146.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.554 0.692 . . . . 0.0 109.942 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 22' ' ' ILE . 20.9 tptt -119.43 156.29 30.43 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 109.845 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.577 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -119.87 171.95 8.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.069 -1.019 . . . . 0.0 110.304 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -165.01 163.86 20.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.365 -0.835 . . . . 0.0 110.127 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.83 98.96 12.35 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.0 Cg_endo -73.54 -177.48 3.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.048 1.552 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 92' ' ' PRO . 17.2 ttpt 42.15 63.59 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.29 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 95' ' ' ARG . . . 156.5 -104.16 0.25 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 94' ' ' GLY . 2.1 mtt180 -42.91 155.35 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -1.121 . . . . 0.0 110.259 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.03 -157.62 0.63 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -54.02 -91.7 0.01 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -42.34 144.58 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -1.132 . . . . 0.0 110.456 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -64.87 -84.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.93 53.76 0.65 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 110.206 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -82.23 -30.11 30.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -1.152 . . . . 0.0 110.211 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -100.27 136.66 39.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 110.207 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.505 ' O ' ' N ' ' A' ' 6' ' ' GLU . 2.4 mtm -64.38 -17.15 63.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 1.1 mt 51.41 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.18 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' MET . 8.4 pt-20 176.52 50.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -131.71 69.98 81.24 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.96 79.64 1.63 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.955 1.502 . . . . 0.0 110.361 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.1 p -122.15 92.1 2.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 121.311 0.576 . . . . 0.0 110.257 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' CG ' ' OE2' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -94.44 -169.75 2.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 110.208 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 12' ' ' SER . . . -90.47 -26.63 22.58 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 2.1 p 171.33 106.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 110.147 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' OE2' ' CG ' ' A' ' 10' ' ' GLU . 15.4 mt-10 -115.4 -129.5 0.3 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.246 -0.909 . . . . 0.0 109.632 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.504 ' OG ' ' N ' ' A' ' 15' ' ' THR . 0.0 OUTLIER -107.23 -170.43 1.7 Allowed 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.695 -0.628 . . . . 0.0 110.259 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 HG23 ' A' ' 16' ' ' THR . 3.3 m -56.49 -18.99 13.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.074 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.919 ' CG2' HG11 ' A' ' 50' ' ' VAL . 69.5 p -139.78 164.28 39.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.583 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.3 Cg_endo -74.99 -21.65 15.66 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.088 1.573 . . . . 0.0 110.721 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 96.9 m-85 -106.67 113.44 26.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.037 -1.04 . . . . 0.0 110.56 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.531 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -144.76 140.59 28.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.815 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.53 -166.88 2.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.837 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.685 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 6.7 t80 -118.69 157.54 27.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.179 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.799 HG13 HD23 ' A' ' 89' ' ' LEU . 5.5 mt -145.85 151.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.44 -174.4 13.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 27.2 t30 69.84 55.28 0.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.163 -1.199 . . . . 0.0 109.998 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 60' ' ' PHE . 3.9 mm? -93.78 123.75 37.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.924 ' N ' HD21 ' A' ' 34' ' ' LEU . 58.5 t30 -42.25 101.71 0.25 Allowed Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HA ' ' HG2' ' A' ' 58' ' ' ARG . 48.2 Cg_endo -75.39 -11.47 20.79 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.065 1.561 . . . . 0.0 110.498 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -81.96 -8.5 59.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 13.4 mttt -124.95 -154.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.971 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.877 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.9 m -100.09 147.59 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.876 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.6 t -64.53 -35.16 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.535 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -51.51 68.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 109.778 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 38.5 mm-40 -56.74 -31.61 64.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.83 . . . . 0.0 109.015 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.924 HD21 ' N ' ' A' ' 26' ' ' ASN . 6.7 mp -66.27 -33.17 75.14 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.384 -0.822 . . . . 0.0 109.069 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.939 ' HD2' HG12 ' A' ' 52' ' ' VAL . 29.1 mmtt -64.72 -55.47 19.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.974 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.8 t -57.26 -32.87 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.592 -0.693 . . . . 0.0 109.552 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 82' ' ' VAL . . . -63.79 -35.62 81.21 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.822 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 82' ' ' VAL . 15.6 mm -80.05 -26.75 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.535 -0.728 . . . . 0.0 109.311 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.823 ' HA ' HG21 ' A' ' 49' ' ' VAL . 52.5 m -79.58 -30.72 41.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.921 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.2 tm-20 -80.53 -39.69 27.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.583 0.706 . . . . 0.0 109.572 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.83 -33.54 75.84 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.132 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.733 ' HE1' HD12 ' A' ' 77' ' ' LEU . 5.5 m-30 -81.82 -23.17 36.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 109.18 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.85 -27.53 44.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.027 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CD ' ' OE2' ' A' ' 40' ' ' GLU . 6.4 mtpt -87.8 -19.47 27.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.448 -0.783 . . . . 0.0 109.284 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -80.64 -60.04 2.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.562 -0.711 . . . . 0.0 109.423 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.0 m-20 149.68 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.571 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.906 HD11 ' HB3' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -106.58 -157.69 0.62 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.47 61.22 0.38 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.019 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.6 m -48.32 117.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.98 0.895 . . . . 0.0 110.068 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.919 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.94 -41.55 14.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.581 ' C ' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -146.57 159.26 43.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.939 HG12 ' HD2' ' A' ' 35' ' ' LYS . 40.9 t -157.57 114.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -113.83 163.81 14.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 110.496 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.876 ' HB ' HG11 ' A' ' 31' ' ' VAL . 21.7 p -83.45 171.53 13.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.63 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -135.29 130.77 5.54 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.4 m 50.45 -140.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -1.16 . . . . 0.0 109.902 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.485 ' H ' HG22 ' A' ' 56' ' ' THR . 41.0 p30 -100.75 79.82 2.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.075 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HA ' HG22 ' A' ' 31' ' ' VAL . 7.7 ttp180 56.65 28.98 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 110.482 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.94 -31.23 10.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 109.889 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.789 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.93 177.52 10.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.566 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -154.2 150.52 22.16 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.298 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 20.7 t80 -103.85 160.6 14.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.365 -1.079 . . . . 0.0 109.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.924 HG22 HG13 ' A' ' 52' ' ' VAL . 88.7 t -154.5 154.42 7.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.435 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -124.13 139.88 53.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.708 -0.62 . . . . 0.0 109.865 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.861 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 21.7 m-85 -109.71 173.45 6.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.718 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.08 15.19 17.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.353 -0.842 . . . . 0.0 111.212 -178.454 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.56 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 2.3 t -166.24 175.49 8.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.718 1.247 . . . . 0.0 112.063 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.15 -25.39 22.98 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -20.95 26.21 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' OD2' ' HB3' ' A' ' 65' ' ' PHE . 8.7 t0 -84.14 -31.68 25.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 71' ' ' LEU . 8.4 tt -75.77 -34.59 60.24 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.485 0.66 . . . . 0.0 109.59 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.5 -35.19 60.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.992 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 1.018 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -76.65 -27.38 55.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.861 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.09 -28.7 64.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.728 HD22 HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -68.95 -45.76 69.92 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.443 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.55 -15.55 63.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.963 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.018 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.2 mm? -72.86 0.01 12.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.225 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.854 HG23 ' HA ' ' A' ' 88' ' ' LYS . 5.8 m -78.23 5.59 9.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 110.672 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.408 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -103.72 14.15 53.38 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.713 HD22 HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -115.3 131.21 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.843 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' A' ' 82' ' ' VAL . 14.1 mttt -75.95 83.85 2.86 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 109.62 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.106 HG11 HG23 ' A' ' 87' ' ' ILE . 1.2 p -31.34 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.81 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.811 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -100.84 28.79 4.94 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.61 15.93 3.89 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.762 ' O ' HG12 ' A' ' 82' ' ' VAL . 6.7 m-20 -158.64 116.62 2.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -1.2 . . . . 0.0 109.478 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 78' ' ' THR . 24.9 tt0 -52.72 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.106 HG23 HG11 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -42.77 154.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 110.215 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.854 ' HA ' HG23 ' A' ' 78' ' ' THR . 7.1 mtpp -129.7 157.15 42.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.836 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 22' ' ' ILE . 3.7 mt -106.68 -179.54 3.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.11 -0.993 . . . . 0.0 110.119 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 175.18 -168.41 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -100.74 122.12 50.33 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.908 . . . . 0.0 110.373 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' CA ' ' HB2' ' A' ' 21' ' ' PHE . 43.4 Cg_endo -70.89 -160.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.938 1.494 . . . . 0.0 110.535 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 20.3 pttt -35.9 139.31 0.15 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.769 -0.582 . . . . 0.0 110.827 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . 151.74 -46.85 0.58 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.1 OUTLIER 42.55 -164.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -1.132 . . . . 0.0 110.317 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.9 t0 59.98 47.09 10.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -129.87 -167.54 12.1 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 97' ' ' GLY . 2.4 p 42.48 -162.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.258 -1.142 . . . . 0.0 110.243 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.91 -38.13 3.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 110.207 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.57 138.83 9.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.212 -1.169 . . . . 0.0 110.277 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 3' ' ' HIS . 24.3 m -134.1 143.55 48.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -1.118 . . . . 0.0 110.26 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 2' ' ' SER . 92.9 m-70 47.61 95.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.412 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -142.73 152.28 42.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.24 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 63.29 29.28 15.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 110.231 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER 59.03 157.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.873 . . . . 0.0 110.167 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.73 135.49 24.73 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.47 -157.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.994 1.523 . . . . 0.0 110.059 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -111.98 46.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.269 0.557 . . . . 0.0 110.228 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 60.58 127.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 110.217 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.13 -59.76 8.06 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -155.42 -84.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -1.171 . . . . 0.0 110.135 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -134.47 -130.1 0.16 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.65 163.93 28.66 Favored 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.698 -0.626 . . . . 0.0 110.211 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 16' ' ' THR . 5.6 m -118.81 -8.77 10.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.146 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.882 ' CG2' HG11 ' A' ' 50' ' ' VAL . 16.2 p -159.89 159.11 27.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.838 . . . . 0.0 110.207 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.18 -18.2 14.46 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.149 1.605 . . . . 0.0 110.913 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 79.9 m-85 -122.34 115.78 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.931 -1.106 . . . . 0.0 111.14 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 2.2 m120 -143.49 151.39 40.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.532 -0.73 . . . . 0.0 109.067 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.806 HD21 ' HE2' ' A' ' 65' ' ' PHE . 1.7 pp -160.22 179.59 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.66 158.12 16.59 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.631 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 88' ' ' LYS . 6.6 mt -148.33 154.21 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.355 -0.841 . . . . 0.0 109.414 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -144.68 -164.87 10.79 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t-20 71.68 35.03 1.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.749 ' CD1' HD22 ' A' ' 34' ' ' LEU . 4.1 mm? -85.3 129.5 34.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.19 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.704 ' H ' HD21 ' A' ' 34' ' ' LEU . 28.4 t-20 -50.06 106.17 0.6 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HG3' ' HE3' ' A' ' 59' ' ' LYS . 47.9 Cg_endo -74.42 -18.88 19.91 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.996 1.524 . . . . 0.0 110.486 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -79.45 -16.21 56.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -106.18 -155.88 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.372 -0.83 . . . . 0.0 109.817 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 2.6 m -103.6 149.39 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 110.181 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.777 ' CG1' HG22 ' A' ' 54' ' ' THR . 3.0 t -69.85 -42.66 79.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -56.96 -34.81 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.503 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.93 -46.47 71.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.79 . . . . 0.0 109.581 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.749 HD22 ' CD1' ' A' ' 25' ' ' LEU . 2.0 mt -54.55 -32.44 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.177 -0.952 . . . . 0.0 108.837 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HD3' ' HB ' ' A' ' 52' ' ' VAL . 13.2 mmtt -64.77 -58.43 6.27 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.131 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 21.9 t -53.24 -35.64 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.497 -0.752 . . . . 0.0 109.369 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.4 -39.01 93.35 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.574 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 70.8 mt -77.92 -26.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.615 ' HA ' HG21 ' A' ' 49' ' ' VAL . 41.0 m -79.16 -29.21 42.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.085 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.84 -38.56 22.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.456 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.862 ' HG ' HD13 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.84 -31.49 71.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.735 ' CE1' HD12 ' A' ' 77' ' ' LEU . 6.9 m-85 -85.37 -22.22 28.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.97 -31.85 59.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.547 -0.721 . . . . 0.0 109.131 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -91.92 -15.41 28.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.59 -0.694 . . . . 0.0 109.134 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.671 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m120 -82.71 -29.04 30.12 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.501 -0.75 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.671 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 36.6 t0 103.85 29.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.011 HD11 ' CB ' ' A' ' 73' ' ' LYS . 3.3 mp -97.73 -151.78 0.38 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.86 61.9 0.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.093 -1.004 . . . . 0.0 110.43 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 39' ' ' SER . 5.9 m -50.07 119.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.878 0.847 . . . . 0.0 109.396 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.882 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.5 t -89.28 -48.14 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.86 -0.525 . . . . 0.0 110.968 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 5.1 m-20 -141.48 115.68 9.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.868 -1.145 . . . . 0.0 111.311 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 63' ' ' VAL . 16.0 m -103.64 143.49 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.437 -0.789 . . . . 0.0 109.679 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -150.32 167.79 25.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 110.532 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.777 HG22 ' CG1' ' A' ' 31' ' ' VAL . 13.7 p -88.9 164.31 15.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 110.578 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -132.63 127.35 4.8 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER 68.19 -143.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -1.112 . . . . 0.0 110.069 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.94 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.158 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.9 31.18 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 110.06 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HE3' ' HG3' ' A' ' 27' ' ' PRO . 19.3 tttt -123.76 -17.34 6.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -109.49 -176.57 3.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 110.156 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.4 152.26 10.9 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.5 t80 -125.12 158.85 32.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -1.049 . . . . 0.0 109.521 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 52' ' ' VAL . 3.4 t -151.95 147.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.852 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' N ' ' OD1' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.47 137.31 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.472 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.806 ' HE2' HD21 ' A' ' 20' ' ' LEU . 25.7 m-85 -100.04 177.46 5.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.665 -0.647 . . . . 0.0 111.101 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.64 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.19 12.02 15.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 111.611 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CD2' ' A' ' 18' ' ' PHE . 5.2 p -173.71 172.11 3.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 0.0 112.2 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.61 -25.76 45.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.25 -28.16 38.5 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.793 179.338 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.495 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 5.5 t0 -79.77 -24.27 41.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.788 HD13 ' C ' ' A' ' 71' ' ' LEU . 2.3 tm? -77.22 -35.65 55.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.48 -35.45 73.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.422 -0.799 . . . . 0.0 109.042 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 1.011 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -75.35 -25.36 57.69 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.027 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.7 -30.7 69.41 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.9 tt -71.83 -45.54 61.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -77.79 -2.13 34.9 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.151 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.924 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -76.74 7.65 4.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 110.483 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -73.65 0.55 12.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.19 12.02 61.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.862 HD13 ' HG ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -102.37 131.83 48.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.289 -1.124 . . . . 0.0 109.678 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.742 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -114.37 80.15 1.36 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.489 1.137 . . . . 0.0 110.11 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.036 ' CG2' HG23 ' A' ' 87' ' ' ILE . 3.5 m -51.17 127.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.68 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 8.2 m-30 38.17 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.477 -0.765 . . . . 0.0 111.331 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 85.44 26.88 34.54 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.541 ' HB2' HG23 ' A' ' 82' ' ' VAL . 10.1 m120 -134.74 78.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.739 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.3 tm-20 -37.19 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.729 0.776 . . . . 0.0 110.747 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.036 HG23 ' CG2' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -47.7 144.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' HG23 ' A' ' 22' ' ' ILE . 25.7 tttt -119.3 156.54 29.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.53 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.6 172.34 7.28 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 110.38 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.5 tm-20 -161.02 146.05 14.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.751 . . . . 0.0 110.133 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.96 111.33 25.97 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 110.192 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.4 Cg_endo -72.97 -170.85 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.038 1.546 . . . . 0.0 110.435 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER 63.91 16.72 10.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.242 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . 63.78 -75.56 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 46.81 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -1.138 . . . . 0.0 110.229 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 95' ' ' ARG . 31.9 t70 -42.82 141.93 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 110.197 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -179.83 96.4 0.1 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -134.89 -92.86 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -1.121 . . . . 0.0 110.449 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.494 ' H ' HG23 ' A' ' 98' ' ' THR . 3.7 ttt180 -172.03 124.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.82 146.66 14.52 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.136 . . . . 0.0 110.29 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.08 35.06 4.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -1.178 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -140.21 126.24 19.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.07 175.4 5.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 110.273 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' A' ' 6' ' ' GLU . 2.2 mp -63.79 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 110.249 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 5' ' ' LEU . 26.2 tt0 62.39 161.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 110.271 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 51.04 79.8 0.33 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.66 -157.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.036 1.545 . . . . 0.0 110.024 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 9' ' ' VAL . 10.9 p -164.73 58.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.212 0.53 . . . . 0.0 110.226 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 130.74 36.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.76 53.7 0.8 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 3.0 t -105.68 25.4 10.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -1.121 . . . . 0.0 110.188 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 12' ' ' SER . 46.5 tt0 169.89 125.6 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.423 1.106 . . . . 0.0 109.203 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -42.19 166.63 0.0 OUTLIER 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.221 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 16' ' ' THR . 5.8 t -105.58 -24.6 12.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 15' ' ' THR . 74.6 p -139.27 164.76 36.66 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.565 -0.71 . . . . 0.0 110.265 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.72 -22.62 11.77 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.022 1.538 . . . . 0.0 111.073 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.541 ' CE2' ' C ' ' A' ' 67' ' ' SER . 91.5 m-85 -104.19 85.5 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.928 -1.107 . . . . 0.0 110.939 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.521 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.7 m-20 -122.61 146.87 47.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.09 -1.006 . . . . 0.0 109.374 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.831 HD21 ' HE2' ' A' ' 65' ' ' PHE . 1.8 pp -154.36 -176.97 6.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -103.18 166.46 10.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.617 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.774 HD12 ' CG2' ' A' ' 63' ' ' VAL . 9.0 mt -144.49 158.79 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -149.19 -178.67 24.41 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.031 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.1 t-20 72.67 54.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.92 . . . . 0.0 110.233 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.923 ' HB3' HD13 ' A' ' 34' ' ' LEU . 21.0 mt -102.23 125.93 49.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.042 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 26.4 t-20 -41.25 110.08 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.733 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.01 -19.94 22.49 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.997 1.525 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -85.54 -7.56 58.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.953 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.583 ' HD3' ' CG ' ' A' ' 83' ' ' PHE . 10.1 mttt -114.15 -157.24 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.371 -0.83 . . . . 0.0 109.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.454 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 3.5 m -110.51 150.09 29.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 110.572 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.911 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.6 t -69.56 -38.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.337 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.4 -34.66 69.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.422 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 5.6 mm-40 -74.82 -32.67 62.03 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.375 -0.828 . . . . 0.0 109.159 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.923 HD13 ' HB3' ' A' ' 25' ' ' LEU . 7.4 mt -66.21 -35.18 79.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.392 -0.818 . . . . 0.0 109.03 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.755 ' HE2' HG12 ' A' ' 31' ' ' VAL . 2.7 mptp? -67.11 -54.08 24.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 32' ' ' ALA . 16.7 t -52.17 -35.97 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 109.581 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.742 ' CB ' HG13 ' A' ' 82' ' ' VAL . . . -64.34 -38.37 90.78 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.841 HD11 ' CG2' ' A' ' 82' ' ' VAL . 20.2 mm -78.02 -26.66 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.369 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.559 ' HA ' HG21 ' A' ' 49' ' ' VAL . 37.6 m -78.97 -31.92 45.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -79.8 -39.27 31.22 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.46 -0.775 . . . . 0.0 109.537 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.859 HD22 HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.6 -33.55 75.92 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.132 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.586 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 7.8 m-85 -82.17 -21.95 36.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.554 -0.716 . . . . 0.0 109.211 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.52 44.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.409 -0.807 . . . . 0.0 109.726 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 14.4 mtmm -104.67 -22.81 13.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -79.31 -30.92 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 35.7 t70 112.62 29.03 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.583 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 1.7 mm? -88.93 -153.16 0.25 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.923 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -165.87 64.09 0.11 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.6 m -62.98 117.87 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.917 0.865 . . . . 0.0 110.079 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.92 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.3 t -92.36 -42.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -144.4 158.22 43.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.949 HG13 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -144.96 156.19 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 109.569 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.449 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -162.51 170.23 19.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.24 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.586 HG22 ' CG1' ' A' ' 31' ' ' VAL . 13.8 p -90.48 164.62 14.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 110.243 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -120.5 131.78 8.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.494 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 99.0 m 58.72 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.937 . . . . 0.0 110.371 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 27.6 t-20 -173.25 84.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.627 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER 66.25 22.18 10.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 110.729 179.43 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.566 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.0 tttm -120.59 -35.84 3.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.852 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.2 m-85 -135.27 -164.3 1.51 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -169.08 165.3 38.81 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.272 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 20' ' ' LEU . 36.8 t80 -128.73 153.1 47.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -1.02 . . . . 0.0 109.524 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.949 HG13 HG13 ' A' ' 52' ' ' VAL . 3.1 t -150.43 144.15 17.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.079 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -107.5 141.07 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 109.663 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.831 ' HE2' HD21 ' A' ' 20' ' ' LEU . 30.8 m-85 -104.3 177.79 4.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.876 . . . . 0.0 110.551 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.626 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.12 15.91 14.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 111.02 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.7 p -179.38 178.28 0.7 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.368 1.08 . . . . 0.0 111.954 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.51 -22.57 50.99 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -27.99 38.77 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.43 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.923 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 85.8 m-20 -80.22 -29.27 38.5 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.838 HD13 ' O ' ' A' ' 71' ' ' LEU . 3.4 tm? -81.41 -32.81 32.57 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.501 0.667 . . . . 0.0 109.314 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.68 -36.05 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.748 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.633 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.98 -30.14 50.09 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . . . -63.82 -28.99 70.24 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.799 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.486 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.4 OUTLIER -74.95 -47.15 31.0 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.843 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 5.01 16.21 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.612 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -79.39 11.66 2.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 110.422 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -6.44 19.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.41 25.03 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 77' ' ' LEU . 1.3 mt -92.76 -171.16 2.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.468 -1.019 . . . . 0.0 110.9 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.578 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.4 mttt 176.55 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.869 0.842 . . . . 0.0 108.978 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.841 ' CG2' HD11 ' A' ' 38' ' ' ILE . 99.3 t -24.34 -101.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.169 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.625 ' N ' HG12 ' A' ' 82' ' ' VAL . 10.2 m-85 -87.86 42.32 1.05 Allowed 'General case' 0 C--N 1.288 -2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 108.728 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.69 29.78 22.98 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.1 t-20 -145.91 88.12 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.449 -1.03 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.578 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -42.95 96.06 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.625 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -48.56 125.73 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.606 -0.684 . . . . 0.0 110.144 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -100.89 129.9 46.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.733 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.754 ' H ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -113.58 176.34 5.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.013 -1.054 . . . . 0.0 111.222 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 3.2 pt-20 -178.39 131.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.459 -0.776 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 1.9 ptpt -60.22 115.34 12.82 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.499 ' CD ' ' HA ' ' A' ' 20' ' ' LEU . 46.1 Cg_endo -72.95 -171.6 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.84 1.442 . . . . 0.0 110.363 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -150.11 119.34 6.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 45.04 60.61 3.88 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.86 110.25 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -1.123 . . . . 0.0 110.293 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.01 133.83 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 110.246 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' C ' HG22 ' A' ' 98' ' ' THR . . . -67.34 -160.0 1.15 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.505 HG22 ' C ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER 177.73 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.263 -1.14 . . . . 0.0 110.47 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.37 9.2 14.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.215 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 112.52 -60.04 0.35 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.281 -1.129 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -152.72 179.83 8.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -1.136 . . . . 0.0 110.266 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -131.61 17.62 4.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.448 ' HA ' ' HE3' ' A' ' 4' ' ' MET . 0.0 OUTLIER 61.39 112.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 mt 62.44 55.76 2.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.274 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.75 -44.37 77.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -136.24 107.49 9.48 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 110.216 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.17 79.37 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.051 1.553 . . . . 0.0 110.416 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 p -142.18 109.02 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.239 0.543 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.512 ' N ' ' OE1' ' A' ' 10' ' ' GLU . 36.5 mp0 -93.3 163.26 13.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.19 71.7 1.0 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.06 -71.07 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -1.151 . . . . 0.0 110.16 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.29 27.75 8.77 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.26 -0.9 . . . . 0.0 110.066 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -173.66 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.256 0.55 . . . . 0.0 110.229 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 16' ' ' THR . 4.6 m -78.65 -2.15 37.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 110.16 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . 1.026 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -178.83 165.19 1.03 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 110.39 -179.928 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.561 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.8 Cg_endo -75.43 -44.16 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.101 1.579 . . . . 0.0 110.651 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 90.6 m-85 -96.15 106.33 18.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.119 -0.988 . . . . 0.0 110.594 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -135.66 146.31 47.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 179.689 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -164.71 169.15 17.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.547 179.79 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 3.5 t80 -101.73 145.97 28.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.732 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 mt -127.78 158.53 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.68 179.84 17.21 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.834 ' C ' HD22 ' A' ' 25' ' ' LEU . 45.8 t30 71.35 76.74 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.413 -1.051 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.834 HD22 ' C ' ' A' ' 24' ' ' ASN . 4.4 mm? -118.88 126.44 51.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.021 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.515 ' HB3' HD21 ' A' ' 34' ' ' LEU . 46.0 t30 -40.43 100.36 0.22 Allowed Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.613 -0.68 . . . . 0.0 110.525 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.7 Cg_endo -75.75 -13.81 19.77 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.411 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -18.26 43.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -108.28 -156.52 0.58 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 0.0 109.753 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.525 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -101.63 147.19 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.987 ' HA ' HD12 ' A' ' 34' ' ' LEU . 3.3 t -69.67 -32.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.486 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.74 85.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.183 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.72 -40.15 84.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.724 . . . . 0.0 109.33 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.987 HD12 ' HA ' ' A' ' 31' ' ' VAL . 40.2 mt -57.3 -37.04 71.84 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -61.45 -58.19 9.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.32 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -58.54 -33.7 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.414 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.61 -36.49 83.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.189 -0.945 . . . . 0.0 108.609 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.604 HG13 HG22 ' A' ' 82' ' ' VAL . 17.0 mt -79.66 -26.14 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.584 -0.697 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -79.79 -30.35 40.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 108.93 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.12 -38.06 27.86 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.514 0.673 . . . . 0.0 109.669 179.464 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.066 HD22 ' CD2' ' A' ' 80' ' ' LEU . 1.1 tt -69.9 -31.19 68.85 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.458 -0.776 . . . . 0.0 109.248 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.888 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 5.5 m-85 -82.87 -23.92 33.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.11 -32.01 61.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -90.02 -18.95 25.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.437 179.353 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m120 -85.49 -20.16 30.13 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.786 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.0 t0 89.42 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 -179.19 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.773 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -80.14 -138.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 47' ' ' LEU . . . -176.52 57.44 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.953 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.681 HG23 ' O ' ' A' ' 49' ' ' VAL . 9.9 m -63.32 117.45 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.047 0.927 . . . . 0.0 110.766 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 1.026 HG21 HG21 ' A' ' 16' ' ' THR . 0.0 OUTLIER -98.2 -34.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.524 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.51 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 56.7 t0 -144.78 148.49 34.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.894 HG22 HG13 ' A' ' 63' ' ' VAL . 3.8 t -152.87 100.28 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 169.23 8.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.124 -0.985 . . . . 0.0 110.388 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.482 ' HB ' HG11 ' A' ' 31' ' ' VAL . 17.4 p -83.52 168.21 16.66 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -122.04 122.02 4.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 60' ' ' PHE . 4.3 m 67.87 -57.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.755 -0.85 . . . . 0.0 110.368 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.504 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER 179.81 -43.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.69 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -168.39 25.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.721 . . . . 0.0 110.123 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.633 ' CB ' ' CE1' ' A' ' 60' ' ' PHE . 2.8 mttt -119.65 -24.83 6.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.803 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.827 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -138.51 -172.38 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.195 -0.941 . . . . 0.0 109.449 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -172.93 151.69 14.55 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.147 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 38.0 m-85 -108.05 150.62 26.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.415 -1.05 . . . . 0.0 109.525 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.894 HG13 HG22 ' A' ' 52' ' ' VAL . 3.9 t -151.36 146.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.264 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 m-20 -122.56 146.6 47.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.646 ' O ' HG21 ' A' ' 50' ' ' VAL . 26.2 m-85 -114.86 -175.21 2.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.861 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.709 ' HG3' HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -129.44 31.34 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.661 -1.274 . . . . 0.0 113.673 -176.623 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.776 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 22.6 p -172.88 172.76 3.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.902 -1.749 . . . . 0.0 113.167 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.77 -27.81 58.2 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -27.1 61.76 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 179.459 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.776 ' OD2' ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -78.23 -32.29 49.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.083 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -65.95 -41.55 91.14 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.284 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' HD23 ' A' ' 71' ' ' LEU . 2.4 tt0 -70.09 -33.11 71.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 178.931 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.773 ' HB2' HD21 ' A' ' 47' ' ' LEU . 15.9 mmtt -81.49 -23.02 37.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.362 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -69.19 -29.91 67.98 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.456 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.45 -48.13 29.38 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.261 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.07 8.51 15.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.269 178.567 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.897 HD23 ' O ' ' A' ' 77' ' ' LEU . 3.0 tt -66.32 -8.81 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 110.837 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.533 ' O ' HG22 ' A' ' 78' ' ' THR . 84.9 m -70.92 5.41 2.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.353 -0.842 . . . . 0.0 111.692 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.44 -6.48 56.52 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.066 ' CD2' HD22 ' A' ' 41' ' ' LEU . 6.8 mp -92.61 120.79 33.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -1.166 . . . . 0.0 110.723 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -95.07 80.69 3.63 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.965 0.888 . . . . 0.0 110.139 179.36 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 87' ' ' ILE . 2.5 t -43.22 120.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.611 ' HB2' HD23 ' A' ' 34' ' ' LEU . 0.6 OUTLIER 48.73 20.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.965 -179.122 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.87 11.67 39.51 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.7 m120 -128.28 110.43 12.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -59.35 76.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.529 -0.732 . . . . 0.0 110.123 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 82' ' ' VAL . 4.9 pt -42.99 140.33 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 110.042 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.8 mttm -108.61 158.72 17.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.205 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.557 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -120.69 170.99 8.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -167.93 122.29 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 110.083 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -57.44 109.21 1.59 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.888 . . . . 0.0 110.376 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 49.7 Cg_endo -81.17 -169.79 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.978 1.515 . . . . 0.0 110.339 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -58.3 -178.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 110.08 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.57 -46.99 1.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.9 11.22 8.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -1.158 . . . . 0.0 110.173 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.15 131.05 42.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.403 ' C ' HG22 ' A' ' 98' ' ' THR . . . -126.74 14.49 6.73 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -176.58 135.45 0.24 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.198 -1.178 . . . . 0.0 110.428 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 98' ' ' THR . 0.6 OUTLIER 51.2 97.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 110.149 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 101' ' ' CYS . . . -75.15 81.48 0.92 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 100' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.277 -1.131 . . . . 0.0 110.241 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 65.26 -73.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -1.136 . . . . 0.0 110.272 -179.983 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 48.37 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 179.966 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -111.03 111.17 22.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.181 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.3 tp -139.59 -59.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.255 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 -166.41 1.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 110.269 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 17.0 t70 -176.06 55.78 0.13 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.143 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.607 ' O ' HG12 ' A' ' 9' ' ' VAL . 48.4 Cg_endo -71.56 -157.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.054 1.555 . . . . 0.0 110.02 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 8' ' ' PRO . 11.9 p 37.51 46.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 121.233 0.539 . . . . 0.0 110.597 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' VAL . 16.3 mt-10 -42.93 165.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.876 . . . . 0.0 110.171 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.58 9.36 6.46 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 m -167.42 97.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -1.114 . . . . 0.0 110.247 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -126.87 -130.47 0.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -167.72 1.83 Allowed 'General case' 0 C--N 1.286 -2.173 0 O-C-N 121.679 -0.638 . . . . 0.0 110.204 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.497 HG21 ' OD2' ' A' ' 51' ' ' ASP . 4.2 m -89.51 -4.41 57.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 110.222 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.831 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -170.52 165.4 5.31 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.95 -34.06 2.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.097 1.577 . . . . 0.0 111.052 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.2 m-85 -109.78 115.62 30.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.737 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.492 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 3.5 m-80 -142.88 152.36 42.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.412 -0.805 . . . . 0.0 109.567 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.735 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.0 pt? -162.91 170.88 17.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 110.416 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -97.93 167.79 10.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' GLY . 14.2 mt -142.69 161.65 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -148.11 177.61 26.25 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 16.9 t30 71.73 43.75 0.55 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -1.095 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.933 ' CD1' HD22 ' A' ' 34' ' ' LEU . 4.2 mm? -92.73 127.63 38.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.932 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.783 ' H ' HD21 ' A' ' 34' ' ' LEU . 63.8 t-20 -40.8 106.61 0.43 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 110.447 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.53 -24.4 16.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.085 1.571 . . . . 0.0 110.389 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -76.44 -10.93 59.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.902 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.8 mmtp -114.68 -155.6 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.959 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.823 ' O ' HD12 ' A' ' 34' ' ' LEU . 6.8 m -115.22 153.39 30.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.082 HG11 HG22 ' A' ' 54' ' ' THR . 2.8 t -69.52 -21.03 24.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.224 -0.922 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.27 89.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 109.308 179.134 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.1 mm-40 -71.49 -45.35 62.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.532 -0.73 . . . . 0.0 109.354 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.933 HD22 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -57.91 -31.07 66.42 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -64.53 -62.09 1.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.513 0.673 . . . . 0.0 109.238 179.092 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 44.2 t -51.93 -38.99 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.716 . . . . 0.0 109.684 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.82 -28.54 70.08 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.036 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 34' ' ' LEU . 39.9 mt -88.08 -27.63 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.006 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 8.9 m -79.97 -26.94 39.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.101 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.0 -38.99 20.23 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.25 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.809 HD22 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -65.99 -34.49 78.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.697 ' CD1' HD13 ' A' ' 77' ' ' LEU . 8.1 m-30 -86.45 -19.14 30.04 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -87.69 -28.12 21.99 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.831 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -90.41 -20.23 23.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.247 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.877 ' OD1' HD21 ' A' ' 77' ' ' LEU . 1.9 m-80 -79.2 -59.63 2.69 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.658 -0.651 . . . . 0.0 109.56 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.605 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.8 m-20 149.01 30.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.275 0.56 . . . . 0.0 109.925 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' ' 73' ' ' LYS . 1.9 mp -99.94 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.836 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.6 63.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 49' ' ' VAL . 7.8 m -49.89 117.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.909 0.862 . . . . 0.0 109.975 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.831 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.4 t -93.6 -44.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 121.165 0.507 . . . . 0.0 110.403 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.497 ' OD2' HG21 ' A' ' 15' ' ' THR . 1.5 t70 -139.28 155.71 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.783 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -136.86 174.44 11.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.318 -0.864 . . . . 0.0 110.101 -179.822 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER 175.17 178.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.168 -0.957 . . . . 0.0 110.057 179.896 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 54' ' ' THR . . . . . 1.082 HG22 HG11 ' A' ' 31' ' ' VAL . 18.5 p -103.14 170.18 8.12 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.626 ' HA3' ' CB ' ' A' ' 60' ' ' PHE . . . -121.95 132.32 8.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 57' ' ' ASN . 53.3 m 57.46 -92.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 110.448 179.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.485 ' N ' HG22 ' A' ' 56' ' ' THR . 1.1 t-20 -154.53 99.32 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 110.744 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 42.1 mtm180 45.12 23.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -121.26 -32.88 3.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.771 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.6 m-85 -119.88 -161.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 109.407 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -167.92 167.65 40.22 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.636 ' O ' HG23 ' A' ' 63' ' ' VAL . 14.6 t80 -142.01 153.58 44.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.394 -1.062 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.728 HG22 HG12 ' A' ' 52' ' ' VAL . 43.7 t -157.56 158.81 2.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.192 -178.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.58 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 11.4 m-20 -123.85 142.35 51.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.679 -0.638 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.836 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 49.6 m-85 -104.73 175.32 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 111.049 -179.215 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.635 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.37 11.76 20.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 111.524 -178.585 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.546 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.3 p -172.7 172.91 4.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 112.178 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -79.14 -23.96 43.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.43 -24.1 29.71 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.11 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 5.6 t0 -82.94 -26.58 31.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.774 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.8 tm? -79.58 -34.47 40.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.287 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.8 -33.86 62.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 109.779 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.769 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -80.62 -21.94 41.05 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.589 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.836 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -77.8 -28.23 50.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.198 179.059 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.979 HD23 HD11 ' A' ' 89' ' ' LEU . 2.0 tm? -75.72 -46.23 32.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.478 ' N ' HD13 ' A' ' 75' ' ' LEU . 1.8 mt-10 -66.68 -26.31 66.97 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.218 179.057 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.877 HD21 ' OD1' ' A' ' 45' ' ' ASN . 6.9 mt -70.7 -20.58 62.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.839 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 75' ' ' LEU . 1.5 t -39.66 -31.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.306 1.05 . . . . 0.0 110.212 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.27 -20.31 9.75 Favored Glycine 0 C--N 1.281 -2.489 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.017 ' CD1' HG23 ' A' ' 82' ' ' VAL . 2.9 pp -66.99 125.84 27.26 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.319 -1.106 . . . . 0.0 110.655 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 11.0 mttt -93.88 78.67 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.301 1.048 . . . . 0.0 110.26 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.017 HG23 ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -43.8 131.09 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.146 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.575 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 3.0 m-85 44.32 24.25 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.467 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 91.21 25.03 25.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' ILE . 39.4 m-20 -140.35 104.8 4.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -1.184 . . . . 0.0 110.343 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 5.9 tt0 -56.35 84.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.289 -0.882 . . . . 0.0 109.933 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 87' ' ' ILE . 2.7 pp -40.09 129.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.523 0.678 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -104.78 132.75 50.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.507 -0.745 . . . . 0.0 109.376 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.979 HD11 HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -105.64 174.07 6.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.888 -1.133 . . . . 0.0 110.737 -179.45 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.41 135.91 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 110.109 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.27 113.29 5.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 110.167 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 46.0 Cg_endo -73.13 -169.64 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.017 1.535 . . . . 0.0 110.432 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 1.7 ttmt 67.55 105.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.62 -9.97 7.21 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.41 ' HG2' ' O ' ' A' ' 95' ' ' ARG . 2.0 tmt_? -101.42 5.6 42.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -1.15 . . . . 0.0 110.224 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.29 157.92 32.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 110.235 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.12 57.49 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -123.44 115.94 22.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -1.152 . . . . 0.0 110.315 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.04 -23.72 9.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.74 87.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 110.242 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p 56.15 -161.31 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -1.178 . . . . 0.0 110.197 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -115.63 -177.76 3.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 30.2 ttp -85.39 -2.98 58.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 110.248 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.447 ' CB ' ' O ' ' A' ' 4' ' ' MET . 4.7 tp 65.58 137.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.18 59.55 4.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -146.18 100.53 4.18 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.51 79.42 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.99 1.521 . . . . 0.0 110.403 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' GLY . 52.6 t -144.05 128.16 13.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.18 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER -58.18 84.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.193 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 43.48 -97.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' GLU . 2.5 m 42.06 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.42 -1.047 . . . . 0.0 110.267 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -167.34 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 110.313 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.46 156.43 0.63 Allowed 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.798 -0.564 . . . . 0.0 109.718 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.2 m -124.29 -25.42 4.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 110.676 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.976 ' CG2' HG11 ' A' ' 50' ' ' VAL . 65.2 p -139.57 164.48 38.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.448 -0.782 . . . . 0.0 110.579 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 50.9 Cg_endo -78.21 -31.6 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.127 1.593 . . . . 0.0 110.695 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 89.9 m-85 -92.82 93.05 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.103 -0.998 . . . . 0.0 110.607 -179.582 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.5 m120 -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.252 -0.905 . . . . 0.0 109.317 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.029 HD11 HD23 ' A' ' 89' ' ' LEU . 2.1 pt? -158.94 -176.63 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.714 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.2 t80 -101.37 156.61 17.35 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.646 HG22 HD21 ' A' ' 25' ' ' LEU . 2.4 mt -147.41 155.77 10.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.078 -1.014 . . . . 0.0 109.572 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -143.13 -162.7 9.42 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t30 71.38 14.09 6.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -1.107 . . . . 0.0 110.025 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.938 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.4 mm? -66.5 124.81 23.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.704 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 32.6 t-20 -40.96 101.09 0.23 Allowed Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.623 -0.673 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 45.8 Cg_endo -72.37 -31.62 11.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.079 1.568 . . . . 0.0 110.433 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 26' ' ' ASN . 28.4 p30 -72.68 -14.8 61.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.2 tmtt? -96.79 -153.78 0.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.79 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -112.45 148.58 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.372 -0.83 . . . . 0.0 110.279 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.56 HG12 ' CE ' ' A' ' 35' ' ' LYS . 3.7 t -68.75 -25.25 30.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 29.9 mm-40 -72.96 -31.67 64.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.938 HD13 ' HB3' ' A' ' 25' ' ' LEU . 23.5 mt -65.89 -31.83 72.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' CE ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -72.1 -56.48 5.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.553 179.484 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 32' ' ' ALA . 5.6 t -61.02 -33.69 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 179.134 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.72 -38.4 90.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.587 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 65.8 mt -75.52 -29.07 20.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.722 . . . . 0.0 109.584 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.855 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -77.46 -31.94 54.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.0 -1.063 . . . . 0.0 108.819 179.084 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.6 tm-20 -81.7 -42.23 20.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.507 0.67 . . . . 0.0 109.556 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.067 HD21 ' CD1' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -59.54 -37.58 78.76 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.748 -0.781 . . . . 0.0 108.966 179.167 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.79 ' CD2' HG13 ' A' ' 49' ' ' VAL . 9.7 m-85 -82.12 -22.65 36.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.68 -17.2 54.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -109.24 -16.98 13.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 109.741 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.713 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -84.4 -31.29 24.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.713 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.9 t0 112.62 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-O 121.971 0.891 . . . . 0.0 108.765 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.761 HD11 ' CG ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -105.59 -155.01 0.53 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.769 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.98 63.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 39' ' ' SER . 4.9 m -49.62 116.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.85 0.833 . . . . 0.0 109.829 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.976 HG11 ' CG2' ' A' ' 16' ' ' THR . 10.5 t -81.25 -38.0 16.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 8.7 t0 -153.6 152.66 31.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.087 -1.008 . . . . 0.0 110.55 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.648 HG13 HG23 ' A' ' 63' ' ' VAL . 13.4 t -134.92 161.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 26.5 mtp180 -155.61 154.87 32.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.009 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.462 ' C ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 p -78.66 166.82 22.08 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.975 . . . . 0.0 110.398 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -141.06 122.3 2.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 55' ' ' GLY . 32.1 m 40.4 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.337 -1.096 . . . . 0.0 111.008 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 56' ' ' THR . 21.4 m120 60.11 -141.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.73 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.538 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 3.6 ptt85 -114.5 34.32 4.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 11.1 pttt -118.47 -19.14 8.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 109.959 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.594 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -119.89 174.16 6.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.547 179.637 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -176.59 148.66 9.19 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.815 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 8.4 t80 -111.51 157.57 20.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.883 . . . . 0.0 109.016 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -141.28 172.34 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.773 -1.204 . . . . 0.0 111.3 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 2.6 m-20 -136.43 135.94 39.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.769 -0.582 . . . . 0.0 109.457 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 16.8 m-85 -106.47 -178.66 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.562 -0.711 . . . . 0.0 110.988 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.576 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 2.1 pp20? -117.45 5.55 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 111.044 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.657 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.4 p -168.96 175.2 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.301 1.048 . . . . 0.0 112.21 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.99 -23.56 41.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.899 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.74 -26.46 31.9 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.013 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.75 ' OD1' HD23 ' A' ' 47' ' ' LEU . 3.4 t0 -81.05 -27.76 35.63 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.088 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -75.5 -37.16 60.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.667 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -69.99 -33.9 72.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.753 . . . . 0.0 109.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.761 ' CG ' HD11 ' A' ' 47' ' ' LEU . 2.7 tppt? -73.4 -25.71 60.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.193 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 1.014 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -72.68 -26.99 61.82 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.943 0.878 . . . . 0.0 108.641 178.599 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.757 ' O ' HD13 ' A' ' 75' ' ' LEU . 1.7 tm? -76.22 -34.47 59.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.261 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -16.76 48.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.729 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.014 HD23 ' HA ' ' A' ' 74' ' ' ALA . 1.1 pp -66.38 -17.83 65.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.98 -1.075 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -47.72 -16.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.569 -0.707 . . . . 0.0 111.751 -179.359 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -82.72 14.78 34.64 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.067 ' CD1' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -101.4 -163.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -1.195 . . . . 0.0 110.507 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.611 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -168.35 49.76 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 109.627 -179.758 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.848 ' CG2' HG23 ' A' ' 87' ' ' ILE . 5.0 t 5.67 -122.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.708 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 3.3 m-85 -72.31 -2.9 20.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.985 -1.072 . . . . 0.0 109.355 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 145.99 35.24 0.06 OUTLIER Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -157.87 101.93 1.81 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -1.215 . . . . 0.0 109.996 179.991 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.611 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 2.8 pt-20 -52.58 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.848 HG23 ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -37.92 148.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.693 0.758 . . . . 0.0 110.75 -179.645 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 16.3 ttpt -121.87 156.81 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 1.029 HD23 HD11 ' A' ' 20' ' ' LEU . 1.8 mp -112.88 173.41 6.39 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.047 -1.033 . . . . 0.0 110.415 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -165.23 120.18 1.31 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.945 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 110.42 2.85 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.097 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.9 Cg_endo -75.71 -170.0 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.028 1.541 . . . . 0.0 110.235 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.52 21.93 6.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.94 15.97 39.85 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.53 97.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.227 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -114.23 -179.01 3.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.65 -91.4 0.08 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.46 167.05 23.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -1.151 . . . . 0.0 110.522 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -126.62 -176.04 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.27 45.07 0.95 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.203 -1.175 . . . . 0.0 110.225 179.962 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 2.5 m -148.03 31.14 0.86 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -1.127 . . . . 0.0 110.171 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 2' ' ' SER . 35.5 m170 54.62 68.47 0.86 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.231 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 ttp -106.13 110.54 22.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.219 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.406 ' C ' HD12 ' A' ' 5' ' ' LEU . 2.8 pp -162.22 158.17 24.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -121.71 -67.25 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 110.247 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -159.7 70.39 3.21 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' C ' HG23 ' A' ' 9' ' ' VAL . 49.5 Cg_endo -71.44 -157.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.959 1.505 . . . . 0.0 110.095 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.431 HG23 ' C ' ' A' ' 8' ' ' PRO . 41.1 t -146.35 101.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 O-C-N 121.762 -0.586 . . . . 0.0 110.176 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 1.1 pm0 -148.41 39.92 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.57 20.81 47.9 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 93.0 p -102.5 -22.14 14.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -1.201 . . . . 0.0 110.191 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' A' ' 12' ' ' SER . 33.3 tt0 68.46 122.71 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.85 1.31 . . . . 0.0 110.367 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -39.25 142.35 0.26 Allowed 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.208 -179.985 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 16' ' ' THR . 7.2 m -103.27 -5.18 23.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 0.0 110.282 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.764 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -166.68 162.89 11.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.325 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.76 -32.87 5.4 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.115 1.587 . . . . 0.0 110.489 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 84.9 m-85 -108.47 107.36 17.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.927 . . . . 0.0 110.432 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -139.25 146.72 40.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.868 . . . . 0.0 109.339 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -163.17 175.1 11.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.12 -0.987 . . . . 0.0 110.924 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 60' ' ' PHE . 2.4 t80 -97.37 147.75 23.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.713 -0.617 . . . . 0.0 110.103 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 63' ' ' VAL . 1.1 mp -133.85 148.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.946 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -135.56 -166.05 10.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' C ' HD23 ' A' ' 25' ' ' LEU . 28.1 t30 67.15 58.16 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.099 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.878 HD11 ' N ' ' A' ' 61' ' ' GLY . 8.1 mt -105.95 123.99 48.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 110.366 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' LEU . 53.3 t-20 -41.45 104.13 0.33 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.774 . . . . 0.0 110.213 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.75 -15.48 26.85 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -78.13 -17.15 57.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.19 -156.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.742 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.526 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -100.33 146.85 26.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.736 HG22 ' CB ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -70.85 -33.27 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.044 -1.063 . . . . 0.0 108.622 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.35 94.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 108.956 178.819 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 12.8 mm-40 -66.56 -33.54 75.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.894 ' O ' HD12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -64.26 -33.8 76.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.186 179.231 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 1.045 ' HD3' HG12 ' A' ' 52' ' ' VAL . 5.2 mmtt -66.29 -53.79 32.5 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.474 -0.766 . . . . 0.0 109.119 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -60.84 -40.94 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.376 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.8 -29.16 69.96 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 108.951 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 34' ' ' LEU . 10.3 mt -85.86 -30.28 6.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.101 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.684 ' HA ' HG11 ' A' ' 49' ' ' VAL . 34.2 p -78.65 -25.77 45.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 109.283 179.202 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -84.43 -39.89 18.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.47 -0.768 . . . . 0.0 109.137 179.39 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.063 HD21 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -62.65 -36.83 84.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.739 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.071 ' CE2' HD21 ' A' ' 77' ' ' LEU . 9.1 m-30 -80.01 -25.19 40.35 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -68.67 -40.15 80.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.488 179.379 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.51 -17.57 53.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.45 -0.781 . . . . 0.0 109.506 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.11 -8.73 58.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.521 -0.737 . . . . 0.0 110.009 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 9.1 t0 84.52 30.26 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.954 0.883 . . . . 0.0 108.848 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.846 HD21 ' CE1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -83.72 -132.34 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.321 0.581 . . . . 0.0 109.544 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 1.022 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 174.5 57.39 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.361 -0.837 . . . . 0.0 109.837 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.684 HG11 ' HA ' ' A' ' 39' ' ' SER . 10.1 m -56.19 117.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.907 0.86 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.765 HG22 ' HB3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -92.42 -44.22 14.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.289 0.566 . . . . 0.0 109.651 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 35.2 t70 -136.76 145.8 45.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -0.902 . . . . 0.0 110.615 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.045 HG12 ' HD3' ' A' ' 35' ' ' LYS . 1.8 t -153.96 119.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.374 -0.829 . . . . 0.0 109.132 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.72 160.04 40.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.891 -1.13 . . . . 0.0 111.266 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.578 ' HB ' HG11 ' A' ' 31' ' ' VAL . 39.2 p -92.21 152.29 19.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.5 -0.75 . . . . 0.0 110.027 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -125.95 124.29 5.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 67.97 -158.86 0.21 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.363 -1.081 . . . . 0.0 110.482 179.751 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.625 ' H ' HG22 ' A' ' 56' ' ' THR . 10.3 t-20 -82.57 74.1 9.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.456 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.736 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER 60.64 14.54 5.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 179.663 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -69.27 -50.51 46.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . 5.3 p90 -156.8 152.24 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.884 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.878 ' N ' HD11 ' A' ' 25' ' ' LEU . . . -124.04 167.95 16.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.1 t80 -119.75 155.3 32.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.406 -1.055 . . . . 0.0 109.721 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.841 HG23 HD13 ' A' ' 22' ' ' ILE . 3.2 t -151.2 143.43 16.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.746 -178.613 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -117.83 143.96 45.81 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.846 ' CE1' HD21 ' A' ' 47' ' ' LEU . 37.6 m-85 -107.92 171.76 7.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.838 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp20? -118.55 16.38 13.74 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.29 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.505 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.0 p -164.37 176.13 9.37 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.466 1.127 . . . . 0.0 112.207 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.91 -25.09 43.74 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -31.07 59.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.093 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 1.022 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 91.3 m-20 -78.7 -28.4 45.12 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 71' ' ' LEU . 1.8 tm? -74.64 -37.84 62.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -65.81 -34.53 78.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 0.0 109.025 178.948 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.707 ' C ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.02 -32.35 59.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.976 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -56.14 -33.57 65.32 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.459 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.588 HD13 ' C ' ' A' ' 75' ' ' LEU . 2.5 tm? -72.47 -46.13 56.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.486 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.52 6.71 16.6 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.346 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.071 HD21 ' CE2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -77.15 -12.61 59.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.773 . . . . 0.0 110.367 -179.896 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.932 ' OG1' HD21 ' A' ' 89' ' ' LEU . 26.1 m -73.68 7.63 2.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.513 -0.742 . . . . 0.0 111.558 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.474 ' HA2' ' HG3' ' A' ' 86' ' ' GLU . . . -124.39 18.34 7.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.063 HD22 HD21 ' A' ' 41' ' ' LEU . 27.3 mt -107.66 111.16 23.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -1.143 . . . . 0.0 110.809 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 82' ' ' VAL . 38.1 mttm -76.91 84.02 3.46 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.07 0.938 . . . . 0.0 109.741 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.886 ' CG1' HG23 ' A' ' 87' ' ' ILE . 1.2 p -36.96 -94.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.415 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.792 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -96.81 29.05 3.17 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.159 -0.963 . . . . 0.0 109.681 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.46 9.54 12.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.722 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.4 m-20 -139.95 106.28 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 78' ' ' THR . 1.6 tm-20 -47.67 88.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.692 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.886 HG23 ' CG1' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.73 145.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 179.777 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 10.0 ttmt -117.58 155.7 29.36 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.647 -0.658 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.932 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.2 OUTLIER -120.66 175.02 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.417 -0.802 . . . . 0.0 110.327 -179.769 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 0.8 OUTLIER -163.54 161.61 24.07 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.542 -0.724 . . . . 0.0 109.663 -179.592 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 7.3 mtpp -103.43 95.63 7.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.314 -0.866 . . . . 0.0 110.288 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.1 Cg_endo -72.24 -173.34 1.08 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.082 1.569 . . . . 0.0 110.5 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 95' ' ' ARG . 4.0 tttm 63.61 48.2 3.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.947 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.61 59.77 0.31 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER 52.17 -141.8 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -1.183 . . . . 0.0 110.167 179.955 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.58 120.63 13.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 110.177 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.45 -167.01 18.44 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 p -114.48 109.63 18.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.263 -1.139 . . . . 0.0 110.296 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -117.97 -46.78 2.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.49 158.55 0.13 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.289 -1.124 . . . . 0.0 110.209 -179.963 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.37 20.34 15.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -1.134 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.44 -171.32 1.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.47 139.24 47.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -131.32 130.55 42.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.262 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -91.31 150.14 21.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD1' ' HD2' ' A' ' 8' ' ' PRO . 9.5 t0 -68.24 136.16 91.35 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 110.189 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 10' ' ' GLU . 49.6 Cg_endo -71.52 -156.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.073 1.564 . . . . 0.0 110.148 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 8' ' ' PRO . 66.7 t -41.77 94.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 O-C-N 121.764 -0.585 . . . . 0.0 110.169 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 12' ' ' SER . 2.2 mt-10 -50.57 103.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.297 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 10' ' ' GLU . . . 44.28 -94.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 92.7 p -133.69 -66.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -1.198 . . . . 0.0 110.249 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 12' ' ' SER . 15.1 tt0 67.54 122.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.76 1.267 . . . . 0.0 110.28 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.462 ' HB3' ' OD1' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -77.27 0.3 22.6 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.552 -179.859 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 15' ' ' THR . 23.8 m 47.79 19.74 0.18 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.564 -0.71 . . . . 0.0 110.873 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.967 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.42 168.78 1.59 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.817 -1.177 . . . . 0.0 110.854 -179.88 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.6 Cg_endo -79.33 -48.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.218 1.641 . . . . 0.0 110.638 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 98.3 m-85 -85.84 110.03 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 14' ' ' SER . 5.6 m-80 -139.23 152.04 47.01 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -162.54 -177.71 5.78 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.716 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.8 t80 -117.78 144.64 45.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.446 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD21 ' A' ' 25' ' ' LEU . 1.1 mt -133.49 155.4 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.333 -0.854 . . . . 0.0 109.132 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -128.18 -174.86 13.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.194 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.3 t30 74.86 13.69 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.906 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.63 HD21 HG22 ' A' ' 22' ' ' ILE . 4.3 mm? -62.59 123.5 18.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.823 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -39.57 99.41 0.19 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.876 -0.515 . . . . 0.0 110.496 179.984 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.8 Cg_endo -78.16 -17.2 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.979 1.515 . . . . 0.0 110.619 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.11 -17.78 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.94 . . . . 0.0 110.071 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.566 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -110.5 -157.07 0.6 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 109.613 179.626 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.483 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.05 140.89 32.53 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 110.365 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.008 HG11 HG22 ' A' ' 54' ' ' THR . 2.6 t -67.24 -34.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.732 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.897 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.86 -34.53 69.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.454 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 44.6 mm-40 -68.23 -43.71 77.35 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.882 HD22 HG12 ' A' ' 82' ' ' VAL . 9.1 mt -61.15 -46.07 92.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.609 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.68 ' HG2' HG22 ' A' ' 52' ' ' VAL . 90.7 mttt -53.54 -51.05 64.14 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.314 0.578 . . . . 0.0 109.495 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 32' ' ' ALA . 11.3 t -63.64 -38.56 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.474 179.234 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.89 -35.64 81.31 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.733 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 93.4 mt -79.24 -28.14 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 109.171 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' SER . . . . . 1.046 ' HA ' HG21 ' A' ' 49' ' ' VAL . 6.9 t -78.0 -31.71 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 108.972 179.2 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.75 -38.85 32.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.603 -0.686 . . . . 0.0 109.765 179.589 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.67 -31.74 71.93 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.315 179.335 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.2 m-85 -82.18 -23.71 35.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 108.928 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.42 65.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.471 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -94.14 -17.26 22.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.684 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.665 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.2 m120 -81.77 -24.57 35.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.665 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 23.6 t70 101.57 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.124 HD11 HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -97.5 -151.04 0.36 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.54 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -168.88 62.34 0.06 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.081 -1.012 . . . . 0.0 109.841 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.046 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.3 m -54.23 117.77 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.043 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.967 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -93.41 -39.13 10.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.981 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -146.75 163.65 35.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.072 -1.017 . . . . 0.0 110.572 179.864 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.68 HG22 ' HG2' ' A' ' 35' ' ' LYS . 14.4 p -165.61 114.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 109.909 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -119.59 165.3 14.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 54' ' ' THR . . . . . 1.008 HG22 HG11 ' A' ' 31' ' ' VAL . 3.8 p -79.56 171.24 15.41 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.43 -0.794 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 60' ' ' PHE . . . -140.45 98.48 0.23 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.634 -1.269 . . . . 0.0 110.479 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 85.6 m 58.78 130.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -1.089 . . . . 0.0 111.779 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' THR . 1.3 m-80 33.18 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.858 -0.526 . . . . 0.0 111.586 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.517 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 3.6 mtp-105 43.5 25.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.074 -1.016 . . . . 0.0 110.313 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.37 -33.27 18.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 55' ' ' GLY . 3.0 m-85 -112.68 -160.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 0.0 109.167 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 179.24 125.99 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.066 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 61.1 m-85 -90.2 158.57 17.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -1.124 . . . . 0.0 109.598 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 52' ' ' VAL . 2.8 t -149.86 141.4 17.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.906 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 52.0 m-20 -112.67 146.46 38.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.0 109.53 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.73 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 50.3 m-85 -112.38 177.22 4.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.878 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -113.79 18.86 17.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 111.475 -178.354 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.63 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 23.4 p -178.83 -179.3 0.6 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.643 1.211 . . . . 0.0 112.325 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.259 . . -81.0 -28.58 35.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.484 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.13 -24.92 59.5 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.229 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.709 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.1 m-20 -83.33 -33.34 25.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 71' ' ' LEU . 9.5 tp -70.67 -36.93 73.59 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.741 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -71.81 -41.17 68.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.689 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.885 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -74.25 -32.62 63.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.134 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 65' ' ' PHE . . . -60.26 -29.92 69.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.747 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.492 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -72.18 -49.03 38.8 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.724 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.09 -0.46 28.2 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.31 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.124 HD21 HD11 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -82.56 17.08 1.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 110.367 -179.725 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.514 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 86.3 m -87.73 5.62 39.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.09 20.92 33.76 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.879 ' CD2' HD12 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -118.12 124.74 48.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.25 -1.147 . . . . 0.0 110.602 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 14.9 mttt -87.98 82.54 7.21 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.613 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.882 HG12 HD22 ' A' ' 34' ' ' LEU . 76.5 t -42.99 106.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.5 OUTLIER 60.09 22.67 11.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 110.397 -179.17 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.84 14.72 30.86 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' ILE . 19.5 m-20 -133.3 103.26 5.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.136 -1.214 . . . . 0.0 110.207 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.7 tt0 -57.52 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.864 HG21 HG21 ' A' ' 82' ' ' VAL . 13.0 pt -41.71 137.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.382 -0.824 . . . . 0.0 110.586 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -104.48 167.86 9.47 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.164 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.54 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 1.4 mp -109.7 179.0 4.25 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.04 -1.038 . . . . 0.0 110.641 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 179.42 137.62 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.949 179.957 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 112.07 22.88 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.5 Cg_endo -74.18 -170.26 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.997 1.525 . . . . 0.0 110.416 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' O ' ' HG3' ' A' ' 93' ' ' LYS . 1.9 pttt -168.22 35.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.03 90.23 0.07 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 124.95 3.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -1.176 . . . . 0.0 110.219 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -175.14 -177.37 1.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.154 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.09 112.23 2.89 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.15 142.91 31.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -1.118 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.73 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.99 -37.45 1.04 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.236 -1.155 . . . . 0.0 110.182 -179.976 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.7 70.49 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -1.132 . . . . 0.0 110.192 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -86.09 47.57 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.202 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.0 mtm -82.43 121.7 27.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 110.197 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 mt -92.83 60.42 3.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.252 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 tp10 -90.51 117.54 29.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.935 . . . . 0.0 110.2 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.99 104.71 23.55 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.163 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 44.1 Cg_endo -73.55 79.61 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.072 1.564 . . . . 0.0 110.36 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.693 HG22 ' H ' ' A' ' 10' ' ' GLU . 1.6 p -122.11 -159.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 121.758 -0.589 . . . . 0.0 109.925 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.693 ' H ' HG22 ' A' ' 9' ' ' VAL . 0.3 OUTLIER 42.96 47.86 5.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 0.0 110.26 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.37 -80.57 1.0 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -156.04 -74.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -1.17 . . . . 0.0 110.035 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.456 ' N ' ' OG ' ' A' ' 12' ' ' SER . 2.4 mt-10 -175.17 30.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.352 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.65 137.67 57.41 Favored 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.764 -0.585 . . . . 0.0 110.107 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 16' ' ' THR . 5.1 m -123.79 8.14 8.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.243 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.8 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -173.52 161.98 3.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 110.516 -179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.77 -40.51 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.249 1.657 . . . . 0.0 110.675 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 65' ' ' PHE . 81.6 m-85 -95.51 111.16 23.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.6 m120 -135.64 151.87 50.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.825 . . . . 0.0 109.687 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -160.01 166.89 29.12 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 110.512 -179.651 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 1.1 t80 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 110.002 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.663 HD12 ' CG2' ' A' ' 63' ' ' VAL . 7.8 mt -126.19 162.56 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -147.81 175.73 26.99 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 30.9 t30 72.71 64.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.582 -0.952 . . . . 0.0 110.07 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.938 HD13 HG13 ' A' ' 31' ' ' VAL . 18.9 mt -95.4 -167.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.507 ' H ' HD11 ' A' ' 34' ' ' LEU . 54.0 t-20 -114.61 107.03 51.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HA ' ' CD ' ' A' ' 58' ' ' ARG . 44.4 Cg_endo -72.27 -1.82 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.064 1.56 . . . . 0.0 110.579 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -113.97 20.52 15.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.671 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' CG ' ' OE2' ' A' ' 33' ' ' GLU . 2.2 tptm -148.12 -157.98 0.87 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.327 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.78 139.9 45.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.685 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.938 HG13 HD13 ' A' ' 25' ' ' LEU . 20.7 t -66.8 -28.42 43.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.08 179.504 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.79 85.18 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.679 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.568 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -64.4 -30.29 71.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.811 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.885 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.63 -37.42 84.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 108.932 178.921 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.921 ' HD3' HG12 ' A' ' 52' ' ' VAL . 13.3 mmtt -61.71 -54.07 47.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.459 -0.775 . . . . 0.0 109.306 179.251 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 42.7 t -49.21 -41.29 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.824 . . . . 0.0 109.88 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.035 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.39 -33.18 74.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.17 -0.956 . . . . 0.0 108.724 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 32.6 mt -82.03 -26.01 9.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.586 -0.696 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.689 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -80.75 -28.34 36.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 108.574 178.969 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -81.45 -41.13 22.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.57 0.7 . . . . 0.0 109.381 179.393 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.12 HD22 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.13 -34.43 78.02 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.096 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.129 ' CD2' HD13 ' A' ' 47' ' ' LEU . 5.9 m-85 -80.79 -23.56 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -73.04 -33.1 65.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 109.105 179.25 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.28 -17.3 24.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.402 179.278 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.17 -20.76 37.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.435 -0.791 . . . . 0.0 109.995 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.2 t70 95.76 29.17 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.992 0.901 . . . . 0.0 108.877 -179.396 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.129 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -91.68 -143.73 0.19 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.316 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' A' ' 66' ' ' GLU . . . -176.29 60.12 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 39' ' ' SER . 8.3 m -55.23 118.23 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.902 0.858 . . . . 0.0 110.214 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.8 ' CB ' HG21 ' A' ' 16' ' ' THR . 0.3 OUTLIER -92.03 -38.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.158 0.504 . . . . 0.0 109.82 -179.498 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.512 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 1.6 t70 -137.21 152.11 49.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 0.0 110.64 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.921 HG12 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -157.82 114.42 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.491 -0.755 . . . . 0.0 109.62 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -134.97 175.47 9.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.656 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.8 p -83.48 175.0 10.12 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.224 -0.923 . . . . 0.0 110.187 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -130.5 117.11 2.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.567 ' HG1' ' HD2' ' A' ' 60' ' ' PHE . 2.8 m 77.05 -64.81 0.31 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.117 -0.637 . . . . 0.0 109.829 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 56' ' ' THR . 18.9 p-10 179.91 -32.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.448 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -177.57 28.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -115.0 -33.61 5.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.205 -0.934 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.698 ' CD1' ' CE2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.91 -179.28 6.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.372 -0.83 . . . . 0.0 109.346 179.175 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.623 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -148.9 168.18 29.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.52 ' C ' ' CG2' ' A' ' 63' ' ' VAL . 5.9 t80 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -1.162 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.817 HG13 HG13 ' A' ' 52' ' ' VAL . 3.7 t -151.63 158.35 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.531 -178.922 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 28.4 m-20 -130.96 142.68 50.37 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.111 -0.993 . . . . 0.0 109.951 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 64.3 m-85 -106.96 172.42 6.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.42 -0.8 . . . . 0.0 110.004 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.742 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.11 17.75 13.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -0.987 . . . . 0.0 111.462 -178.32 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.472 ' OG ' ' OD2' ' A' ' 70' ' ' ASP . 26.7 p -168.17 175.81 6.36 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.525 1.155 . . . . 0.0 112.437 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.83 -24.82 48.56 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.698 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -77.23 -26.6 52.83 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.576 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.617 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 90.2 m-20 -82.9 -30.04 28.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.241 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.6 -36.87 68.21 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.786 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.53 -36.91 63.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 109.973 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.971 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.22 -26.59 52.85 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.654 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 65' ' ' PHE . . . -70.67 -29.37 65.68 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.912 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.462 HD23 ' O ' ' A' ' 75' ' ' LEU . 4.7 tt -71.74 -46.96 56.87 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -4.22 44.05 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.257 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -76.38 6.81 5.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.538 -0.726 . . . . 0.0 110.547 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 78' ' ' THR . 54.3 m -76.65 3.11 12.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 110.299 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.72 28.85 10.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.12 ' CD2' HD22 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.0 120.57 39.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -1.062 . . . . 0.0 110.236 -179.579 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.629 ' N ' HD12 ' A' ' 80' ' ' LEU . 2.1 ttmt -91.58 87.97 6.57 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 123.017 1.389 . . . . 0.0 109.385 178.804 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 37' ' ' ALA . 98.5 t -43.24 -105.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.686 -179.649 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 1.035 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 6.3 m-85 -90.13 40.37 1.0 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.014 -1.054 . . . . 0.0 109.964 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . 97.54 19.57 24.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.547 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 10.4 m120 -147.01 92.58 2.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 110.105 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.6 mt-10 -43.27 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.75 HG21 HG21 ' A' ' 82' ' ' VAL . 2.2 pp -58.67 129.21 20.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 110.203 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -104.63 133.22 49.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.466 179.701 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.554 ' HB2' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -110.72 174.16 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.936 -1.102 . . . . 0.0 111.122 -179.38 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -173.22 132.18 0.49 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.635 -0.666 . . . . 0.0 109.634 -179.7 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -59.33 110.1 2.45 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.15 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' CD ' ' HA ' ' A' ' 20' ' ' LEU . 48.5 Cg_endo -79.22 -169.85 0.88 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.991 1.522 . . . . 0.0 110.451 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.69 47.34 20.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.196 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.54 22.94 18.05 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.78 140.06 55.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -1.131 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -165.03 158.02 16.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.4 -14.35 62.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.76 146.25 24.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -1.161 . . . . 0.0 110.375 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.9 168.99 18.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 110.221 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.17 60.77 0.15 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.925 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 2' ' ' SER . 1.0 OUTLIER -120.79 111.88 18.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -1.144 . . . . 0.0 110.25 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -102.78 82.23 2.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.276 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 ttm -151.03 66.56 0.91 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.166 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.92 118.61 9.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.12 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -101.99 16.04 27.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 0.0 110.198 179.977 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -43.35 -60.05 2.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.191 179.921 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 49.8 Cg_endo -71.47 -157.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.089 1.573 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.545 HG23 ' C ' ' A' ' 8' ' ' PRO . 88.9 t -155.5 125.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.847 -0.533 . . . . 0.0 110.275 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' VAL . 12.2 pt-20 -42.91 162.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 110.21 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.14 80.59 0.32 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -69.81 -6.15 30.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -1.193 . . . . 0.0 110.068 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -170.69 29.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.987 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.8 OUTLIER 41.42 -173.0 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.634 0.731 . . . . 0.0 111.399 179.205 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t -124.53 -16.44 6.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.08 -179.589 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.974 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -119.04 163.9 23.97 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.553 -0.717 . . . . 0.0 110.567 -179.632 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.4 -29.56 6.0 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.201 1.632 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 86.9 m-85 -108.54 113.2 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.667 -179.759 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 2.0 m120 -141.8 149.15 40.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.769 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -164.62 -176.9 4.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.451 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.579 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.7 t80 -108.94 153.35 23.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 110.169 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.92 155.27 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.915 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.24 -169.89 11.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 0.8 OUTLIER 72.0 51.32 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.498 -1.001 . . . . 0.0 110.422 179.935 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 60' ' ' PHE . 13.8 mt -102.51 120.97 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.915 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 34' ' ' LEU . 34.6 t30 -47.13 104.53 0.42 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.581 -0.699 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.6 Cg_endo -75.44 -5.02 16.1 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.045 1.55 . . . . 0.0 110.433 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 42.5 m-20 -80.11 -20.35 45.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.99 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -107.95 -156.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.737 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.5 m -98.5 146.75 25.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.767 HG11 ' HB ' ' A' ' 54' ' ' THR . 4.5 t -67.98 -34.1 65.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.722 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.52 -34.6 78.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.741 179.41 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 59.0 mm-40 -71.44 -34.98 70.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.336 179.367 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 30' ' ' SER . 6.7 mp -66.54 -29.02 69.0 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 1.076 ' HZ2' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.94 -54.98 9.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.461 -0.775 . . . . 0.0 109.1 179.158 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 32' ' ' ALA . 12.2 t -60.15 -35.03 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.817 . . . . 0.0 109.379 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.45 -38.03 88.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.9 mt -76.03 -29.37 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.493 179.042 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' SER . . . . . 1.012 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.9 t -78.66 -29.75 45.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.084 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.3 tm-20 -81.48 -36.95 28.7 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 80' ' ' LEU . 1.1 tt -69.73 -30.2 67.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.502 -0.748 . . . . 0.0 109.093 179.038 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 3.9 m-85 -90.02 -16.71 29.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.492 -0.755 . . . . 0.0 109.388 179.278 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.88 -28.83 18.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HE3' ' OE2' ' A' ' 40' ' ' GLU . 47.6 mttt -89.4 -24.6 21.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.4 m120 -77.41 -59.3 2.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.552 -0.717 . . . . 0.0 109.493 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 p30 148.02 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.489 0.661 . . . . 0.0 110.828 179.419 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.847 HD11 ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -91.76 -154.35 0.37 Allowed 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.381 -0.824 . . . . 0.0 109.96 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.86 63.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 1.012 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.8 m -67.2 115.65 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.974 HG21 HG21 ' A' ' 16' ' ' THR . 0.6 OUTLIER -90.09 -39.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.223 0.535 . . . . 0.0 109.972 -179.602 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.521 ' CB ' ' OD2' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -140.78 156.31 46.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.0 110.566 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.076 HG12 ' HZ2' ' A' ' 35' ' ' LYS . 3.9 t -152.9 100.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.823 . . . . 0.0 110.017 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 2.3 ttp180 -99.69 167.44 10.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.767 ' HB ' HG11 ' A' ' 31' ' ' VAL . 12.7 p -88.25 169.7 11.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.243 -0.911 . . . . 0.0 110.475 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -128.75 115.46 2.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER 65.83 -150.58 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -1.064 . . . . 0.0 110.075 -179.85 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.575 ' H ' HG22 ' A' ' 56' ' ' THR . 73.5 m-20 -63.76 -55.37 23.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -176.39 49.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 110.254 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 16.5 mtpt -123.68 -23.93 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 110.293 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.777 ' O ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -132.48 178.37 6.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -164.63 142.99 8.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 13.5 t80 -97.03 157.77 15.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -1.179 . . . . 0.0 109.763 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.816 HG13 HG22 ' A' ' 52' ' ' VAL . 3.1 t -151.71 140.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.959 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.523 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 2.3 m-20 -108.09 140.82 40.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.473 -0.767 . . . . 0.0 109.056 178.991 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.806 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 8.5 m-85 -103.94 178.34 4.59 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.284 -0.885 . . . . 0.0 110.446 -179.026 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.634 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -108.15 -9.64 15.54 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.799 -178.447 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 17.3 p -168.12 -176.58 3.01 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.812 1.291 . . . . 0.0 113.061 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -83.79 -18.63 37.04 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.567 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.437 ' OE2' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -87.72 -27.09 22.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.069 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.847 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -82.5 -29.75 30.31 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.947 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.706 HD23 ' C ' ' A' ' 71' ' ' LEU . 2.0 tt -72.56 -37.65 68.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.649 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.593 ' N ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -67.47 -40.84 85.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.328 179.205 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 1.044 ' O ' HD23 ' A' ' 77' ' ' LEU . 9.9 mttm -75.61 -27.33 58.45 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.289 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.806 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.03 -28.11 63.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.737 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 89' ' ' LEU . 1.5 tm? -69.55 -46.3 66.76 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.673 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.88 -13.75 61.75 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.939 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -73.12 2.6 6.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 110.396 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.678 ' OG1' HD21 ' A' ' 89' ' ' LEU . 99.7 m -75.1 2.66 10.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.058 -1.026 . . . . 0.0 110.592 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.14 11.99 65.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 41' ' ' LEU . 75.4 mt -89.55 -165.18 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.307 -1.113 . . . . 0.0 110.591 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.617 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -169.27 48.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.703 0.763 . . . . 0.0 109.867 179.796 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.046 HG21 HG23 ' A' ' 87' ' ' ILE . 3.9 t 6.44 -123.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.636 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CD2' ' HG3' ' A' ' 29' ' ' LYS . 16.6 m-85 -73.03 -3.16 24.43 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.149 178.743 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 146.89 35.32 0.06 OUTLIER Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.9 t30 -158.1 101.45 1.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -1.215 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.617 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -50.44 90.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.99 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.046 HG23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -39.84 137.27 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.568 0.699 . . . . 0.0 110.211 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.643 ' O ' HG23 ' A' ' 22' ' ' ILE . 28.4 ttmt -112.78 156.44 22.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.522 -0.736 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -117.01 175.12 5.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 110.643 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 2.4 tt0 -169.04 159.3 9.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.592 -0.692 . . . . 0.0 109.541 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.521 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -92.0 108.65 31.81 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 0.0 110.442 -179.78 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HG3' ' HA ' ' A' ' 20' ' ' LEU . 48.2 Cg_endo -75.3 -169.12 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.001 1.527 . . . . 0.0 110.388 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tttt 46.75 -150.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . 101.03 -48.55 1.13 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 94' ' ' GLY . 16.6 ptt85 -177.82 -139.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -1.159 . . . . 0.0 110.129 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -143.42 116.85 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 110.235 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 98' ' ' THR . . . -116.62 -85.99 1.2 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.4 p 42.82 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.132 . . . . 0.0 110.265 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.64 81.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.913 . . . . 0.0 110.328 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.81 -88.28 0.06 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.121 . . . . 0.0 110.262 179.951 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -101.41 107.58 18.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -1.141 . . . . 0.0 110.195 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -179.31 81.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.233 -179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -82.01 137.8 35.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 110.164 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.0 mt -82.03 177.99 8.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 110.19 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.69 102.7 14.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -174.98 56.7 0.17 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.204 179.936 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 7' ' ' ASP . 49.4 Cg_endo -71.45 -157.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.114 1.586 . . . . 0.0 110.118 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 9' ' ' VAL . 6.0 p -62.67 85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.774 -0.579 . . . . 0.0 110.23 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.59 -158.16 0.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.205 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.13 -11.91 3.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.509 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 5.2 p -170.1 94.22 0.24 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.236 -1.155 . . . . 0.0 110.287 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' OE2' ' N ' ' A' ' 12' ' ' SER . 3.4 mp0 -141.52 93.65 2.59 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.159 -0.963 . . . . 0.0 109.687 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.82 164.94 18.93 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 121.361 0.601 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 15' ' ' THR . 19.6 m -151.01 16.05 0.75 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.166 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.754 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -176.65 166.16 1.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.312 -179.876 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 16' ' ' THR . 51.2 Cg_endo -79.66 -25.93 5.07 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.107 1.583 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.963 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 79.1 m-85 -111.89 108.81 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.815 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -142.15 152.06 42.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 108.999 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.752 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.7 pp -162.65 -176.19 4.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.791 -179.686 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.3 t80 -104.39 154.48 19.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.548 -0.72 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.625 HD12 ' CG2' ' A' ' 63' ' ' VAL . 6.2 mt -143.83 152.73 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.54 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -140.7 -167.11 10.94 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.869 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.9 t30 70.7 38.29 1.27 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.339 -1.095 . . . . 0.0 109.888 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.944 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.8 mm? -88.97 127.97 35.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.297 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.741 ' H ' HD21 ' A' ' 34' ' ' LEU . 34.5 t-20 -39.96 100.22 0.21 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.651 -0.656 . . . . 0.0 110.528 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HB3' ' CG ' ' A' ' 59' ' ' LYS . 47.9 Cg_endo -74.87 -13.14 21.79 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -87.68 -10.01 52.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HZ3' ' HD1' ' A' ' 83' ' ' PHE . 18.2 mttt -112.98 -159.0 0.67 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.772 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.5 m -97.2 146.0 25.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.668 ' HA ' HD12 ' A' ' 34' ' ' LEU . 3.4 t -65.15 -38.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.185 179.38 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -59.6 -37.71 79.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.224 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.602 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.0 -29.86 68.97 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.944 HD13 ' HB3' ' A' ' 25' ' ' LEU . 7.7 mt -68.94 -31.56 70.52 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.328 -0.857 . . . . 0.0 109.437 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.556 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 9.7 mmpt? -69.13 -51.56 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.7 t -60.58 -39.53 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.566 -0.708 . . . . 0.0 109.892 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.984 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . . . -62.26 -34.84 77.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 108.764 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 34' ' ' LEU . 44.7 mt -79.45 -29.79 13.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.597 -0.689 . . . . 0.0 109.193 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 22.6 t -77.81 -28.45 50.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.133 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -81.74 -39.03 24.79 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.534 0.683 . . . . 0.0 109.446 179.402 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.692 HD21 ' CB ' ' A' ' 80' ' ' LEU . 6.0 tp -66.08 -32.8 74.48 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.024 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 7.7 m-85 -85.52 -20.64 29.36 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.418 -0.801 . . . . 0.0 108.898 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.36 -31.66 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.514 -0.741 . . . . 0.0 109.508 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 8.9 mtpt -89.17 -23.39 22.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.77 ' OD1' HD11 ' A' ' 77' ' ' LEU . 1.7 m-80 -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.503 -0.748 . . . . 0.0 109.829 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.7 t70 90.89 31.01 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.011 0.91 . . . . 0.0 108.851 -179.329 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.986 HD11 ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -77.96 -137.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.434 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.772 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -171.16 58.05 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.567 HG11 ' HD2' ' A' ' 42' ' ' PHE . 15.6 m -66.82 113.14 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.772 0.796 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.754 HG11 ' CG2' ' A' ' 16' ' ' THR . 71.3 t -91.07 -24.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 O-C-N 121.814 -0.554 . . . . 0.0 110.291 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -162.49 163.66 27.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 110.387 179.741 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.3 t -150.93 156.94 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -155.61 165.57 36.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.119 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.641 ' HB ' HG11 ' A' ' 31' ' ' VAL . 25.8 p -86.83 161.13 18.51 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -137.35 127.13 3.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 55' ' ' GLY . 6.3 m 49.77 100.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.169 . . . . 0.0 110.713 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' THR . 6.8 m120 39.56 -98.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -141.13 30.53 1.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.007 -1.058 . . . . 0.0 110.636 -179.594 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -121.2 14.17 11.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.995 179.761 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -156.51 178.51 10.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.69 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -178.58 150.95 10.0 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.724 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.565 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 10.6 t80 -113.5 158.53 20.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.971 . . . . 0.0 109.013 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.625 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.4 t -151.09 144.36 16.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.881 -178.249 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HB3' ' HG1' ' A' ' 16' ' ' THR . 1.0 OUTLIER -102.75 146.56 28.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.527 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.7 ' O ' HG21 ' A' ' 16' ' ' THR . 3.7 m-85 -112.38 -172.23 2.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.937 -1.102 . . . . 0.0 111.165 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.772 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -115.21 -7.09 12.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.958 -179.421 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.645 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 24.1 p -176.18 175.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.58 1.181 . . . . 0.0 112.502 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.963 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -76.4 -25.81 54.9 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.108 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -29.47 58.22 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.964 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.986 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.6 -29.7 56.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.938 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -71.78 -38.78 70.25 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.606 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.19 -38.04 87.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.514 -0.741 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.796 ' O ' HD23 ' A' ' 77' ' ' LEU . 2.5 mttp -81.56 -30.51 33.03 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' A' ' 47' ' ' LEU . . . -74.95 -25.18 58.69 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.118 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.1 tt -73.35 -46.75 47.41 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.517 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.46 -14.81 62.25 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.875 178.218 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -71.82 -0.28 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.598 -0.689 . . . . 0.0 110.265 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.54 ' OG1' HD21 ' A' ' 89' ' ' LEU . 24.9 m -76.65 4.42 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.841 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.05 -8.66 86.27 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.692 ' CB ' HD21 ' A' ' 41' ' ' LEU . 3.5 mm? -80.46 -164.89 0.77 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -1.042 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -148.45 51.41 1.0 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.624 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.868 ' HB ' HG23 ' A' ' 87' ' ' ILE . 8.7 p 17.04 -132.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.344 -179.711 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.984 ' CD2' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -78.6 11.47 2.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.447 -1.408 . . . . 0.0 109.666 178.579 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 143.57 36.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.696 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.6 t30 -174.07 115.76 0.21 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -1.19 . . . . 0.0 109.661 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 tt0 -52.5 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.104 -0.997 . . . . 0.0 110.346 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.868 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -44.75 143.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.802 179.668 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 22' ' ' ILE . 9.3 mtmt -119.85 155.09 33.31 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.57 HD23 ' N ' ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.83 172.59 7.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -163.74 105.16 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.316 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 6.4 ptpt -57.78 109.61 1.91 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 0.0 110.219 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.0 Cg_endo -74.9 -175.56 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.001 1.527 . . . . 0.0 110.445 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER 42.59 37.49 1.02 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.947 . . . . 0.0 110.214 179.906 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . -144.1 -156.58 6.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -156.65 159.75 38.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -1.168 . . . . 0.0 110.242 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 19.1 t70 64.08 79.8 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.94 111.41 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.2 134.11 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -1.141 . . . . 0.0 110.469 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.38 43.78 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.252 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -60.25 -157.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.261 -1.141 . . . . 0.0 110.192 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 p -116.76 119.7 36.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 0.0 110.185 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.444 ' O ' ' ND1' ' A' ' 3' ' ' HIS . 0.9 OUTLIER -128.52 28.05 5.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.216 -179.944 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.451 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 1.5 mtp -77.27 -71.3 0.42 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 110.105 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.462 HD23 ' HA ' ' A' ' 5' ' ' LEU . 10.0 mt 47.83 36.45 5.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.22 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 4' ' ' MET . 11.1 pt-20 -154.64 19.4 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -96.46 118.26 65.46 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.173 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.16 79.71 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.895 1.471 . . . . 0.0 110.371 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.6 p -118.82 45.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 121.264 0.554 . . . . 0.0 110.299 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 10' ' ' GLU . 1.9 pt-20 -115.71 102.27 9.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' SER . . . -44.36 -64.27 2.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.567 ' O ' ' CB ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER 71.96 107.09 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.31 -1.112 . . . . 0.0 109.199 -179.571 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 12' ' ' SER . 27.7 tt0 78.6 127.41 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.525 1.155 . . . . 0.0 110.309 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 15' ' ' THR . 0.8 OUTLIER 34.15 -136.14 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.01 179.326 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.693 HG22 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER 78.99 -5.47 2.0 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.632 -0.667 . . . . 0.0 109.934 -179.417 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.984 ' CG2' HG11 ' A' ' 50' ' ' VAL . 20.3 p -140.64 160.99 56.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.417 -0.802 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.43 -22.53 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.013 1.533 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.706 ' HD1' HD13 ' A' ' 71' ' ' LEU . 85.5 m-85 -123.36 115.38 21.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 111.159 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -138.72 150.84 46.59 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.647 HD21 ' HE2' ' A' ' 65' ' ' PHE . 3.1 pp -165.22 -167.15 1.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.125 -0.984 . . . . 0.0 110.647 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.651 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 31.3 t80 -125.07 142.72 51.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.86 . . . . 0.0 110.019 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 3.4 mt -119.99 170.12 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.03 -172.91 15.82 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.695 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t-20 73.26 48.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.61 -0.935 . . . . 0.0 110.177 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 1.061 HD13 HD22 ' A' ' 34' ' ' LEU . 3.7 mm? -93.3 123.04 36.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.74 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.557 ' N ' HD11 ' A' ' 34' ' ' LEU . 22.5 t-20 -43.67 107.31 0.57 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.563 -0.711 . . . . 0.0 110.337 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 45.8 Cg_endo -72.3 -27.94 15.79 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.104 1.581 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -78.84 -17.03 56.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.565 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -106.19 -155.94 0.56 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 109.673 179.727 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 m -114.2 150.29 34.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.164 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.816 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.8 t -69.38 -26.22 30.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.79 92.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.135 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.6 mm-40 -69.78 -46.17 66.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 109.148 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.061 HD22 HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -55.37 -37.3 67.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.55 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.85 -63.12 1.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.076 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.9 t -49.4 -35.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 34' ' ' LEU . . . -62.49 -42.26 99.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.827 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.767 HD11 HG21 ' A' ' 87' ' ' ILE . 16.0 mm -73.11 -28.68 26.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.428 178.863 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.8 -29.44 50.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 0.0 109.044 179.351 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.46 -41.24 16.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.6 -0.687 . . . . 0.0 109.759 179.643 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.73 HD11 HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -63.13 -34.91 78.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.49 -0.756 . . . . 0.0 109.187 179.177 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.133 ' CD2' HD13 ' A' ' 47' ' ' LEU . 8.6 m-85 -87.13 -21.15 26.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.079 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -77.19 -31.53 55.45 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.266 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -84.1 -19.46 34.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.52 -0.738 . . . . 0.0 109.138 179.25 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -87.31 -18.73 29.47 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.649 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.4 t70 87.84 29.62 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 1.133 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -76.89 -137.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.357 179.585 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -176.27 57.55 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.414 HG23 ' O ' ' A' ' 49' ' ' VAL . 10.5 m -55.02 117.69 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.9 0.857 . . . . 0.0 109.87 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.984 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.2 t -90.95 -44.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.346 -179.382 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 17.5 t70 -143.9 148.03 34.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.105 -0.997 . . . . 0.0 110.926 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.94 HG12 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.13 158.31 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.427 -0.796 . . . . 0.0 109.577 179.907 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 62' ' ' TYR . 3.8 mtp180 -165.75 161.43 18.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.42 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.816 HG22 ' CG1' ' A' ' 31' ' ' VAL . 9.6 p -88.02 170.8 10.79 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 110.249 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -133.95 127.02 4.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 57' ' ' ASN . 2.0 m 60.03 -135.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -1.138 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.528 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 14.8 t-20 -102.06 90.09 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.019 -1.051 . . . . 0.0 110.594 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 3.2 mtt180 43.34 45.57 5.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.61 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 18.9 mttt -124.32 -28.42 3.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.028 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.737 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.0 m-85 -138.82 -174.44 3.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 109.369 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -162.15 136.85 4.55 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 63' ' ' VAL . 48.3 m-85 -94.48 159.98 14.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.137 . . . . 0.0 109.577 179.253 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.94 HG22 HG12 ' A' ' 52' ' ' VAL . 24.6 t -158.63 161.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.584 -178.876 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.499 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -134.64 139.72 45.51 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.647 ' HE2' HD21 ' A' ' 20' ' ' LEU . 55.6 m-85 -103.66 175.34 5.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.905 -179.478 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.638 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.66 16.42 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 111.388 -178.543 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 20.7 p -178.38 176.71 1.03 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.434 1.111 . . . . 0.0 112.044 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.467 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.18 -23.52 51.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.802 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.91 -27.52 43.81 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.369 179.999 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.663 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 89.6 m-20 -80.37 -29.98 37.9 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.706 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -75.66 -36.78 60.05 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.323 179.165 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.33 -34.37 74.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.308 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -81.0 -26.29 36.57 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.326 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.837 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -64.77 -29.88 70.87 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.675 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.52 -45.11 22.71 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.505 0.669 . . . . 0.0 109.246 179.12 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -23.28 66.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 110.019 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.926 HD11 ' CD1' ' A' ' 47' ' ' LEU . 20.8 mt -69.69 -5.17 23.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.466 ' OG1' HD12 ' A' ' 89' ' ' LEU . 25.9 m -67.39 -2.02 5.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.525 -0.734 . . . . 0.0 111.205 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.27 10.68 61.63 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 41' ' ' LEU . 6.1 mt -84.8 -161.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -1.051 . . . . 0.0 111.272 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.575 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 9.6 tttm -159.66 52.4 0.35 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.345 1.069 . . . . 0.0 109.821 -179.168 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.739 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -38.45 133.26 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.737 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 1.0 OUTLIER 40.97 34.74 0.3 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.313 -179.228 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 77.68 28.42 57.17 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 m-20 -144.42 107.77 4.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.291 179.643 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.575 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 mt-10 -59.03 92.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.005 -1.059 . . . . 0.0 110.3 -179.161 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.767 HG21 HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -41.16 142.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.712 0.768 . . . . 0.0 110.505 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -121.44 125.15 46.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.516 -0.74 . . . . 0.0 109.217 179.513 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 20' ' ' LEU . 1.3 mt -85.24 176.64 8.22 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.139 -0.975 . . . . 0.0 110.855 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.1 tt0 -176.42 110.68 0.09 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.701 -0.624 . . . . 0.0 109.715 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -63.97 111.15 4.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 110.314 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.0 Cg_endo -74.71 -179.31 4.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.936 1.493 . . . . 0.0 110.385 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 92' ' ' PRO . 1.5 mttp 41.07 44.5 2.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.0 110.403 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.04 -157.39 14.69 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -109.55 -86.98 0.52 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -1.135 . . . . 0.0 110.219 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 5.1 p-10 -174.17 59.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.92 158.94 31.63 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.8 -93.25 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -1.128 . . . . 0.0 110.416 179.988 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 99' ' ' ARG . . . . . 0.494 ' H ' HG23 ' A' ' 98' ' ' THR . 1.0 OUTLIER -78.06 167.37 21.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 110.233 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.79 -175.54 13.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 97.9 m . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.158 . . . . 0.0 110.105 -179.983 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.59 -166.74 2.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -1.18 . . . . 0.0 110.117 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -132.12 73.11 1.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.2 mtm -117.74 33.12 5.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 110.224 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.26 30.78 6.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.94 -155.31 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.54 128.94 94.21 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.191 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.55 -157.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.973 1.512 . . . . 0.0 110.166 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.1 p -152.5 133.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 O-C-N 121.814 -0.554 . . . . 0.0 110.118 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' SER . 2.3 tt0 -43.16 134.53 3.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.14 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.73 61.5 0.32 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 10' ' ' GLU . 57.9 m -108.41 -6.11 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -1.161 . . . . 0.0 110.135 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -144.55 95.14 2.66 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.216 -0.927 . . . . 0.0 109.799 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.34 172.06 0.51 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.265 0.555 . . . . 0.0 110.136 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.778 HG21 ' CG ' ' A' ' 51' ' ' ASP . 3.8 m -87.83 -9.23 54.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.957 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -172.45 165.02 3.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.551 -179.876 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.5 Cg_endo -77.0 -40.49 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.175 1.619 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.672 ' HD1' HD13 ' A' ' 71' ' ' LEU . 95.5 m-85 -100.03 108.98 21.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.664 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.493 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 2.8 m120 -138.41 153.28 48.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.436 -0.79 . . . . 0.0 109.524 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.792 HD12 HD23 ' A' ' 89' ' ' LEU . 2.5 pt? -165.3 174.6 9.98 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 110.267 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -109.17 159.17 17.12 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.679 -0.638 . . . . 0.0 109.921 -179.662 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 88' ' ' LYS . 4.5 mt -142.61 149.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.403 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.6 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -132.1 -172.74 13.13 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.565 -1.303 . . . . 0.0 110.027 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.514 ' C ' HD22 ' A' ' 25' ' ' LEU . 32.3 t30 72.1 49.88 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.527 -0.984 . . . . 0.0 109.858 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.784 ' CD1' HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -95.46 123.54 39.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 110.082 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.654 ' N ' HD21 ' A' ' 34' ' ' LEU . 30.5 t-20 -42.47 101.78 0.25 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 110.287 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.3 Cg_endo -74.52 -16.68 21.4 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.973 1.512 . . . . 0.0 110.338 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.48 -15.97 59.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.032 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 -155.66 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.71 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.5 m -100.18 149.87 23.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.502 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 3.5 t -66.61 -45.87 87.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.817 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.54 83.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 80.6 mm-40 -58.84 -35.86 73.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.79 . . . . 0.0 109.278 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.942 HD23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -65.68 -31.3 72.24 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.176 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HE2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.76 -50.84 61.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.538 -0.727 . . . . 0.0 109.335 179.228 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 22.0 t -59.66 -39.19 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.474 -0.766 . . . . 0.0 109.937 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.931 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -61.45 -33.45 73.76 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.135 -0.978 . . . . 0.0 108.682 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.665 HG12 HD13 ' A' ' 87' ' ' ILE . 42.5 mt -81.04 -30.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 46.4 t -77.22 -26.4 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.063 179.299 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -82.87 -43.26 16.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.707 0.765 . . . . 0.0 109.247 179.302 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 80' ' ' LEU . 1.1 tp -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.153 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.568 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 8.9 m-85 -83.71 -22.13 32.11 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.661 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.57 -32.04 47.54 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.621 0.725 . . . . 0.0 109.286 179.518 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.47 ' HE2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.73 -14.89 33.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.423 -0.798 . . . . 0.0 109.328 179.188 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.02 -18.09 28.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.656 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.1 t0 89.52 29.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.004 0.907 . . . . 0.0 108.765 -179.234 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.568 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.25 -137.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.655 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . 178.94 58.26 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.14 -0.975 . . . . 0.0 109.517 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 49' ' ' VAL . 13.0 m -60.17 116.04 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.987 0.899 . . . . 0.0 110.148 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.957 HG11 ' CG2' ' A' ' 16' ' ' THR . 17.1 t -81.44 -36.19 14.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.894 -0.504 . . . . 0.0 110.561 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.778 ' CG ' HG21 ' A' ' 15' ' ' THR . 0.3 OUTLIER -149.98 154.39 38.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 110.673 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -133.51 173.14 15.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.732 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 170.12 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.939 . . . . 0.0 110.47 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.523 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 28.5 p -100.7 164.74 11.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.225 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.565 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -134.53 136.6 8.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 63.47 -138.51 0.35 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -1.114 . . . . 0.0 110.293 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.0 m-20 -111.82 99.98 8.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 110.529 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 3.2 ptt85 38.37 27.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 111.02 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.3 ttpt -129.51 -5.33 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.736 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -138.58 -168.39 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -173.26 179.4 44.7 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.524 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.687 ' O ' HG23 ' A' ' 63' ' ' VAL . 12.3 t80 -154.88 156.43 36.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.568 -0.96 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.808 HG22 HG12 ' A' ' 52' ' ' VAL . 25.5 t -158.66 164.28 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.009 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.579 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 7.9 m-20 -130.08 140.16 50.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.554 -0.716 . . . . 0.0 109.47 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.67 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 22.3 m-85 -103.09 179.56 4.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.286 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 10.9 pt-20 -113.11 2.54 15.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 110.954 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 56.8 p -165.44 177.68 7.31 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.585 1.183 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -78.27 -24.05 46.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -76.52 -26.85 55.67 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.562 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 77.6 m-20 -86.02 -27.37 24.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.308 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.672 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -77.13 -35.47 56.2 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.659 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.93 -32.43 40.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.755 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -80.85 -25.1 37.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.708 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.65 -26.74 45.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.998 178.936 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.597 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.9 tt -72.97 -46.05 54.51 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.735 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.39 -19.22 61.65 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -62.6 -11.06 14.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.761 -0.587 . . . . 0.0 109.949 179.569 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.525 HG22 ' OE2' ' A' ' 86' ' ' GLU . 18.7 m -39.23 -28.53 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.806 0.812 . . . . 0.0 110.966 -179.463 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.62 -20.55 12.25 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.431 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.839 HD13 HG12 ' A' ' 87' ' ' ILE . 1.5 pp -48.04 -178.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.441 -1.035 . . . . 0.0 111.82 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -167.7 51.41 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.942 HG21 HD23 ' A' ' 34' ' ' LEU . 11.0 p 5.73 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.091 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.931 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 3.4 m-85 -81.58 13.79 2.91 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.437 -1.414 . . . . 0.0 108.985 178.447 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 133.73 34.77 0.29 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.774 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.632 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.8 m120 -158.86 103.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -1.022 . . . . 0.0 109.224 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.728 ' HA ' HD12 ' A' ' 80' ' ' LEU . 3.5 tt0 -49.91 90.52 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 110.371 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.839 HG12 HD13 ' A' ' 80' ' ' LEU . 16.7 pt -49.45 138.73 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.474 -0.766 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.21 175.19 6.37 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD23 HD12 ' A' ' 20' ' ' LEU . 7.1 mp -121.45 -176.66 3.35 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.372 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.72 96.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.648 -0.658 . . . . 0.0 110.184 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.33 115.49 12.53 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.918 . . . . 0.0 110.152 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 20' ' ' LEU . 46.4 Cg_endo -72.94 -174.15 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.943 1.497 . . . . 0.0 110.441 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER 50.58 73.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 179.998 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.15 72.76 0.05 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -128.18 73.75 1.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -1.124 . . . . 0.0 110.252 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -68.29 169.14 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 98' ' ' THR . . . 98.3 -18.62 56.79 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.6 p 42.44 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -1.11 . . . . 0.0 110.327 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -79.32 52.54 1.36 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.25 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.91 -40.59 5.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.183 -1.186 . . . . 0.0 110.236 -179.995 . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 031 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 p -156.18 77.65 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -1.159 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.87 55.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.95 59.95 1.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.178 -179.983 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 mt -55.64 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.76 85.37 3.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 110.209 179.965 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -150.71 75.92 8.32 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.88 . . . . 0.0 110.256 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.74 80.5 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.022 1.538 . . . . 0.0 110.421 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 9' ' ' VAL . 11.8 p -136.8 124.18 31.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 121.78 -0.575 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -57.95 -154.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.862 . . . . 0.0 110.212 179.903 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.07 73.14 0.11 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.987 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 13' ' ' GLU . 20.8 m -76.2 -91.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -1.147 . . . . 0.0 110.029 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 12' ' ' SER . 4.7 mt-10 38.0 97.92 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.992 0.901 . . . . 0.0 110.883 179.463 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -38.21 146.48 0.06 Allowed 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.242 179.728 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 16' ' ' THR . 30.2 m -89.37 -12.14 41.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 110.666 -179.557 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.941 ' CG2' HG11 ' A' ' 50' ' ' VAL . 24.8 p -158.93 153.36 20.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.94 -30.36 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.262 1.664 . . . . 0.0 110.339 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.62 ' HD1' HD22 ' A' ' 71' ' ' LEU . 96.4 m-85 -92.75 106.07 18.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.358 -179.799 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 4.8 m-80 -139.52 152.69 47.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.616 HD23 ' N ' ' A' ' 20' ' ' LEU . 1.6 pt? -165.33 164.73 19.78 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.461 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -91.08 160.75 15.43 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.379 -179.967 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 1.05 HD12 ' CG2' ' A' ' 63' ' ' VAL . 5.4 mt -150.03 146.93 16.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.951 -179.669 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -129.91 -171.47 12.94 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 26.2 t30 73.08 35.27 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.501 -0.999 . . . . 0.0 110.561 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.792 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.1 mm? -84.13 128.21 34.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.964 . . . . 0.0 109.824 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.79 ' H ' HD21 ' A' ' 34' ' ' LEU . 57.6 t-20 -39.8 102.89 0.27 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.663 -0.648 . . . . 0.0 110.61 -179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.02 7.0 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.045 1.55 . . . . 0.0 110.733 -179.729 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -106.07 -14.63 15.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.304 179.593 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -111.23 -156.3 0.58 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.624 -0.673 . . . . 0.0 109.629 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.477 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 2.3 m -105.49 148.53 27.11 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.735 179.283 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 1.018 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.8 t -63.97 -15.6 17.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.849 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -75.34 -38.38 60.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.432 -0.792 . . . . 0.0 109.05 178.828 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 3.8 mt-10 -72.13 -28.02 62.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.502 -0.749 . . . . 0.0 109.046 178.955 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.968 HD23 HG11 ' A' ' 82' ' ' VAL . 4.8 mt -70.79 -43.11 69.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.718 ' HG2' HG22 ' A' ' 52' ' ' VAL . 53.1 mttt -60.65 -43.81 97.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.66 -0.65 . . . . 0.0 110.018 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 32' ' ' ALA . 8.5 t -63.67 -41.1 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.869 179.583 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.717 ' HB2' ' HE1' ' A' ' 83' ' ' PHE . . . -63.05 -38.16 90.09 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.635 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.895 HD11 HG22 ' A' ' 82' ' ' VAL . 17.6 mm -77.7 -28.87 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.234 178.973 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.9 t -76.96 -30.23 55.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.951 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.9 tm-20 -81.27 -45.92 15.53 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.567 0.699 . . . . 0.0 109.585 179.42 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.043 ' HG ' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -56.76 -39.97 74.99 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.302 179.402 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 1.029 ' CE1' HD13 ' A' ' 77' ' ' LEU . 16.2 m-30 -78.43 -25.16 45.92 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.755 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.71 -33.12 41.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.472 ' HG3' ' OE2' ' A' ' 40' ' ' GLU . 2.8 mttt -88.43 -13.07 41.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.534 -0.729 . . . . 0.0 109.432 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -92.36 -14.48 28.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.659 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.603 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.9 t0 86.38 28.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.936 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 77' ' ' LEU . 2.5 tp -76.97 -136.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.401 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . . . -165.35 46.09 0.08 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.093 0.949 . . . . 0.0 108.67 178.923 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -55.29 150.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 122.241 1.02 . . . . 0.0 109.447 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.941 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.5 t -136.18 -34.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.356 -178.984 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' O ' ' HB ' ' A' ' 52' ' ' VAL . 1.9 m-20 -152.61 -179.91 8.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 111.034 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.718 HG22 ' HG2' ' A' ' 35' ' ' LYS . 14.6 p 179.84 113.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.764 -0.585 . . . . 0.0 109.8 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 172.18 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.698 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 54' ' ' THR . . . . . 1.018 HG22 ' CG1' ' A' ' 31' ' ' VAL . 18.9 p -82.34 162.4 22.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -134.21 122.58 3.01 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.734 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.545 HG22 ' OD1' ' A' ' 57' ' ' ASN . 28.8 m 38.95 96.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.392 -1.064 . . . . 0.0 111.119 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.545 ' OD1' HG22 ' A' ' 56' ' ' THR . 9.5 m120 64.13 -146.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.896 . . . . 0.0 110.622 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 31.71 6.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.572 -179.714 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 12.0 tttm -115.54 -20.25 10.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 110.07 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.597 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.52 -170.16 1.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.687 179.73 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 169.62 154.57 9.31 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.711 -179.876 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 21.6 t80 -115.13 163.04 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.555 -0.968 . . . . 0.0 109.514 179.537 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 1.05 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.4 t -148.88 148.22 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.019 -178.601 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -119.71 142.71 48.26 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.425 -0.797 . . . . 0.0 109.993 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 31.0 m-85 -110.91 178.97 4.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.753 . . . . 0.0 109.718 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.549 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -123.99 15.73 9.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.0 110.865 -179.124 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.547 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -165.81 174.94 9.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.835 1.302 . . . . 0.0 112.505 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -87.44 -25.73 23.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.484 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -83.72 -22.83 31.87 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.783 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.78 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t0 -81.45 -33.91 31.76 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.809 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.62 HD22 ' HD1' ' A' ' 18' ' ' PHE . 48.5 tp -69.41 -39.4 77.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.04 -32.86 72.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.409 -0.807 . . . . 0.0 109.398 179.195 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.558 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 38.0 mttm -80.79 -24.21 38.73 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.22 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.987 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -67.34 -29.81 69.47 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.488 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.743 HD22 HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -77.59 -45.44 25.19 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.152 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -17.43 64.48 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.451 -0.781 . . . . 0.0 109.676 179.46 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 1.029 HD13 ' CE1' ' A' ' 42' ' ' PHE . 11.7 mt -67.43 -7.02 21.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.2 m -49.68 -15.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.432 -0.792 . . . . 0.0 111.217 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.31 18.19 19.53 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.487 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.043 HD13 ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -97.28 179.08 5.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -1.21 . . . . 0.0 109.146 179.843 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.672 ' H ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -162.22 53.62 0.22 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 109.752 179.942 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 87' ' ' ILE . 3.5 t 8.5 -125.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.717 ' HE1' ' HB2' ' A' ' 37' ' ' ALA . 4.0 m-30 -75.04 -2.11 25.87 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.001 -1.062 . . . . 0.0 108.82 178.719 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 149.51 35.0 0.04 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' ILE . 58.1 m-20 -158.94 104.16 1.72 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.11 -1.229 . . . . 0.0 110.041 179.958 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.581 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -54.03 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 -179.616 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 1.019 HG23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -40.43 147.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.577 0.703 . . . . 0.0 110.186 179.722 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.6 mmmt -116.31 152.94 32.84 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.643 -0.661 . . . . 0.0 109.503 179.763 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.743 HD11 HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -115.82 173.91 6.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.852 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -165.36 145.25 6.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.832 . . . . 0.0 110.213 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -76.29 115.23 45.35 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.2 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.432 ' HD2' ' HG3' ' A' ' 95' ' ' ARG . 46.2 Cg_endo -73.15 -173.17 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.906 1.477 . . . . 0.0 110.398 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.31 121.33 22.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 110.252 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.29 32.73 5.67 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.432 ' HG3' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -119.0 133.29 55.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -1.093 . . . . 0.0 110.233 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -118.45 -156.44 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 0.0 110.266 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.22 97.73 0.48 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 p -97.05 106.76 19.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.19 -1.182 . . . . 0.0 110.287 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -140.83 -155.66 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 -179.92 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.54 153.26 19.9 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.231 -1.159 . . . . 0.0 110.216 179.931 . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 032 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -117.31 41.05 2.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -1.121 . . . . 0.0 110.203 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 -81.78 0.46 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.517 ' HE2' HD13 ' A' ' 5' ' ' LEU . 8.4 ptm -134.12 -166.82 1.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.883 . . . . 0.0 110.208 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.517 HD13 ' HE2' ' A' ' 4' ' ' MET . 1.0 OUTLIER 63.04 -153.67 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 -179.985 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' LEU . 3.1 tt0 64.97 47.03 2.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.88 144.74 98.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.172 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.08 79.92 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.995 1.524 . . . . 0.0 110.4 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.32 93.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.305 0.574 . . . . 0.0 110.223 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -99.71 -168.97 1.68 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.215 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.07 -14.72 11.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.4 m -101.95 49.61 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -1.129 . . . . 0.0 110.168 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -91.54 27.73 1.92 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 110.21 -179.881 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.93 173.79 0.41 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.223 0.535 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 15' ' ' THR . . . . . 1.042 HG23 HG23 ' A' ' 16' ' ' THR . 5.0 t -121.41 -24.18 5.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.265 -179.923 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 16' ' ' THR . . . . . 1.042 HG23 HG23 ' A' ' 15' ' ' THR . 73.0 p -137.27 159.54 69.21 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.3 Cg_endo -76.51 -15.98 17.23 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.06 1.558 . . . . 0.0 110.896 -179.576 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.643 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 92.1 m-85 -115.62 122.94 47.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 97.9 m-20 -139.43 170.21 16.35 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.644 -0.66 . . . . 0.0 109.271 179.603 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.809 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -169.25 163.55 10.87 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.29 -0.882 . . . . 0.0 110.47 -179.775 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.596 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.72 177.25 5.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.683 -0.636 . . . . 0.0 111.366 -177.72 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 21' ' ' PHE . 15.2 mt -157.28 133.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.98 166.61 23.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.909 ' C ' HD22 ' A' ' 25' ' ' LEU . 35.8 t30 72.48 81.02 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.505 -0.997 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.909 HD22 ' C ' ' A' ' 24' ' ' ASN . 4.2 mm? -119.92 128.79 53.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.532 ' CB ' HD21 ' A' ' 34' ' ' LEU . 31.1 t-20 -41.25 101.89 0.25 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.556 -0.715 . . . . 0.0 110.429 -179.883 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.564 ' HA ' ' HD3' ' A' ' 58' ' ' ARG . 45.8 Cg_endo -72.48 -23.7 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.036 1.545 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 1.7 m-20 -78.46 -16.16 57.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 110.048 179.866 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.2 mmtt -107.86 -155.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.536 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.3 m -102.97 145.03 30.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.918 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.6 t -68.18 -42.5 84.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.431 179.43 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -56.44 -36.08 68.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.185 179.063 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 25.8 mm-40 -64.72 -43.54 93.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.0 109.092 179.109 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.918 HD12 ' HA ' ' A' ' 31' ' ' VAL . 18.6 mt -59.72 -38.88 82.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.365 -0.835 . . . . 0.0 108.802 179.033 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.789 ' HA ' HD12 ' A' ' 38' ' ' ILE . 9.8 mmpt? -59.98 -54.22 48.63 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.537 0.684 . . . . 0.0 109.366 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 32' ' ' ALA . 18.3 t -54.21 -35.49 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 109.675 179.258 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.77 -32.3 73.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.169 -0.957 . . . . 0.0 108.798 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.789 HD12 ' HA ' ' A' ' 35' ' ' LYS . 14.1 mt -82.53 -28.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.853 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -78.75 -28.78 44.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 0.0 109.072 179.164 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.83 -41.12 23.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 109.162 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.073 ' CD2' HD22 ' A' ' 80' ' ' LEU . 1.1 tp -63.45 -34.42 77.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.919 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m-85 -79.9 -23.99 41.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.782 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.69 62.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 109.499 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -89.14 -17.97 28.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 179.465 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -87.85 -14.68 38.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 179.822 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.602 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.1 t70 83.96 30.91 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.916 0.865 . . . . 0.0 108.784 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.618 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -74.82 -129.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.464 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.81 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 173.34 54.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.196 -0.94 . . . . 0.0 109.066 179.642 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 49' ' ' VAL . 10.7 m -57.43 116.88 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.111 0.958 . . . . 0.0 110.392 -179.616 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.95 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -91.54 -39.14 11.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.758 ' CG ' HG21 ' A' ' 15' ' ' THR . 4.0 m-20 -152.65 125.35 8.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.162 -0.961 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.946 HG12 HG22 ' A' ' 63' ' ' VAL . 3.2 m -115.09 153.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.256 -0.903 . . . . 0.0 110.001 179.526 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 1.4 tpt180 -148.98 168.78 22.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.431 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.706 ' HB ' HG11 ' A' ' 31' ' ' VAL . 75.6 p -99.51 159.61 14.9 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.559 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.28 115.74 4.19 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.902 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 58.66 -154.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.498 ' H ' HG22 ' A' ' 56' ' ' THR . 81.5 m-20 -60.55 -51.94 67.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.09 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.582 ' CB ' HG22 ' A' ' 31' ' ' VAL . 2.1 ptp180 -177.3 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -125.12 -21.58 4.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.9 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.878 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -140.69 -154.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.105 -0.997 . . . . 0.0 109.995 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.559 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 172.23 175.61 40.45 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.743 ' O ' HG23 ' A' ' 63' ' ' VAL . 25.7 t80 -143.9 168.4 20.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.493 -1.004 . . . . 0.0 109.732 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.946 HG22 HG12 ' A' ' 52' ' ' VAL . 13.7 t -160.01 163.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.491 -178.89 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.3 m-20 -130.92 136.77 48.89 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.417 -0.802 . . . . 0.0 109.16 179.53 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.677 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 19.0 m-85 -103.24 176.81 5.03 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.495 0.664 . . . . 0.0 111.168 -179.247 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.612 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -115.26 17.1 16.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 111.247 -178.813 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.643 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 35.5 p 179.38 178.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.465 1.126 . . . . 0.0 112.338 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.95 -23.43 48.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.811 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -25.96 43.51 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.248 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.81 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 87.1 m-20 -83.42 -29.02 28.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.314 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.58 -29.42 36.98 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.821 179.655 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 3.6 mt-10 -79.89 -36.59 36.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.773 . . . . 0.0 110.36 -179.942 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.753 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -78.31 -29.58 47.82 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.91 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.0 -27.88 62.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.723 -0.791 . . . . 0.0 108.963 178.895 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.73 -43.35 69.08 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.542 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -13.54 60.73 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.083 178.472 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -72.73 5.03 3.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.604 -0.685 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.801 ' HA ' HD21 ' A' ' 89' ' ' LEU . 8.3 m -66.31 -5.64 11.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.94 -1.1 . . . . 0.0 110.56 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.06 32.26 4.98 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 179.131 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.073 HD22 ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -114.78 132.56 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.127 -179.732 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.614 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.5 mtmt -104.94 78.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.554 1.169 . . . . 0.0 109.976 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.796 HG12 HD23 ' A' ' 34' ' ' LEU . 47.8 t -48.45 132.38 5.98 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.754 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.0 m-85 40.82 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.422 -0.799 . . . . 0.0 110.869 -179.757 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.591 ' O ' ' ND2' ' A' ' 85' ' ' ASN . . . 86.72 28.78 25.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.561 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.591 ' ND2' ' O ' ' A' ' 84' ' ' GLY . 18.9 m120 -143.12 91.77 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -1.175 . . . . 0.0 110.282 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 19.1 tt0 -42.27 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.171 179.821 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 82' ' ' VAL . 2.2 pp -68.74 125.89 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 110.696 -179.806 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.8 mttt -83.85 118.49 23.99 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.645 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 ' HA ' ' A' ' 78' ' ' THR . 0.4 OUTLIER -106.06 -171.19 1.85 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.988 -178.258 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 3.4 mt-10 78.51 177.73 0.14 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.385 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.595 ' N ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 67.95 43.89 0.29 Allowed Pre-proline 0 N--CA 1.493 1.691 0 CA-C-O 121.294 0.569 . . . . 0.0 112.02 178.771 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 91' ' ' LYS . 49.7 Cg_endo -68.78 -162.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.608 1.32 . . . . 0.0 110.425 178.421 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER 172.21 -60.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.603 -0.686 . . . . 0.0 109.671 179.809 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' LYS . . . 43.13 26.41 0.52 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.831 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 93' ' ' LYS . 72.7 ttt180 -146.67 120.67 9.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -1.098 . . . . 0.0 110.436 -179.577 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 42.39 -156.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.313 179.868 . . . . . . . . 3 3 . 1 . 032 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -135.65 -98.03 0.54 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 97' ' ' GLY . 2.5 p 42.44 -147.87 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -1.146 . . . . 0.0 110.261 179.876 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.06 39.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.36 -0.837 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 032 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.73 125.53 1.27 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.315 -1.109 . . . . 0.0 110.205 179.982 . . . . . . . . 0 0 . 1 . 033 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 1.1 p 179.73 -179.55 0.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -1.149 . . . . 0.0 110.19 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.549 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 51.3 p-80 -175.53 107.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 46.9 -157.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 110.201 179.896 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -165.93 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.0 -87.09 0.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 110.203 180.0 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -155.53 113.16 2.23 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.084 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.41 -157.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.945 1.497 . . . . 0.0 110.053 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.8 p -151.96 112.79 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 121.248 0.547 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 12' ' ' SER . 3.8 mt-10 53.34 179.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 110.168 -179.937 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.3 83.86 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 10' ' ' GLU . 60.5 p -158.37 93.7 1.23 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -1.127 . . . . 0.0 110.248 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -120.84 -128.8 0.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.232 -0.917 . . . . 0.0 109.495 179.994 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -41.42 132.44 2.71 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.238 0.542 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 16' ' ' THR . 20.7 m -81.0 -11.62 59.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 110.33 -179.76 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.759 ' CG2' HG11 ' A' ' 50' ' ' VAL . 14.0 p -151.25 164.23 20.95 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.8 Cg_endo -75.17 -34.49 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.052 1.554 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.549 ' CE2' ' C ' ' A' ' 67' ' ' SER . 97.4 m-85 -100.64 102.39 13.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.067 -1.021 . . . . 0.0 110.489 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.503 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 2.0 m120 -137.99 153.2 49.43 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.321 -0.862 . . . . 0.0 109.527 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.786 HD22 HD23 ' A' ' 89' ' ' LEU . 4.6 pp -163.57 -171.78 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.5 t80 -116.54 151.22 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG22 HD11 ' A' ' 25' ' ' LEU . 2.8 mt -131.27 159.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.902 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -142.49 -176.24 16.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.628 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 47.8 t30 71.34 49.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 110.215 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' HA ' ' A' ' 60' ' ' PHE . 10.8 mp -97.26 132.94 42.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.658 ' H ' HD21 ' A' ' 34' ' ' LEU . 39.1 t-20 -41.41 102.06 0.26 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.609 -0.682 . . . . 0.0 110.287 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.9 Cg_endo -77.06 8.06 3.37 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.046 1.55 . . . . 0.0 110.852 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -111.81 -17.67 12.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.986 -1.071 . . . . 0.0 108.948 179.55 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' CG ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.72 -155.52 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.731 -0.605 . . . . 0.0 109.513 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -100.54 142.09 32.5 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.597 179.109 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.929 HG12 ' HE3' ' A' ' 35' ' ' LYS . 3.0 t -63.46 -42.88 97.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.114 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.49 -37.26 72.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 178.959 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 16.0 mm-40 -67.15 -30.22 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.62 179.529 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.111 HD23 HG21 ' A' ' 82' ' ' VAL . 3.0 mt -67.56 -38.4 84.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.929 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.3 -47.31 77.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.839 . . . . 0.0 109.943 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 32' ' ' ALA . 7.3 t -65.09 -34.57 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.131 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.53 -43.98 92.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.298 -0.876 . . . . 0.0 109.068 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.555 HG23 ' CE2' ' A' ' 42' ' ' PHE . 19.5 mm -76.96 -27.95 16.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.929 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.725 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -73.82 -32.75 63.87 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.437 -0.79 . . . . 0.0 109.395 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.9 tt0 -85.24 -43.11 14.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 110.009 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 3.7 tt -55.67 -40.8 72.78 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.569 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.555 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.6 m-30 -87.06 -23.62 24.88 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.447 179.542 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.93 -18.32 59.4 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -102.28 -39.27 7.28 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.588 179.632 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.615 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.1 OUTLIER -51.03 -43.17 60.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.619 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 13.1 m-20 143.22 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.561 0.744 . . . . 0.0 110.151 179.587 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -112.0 -152.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 110.624 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 49' ' ' VAL . . . -164.31 55.83 0.15 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.674 0.749 . . . . 0.0 109.153 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -41.11 118.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.045 0.926 . . . . 0.0 110.151 -179.794 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.8 t -84.24 -44.11 17.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.283 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 5.4 t70 -147.72 160.73 42.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.873 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.813 HG22 ' CG ' ' A' ' 35' ' ' LYS . 7.6 p -150.96 111.15 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 2.2 mpp_? -99.71 165.53 11.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.966 . . . . 0.0 110.261 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.472 HG22 ' HD3' ' A' ' 35' ' ' LYS . 69.0 p -87.96 163.73 16.18 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.644 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -119.19 105.57 1.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.473 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.2 m 67.57 -134.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -1.145 . . . . 0.0 110.016 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.509 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -80.47 -48.58 12.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 110.482 -179.832 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.823 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -177.76 37.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 110.444 -179.877 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 21.5 mttt -113.93 -24.33 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.996 ' HA ' HD13 ' A' ' 25' ' ' LEU . 1.2 m-85 -137.57 -174.99 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.04 154.01 18.37 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.898 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.7 m-85 -107.84 167.23 10.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.188 -1.183 . . . . 0.0 110.031 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 62' ' ' TYR . 50.2 t -157.25 155.44 5.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.939 -178.99 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 51' ' ' ASP . 8.6 m-20 -125.22 139.5 53.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.703 -0.623 . . . . 0.0 109.498 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.873 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 17.7 m-85 -103.83 176.61 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.407 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.645 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -113.98 14.65 18.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 111.479 -178.395 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.9 p 176.94 178.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.371 1.081 . . . . 0.0 112.089 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.47 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.5 -22.71 54.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.553 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -25.47 37.06 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.521 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 88.6 m-20 -82.79 -28.16 30.47 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.164 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.78 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.0 tm? -79.13 -33.7 43.97 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.566 179.389 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 1.4 tp10 -73.46 -39.22 65.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.805 . . . . 0.0 109.733 179.606 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.703 ' HB3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -80.19 -18.04 50.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.524 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.873 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.47 -28.13 46.46 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.178 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.2 tt -79.69 -44.19 21.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -27.8 67.26 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.269 -0.894 . . . . 0.0 109.096 178.9 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.803 ' O ' HD23 ' A' ' 80' ' ' LEU . 15.4 mt -68.8 -7.97 39.08 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.536 0.684 . . . . 0.0 109.826 179.394 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 87.7 m -57.01 -9.14 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.658 -0.651 . . . . 0.0 111.506 -179.667 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.98 26.97 5.7 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.283 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.958 HD11 HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -94.14 -161.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.218 -1.166 . . . . 0.0 110.695 -179.762 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.62 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -164.1 48.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.56 0.695 . . . . 0.0 109.817 179.643 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 1.111 HG21 HD23 ' A' ' 34' ' ' LEU . 7.9 p 8.49 -126.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.203 179.708 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.708 ' N ' HG13 ' A' ' 82' ' ' VAL . 2.8 m-85 -72.44 -1.75 16.9 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.408 -1.432 . . . . 0.0 109.508 179.14 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 147.89 36.42 0.05 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' HG12 ' A' ' 82' ' ' VAL . 15.3 m-20 -163.4 108.02 1.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -1.156 . . . . 0.0 109.418 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.62 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -51.27 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.61 -178.837 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.958 HG12 HD11 ' A' ' 80' ' ' LEU . 2.3 pp -46.38 144.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.651 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 8.1 mtmt -112.03 169.78 8.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.56 -0.712 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.786 HD23 HD22 ' A' ' 20' ' ' LEU . 7.7 mp -113.31 -177.56 3.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.302 -0.874 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -174.64 -174.67 0.85 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 110.243 179.974 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -116.29 106.12 49.5 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.226 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 45.5 Cg_endo -73.41 -170.44 0.66 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.997 1.525 . . . . 0.0 110.43 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.4 OUTLIER 67.66 94.14 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 -179.89 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 138.79 -56.12 0.65 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.446 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -102.52 113.4 26.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -1.132 . . . . 0.0 110.239 -179.983 . . . . . . . . 3 3 . 1 . 033 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.5 134.17 48.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.194 179.94 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.52 162.03 25.76 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.92 135.79 34.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.321 -1.105 . . . . 0.0 110.366 -179.987 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.1 46.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.12 -125.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.992 . . . . . . . . 1 1 . 1 . 033 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.222 -1.164 . . . . 0.0 110.195 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 034 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.481 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 0.1 OUTLIER -112.5 -16.54 12.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -1.136 . . . . 0.0 110.183 179.981 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 2' ' ' SER . 54.5 m80 -153.65 175.39 13.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.26 39.48 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.275 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.81 153.43 49.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 57.63 24.1 10.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 179.973 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.68 146.69 32.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.4 -157.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.077 1.567 . . . . 0.0 110.099 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.766 HG12 ' O ' ' A' ' 9' ' ' VAL . 77.6 t 50.41 51.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.223 0.535 . . . . 0.0 110.147 179.965 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.88 121.54 14.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.293 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.03 46.45 2.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.927 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -70.31 -6.07 32.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.334 -1.098 . . . . 0.0 110.156 179.985 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER 170.12 125.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.451 1.119 . . . . 0.0 109.276 179.593 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.73 178.04 0.66 Allowed 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.135 179.981 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.921 HG23 HG23 ' A' ' 16' ' ' THR . 1.8 t -109.59 -17.46 13.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 110.11 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.973 HG21 HG21 ' A' ' 50' ' ' VAL . 17.6 p -138.6 158.08 70.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.689 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.571 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.7 Cg_endo -75.71 -29.07 7.51 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.136 1.598 . . . . 0.0 110.559 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 88.0 m-85 -106.35 101.89 11.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.774 -179.55 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.516 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.7 m120 -134.71 150.9 50.66 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.131 179.413 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 21' ' ' PHE . 4.3 pp -172.93 -175.69 1.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.861 -179.85 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.716 ' N ' HD12 ' A' ' 20' ' ' LEU . 3.2 t80 -110.29 154.65 23.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.024 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mt -140.15 153.55 22.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -121.04 -177.03 15.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.9 t30 70.46 71.41 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.297 -1.12 . . . . 0.0 110.012 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.91 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -114.1 27.43 9.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.307 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.537 ' HB2' HD21 ' A' ' 34' ' ' LEU . 0.1 OUTLIER 53.13 98.04 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 110.335 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.73 -9.9 22.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.96 1.505 . . . . 0.0 110.519 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -94.75 -12.94 26.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 109.83 179.917 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 12.4 mmtt -115.12 -160.01 0.72 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.449 -0.782 . . . . 0.0 109.536 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.728 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.0 m -112.69 148.09 35.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.795 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.6 t -67.44 -18.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.066 -1.021 . . . . 0.0 108.879 179.328 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 -41.98 80.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 178.861 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 3.8 pt-20 -66.88 -45.96 76.42 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.041 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.91 HD22 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -62.7 -34.21 76.67 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.861 . . . . 0.0 108.72 178.957 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 35' ' ' LYS . . . . . 0.94 ' HD2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -57.79 -49.55 76.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.773 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' A' ' 39' ' ' SER . 91.1 t -64.39 -32.18 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.594 -0.691 . . . . 0.0 109.141 178.584 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.561 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -65.7 -43.0 90.51 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.854 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.821 ' CD1' HG23 ' A' ' 82' ' ' VAL . 24.7 mm -75.63 -24.62 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.568 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 39' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -77.66 -35.2 52.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 179.095 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.07 -38.76 26.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.491 0.662 . . . . 0.0 109.724 179.528 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 1.044 HD21 HD22 ' A' ' 80' ' ' LEU . 10.4 tp -65.52 -32.43 74.02 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.406 179.356 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 42' ' ' PHE . . . . . 0.899 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 7.3 m-85 -87.51 -19.99 27.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.103 179.619 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.27 -26.96 20.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -92.39 -17.44 24.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.477 -0.764 . . . . 0.0 109.212 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 45' ' ' ASN . . . . . 0.608 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.8 m120 -83.23 -59.07 2.58 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.621 -0.674 . . . . 0.0 109.534 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 46' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.6 m-20 146.65 31.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.741 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.799 HD23 ' HB2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -102.27 -156.27 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.192 -0.942 . . . . 0.0 109.874 -179.836 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' ' HG2' ' A' ' 66' ' ' GLU . . . -162.39 56.51 0.23 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.784 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 39' ' ' SER . 10.4 m -45.53 118.79 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 50' ' ' VAL . . . . . 0.973 HG21 HG21 ' A' ' 16' ' ' THR . 0.0 OUTLIER -93.45 -33.89 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.586 ' C ' HG23 ' A' ' 52' ' ' VAL . 11.5 m-20 -149.35 148.24 29.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.322 -0.861 . . . . 0.0 110.686 -179.886 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.94 HG12 ' HD2' ' A' ' 35' ' ' LYS . 57.1 t -156.85 102.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.01 179.672 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -113.17 173.27 6.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 110.332 -179.814 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.795 HG22 ' CG1' ' A' ' 31' ' ' VAL . 2.0 p -82.33 -179.32 7.37 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.238 -0.914 . . . . 0.0 110.171 -179.665 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -140.91 132.5 5.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.659 HG22 ' OD1' ' A' ' 57' ' ' ASN . 63.4 m 58.34 -106.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.371 -1.076 . . . . 0.0 110.586 179.71 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.659 ' OD1' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -130.17 90.56 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.861 -1.149 . . . . 0.0 110.48 -179.701 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.543 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 19.2 mtt85 41.77 29.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.533 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HD3' ' ND2' ' A' ' 57' ' ' ASN . 0.0 OUTLIER -112.39 -32.96 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.915 . . . . 0.0 110.177 179.943 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 60' ' ' PHE . . . . . 0.606 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 m-85 -126.71 -162.59 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 109.361 179.733 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.58 132.12 2.15 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.575 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.712 ' O ' HG23 ' A' ' 63' ' ' VAL . 2.9 m-85 -86.33 158.35 19.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.404 -1.057 . . . . 0.0 109.116 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 63' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 52' ' ' VAL . 25.2 t -158.68 156.32 3.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.947 -179.155 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 64' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 50' ' ' VAL . 80.3 m-20 -142.39 144.88 33.33 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' O ' HG21 ' A' ' 50' ' ' VAL . 23.0 m-85 -114.97 -174.87 2.57 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.483 -0.761 . . . . 0.0 109.001 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.579 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -132.67 29.61 4.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.494 -1.379 . . . . 0.0 113.44 -176.6 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.777 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p -169.09 173.5 6.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.319 -1.488 . . . . 0.0 113.119 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.3 -27.42 52.99 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.393 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -28.89 62.83 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.912 179.41 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.799 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -76.5 -33.26 58.65 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.851 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -62.28 -43.89 97.79 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.997 179.794 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.485 ' N ' HD23 ' A' ' 71' ' ' LEU . 3.9 tt0 -66.26 -35.52 80.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.034 178.806 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.729 ' HB3' HD11 ' A' ' 47' ' ' LEU . 4.8 mttm -78.59 -21.19 48.94 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.13 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.771 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -69.33 -29.4 67.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.767 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 75' ' ' LEU . . . . . 0.67 ' C ' HD23 ' A' ' 75' ' ' LEU . 4.3 tt -77.22 -45.74 25.52 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.496 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.582 ' N ' HD23 ' A' ' 75' ' ' LEU . 8.5 tt0 -71.66 -7.15 46.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.642 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.899 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -57.63 -13.52 4.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 111.09 -179.996 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 78' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 78' ' ' THR . 45.8 m -69.2 3.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.912 . . . . 0.0 111.801 -179.186 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.61 10.95 16.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.477 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 1.044 HD22 HD21 ' A' ' 41' ' ' LEU . 45.6 mt -97.74 112.38 24.29 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.321 -1.105 . . . . 0.0 110.688 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 81' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 1.1 mttp -88.62 80.59 7.27 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.105 0.955 . . . . 0.0 110.295 179.589 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.821 HG23 ' CD1' ' A' ' 38' ' ' ILE . 1.1 p -46.16 126.84 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.697 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 33' ' ' GLU . 1.2 m-85 42.21 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.953 . . . . 0.0 110.653 -179.561 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.51 ' O ' ' ND2' ' A' ' 85' ' ' ASN . . . 97.18 17.68 31.22 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 5.5 m120 -133.54 110.52 9.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -1.142 . . . . 0.0 110.084 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.5 tm-20 -56.65 83.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 87' ' ' ILE . . . . . 0.792 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -39.3 151.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 110.771 -179.479 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 88' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 22' ' ' ILE . 31.9 ttpt -119.26 157.36 28.2 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.548 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 5.1 mp -112.36 179.07 4.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.232 -0.917 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -170.48 161.34 7.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.662 -0.649 . . . . 0.0 109.924 179.856 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.5 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -102.12 100.36 15.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.462 -179.708 . . . . . . . . 3 3 . 1 . 034 nuclear build full ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.1 Cg_endo -75.07 -169.16 0.6 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.081 1.569 . . . . 0.0 110.408 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 92' ' ' PRO . 13.2 tttm 42.38 45.42 3.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.23 139.5 3.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.96 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -178.19 2.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 0.0 110.221 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 98' ' ' THR . 17.0 t70 -84.28 61.37 6.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.201 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 98' ' ' THR . . . 74.5 -110.75 3.17 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.92 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 98' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 96' ' ' ASP . 3.4 p 42.31 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -1.164 . . . . 0.0 110.354 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 166.55 13.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.903 . . . . 0.0 110.148 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear build full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.24 65.34 3.46 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear build full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.268 -1.137 . . . . 0.0 110.249 -179.98 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.489 1.518 0 CA-C-O 121.521 0.677 . . . . 0.0 109.961 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.822 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -148.47 166.48 15.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.74 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.2 Cg_endo -78.8 -42.91 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.233 1.649 . . . . 0.0 110.769 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CE2' ' C ' ' A' ' 67' ' ' SER . 96.3 m-85 -96.88 110.88 23.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 110.516 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -137.32 151.73 48.96 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -161.31 -178.03 6.41 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 110.391 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 62' ' ' TYR . 6.2 t80 -112.4 146.65 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.338 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.3 mt -130.91 155.99 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.827 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 60' ' ' PHE . . . -136.51 -164.74 10.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.912 ' C ' HD12 ' A' ' 25' ' ' LEU . 31.2 t-20 65.64 70.59 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.08 . . . . 0.0 110.092 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.912 HD12 ' C ' ' A' ' 24' ' ' ASN . 10.2 mp -119.16 130.25 55.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.845 . . . . 0.0 110.255 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.779 ' H ' HD21 ' A' ' 34' ' ' LEU . 31.5 t30 -54.15 107.99 1.01 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.506 -0.746 . . . . 0.0 110.346 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.2 Cg_endo -74.49 -8.73 20.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.049 1.552 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 7.1 m120 -84.05 -14.54 50.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -117.57 -157.24 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.39 -0.819 . . . . 0.0 109.859 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.659 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.6 m -100.14 146.92 26.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 54' ' ' THR . 11.2 t -69.79 -30.37 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.319 -0.953 . . . . 0.0 109.059 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -63.72 -38.16 90.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.0 109.034 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 54.7 mm-40 -68.14 -36.31 79.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.854 HD23 HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -62.42 -32.93 73.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.367 -0.833 . . . . 0.0 108.836 178.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.618 ' HG3' HG12 ' A' ' 52' ' ' VAL . 1.6 mptp? -65.82 -50.37 64.88 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.575 -0.703 . . . . 0.0 109.314 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.4 t -58.53 -35.64 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.842 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.57 -35.85 81.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.137 -0.977 . . . . 0.0 108.727 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.581 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 35.9 mt -80.15 -27.11 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.157 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.53 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -79.43 -29.46 41.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.067 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.93 -38.37 27.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.361 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.676 HD22 HD23 ' A' ' 80' ' ' LEU . 5.2 tp -68.12 -32.17 72.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 6.0 m-85 -82.31 -23.19 35.27 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.54 65.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 109.362 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -89.37 -21.15 23.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.727 . . . . 0.0 109.456 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.635 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.1 m-80 -80.57 -20.52 43.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.474 -0.766 . . . . 0.0 109.743 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.635 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.2 t0 91.21 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.939 0.876 . . . . 0.0 108.759 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.882 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -84.11 -139.26 0.06 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -177.21 58.41 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.217 -0.927 . . . . 0.0 109.774 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.2 m -60.03 117.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.965 0.888 . . . . 0.0 109.94 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.822 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.6 t -95.29 -33.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.265 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.518 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 12.4 t0 -144.68 153.77 42.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.977 . . . . 0.0 110.676 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.618 HG12 ' HG3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -155.91 99.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.87 . . . . 0.0 108.979 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -102.26 156.82 17.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.106 -0.996 . . . . 0.0 110.733 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.931 HG22 HG12 ' A' ' 31' ' ' VAL . 44.5 p -90.64 154.65 19.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.429 -0.795 . . . . 0.0 110.319 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' A' ' 60' ' ' PHE . . . -127.49 128.32 6.09 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.578 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 3.4 m 60.72 170.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.836 -0.802 . . . . 0.0 109.878 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.54 ' N ' HG22 ' A' ' 56' ' ' THR . 68.8 m-80 -38.6 -42.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.467 -0.77 . . . . 0.0 110.412 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.543 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 172.45 51.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.817 . . . . 0.0 109.802 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -110.54 -31.24 7.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.306 -0.871 . . . . 0.0 110.494 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.825 ' HA ' HD13 ' A' ' 25' ' ' LEU . 5.9 p90 -159.39 149.33 18.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.026 -1.047 . . . . 0.0 110.424 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -132.82 164.8 24.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.45 162.44 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -1.083 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 52' ' ' VAL . 3.2 t -151.4 141.59 15.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.749 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.485 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 50.2 m-20 -112.06 147.54 35.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.501 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.6 m-85 -108.26 179.84 4.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.821 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.586 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -114.08 13.42 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 111.496 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.54 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.4 p 178.88 179.42 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.381 1.086 . . . . 0.0 112.072 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.25 52.94 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -27.07 37.29 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.727 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 79.4 m-20 -83.43 -25.9 30.83 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.765 HD13 ' O ' ' A' ' 71' ' ' LEU . 3.3 tm? -80.69 -34.79 34.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.477 0.656 . . . . 0.0 109.281 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.92 -36.13 67.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.806 . . . . 0.0 109.487 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.882 ' HB2' HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -76.43 -27.45 56.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.89 -29.5 68.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -71.25 -45.99 62.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -75.92 -4.21 39.68 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.225 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.964 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -77.77 12.01 1.89 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 110.281 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -9.23 12.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.039 -1.038 . . . . 0.0 110.089 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.12 33.98 3.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.009 HD13 ' CD1' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -85.37 -170.15 2.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.125 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -179.1 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.257 1.027 . . . . 0.0 109.876 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HD23 ' A' ' 34' ' ' LEU . 41.4 t -40.97 127.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.994 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 8.4 m-85 43.96 25.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.132 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . 90.7 20.43 40.44 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' VAL . 23.4 m-20 -131.62 102.39 5.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -1.156 . . . . 0.0 109.521 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.582 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -53.47 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.272 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.009 ' CD1' HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -47.46 142.57 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -108.11 163.88 12.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 109.163 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.604 HD23 ' CD1' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -115.53 -179.34 3.61 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 110.459 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.562 ' C ' HG23 ' A' ' 16' ' ' THR . 16.9 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.306 0.574 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.678 ' CG2' HG11 ' A' ' 50' ' ' VAL . 70.1 p -153.85 161.88 28.12 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.288 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.58 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.71 -23.88 14.03 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.025 1.539 . . . . 0.0 110.7 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.58 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 98.4 m-85 -106.37 112.67 25.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 110.562 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 18' ' ' PHE . 3.2 m120 -143.82 153.53 42.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.586 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -166.49 -177.51 4.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.673 ' N ' HD12 ' A' ' 20' ' ' LEU . 35.0 t80 -113.71 151.01 32.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 110.134 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.0 157.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 109.658 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.69 -168.47 11.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.562 ' C ' HD22 ' A' ' 25' ' ' LEU . 2.0 t30 69.31 50.91 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -1.099 . . . . 0.0 110.214 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.97 HD23 ' HA ' ' A' ' 60' ' ' PHE . 3.6 mm? -100.13 123.08 43.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.735 ' N ' HD21 ' A' ' 34' ' ' LEU . 25.7 t-20 -42.92 102.18 0.27 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.59 -0.694 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.37 -14.21 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.02 1.537 . . . . 0.0 110.369 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.428 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 1.9 m-20 -80.25 -19.34 47.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -107.13 -156.31 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.414 -0.804 . . . . 0.0 109.832 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.1 m -103.2 143.14 33.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.967 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.5 t -66.58 -19.2 25.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.107 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . . . -71.54 -41.46 69.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 108.989 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.8 mm-40 -66.11 -37.49 85.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 109.288 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.735 HD21 ' N ' ' A' ' 26' ' ' ASN . 5.0 mp -63.05 -34.58 77.89 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.315 -0.865 . . . . 0.0 108.745 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.614 ' CG ' HG22 ' A' ' 52' ' ' VAL . 2.8 mttt -60.14 -56.91 15.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 25.4 t -60.93 -34.59 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.588 -0.695 . . . . 0.0 109.468 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.35 -33.4 75.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 108.694 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.488 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.2 mt -81.11 -28.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.99 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -78.6 -30.29 46.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.084 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.22 -37.7 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.546 0.689 . . . . 0.0 109.458 179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.912 HD13 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -68.56 -31.56 70.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.087 179.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.681 ' CE1' HD11 ' A' ' 80' ' ' LEU . 13.2 m-85 -88.16 -16.8 32.41 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.4 -29.38 19.11 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.995 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -91.82 -18.74 23.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.465 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.601 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -81.32 -58.73 2.92 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 0.0 109.719 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.1 m-20 148.26 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.27 0.557 . . . . 0.0 109.843 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.74 HD11 ' CB ' ' A' ' 73' ' ' LYS . 4.1 mm? -106.1 -158.94 0.68 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.328 -0.857 . . . . 0.0 109.586 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.813 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -160.41 61.9 0.33 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.955 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.99 HG21 ' HA ' ' A' ' 39' ' ' SER . 6.7 m -52.83 118.12 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.882 0.848 . . . . 0.0 109.856 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.751 HG22 ' HB3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -87.43 -43.12 15.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 121.878 -0.514 . . . . 0.0 109.99 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 4.5 t0 -144.46 158.17 43.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.614 HG22 ' CG ' ' A' ' 35' ' ' LYS . 2.1 p -149.21 156.65 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 0.0 109.706 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -165.26 165.92 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.167 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.967 HG22 ' CG1' ' A' ' 31' ' ' VAL . 12.5 p -79.56 179.46 7.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.403 -0.811 . . . . 0.0 110.329 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -142.1 135.31 6.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 97.8 m 59.43 -83.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.903 . . . . 0.0 110.449 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 55' ' ' GLY . 1.6 m-20 -161.54 97.09 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.046 -1.034 . . . . 0.0 110.642 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.53 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 42.75 27.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.903 . . . . 0.0 110.655 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -119.58 -33.23 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 110.156 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.97 ' HA ' HD23 ' A' ' 25' ' ' LEU . 3.2 m-85 -129.18 177.31 7.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.54 129.12 2.59 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.076 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 63' ' ' VAL . 28.4 t80 -92.82 163.9 13.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 109.644 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 62' ' ' TYR . 27.7 t -157.95 159.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.867 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -126.28 138.33 53.59 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.612 -0.68 . . . . 0.0 109.58 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 24.8 m-85 -102.7 175.26 5.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.676 -0.64 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.813 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 3.0 pt-20 -118.44 14.66 13.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 111.564 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.534 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.7 p -172.61 173.9 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.906 -1.121 . . . . 0.0 112.165 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.542 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.5 -23.91 42.63 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -25.43 30.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.642 ' OD1' HD12 ' A' ' 47' ' ' LEU . 5.4 t0 -82.14 -25.73 34.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.781 HD13 ' C ' ' A' ' 71' ' ' LEU . 2.7 tm? -81.95 -33.64 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -34.37 71.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.756 . . . . 0.0 109.379 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.74 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -77.26 -28.75 53.67 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.12 -27.13 67.07 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -73.55 -48.85 29.8 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.82 -3.72 30.34 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.3 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.968 HD12 ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -76.55 8.8 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.489 -0.757 . . . . 0.0 110.469 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 m -64.58 -8.72 15.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.198 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.97 17.8 48.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.09 HD13 HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -72.31 -171.94 0.84 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.403 -1.057 . . . . 0.0 110.67 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.4 mttt -170.64 49.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.355 1.074 . . . . 0.0 109.655 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.795 HG21 HG21 ' A' ' 87' ' ' ILE . 23.7 t -40.06 124.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.027 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.9 m-85 42.72 29.38 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.188 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.12 25.14 38.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' VAL . 11.4 m120 -134.16 86.37 2.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.603 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.589 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 21.1 tt0 -41.92 100.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.09 HD11 HD13 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -60.18 140.22 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.489 -0.757 . . . . 0.0 110.42 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -111.63 156.3 22.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.153 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.606 ' CD1' HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -120.39 169.73 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.043 -1.035 . . . . 0.0 110.608 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 . . . . . 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.014 -179.98 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 16' ' ' THR . 4.1 m . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 121.194 0.521 . . . . 0.0 110.208 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.967 HG21 ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -167.4 158.24 9.95 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 110.477 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.86 -34.98 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.154 1.608 . . . . 0.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.522 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.1 m-85 -112.22 114.3 27.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.484 ' ND2' ' C ' ' A' ' 18' ' ' PHE . 2.8 m120 -132.87 148.98 52.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -165.4 -177.36 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.618 ' N ' HD12 ' A' ' 20' ' ' LEU . 3.3 t80 -115.2 150.01 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.97 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 88' ' ' LYS . 2.2 mt -129.95 158.34 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.427 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.48 -173.45 13.04 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.84 ' C ' HD22 ' A' ' 25' ' ' LEU . 1.3 t30 72.54 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -1.012 . . . . 0.0 110.197 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.0 mm? -116.45 165.48 13.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 110.106 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 40.8 t30 -95.22 106.74 27.84 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 110.344 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -73.54 -13.92 24.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.042 1.548 . . . . 0.0 110.447 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.439 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 1.9 m-80 -78.67 -17.72 55.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.581 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -113.27 -155.27 0.56 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.44 -0.788 . . . . 0.0 109.862 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.499 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -100.65 142.53 32.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 110.498 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.799 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.9 t -67.37 -32.33 56.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.179 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.94 -39.01 92.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.319 -0.863 . . . . 0.0 108.965 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 70.2 mm-40 -63.79 -36.46 83.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.559 -0.713 . . . . 0.0 109.092 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 31' ' ' VAL . 92.2 mt -61.3 -38.81 88.14 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.37 -0.832 . . . . 0.0 108.908 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.868 ' HD3' HG12 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -58.96 -50.37 74.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -60.09 -37.72 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.477 -0.764 . . . . 0.0 109.668 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -61.35 -28.34 69.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.072 -1.017 . . . . 0.0 109.11 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.579 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 7.0 mt -87.84 -28.06 5.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.482 -0.761 . . . . 0.0 109.14 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 7.5 t -80.61 -24.71 38.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.167 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.52 -37.43 19.66 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.532 -0.73 . . . . 0.0 109.141 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.084 HD22 HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -67.47 -34.72 77.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.092 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 7.1 m-85 -83.47 -22.53 32.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -74.48 -33.72 62.92 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -18.21 25.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 0.0 109.345 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.21 -19.35 39.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.526 -0.734 . . . . 0.0 109.863 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 t70 91.69 29.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.008 0.909 . . . . 0.0 108.839 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -87.95 -140.68 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.717 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -178.28 59.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.6 m -56.01 117.08 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.075 0.941 . . . . 0.0 110.171 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.967 ' HB ' HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -88.98 -36.51 8.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.67 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.2 t70 -143.69 147.31 34.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.056 HG13 HG22 ' A' ' 63' ' ' VAL . 2.6 t -153.23 139.63 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.609 -0.682 . . . . 0.0 109.462 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -158.08 -179.63 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.798 HG22 HG12 ' A' ' 31' ' ' VAL . 17.0 p -84.7 177.95 7.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.316 -0.865 . . . . 0.0 110.594 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -137.23 132.43 5.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.576 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 52.3 m 57.68 -91.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.484 ' N ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -153.02 98.1 2.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.073 -1.017 . . . . 0.0 110.434 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.551 ' HG3' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 41.92 26.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -116.35 -32.31 5.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.8 m-85 -135.97 -175.82 4.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.359 -0.838 . . . . 0.0 109.498 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.6 145.9 13.72 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.101 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.808 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -101.26 161.42 13.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -1.107 . . . . 0.0 109.528 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.056 HG22 HG13 ' A' ' 52' ' ' VAL . 4.7 t -161.46 159.86 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.552 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.1 m-20 -140.93 142.03 34.45 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.709 -0.619 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.714 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 61.2 m-85 -106.16 174.44 5.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.719 -0.613 . . . . 0.0 110.584 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.717 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 6.6 pt-20 -114.67 13.2 17.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 111.849 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.522 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.0 p -170.06 177.26 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.855 -1.153 . . . . 0.0 112.255 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.91 -23.56 48.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.51 -27.57 46.11 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.475 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 83.0 m-20 -83.14 -27.91 29.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.783 HD13 ' C ' ' A' ' 71' ' ' LEU . 1.9 tm? -73.67 -38.67 64.85 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.274 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -37.25 71.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.42 -0.8 . . . . 0.0 109.348 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.792 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.11 -20.44 52.15 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.738 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -71.57 -31.94 67.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.9 tt -76.8 -43.5 36.45 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.551 -0.718 . . . . 0.0 109.081 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -25.0 66.04 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.419 -0.8 . . . . 0.0 109.584 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.092 HD13 ' CZ ' ' A' ' 42' ' ' PHE . 14.2 mt -66.82 -8.22 27.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 110.126 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.898 ' OG1' HD21 ' A' ' 89' ' ' LEU . 5.9 m -48.42 -19.81 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 110.654 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.23 34.78 3.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.084 HD21 HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.33 -165.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 110.694 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.0 mtmt -169.64 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.193 0.997 . . . . 0.0 109.67 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 85' ' ' ASN . 2.9 p -37.83 125.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.179 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.8 m-85 41.75 26.69 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.456 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 89.91 24.38 30.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.751 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.3 m120 -135.04 89.82 2.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -1.137 . . . . 0.0 109.565 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.565 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.8 pt-20 -41.17 106.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 110.858 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.082 HD11 HD13 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -72.54 135.54 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 110.285 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -112.04 159.76 18.15 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.506 -0.747 . . . . 0.0 109.156 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.898 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.2 OUTLIER -117.31 172.7 7.13 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.864 -1.147 . . . . 0.0 110.574 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 110.201 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 16' ' ' THR . 1.9 t . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.514 0.673 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.828 HG21 HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -134.85 157.65 76.67 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 110.496 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -79.57 -30.92 2.22 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 124.204 1.634 . . . . 0.0 110.821 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.869 ' HD1' HD13 ' A' ' 71' ' ' LEU . 56.7 m-85 -103.31 104.52 14.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 110.895 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.517 ' ND2' ' HB3' ' A' ' 64' ' ' ASP . 3.3 m120 -137.85 149.06 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.436 -0.79 . . . . 0.0 109.344 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.3 pp -163.84 -175.58 4.16 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.453 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 41.5 t80 -108.86 167.54 10.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.64 HD12 ' CG2' ' A' ' 63' ' ' VAL . 14.8 mt -147.33 158.89 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.666 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -137.24 179.46 18.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 3.9 t30 70.16 92.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -1.127 . . . . 0.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.954 ' HB3' HD13 ' A' ' 34' ' ' LEU . 21.8 mt -145.02 130.92 19.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.978 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.624 ' HB3' HD21 ' A' ' 34' ' ' LEU . 37.5 t-20 -38.95 99.29 0.19 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.737 -0.602 . . . . 0.0 110.528 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -74.19 -19.28 20.13 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.081 1.569 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -78.5 -13.71 59.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -110.52 -155.65 0.57 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 109.97 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 6.5 m -104.73 152.7 22.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.315 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.949 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.7 t -69.71 -46.01 76.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 109.452 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -49.52 -38.95 32.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.878 . . . . 0.0 109.279 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 28.5 mm-40 -67.97 -40.01 83.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.437 -0.789 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.954 HD13 ' HB3' ' A' ' 25' ' ' LEU . 25.6 mt -60.72 -36.59 79.23 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.298 -0.876 . . . . 0.0 108.742 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 10.3 mmtt -62.32 -57.64 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 32' ' ' ALA . 17.2 t -52.22 -35.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.99 -34.48 78.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 34' ' ' LEU . 4.5 mt -82.1 -27.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.501 ' HA ' HG21 ' A' ' 49' ' ' VAL . 75.2 m -77.86 -30.15 50.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.937 . . . . 0.0 109.023 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.59 -37.02 32.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.752 . . . . 0.0 109.456 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.08 -30.53 68.87 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.587 -0.696 . . . . 0.0 109.145 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.687 ' HE1' HD22 ' A' ' 80' ' ' LEU . 7.1 m-85 -84.7 -22.46 29.75 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.88 -32.42 61.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.437 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -12.44 28.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.0 109.735 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -92.41 -11.17 35.56 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.3 t70 85.12 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.917 0.865 . . . . 0.0 109.281 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.976 HD11 ' HB3' ' A' ' 73' ' ' LYS . 3.0 mm? -86.76 -131.15 0.06 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.863 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 168.38 56.34 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.841 -1.162 . . . . 0.0 109.692 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.6 m -58.16 120.5 4.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.067 0.937 . . . . 0.0 110.375 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -90.37 -46.85 14.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.448 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.472 ' OD2' HG21 ' A' ' 15' ' ' THR . 3.6 m-20 -148.1 118.88 7.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.173 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.871 HG12 HG13 ' A' ' 63' ' ' VAL . 16.6 m -101.24 171.55 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.295 -0.878 . . . . 0.0 109.692 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.82 164.48 16.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 0.0 110.431 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.725 ' HB ' HG11 ' A' ' 31' ' ' VAL . 23.4 p -92.03 162.32 14.42 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.456 -0.777 . . . . 0.0 110.549 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -117.5 121.47 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.549 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 2.1 m 72.0 -56.17 0.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.62 -0.929 . . . . 0.0 110.122 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.545 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.3 OUTLIER 173.74 -35.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.596 ' HA ' HG22 ' A' ' 31' ' ' VAL . 31.8 ttp180 -172.5 26.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.549 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.547 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 34.6 mttp -119.31 -33.74 4.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.654 ' C ' HD12 ' A' ' 25' ' ' LEU . 1.1 m-85 -131.26 -165.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.328 -0.858 . . . . 0.0 109.349 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -171.01 161.93 34.74 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.236 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.0 t80 -123.36 154.81 38.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.42 -1.047 . . . . 0.0 109.554 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.871 HG13 HG12 ' A' ' 52' ' ' VAL . 3.5 t -150.71 146.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.004 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.517 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 1.1 m-20 -118.27 135.06 54.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.529 -0.732 . . . . 0.0 109.507 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.681 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 51.4 m-85 -102.44 171.91 7.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.714 -0.616 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.771 ' HB3' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.58 15.77 16.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.89 . . . . 0.0 111.344 -178.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p -166.82 173.8 9.15 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.603 1.192 . . . . 0.0 112.281 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.453 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.24 -25.72 51.84 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.478 ' OE1' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.38 -26.79 58.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.571 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.863 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 89.1 m-20 -82.41 -30.63 30.05 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.869 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -73.15 -36.56 66.68 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.827 179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -73.39 -38.72 65.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.813 . . . . 0.0 109.98 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.976 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.3 -29.64 47.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 70' ' ' ASP . . . -64.39 -31.33 72.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.841 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 4.6 tt -72.82 -45.18 59.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.1 mt-10 -81.03 -1.13 42.76 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.41 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -77.91 7.83 5.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.282 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.792 ' OG1' HD21 ' A' ' 89' ' ' LEU . 92.4 m -70.29 -2.55 13.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 110.473 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.55 65.45 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.9 HD21 HD11 ' A' ' 87' ' ' ILE . 1.2 pp -71.69 129.4 38.59 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.388 -1.066 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -99.98 84.86 2.94 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.975 0.893 . . . . 0.0 109.518 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.901 HG11 HD23 ' A' ' 25' ' ' LEU . 4.2 p -43.85 118.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.727 -0.789 . . . . 0.0 108.998 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 2.1 m-85 46.01 22.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 110.306 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.03 12.26 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.319 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.801 ' O ' HG12 ' A' ' 82' ' ' VAL . 9.6 m120 -126.49 89.67 3.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.31 . . . . 0.0 110.387 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.9 mp0 -40.33 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.63 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.9 HD11 HD21 ' A' ' 80' ' ' LEU . 12.5 pt -71.28 146.54 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.784 0.802 . . . . 0.0 110.581 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.53 ' O ' HG23 ' A' ' 22' ' ' ILE . 15.9 ttpt -116.06 158.64 22.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -119.07 167.95 11.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.837 -1.164 . . . . 0.0 110.415 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.167 -179.959 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.793 ' C ' HG23 ' A' ' 16' ' ' THR . 7.2 m . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 121.174 0.511 . . . . 0.0 110.143 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.94 ' CG2' HG11 ' A' ' 50' ' ' VAL . 1.4 p 77.8 163.41 0.13 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.565 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.8 Cg_endo -77.85 -31.75 2.99 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.227 1.646 . . . . 0.0 110.91 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 74.4 m-85 -86.61 102.39 14.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.949 -1.094 . . . . 0.0 110.557 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 16' ' ' THR . 67.0 m-20 -139.52 157.74 45.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.219 -0.926 . . . . 0.0 109.623 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 20' ' ' LEU . 2.2 pp -167.02 -177.08 3.62 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.288 -0.882 . . . . 0.0 110.416 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 t80 -117.29 146.58 43.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.574 HD12 ' CG2' ' A' ' 63' ' ' VAL . 2.2 mt -129.93 160.5 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -136.63 -172.67 12.64 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.704 ' C ' HD22 ' A' ' 25' ' ' LEU . 10.1 t-20 72.33 63.95 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.496 -1.002 . . . . 0.0 110.47 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.863 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.1 mm? -106.53 119.54 39.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.762 ' HB2' HD21 ' A' ' 34' ' ' LEU . 11.6 t-20 -41.31 107.21 0.47 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.704 -0.622 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.79 -30.3 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.55 . . . . 0.0 110.042 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -78.83 -11.73 60.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.852 . . . . 0.0 109.63 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' CD ' ' A' ' 33' ' ' GLU . 4.4 mmtp -111.31 -156.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.342 -0.849 . . . . 0.0 109.74 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -111.96 150.71 30.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.335 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.956 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.2 t -72.83 -19.97 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.376 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -74.38 -45.2 48.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.573 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -62.08 -38.03 87.29 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 31' ' ' VAL . 44.4 mt -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.226 -0.921 . . . . 0.0 108.912 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 1.7 mptp? -58.17 -48.88 78.92 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.547 0.689 . . . . 0.0 109.379 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 32' ' ' ALA . 26.4 t -56.06 -35.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.723 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -63.3 -37.32 86.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 108.658 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 42' ' ' PHE . 34.6 mt -81.41 -25.0 10.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.79 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 3.6 p -80.35 -26.95 38.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.066 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.92 -41.92 15.47 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.661 0.743 . . . . 0.0 109.31 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.937 HD22 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.0 -35.74 81.68 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.081 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.783 ' CE1' HD11 ' A' ' 80' ' ' LEU . 9.4 m-30 -85.34 -21.82 28.75 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.751 0.786 . . . . 0.0 108.943 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.57 -35.18 60.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.466 0.65 . . . . 0.0 109.509 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -84.11 -15.38 47.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 109.366 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.64 -10.94 44.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.859 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.3 t0 83.79 29.17 0.08 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.946 0.879 . . . . 0.0 108.832 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.94 HD21 ' CE1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -73.84 -130.84 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.052 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 173.27 57.45 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.447 -0.783 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 49' ' ' VAL . 15.8 m -57.26 117.44 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.936 0.874 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.94 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -93.42 -34.18 5.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.554 ' HB2' ' CG2' ' A' ' 15' ' ' THR . 0.7 OUTLIER -149.03 152.19 35.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.823 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.698 HG13 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -157.85 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.485 -0.76 . . . . 0.0 109.072 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.472 ' C ' ' CE ' ' A' ' 35' ' ' LYS . 7.1 mmm180 -106.96 168.23 9.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.772 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.956 ' HB ' HG11 ' A' ' 31' ' ' VAL . 4.4 p -80.17 170.94 15.74 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.438 -0.789 . . . . 0.0 110.279 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -128.88 114.1 1.7 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.4 m 67.66 -139.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 110.312 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.476 ' H ' HG22 ' A' ' 56' ' ' THR . 80.8 m-20 -98.24 76.35 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 36.8 mtt180 57.8 42.12 23.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.486 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 21.2 mttt -119.46 -31.44 4.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.863 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.8 m-85 -139.79 -169.26 2.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -166.8 140.59 6.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 2.3 m-30 -99.13 157.12 16.58 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.258 -1.143 . . . . 0.0 109.591 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.698 HG13 HG13 ' A' ' 52' ' ' VAL . 3.9 t -151.24 143.73 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.7 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.521 ' OD2' ' CG2' ' A' ' 15' ' ' THR . 0.8 OUTLIER -122.34 140.9 52.13 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.365 -0.835 . . . . 0.0 109.979 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.94 ' CE1' HD21 ' A' ' 47' ' ' LEU . 14.2 m-85 -107.48 172.31 6.9 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.877 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -122.52 19.2 10.45 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.067 -1.021 . . . . 0.0 111.115 -178.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.2 p -165.06 176.22 8.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.588 1.185 . . . . 0.0 112.251 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.18 -25.81 42.73 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -32.06 63.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.036 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 1.052 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 90.4 m-20 -77.81 -29.57 50.76 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.783 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tt -71.22 -39.73 71.54 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.63 ' N ' HD23 ' A' ' 71' ' ' LEU . 5.9 tt0 -62.16 -38.34 88.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' LEU . 23.9 mmtt -72.41 -24.62 61.26 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 71' ' ' LEU . . . -63.97 -34.92 79.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 75' ' ' LEU . 7.0 tt -72.02 -44.64 63.09 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.4 9.72 14.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.094 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -75.89 -13.05 60.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.602 -0.686 . . . . 0.0 110.585 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.625 ' CA ' HD21 ' A' ' 89' ' ' LEU . 96.4 m -72.38 3.66 4.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.29 39.35 2.92 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 87' ' ' ILE . 7.4 mt -100.14 -167.55 1.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -1.009 . . . . 0.0 111.017 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -167.61 51.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.069 0.937 . . . . 0.0 108.925 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 85' ' ' ASN . 4.1 p -34.66 118.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.248 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 15.1 m-85 38.35 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 0.0 110.557 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 96.8 22.0 19.55 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.853 ' O ' HG12 ' A' ' 82' ' ' VAL . 5.9 m-20 -134.01 84.34 2.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.093 -1.24 . . . . 0.0 109.853 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.553 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 23.4 tt0 -40.11 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.666 0.746 . . . . 0.0 110.44 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -59.55 123.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.607 -0.683 . . . . 0.0 110.499 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.5 mttp -95.25 127.88 41.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.003 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.625 HD21 ' CA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -109.34 169.67 8.55 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.399 -179.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.499 0.666 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.946 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.57 172.79 5.44 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.65 -0.656 . . . . 0.0 110.691 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.5 Cg_endo -77.86 -47.0 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.136 1.598 . . . . 0.0 110.552 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.647 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.6 m-85 -87.51 111.12 20.86 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 110.22 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.01 150.39 32.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.374 -0.828 . . . . 0.0 109.113 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.184 HD12 ' CE1' ' A' ' 65' ' ' PHE . 13.9 mt -146.42 170.2 17.32 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.361 -0.837 . . . . 0.0 111.22 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.656 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 5.8 t80 -126.06 140.76 52.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.79 HD12 HG21 ' A' ' 63' ' ' VAL . 8.6 mt -137.63 147.8 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 110.774 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.06 -167.66 11.59 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 21.4 t-20 70.92 36.87 1.38 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -1.093 . . . . 0.0 110.372 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.1 mm? -88.4 126.97 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.504 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 36.4 t-20 -40.9 107.76 0.5 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.661 -0.649 . . . . 0.0 110.378 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.41 -8.36 21.67 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.047 1.551 . . . . 0.0 110.289 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 28.1 m120 -96.71 -20.75 18.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.638 ' CD ' ' CE1' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -103.48 -158.9 0.69 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -103.8 148.27 26.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.286 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.86 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.1 t -69.71 -26.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.912 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -65.36 -41.16 94.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.416 -0.802 . . . . 0.0 109.031 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.6 mm-40 -64.27 -45.26 88.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 31' ' ' VAL . 8.4 mt -60.09 -39.02 84.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.02 -57.17 14.25 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.539 0.685 . . . . 0.0 109.687 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 32' ' ' ALA . 15.0 t -57.23 -31.52 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.852 . . . . 0.0 109.714 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.08 -39.06 92.66 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.183 -0.948 . . . . 0.0 108.822 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 19.3 mt -78.3 -24.72 13.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 109.362 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.517 ' HA ' HG21 ' A' ' 49' ' ' VAL . 30.4 t -80.83 -33.22 34.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.147 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.61 -37.04 43.27 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.581 0.705 . . . . 0.0 109.461 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.616 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.33 -31.94 69.46 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.102 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.913 ' CD2' HD22 ' A' ' 47' ' ' LEU . 3.3 m-85 -77.74 -26.28 49.82 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.89 -29.67 61.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.549 -0.719 . . . . 0.0 109.706 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.478 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.19 -22.42 17.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.703 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.8 m-80 -74.53 -42.15 59.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.703 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.6 t70 122.59 28.86 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.534 0 C-N-CA 123.682 0.793 . . . . 0.0 109.46 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.015 HD11 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -96.82 -153.87 0.43 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.463 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.72 61.45 0.2 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 ' CD2' ' A' ' 42' ' ' PHE . 6.0 m -55.23 115.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 122.08 0.943 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.946 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -91.28 -38.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -143.5 154.02 43.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.348 -0.845 . . . . 0.0 110.425 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -157.93 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.395 -0.816 . . . . 0.0 109.172 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -121.3 165.66 15.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.006 -1.059 . . . . 0.0 111.055 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.694 ' HB ' HG11 ' A' ' 31' ' ' VAL . 13.0 p -88.37 156.74 18.99 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -124.9 118.1 3.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 57' ' ' ASN . 3.5 m 66.77 -175.74 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -1.063 . . . . 0.0 110.757 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.69 ' H ' HG22 ' A' ' 56' ' ' THR . 16.9 m120 -63.95 65.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.392 -0.817 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' THR . 2.1 mtt180 61.74 59.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 110.694 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -120.41 -34.8 3.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.808 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.2 p90 -165.44 140.37 4.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.266 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -112.33 163.75 12.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.716 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 39.1 m-85 -114.26 163.42 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -1.003 . . . . 0.0 109.635 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.79 HG21 HD12 ' A' ' 22' ' ' ILE . 2.9 t -152.0 139.46 13.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.043 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' PHE . 3.6 m-20 -106.81 140.44 39.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.023 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 1.184 ' CE1' HD12 ' A' ' 20' ' ' LEU . 13.1 m-85 -107.48 170.43 7.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 0.0 110.631 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.727 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -116.22 16.08 15.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 111.328 -178.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.552 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 3.1 t -163.44 175.32 10.9 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.748 1.261 . . . . 0.0 112.272 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.74 -24.67 22.62 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -89.35 -22.16 22.75 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 10.7 t0 -81.4 -34.02 31.87 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.681 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 7.6 tt -76.28 -34.6 59.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -37.35 84.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.421 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 1.015 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.8 mtmt -72.3 -27.69 62.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.914 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -62.53 -34.07 76.18 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 5.5 tt -71.05 -44.49 65.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.29 1.18 22.57 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.488 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.045 HD12 HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -79.75 12.64 2.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.855 . . . . 0.0 110.414 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -78.28 2.67 17.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.08 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.06 33.63 5.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.045 HD11 HD12 ' A' ' 77' ' ' LEU . 22.3 mt -98.44 -166.25 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.253 -1.145 . . . . 0.0 110.982 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.9 mttt -166.78 49.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.304 1.049 . . . . 0.0 109.416 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.794 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -38.25 126.94 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.288 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.638 ' CE1' ' CD ' ' A' ' 29' ' ' LYS . 9.0 m-85 42.46 26.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 110.414 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 90.55 21.67 36.63 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' VAL . 36.3 m-80 -136.19 99.51 4.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -1.136 . . . . 0.0 109.393 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.569 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -48.79 90.84 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 110.61 -179.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -48.83 135.24 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.85 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.2 ttpt -104.23 152.65 21.93 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -124.79 172.8 9.04 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.539 -0.726 . . . . 0.0 110.482 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 . . . . . 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.962 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.232 0.539 . . . . 0.0 110.186 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 1.014 ' CG2' HG11 ' A' ' 50' ' ' VAL . 1.9 p -162.98 169.03 9.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 48.4 Cg_endo -76.58 -25.77 9.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.095 1.576 . . . . 0.0 110.734 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.721 ' CD1' HD13 ' A' ' 71' ' ' LEU . 87.6 m-85 -121.33 113.11 19.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.95 -1.094 . . . . 0.0 111.126 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -139.68 150.48 44.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 109.092 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -161.99 178.61 8.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.464 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -97.93 162.87 13.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.671 . . . . 0.0 109.374 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.062 HD12 ' CG2' ' A' ' 63' ' ' VAL . 6.0 mt -153.82 152.08 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.922 -1.111 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -143.5 -166.29 11.17 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.112 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.575 ' C ' HD22 ' A' ' 25' ' ' LEU . 6.7 t30 72.71 46.1 0.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.553 -0.969 . . . . 0.0 109.883 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.928 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.9 mm? -100.56 128.71 46.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.551 ' HB3' HD21 ' A' ' 34' ' ' LEU . 56.9 t-20 -44.89 103.48 0.34 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.255 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.4 Cg_endo -73.63 -20.9 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.977 1.514 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -14.7 60.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.861 . . . . 0.0 109.965 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 3.0 mmtt -110.91 -155.75 0.57 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -106.63 149.57 27.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.975 HG11 HG22 ' A' ' 54' ' ' THR . 3.1 t -67.97 -40.93 84.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.4 64.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.1 mm-40 -66.29 -35.39 80.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 109.308 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.928 HD13 ' HB3' ' A' ' 25' ' ' LEU . 55.6 mt -65.96 -36.31 82.98 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.367 -0.833 . . . . 0.0 109.081 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.533 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -60.89 -47.49 86.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.356 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 50.2 t -58.82 -41.51 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.611 -0.68 . . . . 0.0 110.072 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -61.49 -30.47 70.63 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.99 -1.069 . . . . 0.0 109.155 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.625 HD12 HD13 ' A' ' 87' ' ' ILE . 23.0 mm -86.34 -28.48 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.111 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.715 ' HA ' HG21 ' A' ' 49' ' ' VAL . 15.7 t -78.87 -26.27 43.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.334 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.09 -38.91 20.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.85 HD23 ' CD1' ' A' ' 77' ' ' LEU . 2.7 tp -63.98 -36.5 84.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CD2' HD13 ' A' ' 47' ' ' LEU . 12.1 m-85 -83.25 -21.85 33.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -81.33 -20.36 40.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -104.18 -16.43 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.553 -0.717 . . . . 0.0 109.625 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.72 -29.63 23.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 34.6 t70 111.99 28.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -101.08 -155.2 0.5 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.891 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -169.1 64.21 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.248 -0.908 . . . . 0.0 109.783 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.715 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.9 m -49.37 115.07 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.895 0.855 . . . . 0.0 110.096 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.014 HG11 ' CG2' ' A' ' 16' ' ' THR . 10.6 t -82.83 -31.66 9.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.832 -0.543 . . . . 0.0 110.567 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 20.9 t0 -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.752 HG22 HG13 ' A' ' 63' ' ' VAL . 3.5 t -154.2 94.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.747 . . . . 0.0 109.276 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.541 ' CG ' ' HB3' ' A' ' 62' ' ' TYR . 10.7 ptp180 -108.95 170.21 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.762 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.975 HG22 HG11 ' A' ' 31' ' ' VAL . 4.9 p -80.63 164.43 22.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.392 -0.818 . . . . 0.0 110.363 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 60' ' ' PHE . . . -134.58 124.0 3.35 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.496 HG22 ' OD1' ' A' ' 57' ' ' ASN . 25.3 m 44.12 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.495 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.496 ' OD1' HG22 ' A' ' 56' ' ' THR . 10.9 m120 60.75 -141.05 0.54 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.375 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -116.0 32.46 6.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 -20.67 11.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.605 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.3 t80 -119.19 -171.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 110.24 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 175.88 154.93 12.04 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -118.78 159.76 23.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -1.036 . . . . 0.0 109.31 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.062 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.2 t -150.54 143.07 17.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.862 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -116.42 148.87 40.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.661 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.679 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 14.0 m-85 -110.72 177.9 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.891 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -115.35 13.54 16.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 111.516 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.4 p 179.17 175.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.958 -1.089 . . . . 0.0 112.135 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.52 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -78.54 -24.04 45.89 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 -26.49 32.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.999 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.0 t0 -80.7 -25.86 37.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.721 HD13 ' CD1' ' A' ' 18' ' ' PHE . 4.4 tt -80.19 -33.83 37.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.29 -33.74 70.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.6 -0.688 . . . . 0.0 109.518 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HB2' HD21 ' A' ' 47' ' ' LEU . 1.6 mmtt -77.22 -27.92 53.59 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.679 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.53 -24.54 61.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.11 -48.39 29.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -10.85 60.4 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.85 ' CD1' HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -67.22 -2.47 5.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.58 -0.7 . . . . 0.0 110.489 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.46 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 12.0 m -45.16 -24.8 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.034 . . . . 0.0 110.349 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' LEU . . . -63.32 -16.92 58.8 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.801 HD11 ' HG3' ' A' ' 86' ' ' GLU . 3.4 pp -45.07 175.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.622 -0.928 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HA ' ' CA ' ' A' ' 86' ' ' GLU . 2.7 mttt -177.16 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.332 1.063 . . . . 0.0 109.362 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.808 HG22 HD23 ' A' ' 34' ' ' LEU . 1.7 p -37.98 123.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.621 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.4 m-85 42.42 26.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.483 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 90.11 23.84 31.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.674 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 m120 -135.41 84.43 2.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -1.194 . . . . 0.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.801 ' HG3' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -37.77 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.543 0.687 . . . . 0.0 110.744 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.776 ' CG1' HD13 ' A' ' 80' ' ' LEU . 4.9 pt -49.73 141.25 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.3 mmtm -107.57 155.9 19.6 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.082 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.574 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -120.25 172.76 7.56 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 110.573 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 1.027 HG23 HG23 ' A' ' 16' ' ' THR . 3.2 t . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 121.545 0.688 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 1.027 HG23 HG23 ' A' ' 15' ' ' THR . 81.8 p -124.46 153.21 69.29 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.581 -0.7 . . . . 0.0 110.716 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.3 Cg_endo -80.06 -22.37 7.35 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.155 1.608 . . . . 0.0 110.538 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.7 m-85 -107.02 113.06 26.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 110.876 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.4 m120 -139.06 150.76 46.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.528 -0.733 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.756 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -167.53 -179.63 4.47 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.646 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -109.24 154.95 21.7 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.938 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.67 HD12 ' CG2' ' A' ' 63' ' ' VAL . 3.7 mt -141.89 148.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.597 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -134.1 -169.29 12.0 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.7 t30 72.8 30.31 1.77 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.961 . . . . 0.0 110.021 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.99 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.8 mm? -82.26 128.65 34.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.745 ' H ' HD21 ' A' ' 34' ' ' LEU . 30.3 t-20 -40.07 100.27 0.21 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.65 -0.656 . . . . 0.0 110.371 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.6 Cg_endo -74.18 -16.72 22.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.455 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -83.87 -13.43 53.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.74 -156.86 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.8 m -104.15 152.06 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.54 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.023 HG11 HG22 ' A' ' 54' ' ' THR . 3.0 t -68.71 -28.38 39.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.454 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.515 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -62.25 -43.4 98.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 72.9 mm-40 -69.42 -31.1 69.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.737 . . . . 0.0 109.266 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.99 HD13 ' HB3' ' A' ' 25' ' ' LEU . 6.5 mt -68.01 -33.88 75.45 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.357 -0.839 . . . . 0.0 109.124 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HE3' HG12 ' A' ' 31' ' ' VAL . 3.5 mtmt -66.08 -52.13 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.567 -0.708 . . . . 0.0 109.436 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.2 t -56.86 -39.71 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 110.059 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -61.91 -34.65 76.44 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 109.047 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 34' ' ' LEU . 10.5 mt -82.3 -28.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.255 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -79.01 -27.36 43.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -83.81 -38.22 21.53 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 109.206 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.686 HD21 ' HG ' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -65.63 -34.51 78.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.63 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 8.0 m-85 -85.11 -20.41 30.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.89 -33.19 45.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.457 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -23.28 25.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.8 OUTLIER -83.73 -20.53 33.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 11.4 m-20 89.44 28.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.256 1.027 . . . . 0.0 108.326 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.03 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -75.91 -143.71 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -164.56 60.15 0.14 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.023 -1.048 . . . . 0.0 110.262 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.495 HG13 ' CB ' ' A' ' 42' ' ' PHE . 16.9 m -66.58 116.59 6.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.767 0.794 . . . . 0.0 109.859 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.909 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.4 t -99.26 -38.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.833 -0.542 . . . . 0.0 109.96 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.553 ' C ' HG23 ' A' ' 52' ' ' VAL . 15.2 t0 -143.51 154.53 43.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 110.447 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.0 HG22 HG13 ' A' ' 63' ' ' VAL . 20.5 t -154.74 105.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.747 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.03 167.98 9.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 1.023 HG22 HG11 ' A' ' 31' ' ' VAL . 16.3 p -81.11 160.0 24.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.367 -0.833 . . . . 0.0 110.233 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 56' ' ' THR . . . -130.91 120.13 2.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.764 HG23 ' N ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 70.46 -166.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.26 -1.141 . . . . 0.0 110.108 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.764 ' N ' HG23 ' A' ' 56' ' ' THR . 31.0 t-20 -42.99 -76.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.459 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.572 ' HG3' HG22 ' A' ' 31' ' ' VAL . 10.7 ttp180 -162.41 28.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.217 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' A' ' 24' ' ' ASN . 19.3 tptm -117.03 -6.27 11.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 109.858 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.669 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -121.84 -173.0 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.928 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.529 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 174.76 146.52 5.75 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.661 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.545 -0.974 . . . . 0.0 109.478 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.0 HG13 HG22 ' A' ' 52' ' ' VAL . 4.9 t -152.01 142.78 15.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.171 -0.955 . . . . 0.0 110.831 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -112.24 143.76 42.78 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.308 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 12.6 m-85 -107.53 177.09 4.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.601 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -117.28 12.36 14.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 111.427 -178.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.2 p -173.0 173.99 3.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.048 -1.032 . . . . 0.0 112.107 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.31 -23.86 43.23 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -25.05 31.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.936 ' OD1' HD12 ' A' ' 47' ' ' LEU . 3.9 t0 -81.99 -27.35 33.21 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.57 HD12 ' HD2' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -81.13 -33.74 33.0 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -72.88 -32.56 65.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.717 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 1.03 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -78.16 -29.89 48.88 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.74 -31.79 72.97 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.626 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.9 tm? -72.11 -45.75 59.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.87 -19.4 58.89 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.085 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -71.58 -4.0 24.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.582 -0.699 . . . . 0.0 109.977 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 78' ' ' THR . 87.4 m -74.4 3.98 6.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.337 -0.852 . . . . 0.0 111.039 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.84 -8.75 75.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.686 ' HG ' HD21 ' A' ' 41' ' ' LEU . 3.5 mm? -79.36 -164.21 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.361 -1.082 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -149.26 50.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.801 ' HB ' HG23 ' A' ' 87' ' ' ILE . 8.9 p 13.92 -132.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.06 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.781 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -69.28 -3.36 13.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.448 -1.408 . . . . 0.0 109.919 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 152.05 36.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.768 ' O ' HG12 ' A' ' 82' ' ' VAL . 11.7 t-20 -170.45 116.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -1.037 . . . . 0.0 109.346 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.592 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -52.03 89.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 0.0 110.385 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.801 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.4 135.08 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.629 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 26.5 mttt -103.88 170.95 7.62 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 20' ' ' LEU . 4.9 mp -122.91 -175.28 3.13 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 110.492 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.498 ' CB ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--N 1.297 -1.691 0 O-C-N 121.696 -0.627 . . . . 0.0 110.242 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.837 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 121.216 0.531 . . . . 0.0 110.072 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.911 HG21 ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER 179.15 162.37 0.73 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.563 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.43 -36.63 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.27 1.669 . . . . 0.0 110.832 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 95.6 m-85 -106.49 112.77 25.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.987 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 1.9 m120 -136.04 144.87 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.278 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 20' ' ' LEU . 2.9 pp -155.52 -176.08 5.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 52.9 t80 -110.64 159.35 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.599 HG22 HD21 ' A' ' 25' ' ' LEU . 24.9 mt -137.6 159.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.793 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' ILE . . . -147.44 176.77 26.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 88' ' ' LYS . 2.8 t30 62.62 57.73 1.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -1.137 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.905 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.2 mm? -90.32 -90.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.782 ' CB ' HD21 ' A' ' 34' ' ' LEU . 37.2 t-20 -179.15 92.01 0.21 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.27 -13.86 28.27 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.966 1.508 . . . . 0.0 110.441 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -82.49 -14.36 55.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.973 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -116.57 -156.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.844 . . . . 0.0 109.882 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -99.57 147.98 24.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 54' ' ' THR . 21.9 t -68.92 -27.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.55 -40.8 89.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.067 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 43.0 mm-40 -67.59 -33.0 74.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.499 -0.75 . . . . 0.0 109.325 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.905 HD13 ' HB3' ' A' ' 25' ' ' LEU . 20.2 mt -66.01 -37.85 86.97 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.417 -0.802 . . . . 0.0 109.017 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.422 ' CG ' ' HB ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -60.83 -50.16 74.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 32' ' ' ALA . 10.5 t -60.83 -35.12 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.526 -0.734 . . . . 0.0 109.247 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.714 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -59.68 -31.98 70.07 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.849 ' CD1' HD13 ' A' ' 87' ' ' ILE . 29.1 mm -80.71 -31.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.616 -0.677 . . . . 0.0 109.367 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -78.55 -23.59 46.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 108.914 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.939 HD21 ' HB3' ' A' ' 80' ' ' LEU . 6.3 tp -66.7 -32.98 74.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.617 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 10.4 m-85 -87.72 -20.75 25.8 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -80.98 -29.16 35.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.211 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HG3' ' OE1' ' A' ' 40' ' ' GLU . 17.2 mttt -87.34 -17.72 31.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 109.387 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.627 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.2 m-80 -92.27 -20.34 21.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.925 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.2 t0 90.21 29.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.939 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -74.8 -137.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.76 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -173.63 58.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.188 -0.945 . . . . 0.0 109.604 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.553 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 12.8 m -58.42 117.51 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.942 0.877 . . . . 0.0 110.141 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.911 ' HB ' HG21 ' A' ' 16' ' ' THR . 1.9 t -96.64 -33.54 4.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.909 -0.494 . . . . 0.0 109.866 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.536 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 6.9 t70 -144.27 149.34 36.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.067 -1.02 . . . . 0.0 110.884 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.6 HG12 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -138.16 150.66 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 0.0 109.776 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -154.96 164.26 39.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.938 . . . . 0.0 110.405 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.73 HG22 HG12 ' A' ' 31' ' ' VAL . 63.0 p -94.86 167.13 11.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.822 . . . . 0.0 110.571 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -126.5 117.33 2.77 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.1 m 55.43 -161.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -1.125 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.647 ' H ' HG22 ' A' ' 56' ' ' THR . 35.9 m120 -42.43 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.569 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 2.3 ptp180 -162.93 49.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.327 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -124.5 -23.13 4.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.398 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -128.14 -179.8 5.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -163.87 164.59 36.52 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 2.6 t80 -120.74 166.27 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.977 . . . . 0.0 109.291 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.606 HG12 HD11 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -165.48 168.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.818 -1.176 . . . . 0.0 111.543 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 76.5 m-20 -137.13 142.4 42.26 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.772 ' CE2' ' HB2' ' A' ' 74' ' ' ALA . 28.2 m-85 -104.6 -178.43 3.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.732 -0.605 . . . . 0.0 110.721 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.579 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.69 17.99 13.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 0.0 111.05 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 18.9 p 177.95 176.63 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.463 1.125 . . . . 0.0 112.135 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.99 -24.26 55.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -28.6 49.68 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.363 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.76 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 88.3 m-20 -79.22 -28.02 42.51 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.54 -36.88 57.43 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.064 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.65 -32.78 72.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.419 -0.801 . . . . 0.0 109.576 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.939 ' HB2' HD21 ' A' ' 47' ' ' LEU . 5.3 mmtp -76.8 -29.4 55.98 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.772 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -64.83 -29.94 70.92 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.1 -44.03 60.96 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.14 -7.2 47.75 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -73.07 4.93 3.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 110.63 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 78' ' ' THR . 89.5 m -78.13 6.95 6.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 110.541 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.437 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . -118.32 19.55 10.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.939 ' HB3' HD21 ' A' ' 41' ' ' LEU . 2.8 mt -124.61 122.57 37.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.141 -1.211 . . . . 0.0 111.395 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.7 mttm -92.69 89.24 6.58 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.372 1.082 . . . . 0.0 108.517 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.989 HG21 HG23 ' A' ' 87' ' ' ILE . 3.0 m -36.93 -104.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -82.43 20.08 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.063 -1.023 . . . . 0.0 110.647 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.458 ' C ' ' ND2' ' A' ' 85' ' ' ASN . . . 122.71 10.33 5.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 82' ' ' VAL . 1.5 m-80 -145.25 117.45 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.236 -1.155 . . . . 0.0 109.726 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 80' ' ' LEU . 7.4 tp10 -56.68 83.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.419 -0.8 . . . . 0.0 109.982 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.989 HG23 HG21 ' A' ' 82' ' ' VAL . 1.7 pt -43.57 126.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -102.22 131.86 48.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.746 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -108.44 173.07 6.48 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.926 -1.108 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' CG ' ' O ' ' A' ' 89' ' ' LEU . 3.8 mt-10 . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.138 179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.646 HG22 HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.5 2.072 0 CA-C-O 121.326 0.584 . . . . 0.0 109.917 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.972 ' CG2' HG11 ' A' ' 50' ' ' VAL . 45.9 p -130.24 153.4 81.2 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 110.309 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.56 -22.08 6.91 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.127 1.593 . . . . 0.0 110.742 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 75.3 m-85 -113.57 108.78 17.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.975 -1.078 . . . . 0.0 111.027 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.517 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 1.1 m120 -137.91 149.0 45.83 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 109.041 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -164.27 171.61 14.66 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 110.261 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.651 ' C ' HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.99 160.14 16.53 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.47 -0.769 . . . . 0.0 109.207 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.778 HD13 HG23 ' A' ' 63' ' ' VAL . 1.6 mp -147.61 161.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.975 -1.078 . . . . 0.0 109.673 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -160.28 -160.07 10.32 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.084 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 2.3 t30 67.16 55.09 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -1.05 . . . . 0.0 110.141 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.648 ' HB3' HD22 ' A' ' 34' ' ' LEU . 3.7 mt -104.12 -133.67 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.321 -0.862 . . . . 0.0 110.066 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 36.4 t-20 -143.0 109.78 5.49 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.111 -0.993 . . . . 0.0 110.235 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.59 2.66 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.993 1.522 . . . . 0.0 110.698 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 34.7 m-80 -113.59 18.3 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.968 . . . . 0.0 109.169 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.6 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.0 tptt -138.64 -158.34 0.85 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.717 -0.614 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -107.29 142.59 36.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.778 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.6 t -69.29 -32.07 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.386 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -62.83 -27.81 69.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.003 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 11.3 mm-40 -77.59 -42.3 35.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' A' ' 31' ' ' VAL . 3.8 mt -61.89 -37.93 86.43 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.259 -0.901 . . . . 0.0 109.092 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.744 ' HG3' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -63.17 -52.07 63.85 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.618 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 32' ' ' ALA . 48.7 t -63.41 -28.14 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.252 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.43 -34.14 77.5 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 108.587 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.655 HD11 HG21 ' A' ' 87' ' ' ILE . 6.5 mt -83.89 -25.48 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.589 ' HA ' HG21 ' A' ' 49' ' ' VAL . 13.1 m -80.3 -28.86 38.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -82.43 -37.34 25.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.533 -0.73 . . . . 0.0 109.238 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.646 HD23 ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -70.23 -30.44 67.51 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.555 -0.716 . . . . 0.0 109.18 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.844 ' CE1' HD22 ' A' ' 77' ' ' LEU . 3.2 m-85 -91.99 -14.63 29.13 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -0.82 . . . . 0.0 109.363 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -92.19 -28.57 16.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.697 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.513 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.51 -21.23 21.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.41 -0.806 . . . . 0.0 109.089 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -79.25 -60.01 2.54 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.388 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 147.37 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.186 0.517 . . . . 0.0 109.802 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.885 HD21 ' HB3' ' A' ' 73' ' ' LYS . 3.8 mm? -98.35 -157.72 0.62 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.558 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -156.93 63.82 0.51 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.7 m -58.28 117.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.929 0.871 . . . . 0.0 109.789 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.972 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -90.31 -44.26 14.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 O-C-N 121.735 -0.603 . . . . 0.0 110.188 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.501 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 34.3 t0 -141.04 152.74 45.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.07 -1.019 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.809 HG22 HG13 ' A' ' 63' ' ' VAL . 2.8 t -152.36 105.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 167.45 10.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.778 HG22 ' CG1' ' A' ' 31' ' ' VAL . 47.3 p -85.16 163.65 18.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.4 -0.812 . . . . 0.0 110.416 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.497 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -137.76 137.32 8.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.553 HG22 ' N ' ' A' ' 57' ' ' ASN . 28.8 m 60.36 176.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -1.115 . . . . 0.0 109.961 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.553 ' N ' HG22 ' A' ' 56' ' ' THR . 20.0 m120 -40.98 -59.68 1.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.581 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -168.08 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.965 . . . . 0.0 110.193 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.623 ' C ' HD12 ' A' ' 25' ' ' LEU . 12.0 tttt -127.14 -11.04 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.448 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.3 t80 -122.18 179.41 4.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.26 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.64 163.79 31.33 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.5 t80 -126.25 157.24 38.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.467 -1.019 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.809 HG13 HG22 ' A' ' 52' ' ' VAL . 4.2 t -151.72 145.2 16.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.813 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -116.35 144.01 44.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.405 -0.81 . . . . 0.0 109.705 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.838 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 19.6 m-85 -107.05 176.71 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.571 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.622 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -112.28 13.62 20.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 111.609 -178.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 25.0 p 177.66 178.16 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.401 1.096 . . . . 0.0 112.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.68 -22.65 53.69 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.455 ' OE2' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.59 -25.84 38.23 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.493 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.759 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 85.4 m-20 -83.3 -27.81 29.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.777 HD13 ' C ' ' A' ' 71' ' ' LEU . 3.0 tm? -78.7 -34.06 46.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.772 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.03 -38.51 61.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.885 ' HB3' HD21 ' A' ' 47' ' ' LEU . 14.7 mtmt -79.55 -18.21 52.3 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.838 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -79.26 -28.1 42.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.379 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.45 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.6 tt -79.12 -44.32 22.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.435 -0.791 . . . . 0.0 109.105 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.0 mt-10 -71.34 -24.26 62.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.308 -0.87 . . . . 0.0 109.29 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -64.45 -15.05 60.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.0 109.972 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -37.93 -28.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.878 0.847 . . . . 0.0 110.891 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -51.73 -26.17 16.62 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 87' ' ' ILE . 1.6 pt? -65.52 131.91 47.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -1.18 . . . . 0.0 110.896 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 3.5 mttm -109.9 80.76 1.35 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.08 0.943 . . . . 0.0 109.964 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -39.71 122.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.421 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.6 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.9 m-85 43.33 24.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 93.38 19.16 36.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.56 ' O ' HG12 ' A' ' 82' ' ' VAL . 1.3 m-80 -133.31 91.7 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 110.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 9.2 tt0 -41.1 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 110.733 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -47.64 141.33 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.771 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -116.32 157.89 24.28 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.86 174.68 8.2 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.163 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 110.166 179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 1.015 HG23 HG23 ' A' ' 16' ' ' THR . 5.3 t . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.561 0.696 . . . . 0.0 110.173 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 1.015 HG23 HG23 ' A' ' 15' ' ' THR . 32.0 p -119.64 163.29 28.19 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.579 -0.7 . . . . 0.0 110.417 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.67 -27.65 10.49 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.015 1.534 . . . . 0.0 110.661 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 97.7 m-85 -102.63 112.52 25.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.374 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.7 m120 -143.05 151.97 41.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.748 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.0 pp -161.3 -176.41 5.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.408 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 16.3 t80 -108.75 161.5 15.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.897 HD12 HG21 ' A' ' 63' ' ' VAL . 5.1 mt -140.19 159.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -143.5 170.82 25.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.659 ' C ' HD22 ' A' ' 25' ' ' LEU . 28.2 t30 67.81 71.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -1.118 . . . . 0.0 109.944 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.773 HD13 HD12 ' A' ' 34' ' ' LEU . 4.2 mm? -106.15 19.68 20.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' PHE . 2.8 t30 55.94 99.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 47.2 Cg_endo -73.39 -19.57 21.92 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.02 1.537 . . . . 0.0 110.289 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.2 -19.83 56.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 83' ' ' PHE . 5.6 tmtt? -98.54 -154.29 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.855 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.724 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -113.56 139.56 48.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 110.384 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.897 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.6 t -67.98 -29.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.003 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.45 -37.35 87.21 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 69.3 mm-40 -70.68 -27.53 64.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.773 HD12 HD13 ' A' ' 25' ' ' LEU . 3.2 mm? -64.43 -42.58 95.94 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.404 -0.81 . . . . 0.0 109.106 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.829 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.89 -54.65 27.55 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.981 -0.687 . . . . 0.0 109.8 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 32' ' ' ALA . 4.9 t -62.66 -30.21 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.747 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -65.97 -40.01 90.9 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.758 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 34' ' ' LEU . 10.8 mm -78.58 -24.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.109 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.861 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.4 p -79.78 -32.94 40.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.26 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -80.34 -37.9 31.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.148 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.35 -30.91 69.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 0.0 109.167 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 5.5 m-85 -89.03 -16.0 32.7 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.499 -0.751 . . . . 0.0 109.328 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -90.8 -27.37 18.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.67 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.474 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -92.02 -21.1 20.69 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.694 0.759 . . . . 0.0 109.305 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -81.25 -59.16 2.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.2 m-20 144.61 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.204 0.601 . . . . 0.0 109.64 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' OD1' ' A' ' 70' ' ' ASP . 2.7 mm? -99.26 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.205 -0.935 . . . . 0.0 109.842 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.82 61.87 0.47 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 39' ' ' SER . 11.7 m -58.28 116.14 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.814 0.816 . . . . 0.0 109.843 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.853 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.0 OUTLIER -88.95 -45.55 15.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 121.209 0.528 . . . . 0.0 109.779 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 12.6 t0 -143.37 159.22 42.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.637 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 35' ' ' LYS . 6.2 p -158.81 100.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 110.068 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -96.58 164.72 12.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.897 ' HB ' HG11 ' A' ' 31' ' ' VAL . 1.3 p -87.32 159.15 18.87 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.167 -0.958 . . . . 0.0 110.14 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -121.04 120.37 4.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.583 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 10.0 m 50.42 102.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -1.124 . . . . 0.0 110.544 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' THR . 90.5 m-20 41.26 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.441 -0.787 . . . . 0.0 110.675 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.583 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -149.0 52.45 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 0.0 110.454 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 4.2 tmtt? -123.74 -24.31 4.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.926 . . . . 0.0 110.34 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.762 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.6 m-85 -138.15 -158.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.371 -0.831 . . . . 0.0 109.37 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.513 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 168.83 165.77 26.77 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.267 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.569 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 10.2 t80 -122.84 158.53 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.564 -0.962 . . . . 0.0 109.38 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.897 HG21 HD12 ' A' ' 22' ' ' ILE . 3.7 t -149.72 144.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.112 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 2.9 m-20 -114.31 139.18 49.65 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.696 ' HE2' HD21 ' A' ' 20' ' ' LEU . 17.8 m-85 -104.15 173.81 6.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.442 -0.786 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.695 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.16 13.48 15.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 111.577 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.535 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.7 p -171.82 173.87 4.39 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.207 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.51 -24.32 42.32 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.98 -25.2 32.5 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.989 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.866 ' OD1' HD12 ' A' ' 47' ' ' LEU . 4.8 t0 -83.12 -25.55 31.83 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.784 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.7 tm? -82.73 -31.24 28.56 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.69 -34.68 62.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.581 -0.699 . . . . 0.0 109.529 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.833 ' HG2' HD21 ' A' ' 47' ' ' LEU . 1.5 tppt? -78.56 -28.4 45.94 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.686 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -70.06 -25.99 63.8 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -72.96 -48.65 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -5.77 45.12 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.176 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -75.85 6.31 5.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.491 -0.755 . . . . 0.0 110.446 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -65.27 -8.42 17.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.074 -1.016 . . . . 0.0 110.312 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.24 29.55 8.1 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.148 HD22 HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.31 117.1 30.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -1.057 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -112.47 93.39 4.42 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.944 1.354 . . . . 0.0 109.381 178.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.747 HG13 ' HB1' ' A' ' 37' ' ' ALA . 23.5 t -46.66 -113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.269 -2.93 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.29 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 21.9 m-85 -80.31 47.57 0.93 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 120.705 -1.247 . . . . 0.0 109.673 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 81' ' ' LYS . . . 81.29 26.34 52.22 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 85' ' ' ASN . 7.9 p-10 -137.63 74.94 1.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -1.102 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.5 tm-20 -43.05 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.666 HD13 ' N ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -54.13 127.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.512 0.673 . . . . 0.0 110.402 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 23' ' ' GLY . 4.4 mttt -102.54 129.84 49.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.802 . . . . 0.0 109.577 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.487 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -111.18 172.99 6.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.964 -1.085 . . . . 0.0 110.685 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.751 . . . . 0.0 109.995 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.532 0.682 . . . . 0.0 109.867 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.819 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -135.34 164.95 40.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.1 Cg_endo -77.24 -38.49 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.167 1.614 . . . . 0.0 110.53 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.3 m-85 -94.24 107.14 19.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.572 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' PHE . 6.8 m120 -136.41 154.3 50.83 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.356 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.866 HD22 ' N ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -170.51 -176.71 2.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 110.809 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.866 ' N ' HD22 ' A' ' 20' ' ' LEU . 4.5 t80 -105.04 146.74 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.507 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 20' ' ' LEU . 1.5 mt -141.09 149.76 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -149.36 -156.22 7.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.868 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 2.1 t30 67.52 41.59 2.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -1.022 . . . . 0.0 110.027 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 34' ' ' LEU . 3.6 mm? -84.73 -167.82 1.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -119.98 107.3 40.09 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HG3' ' A' ' 58' ' ' ARG . 44.9 Cg_endo -73.25 -5.0 16.41 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.082 1.569 . . . . 0.0 110.324 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -79.78 -18.69 50.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.735 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 -155.51 0.58 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.554 -0.716 . . . . 0.0 109.709 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.607 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.21 141.28 32.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -0.999 . . . . 0.0 110.51 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 58' ' ' ARG . 3.3 t -65.48 -29.86 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.178 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -65.84 -38.67 89.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.849 . . . . 0.0 109.047 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 63.6 mm-40 -67.12 -30.73 70.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 25' ' ' LEU . 3.9 mm? -66.53 -40.61 89.2 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.382 -0.824 . . . . 0.0 108.917 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.614 ' HG2' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -58.4 -53.3 59.83 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.362 -0.836 . . . . 0.0 108.911 178.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -65.27 -30.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.45 -29.63 70.88 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.534 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.658 HD11 HG21 ' A' ' 87' ' ' ILE . 12.9 mm -84.04 -28.55 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.198 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.966 ' HA ' HG21 ' A' ' 49' ' ' VAL . 31.0 t -80.05 -27.83 39.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 108.893 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.526 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 2.8 tm-20 -81.88 -36.32 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.377 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.107 ' CD2' HD13 ' A' ' 80' ' ' LEU . 5.0 tp -70.96 -31.08 67.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.077 ' CE1' HD13 ' A' ' 77' ' ' LEU . 3.5 m-30 -90.98 -14.88 30.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.481 -0.762 . . . . 0.0 109.393 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -90.02 -27.27 19.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.405 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.43 -22.22 20.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.811 . . . . 0.0 109.225 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.4 m-80 -79.59 -58.99 2.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.684 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.2 m-20 148.03 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.143 0.497 . . . . 0.0 110.153 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.901 HD11 ' HB3' ' A' ' 73' ' ' LYS . 6.3 mp -103.4 -158.17 0.65 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.69 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.87 64.28 0.46 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.966 HG21 ' HA ' ' A' ' 39' ' ' SER . 9.5 m -53.08 118.01 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.995 0.903 . . . . 0.0 109.761 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.8 t -89.54 -39.12 12.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.064 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.488 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -150.22 158.12 43.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.698 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.739 HG23 HG22 ' A' ' 63' ' ' VAL . 9.8 p -144.07 159.97 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.43 -0.794 . . . . 0.0 109.594 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -155.55 164.08 39.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 110.104 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.549 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -116.83 154.89 29.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 110.513 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -123.71 127.84 6.69 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.9 m 71.31 -171.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.384 -1.068 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.696 ' H ' HG22 ' A' ' 56' ' ' THR . 3.7 p30 -48.67 -53.0 20.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.556 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.656 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -179.41 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.115 -0.991 . . . . 0.0 110.565 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.529 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -126.73 -22.87 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.561 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.576 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.6 m-85 -122.57 -177.18 3.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.937 . . . . 0.0 109.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . 176.54 135.43 2.16 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.235 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.731 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -98.09 169.53 9.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.989 . . . . 0.0 109.423 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.739 HG22 HG23 ' A' ' 52' ' ' VAL . 17.6 t -158.82 162.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.139 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -130.99 140.6 50.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.697 -0.627 . . . . 0.0 109.479 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.789 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 16.8 m-85 -110.87 174.64 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.845 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.668 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.84 11.53 19.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.498 -0.751 . . . . 0.0 111.309 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.645 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.6 p -173.08 173.51 3.65 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.26 1.029 . . . . 0.0 112.185 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.519 ' N ' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.64 -23.56 45.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -84.44 -23.69 29.86 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.277 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 4.4 t0 -83.69 -26.94 29.39 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 71' ' ' LEU . 9.8 tt -81.4 -33.98 31.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.266 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -74.96 -32.96 61.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.456 -0.777 . . . . 0.0 109.621 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.901 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -81.47 -23.19 37.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.789 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.99 -29.94 63.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.66 ' C ' HD13 ' A' ' 75' ' ' LEU . 3.1 tm? -75.96 -45.53 34.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -66.94 -23.39 65.96 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.435 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.077 HD13 ' CE1' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -67.57 -8.05 31.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.55 0.691 . . . . 0.0 110.391 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 87' ' ' ILE . 22.2 m -67.4 0.37 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.646 -0.659 . . . . 0.0 111.556 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.1 16.93 54.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.107 HD13 ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -103.09 -159.12 0.71 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.988 . . . . 0.0 110.541 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -164.76 49.67 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.344 1.068 . . . . 0.0 108.914 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.749 HG21 HG23 ' A' ' 87' ' ' ILE . 17.0 t 0.35 -115.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.769 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 4.0 m-30 -76.81 9.32 2.93 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 128.51 35.34 0.5 Allowed Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.522 ' CA ' ' HG3' ' A' ' 81' ' ' LYS . 12.2 m120 -161.73 100.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 109.565 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.586 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -49.55 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.308 -0.87 . . . . 0.0 110.406 -179.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.749 HG23 HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -42.71 143.13 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 5.5 mtpp -119.26 159.68 23.63 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.596 -0.69 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -112.82 -179.2 3.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 110.226 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.472 ' HG2' ' HB3' ' A' ' 21' ' ' PHE . 1.3 tt0 . . . . . 0 C--N 1.299 -1.63 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.744 -179.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 16' ' ' THR . 5.7 t . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.535 0.683 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.928 ' CG2' HG11 ' A' ' 50' ' ' VAL . 39.1 p -105.6 161.85 21.53 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.4 Cg_endo -74.85 -25.45 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.083 1.57 . . . . 0.0 110.762 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.711 ' CD1' HD22 ' A' ' 71' ' ' LEU . 97.6 m-85 -102.2 110.16 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.973 -1.079 . . . . 0.0 110.567 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.462 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 2.0 m120 -140.88 149.75 42.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.712 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -163.72 -175.97 4.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 8.2 t80 -118.4 144.53 45.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.542 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 mt -127.46 157.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.196 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.96 -169.68 11.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.714 ' C ' HD22 ' A' ' 25' ' ' LEU . 42.1 t30 72.67 71.8 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.562 -0.963 . . . . 0.0 110.132 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.983 HD13 HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -110.59 157.78 19.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 110.268 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.519 ' ND2' ' OD1' ' A' ' 28' ' ' ASN . 39.4 t-20 -87.88 109.69 29.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.07 -28.33 12.98 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.967 1.509 . . . . 0.0 110.687 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.519 ' OD1' ' ND2' ' A' ' 26' ' ' ASN . 32.7 p30 -75.0 -13.68 60.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -110.49 -154.94 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.514 -0.741 . . . . 0.0 109.681 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.555 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.4 m -109.98 145.64 36.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.496 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.655 HG12 ' HE3' ' A' ' 35' ' ' LYS . 2.9 t -69.97 -30.95 46.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.2 -0.937 . . . . 0.0 109.389 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -67.1 -37.19 83.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.856 . . . . 0.0 109.26 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 63.2 mm-40 -68.71 -34.28 75.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.41 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.983 HD22 HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.03 -35.57 81.59 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.403 -0.811 . . . . 0.0 109.104 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.707 ' HG3' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -64.38 -48.2 76.35 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.472 -0.767 . . . . 0.0 109.25 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 32' ' ' ALA . 9.9 t -61.26 -34.61 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.703 ' CB ' HG23 ' A' ' 82' ' ' VAL . . . -62.89 -34.05 76.6 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.214 -0.929 . . . . 0.0 108.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.791 ' CD1' HD13 ' A' ' 87' ' ' ILE . 22.4 mm -81.86 -28.04 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.736 ' HA ' HG21 ' A' ' 49' ' ' VAL . 11.5 t -79.02 -27.68 43.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.049 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.16 -39.15 23.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.601 0.715 . . . . 0.0 109.125 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.714 HD22 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.08 -32.73 74.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.923 ' CD2' HD23 ' A' ' 47' ' ' LEU . 9.3 m-85 -86.31 -19.16 30.26 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.393 -0.817 . . . . 0.0 109.212 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.48 -26.37 20.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.766 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -91.8 -19.14 22.87 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.485 -0.76 . . . . 0.0 109.051 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.617 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -81.89 -59.48 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.601 -0.687 . . . . 0.0 109.483 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.4 m-20 147.41 30.61 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.15 0.5 . . . . 0.0 110.002 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.923 HD23 ' CD2' ' A' ' 42' ' ' PHE . 3.4 mp -103.59 -157.06 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.41 65.29 0.44 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 39' ' ' SER . 5.8 m -53.17 117.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.935 0.874 . . . . 0.0 109.904 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.928 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.24 -44.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.164 0.506 . . . . 0.0 109.943 -179.489 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 13.2 t70 -138.78 149.53 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 35' ' ' LYS . 2.4 t -152.3 102.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.78 . . . . 0.0 109.466 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 62' ' ' TYR . 64.1 mtm180 -114.37 168.83 9.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.089 -1.007 . . . . 0.0 110.466 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.629 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.3 p -76.35 179.02 6.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -138.73 131.63 5.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.9 HG22 ' OD1' ' A' ' 57' ' ' ASN . 53.5 m 57.32 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.9 ' OD1' HG22 ' A' ' 56' ' ' THR . 23.0 p-10 -161.0 90.54 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 110.489 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.3 ttp180 53.27 19.84 1.68 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -113.01 -30.0 7.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.689 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.0 m-85 -138.6 -177.74 5.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -159.83 135.47 4.13 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.193 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.684 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 2.6 m-85 -91.47 154.78 18.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -1.15 . . . . 0.0 109.635 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 52' ' ' VAL . 3.7 t -151.78 143.7 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.843 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.79 143.51 47.81 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.428 -0.795 . . . . 0.0 109.58 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.946 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 53.8 m-85 -108.2 173.48 6.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.946 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.722 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.25 16.68 14.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 111.622 -178.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 2.4 t -165.18 175.68 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.729 1.252 . . . . 0.0 112.216 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.544 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -88.23 -25.41 22.88 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.451 ' OE1' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.86 -21.65 26.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 9.4 t0 -84.0 -31.01 25.71 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.711 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.7 tp -75.16 -35.57 61.59 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.482 0.658 . . . . 0.0 109.336 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.86 -37.87 67.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.698 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 1.039 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.05 -26.74 56.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.946 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.05 -26.77 61.4 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.949 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -70.94 -47.16 60.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.73 -15.78 63.21 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.748 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.2 mm? -73.22 1.37 9.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.586 -0.696 . . . . 0.0 110.246 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.99 ' OG1' HD13 ' A' ' 89' ' ' LEU . 38.7 m -76.29 4.13 9.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.584 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.97 19.22 33.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.006 HD21 HD11 ' A' ' 87' ' ' ILE . 2.5 pp -100.33 122.65 43.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.217 -1.167 . . . . 0.0 110.56 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 85' ' ' ASN . 2.2 ttmt -82.9 81.55 8.56 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.905 1.336 . . . . 0.0 110.147 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.774 HG22 ' N ' ' A' ' 83' ' ' PHE . 1.7 p -36.32 -98.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.27 -2.851 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.774 ' N ' HG22 ' A' ' 82' ' ' VAL . 2.2 m-30 -91.29 20.67 4.96 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.026 -1.046 . . . . 0.0 110.533 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.554 ' CA ' ' HG2' ' A' ' 81' ' ' LYS . . . 120.77 23.16 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.584 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 1.9 m-20 -155.58 100.04 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 0.0 109.745 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -42.69 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.085 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.006 HD11 HD21 ' A' ' 80' ' ' LEU . 6.1 pt -42.89 154.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.278 -0.889 . . . . 0.0 110.575 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -121.66 157.92 29.8 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.76 -0.588 . . . . 0.0 109.457 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.99 HD13 ' OG1' ' A' ' 78' ' ' THR . 7.7 mp -112.0 -179.04 3.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.058 -1.026 . . . . 0.0 110.488 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.437 ' N ' ' O ' ' A' ' 21' ' ' PHE . 2.2 tt0 . . . . . 0 C--N 1.299 -1.6 0 O-C-N 121.659 -0.651 . . . . 0.0 110.159 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 15' ' ' THR . 7.9 m . . . . . 0 N--CA 1.49 1.571 0 CA-C-O 121.237 0.541 . . . . 0.0 110.32 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.785 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -171.15 164.32 4.99 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.41 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.7 Cg_endo -77.98 -27.21 5.93 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.201 1.632 . . . . 0.0 110.715 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 87.3 m-85 -110.24 116.73 32.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.6 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 5.9 m120 -142.8 157.01 45.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -0.809 . . . . 0.0 109.73 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.824 HD23 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -164.3 168.33 18.84 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.478 -0.763 . . . . 0.0 110.192 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.565 ' N ' HD22 ' A' ' 20' ' ' LEU . 45.6 t80 -102.6 157.24 17.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 11.4 mt -126.68 165.89 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -160.01 106.59 0.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.625 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 7.9 t-20 147.5 66.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.092 HD13 HD22 ' A' ' 34' ' ' LEU . 4.6 mm? -98.44 133.54 42.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 110.958 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.585 ' HB2' HD11 ' A' ' 34' ' ' LEU . 9.6 t-20 -58.36 113.11 5.9 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.706 -0.621 . . . . 0.0 109.946 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.76 -36.91 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.901 1.474 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -74.87 -16.27 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.623 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.574 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 4.1 mmtt -110.4 -155.2 0.56 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.694 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -122.01 148.52 44.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.986 HG13 ' CD1' ' A' ' 25' ' ' LEU . 2.5 t -69.62 -35.52 66.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.244 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -54.98 -44.7 74.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 108.906 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 20.8 mm-40 -61.88 -44.77 96.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.092 HD22 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.26 -31.29 65.42 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.828 ' HD2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.87 -60.71 3.41 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 83.7 t -58.47 -40.48 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.54 -0.725 . . . . 0.0 109.07 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.69 -33.03 73.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 34' ' ' LEU . 23.8 mt -80.32 -30.23 12.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.562 -0.711 . . . . 0.0 109.138 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 1.4 t -77.42 -27.28 52.27 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.634 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -84.02 -40.92 17.81 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.534 0.683 . . . . 0.0 109.414 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.109 HD21 HD22 ' A' ' 80' ' ' LEU . 6.2 tp -61.75 -35.29 77.67 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.142 ' CE2' HD13 ' A' ' 77' ' ' LEU . 7.3 m-85 -84.62 -22.63 29.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -72.23 -34.81 68.6 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.556 0.694 . . . . 0.0 109.285 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HE2' ' OE1' ' A' ' 40' ' ' GLU . 9.6 mtmt -78.08 -17.81 56.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.442 -0.787 . . . . 0.0 109.242 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.614 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -88.46 -16.26 33.25 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.583 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 88.86 30.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.884 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -82.1 -138.3 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -178.95 57.39 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.0 m -50.96 117.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.834 0.826 . . . . 0.0 110.033 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.785 HG21 HG21 ' A' ' 16' ' ' THR . 0.5 OUTLIER -89.22 -45.31 15.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-O 121.226 0.536 . . . . 0.0 109.94 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -143.69 160.22 41.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.781 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.828 HG12 ' HD2' ' A' ' 35' ' ' LYS . 2.5 t -152.4 157.49 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.848 . . . . 0.0 109.494 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.09 164.25 33.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.206 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.474 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.9 p -91.83 156.18 17.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 110.847 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.579 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.57 129.51 9.34 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.752 HG21 ' HD2' ' A' ' 59' ' ' LYS . 2.6 m 59.61 13.59 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.99 . . . . 0.0 109.39 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER 70.66 15.75 6.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 111.328 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 168.19 -21.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.807 -1.183 . . . . 0.0 111.543 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HD2' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -89.06 -65.34 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.929 -1.107 . . . . 0.0 111.728 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 1.2 m-85 -103.66 -148.53 0.39 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.043 -1.035 . . . . 0.0 110.617 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 178.62 -179.85 48.63 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.583 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 40.9 t80 -151.96 150.44 30.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.801 HG22 HG13 ' A' ' 52' ' ' VAL . 4.0 t -150.69 153.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.219 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.583 ' OD1' ' CZ ' ' A' ' 62' ' ' TYR . 3.6 m-20 -122.27 138.03 54.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 66.4 m-85 -104.66 172.32 6.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 109.912 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.765 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -117.52 17.11 14.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 111.254 -178.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 14.8 p -167.6 173.4 8.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.563 1.173 . . . . 0.0 112.314 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -76.33 -25.31 54.61 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -76.55 -27.73 56.01 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.518 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.605 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 87.8 m-20 -79.92 -30.35 39.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 12.6 tp -71.82 -38.73 70.15 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.297 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -71.48 -30.88 66.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.741 . . . . 0.0 109.621 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . 33.7 mmtt -83.49 -27.2 29.59 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.636 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.8 -30.93 71.64 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -78.06 -44.28 26.8 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -21.64 59.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.363 -0.836 . . . . 0.0 109.494 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.142 HD13 ' CE2' ' A' ' 42' ' ' PHE . 2.9 mt -72.19 -4.9 32.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 1.027 ' OG1' HD11 ' A' ' 89' ' ' LEU . 32.3 m -71.47 2.27 5.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 110.956 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.94 -3.15 56.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.109 HD22 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -91.34 135.59 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 110.346 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.51 76.06 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.998 0.904 . . . . 0.0 110.573 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.885 ' HB ' HG23 ' A' ' 87' ' ' ILE . 3.4 t -43.17 129.28 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER 46.34 22.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.518 -179.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.95 17.62 43.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 2.1 m-80 -133.89 110.35 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.052 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 29.2 tt0 -58.05 81.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.099 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 82' ' ' VAL . 2.7 pt -43.84 123.69 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.454 -0.779 . . . . 0.0 110.406 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.6 mtpm? -106.72 132.75 52.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.46 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.027 HD11 ' OG1' ' A' ' 78' ' ' THR . 0.0 OUTLIER -121.69 179.25 4.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.944 -1.098 . . . . 0.0 111.329 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.532 0 O-C-N 121.641 -0.662 . . . . 0.0 109.616 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.838 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 121.202 0.525 . . . . 0.0 110.138 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 15' ' ' THR . 1.1 p -164.79 154.6 11.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 110.734 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 65' ' ' PHE . 51.3 Cg_endo -76.78 -39.82 0.62 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.205 1.634 . . . . 0.0 110.585 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.568 ' CE2' ' CA ' ' A' ' 68' ' ' ALA . 94.4 m-85 -121.57 119.92 33.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.796 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 18' ' ' PHE . 15.5 m-20 -139.94 152.39 46.32 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.33 -0.856 . . . . 0.0 109.411 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.0 pp -164.09 -175.0 3.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 6.1 t80 -109.34 141.91 41.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.492 -0.755 . . . . 0.0 110.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 88' ' ' LYS . 1.0 OUTLIER -122.05 160.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.82 -175.87 14.08 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.58 ' C ' HD22 ' A' ' 25' ' ' LEU . 11.9 t30 71.52 54.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.437 -1.037 . . . . 0.0 110.506 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.3 mm? -105.35 129.05 53.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.958 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.431 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 34.5 t-20 -40.54 100.6 0.22 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.72 -0.612 . . . . 0.0 110.502 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -73.73 -17.22 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.074 1.565 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.92 -14.8 40.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.721 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 8.5 mmtt -106.27 -157.79 0.63 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.496 -0.753 . . . . 0.0 109.554 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -106.25 142.88 35.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.765 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.908 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.7 t -66.1 -22.85 30.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.639 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -67.58 -38.96 84.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' OE2' ' CD1' ' A' ' 83' ' ' PHE . 1.8 pt-20 -65.67 -38.3 88.91 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 31' ' ' VAL . 50.9 mt -60.98 -36.09 78.51 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.43 -60.49 3.71 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 28.7 t -60.51 -32.74 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -64.8 -38.07 89.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 108.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.572 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 24.5 mt -80.07 -24.46 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.413 -0.804 . . . . 0.0 108.995 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.801 ' HA ' HG21 ' A' ' 49' ' ' VAL . 7.8 p -80.13 -30.74 39.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 109.053 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.93 -40.73 21.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.562 0.696 . . . . 0.0 109.609 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.87 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -65.53 -35.05 79.71 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 109.178 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.733 ' HD2' HD22 ' A' ' 47' ' ' LEU . 9.2 m-85 -83.0 -21.64 33.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.43 -24.7 57.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.494 ' NZ ' ' OE1' ' A' ' 40' ' ' GLU . 9.5 mttp -104.17 -17.23 14.97 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.587 -0.695 . . . . 0.0 109.519 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.674 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -81.3 -21.87 38.99 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.369 -0.832 . . . . 0.0 109.934 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.674 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.5 t0 99.34 29.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.733 HD22 ' HD2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -100.93 -149.85 0.38 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.44 61.23 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.801 HG21 ' HA ' ' A' ' 39' ' ' SER . 6.5 m -50.9 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.001 0.905 . . . . 0.0 110.133 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.692 ' HB ' HG21 ' A' ' 16' ' ' THR . 2.8 t -89.04 -35.68 7.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.264 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 8.4 t0 -146.85 156.18 42.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.116 -0.99 . . . . 0.0 111.229 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.593 ' CG1' ' CG ' ' A' ' 35' ' ' LYS . 14.8 p -153.17 146.59 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.436 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -149.59 166.54 28.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.908 HG22 ' CG1' ' A' ' 31' ' ' VAL . 15.7 p -87.75 160.45 18.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 110.528 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -125.63 126.0 5.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.8 m 59.34 -166.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -1.078 . . . . 0.0 110.073 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.706 ' H ' HG22 ' A' ' 56' ' ' THR . 0.7 OUTLIER -41.76 -65.78 0.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.402 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.642 ' HG3' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -173.89 51.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -124.47 -23.34 4.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.935 . . . . 0.0 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.925 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -124.6 -177.05 3.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -168.0 141.75 7.03 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.866 ' O ' HG23 ' A' ' 63' ' ' VAL . 48.2 t80 -94.62 169.07 10.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -1.151 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 62' ' ' TYR . 2.4 t -163.64 163.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.482 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -137.07 144.63 43.25 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.802 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 31.8 m-85 -108.25 176.58 5.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.608 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -109.77 16.37 22.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 111.584 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p 178.17 178.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.139 . . . . 0.0 112.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.568 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.05 -23.28 52.04 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -26.2 41.06 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.361 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.693 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 85.9 m-20 -83.01 -28.0 29.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.6 tm? -77.96 -34.19 51.19 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.827 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.49 -40.05 62.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.849 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.788 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.03 -30.63 61.12 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.802 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.16 -28.48 67.33 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 89' ' ' LEU . 5.7 tt -69.79 -45.18 68.54 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -12.47 60.68 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.164 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.993 HD12 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -76.07 4.62 8.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.54 -0.725 . . . . 0.0 109.939 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 1.025 ' OG1' HD21 ' A' ' 89' ' ' LEU . 11.1 m -72.89 1.18 9.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.115 -0.991 . . . . 0.0 110.552 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -106.2 1.42 37.79 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.039 HD21 HD11 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -84.8 124.0 31.07 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.151 -1.205 . . . . 0.0 111.257 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 82' ' ' VAL . 32.2 mtpt -83.38 84.33 7.55 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.908 0.861 . . . . 0.0 109.189 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.972 ' CG1' HG23 ' A' ' 87' ' ' ILE . 1.2 p -34.76 -94.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.798 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -98.56 31.89 2.73 Favored 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.138 -0.976 . . . . 0.0 109.427 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.454 ' C ' ' HE3' ' A' ' 81' ' ' LYS . . . 108.35 15.51 13.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.647 ' O ' HG12 ' A' ' 82' ' ' VAL . 5.1 m120 -143.42 98.18 3.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -1.039 . . . . 0.0 109.528 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 35.1 tt0 -41.72 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.476 -0.765 . . . . 0.0 110.548 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.039 HD11 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.25 145.39 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.697 ' HA ' HG23 ' A' ' 78' ' ' THR . 18.5 tttt -120.87 155.77 33.42 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.566 -0.708 . . . . 0.0 109.904 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.025 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -120.38 171.35 8.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.798 ' O ' HG23 ' A' ' 16' ' ' THR . 4.3 m . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 121.258 0.551 . . . . 0.0 110.118 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.812 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -172.2 162.53 4.35 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.525 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.0 Cg_endo -79.95 -25.96 4.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.187 1.625 . . . . 0.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.4 m-85 -116.25 119.7 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 0.0 110.951 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 30.2 m-20 -135.42 171.0 15.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.211 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.655 HD12 ' CE2' ' A' ' 65' ' ' PHE . 11.2 mt -156.44 165.89 35.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 111.137 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -97.96 157.59 16.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.977 HG22 HD21 ' A' ' 25' ' ' LEU . 65.2 mt -149.39 146.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.323 -0.861 . . . . 0.0 110.121 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.92 179.91 22.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 48.1 t30 71.15 23.35 4.15 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.495 -1.003 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.005 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.1 mm? -68.37 122.93 19.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.567 ' O ' HD11 ' A' ' 34' ' ' LEU . 28.1 t-20 -41.09 100.85 0.23 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.654 -0.653 . . . . 0.0 110.421 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.8 Cg_endo -75.69 -26.51 9.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.071 1.564 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -74.69 -24.1 58.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.966 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.7 mmtt -90.9 -154.45 0.35 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.603 -0.686 . . . . 0.0 109.72 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.1 m -101.9 143.83 31.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.764 ' CG1' HG21 ' A' ' 54' ' ' THR . 3.7 t -69.0 -31.02 48.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.7 -33.7 76.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.118 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 66.0 mm-40 -70.66 -36.58 73.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 109.359 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.005 HD13 ' HB3' ' A' ' 25' ' ' LEU . 42.3 mt -63.24 -34.57 77.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.442 -0.786 . . . . 0.0 109.061 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.715 ' HZ2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -64.94 -55.84 16.78 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.213 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.5 t -58.3 -40.78 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 0.0 109.385 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.727 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -59.32 -29.07 67.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.97 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.474 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 47.0 mt -83.95 -32.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.385 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.7 t -79.27 -23.14 43.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.97 -39.31 17.04 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.947 HD21 ' HB3' ' A' ' 80' ' ' LEU . 4.9 tp -63.45 -36.89 85.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.56 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 10.2 m-85 -83.56 -22.02 32.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.43 -21.76 45.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.97 -20.43 14.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.675 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -82.48 -21.12 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.459 -0.776 . . . . 0.0 109.788 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.675 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.3 t70 98.61 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.868 0.842 . . . . 0.0 108.891 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.937 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -91.33 -145.28 0.19 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -177.33 61.01 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.9 m -63.24 115.44 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 122.012 0.91 . . . . 0.0 110.317 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.812 ' CB ' HG21 ' A' ' 16' ' ' THR . 19.6 t -82.0 -23.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.509 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.783 ' CG ' HG21 ' A' ' 15' ' ' THR . 0.2 OUTLIER -155.79 155.67 33.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 0.0 110.673 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.715 HG12 ' HZ2' ' A' ' 35' ' ' LYS . 3.4 t -152.87 128.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.805 . . . . 0.0 109.963 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -128.51 178.64 6.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.764 HG21 ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -149.98 151.49 33.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 110.691 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 56' ' ' THR . . . -173.0 -160.86 22.38 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 56' ' ' THR . 5.7 m 57.07 85.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -1.042 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.3 m-20 39.58 48.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.446 -0.784 . . . . 0.0 110.936 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 10.1 ptm180 37.44 35.51 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.577 -0.702 . . . . 0.0 111.004 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 25' ' ' LEU . 20.0 tttt -121.92 -19.26 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 110.193 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -124.53 170.36 10.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -163.35 172.8 39.39 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.422 ' CE2' ' HD1' ' A' ' 21' ' ' PHE . 1.3 t80 -121.88 162.56 20.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.828 -0.807 . . . . 0.0 109.976 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.559 HG23 HG13 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -145.29 167.4 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.117 -0.989 . . . . 0.0 110.834 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.545 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 2.8 m-20 -141.69 144.1 33.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.56 -0.712 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.843 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 61.5 m-85 -118.3 -178.55 3.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 7.5 pt-20 -113.96 8.93 17.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.477 -0.764 . . . . 0.0 111.016 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.653 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 32.1 p -167.81 176.1 6.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.572 1.177 . . . . 0.0 112.423 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.34 -24.32 50.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -28.69 57.75 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.364 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.697 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.0 m-20 -82.54 -27.78 31.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -72.56 -37.34 68.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.876 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.02 -38.47 61.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 109.979 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.955 ' O ' HD23 ' A' ' 77' ' ' LEU . 11.2 ttmm -76.68 -25.75 54.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.843 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -69.77 -31.75 69.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 75' ' ' LEU . 5.6 tt -70.86 -43.11 69.15 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -10.58 59.94 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.163 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.955 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -72.48 1.82 7.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.549 -0.72 . . . . 0.0 110.658 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.565 ' CA ' HD21 ' A' ' 89' ' ' LEU . 15.4 m -78.52 6.07 9.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.36 24.18 32.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.947 ' HB3' HD21 ' A' ' 41' ' ' LEU . 4.7 mt -127.11 128.14 45.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -1.188 . . . . 0.0 110.837 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 82' ' ' VAL . 21.3 mtmt -84.82 83.24 8.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.768 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.82 HG21 HG21 ' A' ' 87' ' ' ILE . 74.3 t -32.2 -98.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.063 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.667 ' N ' HG12 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -85.38 23.06 1.38 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.665 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.94 20.44 5.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 87' ' ' ILE . 66.6 m-80 -154.71 116.12 4.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -1.102 . . . . 0.0 109.363 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 1.1 pt-20 -55.56 84.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 110.14 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.82 HG21 HG21 ' A' ' 82' ' ' VAL . 24.4 pt -41.01 130.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.508 -0.745 . . . . 0.0 110.091 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.504 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 3.4 mttt -98.15 122.58 41.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.373 -0.829 . . . . 0.0 109.774 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.582 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -118.87 172.49 7.5 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.39 -0.819 . . . . 0.0 110.386 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 11.3 pt-20 . . . . . 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.469 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 15' ' ' THR . 4.6 m . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.205 0.526 . . . . 0.0 110.082 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.815 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.63 166.27 1.86 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.064 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 16' ' ' THR . 48.0 Cg_endo -76.15 -31.95 4.47 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.95 1.5 . . . . 0.0 110.798 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.6 m-85 -111.62 106.93 15.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.026 -1.046 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 16' ' ' THR . 43.7 m-20 -139.79 156.06 46.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.352 -0.843 . . . . 0.0 109.814 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 21' ' ' PHE . 3.5 pp -169.78 -168.55 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.288 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.627 ' N ' HD12 ' A' ' 20' ' ' LEU . 22.0 t80 -111.95 158.46 19.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 110.265 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.966 HD12 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -140.73 160.11 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.104 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -141.76 -170.66 12.53 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.517 -1.325 . . . . 0.0 109.923 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 4.6 t30 73.85 34.31 0.91 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.622 -0.928 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.049 HD22 ' O ' ' A' ' 60' ' ' PHE . 7.9 mp -85.57 134.73 34.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.788 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 35.0 t-20 -60.2 109.89 2.39 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 110.464 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -74.55 -26.26 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.062 1.559 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.44 -25.11 57.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 109.897 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HE3' ' CE1' ' A' ' 83' ' ' PHE . 6.6 mmtt -91.23 -154.41 0.36 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.729 . . . . 0.0 109.665 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.61 140.79 44.62 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.682 HG12 ' HE2' ' A' ' 35' ' ' LYS . 3.0 t -67.48 -35.36 73.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.096 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -61.08 -32.23 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.181 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 65.7 mm-40 -73.45 -34.34 65.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.481 -0.762 . . . . 0.0 109.229 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.966 HD22 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -66.3 -30.37 70.77 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.375 -0.828 . . . . 0.0 109.068 179.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.682 ' HE2' HG12 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -68.74 -56.27 8.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -62.91 -37.44 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.55 -32.77 74.34 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.844 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 34' ' ' LEU . 13.5 mt -81.46 -28.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.475 -0.765 . . . . 0.0 109.107 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 1.024 ' HA ' HG21 ' A' ' 49' ' ' VAL . 3.6 m -77.82 -30.94 51.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.16 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.99 -37.63 33.87 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.986 HD22 HD21 ' A' ' 80' ' ' LEU . 1.1 tt -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.228 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 47' ' ' LEU . 15.3 m-85 -87.55 -17.18 32.6 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.361 -0.837 . . . . 0.0 109.363 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -88.44 -28.97 20.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.2 mttt -91.44 -20.93 21.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.768 . . . . 0.0 109.395 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -79.08 -58.89 3.0 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.53 -0.731 . . . . 0.0 109.633 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 148.47 29.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -108.74 -158.86 0.66 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 109.593 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -160.33 65.37 0.33 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.018 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.024 HG21 ' HA ' ' A' ' 39' ' ' SER . 11.0 m -54.59 115.44 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.811 0.815 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.815 HG11 ' CG2' ' A' ' 16' ' ' THR . 11.5 t -82.51 -35.9 13.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 121.88 -0.513 . . . . 0.0 110.482 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -152.84 164.02 38.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 0.0 110.723 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.61 HG22 ' HG3' ' A' ' 35' ' ' LYS . 5.4 p -159.0 102.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.723 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -93.87 163.34 13.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.626 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.1 p -85.05 161.68 19.62 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.313 -0.867 . . . . 0.0 110.715 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -115.33 121.8 5.4 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 9.1 m -21.54 142.39 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.605 0.717 . . . . 0.0 112.445 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER 72.4 18.78 4.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.476 -0.765 . . . . 0.0 109.959 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.589 ' HD2' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 42.46 27.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.788 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.456 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -110.92 -17.93 13.19 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 1.049 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -130.08 -168.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.042 -1.036 . . . . 0.0 109.601 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 177.88 155.79 14.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.0 m-85 -108.9 162.18 14.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.966 HG21 HD12 ' A' ' 22' ' ' ILE . 3.2 t -150.13 143.17 17.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.891 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.13 144.97 42.28 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.547 -0.721 . . . . 0.0 109.717 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 13.1 m-85 -109.68 177.79 4.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.323 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.589 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 2.3 pp20? -114.21 8.4 16.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 111.285 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 10.0 p -175.41 177.15 1.87 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.278 1.037 . . . . 0.0 111.972 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.429 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -79.04 -22.87 44.75 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -82.22 -26.51 33.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.264 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.595 ' OD1' HD23 ' A' ' 47' ' ' LEU . 2.9 t0 -82.42 -26.61 32.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.422 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.1 tp -80.6 -33.71 35.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.62 -34.53 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.514 -0.741 . . . . 0.0 109.357 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.17 -29.08 60.32 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.51 -26.68 65.57 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.0 tt -72.98 -46.61 51.3 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -10.72 60.05 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.999 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.916 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -73.14 4.26 4.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.573 -0.705 . . . . 0.0 110.379 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 m -58.01 -14.27 6.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.54 37.69 3.33 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.011 HD13 HD11 ' A' ' 87' ' ' ILE . 4.2 mt -90.03 -168.56 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.535 -0.979 . . . . 0.0 111.159 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.587 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 17.7 mttt 170.89 53.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 108.927 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.787 HG11 HD23 ' A' ' 34' ' ' LEU . 90.7 t -24.96 -100.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.991 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.626 ' N ' HG12 ' A' ' 82' ' ' VAL . 12.7 m-85 -89.64 39.99 0.97 Allowed 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.24 24.65 28.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 7.3 p-10 -138.52 86.21 2.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.538 -0.978 . . . . 0.0 109.016 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.587 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 1.1 pt-20 -41.74 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 110.686 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 80' ' ' LEU . 3.6 pt -51.27 146.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.554 0.692 . . . . 0.0 109.942 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 22' ' ' ILE . 20.9 tptt -119.43 156.29 30.43 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 109.845 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.577 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -119.87 171.95 8.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.069 -1.019 . . . . 0.0 110.304 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.663 0 O-C-N 121.365 -0.835 . . . . 0.0 110.127 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 HG23 ' A' ' 16' ' ' THR . 3.3 m . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.433 0.635 . . . . 0.0 110.074 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.919 ' CG2' HG11 ' A' ' 50' ' ' VAL . 69.5 p -139.78 164.28 39.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.583 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.3 Cg_endo -74.99 -21.65 15.66 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.088 1.573 . . . . 0.0 110.721 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 96.9 m-85 -106.67 113.44 26.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.037 -1.04 . . . . 0.0 110.56 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.531 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -144.76 140.59 28.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.815 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.53 -166.88 2.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.837 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.685 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 6.7 t80 -118.69 157.54 27.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.179 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.799 HG13 HD23 ' A' ' 89' ' ' LEU . 5.5 mt -145.85 151.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.44 -174.4 13.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 27.2 t30 69.84 55.28 0.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.163 -1.199 . . . . 0.0 109.998 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 60' ' ' PHE . 3.9 mm? -93.78 123.75 37.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.924 ' N ' HD21 ' A' ' 34' ' ' LEU . 58.5 t30 -42.25 101.71 0.25 Allowed Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HA ' ' HG2' ' A' ' 58' ' ' ARG . 48.2 Cg_endo -75.39 -11.47 20.79 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.065 1.561 . . . . 0.0 110.498 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -81.96 -8.5 59.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 13.4 mttt -124.95 -154.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.971 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.877 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.9 m -100.09 147.59 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.876 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.6 t -64.53 -35.16 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.535 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -51.51 68.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 109.778 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 38.5 mm-40 -56.74 -31.61 64.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.83 . . . . 0.0 109.015 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.924 HD21 ' N ' ' A' ' 26' ' ' ASN . 6.7 mp -66.27 -33.17 75.14 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.384 -0.822 . . . . 0.0 109.069 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.939 ' HD2' HG12 ' A' ' 52' ' ' VAL . 29.1 mmtt -64.72 -55.47 19.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.974 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.8 t -57.26 -32.87 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.592 -0.693 . . . . 0.0 109.552 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 82' ' ' VAL . . . -63.79 -35.62 81.21 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.822 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 82' ' ' VAL . 15.6 mm -80.05 -26.75 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.535 -0.728 . . . . 0.0 109.311 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.823 ' HA ' HG21 ' A' ' 49' ' ' VAL . 52.5 m -79.58 -30.72 41.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.921 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.2 tm-20 -80.53 -39.69 27.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.583 0.706 . . . . 0.0 109.572 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.83 -33.54 75.84 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.132 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.733 ' HE1' HD12 ' A' ' 77' ' ' LEU . 5.5 m-30 -81.82 -23.17 36.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 109.18 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.85 -27.53 44.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.027 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CD ' ' OE2' ' A' ' 40' ' ' GLU . 6.4 mtpt -87.8 -19.47 27.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.448 -0.783 . . . . 0.0 109.284 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -80.64 -60.04 2.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.562 -0.711 . . . . 0.0 109.423 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.0 m-20 149.68 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.571 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.906 HD11 ' HB3' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -106.58 -157.69 0.62 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.47 61.22 0.38 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.019 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.6 m -48.32 117.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.98 0.895 . . . . 0.0 110.068 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.919 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.94 -41.55 14.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.581 ' C ' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -146.57 159.26 43.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.939 HG12 ' HD2' ' A' ' 35' ' ' LYS . 40.9 t -157.57 114.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.418 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -113.83 163.81 14.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 110.496 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.876 ' HB ' HG11 ' A' ' 31' ' ' VAL . 21.7 p -83.45 171.53 13.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.63 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -135.29 130.77 5.54 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.4 m 50.45 -140.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -1.16 . . . . 0.0 109.902 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.485 ' H ' HG22 ' A' ' 56' ' ' THR . 41.0 p30 -100.75 79.82 2.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.075 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HA ' HG22 ' A' ' 31' ' ' VAL . 7.7 ttp180 56.65 28.98 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 110.482 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.94 -31.23 10.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 109.889 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.789 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.93 177.52 10.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.566 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -154.2 150.52 22.16 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.298 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 20.7 t80 -103.85 160.6 14.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.365 -1.079 . . . . 0.0 109.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.924 HG22 HG13 ' A' ' 52' ' ' VAL . 88.7 t -154.5 154.42 7.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.435 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -124.13 139.88 53.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.708 -0.62 . . . . 0.0 109.865 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.861 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 21.7 m-85 -109.71 173.45 6.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.718 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.08 15.19 17.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.353 -0.842 . . . . 0.0 111.212 -178.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.56 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 2.3 t -166.24 175.49 8.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.718 1.247 . . . . 0.0 112.063 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.15 -25.39 22.98 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -20.95 26.21 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.45 ' OD2' ' HB3' ' A' ' 65' ' ' PHE . 8.7 t0 -84.14 -31.68 25.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 71' ' ' LEU . 8.4 tt -75.77 -34.59 60.24 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.485 0.66 . . . . 0.0 109.59 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.5 -35.19 60.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.992 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 1.018 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -76.65 -27.38 55.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.861 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.09 -28.7 64.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.728 HD22 HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -68.95 -45.76 69.92 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.55 -15.55 63.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.963 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.018 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.2 mm? -72.86 0.01 12.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.225 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.854 HG23 ' HA ' ' A' ' 88' ' ' LYS . 5.8 m -78.23 5.59 9.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 110.672 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.408 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -103.72 14.15 53.38 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.713 HD22 HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -115.3 131.21 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.843 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' A' ' 82' ' ' VAL . 14.1 mttt -75.95 83.85 2.86 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 109.62 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.106 HG11 HG23 ' A' ' 87' ' ' ILE . 1.2 p -31.34 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.81 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.811 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -100.84 28.79 4.94 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.61 15.93 3.89 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.762 ' O ' HG12 ' A' ' 82' ' ' VAL . 6.7 m-20 -158.64 116.62 2.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -1.2 . . . . 0.0 109.478 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 78' ' ' THR . 24.9 tt0 -52.72 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.106 HG23 HG11 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -42.77 154.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 110.215 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.854 ' HA ' HG23 ' A' ' 78' ' ' THR . 7.1 mtpp -129.7 157.15 42.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.836 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 22' ' ' ILE . 3.7 mt -106.68 -179.54 3.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.11 -0.993 . . . . 0.0 110.119 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 . . . . . 0 C--N 1.299 -1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 110.219 -179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 16' ' ' THR . 5.6 m . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.311 0.577 . . . . 0.0 110.146 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.882 ' CG2' HG11 ' A' ' 50' ' ' VAL . 16.2 p -159.89 159.11 27.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.838 . . . . 0.0 110.207 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.18 -18.2 14.46 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.149 1.605 . . . . 0.0 110.913 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 79.9 m-85 -122.34 115.78 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.931 -1.106 . . . . 0.0 111.14 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.488 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 2.2 m120 -143.49 151.39 40.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.532 -0.73 . . . . 0.0 109.067 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.806 HD21 ' HE2' ' A' ' 65' ' ' PHE . 1.7 pp -160.22 179.59 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.66 158.12 16.59 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.631 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 88' ' ' LYS . 6.6 mt -148.33 154.21 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.355 -0.841 . . . . 0.0 109.414 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -144.68 -164.87 10.79 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.7 t30 71.68 35.03 1.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.749 ' CD1' HD22 ' A' ' 34' ' ' LEU . 4.1 mm? -85.3 129.5 34.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.19 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.704 ' H ' HD21 ' A' ' 34' ' ' LEU . 28.4 t-20 -50.06 106.17 0.6 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HG3' ' HE3' ' A' ' 59' ' ' LYS . 47.9 Cg_endo -74.42 -18.88 19.91 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.996 1.524 . . . . 0.0 110.486 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -79.45 -16.21 56.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -106.18 -155.88 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.372 -0.83 . . . . 0.0 109.817 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 2.6 m -103.6 149.39 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 110.181 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.777 ' CG1' HG22 ' A' ' 54' ' ' THR . 3.0 t -69.85 -42.66 79.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -56.96 -34.81 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.503 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.93 -46.47 71.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.79 . . . . 0.0 109.581 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.749 HD22 ' CD1' ' A' ' 25' ' ' LEU . 2.0 mt -54.55 -32.44 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.177 -0.952 . . . . 0.0 108.837 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HD3' ' HB ' ' A' ' 52' ' ' VAL . 13.2 mmtt -64.77 -58.43 6.27 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.131 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 21.9 t -53.24 -35.64 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.497 -0.752 . . . . 0.0 109.369 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.4 -39.01 93.35 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.574 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 70.8 mt -77.92 -26.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.615 ' HA ' HG21 ' A' ' 49' ' ' VAL . 41.0 m -79.16 -29.21 42.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.085 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.84 -38.56 22.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.456 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.862 ' HG ' HD13 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.84 -31.49 71.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.735 ' CE1' HD12 ' A' ' 77' ' ' LEU . 6.9 m-85 -85.37 -22.22 28.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.97 -31.85 59.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.547 -0.721 . . . . 0.0 109.131 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -91.92 -15.41 28.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.59 -0.694 . . . . 0.0 109.134 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.671 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -82.71 -29.04 30.12 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.501 -0.75 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.671 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 36.6 t0 103.85 29.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.011 HD11 ' CB ' ' A' ' 73' ' ' LYS . 3.3 mp -97.73 -151.78 0.38 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.86 61.9 0.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.093 -1.004 . . . . 0.0 110.43 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 39' ' ' SER . 5.9 m -50.07 119.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.878 0.847 . . . . 0.0 109.396 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.882 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.5 t -89.28 -48.14 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.86 -0.525 . . . . 0.0 110.968 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 5.1 m-20 -141.48 115.68 9.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.868 -1.145 . . . . 0.0 111.311 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 63' ' ' VAL . 16.0 m -103.64 143.49 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.437 -0.789 . . . . 0.0 109.679 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -150.32 167.79 25.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 110.532 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.777 HG22 ' CG1' ' A' ' 31' ' ' VAL . 13.7 p -88.9 164.31 15.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 110.578 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -132.63 127.35 4.8 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER 68.19 -143.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -1.112 . . . . 0.0 110.069 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.94 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.158 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.9 31.18 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 110.06 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HE3' ' HG3' ' A' ' 27' ' ' PRO . 19.3 tttt -123.76 -17.34 6.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.601 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -109.49 -176.57 3.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 110.156 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.4 152.26 10.9 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.5 t80 -125.12 158.85 32.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -1.049 . . . . 0.0 109.521 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 52' ' ' VAL . 3.4 t -151.95 147.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.852 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.47 137.31 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.472 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.806 ' HE2' HD21 ' A' ' 20' ' ' LEU . 25.7 m-85 -100.04 177.46 5.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.665 -0.647 . . . . 0.0 111.101 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.64 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.19 12.02 15.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 111.611 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CD2' ' A' ' 18' ' ' PHE . 5.2 p -173.71 172.11 3.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 0.0 112.2 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.61 -25.76 45.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.25 -28.16 38.5 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.793 179.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.495 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 5.5 t0 -79.77 -24.27 41.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.788 HD13 ' C ' ' A' ' 71' ' ' LEU . 2.3 tm? -77.22 -35.65 55.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.48 -35.45 73.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.422 -0.799 . . . . 0.0 109.042 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 1.011 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -75.35 -25.36 57.69 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.7 -30.7 69.41 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.9 tt -71.83 -45.54 61.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -77.79 -2.13 34.9 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.151 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.924 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -76.74 7.65 4.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 110.483 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -73.65 0.55 12.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.19 12.02 61.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.862 HD13 ' HG ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -102.37 131.83 48.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.289 -1.124 . . . . 0.0 109.678 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.742 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -114.37 80.15 1.36 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.489 1.137 . . . . 0.0 110.11 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.036 ' CG2' HG23 ' A' ' 87' ' ' ILE . 3.5 m -51.17 127.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.68 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 8.2 m-30 38.17 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.477 -0.765 . . . . 0.0 111.331 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 85.44 26.88 34.54 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.541 ' HB2' HG23 ' A' ' 82' ' ' VAL . 10.1 m120 -134.74 78.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.739 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.3 tm-20 -37.19 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.729 0.776 . . . . 0.0 110.747 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.036 HG23 ' CG2' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -47.7 144.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' HG23 ' A' ' 22' ' ' ILE . 25.7 tttt -119.3 156.54 29.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.6 172.34 7.28 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 110.38 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.5 tm-20 . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.751 . . . . 0.0 110.133 -179.928 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 16' ' ' THR . 5.8 t . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.555 0.693 . . . . 0.0 110.069 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 15' ' ' THR . 74.6 p -139.27 164.76 36.66 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.565 -0.71 . . . . 0.0 110.265 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.72 -22.62 11.77 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.022 1.538 . . . . 0.0 111.073 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.541 ' CE2' ' C ' ' A' ' 67' ' ' SER . 91.5 m-85 -104.19 85.5 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.928 -1.107 . . . . 0.0 110.939 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.521 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.7 m-20 -122.61 146.87 47.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.09 -1.006 . . . . 0.0 109.374 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.831 HD21 ' HE2' ' A' ' 65' ' ' PHE . 1.8 pp -154.36 -176.97 6.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -103.18 166.46 10.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.617 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.774 HD12 ' CG2' ' A' ' 63' ' ' VAL . 9.0 mt -144.49 158.79 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -149.19 -178.67 24.41 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.031 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 20.5 t30 72.67 54.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.92 . . . . 0.0 110.233 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.923 ' HB3' HD13 ' A' ' 34' ' ' LEU . 21.0 mt -102.23 125.93 49.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.042 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 26.4 t-20 -41.25 110.08 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.733 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.01 -19.94 22.49 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.997 1.525 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -85.54 -7.56 58.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.953 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.583 ' HD3' ' CG ' ' A' ' 83' ' ' PHE . 10.1 mttt -114.15 -157.24 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.371 -0.83 . . . . 0.0 109.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.454 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 3.5 m -110.51 150.09 29.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 110.572 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.911 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.6 t -69.56 -38.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.337 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.4 -34.66 69.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.422 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 5.6 mm-40 -74.82 -32.67 62.03 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.375 -0.828 . . . . 0.0 109.159 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.923 HD13 ' HB3' ' A' ' 25' ' ' LEU . 7.4 mt -66.21 -35.18 79.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.392 -0.818 . . . . 0.0 109.03 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.755 ' HE2' HG12 ' A' ' 31' ' ' VAL . 2.7 mptp? -67.11 -54.08 24.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 32' ' ' ALA . 16.7 t -52.17 -35.97 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 109.581 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.742 ' CB ' HG13 ' A' ' 82' ' ' VAL . . . -64.34 -38.37 90.78 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.841 HD11 ' CG2' ' A' ' 82' ' ' VAL . 20.2 mm -78.02 -26.66 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.369 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.559 ' HA ' HG21 ' A' ' 49' ' ' VAL . 37.6 m -78.97 -31.92 45.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -79.8 -39.27 31.22 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.46 -0.775 . . . . 0.0 109.537 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.859 HD22 HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.6 -33.55 75.92 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.132 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.586 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 7.8 m-85 -82.17 -21.95 36.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.554 -0.716 . . . . 0.0 109.211 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.52 44.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.409 -0.807 . . . . 0.0 109.726 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 14.4 mtmm -104.67 -22.81 13.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -79.31 -30.92 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 35.7 t70 112.62 29.03 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.583 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 1.7 mm? -88.93 -153.16 0.25 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.923 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -165.87 64.09 0.11 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.6 m -62.98 117.87 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.917 0.865 . . . . 0.0 110.079 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.92 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.3 t -92.36 -42.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -144.4 158.22 43.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.949 HG13 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -144.96 156.19 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 109.569 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.449 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -162.51 170.23 19.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.24 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.586 HG22 ' CG1' ' A' ' 31' ' ' VAL . 13.8 p -90.48 164.62 14.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 110.243 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -120.5 131.78 8.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.494 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 99.0 m 58.72 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.937 . . . . 0.0 110.371 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 27.6 t-20 -173.25 84.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.627 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER 66.25 22.18 10.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 110.729 179.43 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.566 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.0 tttm -120.59 -35.84 3.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.852 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.2 m-85 -135.27 -164.3 1.51 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -169.08 165.3 38.81 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.272 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 20' ' ' LEU . 36.8 t80 -128.73 153.1 47.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -1.02 . . . . 0.0 109.524 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.949 HG13 HG13 ' A' ' 52' ' ' VAL . 3.1 t -150.43 144.15 17.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.079 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -107.5 141.07 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 109.663 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.831 ' HE2' HD21 ' A' ' 20' ' ' LEU . 30.8 m-85 -104.3 177.79 4.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.876 . . . . 0.0 110.551 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.626 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.12 15.91 14.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 111.02 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.7 p -179.38 178.28 0.7 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.368 1.08 . . . . 0.0 111.954 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.51 -22.57 50.99 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -27.99 38.77 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.43 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.923 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 85.8 m-20 -80.22 -29.27 38.5 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.838 ' O ' HD13 ' A' ' 71' ' ' LEU . 3.4 tm? -81.41 -32.81 32.57 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.501 0.667 . . . . 0.0 109.314 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.68 -36.05 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.748 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.633 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.98 -30.14 50.09 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . . . -63.82 -28.99 70.24 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.799 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -74.95 -47.15 31.0 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 5.01 16.21 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.612 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -79.39 11.66 2.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 110.422 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -6.44 19.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.41 25.03 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 77' ' ' LEU . 1.3 mt -92.76 -171.16 2.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.468 -1.019 . . . . 0.0 110.9 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.578 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.4 mttt 176.55 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.869 0.842 . . . . 0.0 108.978 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.841 ' CG2' HD11 ' A' ' 38' ' ' ILE . 99.3 t -24.34 -101.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.169 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.625 ' N ' HG12 ' A' ' 82' ' ' VAL . 10.2 m-85 -87.86 42.32 1.05 Allowed 'General case' 0 C--N 1.288 -2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 108.728 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.69 29.78 22.98 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 1.1 t-20 -145.91 88.12 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.449 -1.03 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.578 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -42.95 96.06 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.625 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -48.56 125.73 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.606 -0.684 . . . . 0.0 110.144 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -100.89 129.9 46.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.733 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.754 ' H ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -113.58 176.34 5.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.013 -1.054 . . . . 0.0 111.222 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 3.2 pt-20 . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.459 -0.776 . . . . 0.0 110.23 -179.855 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 16' ' ' THR . 4.6 m . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 121.236 0.541 . . . . 0.0 110.16 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 1.026 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -178.83 165.19 1.03 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 110.39 -179.928 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.561 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.8 Cg_endo -75.43 -44.16 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.101 1.579 . . . . 0.0 110.651 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 90.6 m-85 -96.15 106.33 18.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.119 -0.988 . . . . 0.0 110.594 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' ND2' ' C ' ' A' ' 18' ' ' PHE . 2.0 m120 -135.66 146.31 47.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -164.71 169.15 17.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.547 179.79 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 3.5 t80 -101.73 145.97 28.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.732 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 mt -127.78 158.53 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.68 179.84 17.21 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.834 ' C ' HD22 ' A' ' 25' ' ' LEU . 45.8 t30 71.35 76.74 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.413 -1.051 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.834 HD22 ' C ' ' A' ' 24' ' ' ASN . 4.4 mm? -118.88 126.44 51.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.021 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.515 ' HB3' HD21 ' A' ' 34' ' ' LEU . 46.0 t30 -40.43 100.36 0.22 Allowed Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.613 -0.68 . . . . 0.0 110.525 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.7 Cg_endo -75.75 -13.81 19.77 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.411 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -18.26 43.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -108.28 -156.52 0.58 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 0.0 109.753 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.525 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -101.63 147.19 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.987 ' HA ' HD12 ' A' ' 34' ' ' LEU . 3.3 t -69.67 -32.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.486 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.74 85.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.183 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.72 -40.15 84.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.724 . . . . 0.0 109.33 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.987 HD12 ' HA ' ' A' ' 31' ' ' VAL . 40.2 mt -57.3 -37.04 71.84 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -61.45 -58.19 9.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.32 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -58.54 -33.7 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.414 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.61 -36.49 83.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.189 -0.945 . . . . 0.0 108.609 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.604 HG13 HG22 ' A' ' 82' ' ' VAL . 17.0 mt -79.66 -26.14 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.584 -0.697 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -79.79 -30.35 40.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 108.93 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.12 -38.06 27.86 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.514 0.673 . . . . 0.0 109.669 179.464 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.066 HD22 ' CD2' ' A' ' 80' ' ' LEU . 1.1 tt -69.9 -31.19 68.85 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.458 -0.776 . . . . 0.0 109.248 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.888 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 5.5 m-85 -82.87 -23.92 33.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.11 -32.01 61.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -90.02 -18.95 25.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.437 179.353 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.3 m-80 -85.49 -20.16 30.13 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.786 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.0 t0 89.42 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 -179.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.773 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -80.14 -138.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 47' ' ' LEU . . . -176.52 57.44 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.953 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.681 ' O ' HG23 ' A' ' 49' ' ' VAL . 9.9 m -63.32 117.45 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.047 0.927 . . . . 0.0 110.766 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 1.026 HG21 HG21 ' A' ' 16' ' ' THR . 0.0 OUTLIER -98.2 -34.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.524 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.51 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 56.7 t0 -144.78 148.49 34.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.894 HG22 HG13 ' A' ' 63' ' ' VAL . 3.8 t -152.87 100.28 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 169.23 8.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.124 -0.985 . . . . 0.0 110.388 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.482 ' HB ' HG11 ' A' ' 31' ' ' VAL . 17.4 p -83.52 168.21 16.66 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -122.04 122.02 4.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 60' ' ' PHE . 4.3 m 67.87 -57.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.755 -0.85 . . . . 0.0 110.368 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.504 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER 179.81 -43.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.69 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -168.39 25.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.721 . . . . 0.0 110.123 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.633 ' CB ' ' CE1' ' A' ' 60' ' ' PHE . 2.8 mttt -119.65 -24.83 6.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.803 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.827 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -138.51 -172.38 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.195 -0.941 . . . . 0.0 109.449 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -172.93 151.69 14.55 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.147 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 38.0 m-85 -108.05 150.62 26.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.415 -1.05 . . . . 0.0 109.525 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.894 HG13 HG22 ' A' ' 52' ' ' VAL . 3.9 t -151.36 146.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.264 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 m-20 -122.56 146.6 47.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.646 ' O ' HG21 ' A' ' 50' ' ' VAL . 26.2 m-85 -114.86 -175.21 2.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.861 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.709 ' HG3' HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -129.44 31.34 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.661 -1.274 . . . . 0.0 113.673 -176.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.776 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 22.6 p -172.88 172.76 3.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.902 -1.749 . . . . 0.0 113.167 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.77 -27.81 58.2 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -27.1 61.76 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 179.459 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.776 ' OD2' ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -78.23 -32.29 49.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.083 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -65.95 -41.55 91.14 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.284 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' HD23 ' A' ' 71' ' ' LEU . 2.4 tt0 -70.09 -33.11 71.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 178.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.773 ' HB2' HD21 ' A' ' 47' ' ' LEU . 15.9 mmtt -81.49 -23.02 37.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -69.19 -29.91 67.98 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.456 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.45 -48.13 29.38 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.261 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.07 8.51 15.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.269 178.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.897 HD23 ' O ' ' A' ' 77' ' ' LEU . 3.0 tt -66.32 -8.81 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 110.837 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 78' ' ' THR . 84.9 m -70.92 5.41 2.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.353 -0.842 . . . . 0.0 111.692 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.44 -6.48 56.52 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.066 ' CD2' HD22 ' A' ' 41' ' ' LEU . 6.8 mp -92.61 120.79 33.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -1.166 . . . . 0.0 110.723 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -95.07 80.69 3.63 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.965 0.888 . . . . 0.0 110.139 179.36 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 87' ' ' ILE . 2.5 t -43.22 120.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.611 ' HB2' HD23 ' A' ' 34' ' ' LEU . 0.6 OUTLIER 48.73 20.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.965 -179.122 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.87 11.67 39.51 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.7 m120 -128.28 110.43 12.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -59.35 76.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.529 -0.732 . . . . 0.0 110.123 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 82' ' ' VAL . 4.9 pt -42.99 140.33 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 110.042 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.8 mttm -108.61 158.72 17.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.205 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.557 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -120.69 170.99 8.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 110.083 179.944 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.497 HG21 ' OD2' ' A' ' 51' ' ' ASP . 4.2 m . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 121.268 0.556 . . . . 0.0 110.222 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.831 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -170.52 165.4 5.31 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.95 -34.06 2.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.097 1.577 . . . . 0.0 111.052 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.2 m-85 -109.78 115.62 30.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.737 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.492 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 3.5 m-80 -142.88 152.36 42.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.412 -0.805 . . . . 0.0 109.567 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.735 HD23 ' N ' ' A' ' 20' ' ' LEU . 2.0 pt? -162.91 170.88 17.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 110.416 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -97.93 167.79 10.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' GLY . 14.2 mt -142.69 161.65 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -148.11 177.61 26.25 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 16.9 t30 71.73 43.75 0.55 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -1.095 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.933 ' CD1' HD22 ' A' ' 34' ' ' LEU . 4.2 mm? -92.73 127.63 38.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.932 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.783 ' H ' HD21 ' A' ' 34' ' ' LEU . 63.8 t-20 -40.8 106.61 0.43 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 110.447 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.53 -24.4 16.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.085 1.571 . . . . 0.0 110.389 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -76.44 -10.93 59.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.902 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.8 mmtp -114.68 -155.6 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.959 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.823 ' O ' HD12 ' A' ' 34' ' ' LEU . 6.8 m -115.22 153.39 30.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.082 HG11 HG22 ' A' ' 54' ' ' THR . 2.8 t -69.52 -21.03 24.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.224 -0.922 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.27 89.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 109.308 179.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.1 mm-40 -71.49 -45.35 62.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.532 -0.73 . . . . 0.0 109.354 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.933 HD22 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -57.91 -31.07 66.42 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.575 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -64.53 -62.09 1.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.513 0.673 . . . . 0.0 109.238 179.092 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 44.2 t -51.93 -38.99 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.716 . . . . 0.0 109.684 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.82 -28.54 70.08 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.036 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 34' ' ' LEU . 39.9 mt -88.08 -27.63 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.006 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 8.9 m -79.97 -26.94 39.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.101 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.0 -38.99 20.23 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.25 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.809 HD22 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -65.99 -34.49 78.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.697 ' CD1' HD13 ' A' ' 77' ' ' LEU . 8.1 m-30 -86.45 -19.14 30.04 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -87.69 -28.12 21.99 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.831 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -90.41 -20.23 23.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.247 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.877 ' OD1' HD21 ' A' ' 77' ' ' LEU . 1.9 m-80 -79.2 -59.63 2.69 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.658 -0.651 . . . . 0.0 109.56 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.605 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.8 m-20 149.01 30.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.275 0.56 . . . . 0.0 109.925 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' ' 73' ' ' LYS . 1.9 mp -99.94 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.836 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.6 63.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 49' ' ' VAL . 7.8 m -49.89 117.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.909 0.862 . . . . 0.0 109.975 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.831 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.4 t -93.6 -44.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 121.165 0.507 . . . . 0.0 110.403 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.497 ' OD2' HG21 ' A' ' 15' ' ' THR . 1.5 t70 -139.28 155.71 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.783 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -136.86 174.44 11.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.318 -0.864 . . . . 0.0 110.101 -179.822 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER 175.17 178.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.168 -0.957 . . . . 0.0 110.057 179.896 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 1.082 HG22 HG11 ' A' ' 31' ' ' VAL . 18.5 p -103.14 170.18 8.12 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.626 ' HA3' ' CB ' ' A' ' 60' ' ' PHE . . . -121.95 132.32 8.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 57' ' ' ASN . 53.3 m 57.46 -92.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 110.448 179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.485 ' N ' HG22 ' A' ' 56' ' ' THR . 1.1 t-20 -154.53 99.32 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 110.744 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 42.1 mtm180 45.12 23.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -121.26 -32.88 3.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.771 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.6 m-85 -119.88 -161.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 109.407 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -167.92 167.65 40.22 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.636 ' O ' HG23 ' A' ' 63' ' ' VAL . 14.6 t80 -142.01 153.58 44.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.394 -1.062 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.728 HG22 HG12 ' A' ' 52' ' ' VAL . 43.7 t -157.56 158.81 2.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.192 -178.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.58 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 11.4 m-20 -123.85 142.35 51.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.679 -0.638 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.836 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 49.6 m-85 -104.73 175.32 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 111.049 -179.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.635 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.37 11.76 20.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 111.524 -178.585 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.546 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.3 p -172.7 172.91 4.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 112.178 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -79.14 -23.96 43.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.43 -24.1 29.71 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.11 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 5.6 t0 -82.94 -26.58 31.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.774 HD13 ' C ' ' A' ' 71' ' ' LEU . 2.8 tm? -79.58 -34.47 40.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.287 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.8 -33.86 62.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 109.779 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.769 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -80.62 -21.94 41.05 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.589 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.836 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -77.8 -28.23 50.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.198 179.059 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.979 HD23 HD11 ' A' ' 89' ' ' LEU . 2.0 tm? -75.72 -46.23 32.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.478 ' N ' HD13 ' A' ' 75' ' ' LEU . 1.8 mt-10 -66.68 -26.31 66.97 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.218 179.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.877 HD21 ' OD1' ' A' ' 45' ' ' ASN . 6.9 mt -70.7 -20.58 62.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.839 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 75' ' ' LEU . 1.5 t -39.66 -31.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.306 1.05 . . . . 0.0 110.212 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.27 -20.31 9.75 Favored Glycine 0 C--N 1.281 -2.489 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.017 ' CD1' HG23 ' A' ' 82' ' ' VAL . 2.9 pp -66.99 125.84 27.26 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.319 -1.106 . . . . 0.0 110.655 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 11.0 mttt -93.88 78.67 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.301 1.048 . . . . 0.0 110.26 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.017 HG23 ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -43.8 131.09 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.146 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.575 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 3.0 m-85 44.32 24.25 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.467 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 91.21 25.03 25.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' ILE . 39.4 m-20 -140.35 104.8 4.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -1.184 . . . . 0.0 110.343 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 5.9 tt0 -56.35 84.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.289 -0.882 . . . . 0.0 109.933 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 87' ' ' ILE . 2.7 pp -40.09 129.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.523 0.678 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -104.78 132.75 50.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.507 -0.745 . . . . 0.0 109.376 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.979 HD11 HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -105.64 174.07 6.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.888 -1.133 . . . . 0.0 110.737 -179.45 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 110.109 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.2 m . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.249 0.547 . . . . 0.0 110.676 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.976 ' CG2' HG11 ' A' ' 50' ' ' VAL . 65.2 p -139.57 164.48 38.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.448 -0.782 . . . . 0.0 110.579 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 50.9 Cg_endo -78.21 -31.6 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.127 1.593 . . . . 0.0 110.695 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 89.9 m-85 -92.82 93.05 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.103 -0.998 . . . . 0.0 110.607 -179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.5 m120 -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.252 -0.905 . . . . 0.0 109.317 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.029 HD11 HD23 ' A' ' 89' ' ' LEU . 2.1 pt? -158.94 -176.63 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.714 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.2 t80 -101.37 156.61 17.35 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.646 HG22 HD21 ' A' ' 25' ' ' LEU . 2.4 mt -147.41 155.77 10.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.078 -1.014 . . . . 0.0 109.572 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.545 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -143.13 -162.7 9.42 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t30 71.38 14.09 6.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -1.107 . . . . 0.0 110.025 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.938 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.4 mm? -66.5 124.81 23.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.704 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 32.6 t-20 -40.96 101.09 0.23 Allowed Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.623 -0.673 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 45.8 Cg_endo -72.37 -31.62 11.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.079 1.568 . . . . 0.0 110.433 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 26' ' ' ASN . 28.4 p30 -72.68 -14.8 61.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.2 tmtt? -96.79 -153.78 0.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.79 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -112.45 148.58 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.372 -0.83 . . . . 0.0 110.279 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.56 HG12 ' NZ ' ' A' ' 35' ' ' LYS . 3.7 t -68.75 -25.25 30.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 29.9 mm-40 -72.96 -31.67 64.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.938 HD13 ' HB3' ' A' ' 25' ' ' LEU . 23.5 mt -65.89 -31.83 72.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.56 ' NZ ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -72.1 -56.48 5.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.553 179.484 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 32' ' ' ALA . 5.6 t -61.02 -33.69 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 179.134 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.72 -38.4 90.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.587 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 65.8 mt -75.52 -29.07 20.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.722 . . . . 0.0 109.584 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.855 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -77.46 -31.94 54.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.0 -1.063 . . . . 0.0 108.819 179.084 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.6 tm-20 -81.7 -42.23 20.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.507 0.67 . . . . 0.0 109.556 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.067 HD21 ' CD1' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -59.54 -37.58 78.76 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.748 -0.781 . . . . 0.0 108.966 179.167 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.79 ' CD2' HG13 ' A' ' 49' ' ' VAL . 9.7 m-85 -82.12 -22.65 36.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.68 -17.2 54.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -109.24 -16.98 13.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 109.741 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.713 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -84.4 -31.29 24.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.713 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.9 t0 112.62 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-O 121.971 0.891 . . . . 0.0 108.765 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.761 HD11 ' CG ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -105.59 -155.01 0.53 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.769 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.98 63.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 39' ' ' SER . 4.9 m -49.62 116.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.85 0.833 . . . . 0.0 109.829 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.976 HG11 ' CG2' ' A' ' 16' ' ' THR . 10.5 t -81.25 -38.0 16.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 8.7 t0 -153.6 152.66 31.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.087 -1.008 . . . . 0.0 110.55 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.648 HG13 HG23 ' A' ' 63' ' ' VAL . 13.4 t -134.92 161.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 26.5 mtp180 -155.61 154.87 32.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.009 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.462 ' C ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 p -78.66 166.82 22.08 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.975 . . . . 0.0 110.398 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -141.06 122.3 2.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 55' ' ' GLY . 32.1 m 40.4 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.337 -1.096 . . . . 0.0 111.008 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 56' ' ' THR . 21.4 m120 60.11 -141.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.73 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.538 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 3.6 ptt85 -114.5 34.32 4.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 11.1 pttt -118.47 -19.14 8.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 109.959 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.594 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -119.89 174.16 6.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.547 179.637 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -176.59 148.66 9.19 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.815 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 8.4 t80 -111.51 157.57 20.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.883 . . . . 0.0 109.016 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -141.28 172.34 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.773 -1.204 . . . . 0.0 111.3 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 2.6 m-20 -136.43 135.94 39.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.769 -0.582 . . . . 0.0 109.457 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 16.8 m-85 -106.47 -178.66 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.562 -0.711 . . . . 0.0 110.988 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.576 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 2.1 pp20? -117.45 5.55 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 111.044 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.657 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.4 p -168.96 175.2 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.301 1.048 . . . . 0.0 112.21 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.99 -23.56 41.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.74 -26.46 31.9 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.013 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.75 ' OD1' HD23 ' A' ' 47' ' ' LEU . 3.4 t0 -81.05 -27.76 35.63 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -75.5 -37.16 60.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -69.99 -33.9 72.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.753 . . . . 0.0 109.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.761 ' CG ' HD11 ' A' ' 47' ' ' LEU . 2.7 tppt? -73.4 -25.71 60.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 1.014 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -72.68 -26.99 61.82 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.943 0.878 . . . . 0.0 108.641 178.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.7 tm? -76.22 -34.47 59.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -16.76 48.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.729 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.014 HD23 ' HA ' ' A' ' 74' ' ' ALA . 1.1 pp -66.38 -17.83 65.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.98 -1.075 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -47.72 -16.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.569 -0.707 . . . . 0.0 111.751 -179.359 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -82.72 14.78 34.64 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.067 ' CD1' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -101.4 -163.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -1.195 . . . . 0.0 110.507 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.611 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -168.35 49.76 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 109.627 -179.758 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.848 ' CG2' HG23 ' A' ' 87' ' ' ILE . 5.0 t 5.67 -122.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.708 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 3.3 m-85 -72.31 -2.9 20.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.985 -1.072 . . . . 0.0 109.355 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 145.99 35.24 0.06 OUTLIER Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.1 m-20 -157.87 101.93 1.81 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -1.215 . . . . 0.0 109.996 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.611 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 2.8 pt-20 -52.58 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.848 HG23 ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -37.92 148.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.693 0.758 . . . . 0.0 110.75 -179.645 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 16.3 ttpt -121.87 156.81 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 1.029 HD23 HD11 ' A' ' 20' ' ' LEU . 1.8 mp -112.88 173.41 6.39 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.047 -1.033 . . . . 0.0 110.415 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 16' ' ' THR . 7.2 m . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 121.193 0.521 . . . . 0.0 110.282 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.764 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -166.68 162.89 11.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.325 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.76 -32.87 5.4 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.115 1.587 . . . . 0.0 110.489 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 84.9 m-85 -108.47 107.36 17.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.927 . . . . 0.0 110.432 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.514 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -139.25 146.72 40.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.868 . . . . 0.0 109.339 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -163.17 175.1 11.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.12 -0.987 . . . . 0.0 110.924 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 60' ' ' PHE . 2.4 t80 -97.37 147.75 23.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.713 -0.617 . . . . 0.0 110.103 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 63' ' ' VAL . 1.1 mp -133.85 148.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.946 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -135.56 -166.05 10.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' C ' HD23 ' A' ' 25' ' ' LEU . 28.1 t30 67.15 58.16 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.099 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.878 HD11 ' N ' ' A' ' 61' ' ' GLY . 8.1 mt -105.95 123.99 48.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 110.366 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' LEU . 53.3 t-20 -41.45 104.13 0.33 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.774 . . . . 0.0 110.213 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.75 -15.48 26.85 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -78.13 -17.15 57.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.19 -156.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.742 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.526 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -100.33 146.85 26.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.736 HG22 ' CB ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -70.85 -33.27 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.044 -1.063 . . . . 0.0 108.622 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.35 94.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 108.956 178.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.526 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 12.8 mm-40 -66.56 -33.54 75.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.894 ' O ' HD12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -64.26 -33.8 76.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.186 179.231 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 1.045 ' HD3' HG12 ' A' ' 52' ' ' VAL . 5.2 mmtt -66.29 -53.79 32.5 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.474 -0.766 . . . . 0.0 109.119 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -60.84 -40.94 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.376 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.8 -29.16 69.96 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 108.951 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 34' ' ' LEU . 10.3 mt -85.86 -30.28 6.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.101 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.684 ' HA ' HG11 ' A' ' 49' ' ' VAL . 34.2 p -78.65 -25.77 45.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 109.283 179.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -84.43 -39.89 18.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.47 -0.768 . . . . 0.0 109.137 179.39 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.063 HD21 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -62.65 -36.83 84.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.739 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.071 ' CE2' HD21 ' A' ' 77' ' ' LEU . 9.1 m-30 -80.01 -25.19 40.35 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -68.67 -40.15 80.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.488 179.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.51 -17.57 53.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.45 -0.781 . . . . 0.0 109.506 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.11 -8.73 58.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.521 -0.737 . . . . 0.0 110.009 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 9.1 t0 84.52 30.26 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.954 0.883 . . . . 0.0 108.848 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.846 HD21 ' CE1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -83.72 -132.34 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.321 0.581 . . . . 0.0 109.544 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 1.022 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 174.5 57.39 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.361 -0.837 . . . . 0.0 109.837 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.684 HG11 ' HA ' ' A' ' 39' ' ' SER . 10.1 m -56.19 117.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.907 0.86 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.765 HG22 ' HB3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -92.42 -44.22 14.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.289 0.566 . . . . 0.0 109.651 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 35.2 t70 -136.76 145.8 45.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -0.902 . . . . 0.0 110.615 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.045 HG12 ' HD3' ' A' ' 35' ' ' LYS . 1.8 t -153.96 119.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.374 -0.829 . . . . 0.0 109.132 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.72 160.04 40.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.891 -1.13 . . . . 0.0 111.266 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.578 ' HB ' HG11 ' A' ' 31' ' ' VAL . 39.2 p -92.21 152.29 19.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.5 -0.75 . . . . 0.0 110.027 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -125.95 124.29 5.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 67.97 -158.86 0.21 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.363 -1.081 . . . . 0.0 110.482 179.751 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.625 ' H ' HG22 ' A' ' 56' ' ' THR . 10.3 t-20 -82.57 74.1 9.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.456 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.736 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER 60.64 14.54 5.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 179.663 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -69.27 -50.51 46.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . 5.3 p90 -156.8 152.24 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.884 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.878 ' N ' HD11 ' A' ' 25' ' ' LEU . . . -124.04 167.95 16.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.1 t80 -119.75 155.3 32.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.406 -1.055 . . . . 0.0 109.721 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.841 HG23 HD13 ' A' ' 22' ' ' ILE . 3.2 t -151.2 143.43 16.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.746 -178.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -117.83 143.96 45.81 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.846 ' CE1' HD21 ' A' ' 47' ' ' LEU . 37.6 m-85 -107.92 171.76 7.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.838 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp20? -118.55 16.38 13.74 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.29 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.505 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.0 p -164.37 176.13 9.37 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.466 1.127 . . . . 0.0 112.207 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.91 -25.09 43.74 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -31.07 59.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.093 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 1.022 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 91.3 m-20 -78.7 -28.4 45.12 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.77 HD13 ' C ' ' A' ' 71' ' ' LEU . 1.8 tm? -74.64 -37.84 62.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -65.81 -34.53 78.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 0.0 109.025 178.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.707 ' C ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.02 -32.35 59.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -56.14 -33.57 65.32 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.588 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.5 tm? -72.47 -46.13 56.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.486 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.52 6.71 16.6 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.346 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.071 HD21 ' CE2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -77.15 -12.61 59.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.773 . . . . 0.0 110.367 -179.896 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.932 ' OG1' HD21 ' A' ' 89' ' ' LEU . 26.1 m -73.68 7.63 2.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.513 -0.742 . . . . 0.0 111.558 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.474 ' HA2' ' HG3' ' A' ' 86' ' ' GLU . . . -124.39 18.34 7.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.063 HD22 HD21 ' A' ' 41' ' ' LEU . 27.3 mt -107.66 111.16 23.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -1.143 . . . . 0.0 110.809 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 82' ' ' VAL . 38.1 mttm -76.91 84.02 3.46 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.07 0.938 . . . . 0.0 109.741 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.886 ' CG1' HG23 ' A' ' 87' ' ' ILE . 1.2 p -36.96 -94.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.415 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.792 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -96.81 29.05 3.17 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.159 -0.963 . . . . 0.0 109.681 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.46 9.54 12.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.722 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.4 m-20 -139.95 106.28 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 78' ' ' THR . 1.6 tm-20 -47.67 88.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.692 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.886 HG23 ' CG1' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.73 145.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 179.777 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 10.0 ttmt -117.58 155.7 29.36 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.647 -0.658 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.932 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.2 OUTLIER -120.66 175.02 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.417 -0.802 . . . . 0.0 110.327 -179.769 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.517 0 O-C-N 121.542 -0.724 . . . . 0.0 109.663 -179.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 15' ' ' THR . 23.8 m . . . . . 0 N--CA 1.493 1.709 0 CA-C-O 121.055 0.455 . . . . 0.0 110.873 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.967 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.42 168.78 1.59 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.817 -1.177 . . . . 0.0 110.854 -179.88 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.6 Cg_endo -79.33 -48.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.218 1.641 . . . . 0.0 110.638 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 98.3 m-85 -85.84 110.03 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.443 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 5.6 m-80 -139.23 152.04 47.01 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -162.54 -177.71 5.78 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.716 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.8 t80 -117.78 144.64 45.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.446 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD21 ' A' ' 25' ' ' LEU . 1.1 mt -133.49 155.4 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.333 -0.854 . . . . 0.0 109.132 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -128.18 -174.86 13.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.194 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.3 t30 74.86 13.69 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.906 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.63 HD21 HG22 ' A' ' 22' ' ' ILE . 4.3 mm? -62.59 123.5 18.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.823 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -39.57 99.41 0.19 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.876 -0.515 . . . . 0.0 110.496 179.984 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.8 Cg_endo -78.16 -17.2 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.979 1.515 . . . . 0.0 110.619 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.11 -17.78 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.94 . . . . 0.0 110.071 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.566 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -110.5 -157.07 0.6 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 109.613 179.626 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.483 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.05 140.89 32.53 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 110.365 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.008 HG11 HG22 ' A' ' 54' ' ' THR . 2.6 t -67.24 -34.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.732 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.897 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.86 -34.53 69.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 44.6 mm-40 -68.23 -43.71 77.35 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.882 HD22 HG12 ' A' ' 82' ' ' VAL . 9.1 mt -61.15 -46.07 92.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.68 ' HG2' HG22 ' A' ' 52' ' ' VAL . 90.7 mttt -53.54 -51.05 64.14 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.314 0.578 . . . . 0.0 109.495 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 32' ' ' ALA . 11.3 t -63.64 -38.56 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.474 179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.89 -35.64 81.31 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.733 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 93.4 mt -79.24 -28.14 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 109.171 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 1.046 ' HA ' HG21 ' A' ' 49' ' ' VAL . 6.9 t -78.0 -31.71 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 108.972 179.2 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.75 -38.85 32.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.603 -0.686 . . . . 0.0 109.765 179.589 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.67 -31.74 71.93 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.315 179.335 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.2 m-85 -82.18 -23.71 35.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 108.928 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.42 65.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.471 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -94.14 -17.26 22.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.684 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.665 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -81.77 -24.57 35.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.665 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 23.6 t70 101.57 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.124 HD11 HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -97.5 -151.04 0.36 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.54 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -168.88 62.34 0.06 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.081 -1.012 . . . . 0.0 109.841 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.046 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.3 m -54.23 117.77 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.043 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.967 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -93.41 -39.13 10.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.981 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -146.75 163.65 35.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.072 -1.017 . . . . 0.0 110.572 179.864 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.68 HG22 ' HG2' ' A' ' 35' ' ' LYS . 14.4 p -165.61 114.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 109.909 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -119.59 165.3 14.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 1.008 HG22 HG11 ' A' ' 31' ' ' VAL . 3.8 p -79.56 171.24 15.41 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.43 -0.794 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 60' ' ' PHE . . . -140.45 98.48 0.23 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.634 -1.269 . . . . 0.0 110.479 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 85.6 m 58.78 130.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -1.089 . . . . 0.0 111.779 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' THR . 1.3 m-80 33.18 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.858 -0.526 . . . . 0.0 111.586 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.517 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 3.6 mtp-105 43.5 25.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.074 -1.016 . . . . 0.0 110.313 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.37 -33.27 18.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 55' ' ' GLY . 3.0 m-85 -112.68 -160.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 0.0 109.167 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 179.24 125.99 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.066 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 61.1 m-85 -90.2 158.57 17.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -1.124 . . . . 0.0 109.598 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 52' ' ' VAL . 2.8 t -149.86 141.4 17.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.906 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 52.0 m-20 -112.67 146.46 38.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.0 109.53 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.73 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 50.3 m-85 -112.38 177.22 4.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.878 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -113.79 18.86 17.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 111.475 -178.354 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.63 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 23.4 p -178.83 -179.3 0.6 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.643 1.211 . . . . 0.0 112.325 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.259 . . -81.0 -28.58 35.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.13 -24.92 59.5 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.229 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.709 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.1 m-20 -83.33 -33.34 25.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 71' ' ' LEU . 9.5 tp -70.67 -36.93 73.59 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.741 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -71.81 -41.17 68.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.689 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.885 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -74.25 -32.62 63.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.134 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 65' ' ' PHE . . . -60.26 -29.92 69.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -72.18 -49.03 38.8 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.724 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.09 -0.46 28.2 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.31 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.124 HD21 HD11 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -82.56 17.08 1.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 110.367 -179.725 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.514 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 86.3 m -87.73 5.62 39.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.09 20.92 33.76 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.879 ' CD2' HD12 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -118.12 124.74 48.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.25 -1.147 . . . . 0.0 110.602 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 14.9 mttt -87.98 82.54 7.21 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.613 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.882 HG12 HD22 ' A' ' 34' ' ' LEU . 76.5 t -42.99 106.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.5 OUTLIER 60.09 22.67 11.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 110.397 -179.17 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.84 14.72 30.86 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' ILE . 19.5 m-20 -133.3 103.26 5.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.136 -1.214 . . . . 0.0 110.207 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.7 tt0 -57.52 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.864 HG21 HG21 ' A' ' 82' ' ' VAL . 13.0 pt -41.71 137.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.382 -0.824 . . . . 0.0 110.586 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -104.48 167.86 9.47 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.164 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.54 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 1.4 mp -109.7 179.0 4.25 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.04 -1.038 . . . . 0.0 110.641 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.949 179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 16' ' ' THR . 5.1 m . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 121.193 0.52 . . . . 0.0 110.243 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.8 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -173.52 161.98 3.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 110.516 -179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.77 -40.51 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.249 1.657 . . . . 0.0 110.675 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 65' ' ' PHE . 81.6 m-85 -95.51 111.16 23.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 m120 -135.64 151.87 50.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.825 . . . . 0.0 109.687 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -160.01 166.89 29.12 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 110.512 -179.651 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 1.1 t80 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 110.002 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.663 HD12 ' CG2' ' A' ' 63' ' ' VAL . 7.8 mt -126.19 162.56 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -147.81 175.73 26.99 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 30.9 t30 72.71 64.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.582 -0.952 . . . . 0.0 110.07 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.938 HD13 HG13 ' A' ' 31' ' ' VAL . 18.9 mt -95.4 -167.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.507 ' H ' HD11 ' A' ' 34' ' ' LEU . 54.0 t-20 -114.61 107.03 51.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HA ' ' CD ' ' A' ' 58' ' ' ARG . 44.4 Cg_endo -72.27 -1.82 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.064 1.56 . . . . 0.0 110.579 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -113.97 20.52 15.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.671 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.507 ' CG ' ' OE2' ' A' ' 33' ' ' GLU . 2.2 tptm -148.12 -157.98 0.87 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.78 139.9 45.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.685 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.938 HG13 HD13 ' A' ' 25' ' ' LEU . 20.7 t -66.8 -28.42 43.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.08 179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.79 85.18 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.568 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -64.4 -30.29 71.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.811 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.885 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.63 -37.42 84.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 108.932 178.921 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.921 ' HD3' HG12 ' A' ' 52' ' ' VAL . 13.3 mmtt -61.71 -54.07 47.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.459 -0.775 . . . . 0.0 109.306 179.251 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 42.7 t -49.21 -41.29 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.824 . . . . 0.0 109.88 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.035 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.39 -33.18 74.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.17 -0.956 . . . . 0.0 108.724 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 32.6 mt -82.03 -26.01 9.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.586 -0.696 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.689 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -80.75 -28.34 36.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 108.574 178.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -81.45 -41.13 22.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.57 0.7 . . . . 0.0 109.381 179.393 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.12 HD22 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.13 -34.43 78.02 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.096 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.129 ' CD2' HD13 ' A' ' 47' ' ' LEU . 5.9 m-85 -80.79 -23.56 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -73.04 -33.1 65.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 109.105 179.25 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.28 -17.3 24.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.402 179.278 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.17 -20.76 37.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.435 -0.791 . . . . 0.0 109.995 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.2 t70 95.76 29.17 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.992 0.901 . . . . 0.0 108.877 -179.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.129 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -91.68 -143.73 0.19 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.316 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' A' ' 66' ' ' GLU . . . -176.29 60.12 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 39' ' ' SER . 8.3 m -55.23 118.23 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.902 0.858 . . . . 0.0 110.214 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.8 ' CB ' HG21 ' A' ' 16' ' ' THR . 0.3 OUTLIER -92.03 -38.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.158 0.504 . . . . 0.0 109.82 -179.498 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.512 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 1.6 t70 -137.21 152.11 49.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 0.0 110.64 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.921 HG12 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -157.82 114.42 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.491 -0.755 . . . . 0.0 109.62 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -134.97 175.47 9.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.656 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.8 p -83.48 175.0 10.12 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.224 -0.923 . . . . 0.0 110.187 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -130.5 117.11 2.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.567 ' HG1' ' HD2' ' A' ' 60' ' ' PHE . 2.8 m 77.05 -64.81 0.31 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.117 -0.637 . . . . 0.0 109.829 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 56' ' ' THR . 18.9 p-10 179.91 -32.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.448 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -177.57 28.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -115.0 -33.61 5.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.205 -0.934 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.698 ' CD1' ' CE2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.91 -179.28 6.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.372 -0.83 . . . . 0.0 109.346 179.175 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.623 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -148.9 168.18 29.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.52 ' C ' ' CG2' ' A' ' 63' ' ' VAL . 5.9 t80 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -1.162 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.817 HG13 HG13 ' A' ' 52' ' ' VAL . 3.7 t -151.63 158.35 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.531 -178.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 28.4 m-20 -130.96 142.68 50.37 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.111 -0.993 . . . . 0.0 109.951 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 64.3 m-85 -106.96 172.42 6.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.42 -0.8 . . . . 0.0 110.004 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.742 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.11 17.75 13.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -0.987 . . . . 0.0 111.462 -178.32 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.472 ' OG ' ' OD2' ' A' ' 70' ' ' ASP . 26.7 p -168.17 175.81 6.36 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.525 1.155 . . . . 0.0 112.437 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.83 -24.82 48.56 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -77.23 -26.6 52.83 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.576 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.617 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 90.2 m-20 -82.9 -30.04 28.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.6 -36.87 68.21 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.786 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.53 -36.91 63.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 109.973 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.971 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.22 -26.59 52.85 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.654 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 65' ' ' PHE . . . -70.67 -29.37 65.68 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.912 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.462 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.7 tt -71.74 -46.96 56.87 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -4.22 44.05 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.257 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -76.38 6.81 5.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.538 -0.726 . . . . 0.0 110.547 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 78' ' ' THR . 54.3 m -76.65 3.11 12.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 110.299 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.72 28.85 10.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.12 ' CD2' HD22 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.0 120.57 39.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -1.062 . . . . 0.0 110.236 -179.579 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.629 ' N ' HD12 ' A' ' 80' ' ' LEU . 2.1 ttmt -91.58 87.97 6.57 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 123.017 1.389 . . . . 0.0 109.385 178.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 37' ' ' ALA . 98.5 t -43.24 -105.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.686 -179.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 1.035 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 6.3 m-85 -90.13 40.37 1.0 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.014 -1.054 . . . . 0.0 109.964 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.416 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . 97.54 19.57 24.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.547 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 12.4 m-80 -147.01 92.58 2.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 110.105 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.6 mt-10 -43.27 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.75 HG21 HG21 ' A' ' 82' ' ' VAL . 2.2 pp -58.67 129.21 20.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 110.203 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -104.63 133.22 49.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.466 179.701 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.554 ' HB2' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -110.72 174.16 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.936 -1.102 . . . . 0.0 111.122 -179.38 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.302 -1.481 0 O-C-N 121.635 -0.666 . . . . 0.0 109.634 -179.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.552 0.691 . . . . 0.0 110.08 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.974 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -119.04 163.9 23.97 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.553 -0.717 . . . . 0.0 110.567 -179.632 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.4 -29.56 6.0 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.201 1.632 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 86.9 m-85 -108.54 113.2 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.667 -179.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 2.0 m120 -141.8 149.15 40.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.769 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -164.62 -176.9 4.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.451 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.579 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.7 t80 -108.94 153.35 23.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 110.169 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.92 155.27 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.915 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.24 -169.89 11.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.0 t30 72.0 51.32 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.498 -1.001 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 60' ' ' PHE . 13.8 mt -102.51 120.97 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.915 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 34' ' ' LEU . 34.6 t30 -47.13 104.53 0.42 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.581 -0.699 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.6 Cg_endo -75.44 -5.02 16.1 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.045 1.55 . . . . 0.0 110.433 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.11 -20.35 45.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.99 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -107.95 -156.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.737 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.5 m -98.5 146.75 25.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.767 HG11 ' HB ' ' A' ' 54' ' ' THR . 4.5 t -67.98 -34.1 65.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.722 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.52 -34.6 78.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.741 179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 59.0 mm-40 -71.44 -34.98 70.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.336 179.367 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 30' ' ' SER . 6.7 mp -66.54 -29.02 69.0 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 1.076 ' HZ2' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.94 -54.98 9.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.461 -0.775 . . . . 0.0 109.1 179.158 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 32' ' ' ALA . 12.2 t -60.15 -35.03 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.817 . . . . 0.0 109.379 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.45 -38.03 88.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.9 mt -76.03 -29.37 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.493 179.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 1.012 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.9 t -78.66 -29.75 45.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.084 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.3 tm-20 -81.48 -36.95 28.7 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 80' ' ' LEU . 1.1 tt -69.73 -30.2 67.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.502 -0.748 . . . . 0.0 109.093 179.038 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 3.9 m-85 -90.02 -16.71 29.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.492 -0.755 . . . . 0.0 109.388 179.278 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.88 -28.83 18.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HE3' ' OE2' ' A' ' 40' ' ' GLU . 47.6 mttt -89.4 -24.6 21.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -77.41 -59.3 2.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.552 -0.717 . . . . 0.0 109.493 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 p30 148.02 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.489 0.661 . . . . 0.0 110.828 179.419 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.847 HD11 ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -91.76 -154.35 0.37 Allowed 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.381 -0.824 . . . . 0.0 109.96 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.86 63.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 1.012 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.8 m -67.2 115.65 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.974 HG21 HG21 ' A' ' 16' ' ' THR . 0.6 OUTLIER -90.09 -39.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.223 0.535 . . . . 0.0 109.972 -179.602 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.521 ' CB ' ' OD2' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -140.78 156.31 46.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.0 110.566 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.076 HG12 ' HZ2' ' A' ' 35' ' ' LYS . 3.9 t -152.9 100.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.823 . . . . 0.0 110.017 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.512 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 2.3 ttp180 -99.69 167.44 10.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.767 ' HB ' HG11 ' A' ' 31' ' ' VAL . 12.7 p -88.25 169.7 11.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.243 -0.911 . . . . 0.0 110.475 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -128.75 115.46 2.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER 65.83 -150.58 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -1.064 . . . . 0.0 110.075 -179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.575 ' H ' HG22 ' A' ' 56' ' ' THR . 73.5 m-20 -63.76 -55.37 23.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -176.39 49.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 110.254 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 16.5 mtpt -123.68 -23.93 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 110.293 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.777 ' O ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -132.48 178.37 6.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -164.63 142.99 8.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 13.5 t80 -97.03 157.77 15.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -1.179 . . . . 0.0 109.763 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.816 HG13 HG22 ' A' ' 52' ' ' VAL . 3.1 t -151.71 140.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.959 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.523 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 2.3 m-20 -108.09 140.82 40.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.473 -0.767 . . . . 0.0 109.056 178.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.806 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 8.5 m-85 -103.94 178.34 4.59 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.284 -0.885 . . . . 0.0 110.446 -179.026 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.634 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -108.15 -9.64 15.54 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.799 -178.447 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 17.3 p -168.12 -176.58 3.01 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.812 1.291 . . . . 0.0 113.061 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -83.79 -18.63 37.04 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.437 ' OE2' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -87.72 -27.09 22.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.069 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.847 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -82.5 -29.75 30.31 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 71' ' ' LEU . 2.0 tt -72.56 -37.65 68.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.593 ' N ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -67.47 -40.84 85.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.328 179.205 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 1.044 ' O ' HD23 ' A' ' 77' ' ' LEU . 9.9 mttm -75.61 -27.33 58.45 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.289 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.806 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.03 -28.11 63.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 89' ' ' LEU . 1.5 tm? -69.55 -46.3 66.76 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.88 -13.75 61.75 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.939 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -73.12 2.6 6.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 110.396 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.678 ' OG1' HD21 ' A' ' 89' ' ' LEU . 99.7 m -75.1 2.66 10.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.058 -1.026 . . . . 0.0 110.592 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.14 11.99 65.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 41' ' ' LEU . 75.4 mt -89.55 -165.18 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.307 -1.113 . . . . 0.0 110.591 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.617 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -169.27 48.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.703 0.763 . . . . 0.0 109.867 179.796 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.046 HG21 HG23 ' A' ' 87' ' ' ILE . 3.9 t 6.44 -123.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.636 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CD2' ' HG3' ' A' ' 29' ' ' LYS . 16.6 m-85 -73.03 -3.16 24.43 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.149 178.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 146.89 35.32 0.06 OUTLIER Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.9 t30 -158.1 101.45 1.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -1.215 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.617 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -50.44 90.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.046 HG23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -39.84 137.27 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.568 0.699 . . . . 0.0 110.211 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.643 ' O ' HG23 ' A' ' 22' ' ' ILE . 28.4 ttmt -112.78 156.44 22.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.522 -0.736 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -117.01 175.12 5.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 110.643 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 . . . . . 0 C--N 1.301 -1.527 0 O-C-N 121.592 -0.692 . . . . 0.0 109.541 -179.503 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 15' ' ' THR . 19.6 m . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 121.29 0.567 . . . . 0.0 110.166 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.754 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -176.65 166.16 1.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.312 -179.876 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 16' ' ' THR . 51.2 Cg_endo -79.66 -25.93 5.07 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.107 1.583 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.963 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 79.1 m-85 -111.89 108.81 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.815 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -142.15 152.06 42.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 108.999 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.752 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.7 pp -162.65 -176.19 4.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.791 -179.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.3 t80 -104.39 154.48 19.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.548 -0.72 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.625 HD12 ' CG2' ' A' ' 63' ' ' VAL . 6.2 mt -143.83 152.73 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.54 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -140.7 -167.11 10.94 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.869 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.9 t30 70.7 38.29 1.27 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.339 -1.095 . . . . 0.0 109.888 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.944 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.8 mm? -88.97 127.97 35.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.297 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.741 ' H ' HD21 ' A' ' 34' ' ' LEU . 34.5 t-20 -39.96 100.22 0.21 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.651 -0.656 . . . . 0.0 110.528 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HB3' ' CG ' ' A' ' 59' ' ' LYS . 47.9 Cg_endo -74.87 -13.14 21.79 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -87.68 -10.01 52.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HZ3' ' HD1' ' A' ' 83' ' ' PHE . 18.2 mttt -112.98 -159.0 0.67 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.772 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.5 m -97.2 146.0 25.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.668 ' HA ' HD12 ' A' ' 34' ' ' LEU . 3.4 t -65.15 -38.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.185 179.38 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -59.6 -37.71 79.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.224 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.602 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.0 -29.86 68.97 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.944 HD13 ' HB3' ' A' ' 25' ' ' LEU . 7.7 mt -68.94 -31.56 70.52 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.328 -0.857 . . . . 0.0 109.437 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.556 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 9.7 mmpt? -69.13 -51.56 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.7 t -60.58 -39.53 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.566 -0.708 . . . . 0.0 109.892 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.984 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . . . -62.26 -34.84 77.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 108.764 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 34' ' ' LEU . 44.7 mt -79.45 -29.79 13.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.597 -0.689 . . . . 0.0 109.193 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 22.6 t -77.81 -28.45 50.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.133 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -81.74 -39.03 24.79 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.534 0.683 . . . . 0.0 109.446 179.402 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.692 HD21 ' CB ' ' A' ' 80' ' ' LEU . 6.0 tp -66.08 -32.8 74.48 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.024 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 7.7 m-85 -85.52 -20.64 29.36 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.418 -0.801 . . . . 0.0 108.898 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.36 -31.66 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.514 -0.741 . . . . 0.0 109.508 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 8.9 mtpt -89.17 -23.39 22.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.77 ' OD1' HD11 ' A' ' 77' ' ' LEU . 1.7 m-80 -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.503 -0.748 . . . . 0.0 109.829 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.7 t70 90.89 31.01 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.011 0.91 . . . . 0.0 108.851 -179.329 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.986 HD11 ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -77.96 -137.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.434 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.772 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -171.16 58.05 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.567 HG11 ' HD2' ' A' ' 42' ' ' PHE . 15.6 m -66.82 113.14 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.772 0.796 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.754 HG11 ' CG2' ' A' ' 16' ' ' THR . 71.3 t -91.07 -24.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 O-C-N 121.814 -0.554 . . . . 0.0 110.291 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -162.49 163.66 27.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 110.387 179.741 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.3 t -150.93 156.94 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -155.61 165.57 36.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.119 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.641 ' HB ' HG11 ' A' ' 31' ' ' VAL . 25.8 p -86.83 161.13 18.51 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -137.35 127.13 3.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 55' ' ' GLY . 6.3 m 49.77 100.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.169 . . . . 0.0 110.713 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' THR . 3.6 m-80 39.56 -98.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -141.13 30.53 1.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.007 -1.058 . . . . 0.0 110.636 -179.594 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -121.2 14.17 11.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.995 179.761 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -156.51 178.51 10.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.69 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -178.58 150.95 10.0 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.724 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.565 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 10.6 t80 -113.5 158.53 20.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.971 . . . . 0.0 109.013 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.625 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.4 t -151.09 144.36 16.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.881 -178.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HB3' ' HG1' ' A' ' 16' ' ' THR . 1.0 OUTLIER -102.75 146.56 28.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.527 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.7 ' O ' HG21 ' A' ' 16' ' ' THR . 3.7 m-85 -112.38 -172.23 2.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.937 -1.102 . . . . 0.0 111.165 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.772 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -115.21 -7.09 12.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.958 -179.421 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.645 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 24.1 p -176.18 175.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.58 1.181 . . . . 0.0 112.502 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.963 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -76.4 -25.81 54.9 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -29.47 58.22 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.964 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.986 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.6 -29.7 56.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.938 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -71.78 -38.78 70.25 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.606 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.19 -38.04 87.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.514 -0.741 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.796 ' O ' HD23 ' A' ' 77' ' ' LEU . 2.5 mttp -81.56 -30.51 33.03 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' A' ' 47' ' ' LEU . . . -74.95 -25.18 58.69 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.118 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 75' ' ' LEU . 6.1 tt -73.35 -46.75 47.41 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.46 -14.81 62.25 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.875 178.218 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -71.82 -0.28 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.598 -0.689 . . . . 0.0 110.265 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.54 ' OG1' HD21 ' A' ' 89' ' ' LEU . 24.9 m -76.65 4.42 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.841 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.05 -8.66 86.27 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.692 ' CB ' HD21 ' A' ' 41' ' ' LEU . 3.5 mm? -80.46 -164.89 0.77 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -1.042 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -148.45 51.41 1.0 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.624 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.868 ' HB ' HG23 ' A' ' 87' ' ' ILE . 8.7 p 17.04 -132.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.344 -179.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.984 ' CD2' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -78.6 11.47 2.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.447 -1.408 . . . . 0.0 109.666 178.579 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 143.57 36.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.696 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.6 t30 -174.07 115.76 0.21 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -1.19 . . . . 0.0 109.661 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 tt0 -52.5 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.104 -0.997 . . . . 0.0 110.346 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.868 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -44.75 143.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.802 179.668 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 22' ' ' ILE . 9.3 mtmt -119.85 155.09 33.31 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.57 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.83 172.59 7.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.412 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.316 179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.551 ' CG2' HG23 ' A' ' 16' ' ' THR . 0.5 OUTLIER . . . . . 0 N--CA 1.499 2.01 0 CA-C-O 121.376 0.608 . . . . 0.0 109.934 . . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.984 ' CG2' HG11 ' A' ' 50' ' ' VAL . 20.3 p -140.64 160.99 56.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.417 -0.802 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.43 -22.53 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.013 1.533 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.706 ' HD1' HD13 ' A' ' 71' ' ' LEU . 85.5 m-85 -123.36 115.38 21.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 111.159 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -138.72 150.84 46.59 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.647 HD21 ' HE2' ' A' ' 65' ' ' PHE . 3.1 pp -165.22 -167.15 1.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.125 -0.984 . . . . 0.0 110.647 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.651 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 31.3 t80 -125.07 142.72 51.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.86 . . . . 0.0 110.019 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 3.4 mt -119.99 170.12 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.03 -172.91 15.82 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t-20 73.26 48.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.61 -0.935 . . . . 0.0 110.177 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 1.061 HD13 HD22 ' A' ' 34' ' ' LEU . 3.7 mm? -93.3 123.04 36.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.557 ' N ' HD11 ' A' ' 34' ' ' LEU . 22.5 t-20 -43.67 107.31 0.57 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.563 -0.711 . . . . 0.0 110.337 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 45.8 Cg_endo -72.3 -27.94 15.79 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.104 1.581 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -78.84 -17.03 56.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.565 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -106.19 -155.94 0.56 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 109.673 179.727 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 m -114.2 150.29 34.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.164 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.816 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.8 t -69.38 -26.22 30.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.79 92.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.135 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.6 mm-40 -69.78 -46.17 66.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 109.148 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.061 HD22 HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -55.37 -37.3 67.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.55 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.85 -63.12 1.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.076 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.9 t -49.4 -35.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 34' ' ' LEU . . . -62.49 -42.26 99.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.767 HD11 HG21 ' A' ' 87' ' ' ILE . 16.0 mm -73.11 -28.68 26.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.428 178.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.8 -29.44 50.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 0.0 109.044 179.351 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.46 -41.24 16.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.6 -0.687 . . . . 0.0 109.759 179.643 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.73 HD11 HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -63.13 -34.91 78.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.49 -0.756 . . . . 0.0 109.187 179.177 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.133 ' CD2' HD13 ' A' ' 47' ' ' LEU . 8.6 m-85 -87.13 -21.15 26.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.079 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -77.19 -31.53 55.45 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.266 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.461 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -84.1 -19.46 34.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.52 -0.738 . . . . 0.0 109.138 179.25 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -87.31 -18.73 29.47 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.649 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.4 t70 87.84 29.62 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 1.133 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -76.89 -137.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.357 179.585 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -176.27 57.55 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 49' ' ' VAL . 10.5 m -55.02 117.69 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.9 0.857 . . . . 0.0 109.87 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.984 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.2 t -90.95 -44.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.346 -179.382 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 17.5 t70 -143.9 148.03 34.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.105 -0.997 . . . . 0.0 110.926 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.94 HG12 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.13 158.31 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.427 -0.796 . . . . 0.0 109.577 179.907 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 62' ' ' TYR . 3.8 mtp180 -165.75 161.43 18.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.42 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.816 HG22 ' CG1' ' A' ' 31' ' ' VAL . 9.6 p -88.02 170.8 10.79 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 110.249 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -133.95 127.02 4.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 57' ' ' ASN . 2.0 m 60.03 -135.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -1.138 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.528 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 14.8 t-20 -102.06 90.09 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.019 -1.051 . . . . 0.0 110.594 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 3.2 mtt180 43.34 45.57 5.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.61 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 18.9 mttt -124.32 -28.42 3.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.028 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.737 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.0 m-85 -138.82 -174.44 3.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 109.369 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -162.15 136.85 4.55 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 63' ' ' VAL . 48.3 m-85 -94.48 159.98 14.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.137 . . . . 0.0 109.577 179.253 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.94 HG22 HG12 ' A' ' 52' ' ' VAL . 24.6 t -158.63 161.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.584 -178.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.499 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -134.64 139.72 45.51 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.647 ' HE2' HD21 ' A' ' 20' ' ' LEU . 55.6 m-85 -103.66 175.34 5.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.905 -179.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.638 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.66 16.42 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 111.388 -178.543 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 20.7 p -178.38 176.71 1.03 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.434 1.111 . . . . 0.0 112.044 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.467 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.18 -23.52 51.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.447 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.91 -27.52 43.81 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.369 179.999 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.663 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 89.6 m-20 -80.37 -29.98 37.9 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.706 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -75.66 -36.78 60.05 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.323 179.165 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.33 -34.37 74.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.308 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.481 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -81.0 -26.29 36.57 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.326 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.837 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -64.77 -29.88 70.87 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.675 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.52 -45.11 22.71 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.505 0.669 . . . . 0.0 109.246 179.12 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -23.28 66.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 110.019 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.926 HD11 ' CD1' ' A' ' 47' ' ' LEU . 20.8 mt -69.69 -5.17 23.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.466 ' OG1' HD12 ' A' ' 89' ' ' LEU . 25.9 m -67.39 -2.02 5.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.525 -0.734 . . . . 0.0 111.205 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.27 10.68 61.63 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 41' ' ' LEU . 6.1 mt -84.8 -161.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -1.051 . . . . 0.0 111.272 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.575 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 9.6 tttm -159.66 52.4 0.35 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.345 1.069 . . . . 0.0 109.821 -179.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.739 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -38.45 133.26 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.737 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 1.0 OUTLIER 40.97 34.74 0.3 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.313 -179.228 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 77.68 28.42 57.17 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 m-20 -144.42 107.77 4.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.291 179.643 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.575 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 mt-10 -59.03 92.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.005 -1.059 . . . . 0.0 110.3 -179.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.767 HG21 HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -41.16 142.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.712 0.768 . . . . 0.0 110.505 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -121.44 125.15 46.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.516 -0.74 . . . . 0.0 109.217 179.513 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 20' ' ' LEU . 1.3 mt -85.24 176.64 8.22 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.139 -0.975 . . . . 0.0 110.855 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 . . . . . 0 C--N 1.298 -1.631 0 O-C-N 121.701 -0.624 . . . . 0.0 109.715 -179.704 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.778 HG21 ' CG ' ' A' ' 51' ' ' ASP . 3.8 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.306 0.574 . . . . 0.0 110.227 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.957 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -172.45 165.02 3.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.551 -179.876 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.5 Cg_endo -77.0 -40.49 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.175 1.619 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.672 ' HD1' HD13 ' A' ' 71' ' ' LEU . 95.5 m-85 -100.03 108.98 21.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.493 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 2.8 m120 -138.41 153.28 48.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.436 -0.79 . . . . 0.0 109.524 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.792 HD12 HD23 ' A' ' 89' ' ' LEU . 2.5 pt? -165.3 174.6 9.98 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 110.267 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -109.17 159.17 17.12 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.679 -0.638 . . . . 0.0 109.921 -179.662 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 88' ' ' LYS . 4.5 mt -142.61 149.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.403 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.6 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -132.1 -172.74 13.13 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.565 -1.303 . . . . 0.0 110.027 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.514 ' C ' HD22 ' A' ' 25' ' ' LEU . 32.3 t30 72.1 49.88 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.527 -0.984 . . . . 0.0 109.858 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.784 ' CD1' HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -95.46 123.54 39.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 110.082 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.654 ' N ' HD21 ' A' ' 34' ' ' LEU . 30.5 t-20 -42.47 101.78 0.25 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 110.287 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.3 Cg_endo -74.52 -16.68 21.4 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.973 1.512 . . . . 0.0 110.338 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.48 -15.97 59.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.032 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 -155.66 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.71 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.5 m -100.18 149.87 23.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.502 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 3.5 t -66.61 -45.87 87.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.817 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.54 83.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 80.6 mm-40 -58.84 -35.86 73.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.79 . . . . 0.0 109.278 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.942 HD23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -65.68 -31.3 72.24 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.176 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HE2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.76 -50.84 61.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.538 -0.727 . . . . 0.0 109.335 179.228 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 22.0 t -59.66 -39.19 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.474 -0.766 . . . . 0.0 109.937 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.931 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -61.45 -33.45 73.76 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.135 -0.978 . . . . 0.0 108.682 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.665 HG12 HD13 ' A' ' 87' ' ' ILE . 42.5 mt -81.04 -30.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 46.4 t -77.22 -26.4 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.063 179.299 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -82.87 -43.26 16.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.707 0.765 . . . . 0.0 109.247 179.302 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 80' ' ' LEU . 1.1 tp -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.153 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.568 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 8.9 m-85 -83.71 -22.13 32.11 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.661 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.57 -32.04 47.54 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.621 0.725 . . . . 0.0 109.286 179.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.47 ' HE2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.73 -14.89 33.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.423 -0.798 . . . . 0.0 109.328 179.188 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.02 -18.09 28.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.656 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.1 t0 89.52 29.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.004 0.907 . . . . 0.0 108.765 -179.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.568 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.25 -137.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.655 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . 178.94 58.26 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.14 -0.975 . . . . 0.0 109.517 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 49' ' ' VAL . 13.0 m -60.17 116.04 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.987 0.899 . . . . 0.0 110.148 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.957 HG11 ' CG2' ' A' ' 16' ' ' THR . 17.1 t -81.44 -36.19 14.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.894 -0.504 . . . . 0.0 110.561 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.778 ' CG ' HG21 ' A' ' 15' ' ' THR . 0.3 OUTLIER -149.98 154.39 38.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 110.673 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -133.51 173.14 15.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.732 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 170.12 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.939 . . . . 0.0 110.47 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.523 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 28.5 p -100.7 164.74 11.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.225 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.565 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -134.53 136.6 8.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 63.47 -138.51 0.35 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -1.114 . . . . 0.0 110.293 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.0 m-20 -111.82 99.98 8.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 110.529 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 3.2 ptt85 38.37 27.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 111.02 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.3 ttpt -129.51 -5.33 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.736 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -138.58 -168.39 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -173.26 179.4 44.7 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.524 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.687 ' O ' HG23 ' A' ' 63' ' ' VAL . 12.3 t80 -154.88 156.43 36.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.568 -0.96 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.808 HG22 HG12 ' A' ' 52' ' ' VAL . 25.5 t -158.66 164.28 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.009 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.579 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 7.9 m-20 -130.08 140.16 50.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.554 -0.716 . . . . 0.0 109.47 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.67 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 22.3 m-85 -103.09 179.56 4.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.286 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 10.9 pt-20 -113.11 2.54 15.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 110.954 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 56.8 p -165.44 177.68 7.31 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.585 1.183 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -78.27 -24.05 46.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -76.52 -26.85 55.67 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.562 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 77.6 m-20 -86.02 -27.37 24.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.672 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -77.13 -35.47 56.2 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.659 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.93 -32.43 40.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.755 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -80.85 -25.1 37.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.708 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.65 -26.74 45.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.998 178.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.597 ' C ' HD23 ' A' ' 75' ' ' LEU . 6.9 tt -72.97 -46.05 54.51 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.39 -19.22 61.65 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -62.6 -11.06 14.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.761 -0.587 . . . . 0.0 109.949 179.569 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.525 HG22 ' OE2' ' A' ' 86' ' ' GLU . 18.7 m -39.23 -28.53 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.806 0.812 . . . . 0.0 110.966 -179.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.62 -20.55 12.25 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.431 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.839 HD13 HG12 ' A' ' 87' ' ' ILE . 1.5 pp -48.04 -178.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.441 -1.035 . . . . 0.0 111.82 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -167.7 51.41 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.942 HG21 HD23 ' A' ' 34' ' ' LEU . 11.0 p 5.73 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.091 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.931 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 3.4 m-85 -81.58 13.79 2.91 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.437 -1.414 . . . . 0.0 108.985 178.447 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 133.73 34.77 0.29 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.632 ' O ' HG12 ' A' ' 82' ' ' VAL . 24.8 m-80 -158.86 103.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -1.022 . . . . 0.0 109.224 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.728 ' HA ' HD12 ' A' ' 80' ' ' LEU . 3.5 tt0 -49.91 90.52 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 110.371 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.839 HG12 HD13 ' A' ' 80' ' ' LEU . 16.7 pt -49.45 138.73 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.474 -0.766 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.21 175.19 6.37 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.792 HD23 HD12 ' A' ' 20' ' ' LEU . 7.1 mp -121.45 -176.66 3.35 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.372 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.648 -0.658 . . . . 0.0 110.184 179.971 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 16' ' ' THR . 30.2 m . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.21 0.529 . . . . 0.0 110.666 . . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.941 ' CG2' HG11 ' A' ' 50' ' ' VAL . 24.8 p -158.93 153.36 20.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.94 -30.36 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.262 1.664 . . . . 0.0 110.339 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.62 ' HD1' HD22 ' A' ' 71' ' ' LEU . 96.4 m-85 -92.75 106.07 18.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.358 -179.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 4.8 m120 -139.52 152.69 47.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.616 ' N ' HD23 ' A' ' 20' ' ' LEU . 1.6 pt? -165.33 164.73 19.78 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.461 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -91.08 160.75 15.43 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.379 -179.967 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 1.05 HD12 ' CG2' ' A' ' 63' ' ' VAL . 5.4 mt -150.03 146.93 16.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.951 -179.669 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -129.91 -171.47 12.94 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 26.2 t30 73.08 35.27 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.501 -0.999 . . . . 0.0 110.561 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.792 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.1 mm? -84.13 128.21 34.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.964 . . . . 0.0 109.824 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.79 ' H ' HD21 ' A' ' 34' ' ' LEU . 57.6 t-20 -39.8 102.89 0.27 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.663 -0.648 . . . . 0.0 110.61 -179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.02 7.0 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.045 1.55 . . . . 0.0 110.733 -179.729 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -106.07 -14.63 15.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.304 179.593 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -111.23 -156.3 0.58 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.624 -0.673 . . . . 0.0 109.629 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.477 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 2.3 m -105.49 148.53 27.11 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.735 179.283 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 1.018 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.8 t -63.97 -15.6 17.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.849 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -75.34 -38.38 60.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.432 -0.792 . . . . 0.0 109.05 178.828 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 3.8 mt-10 -72.13 -28.02 62.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.502 -0.749 . . . . 0.0 109.046 178.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.968 HD23 HG11 ' A' ' 82' ' ' VAL . 4.8 mt -70.79 -43.11 69.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.718 ' HG2' HG22 ' A' ' 52' ' ' VAL . 53.1 mttt -60.65 -43.81 97.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.66 -0.65 . . . . 0.0 110.018 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 32' ' ' ALA . 8.5 t -63.67 -41.1 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.869 179.583 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.717 ' HB2' ' HE1' ' A' ' 83' ' ' PHE . . . -63.05 -38.16 90.09 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.635 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.895 HD11 HG22 ' A' ' 82' ' ' VAL . 17.6 mm -77.7 -28.87 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.234 178.973 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.9 t -76.96 -30.23 55.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.951 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.9 tm-20 -81.27 -45.92 15.53 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.567 0.699 . . . . 0.0 109.585 179.42 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.043 ' HG ' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -56.76 -39.97 74.99 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.302 179.402 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 1.029 ' CE1' HD13 ' A' ' 77' ' ' LEU . 16.2 m-30 -78.43 -25.16 45.92 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.755 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.71 -33.12 41.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.472 ' HG3' ' OE2' ' A' ' 40' ' ' GLU . 2.8 mttt -88.43 -13.07 41.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.534 -0.729 . . . . 0.0 109.432 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -92.36 -14.48 28.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.659 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.603 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.9 t0 86.38 28.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 77' ' ' LEU . 2.5 tp -76.97 -136.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.401 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . . . -165.35 46.09 0.08 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.093 0.949 . . . . 0.0 108.67 178.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -55.29 150.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 122.241 1.02 . . . . 0.0 109.447 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.941 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.5 t -136.18 -34.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.356 -178.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' O ' ' HB ' ' A' ' 52' ' ' VAL . 1.9 m-20 -152.61 -179.91 8.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 111.034 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.718 HG22 ' HG2' ' A' ' 35' ' ' LYS . 14.6 p 179.84 113.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.764 -0.585 . . . . 0.0 109.8 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 172.18 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.698 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 1.018 HG22 ' CG1' ' A' ' 31' ' ' VAL . 18.9 p -82.34 162.4 22.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -134.21 122.58 3.01 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.734 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.545 HG22 ' OD1' ' A' ' 57' ' ' ASN . 28.8 m 38.95 96.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.392 -1.064 . . . . 0.0 111.119 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.545 ' OD1' HG22 ' A' ' 56' ' ' THR . 9.5 m120 64.13 -146.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.896 . . . . 0.0 110.622 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 31.71 6.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.572 -179.714 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.442 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 12.0 tttm -115.54 -20.25 10.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 110.07 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.597 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.52 -170.16 1.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.687 179.73 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 169.62 154.57 9.31 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.711 -179.876 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 21.6 t80 -115.13 163.04 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.555 -0.968 . . . . 0.0 109.514 179.537 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 1.05 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.4 t -148.88 148.22 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.019 -178.601 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -119.71 142.71 48.26 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.425 -0.797 . . . . 0.0 109.993 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 31.0 m-85 -110.91 178.97 4.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.753 . . . . 0.0 109.718 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.549 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -123.99 15.73 9.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.0 110.865 -179.124 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.547 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -165.81 174.94 9.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.835 1.302 . . . . 0.0 112.505 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -87.44 -25.73 23.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.484 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.484 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -83.72 -22.83 31.87 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.783 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.78 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t0 -81.45 -33.91 31.76 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.809 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.62 HD22 ' HD1' ' A' ' 18' ' ' PHE . 48.5 tp -69.41 -39.4 77.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.04 -32.86 72.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.409 -0.807 . . . . 0.0 109.398 179.195 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.558 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 38.0 mttm -80.79 -24.21 38.73 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.22 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.987 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -67.34 -29.81 69.47 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.488 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.743 HD22 HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -77.59 -45.44 25.19 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.152 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -17.43 64.48 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.451 -0.781 . . . . 0.0 109.676 179.46 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 1.029 HD13 ' CE1' ' A' ' 42' ' ' PHE . 11.7 mt -67.43 -7.02 21.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.2 m -49.68 -15.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.432 -0.792 . . . . 0.0 111.217 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.31 18.19 19.53 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.487 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.043 HD13 ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -97.28 179.08 5.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -1.21 . . . . 0.0 109.146 179.843 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.672 ' H ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -162.22 53.62 0.22 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 109.752 179.942 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 87' ' ' ILE . 3.5 t 8.5 -125.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.717 ' HE1' ' HB2' ' A' ' 37' ' ' ALA . 4.0 m-30 -75.04 -2.11 25.87 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.001 -1.062 . . . . 0.0 108.82 178.719 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 149.51 35.0 0.04 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' ILE . 58.1 m-20 -158.94 104.16 1.72 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.11 -1.229 . . . . 0.0 110.041 179.958 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.581 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -54.03 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 -179.616 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 1.019 HG23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -40.43 147.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.577 0.703 . . . . 0.0 110.186 179.722 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.6 mmmt -116.31 152.94 32.84 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.643 -0.661 . . . . 0.0 109.503 179.763 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.743 HD11 HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -115.82 173.91 6.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.852 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.832 . . . . 0.0 110.213 179.961 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 1.042 HG23 HG23 ' A' ' 16' ' ' THR . 5.0 t . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.509 0.671 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 1.042 HG23 HG23 ' A' ' 15' ' ' THR . 73.0 p -137.27 159.54 69.21 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.3 Cg_endo -76.51 -15.98 17.23 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.06 1.558 . . . . 0.0 110.896 -179.576 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.643 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 92.1 m-85 -115.62 122.94 47.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 97.9 m-20 -139.43 170.21 16.35 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.644 -0.66 . . . . 0.0 109.271 179.603 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.809 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -169.25 163.55 10.87 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.29 -0.882 . . . . 0.0 110.47 -179.775 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.596 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.72 177.25 5.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.683 -0.636 . . . . 0.0 111.366 -177.72 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 21' ' ' PHE . 15.2 mt -157.28 133.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.98 166.61 23.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.909 ' C ' HD22 ' A' ' 25' ' ' LEU . 35.8 t30 72.48 81.02 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.505 -0.997 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.909 HD22 ' C ' ' A' ' 24' ' ' ASN . 4.2 mm? -119.92 128.79 53.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.532 ' CB ' HD21 ' A' ' 34' ' ' LEU . 31.1 t-20 -41.25 101.89 0.25 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.556 -0.715 . . . . 0.0 110.429 -179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.564 ' HA ' ' HD3' ' A' ' 58' ' ' ARG . 45.8 Cg_endo -72.48 -23.7 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.036 1.545 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 1.7 m-20 -78.46 -16.16 57.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 110.048 179.866 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.2 mmtt -107.86 -155.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.536 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.3 m -102.97 145.03 30.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.918 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.6 t -68.18 -42.5 84.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.431 179.43 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -56.44 -36.08 68.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.185 179.063 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 25.8 mm-40 -64.72 -43.54 93.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.0 109.092 179.109 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.918 HD12 ' HA ' ' A' ' 31' ' ' VAL . 18.6 mt -59.72 -38.88 82.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.365 -0.835 . . . . 0.0 108.802 179.033 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.789 ' HA ' HD12 ' A' ' 38' ' ' ILE . 9.8 mmpt? -59.98 -54.22 48.63 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.537 0.684 . . . . 0.0 109.366 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 32' ' ' ALA . 18.3 t -54.21 -35.49 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 109.675 179.258 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.77 -32.3 73.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.169 -0.957 . . . . 0.0 108.798 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.789 HD12 ' HA ' ' A' ' 35' ' ' LYS . 14.1 mt -82.53 -28.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.853 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -78.75 -28.78 44.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 0.0 109.072 179.164 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.83 -41.12 23.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 109.162 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.073 ' CD2' HD22 ' A' ' 80' ' ' LEU . 1.1 tp -63.45 -34.42 77.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m-85 -79.9 -23.99 41.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.782 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.69 62.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 109.499 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -89.14 -17.97 28.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 179.465 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -87.85 -14.68 38.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 179.822 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.602 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.1 t70 83.96 30.91 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.916 0.865 . . . . 0.0 108.784 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.618 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -74.82 -129.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.464 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.81 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 173.34 54.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.196 -0.94 . . . . 0.0 109.066 179.642 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 49' ' ' VAL . 10.7 m -57.43 116.88 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.111 0.958 . . . . 0.0 110.392 -179.616 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.95 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -91.54 -39.14 11.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.758 ' CG ' HG21 ' A' ' 15' ' ' THR . 4.0 m-20 -152.65 125.35 8.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.162 -0.961 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.946 HG12 HG22 ' A' ' 63' ' ' VAL . 3.2 m -115.09 153.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.256 -0.903 . . . . 0.0 110.001 179.526 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 1.4 tpt180 -148.98 168.78 22.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.431 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.706 ' HB ' HG11 ' A' ' 31' ' ' VAL . 75.6 p -99.51 159.61 14.9 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.559 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.28 115.74 4.19 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 58.66 -154.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.498 ' H ' HG22 ' A' ' 56' ' ' THR . 81.5 m-20 -60.55 -51.94 67.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.09 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.582 ' CB ' HG22 ' A' ' 31' ' ' VAL . 2.1 ptp180 -177.3 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -125.12 -21.58 4.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.9 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.878 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -140.69 -154.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.105 -0.997 . . . . 0.0 109.995 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.559 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 172.23 175.61 40.45 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.743 ' O ' HG23 ' A' ' 63' ' ' VAL . 25.7 t80 -143.9 168.4 20.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.493 -1.004 . . . . 0.0 109.732 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.946 HG22 HG12 ' A' ' 52' ' ' VAL . 13.7 t -160.01 163.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.491 -178.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.3 m-20 -130.92 136.77 48.89 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.417 -0.802 . . . . 0.0 109.16 179.53 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.677 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 19.0 m-85 -103.24 176.81 5.03 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.495 0.664 . . . . 0.0 111.168 -179.247 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.612 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -115.26 17.1 16.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 111.247 -178.813 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.643 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 35.5 p 179.38 178.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.465 1.126 . . . . 0.0 112.338 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.95 -23.43 48.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -25.96 43.51 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.248 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.81 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 87.1 m-20 -83.42 -29.02 28.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.314 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.58 -29.42 36.98 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.821 179.655 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 3.6 mt-10 -79.89 -36.59 36.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.773 . . . . 0.0 110.36 -179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.753 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -78.31 -29.58 47.82 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.91 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.0 -27.88 62.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.723 -0.791 . . . . 0.0 108.963 178.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.73 -43.35 69.08 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.542 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -13.54 60.73 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.083 178.472 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -72.73 5.03 3.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.604 -0.685 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.801 ' HA ' HD21 ' A' ' 89' ' ' LEU . 8.3 m -66.31 -5.64 11.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.94 -1.1 . . . . 0.0 110.56 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.06 32.26 4.98 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 179.131 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.073 HD22 ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -114.78 132.56 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.127 -179.732 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.614 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.5 mtmt -104.94 78.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.554 1.169 . . . . 0.0 109.976 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.796 HG12 HD23 ' A' ' 34' ' ' LEU . 47.8 t -48.45 132.38 5.98 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.754 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.0 m-85 40.82 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.422 -0.799 . . . . 0.0 110.869 -179.757 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 86.72 28.78 25.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.561 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 87' ' ' ILE . 88.1 m-20 -143.12 91.77 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -1.175 . . . . 0.0 110.282 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 19.1 tt0 -42.27 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.171 179.821 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 82' ' ' VAL . 2.2 pp -68.74 125.89 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 110.696 -179.806 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.8 mttt -83.85 118.49 23.99 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.645 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 ' HA ' ' A' ' 78' ' ' THR . 0.4 OUTLIER -106.06 -171.19 1.85 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.988 -178.258 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 3.4 mt-10 . . . . . 0 N--CA 1.501 2.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.385 179.813 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 16' ' ' THR . 20.7 m . . . . . 0 N--CA 1.491 1.618 0 CA-C-O 121.243 0.544 . . . . 0.0 110.33 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.759 ' CG2' HG11 ' A' ' 50' ' ' VAL . 14.0 p -151.25 164.23 20.95 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.8 Cg_endo -75.17 -34.49 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.052 1.554 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.549 ' CE2' ' C ' ' A' ' 67' ' ' SER . 97.4 m-85 -100.64 102.39 13.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.067 -1.021 . . . . 0.0 110.489 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.0 m120 -137.99 153.2 49.43 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.321 -0.862 . . . . 0.0 109.527 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.786 HD22 HD23 ' A' ' 89' ' ' LEU . 4.6 pp -163.57 -171.78 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.5 t80 -116.54 151.22 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.519 HG22 HD11 ' A' ' 25' ' ' LEU . 2.8 mt -131.27 159.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.902 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -142.49 -176.24 16.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.628 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 47.8 t30 71.34 49.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 110.215 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' HA ' ' A' ' 60' ' ' PHE . 10.8 mp -97.26 132.94 42.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.658 ' H ' HD21 ' A' ' 34' ' ' LEU . 39.1 t-20 -41.41 102.06 0.26 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.609 -0.682 . . . . 0.0 110.287 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.9 Cg_endo -77.06 8.06 3.37 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.046 1.55 . . . . 0.0 110.852 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -111.81 -17.67 12.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.986 -1.071 . . . . 0.0 108.948 179.55 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' CG ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.72 -155.52 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.731 -0.605 . . . . 0.0 109.513 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -100.54 142.09 32.5 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.597 179.109 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.929 HG12 ' HE3' ' A' ' 35' ' ' LYS . 3.0 t -63.46 -42.88 97.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.114 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.49 -37.26 72.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 178.959 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 16.0 mm-40 -67.15 -30.22 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.62 179.529 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.111 HD23 HG21 ' A' ' 82' ' ' VAL . 3.0 mt -67.56 -38.4 84.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.929 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.3 -47.31 77.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.839 . . . . 0.0 109.943 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 32' ' ' ALA . 7.3 t -65.09 -34.57 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.131 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.53 -43.98 92.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.298 -0.876 . . . . 0.0 109.068 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.555 HG23 ' CE2' ' A' ' 42' ' ' PHE . 19.5 mm -76.96 -27.95 16.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.929 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.725 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -73.82 -32.75 63.87 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.437 -0.79 . . . . 0.0 109.395 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.9 tt0 -85.24 -43.11 14.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 110.009 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 3.7 tt -55.67 -40.8 72.78 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.569 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.555 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.6 m-30 -87.06 -23.62 24.88 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.447 179.542 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.93 -18.32 59.4 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -102.28 -39.27 7.28 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.588 179.632 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.615 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -51.03 -43.17 60.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.619 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 13.1 m-20 143.22 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.561 0.744 . . . . 0.0 110.151 179.587 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -112.0 -152.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 110.624 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 49' ' ' VAL . . . -164.31 55.83 0.15 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.674 0.749 . . . . 0.0 109.153 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -41.11 118.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.045 0.926 . . . . 0.0 110.151 -179.794 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.759 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.8 t -84.24 -44.11 17.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.283 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 5.4 t70 -147.72 160.73 42.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.873 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.813 HG22 ' CG ' ' A' ' 35' ' ' LYS . 7.6 p -150.96 111.15 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 2.2 mpp_? -99.71 165.53 11.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.966 . . . . 0.0 110.261 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.472 HG22 ' HD3' ' A' ' 35' ' ' LYS . 69.0 p -87.96 163.73 16.18 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.644 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -119.19 105.57 1.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.473 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.2 m 67.57 -134.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -1.145 . . . . 0.0 110.016 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.509 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -80.47 -48.58 12.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 110.482 -179.832 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.823 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -177.76 37.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 110.444 -179.877 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 21.5 mttt -113.93 -24.33 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.996 ' HA ' HD13 ' A' ' 25' ' ' LEU . 1.2 m-85 -137.57 -174.99 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.04 154.01 18.37 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.898 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.7 m-85 -107.84 167.23 10.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.188 -1.183 . . . . 0.0 110.031 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 62' ' ' TYR . 50.2 t -157.25 155.44 5.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.939 -178.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 51' ' ' ASP . 8.6 m-20 -125.22 139.5 53.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.703 -0.623 . . . . 0.0 109.498 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.873 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 17.7 m-85 -103.83 176.61 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.407 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.645 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -113.98 14.65 18.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 111.479 -178.395 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.9 p 176.94 178.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.371 1.081 . . . . 0.0 112.089 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.47 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.5 -22.71 54.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.553 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -25.47 37.06 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.521 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 88.6 m-20 -82.79 -28.16 30.47 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.164 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.78 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.0 tm? -79.13 -33.7 43.97 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.566 179.389 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 1.4 tp10 -73.46 -39.22 65.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.805 . . . . 0.0 109.733 179.606 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.703 ' HB3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -80.19 -18.04 50.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.524 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.873 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.47 -28.13 46.46 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.178 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 75' ' ' LEU . 7.2 tt -79.69 -44.19 21.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -27.8 67.26 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.269 -0.894 . . . . 0.0 109.096 178.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.803 ' O ' HD23 ' A' ' 80' ' ' LEU . 15.4 mt -68.8 -7.97 39.08 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.536 0.684 . . . . 0.0 109.826 179.394 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 87.7 m -57.01 -9.14 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.658 -0.651 . . . . 0.0 111.506 -179.667 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.98 26.97 5.7 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.958 HD11 HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -94.14 -161.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.218 -1.166 . . . . 0.0 110.695 -179.762 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.62 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -164.1 48.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.56 0.695 . . . . 0.0 109.817 179.643 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 1.111 HG21 HD23 ' A' ' 34' ' ' LEU . 7.9 p 8.49 -126.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.203 179.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.708 ' N ' HG13 ' A' ' 82' ' ' VAL . 2.8 m-85 -72.44 -1.75 16.9 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.408 -1.432 . . . . 0.0 109.508 179.14 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 147.89 36.42 0.05 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' HG12 ' A' ' 82' ' ' VAL . 15.3 m-20 -163.4 108.02 1.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -1.156 . . . . 0.0 109.418 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.62 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -51.27 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.61 -178.837 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.958 HG12 HD11 ' A' ' 80' ' ' LEU . 2.3 pp -46.38 144.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.651 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 8.1 mtmt -112.03 169.78 8.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.56 -0.712 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.786 HD23 HD22 ' A' ' 20' ' ' LEU . 7.7 mp -113.31 -177.56 3.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.302 -0.874 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 110.243 179.974 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.921 HG23 HG23 ' A' ' 16' ' ' THR . 1.8 t . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.511 0.672 . . . . 0.0 110.11 . . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.973 HG21 HG21 ' A' ' 50' ' ' VAL . 17.6 p -138.6 158.08 70.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.689 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.571 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.7 Cg_endo -75.71 -29.07 7.51 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.136 1.598 . . . . 0.0 110.559 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 88.0 m-85 -106.35 101.89 11.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.774 -179.55 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.516 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.7 m120 -134.71 150.9 50.66 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.131 179.413 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 21' ' ' PHE . 4.3 pp -172.93 -175.69 1.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.861 -179.85 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.716 ' N ' HD12 ' A' ' 20' ' ' LEU . 3.2 t80 -110.29 154.65 23.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.024 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.548 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mt -140.15 153.55 22.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -121.04 -177.03 15.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.9 t30 70.46 71.41 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.297 -1.12 . . . . 0.0 110.012 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.91 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -114.1 27.43 9.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.307 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.537 ' HB2' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 53.13 98.04 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 110.335 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.73 -9.9 22.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.96 1.505 . . . . 0.0 110.519 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -94.75 -12.94 26.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 109.83 179.917 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 12.4 mmtt -115.12 -160.01 0.72 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.449 -0.782 . . . . 0.0 109.536 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.728 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.0 m -112.69 148.09 35.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.795 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.6 t -67.44 -18.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.066 -1.021 . . . . 0.0 108.879 179.328 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 -41.98 80.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 178.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 3.8 pt-20 -66.88 -45.96 76.42 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.041 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.91 HD22 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -62.7 -34.21 76.67 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.861 . . . . 0.0 108.72 178.957 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . 0.94 ' HD2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -57.79 -49.55 76.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.773 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' A' ' 39' ' ' SER . 91.1 t -64.39 -32.18 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.594 -0.691 . . . . 0.0 109.141 178.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.561 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -65.7 -43.0 90.51 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.821 ' CD1' HG23 ' A' ' 82' ' ' VAL . 24.7 mm -75.63 -24.62 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.568 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 39' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -77.66 -35.2 52.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 179.095 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.07 -38.76 26.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.491 0.662 . . . . 0.0 109.724 179.528 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 1.044 HD21 HD22 ' A' ' 80' ' ' LEU . 10.4 tp -65.52 -32.43 74.02 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.406 179.356 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 42' ' ' PHE . . . . . 0.899 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 7.3 m-85 -87.51 -19.99 27.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.103 179.619 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.27 -26.96 20.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -92.39 -17.44 24.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.477 -0.764 . . . . 0.0 109.212 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 45' ' ' ASN . . . . . 0.608 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -83.23 -59.07 2.58 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.621 -0.674 . . . . 0.0 109.534 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.6 m-20 146.65 31.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.741 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.799 HD23 ' HB2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -102.27 -156.27 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.192 -0.942 . . . . 0.0 109.874 -179.836 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' ' HG2' ' A' ' 66' ' ' GLU . . . -162.39 56.51 0.23 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.784 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 39' ' ' SER . 10.4 m -45.53 118.79 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 50' ' ' VAL . . . . . 0.973 HG21 HG21 ' A' ' 16' ' ' THR . 0.0 OUTLIER -93.45 -33.89 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.586 ' C ' HG23 ' A' ' 52' ' ' VAL . 11.5 m-20 -149.35 148.24 29.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.322 -0.861 . . . . 0.0 110.686 -179.886 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.94 HG12 ' HD2' ' A' ' 35' ' ' LYS . 57.1 t -156.85 102.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.01 179.672 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -113.17 173.27 6.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 110.332 -179.814 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 54' ' ' THR . . . . . 0.795 HG22 ' CG1' ' A' ' 31' ' ' VAL . 2.0 p -82.33 -179.32 7.37 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.238 -0.914 . . . . 0.0 110.171 -179.665 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -140.91 132.5 5.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.809 HG22 ' ND2' ' A' ' 57' ' ' ASN . 63.4 m 58.34 -106.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.371 -1.076 . . . . 0.0 110.586 179.71 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.809 ' ND2' HG22 ' A' ' 56' ' ' THR . 7.9 p30 -130.17 90.56 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.861 -1.149 . . . . 0.0 110.48 -179.701 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.543 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 19.2 mtt85 41.77 29.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.533 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -112.39 -32.96 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.915 . . . . 0.0 110.177 179.943 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 60' ' ' PHE . . . . . 0.606 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 m-85 -126.71 -162.59 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 109.361 179.733 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.58 132.12 2.15 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.575 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.712 ' O ' HG23 ' A' ' 63' ' ' VAL . 2.9 m-85 -86.33 158.35 19.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.404 -1.057 . . . . 0.0 109.116 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 63' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 52' ' ' VAL . 25.2 t -158.68 156.32 3.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.947 -179.155 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 64' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 50' ' ' VAL . 80.3 m-20 -142.39 144.88 33.33 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 65' ' ' PHE . . . . . 0.638 ' O ' HG21 ' A' ' 50' ' ' VAL . 23.0 m-85 -114.97 -174.87 2.57 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.483 -0.761 . . . . 0.0 109.001 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.579 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -132.67 29.61 4.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.494 -1.379 . . . . 0.0 113.44 -176.6 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.777 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p -169.09 173.5 6.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.319 -1.488 . . . . 0.0 113.119 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.3 -27.42 52.99 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.393 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -28.89 62.83 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.912 179.41 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.799 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -76.5 -33.26 58.65 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.851 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -62.28 -43.89 97.79 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.997 179.794 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.485 ' N ' HD23 ' A' ' 71' ' ' LEU . 3.9 tt0 -66.26 -35.52 80.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.034 178.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.729 ' HB3' HD11 ' A' ' 47' ' ' LEU . 4.8 mttm -78.59 -21.19 48.94 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.13 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.771 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -69.33 -29.4 67.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 75' ' ' LEU . . . . . 0.67 HD23 ' C ' ' A' ' 75' ' ' LEU . 4.3 tt -77.22 -45.74 25.52 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.582 ' N ' HD23 ' A' ' 75' ' ' LEU . 8.5 tt0 -71.66 -7.15 46.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.642 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.899 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -57.63 -13.52 4.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 111.09 -179.996 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 78' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 78' ' ' THR . 45.8 m -69.2 3.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.912 . . . . 0.0 111.801 -179.186 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.61 10.95 16.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.477 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 1.044 HD22 HD21 ' A' ' 41' ' ' LEU . 45.6 mt -97.74 112.38 24.29 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.321 -1.105 . . . . 0.0 110.688 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 81' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 1.1 mttp -88.62 80.59 7.27 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.105 0.955 . . . . 0.0 110.295 179.589 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.821 HG23 ' CD1' ' A' ' 38' ' ' ILE . 1.1 p -46.16 126.84 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.697 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 33' ' ' GLU . 1.2 m-85 42.21 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.953 . . . . 0.0 110.653 -179.561 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 97.18 17.68 31.22 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 84.7 m-20 -133.54 110.52 9.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -1.142 . . . . 0.0 110.084 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.5 tm-20 -56.65 83.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 87' ' ' ILE . . . . . 0.792 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -39.3 151.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 110.771 -179.479 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild core ' A' A ' 88' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 22' ' ' ILE . 31.9 ttpt -119.26 157.36 28.2 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.548 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 5.1 mp -112.36 179.07 4.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.232 -0.917 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 O-C-N 121.662 -0.649 . . . . 0.0 109.924 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.336 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 24.0 p -145.19 65.41 1.25 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.25 -1.147 . . . . 0.0 110.195 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.421 ' O ' ' C ' ' A' ' 4' ' ' MET . 0.1 OUTLIER -110.44 77.68 1.06 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.223 -0.923 . . . . 0.0 110.183 -179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.421 ' C ' ' O ' ' A' ' 3' ' ' HIS . 2.7 tpp -43.19 -50.5 6.34 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 110.185 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.86 48.49 5.34 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.203 -0.936 . . . . 0.0 110.212 179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -91.21 153.51 19.95 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.289 -0.882 . . . . 0.0 110.174 -179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -80.74 153.77 73.14 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.272 -0.893 . . . . 0.0 110.206 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.03 79.67 1.65 Allowed 'Trans proline' 0 C--N 1.304 -1.763 0 O-C-N 123.984 1.518 . . . . 0.0 110.384 179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 7.5 p -160.21 135.17 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.844 0 CA-C-O 121.315 0.579 . . . . 0.0 110.166 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -84.76 129.61 34.8 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 110.207 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.445 ' O ' ' HB3' ' A' ' 12' ' ' SER . . . -133.92 74.14 0.44 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 11' ' ' GLY . 5.5 t 63.02 11.08 4.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.279 -1.13 . . . . 0.0 110.215 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER 46.53 26.06 0.47 Allowed 'General case' 0 N--CA 1.488 1.459 0 CA-C-O 122.133 0.968 . . . . 0.0 110.064 179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.418 ' OG ' ' HB3' ' A' ' 12' ' ' SER . 0.0 OUTLIER -128.57 160.04 33.63 Favored 'General case' 0 C--N 1.288 -2.094 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.199 179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.96 -13.24 10.04 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.285 -0.884 . . . . 0.0 109.961 179.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.822 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -148.47 166.48 15.44 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.521 -0.737 . . . . 0.0 110.74 -179.65 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.2 Cg_endo -78.8 -42.91 0.18 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 124.233 1.649 . . . . 0.0 110.769 -179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CE2' ' C ' ' A' ' 67' ' ' SER . 96.3 m-85 -96.88 110.88 23.3 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.113 -0.992 . . . . 0.0 110.516 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.528 ' ND2' ' N ' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -137.32 151.73 48.96 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.398 -0.814 . . . . 0.0 109.901 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -161.31 -178.03 6.41 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.367 -0.833 . . . . 0.0 110.391 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.658 ' CD1' ' CE2' ' A' ' 62' ' ' TYR . 6.2 t80 -112.4 146.65 37.97 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.389 -0.82 . . . . 0.0 110.338 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.533 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.3 mt -130.91 155.99 42.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -0.887 . . . . 0.0 109.827 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' HA2' ' CB ' ' A' ' 60' ' ' PHE . . . -136.51 -164.74 10.29 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.912 ' C ' HD12 ' A' ' 25' ' ' LEU . 31.2 t-20 65.64 70.59 0.44 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.365 -1.08 . . . . 0.0 110.092 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.912 HD12 ' C ' ' A' ' 24' ' ' ASN . 10.2 mp -119.16 130.25 55.43 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.347 -0.845 . . . . 0.0 110.255 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.779 ' H ' HD21 ' A' ' 34' ' ' LEU . 31.5 t30 -54.15 107.99 1.01 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.506 -0.746 . . . . 0.0 110.346 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.2 Cg_endo -74.49 -8.73 20.94 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.049 1.552 . . . . 0.0 110.458 -179.963 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.408 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 7.1 m120 -84.05 -14.54 50.3 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.233 -0.917 . . . . 0.0 110.045 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -117.57 -157.24 0.66 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.39 -0.819 . . . . 0.0 109.859 179.862 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.659 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.6 m -100.14 146.92 26.26 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.264 -0.898 . . . . 0.0 110.338 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.931 HG12 HG22 ' A' ' 54' ' ' THR . 11.2 t -69.79 -30.37 44.35 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 119.319 -0.953 . . . . 0.0 109.059 179.193 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.474 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -63.72 -38.16 90.05 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.393 -0.817 . . . . 0.0 109.034 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.468 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 54.7 mm-40 -68.14 -36.31 79.48 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.854 HD23 HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -62.42 -32.93 73.86 Favored 'General case' 0 N--CA 1.485 1.286 0 O-C-N 121.367 -0.833 . . . . 0.0 108.836 178.863 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.618 ' HG3' HG12 ' A' ' 52' ' ' VAL . 1.6 mptp? -65.82 -50.37 64.88 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.575 -0.703 . . . . 0.0 109.314 179.345 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.485 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.4 t -58.53 -35.64 55.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.842 179.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.57 -35.85 81.84 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.137 -0.977 . . . . 0.0 108.727 179.494 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.581 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 35.9 mt -80.15 -27.11 11.94 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 O-C-N 121.551 -0.718 . . . . 0.0 109.157 178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.53 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -79.43 -29.46 41.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.242 -0.911 . . . . 0.0 109.067 179.164 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.485 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.93 -38.37 27.94 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.595 0.712 . . . . 0.0 109.361 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.676 HD22 HD23 ' A' ' 80' ' ' LEU . 5.2 tp -68.12 -32.17 72.27 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 6.0 m-85 -82.31 -23.19 35.27 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 179.109 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -73.41 -33.54 65.03 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.463 -0.773 . . . . 0.0 109.362 179.507 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mttm -89.37 -21.15 23.23 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.536 -0.727 . . . . 0.0 109.456 179.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.635 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.1 m-80 -80.57 -20.52 43.19 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.474 -0.766 . . . . 0.0 109.743 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.635 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.2 t0 91.21 29.95 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.034 0 CA-C-O 121.939 0.876 . . . . 0.0 108.759 -179.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.882 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -84.11 -139.26 0.06 Allowed 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.379 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.727 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -177.21 58.41 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.217 -0.927 . . . . 0.0 109.774 179.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.53 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.2 m -60.03 117.14 2.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 CA-C-O 121.965 0.888 . . . . 0.0 109.94 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.822 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.6 t -95.29 -33.91 5.09 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.913 0 CA-C-N 116.092 -0.503 . . . . 0.0 110.265 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.518 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 12.4 t0 -144.68 153.77 42.08 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.136 -0.977 . . . . 0.0 110.676 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.618 HG12 ' HG3' ' A' ' 35' ' ' LYS . 0.7 OUTLIER -155.91 99.69 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.309 -0.87 . . . . 0.0 108.979 179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.3 ttp180 -102.26 156.82 17.32 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.106 -0.996 . . . . 0.0 110.733 -179.31 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.931 HG22 HG12 ' A' ' 31' ' ' VAL . 44.5 p -90.64 154.65 19.42 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.429 -0.795 . . . . 0.0 110.319 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.577 ' HA3' ' CD1' ' A' ' 60' ' ' PHE . . . -127.49 128.32 6.09 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.3 -1.52 . . . . 0.0 109.3 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.578 ' OG1' ' CZ ' ' A' ' 60' ' ' PHE . 3.4 m 60.72 170.99 0.09 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.836 -0.802 . . . . 0.0 109.878 -179.348 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.54 ' N ' HG22 ' A' ' 56' ' ' THR . 68.8 m-80 -38.6 -42.25 0.76 Allowed 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.467 -0.77 . . . . 0.0 110.412 -179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.543 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 172.45 51.24 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.392 -0.817 . . . . 0.0 109.802 179.675 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' HB3' ' CD2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -110.54 -31.24 7.32 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.306 -0.871 . . . . 0.0 110.494 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.825 ' HA ' HD13 ' A' ' 25' ' ' LEU . 5.9 p90 -159.39 149.33 18.83 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.026 -1.047 . . . . 0.0 110.424 -179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.48 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -132.82 164.8 24.03 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.658 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 15.0 m-85 -110.45 162.44 14.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.358 -1.083 . . . . 0.0 110.055 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.611 HG22 HG13 ' A' ' 52' ' ' VAL . 3.2 t -151.4 141.59 15.72 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 C-N-CA 119.539 -0.864 . . . . 0.0 110.749 -178.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.485 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 50.2 m-20 -112.06 147.54 35.81 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.478 -0.764 . . . . 0.0 109.501 179.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.641 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 31.6 m-85 -108.26 179.84 4.09 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -0.875 . . . . 0.0 110.821 -179.43 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.586 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -114.08 13.42 18.12 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.353 -0.842 . . . . 0.0 111.496 -178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.54 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.4 p 178.88 179.42 0.4 Allowed 'General case' 0 N--CA 1.495 1.787 0 CA-C-O 122.381 1.086 . . . . 0.0 112.072 179.769 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.12 -22.25 52.94 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 107.525 -1.287 . . . . 0.0 107.525 177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.65 -27.07 37.29 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.47 -179.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.727 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 79.4 m-20 -83.43 -25.9 30.83 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.765 ' O ' HD13 ' A' ' 71' ' ' LEU . 3.3 tm? -80.69 -34.79 34.37 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.477 0.656 . . . . 0.0 109.281 179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -72.92 -36.13 67.19 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.411 -0.806 . . . . 0.0 109.487 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.882 ' HB2' HD21 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -76.43 -27.45 56.24 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.367 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.641 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.89 -29.5 68.62 Favored 'General case' 0 C--N 1.303 -1.422 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.498 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.5 OUTLIER -71.25 -45.99 62.0 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 108.035 -1.098 . . . . 0.0 108.035 178.499 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -75.92 -4.21 39.68 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.225 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.964 ' O ' HD12 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -77.77 12.01 1.89 Allowed 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.394 -0.816 . . . . 0.0 110.281 179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.56 -9.23 12.3 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.039 -1.038 . . . . 0.0 110.089 179.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.12 33.98 3.9 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.173 -1.571 . . . . 0.0 109.173 179.129 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.009 HD13 ' CD1' ' A' ' 87' ' ' ILE . 0.2 OUTLIER -85.37 -170.15 2.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.288 -1.125 . . . . 0.0 110.431 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.582 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.8 OUTLIER -179.1 47.9 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 122.257 1.027 . . . . 0.0 109.876 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.854 HG11 HD23 ' A' ' 34' ' ' LEU . 41.4 t -40.97 127.96 0.57 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.407 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.994 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 8.4 m-85 43.96 25.88 0.12 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.231 -0.918 . . . . 0.0 110.132 -179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.427 ' C ' ' OD1' ' A' ' 85' ' ' ASN . . . 90.7 20.43 40.44 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 179.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.489 ' N ' ' O ' ' A' ' 82' ' ' VAL . 23.4 m-20 -131.62 102.39 5.88 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.235 -1.156 . . . . 0.0 109.521 179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.582 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.0 OUTLIER -53.47 92.86 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.21 -0.931 . . . . 0.0 110.272 -179.337 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.009 ' CD1' HD13 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -47.46 142.57 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.399 -0.813 . . . . 0.0 110.102 -179.985 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.533 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.4 OUTLIER -108.11 163.88 12.78 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.559 -0.713 . . . . 0.0 109.163 179.505 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.604 HD23 ' CD1' ' A' ' 20' ' ' LEU . 0.4 OUTLIER -115.53 -179.34 3.61 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.196 -0.94 . . . . 0.0 110.459 -179.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.507 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -172.3 154.15 3.19 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.594 -0.691 . . . . 0.0 110.183 179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.414 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 50.7 mttt -102.26 98.88 11.28 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -0.923 . . . . 0.0 110.248 -179.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.7 Cg_endo -72.71 -174.16 1.41 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.021 1.537 . . . . 0.0 110.451 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.8 ptpt -72.09 155.79 39.9 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.262 -0.899 . . . . 0.0 110.305 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 95' ' ' ARG . . . 88.95 25.18 30.08 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.418 ' C ' ' O ' ' A' ' 94' ' ' GLY . 4.9 mpp_? -43.11 -45.22 5.31 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.209 -1.171 . . . . 0.0 110.201 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -80.55 -166.38 1.07 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.314 -0.866 . . . . 0.0 110.148 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 144.29 -15.82 2.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -83.74 -29.23 27.65 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.251 -1.147 . . . . 0.0 110.248 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -131.77 -74.15 0.52 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.226 -0.921 . . . . 0.0 110.233 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.53 161.05 10.79 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.296 -1.12 . . . . 0.0 110.242 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.385 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.6 p -66.87 172.35 4.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.202 -1.175 . . . . 0.0 110.199 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 52.35 43.82 30.45 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.259 -0.9 . . . . 0.0 110.146 179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.7 ttp -118.79 85.48 2.37 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.232 -0.918 . . . . 0.0 110.204 179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.4 ' O ' ' O ' ' A' ' 6' ' ' GLU . 0.3 OUTLIER -129.1 71.86 1.44 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.259 -0.901 . . . . 0.0 110.173 -179.998 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.404 ' O ' ' CG ' ' A' ' 7' ' ' ASP . 1.1 tt0 47.73 93.42 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.231 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.565 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.8 OUTLIER 179.38 -59.41 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.345 -0.847 . . . . 0.0 110.209 -179.92 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.565 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 43.7 Cg_endo -71.62 79.85 1.49 Allowed 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.026 1.54 . . . . 0.0 110.427 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.677 HG13 ' O ' ' A' ' 9' ' ' VAL . 12.1 p -126.87 70.33 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.834 0 CA-C-O 121.219 0.533 . . . . 0.0 110.197 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -77.34 -177.61 4.72 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.271 -0.893 . . . . 0.0 110.23 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 50.28 22.29 4.96 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.45 54.92 1.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.19 -1.182 . . . . 0.0 110.181 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -168.15 28.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 110.126 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.99 141.46 29.48 Favored 'General case' 0 C--N 1.29 -2.009 0 CA-C-O 121.32 0.581 . . . . 0.0 110.143 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.562 ' C ' HG23 ' A' ' 16' ' ' THR . 16.9 m -98.36 -7.07 29.5 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.156 -0.965 . . . . 0.0 110.3 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.678 ' CG2' HG11 ' A' ' 50' ' ' VAL . 70.1 p -153.85 161.88 28.12 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.191 -0.943 . . . . 0.0 110.288 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.58 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.71 -23.88 14.03 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.025 1.539 . . . . 0.0 110.7 -179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.58 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 98.4 m-85 -106.37 112.67 25.79 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.113 -0.992 . . . . 0.0 110.562 -179.724 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.429 ' OD1' ' C ' ' A' ' 18' ' ' PHE . 3.2 m120 -143.82 153.53 42.47 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.341 -0.849 . . . . 0.0 109.586 179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -166.49 -177.51 4.03 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.214 -0.929 . . . . 0.0 110.476 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.673 ' N ' HD12 ' A' ' 20' ' ' LEU . 35.0 t80 -113.71 151.01 32.48 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.372 -0.83 . . . . 0.0 110.134 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.531 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.0 157.86 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.285 -0.885 . . . . 0.0 109.658 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.502 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -133.69 -168.47 11.85 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.562 ' C ' HD22 ' A' ' 25' ' ' LEU . 2.0 t30 69.31 50.91 0.52 Allowed 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.332 -1.099 . . . . 0.0 110.214 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.97 HD23 ' HA ' ' A' ' 60' ' ' PHE . 3.6 mm? -100.13 123.08 43.95 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.219 -0.926 . . . . 0.0 110.161 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.735 ' N ' HD21 ' A' ' 34' ' ' LEU . 25.7 t-20 -42.92 102.18 0.27 Allowed Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.59 -0.694 . . . . 0.0 110.457 -179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.3 Cg_endo -75.37 -14.21 20.43 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.02 1.537 . . . . 0.0 110.369 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.428 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 1.9 m-20 -80.25 -19.34 47.07 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.304 -0.873 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 1.0 OUTLIER -107.13 -156.31 0.58 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.414 -0.804 . . . . 0.0 109.832 179.712 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.539 ' O ' ' CD1' ' A' ' 34' ' ' LEU . 1.1 m -103.2 143.14 33.01 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.247 -0.908 . . . . 0.0 110.047 179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.967 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.5 t -66.58 -19.2 25.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.127 -1.029 . . . . 0.0 109.107 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.488 ' HA ' ' HD2' ' A' ' 35' ' ' LYS . . . -71.54 -41.46 69.12 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.422 -0.799 . . . . 0.0 108.989 178.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.58 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.8 mm-40 -66.11 -37.49 85.86 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.628 -0.67 . . . . 0.0 109.288 179.025 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.735 HD21 ' N ' ' A' ' 26' ' ' ASN . 5.0 mp -63.05 -34.58 77.89 Favored 'General case' 0 C--N 1.308 -1.239 0 O-C-N 121.315 -0.865 . . . . 0.0 108.745 178.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.614 ' CG ' HG22 ' A' ' 52' ' ' VAL . 2.8 mttt -60.14 -56.91 15.8 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 178.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.491 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 25.4 t -60.93 -34.59 60.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.588 -0.695 . . . . 0.0 109.468 178.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.521 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.35 -33.4 75.44 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.24 -0.913 . . . . 0.0 108.694 179.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.488 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 42.2 mt -81.11 -28.42 10.93 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.436 0 O-C-N 121.503 -0.748 . . . . 0.0 109.256 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.99 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.3 OUTLIER -78.6 -30.29 46.55 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.209 -0.932 . . . . 0.0 109.084 179.175 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.22 -37.7 32.59 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-O 121.546 0.689 . . . . 0.0 109.458 179.482 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.912 HD13 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -68.56 -31.56 70.86 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 119.805 -0.758 . . . . 0.0 109.087 179.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.681 ' CE1' HD11 ' A' ' 80' ' ' LEU . 13.2 m-85 -88.16 -16.8 32.41 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.37 -0.831 . . . . 0.0 109.42 179.429 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.422 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.4 -29.38 19.11 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.046 -1.034 . . . . 0.0 109.995 -179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.5 mttm -91.82 -18.74 23.39 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.41 -0.806 . . . . 0.0 109.465 179.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.601 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -81.32 -58.73 2.92 Favored 'General case' 0 C--N 1.303 -1.434 0 O-C-N 121.496 -0.752 . . . . 0.0 109.719 179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.601 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.1 m-20 148.26 30.34 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.095 0 CA-C-O 121.27 0.557 . . . . 0.0 109.843 179.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.74 HD11 ' CB ' ' A' ' 73' ' ' LYS . 4.1 mm? -106.1 -158.94 0.68 Allowed 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.328 -0.857 . . . . 0.0 109.586 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.813 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -160.41 61.9 0.33 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.271 -0.893 . . . . 0.0 109.955 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.99 HG21 ' HA ' ' A' ' 39' ' ' SER . 6.7 m -52.83 118.12 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.501 0 CA-C-O 121.882 0.848 . . . . 0.0 109.856 179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.751 HG22 ' HB3' ' A' ' 66' ' ' GLU . 0.6 OUTLIER -87.43 -43.12 15.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 O-C-N 121.878 -0.514 . . . . 0.0 109.99 -179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.482 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 4.5 t0 -144.46 158.17 43.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.106 -0.996 . . . . 0.0 111.018 -179.76 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.614 HG22 ' CG ' ' A' ' 35' ' ' LYS . 2.1 p -149.21 156.65 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.393 -0.817 . . . . 0.0 109.706 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.504 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.3 OUTLIER -165.26 165.92 19.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.168 -0.957 . . . . 0.0 110.167 179.982 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.967 HG22 ' CG1' ' A' ' 31' ' ' VAL . 12.5 p -79.56 179.46 7.47 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 121.403 -0.811 . . . . 0.0 110.329 -179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.529 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -142.1 135.31 6.6 Favored Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.575 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 97.8 m 59.43 -83.48 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.665 -0.903 . . . . 0.0 110.449 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 55' ' ' GLY . 1.6 m-20 -161.54 97.09 1.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.046 -1.034 . . . . 0.0 110.642 -179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.53 ' HG2' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER 42.75 27.09 0.08 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.254 -0.903 . . . . 0.0 110.655 179.474 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.538 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -119.58 -33.23 4.1 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.122 -0.986 . . . . 0.0 110.156 179.928 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.97 ' HA ' HD23 ' A' ' 25' ' ' LEU . 3.2 m-85 -129.18 177.31 7.24 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.257 -0.902 . . . . 0.0 109.621 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.54 129.12 2.59 Favored Glycine 0 N--CA 1.488 2.133 0 C-N-CA 119.557 -1.306 . . . . 0.0 110.076 -179.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.693 ' O ' HG23 ' A' ' 63' ' ' VAL . 28.4 t80 -92.82 163.9 13.54 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.292 -1.123 . . . . 0.0 109.644 179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.693 HG23 ' O ' ' A' ' 62' ' ' TYR . 27.7 t -157.95 159.33 2.5 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.867 -178.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.508 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -126.28 138.33 53.59 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.612 -0.68 . . . . 0.0 109.58 179.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.642 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 24.8 m-85 -102.7 175.26 5.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.676 -0.64 . . . . 0.0 110.3 -179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.813 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 3.0 pt-20 -118.44 14.66 13.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.261 -0.899 . . . . 0.0 111.564 -178.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.534 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.7 p -172.61 173.9 3.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.906 -1.121 . . . . 0.0 112.165 179.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.542 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.5 -23.91 42.63 Favored 'General case' 0 C--N 1.299 -1.608 0 N-CA-C 107.464 -1.31 . . . . 0.0 107.464 178.021 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.94 -25.43 30.11 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 115.332 -0.849 . . . . 0.0 108.993 179.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.642 ' OD1' HD12 ' A' ' 47' ' ' LEU . 5.4 t0 -82.14 -25.73 34.11 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 178.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.781 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.7 tm? -81.95 -33.64 30.19 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -71.12 -34.37 71.0 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.49 -0.756 . . . . 0.0 109.379 179.137 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.74 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.2 OUTLIER -77.26 -28.75 53.67 Favored 'General case' 0 C--N 1.308 -1.221 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 178.297 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.642 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -67.12 -27.13 67.07 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 178.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.606 HD22 ' CD1' ' A' ' 89' ' ' LEU . 0.4 OUTLIER -73.55 -48.85 29.8 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 178.668 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -73.82 -3.72 30.34 Favored 'General case' 0 C--N 1.305 -1.333 0 C-N-CA 119.677 -0.809 . . . . 0.0 109.3 178.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.968 HD12 ' CD1' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -76.55 8.8 3.18 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.489 -0.757 . . . . 0.0 110.469 -179.978 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 4.6 m -64.58 -8.72 15.16 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.08 -1.013 . . . . 0.0 110.198 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.97 17.8 48.6 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 108.884 -1.686 . . . . 0.0 108.884 179.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.09 HD13 HD11 ' A' ' 87' ' ' ILE . 0.2 OUTLIER -72.31 -171.94 0.84 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.403 -1.057 . . . . 0.0 110.67 -179.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.589 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.4 mttt -170.64 49.85 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.355 1.074 . . . . 0.0 109.655 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.795 HG21 HG21 ' A' ' 87' ' ' ILE . 23.7 t -40.06 124.09 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.416 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.027 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.58 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.9 m-85 42.72 29.38 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.251 -0.906 . . . . 0.0 110.188 -179.546 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.12 25.14 38.13 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.513 ' N ' ' O ' ' A' ' 82' ' ' VAL . 11.4 m120 -134.16 86.37 2.27 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.38 -1.071 . . . . 0.0 109.603 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.589 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 21.1 tt0 -41.92 100.33 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.287 -0.883 . . . . 0.0 110.5 -179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.09 HD11 HD13 ' A' ' 80' ' ' LEU . 0.8 OUTLIER -60.18 140.22 18.52 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 O-C-N 121.489 -0.757 . . . . 0.0 110.42 -179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.531 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -111.63 156.3 22.04 Favored 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.153 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.606 ' CD1' HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -120.39 169.73 10.03 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 121.043 -1.035 . . . . 0.0 110.608 -179.464 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.463 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 2.9 tt0 -168.15 156.14 8.54 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.386 -0.821 . . . . 0.0 110.014 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 33.9 tttt -84.93 110.77 30.68 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.337 -0.852 . . . . 0.0 110.288 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.2 Cg_endo -73.39 -170.52 0.67 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.049 1.552 . . . . 0.0 110.436 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 2.1 mttp -133.64 -37.51 0.93 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.249 -0.907 . . . . 0.0 110.206 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 97.63 28.68 8.24 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 12.6 tpp180 -166.86 -56.75 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.168 -1.195 . . . . 0.0 110.191 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -171.96 -161.2 0.18 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.166 -0.959 . . . . 0.0 110.212 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.419 ' O ' ' O ' ' A' ' 98' ' ' THR . . . 165.25 -157.6 30.12 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.419 ' O ' ' O ' ' A' ' 97' ' ' GLY . 2.5 p 42.6 -163.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.279 -1.13 . . . . 0.0 110.303 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.98 154.97 39.81 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.267 -0.896 . . . . 0.0 110.169 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.17 85.96 1.88 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.28 -1.13 . . . . 0.0 110.165 -179.989 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 54.5 p -93.52 -8.98 39.86 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.198 -1.177 . . . . 0.0 110.234 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -97.73 -149.65 0.34 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.237 -0.914 . . . . 0.0 110.162 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 17.3 tpp -128.95 -54.68 1.21 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER 51.48 67.15 1.0 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.272 -0.893 . . . . 0.0 110.208 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 36.8 mm-40 -74.99 -84.18 0.05 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.344 -0.847 . . . . 0.0 110.152 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -141.85 159.93 57.71 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.328 -0.857 . . . . 0.0 110.214 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -71.37 -156.89 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.056 1.556 . . . . 0.0 110.089 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.663 HG22 ' H ' ' A' ' 10' ' ' GLU . 1.5 p -109.6 -157.88 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.284 0.564 . . . . 0.0 109.89 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.663 ' H ' HG22 ' A' ' 9' ' ' VAL . 1.7 pt-20 -68.26 170.95 7.81 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.259 -0.901 . . . . 0.0 110.296 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.51 69.43 2.01 Favored Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.24 17.59 14.0 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.257 -1.143 . . . . 0.0 110.26 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.437 ' O ' ' O ' ' A' ' 14' ' ' SER . 2.2 mt-10 -91.52 28.12 1.81 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.246 -0.909 . . . . 0.0 110.281 -179.859 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.437 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.6 OUTLIER -52.5 -173.09 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.014 0 CA-C-O 121.183 0.516 . . . . 0.0 110.196 179.948 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.843 ' O ' HG23 ' A' ' 16' ' ' THR . 4.1 m -73.6 -5.83 42.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.255 -0.903 . . . . 0.0 110.208 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.967 HG21 ' HB ' ' A' ' 50' ' ' VAL . 0.6 OUTLIER -167.4 158.24 9.95 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.259 -0.9 . . . . 0.0 110.477 -179.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.86 -34.98 2.79 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.154 1.608 . . . . 0.0 110.531 -179.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.522 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.1 m-85 -112.22 114.3 27.02 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.281 -0.887 . . . . 0.0 110.64 -179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.484 ' ND2' ' C ' ' A' ' 18' ' ' PHE . 2.8 m120 -132.87 148.98 52.3 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.325 -0.86 . . . . 0.0 109.309 179.487 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.76 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -165.4 -177.36 4.43 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.156 -0.965 . . . . 0.0 110.619 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.618 ' N ' HD12 ' A' ' 20' ' ' LEU . 3.3 t80 -115.2 150.01 36.79 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.52 -0.737 . . . . 0.0 109.97 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.546 HG23 ' O ' ' A' ' 88' ' ' LYS . 2.2 mt -129.95 158.34 42.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.33 -0.856 . . . . 0.0 109.427 179.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.48 -173.45 13.04 Favored Glycine 0 N--CA 1.488 2.11 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 -179.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.84 ' C ' HD22 ' A' ' 25' ' ' LEU . 1.3 t30 72.54 72.29 0.15 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.48 -1.012 . . . . 0.0 110.197 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.865 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.0 mm? -116.45 165.48 13.18 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.381 -0.824 . . . . 0.0 110.106 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.501 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 40.8 t30 -95.22 106.74 27.84 Favored Pre-proline 0 C--N 1.302 -1.48 0 O-C-N 121.326 -0.859 . . . . 0.0 110.344 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.0 Cg_endo -73.54 -13.92 24.91 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.042 1.548 . . . . 0.0 110.447 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.439 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 1.9 m-80 -78.67 -17.72 55.51 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.201 -0.937 . . . . 0.0 109.909 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.581 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -113.27 -155.27 0.56 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.44 -0.788 . . . . 0.0 109.862 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.499 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -100.65 142.53 32.0 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.246 -0.909 . . . . 0.0 110.498 -179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.799 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.9 t -67.37 -32.33 56.86 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 C-N-CA 119.311 -0.955 . . . . 0.0 109.179 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.94 -39.01 92.85 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.319 -0.863 . . . . 0.0 108.965 178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.588 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 70.2 mm-40 -63.79 -36.46 83.96 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.559 -0.713 . . . . 0.0 109.092 179.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 31' ' ' VAL . 92.2 mt -61.3 -38.81 88.14 Favored 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.37 -0.832 . . . . 0.0 108.908 178.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.868 ' HD3' HG12 ' A' ' 52' ' ' VAL . 0.8 OUTLIER -58.96 -50.37 74.32 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.087 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -60.09 -37.72 74.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.477 -0.764 . . . . 0.0 109.668 178.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.56 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -61.35 -28.34 69.15 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.072 -1.017 . . . . 0.0 109.11 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.579 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 7.0 mt -87.84 -28.06 5.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 O-C-N 121.482 -0.761 . . . . 0.0 109.14 178.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.608 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 7.5 t -80.61 -24.71 38.9 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.268 -0.895 . . . . 0.0 109.167 179.127 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.533 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.52 -37.43 19.66 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.532 -0.73 . . . . 0.0 109.141 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.084 HD22 HD21 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -67.47 -34.72 77.76 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.683 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.092 ' CZ ' HD13 ' A' ' 77' ' ' LEU . 7.1 m-85 -83.47 -22.53 32.53 Favored 'General case' 0 C--N 1.301 -1.508 0 N-CA-C 108.629 -0.878 . . . . 0.0 108.629 179.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -74.48 -33.72 62.92 Favored 'General case' 0 N--CA 1.49 1.572 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 179.147 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.65 -18.21 25.5 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.574 -0.704 . . . . 0.0 109.345 179.24 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.21 -19.35 39.95 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.526 -0.734 . . . . 0.0 109.863 179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 t70 91.69 29.73 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.137 0 CA-C-O 122.008 0.909 . . . . 0.0 108.839 -179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.792 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -87.95 -140.68 0.11 Allowed 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.324 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.717 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -178.28 59.34 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.725 0 O-C-N 121.206 -0.934 . . . . 0.0 109.605 179.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.6 m -56.01 117.08 1.08 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.075 0.941 . . . . 0.0 110.171 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.967 ' HB ' HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -88.98 -36.51 8.92 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.919 0 CA-C-N 115.976 -0.557 . . . . 0.0 109.67 -179.766 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.521 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 24.2 t70 -143.69 147.31 34.08 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.193 -0.942 . . . . 0.0 111.014 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.056 HG13 HG22 ' A' ' 63' ' ' VAL . 2.6 t -153.23 139.63 12.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.609 -0.682 . . . . 0.0 109.462 179.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.411 ' O ' ' HE3' ' A' ' 35' ' ' LYS . 0.2 OUTLIER -158.08 -179.63 8.3 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.103 -0.998 . . . . 0.0 110.25 -179.682 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.798 HG22 HG12 ' A' ' 31' ' ' VAL . 17.0 p -84.7 177.95 7.84 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.316 -0.865 . . . . 0.0 110.594 -179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -137.23 132.43 5.97 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.576 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 52.3 m 57.68 -91.33 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.492 -1.005 . . . . 0.0 110.404 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.484 ' N ' HG22 ' A' ' 56' ' ' THR . 0.1 OUTLIER -153.02 98.1 2.27 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.073 -1.017 . . . . 0.0 110.434 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.551 ' HG3' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 41.92 26.8 0.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.249 -0.907 . . . . 0.0 110.447 179.753 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -116.35 -32.31 5.32 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.212 -0.93 . . . . 0.0 110.083 179.887 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.865 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.8 m-85 -135.97 -175.82 4.1 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.359 -0.838 . . . . 0.0 109.498 179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -153.6 145.9 13.72 Favored Glycine 0 N--CA 1.489 2.231 0 C-N-CA 119.566 -1.302 . . . . 0.0 110.101 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.808 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -101.26 161.42 13.62 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.317 -1.107 . . . . 0.0 109.528 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.056 HG22 HG13 ' A' ' 52' ' ' VAL . 4.7 t -161.46 159.86 1.67 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.297 -0.961 . . . . 0.0 110.552 -179.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HB2' ' HB3' ' A' ' 51' ' ' ASP . 2.1 m-20 -140.93 142.03 34.45 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.709 -0.619 . . . . 0.0 109.516 179.66 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.714 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 61.2 m-85 -106.16 174.44 5.88 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.719 -0.613 . . . . 0.0 110.584 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.717 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 6.6 pt-20 -114.67 13.2 17.33 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.2 -0.937 . . . . 0.0 111.849 -178.207 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.522 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 26.0 p -170.06 177.26 4.34 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.855 -1.153 . . . . 0.0 112.255 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.91 -23.56 48.64 Favored 'General case' 0 C--N 1.297 -1.687 0 N-CA-C 107.491 -1.3 . . . . 0.0 107.491 177.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HD2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.51 -27.57 46.11 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 115.036 -0.983 . . . . 0.0 109.475 -179.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.657 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 83.0 m-20 -83.14 -27.91 29.78 Favored 'General case' 0 C--N 1.305 -1.332 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 178.229 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.783 HD13 ' C ' ' A' ' 71' ' ' LEU . 1.9 tm? -73.67 -38.67 64.85 Favored 'General case' 0 C--N 1.305 -1.368 0 C-N-CA 119.979 -0.688 . . . . 0.0 109.274 179.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -71.37 -37.25 71.62 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.42 -0.8 . . . . 0.0 109.348 179.295 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.792 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.11 -20.44 52.15 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.327 -1.36 . . . . 0.0 107.327 178.169 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.738 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -71.57 -31.94 67.52 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.439 ' C ' HD23 ' A' ' 75' ' ' LEU . 5.9 tt -76.8 -43.5 36.45 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.551 -0.718 . . . . 0.0 109.081 179.164 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.06 -25.0 66.04 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.419 -0.8 . . . . 0.0 109.584 179.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.092 HD13 ' CZ ' ' A' ' 42' ' ' PHE . 14.2 mt -66.82 -8.22 27.08 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 110.126 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.898 ' OG1' HD21 ' A' ' 89' ' ' LEU . 5.9 m -48.42 -19.81 0.35 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.526 -0.734 . . . . 0.0 110.654 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.23 34.78 3.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.149 -1.58 . . . . 0.0 109.149 179.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.084 HD21 HD22 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -82.33 -165.13 0.94 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.403 -1.057 . . . . 0.0 110.694 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.565 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 3.0 mtmt -169.64 47.93 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 122.193 0.997 . . . . 0.0 109.67 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.751 HG12 ' O ' ' A' ' 85' ' ' ASN . 2.9 p -37.83 125.48 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.303 0 CA-C-N 115.31 -0.859 . . . . 0.0 110.179 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.588 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.8 m-85 41.75 26.69 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.191 -0.943 . . . . 0.0 110.456 -179.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.462 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 89.91 24.38 30.09 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.913 -1.275 . . . . 0.0 109.913 179.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.751 ' O ' HG12 ' A' ' 82' ' ' VAL . 12.3 m120 -135.04 89.82 2.56 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.267 -1.137 . . . . 0.0 109.565 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.565 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.8 pt-20 -41.17 106.22 0.05 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.224 -0.923 . . . . 0.0 110.858 -179.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.082 HD11 HD13 ' A' ' 80' ' ' LEU . 1.0 OUTLIER -72.54 135.54 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.477 -0.764 . . . . 0.0 110.285 179.945 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.546 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -112.04 159.76 18.15 Favored 'General case' 0 C--N 1.3 -1.573 0 O-C-N 121.506 -0.747 . . . . 0.0 109.156 179.461 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.898 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.2 OUTLIER -117.31 172.7 7.13 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 120.864 -1.147 . . . . 0.0 110.574 -179.707 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.449 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -173.85 125.12 0.36 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.392 -0.818 . . . . 0.0 110.201 -179.917 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.3 111.25 4.68 Favored Pre-proline 0 N--CA 1.492 1.645 0 O-C-N 121.208 -0.932 . . . . 0.0 110.232 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.8 Cg_endo -76.17 -175.31 2.47 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.988 1.52 . . . . 0.0 110.444 -179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.36 10.92 17.17 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.0 110.209 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 85.82 29.41 26.35 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.95 132.19 53.07 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.258 -1.142 . . . . 0.0 110.172 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -154.99 -173.21 4.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.255 -0.903 . . . . 0.0 110.212 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 105.98 25.99 6.24 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -130.96 109.44 10.53 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.202 -1.175 . . . . 0.0 110.263 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 4.9 ttt-85 -163.27 169.74 18.71 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.192 -0.943 . . . . 0.0 110.22 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -73.62 -101.53 0.08 OUTLIER Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.297 -1.119 . . . . 0.0 110.152 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.343 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.18 -35.2 73.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.306 -1.114 . . . . 0.0 110.194 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 3.2 t-160 -83.52 62.81 7.01 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.422 ' O ' ' O ' ' A' ' 5' ' ' LEU . 9.6 ttm -86.6 13.81 7.95 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.288 -0.882 . . . . 0.0 110.168 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.448 ' HA ' HD13 ' A' ' 5' ' ' LEU . 0.9 OUTLIER 61.07 144.65 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.182 -0.949 . . . . 0.0 110.233 -179.968 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -161.42 150.19 15.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.219 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 17.8 p-10 -149.16 132.55 8.37 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.332 -0.855 . . . . 0.0 110.255 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.6 -157.1 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.991 1.522 . . . . 0.0 110.099 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 68.5 t 53.06 97.4 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.96 0 CA-C-O 121.298 0.571 . . . . 0.0 110.232 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 -104.8 -173.86 2.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.181 -0.95 . . . . 0.0 110.24 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -105.01 58.59 0.47 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.0 m -138.0 39.51 2.34 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.301 -1.117 . . . . 0.0 110.249 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -169.41 29.05 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 CA-C-O 121.969 0.89 . . . . 0.0 110.134 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.443 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.4 OUTLIER -49.16 -179.98 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.216 0.531 . . . . 0.0 110.237 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.487 HG23 HG23 ' A' ' 16' ' ' THR . 1.9 t -83.4 -18.52 38.48 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.828 HG21 HG21 ' A' ' 50' ' ' VAL . 0.9 OUTLIER -134.85 157.65 76.67 Favored Pre-proline 0 C--N 1.3 -1.579 0 O-C-N 121.511 -0.743 . . . . 0.0 110.496 -179.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_endo -79.57 -30.92 2.22 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 O-C-N 124.204 1.634 . . . . 0.0 110.821 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.869 ' HD1' HD13 ' A' ' 71' ' ' LEU . 56.7 m-85 -103.31 104.52 14.64 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.993 -1.067 . . . . 0.0 110.895 -179.233 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.517 ' ND2' ' HB3' ' A' ' 64' ' ' ASP . 3.3 m120 -137.85 149.06 45.97 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.436 -0.79 . . . . 0.0 109.344 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.748 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.3 pp -163.84 -175.58 4.16 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.187 -0.946 . . . . 0.0 110.453 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.468 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 41.5 t80 -108.86 167.54 10.01 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.329 -0.857 . . . . 0.0 110.229 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.64 HD12 ' CG2' ' A' ' 63' ' ' VAL . 14.8 mt -147.33 158.89 9.13 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.348 -0.845 . . . . 0.0 109.666 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -137.24 179.46 18.03 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.93 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 3.9 t30 70.16 92.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.284 -1.127 . . . . 0.0 110.31 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.954 ' HB3' HD13 ' A' ' 34' ' ' LEU . 21.8 mt -145.02 130.92 19.17 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.387 -0.82 . . . . 0.0 109.978 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.624 ' HB3' HD21 ' A' ' 34' ' ' LEU . 37.5 t-20 -38.95 99.29 0.19 Allowed Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 121.737 -0.602 . . . . 0.0 110.528 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.435 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -74.19 -19.28 20.13 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.081 1.569 . . . . 0.0 110.524 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 17.7 m-80 -78.5 -13.71 59.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.113 -0.992 . . . . 0.0 109.891 179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.1 mmtt -110.52 -155.65 0.57 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.412 -0.805 . . . . 0.0 109.97 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.48 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 6.5 m -104.73 152.7 22.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.292 -0.88 . . . . 0.0 110.315 179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.949 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.7 t -69.71 -46.01 76.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.205 -0.934 . . . . 0.0 109.452 179.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.552 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -49.52 -38.95 32.54 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.294 -0.878 . . . . 0.0 109.279 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 28.5 mm-40 -67.97 -40.01 83.24 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.437 -0.789 . . . . 0.0 109.269 179.256 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.954 HD13 ' HB3' ' A' ' 25' ' ' LEU . 25.6 mt -60.72 -36.59 79.23 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 121.298 -0.876 . . . . 0.0 108.742 178.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 31' ' ' VAL . 10.3 mmtt -62.32 -57.64 10.62 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 179.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.552 HG23 ' O ' ' A' ' 32' ' ' ALA . 17.2 t -52.22 -35.18 19.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.386 -0.821 . . . . 0.0 109.211 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.99 -34.48 78.08 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 179.126 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 34' ' ' LEU . 4.5 mt -82.1 -27.54 9.29 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.501 ' HA ' HG21 ' A' ' 49' ' ' VAL . 75.2 m -77.86 -30.15 50.78 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.2 -0.937 . . . . 0.0 109.023 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -80.59 -37.02 32.01 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.496 -0.752 . . . . 0.0 109.456 179.447 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.521 ' HG ' ' HB2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.08 -30.53 68.87 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.587 -0.696 . . . . 0.0 109.145 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.687 ' HE1' HD22 ' A' ' 80' ' ' LEU . 7.1 m-85 -84.7 -22.46 29.75 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 108.758 -0.831 . . . . 0.0 108.758 178.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.88 -32.42 61.86 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.532 -0.73 . . . . 0.0 109.437 179.535 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.93 -12.44 28.8 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.466 -0.771 . . . . 0.0 109.735 179.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.597 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -92.41 -11.17 35.56 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.306 -0.871 . . . . 0.0 110.114 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.3 t70 85.12 31.22 0.04 OUTLIER 'General case' 0 N--CA 1.499 1.997 0 CA-C-O 121.917 0.865 . . . . 0.0 109.281 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.976 HD11 ' HB3' ' A' ' 73' ' ' LYS . 3.0 mm? -86.76 -131.15 0.06 Allowed 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 179.461 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.863 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 168.38 56.34 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.701 0 O-C-N 120.841 -1.162 . . . . 0.0 109.692 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.501 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.6 m -58.16 120.5 4.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.64 0 CA-C-O 122.067 0.937 . . . . 0.0 110.375 -179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.828 HG21 HG21 ' A' ' 16' ' ' THR . 0.9 OUTLIER -90.37 -46.85 14.84 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.87 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.448 -179.261 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.472 ' OD2' HG21 ' A' ' 15' ' ' THR . 3.6 m-20 -148.1 118.88 7.55 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.018 -1.051 . . . . 0.0 111.173 -179.507 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.871 HG12 HG13 ' A' ' 63' ' ' VAL . 16.6 m -101.24 171.55 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.398 0 O-C-N 121.295 -0.878 . . . . 0.0 109.692 179.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.444 ' HG3' ' O ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -166.82 164.48 16.44 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.218 -0.926 . . . . 0.0 110.431 179.919 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.725 ' HB ' HG11 ' A' ' 31' ' ' VAL . 23.4 p -92.03 162.32 14.42 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.456 -0.777 . . . . 0.0 110.549 -179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.524 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -117.5 121.47 5.12 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.435 -1.466 . . . . 0.0 109.435 179.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.549 ' OG1' ' CD2' ' A' ' 60' ' ' PHE . 2.1 m 72.0 -56.17 0.65 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.62 -0.929 . . . . 0.0 110.122 -179.834 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.545 ' O ' HG21 ' A' ' 31' ' ' VAL . 0.3 OUTLIER 173.74 -35.64 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.25 -0.906 . . . . 0.0 110.111 -179.984 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.596 ' HA ' HG22 ' A' ' 31' ' ' VAL . 31.8 ttp180 -172.5 26.21 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -0.932 . . . . 0.0 110.549 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.547 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 34.6 mttp -119.31 -33.74 4.02 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.287 -0.883 . . . . 0.0 109.771 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.654 ' C ' HD12 ' A' ' 25' ' ' LEU . 1.1 m-85 -131.26 -165.83 1.62 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.328 -0.858 . . . . 0.0 109.349 179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.492 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -171.01 161.93 34.74 Favored Glycine 0 N--CA 1.489 2.217 0 C-N-CA 119.603 -1.284 . . . . 0.0 110.236 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.621 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.0 t80 -123.36 154.81 38.44 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.42 -1.047 . . . . 0.0 109.554 179.527 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.871 HG13 HG12 ' A' ' 52' ' ' VAL . 3.5 t -150.71 146.26 16.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.218 -0.993 . . . . 0.0 111.004 -178.467 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.517 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 1.1 m-20 -118.27 135.06 54.51 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.529 -0.732 . . . . 0.0 109.507 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.681 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 51.4 m-85 -102.44 171.91 7.18 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.714 -0.616 . . . . 0.0 109.985 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.771 ' HB3' HG22 ' A' ' 50' ' ' VAL . 1.0 OUTLIER -115.58 15.77 16.58 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.275 -0.89 . . . . 0.0 111.344 -178.218 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.566 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p -166.82 173.8 9.15 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-O 122.603 1.192 . . . . 0.0 112.281 179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.453 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.24 -25.72 51.84 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.478 ' OE1' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -75.38 -26.79 58.77 Favored 'General case' 0 C--N 1.298 -1.668 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.571 179.88 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.863 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 89.1 m-20 -82.41 -30.63 30.05 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 107.657 -1.238 . . . . 0.0 107.657 178.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.869 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -73.15 -36.56 66.68 Favored 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 119.931 -0.707 . . . . 0.0 109.827 179.474 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 15.2 tt0 -73.39 -38.72 65.53 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.4 -0.813 . . . . 0.0 109.98 179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.976 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -78.3 -29.64 47.93 Favored 'General case' 0 C--N 1.305 -1.349 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 178.766 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.693 ' HB2' ' O ' ' A' ' 70' ' ' ASP . . . -64.39 -31.33 72.49 Favored 'General case' 0 C--N 1.303 -1.421 0 C-N-CA 119.63 -0.828 . . . . 0.0 108.841 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.502 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 4.6 tt -72.82 -45.18 59.8 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 108.015 -1.106 . . . . 0.0 108.015 178.523 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.1 mt-10 -81.03 -1.13 42.76 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 119.776 -0.77 . . . . 0.0 109.41 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.747 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -77.91 7.83 5.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.486 -0.759 . . . . 0.0 110.282 -179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.792 ' OG1' HD21 ' A' ' 89' ' ' LEU . 92.4 m -70.29 -2.55 13.75 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.085 -1.009 . . . . 0.0 110.473 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.76 -18.55 65.45 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.036 -1.626 . . . . 0.0 109.036 179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.9 HD21 HD11 ' A' ' 87' ' ' ILE . 1.2 pp -71.69 129.4 38.59 Favored 'General case' 0 N--CA 1.486 1.333 0 O-C-N 121.388 -1.066 . . . . 0.0 110.794 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -99.98 84.86 2.94 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.975 0.893 . . . . 0.0 109.518 179.611 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.901 HG11 HD23 ' A' ' 25' ' ' LEU . 4.2 p -43.85 118.29 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 119.727 -0.789 . . . . 0.0 108.998 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 2.1 m-85 46.01 22.98 0.15 Allowed 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.083 -1.01 . . . . 0.0 110.306 -178.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 99.03 12.26 43.41 Favored Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.695 -1.24 . . . . 0.0 110.319 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.801 ' O ' HG12 ' A' ' 82' ' ' VAL . 9.6 m120 -126.49 89.67 3.04 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.31 . . . . 0.0 110.387 179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.9 mp0 -40.33 105.35 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.251 -0.906 . . . . 0.0 110.63 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.9 HD11 HD21 ' A' ' 80' ' ' LEU . 12.5 pt -71.28 146.54 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 CA-C-O 121.784 0.802 . . . . 0.0 110.581 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.53 ' O ' HG23 ' A' ' 22' ' ' ILE . 15.9 ttpt -116.06 158.64 22.85 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 109.2 -0.667 . . . . 0.0 109.2 179.065 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -119.07 167.95 11.3 Favored 'General case' 0 C--N 1.298 -1.658 0 O-C-N 120.837 -1.164 . . . . 0.0 110.415 -179.594 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.43 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.2 pt-20 -168.9 158.09 8.56 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.393 -0.817 . . . . 0.0 110.167 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.71 112.1 31.67 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.261 -0.9 . . . . 0.0 110.24 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.434 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 45.9 Cg_endo -72.7 -170.93 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.949 1.499 . . . . 0.0 110.438 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.1 tttt -48.93 111.74 0.52 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.278 -0.889 . . . . 0.0 110.253 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -171.79 -41.17 0.04 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.514 -1.434 . . . . 0.0 109.514 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.93 38.91 0.52 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.214 -1.168 . . . . 0.0 110.185 179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -120.86 173.35 7.28 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.32 -0.863 . . . . 0.0 110.227 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -153.34 26.78 0.78 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.596 -1.402 . . . . 0.0 109.596 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.95 143.65 11.11 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.189 -1.183 . . . . 0.0 110.391 -179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.3 mtt-85 -145.04 63.17 1.29 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.231 -0.918 . . . . 0.0 110.213 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -163.11 31.02 0.28 Allowed Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.491 -1.444 . . . . 0.0 109.491 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.492 1.664 0 O-C-N 121.31 -1.112 . . . . 0.0 110.194 179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.296 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 53.5 p 45.95 28.74 0.65 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.253 -1.146 . . . . 0.0 110.246 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.45 ' O ' ' CB ' ' A' ' 4' ' ' MET . 0.6 OUTLIER -82.22 50.43 1.59 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.221 -0.924 . . . . 0.0 110.182 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.45 ' CB ' ' O ' ' A' ' 3' ' ' HIS . 0.0 OUTLIER 65.28 137.81 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.28 -0.888 . . . . 0.0 110.22 -179.916 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 57.47 176.92 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.346 -0.846 . . . . 0.0 110.218 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -153.23 61.35 0.77 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.222 -0.924 . . . . 0.0 110.21 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.409 ' HA ' ' HD2' ' A' ' 8' ' ' PRO . 11.9 p-10 -138.92 105.14 7.39 Favored Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.228 -0.92 . . . . 0.0 110.353 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.495 ' O ' ' HB ' ' A' ' 9' ' ' VAL . 43.3 Cg_endo -71.26 81.71 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.662 0 O-C-N 123.963 1.507 . . . . 0.0 110.268 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 8' ' ' PRO . 67.6 t 58.75 138.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 CA-C-O 121.383 0.611 . . . . 0.0 110.359 -179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -111.67 177.98 4.47 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.211 -0.931 . . . . 0.0 110.23 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.43 ' C ' ' OG ' ' A' ' 12' ' ' SER . . . -122.82 99.02 0.63 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.43 ' OG ' ' C ' ' A' ' 11' ' ' GLY . 0.5 OUTLIER -165.01 97.28 0.73 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.21 -1.171 . . . . 0.0 110.095 179.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -169.36 28.81 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.278 -0.889 . . . . 0.0 110.314 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.32 159.51 14.91 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-O 121.345 0.593 . . . . 0.0 110.397 -179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.793 ' C ' HG23 ' A' ' 16' ' ' THR . 7.2 m -90.37 42.19 1.09 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.344 -0.848 . . . . 0.0 110.143 179.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.94 ' CG2' HG11 ' A' ' 50' ' ' VAL . 1.4 p 77.8 163.41 0.13 Allowed Pre-proline 0 N--CA 1.502 2.14 0 CA-C-O 121.042 0.449 . . . . 0.0 110.565 -179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.422 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.8 Cg_endo -77.85 -31.75 2.99 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.227 1.646 . . . . 0.0 110.91 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.576 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 74.4 m-85 -86.61 102.39 14.12 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.949 -1.094 . . . . 0.0 110.557 -179.559 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.479 ' ND2' ' O ' ' A' ' 16' ' ' THR . 67.0 m-20 -139.52 157.74 45.3 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.219 -0.926 . . . . 0.0 109.623 179.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.73 ' C ' HD12 ' A' ' 20' ' ' LEU . 2.2 pp -167.02 -177.08 3.62 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.288 -0.882 . . . . 0.0 110.416 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.542 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 1.5 t80 -117.29 146.58 43.24 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.574 HD12 ' CG2' ' A' ' 63' ' ' VAL . 2.2 mt -129.93 160.5 40.91 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.297 -0.877 . . . . 0.0 109.469 179.62 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.506 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -136.63 -172.67 12.64 Favored Glycine 0 N--CA 1.486 1.995 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 -179.631 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.704 ' C ' HD22 ' A' ' 25' ' ' LEU . 10.1 t-20 72.33 63.95 0.12 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.496 -1.002 . . . . 0.0 110.47 179.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.863 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.1 mm? -106.53 119.54 39.55 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.306 -0.871 . . . . 0.0 109.92 179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.762 ' HB2' HD21 ' A' ' 34' ' ' LEU . 11.6 t-20 -41.31 107.21 0.47 Allowed Pre-proline 0 C--N 1.297 -1.693 0 O-C-N 121.704 -0.622 . . . . 0.0 110.189 179.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -70.79 -30.3 17.7 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.044 1.55 . . . . 0.0 110.042 179.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 12.4 m-80 -78.83 -11.73 60.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.338 -0.852 . . . . 0.0 109.63 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.434 ' HD2' ' CD ' ' A' ' 33' ' ' GLU . 4.4 mmtp -111.31 -156.15 0.58 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.342 -0.849 . . . . 0.0 109.74 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.6 m -111.96 150.71 30.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.335 179.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.956 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.2 t -72.83 -19.97 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.211 -0.931 . . . . 0.0 109.376 179.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -74.38 -45.2 48.42 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.573 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -62.08 -38.03 87.29 Favored 'General case' 0 C--N 1.301 -1.522 0 N-CA-C 108.805 -0.813 . . . . 0.0 108.805 178.967 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 31' ' ' VAL . 44.4 mt -63.3 -40.0 96.14 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.226 -0.921 . . . . 0.0 108.912 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.55 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 1.7 mptp? -58.17 -48.88 78.92 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.547 0.689 . . . . 0.0 109.379 179.257 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 32' ' ' ALA . 26.4 t -56.06 -35.39 41.31 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.399 -0.813 . . . . 0.0 109.723 179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.85 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -63.3 -37.32 86.81 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.159 -0.963 . . . . 0.0 108.658 179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 42' ' ' PHE . 34.6 mt -81.41 -25.0 10.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.531 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.79 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 3.6 p -80.35 -26.95 38.42 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.839 . . . . 0.0 109.066 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.92 -41.92 15.47 Favored 'General case' 0 C--N 1.304 -1.401 0 CA-C-O 121.661 0.743 . . . . 0.0 109.31 179.365 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.937 HD22 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -64.0 -35.74 81.68 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.897 -0.721 . . . . 0.0 109.081 179.227 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.783 ' CE1' HD11 ' A' ' 80' ' ' LEU . 9.4 m-30 -85.34 -21.82 28.75 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.751 0.786 . . . . 0.0 108.943 179.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.79 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.57 -35.18 60.68 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-O 121.466 0.65 . . . . 0.0 109.509 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 21.4 mttt -84.11 -15.38 47.49 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.489 -0.757 . . . . 0.0 109.366 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.591 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.64 -10.94 44.04 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.508 -0.745 . . . . 0.0 109.859 179.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.591 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.3 t0 83.79 29.17 0.08 Allowed 'General case' 0 N--CA 1.496 1.855 0 CA-C-O 121.946 0.879 . . . . 0.0 108.832 -179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.94 HD21 ' CE1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -73.84 -130.84 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.65 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.052 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 173.27 57.45 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.745 0 O-C-N 121.447 -0.783 . . . . 0.0 109.377 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.456 ' O ' HG23 ' A' ' 49' ' ' VAL . 15.8 m -57.26 117.44 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.678 0 CA-C-O 121.936 0.874 . . . . 0.0 110.836 -179.393 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.94 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.2 OUTLIER -93.42 -34.18 5.69 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.8 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.554 ' HB2' ' CG2' ' A' ' 15' ' ' THR . 0.7 OUTLIER -149.03 152.19 35.83 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.211 -0.931 . . . . 0.0 110.823 179.731 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.698 HG13 HG13 ' A' ' 63' ' ' VAL . 0.2 OUTLIER -157.85 93.99 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 O-C-N 121.485 -0.76 . . . . 0.0 109.072 179.449 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.472 ' C ' ' CE ' ' A' ' 35' ' ' LYS . 7.1 mmm180 -106.96 168.23 9.34 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.118 -0.989 . . . . 0.0 110.772 -179.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.956 ' HB ' HG11 ' A' ' 31' ' ' VAL . 4.4 p -80.17 170.94 15.74 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 121.438 -0.789 . . . . 0.0 110.279 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.469 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -128.88 114.1 1.7 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.476 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.4 m 67.66 -139.79 0.12 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.272 -1.134 . . . . 0.0 110.312 179.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.476 ' H ' HG22 ' A' ' 56' ' ' THR . 80.8 m-20 -98.24 76.35 2.33 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.169 -0.957 . . . . 0.0 110.502 -179.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.407 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 36.8 mtt180 57.8 42.12 23.9 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 0.0 110.486 179.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.567 ' O ' ' CD1' ' A' ' 60' ' ' PHE . 21.2 mttt -119.46 -31.44 4.61 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.296 -0.877 . . . . 0.0 109.8 179.629 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.863 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.8 m-85 -139.79 -169.26 2.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.425 -0.797 . . . . 0.0 109.588 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -166.8 140.59 6.4 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.925 -1.27 . . . . 0.0 109.925 179.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.609 ' CD1' ' N ' ' A' ' 62' ' ' TYR . 2.3 m-30 -99.13 157.12 16.58 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.258 -1.143 . . . . 0.0 109.591 179.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.698 HG13 HG13 ' A' ' 52' ' ' VAL . 3.9 t -151.24 143.73 16.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 C-N-CA 119.487 -0.885 . . . . 0.0 110.7 -178.799 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.521 ' OD2' ' CG2' ' A' ' 15' ' ' THR . 0.8 OUTLIER -122.34 140.9 52.13 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.365 -0.835 . . . . 0.0 109.979 179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.94 ' CE1' HD21 ' A' ' 47' ' ' LEU . 14.2 m-85 -107.48 172.31 6.9 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.601 -0.687 . . . . 0.0 109.34 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.877 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 0.2 OUTLIER -122.52 19.2 10.45 Favored 'General case' 0 C--N 1.295 -1.762 0 O-C-N 121.067 -1.021 . . . . 0.0 111.115 -178.506 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.2 p -165.06 176.22 8.75 Favored 'General case' 0 N--CA 1.496 1.839 0 CA-C-O 122.588 1.185 . . . . 0.0 112.251 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -79.18 -25.81 42.73 Favored 'General case' 0 C--N 1.297 -1.69 0 N-CA-C 107.529 -1.285 . . . . 0.0 107.529 177.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.79 -32.06 63.58 Favored 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.036 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 1.052 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 90.4 m-20 -77.81 -29.57 50.76 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.747 -1.575 . . . . 0.0 106.747 177.737 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.783 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 1.9 tt -71.22 -39.73 71.54 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.63 ' N ' HD23 ' A' ' 71' ' ' LEU . 5.9 tt0 -62.16 -38.34 88.67 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.78 -0.822 . . . . 0.0 108.78 178.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.437 ' O ' ' N ' ' A' ' 77' ' ' LEU . 23.9 mmtt -72.41 -24.62 61.26 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 106.704 -1.591 . . . . 0.0 106.704 177.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.783 ' HB3' ' O ' ' A' ' 71' ' ' LEU . . . -63.97 -34.92 79.07 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.42 HD23 ' C ' ' A' ' 75' ' ' LEU . 7.0 tt -72.02 -44.64 63.09 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 178.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -85.4 9.72 14.8 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 119.81 -0.756 . . . . 0.0 109.094 178.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.672 HD13 ' HA ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -75.89 -13.05 60.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.602 -0.686 . . . . 0.0 110.585 -179.718 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.625 ' CA ' HD21 ' A' ' 89' ' ' LEU . 96.4 m -72.38 3.66 4.54 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.429 -0.794 . . . . 0.0 111.308 -179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -111.29 39.35 2.92 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 108.716 -1.754 . . . . 0.0 108.716 179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.067 HD12 HD11 ' A' ' 87' ' ' ILE . 7.4 mt -100.14 -167.55 1.47 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.485 -1.009 . . . . 0.0 111.017 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.553 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.0 OUTLIER -167.61 51.13 0.06 Allowed 'General case' 0 N--CA 1.492 1.66 0 CA-C-O 122.069 0.937 . . . . 0.0 108.925 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.853 HG12 ' O ' ' A' ' 85' ' ' ASN . 4.1 p -34.66 118.18 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.285 -2.217 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.248 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.85 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 15.1 m-85 38.35 29.1 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.494 -0.754 . . . . 0.0 110.557 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.491 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 96.8 22.0 19.55 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 110.395 -1.082 . . . . 0.0 110.395 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.853 ' O ' HG12 ' A' ' 82' ' ' VAL . 5.9 m-20 -134.01 84.34 2.11 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.093 -1.24 . . . . 0.0 109.853 179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.553 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 23.4 tt0 -40.11 96.61 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.666 0.746 . . . . 0.0 110.44 -179.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.067 HD11 HD12 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -59.55 123.82 12.66 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.607 -0.683 . . . . 0.0 110.499 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.525 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.5 mttp -95.25 127.88 41.64 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.38 -0.825 . . . . 0.0 109.003 179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.625 HD21 ' CA ' ' A' ' 78' ' ' THR . 0.2 OUTLIER -109.34 169.67 8.55 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 120.954 -1.091 . . . . 0.0 111.399 -179.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.487 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -166.85 173.98 8.96 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.878 -0.514 . . . . 0.0 109.683 179.854 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -95.28 106.26 25.02 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.254 -0.904 . . . . 0.0 110.379 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.8 Cg_endo -74.69 -168.93 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.956 1.503 . . . . 0.0 110.428 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.457 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 66.63 105.61 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.259 -0.901 . . . . 0.0 110.209 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . -175.86 -43.28 0.06 OUTLIER Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.459 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.2 OUTLIER 45.42 -171.65 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.205 -1.174 . . . . 0.0 110.247 -179.993 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -87.95 -173.55 4.32 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.226 -0.922 . . . . 0.0 110.156 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 77.75 -156.26 44.08 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.608 -1.397 . . . . 0.0 109.608 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -152.02 151.83 31.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.255 -1.144 . . . . 0.0 110.468 179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.1 ttm-85 -170.52 42.86 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.225 -0.922 . . . . 0.0 110.231 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -97.36 -118.93 3.79 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.645 0 O-C-N 121.242 -1.152 . . . . 0.0 110.198 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.318 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.8 -24.15 19.48 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -1.148 . . . . 0.0 110.2 -179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 1.1 t-160 -110.55 26.88 10.21 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.257 -0.902 . . . . 0.0 110.184 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.441 ' O ' ' O ' ' A' ' 5' ' ' LEU . 1.1 ttp -140.84 55.96 1.57 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.244 -0.91 . . . . 0.0 110.164 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.441 ' O ' ' O ' ' A' ' 4' ' ' MET . 0.7 OUTLIER -51.88 -174.99 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.292 -0.88 . . . . 0.0 110.268 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -169.47 109.78 0.44 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.225 -0.922 . . . . 0.0 110.218 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.523 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 5.0 t70 -162.93 50.72 0.27 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.262 -0.899 . . . . 0.0 110.227 179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.523 ' CD ' ' N ' ' A' ' 7' ' ' ASP . 48.4 Cg_endo -71.37 -156.95 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.075 1.566 . . . . 0.0 110.043 -179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 55.2 t 52.25 98.65 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.973 0 CA-C-O 121.318 0.58 . . . . 0.0 110.235 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.415 ' O ' ' C ' ' A' ' 11' ' ' GLY . 1.1 tt0 -51.46 177.14 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.146 -0.971 . . . . 0.0 110.236 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 10' ' ' GLU . . . -44.03 -73.84 0.23 Allowed Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -178.63 -68.44 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.245 -1.15 . . . . 0.0 110.116 179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.84 30.06 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 110.217 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -48.25 159.09 0.22 Allowed 'General case' 0 C--N 1.29 -2.021 0 CA-C-O 121.403 0.62 . . . . 0.0 110.28 -179.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t -119.88 -13.78 9.02 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.403 -0.81 . . . . 0.0 109.915 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.946 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -124.57 172.79 5.44 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.65 -0.656 . . . . 0.0 110.691 -179.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.716 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.5 Cg_endo -77.86 -47.0 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 124.136 1.598 . . . . 0.0 110.552 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.647 ' HB3' HD12 ' A' ' 71' ' ' LEU . 55.6 m-85 -87.51 111.12 20.86 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.169 -0.957 . . . . 0.0 110.22 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -113.01 150.39 32.01 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.374 -0.828 . . . . 0.0 109.113 179.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.184 HD12 ' CE1' ' A' ' 65' ' ' PHE . 13.9 mt -146.42 170.2 17.32 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.361 -0.837 . . . . 0.0 111.22 -179.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.656 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 5.8 t80 -126.06 140.76 52.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.739 -0.837 . . . . 0.0 108.739 178.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.79 HD12 HG21 ' A' ' 63' ' ' VAL . 8.6 mt -137.63 147.8 26.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.504 0 O-C-N 120.949 -1.094 . . . . 0.0 110.774 -179.233 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.526 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.06 -167.66 11.59 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 21.4 t-20 70.92 36.87 1.38 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.341 -1.093 . . . . 0.0 110.372 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.808 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.1 mm? -88.4 126.97 35.48 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.255 -0.903 . . . . 0.0 110.101 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.504 ' ND2' ' HG3' ' A' ' 29' ' ' LYS . 36.4 t-20 -40.9 107.76 0.5 Allowed Pre-proline 0 C--N 1.302 -1.494 0 O-C-N 121.661 -0.649 . . . . 0.0 110.378 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -73.41 -8.36 21.67 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.047 1.551 . . . . 0.0 110.289 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.413 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 28.1 m120 -96.71 -20.75 18.03 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.216 -0.928 . . . . 0.0 109.601 179.739 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.638 ' CD ' ' CE1' ' A' ' 83' ' ' PHE . 0.2 OUTLIER -103.48 -158.9 0.69 Allowed 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.544 -0.722 . . . . 0.0 109.382 179.597 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.484 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -103.8 148.27 26.3 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.142 -0.974 . . . . 0.0 110.286 179.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.86 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.1 t -69.71 -26.17 30.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 O-C-N 121.123 -0.986 . . . . 0.0 108.912 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.714 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -65.36 -41.16 94.09 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.416 -0.802 . . . . 0.0 109.031 178.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.594 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.6 mm-40 -64.27 -45.26 88.83 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 178.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.86 HD12 ' HA ' ' A' ' 31' ' ' VAL . 8.4 mt -60.09 -39.02 84.65 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 178.52 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.548 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -59.02 -57.17 14.25 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-O 121.539 0.685 . . . . 0.0 109.687 179.242 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG23 ' O ' ' A' ' 32' ' ' ALA . 15.0 t -57.23 -31.52 38.01 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.336 -0.852 . . . . 0.0 109.714 179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.522 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -65.08 -39.06 92.66 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.183 -0.948 . . . . 0.0 108.822 179.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 19.3 mt -78.3 -24.72 13.76 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.547 -0.721 . . . . 0.0 109.362 178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.517 ' HA ' HG21 ' A' ' 49' ' ' VAL . 30.4 t -80.83 -33.22 34.78 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -0.929 . . . . 0.0 109.147 179.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -78.61 -37.04 43.27 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-O 121.581 0.705 . . . . 0.0 109.461 179.427 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.616 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -70.33 -31.94 69.46 Favored 'General case' 0 C--N 1.302 -1.48 0 C-N-CA 119.766 -0.773 . . . . 0.0 109.102 179.065 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.913 ' CD2' HD22 ' A' ' 47' ' ' LEU . 3.3 m-85 -77.74 -26.28 49.82 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.73 -0.841 . . . . 0.0 108.73 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.89 -29.67 61.06 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.549 -0.719 . . . . 0.0 109.706 179.593 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.478 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -96.19 -22.42 17.29 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.447 -0.783 . . . . 0.0 109.762 179.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.703 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.8 m-80 -74.53 -42.15 59.37 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 121.301 -0.874 . . . . 0.0 109.752 179.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.703 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.6 t70 122.59 28.86 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.534 0 C-N-CA 123.682 0.793 . . . . 0.0 109.46 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.015 HD11 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -96.82 -153.87 0.43 Allowed 'General case' 0 C--N 1.295 -1.782 0 C-N-CA 120.059 -0.656 . . . . 0.0 109.463 179.693 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -162.72 61.45 0.2 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.197 -0.939 . . . . 0.0 109.952 179.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.679 HG13 ' CD2' ' A' ' 42' ' ' PHE . 6.0 m -55.23 115.77 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 122.08 0.943 . . . . 0.0 110.332 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.946 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -91.28 -38.36 10.46 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.886 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.996 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.534 ' O ' HG22 ' A' ' 52' ' ' VAL . 0.6 OUTLIER -143.5 154.02 43.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.348 -0.845 . . . . 0.0 110.425 179.474 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.67 HG13 HG22 ' A' ' 63' ' ' VAL . 0.3 OUTLIER -157.93 110.72 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.825 0 O-C-N 121.395 -0.816 . . . . 0.0 109.172 179.685 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -121.3 165.66 15.16 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.006 -1.059 . . . . 0.0 111.055 -179.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.694 ' HB ' HG11 ' A' ' 31' ' ' VAL . 13.0 p -88.37 156.74 18.99 Favored 'General case' 0 C--N 1.306 -1.294 0 O-C-N 121.331 -0.856 . . . . 0.0 109.888 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -124.9 118.1 3.21 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.992 -1.243 . . . . 0.0 109.992 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.69 HG22 ' H ' ' A' ' 57' ' ' ASN . 3.5 m 66.77 -175.74 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.393 -1.063 . . . . 0.0 110.757 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.69 ' H ' HG22 ' A' ' 56' ' ' THR . 16.9 m120 -63.95 65.56 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.392 -0.817 . . . . 0.0 110.823 -179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.52 ' N ' ' O ' ' A' ' 56' ' ' THR . 2.1 mtt180 61.74 59.19 1.83 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.2 -0.938 . . . . 0.0 110.694 179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.576 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -120.41 -34.8 3.55 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.299 -0.876 . . . . 0.0 109.592 179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.808 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.2 p90 -165.44 140.37 4.99 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.638 -0.664 . . . . 0.0 109.266 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.484 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -112.33 163.75 12.15 Favored Glycine 0 N--CA 1.489 2.222 0 C-N-CA 119.645 -1.264 . . . . 0.0 110.716 -178.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.656 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 39.1 m-85 -114.26 163.42 15.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.496 -1.003 . . . . 0.0 109.635 179.425 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.79 HG21 HD12 ' A' ' 22' ' ' ILE . 2.9 t -152.0 139.46 13.58 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.373 -0.931 . . . . 0.0 111.043 -178.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' HA ' ' O ' ' A' ' 18' ' ' PHE . 3.6 m-20 -106.81 140.44 39.64 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.47 -0.769 . . . . 0.0 109.023 178.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 1.184 ' CE1' HD12 ' A' ' 20' ' ' LEU . 13.1 m-85 -107.48 170.43 7.97 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.196 -0.94 . . . . 0.0 110.631 -179.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.727 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -116.22 16.08 15.9 Favored 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.591 -0.693 . . . . 0.0 111.328 -178.016 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.552 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 3.1 t -163.44 175.32 10.9 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 122.748 1.261 . . . . 0.0 112.272 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.478 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.74 -24.67 22.62 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 177.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.403 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -89.35 -22.16 22.75 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.831 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' CB ' ' HB3' ' A' ' 67' ' ' SER . 10.7 t0 -81.4 -34.02 31.87 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 177.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.681 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 7.6 tt -76.28 -34.6 59.11 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 178.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -66.87 -37.35 84.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.401 -0.812 . . . . 0.0 109.421 179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 1.015 ' HB3' HD11 ' A' ' 47' ' ' LEU . 1.8 mtmt -72.3 -27.69 62.62 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 178.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.914 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -62.53 -34.07 76.18 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.08 -0.711 . . . . 0.0 109.08 178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.538 ' HA ' ' CD1' ' A' ' 89' ' ' LEU . 5.5 tt -71.05 -44.49 65.67 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.29 1.18 22.57 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.488 178.677 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.045 HD12 HD11 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -79.75 12.64 2.51 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.333 -0.855 . . . . 0.0 110.414 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 2.3 m -78.28 2.67 17.68 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.972 -1.08 . . . . 0.0 110.155 179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.06 33.63 5.81 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 179.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.045 HD11 HD12 ' A' ' 77' ' ' LEU . 22.3 mt -98.44 -166.25 1.34 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.253 -1.145 . . . . 0.0 110.982 -179.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.9 mttt -166.78 49.61 0.07 Allowed 'General case' 0 N--CA 1.492 1.667 0 CA-C-O 122.304 1.049 . . . . 0.0 109.416 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.794 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.3 OUTLIER -38.25 126.94 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.282 -2.356 0 CA-C-N 115.077 -0.965 . . . . 0.0 110.288 -179.383 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.638 ' CE1' ' CD ' ' A' ' 29' ' ' LYS . 9.0 m-85 42.46 26.6 0.07 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.304 -0.872 . . . . 0.0 110.414 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.446 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 90.55 21.67 36.63 Favored Glycine 0 N--CA 1.492 2.418 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.522 ' N ' ' O ' ' A' ' 82' ' ' VAL . 36.3 m-80 -136.19 99.51 4.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.27 -1.136 . . . . 0.0 109.393 179.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.569 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -48.79 90.84 0.0 OUTLIER 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.288 -0.882 . . . . 0.0 110.61 -179.099 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.965 HD11 HD12 ' A' ' 80' ' ' LEU . 0.6 OUTLIER -48.83 135.24 5.96 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 C-N-CA 119.837 -0.745 . . . . 0.0 109.85 179.627 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.589 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.2 ttpt -104.23 152.65 21.93 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.375 -0.828 . . . . 0.0 108.889 179.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.873 HD13 ' O ' ' A' ' 74' ' ' ALA . 0.2 OUTLIER -124.79 172.8 9.04 Favored 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.539 -0.726 . . . . 0.0 110.482 -179.454 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.7 tt0 -164.16 174.0 11.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.417 -0.802 . . . . 0.0 110.096 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.415 ' HA ' ' HD2' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -100.48 101.02 13.56 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.21 -0.931 . . . . 0.0 110.244 179.956 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.4 Cg_endo -72.71 -171.13 0.69 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 124.057 1.556 . . . . 0.0 110.437 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.432 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 6.4 ttmt 65.36 101.55 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.233 -0.917 . . . . 0.0 110.214 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.443 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . -44.58 123.01 5.06 Favored Glycine 0 N--CA 1.49 2.238 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.443 ' O ' ' O ' ' A' ' 94' ' ' GLY . 2.7 tmm_? 59.73 148.41 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.237 -1.155 . . . . 0.0 110.199 -179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.434 ' N ' ' HD2' ' A' ' 95' ' ' ARG . 2.6 t70 -162.33 67.61 0.24 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 110.243 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 155.18 -84.32 0.15 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -150.46 155.0 38.69 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.274 -1.133 . . . . 0.0 110.396 179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.6 ttm180 -71.84 -37.49 70.26 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.26 -0.9 . . . . 0.0 110.154 -179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 71.48 -111.81 3.84 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.214 -1.168 . . . . 0.0 110.222 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.373 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 34.9 m -127.46 -165.35 1.46 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.303 -1.116 . . . . 0.0 110.178 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -119.54 23.22 11.31 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.293 -0.879 . . . . 0.0 110.193 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -123.63 39.48 3.95 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.209 -0.932 . . . . 0.0 110.134 -179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tp 49.57 87.38 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.225 -0.922 . . . . 0.0 110.147 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.427 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 3.5 mt-10 -140.36 107.75 5.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.309 -0.869 . . . . 0.0 110.126 179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.573 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.5 OUTLIER 174.29 -60.44 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.194 -0.942 . . . . 0.0 110.201 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 49.3 Cg_endo -71.45 -157.05 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.056 1.556 . . . . 0.0 110.062 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.639 HG13 ' O ' ' A' ' 9' ' ' VAL . 9.8 p -164.28 120.6 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.951 0 O-C-N 121.81 -0.556 . . . . 0.0 110.191 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 88.4 mt-10 -76.54 -177.72 4.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.233 -0.917 . . . . 0.0 110.175 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 114.03 11.55 12.27 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -116.77 24.4 11.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.243 -1.151 . . . . 0.0 110.231 -179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.497 ' HG3' ' N ' ' A' ' 14' ' ' SER . 3.0 pt-20 -117.92 -129.6 0.29 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.224 -0.923 . . . . 0.0 109.446 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.497 ' N ' ' HG3' ' A' ' 13' ' ' GLU . 0.1 OUTLIER 46.99 -175.44 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.128 0 O-C-N 121.662 -0.649 . . . . 0.0 110.257 -179.94 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.818 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m -105.01 -2.16 24.82 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.27 -0.894 . . . . 0.0 110.186 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 1.014 ' CG2' HG11 ' A' ' 50' ' ' VAL . 1.9 p -162.98 169.03 9.45 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.258 -0.901 . . . . 0.0 110.349 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.473 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 48.4 Cg_endo -76.58 -25.77 9.16 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.095 1.576 . . . . 0.0 110.734 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.721 ' CD1' HD13 ' A' ' 71' ' ' LEU . 87.6 m-85 -121.33 113.11 19.45 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.95 -1.094 . . . . 0.0 111.126 -179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -139.68 150.48 44.94 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.471 -0.768 . . . . 0.0 109.092 179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 20' ' ' LEU . 0.5 OUTLIER -161.99 178.61 8.7 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.178 -0.951 . . . . 0.0 110.557 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.464 ' O ' HG13 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -97.93 162.87 13.03 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.627 -0.671 . . . . 0.0 109.374 -179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.062 HD12 ' CG2' ' A' ' 63' ' ' VAL . 6.0 mt -153.82 152.08 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 120.922 -1.111 . . . . 0.0 109.542 -179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.605 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -143.5 -166.29 11.17 Favored Glycine 0 N--CA 1.487 2.083 0 C-N-CA 119.246 -1.454 . . . . 0.0 110.112 -179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.575 ' C ' HD22 ' A' ' 25' ' ' LEU . 6.7 t30 72.71 46.1 0.29 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.553 -0.969 . . . . 0.0 109.883 -179.501 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.928 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.9 mm? -100.56 128.71 46.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.391 -0.818 . . . . 0.0 110.071 179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.551 ' HB3' HD21 ' A' ' 34' ' ' LEU . 56.9 t-20 -44.89 103.48 0.34 Allowed Pre-proline 0 C--N 1.301 -1.515 0 O-C-N 121.434 -0.791 . . . . 0.0 110.255 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.4 Cg_endo -73.63 -20.9 19.81 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.977 1.514 . . . . 0.0 110.373 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -76.29 -14.7 60.1 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.323 -0.861 . . . . 0.0 109.965 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.568 ' HG3' ' CE2' ' A' ' 83' ' ' PHE . 3.0 mmtt -110.91 -155.75 0.57 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.404 -0.81 . . . . 0.0 109.837 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.2 m -106.63 149.57 27.08 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.263 -0.898 . . . . 0.0 110.224 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.975 HG11 HG22 ' A' ' 54' ' ' THR . 3.1 t -67.97 -40.93 84.15 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 O-C-N 121.172 -0.955 . . . . 0.0 109.503 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -52.72 -42.4 64.84 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.283 -0.886 . . . . 0.0 109.216 179.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 24.1 mm-40 -66.29 -35.39 80.27 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.518 -0.739 . . . . 0.0 109.308 179.049 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.928 HD13 ' HB3' ' A' ' 25' ' ' LEU . 55.6 mt -65.96 -36.31 82.98 Favored 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.367 -0.833 . . . . 0.0 109.081 179.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.533 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.7 OUTLIER -60.89 -47.49 86.17 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.356 179.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 50.2 t -58.82 -41.51 82.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.611 -0.68 . . . . 0.0 110.072 179.353 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.586 ' HB3' HG23 ' A' ' 82' ' ' VAL . . . -61.49 -30.47 70.63 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 120.99 -1.069 . . . . 0.0 109.155 179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.625 HD12 HD13 ' A' ' 87' ' ' ILE . 23.0 mm -86.34 -28.48 6.01 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 C-N-CA 119.766 -0.774 . . . . 0.0 109.111 178.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.715 ' HA ' HG21 ' A' ' 49' ' ' VAL . 15.7 t -78.87 -26.27 43.98 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.32 -0.862 . . . . 0.0 109.334 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.09 -38.91 20.19 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.492 -0.755 . . . . 0.0 109.133 179.396 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.85 HD23 ' CD1' ' A' ' 77' ' ' LEU . 2.7 tp -63.98 -36.5 84.17 Favored 'General case' 0 C--N 1.3 -1.544 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.582 ' CD2' HD13 ' A' ' 47' ' ' LEU . 12.1 m-85 -83.25 -21.85 33.23 Favored 'General case' 0 C--N 1.305 -1.368 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.563 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -81.33 -20.36 40.87 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.483 -0.76 . . . . 0.0 109.071 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.2 mmtt -104.18 -16.43 15.22 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.553 -0.717 . . . . 0.0 109.625 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.72 -29.63 23.77 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.31 -0.869 . . . . 0.0 109.895 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 34.6 t70 111.99 28.66 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -179.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.582 HD13 ' CD2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -101.08 -155.2 0.5 Allowed 'General case' 0 C--N 1.297 -1.684 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.699 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.891 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -169.1 64.21 0.06 Allowed 'General case' 0 C--N 1.296 -1.735 0 O-C-N 121.248 -0.908 . . . . 0.0 109.783 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.715 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.9 m -49.37 115.07 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 CA-C-O 121.895 0.855 . . . . 0.0 110.096 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.014 HG11 ' CG2' ' A' ' 16' ' ' THR . 10.6 t -82.83 -31.66 9.33 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 O-C-N 121.832 -0.543 . . . . 0.0 110.567 -179.609 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.516 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 20.9 t0 -149.5 148.97 30.03 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.05 -1.031 . . . . 0.0 110.785 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.752 HG22 HG13 ' A' ' 63' ' ' VAL . 3.5 t -154.2 94.12 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 121.505 -0.747 . . . . 0.0 109.276 179.597 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.541 ' CG ' ' HB3' ' A' ' 62' ' ' TYR . 10.7 ptp180 -108.95 170.21 8.19 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.762 -179.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.975 HG22 HG11 ' A' ' 31' ' ' VAL . 4.9 p -80.63 164.43 22.88 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 121.392 -0.818 . . . . 0.0 110.363 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 60' ' ' PHE . . . -134.58 124.0 3.35 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.496 HG22 ' OD1' ' A' ' 57' ' ' ASN . 25.3 m 44.12 95.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.209 -1.171 . . . . 0.0 110.495 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.496 ' OD1' HG22 ' A' ' 56' ' ' THR . 10.9 m120 60.75 -141.05 0.54 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.196 -0.94 . . . . 0.0 110.375 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.2 ptp180 -116.0 32.46 6.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.167 -0.958 . . . . 0.0 110.208 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.83 -20.67 11.52 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.242 -0.911 . . . . 0.0 110.195 179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.605 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.3 t80 -119.19 -171.15 2.05 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.285 -0.884 . . . . 0.0 110.24 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.482 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 175.88 154.93 12.04 Favored Glycine 0 N--CA 1.492 2.427 0 C-N-CA 119.812 -1.185 . . . . 0.0 110.505 -179.832 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.605 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -118.78 159.76 23.12 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.438 -1.036 . . . . 0.0 109.31 179.434 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.062 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.2 t -150.54 143.07 17.16 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.528 0 C-N-CA 119.189 -1.004 . . . . 0.0 110.862 -178.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -116.42 148.87 40.26 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.47 -0.769 . . . . 0.0 109.661 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.679 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 14.0 m-85 -110.72 177.9 4.53 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.308 -0.87 . . . . 0.0 110.296 -179.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.891 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -115.35 13.54 16.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.233 -0.917 . . . . 0.0 111.516 -178.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 5.4 p 179.17 175.42 0.66 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.958 -1.089 . . . . 0.0 112.135 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.52 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -78.54 -24.04 45.89 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 107.413 -1.328 . . . . 0.0 107.413 177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.52 -26.49 32.46 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.999 179.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.526 ' O ' ' CD2' ' A' ' 47' ' ' LEU . 4.0 t0 -80.7 -25.86 37.87 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 178.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.721 HD13 ' CD1' ' A' ' 18' ' ' PHE . 4.4 tt -80.19 -33.83 37.94 Favored 'General case' 0 C--N 1.304 -1.372 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.732 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -71.29 -33.74 70.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.6 -0.688 . . . . 0.0 109.518 179.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.523 ' HB2' HD21 ' A' ' 47' ' ' LEU . 1.6 mmtt -77.22 -27.92 53.59 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 178.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.679 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.53 -24.54 61.97 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.731 -0.84 . . . . 0.0 108.731 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 7.1 tt -74.11 -48.39 29.92 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.83 -10.85 60.4 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 178.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.85 ' CD1' HD23 ' A' ' 41' ' ' LEU . 0.2 OUTLIER -67.22 -2.47 5.91 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.58 -0.7 . . . . 0.0 110.489 179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.46 ' O ' ' OE1' ' A' ' 86' ' ' GLU . 12.0 m -45.16 -24.8 0.28 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.046 -1.034 . . . . 0.0 110.349 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 80' ' ' LEU . . . -63.32 -16.92 58.8 Favored Glycine 0 N--CA 1.492 2.395 0 N-CA-C 108.849 -1.7 . . . . 0.0 108.849 179.271 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.801 HD11 ' HG3' ' A' ' 86' ' ' GLU . 3.4 pp -45.07 175.56 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.622 -0.928 . . . . 0.0 111.345 -179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.511 ' HA ' ' CA ' ' A' ' 86' ' ' GLU . 2.7 mttt -177.16 57.05 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 CA-C-O 122.332 1.063 . . . . 0.0 109.362 -179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.808 HG22 HD23 ' A' ' 34' ' ' LEU . 1.7 p -37.98 123.76 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.427 0 CA-C-N 115.06 -0.973 . . . . 0.0 110.621 -179.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 4.4 m-85 42.42 26.28 0.06 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.219 -0.925 . . . . 0.0 110.483 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 90.11 23.84 31.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.674 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.9 m120 -135.41 84.43 2.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.17 -1.194 . . . . 0.0 110.01 179.746 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.801 ' HG3' HD11 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -37.77 92.5 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.729 0 CA-C-O 121.543 0.687 . . . . 0.0 110.744 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.776 ' CG1' HD13 ' A' ' 80' ' ' LEU . 4.9 pt -49.73 141.25 3.07 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.607 -0.683 . . . . 0.0 110.037 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.556 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 2.3 mmtm -107.57 155.9 19.6 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.502 -0.749 . . . . 0.0 109.082 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.574 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -120.25 172.76 7.56 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.13 -0.981 . . . . 0.0 110.573 -179.472 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.468 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -156.32 156.03 33.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.386 -0.821 . . . . 0.0 110.048 179.887 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.45 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 4.4 mtmp? -97.39 104.9 22.05 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.224 -0.923 . . . . 0.0 110.374 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.468 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.3 Cg_endo -73.65 -170.35 0.66 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.953 1.501 . . . . 0.0 110.371 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.7 mttt 53.2 -170.51 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.252 -0.905 . . . . 0.0 110.279 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 94.89 -65.83 1.37 Allowed Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 13.6 mtm-85 -71.49 109.04 5.2 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.253 -1.145 . . . . 0.0 110.244 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -143.16 103.99 4.22 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.245 -0.91 . . . . 0.0 110.125 179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 117.93 -60.07 0.47 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -129.67 -92.92 0.44 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.188 -1.184 . . . . 0.0 110.465 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.498 ' H ' HG23 ' A' ' 98' ' ' THR . 0.9 OUTLIER 177.48 170.39 0.61 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.194 -0.941 . . . . 0.0 110.193 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.474 ' O ' ' C ' ' A' ' 101' ' ' CYS . . . 66.79 145.85 0.07 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 -179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.474 ' C ' ' O ' ' A' ' 100' ' ' GLY . 14.5 p . . . . . 0 N--CA 1.497 1.896 0 CA-C-O 118.001 -0.999 . . . . 0.0 110.923 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.31 0 N-CA-C 109.575 -1.41 . . . . 0.0 109.575 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.2 p -156.47 69.6 0.63 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.191 -1.182 . . . . 0.0 110.131 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.5 m80 -99.67 -71.42 0.7 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.245 -0.91 . . . . 0.0 110.23 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 62.8 mtp 47.03 -158.7 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.31 -0.869 . . . . 0.0 110.186 -179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.2 mp -118.51 38.75 3.65 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.199 -0.938 . . . . 0.0 110.297 -179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 -60.37 107.54 0.68 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.269 -0.894 . . . . 0.0 110.222 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -139.26 148.43 56.97 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.32 -0.862 . . . . 0.0 110.275 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.92 80.41 1.51 Allowed 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 124.107 1.583 . . . . 0.0 110.41 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 9' ' ' VAL . 14.0 p -96.64 47.35 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 CA-C-O 121.249 0.547 . . . . 0.0 110.28 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -141.16 136.38 31.77 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.098 -1.001 . . . . 0.0 110.342 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 12' ' ' SER . . . -123.79 42.93 1.49 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.376 -1.49 . . . . 0.0 109.376 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.465 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 1.1 m 58.81 83.06 0.13 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -1.14 . . . . 0.0 110.185 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.418 ' O ' ' C ' ' A' ' 14' ' ' SER . 0.8 OUTLIER -95.77 28.96 2.83 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.305 -0.872 . . . . 0.0 110.293 -179.816 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.418 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -40.26 141.5 0.49 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-O 121.281 0.562 . . . . 0.0 110.293 179.998 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 1.027 HG23 HG23 ' A' ' 16' ' ' THR . 3.2 t -115.21 -19.99 10.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.161 -0.962 . . . . 0.0 110.267 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 1.027 HG23 HG23 ' A' ' 15' ' ' THR . 81.8 p -124.46 153.21 69.29 Favored Pre-proline 0 C--N 1.298 -1.664 0 O-C-N 121.581 -0.7 . . . . 0.0 110.716 -179.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.531 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.3 Cg_endo -80.06 -22.37 7.35 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.155 1.608 . . . . 0.0 110.538 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.7 m-85 -107.02 113.06 26.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.077 -1.014 . . . . 0.0 110.876 -179.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.456 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 3.4 m120 -139.06 150.76 46.13 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.528 -0.733 . . . . 0.0 109.404 179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.756 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -167.53 -179.63 4.47 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.326 -0.859 . . . . 0.0 110.198 -179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.646 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -109.24 154.95 21.7 Favored 'General case' 0 C--N 1.295 -1.767 0 C-N-CA 120.164 -0.614 . . . . 0.0 109.938 -179.597 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.67 HD12 ' CG2' ' A' ' 63' ' ' VAL . 3.7 mt -141.89 148.87 20.22 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 O-C-N 121.301 -0.875 . . . . 0.0 109.395 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.597 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -134.1 -169.29 12.0 Favored Glycine 0 N--CA 1.486 2.019 0 C-N-CA 119.379 -1.391 . . . . 0.0 110.109 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.7 t30 72.8 30.31 1.77 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.566 -0.961 . . . . 0.0 110.021 -179.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.99 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.8 mm? -82.26 128.65 34.39 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.372 -0.83 . . . . 0.0 110.116 179.788 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.745 ' H ' HD21 ' A' ' 34' ' ' LEU . 30.3 t-20 -40.07 100.27 0.21 Allowed Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.65 -0.656 . . . . 0.0 110.371 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.6 Cg_endo -74.18 -16.72 22.3 Favored 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 124.069 1.563 . . . . 0.0 110.455 -179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -83.87 -13.43 53.61 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.253 -0.904 . . . . 0.0 110.064 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -111.74 -156.86 0.6 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.322 -0.861 . . . . 0.0 109.913 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.8 m -104.15 152.06 22.58 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.54 -179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.023 HG11 HG22 ' A' ' 54' ' ' THR . 3.0 t -68.71 -28.38 39.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 O-C-N 121.245 -0.91 . . . . 0.0 109.454 179.525 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.515 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -62.25 -43.4 98.91 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 109.169 179.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.558 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 72.9 mm-40 -69.42 -31.1 69.23 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.52 -0.737 . . . . 0.0 109.266 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.99 HD13 ' HB3' ' A' ' 25' ' ' LEU . 6.5 mt -68.01 -33.88 75.45 Favored 'General case' 0 N--CA 1.486 1.363 0 O-C-N 121.357 -0.839 . . . . 0.0 109.124 179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.65 ' HE3' HG12 ' A' ' 31' ' ' VAL . 3.5 mtmt -66.08 -52.13 51.63 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.567 -0.708 . . . . 0.0 109.436 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.534 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 17.2 t -56.86 -39.71 66.56 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.551 -0.718 . . . . 0.0 110.059 179.332 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.781 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -61.91 -34.65 76.44 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.076 -1.015 . . . . 0.0 109.047 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.581 HD12 ' O ' ' A' ' 34' ' ' LEU . 10.5 mt -82.3 -28.23 9.06 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.527 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.255 178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.562 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -79.01 -27.36 43.25 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.312 -0.867 . . . . 0.0 109.379 179.507 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.534 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -83.81 -38.22 21.53 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.569 -0.707 . . . . 0.0 109.206 179.453 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.686 HD21 ' HG ' ' A' ' 80' ' ' LEU . 0.6 OUTLIER -65.63 -34.51 78.39 Favored 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 178.88 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.63 ' CZ ' HD23 ' A' ' 77' ' ' LEU . 8.0 m-85 -85.11 -20.41 30.37 Favored 'General case' 0 C--N 1.304 -1.395 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 178.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.562 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.89 -33.19 45.87 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.937 -0.705 . . . . 0.0 109.457 179.419 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.63 -23.28 25.75 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.476 -0.765 . . . . 0.0 109.604 179.433 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.8 OUTLIER -83.73 -20.53 33.26 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.352 -0.842 . . . . 0.0 109.903 179.827 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 11.4 m-20 89.44 28.95 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.74 0 CA-C-O 122.256 1.027 . . . . 0.0 108.326 -179.227 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.03 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -75.91 -143.71 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.771 0 N-CA-C 108.761 -0.829 . . . . 0.0 108.761 179.45 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.596 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -164.56 60.15 0.14 Allowed 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.023 -1.048 . . . . 0.0 110.262 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.495 HG13 ' CB ' ' A' ' 42' ' ' PHE . 16.9 m -66.58 116.59 6.03 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.57 0 CA-C-O 121.767 0.794 . . . . 0.0 109.859 179.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.909 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.4 t -99.26 -38.74 7.15 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 O-C-N 121.833 -0.542 . . . . 0.0 109.96 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.553 ' C ' HG23 ' A' ' 52' ' ' VAL . 15.2 t0 -143.51 154.53 43.73 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.226 -0.921 . . . . 0.0 110.447 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.0 HG22 HG13 ' A' ' 63' ' ' VAL . 20.5 t -154.74 105.99 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.357 -0.839 . . . . 0.0 109.747 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -111.03 167.98 9.84 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.062 -1.024 . . . . 0.0 110.494 -179.631 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 1.023 HG22 HG11 ' A' ' 31' ' ' VAL . 16.3 p -81.11 160.0 24.56 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.367 -0.833 . . . . 0.0 110.233 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.707 ' O ' HG22 ' A' ' 56' ' ' THR . . . -130.91 120.13 2.87 Favored Glycine 0 N--CA 1.489 2.205 0 N-CA-C 109.179 -1.569 . . . . 0.0 109.179 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.764 HG23 ' N ' ' A' ' 57' ' ' ASN . 0.4 OUTLIER 70.46 -166.81 0.16 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.26 -1.141 . . . . 0.0 110.108 -179.784 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.764 ' N ' HG23 ' A' ' 56' ' ' THR . 31.0 t-20 -42.99 -76.77 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.21 -0.931 . . . . 0.0 110.459 -179.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.572 ' HG3' HG22 ' A' ' 31' ' ' VAL . 10.7 ttp180 -162.41 28.37 0.11 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.188 -0.945 . . . . 0.0 110.217 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.508 ' CE ' ' HA ' ' A' ' 24' ' ' ASN . 19.3 tptm -117.03 -6.27 11.41 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.279 -0.888 . . . . 0.0 109.858 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.669 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.6 OUTLIER -121.84 -173.0 2.55 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.356 -0.84 . . . . 0.0 109.928 179.992 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.529 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 174.76 146.52 5.75 Favored Glycine 0 N--CA 1.494 2.538 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.661 -179.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.619 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 13.3 t80 -108.08 158.86 17.04 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.545 -0.974 . . . . 0.0 109.478 179.373 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.0 HG13 HG22 ' A' ' 52' ' ' VAL . 4.9 t -152.01 142.78 15.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.171 -0.955 . . . . 0.0 110.831 -178.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -112.24 143.76 42.78 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.433 -0.792 . . . . 0.0 109.308 179.367 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 12.6 m-85 -107.53 177.09 4.94 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.255 -0.903 . . . . 0.0 110.809 -179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.601 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -117.28 12.36 14.32 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.312 -0.868 . . . . 0.0 111.427 -178.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.2 p -173.0 173.99 3.59 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.048 -1.032 . . . . 0.0 112.107 179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.449 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.31 -23.86 43.23 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 177.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -83.67 -25.05 31.05 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.289 -0.869 . . . . 0.0 109.093 179.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.936 ' OD1' HD12 ' A' ' 47' ' ' LEU . 3.9 t0 -81.99 -27.35 33.21 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 178.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.57 HD12 ' HD2' ' A' ' 65' ' ' PHE . 1.0 OUTLIER -81.13 -33.74 33.0 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 109.085 -0.709 . . . . 0.0 109.085 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 70.4 tt0 -72.88 -32.56 65.48 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.717 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 1.03 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -78.16 -29.89 48.88 Favored 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 178.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.74 -31.79 72.97 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 178.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.626 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.9 tm? -72.11 -45.75 59.36 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.2 mm-40 -75.87 -19.4 58.89 Favored 'General case' 0 C--N 1.306 -1.306 0 C-N-CA 119.631 -0.828 . . . . 0.0 109.085 178.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -71.58 -4.0 24.6 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.582 -0.699 . . . . 0.0 109.977 179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.51 HG22 ' O ' ' A' ' 78' ' ' THR . 87.4 m -74.4 3.98 6.64 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.337 -0.852 . . . . 0.0 111.039 -179.577 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.84 -8.75 75.7 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 109.168 -1.573 . . . . 0.0 109.168 179.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.686 ' HG ' HD21 ' A' ' 41' ' ' LEU . 3.5 mm? -79.36 -164.21 0.6 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.361 -1.082 . . . . 0.0 110.817 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.592 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -149.26 50.55 0.96 Allowed 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.491 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.801 ' HB ' HG23 ' A' ' 87' ' ' ILE . 8.9 p 13.92 -132.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.467 0 CA-C-N 114.6 -1.182 . . . . 0.0 111.06 -179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.781 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -69.28 -3.36 13.56 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.448 -1.408 . . . . 0.0 109.919 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.441 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 152.05 36.89 0.03 OUTLIER Glycine 0 N--CA 1.49 2.251 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.768 ' O ' HG12 ' A' ' 82' ' ' VAL . 11.7 t-20 -170.45 116.83 0.51 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.437 -1.037 . . . . 0.0 109.346 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.592 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.3 OUTLIER -52.03 89.0 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.156 -0.965 . . . . 0.0 110.385 -179.317 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.801 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.4 135.08 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.857 -0.737 . . . . 0.0 109.629 179.605 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.527 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 26.5 mttt -103.88 170.95 7.62 Favored 'General case' 0 C--N 1.298 -1.66 0 O-C-N 121.458 -0.776 . . . . 0.0 109.704 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.601 HD23 HD22 ' A' ' 20' ' ' LEU . 4.9 mp -122.91 -175.28 3.13 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.307 -0.871 . . . . 0.0 110.492 -179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.498 ' CB ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -165.34 141.89 5.57 Favored 'General case' 0 C--N 1.297 -1.691 0 O-C-N 121.696 -0.627 . . . . 0.0 110.242 179.973 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -101.1 100.62 13.62 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.195 -0.941 . . . . 0.0 110.124 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.0 Cg_endo -72.84 -174.23 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.982 1.517 . . . . 0.0 110.455 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.98 22.53 2.26 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.338 -0.851 . . . . 0.0 110.252 179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 53.96 26.5 34.36 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.542 -1.423 . . . . 0.0 109.542 179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 29.2 mmt180 -129.87 51.93 2.04 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.327 -1.102 . . . . 0.0 110.258 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 58.45 160.86 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.254 -0.904 . . . . 0.0 110.159 179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -89.54 -69.03 1.24 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.578 -1.409 . . . . 0.0 109.578 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 3.0 p -93.19 176.64 6.33 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.206 -1.173 . . . . 0.0 110.268 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 3.9 ttt-85 -124.13 160.42 27.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.222 -0.924 . . . . 0.0 110.171 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -54.87 -65.39 3.57 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.491 1.595 0 O-C-N 121.203 -1.175 . . . . 0.0 110.219 -179.959 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.4 t -135.57 114.58 12.18 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 110.253 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 11.2 p80 -138.72 51.85 1.81 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.315 -0.865 . . . . 0.0 110.177 -179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.495 ' O ' ' N ' ' A' ' 6' ' ' GLU . 19.7 ptm -126.69 -162.27 1.13 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.221 -0.925 . . . . 0.0 110.259 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.511 ' HA ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 66.13 -64.09 0.22 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.495 ' N ' ' O ' ' A' ' 4' ' ' MET . 0.5 OUTLIER -143.04 -172.44 3.67 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.214 -0.929 . . . . 0.0 110.272 179.986 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.422 ' HB2' ' HD2' ' A' ' 8' ' ' PRO . 22.9 p30 -119.91 163.51 27.44 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.212 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 7' ' ' ASP . 49.1 Cg_endo -71.52 -157.01 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.973 1.512 . . . . 0.0 110.065 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 8.4 p -167.92 141.49 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 O-C-N 121.791 -0.568 . . . . 0.0 110.218 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -59.77 -159.54 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 0.0 110.236 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' A' ' 12' ' ' SER . . . -97.76 -82.21 1.64 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.453 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 3.8 m 56.8 85.28 0.08 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -1.139 . . . . 0.0 110.216 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -108.72 27.96 8.9 Favored 'General case' 0 C--N 1.304 -1.404 0 O-C-N 121.265 -0.897 . . . . 0.0 110.243 -179.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.11 167.52 6.38 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-O 121.171 0.51 . . . . 0.0 110.206 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.837 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m -77.35 -6.46 53.36 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.072 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.911 HG21 ' HB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER 179.15 162.37 0.73 Allowed Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.242 -0.911 . . . . 0.0 110.563 -179.861 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.42 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.43 -36.63 0.88 Allowed 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.27 1.669 . . . . 0.0 110.832 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 95.6 m-85 -106.49 112.77 25.93 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.113 -0.992 . . . . 0.0 110.987 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.473 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 1.9 m120 -136.04 144.87 45.48 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.374 -0.829 . . . . 0.0 109.278 179.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.741 ' C ' HD12 ' A' ' 20' ' ' LEU . 2.9 pp -155.52 -176.08 5.76 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.105 -0.997 . . . . 0.0 110.639 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.485 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 52.9 t80 -110.64 159.35 17.65 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.392 -0.817 . . . . 0.0 110.016 179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.599 HG22 HD21 ' A' ' 25' ' ' LEU . 24.9 mt -137.6 159.06 34.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.378 -0.826 . . . . 0.0 109.793 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.512 ' O ' ' HA ' ' A' ' 87' ' ' ILE . . . -147.44 176.77 26.12 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.677 -1.369 . . . . 0.0 109.677 -179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.457 ' HB2' ' HG3' ' A' ' 88' ' ' LYS . 2.8 t30 62.62 57.73 1.76 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.267 -1.137 . . . . 0.0 110.245 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.905 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.2 mm? -90.32 -90.47 0.15 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 110.132 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.782 ' CB ' HD21 ' A' ' 34' ' ' LEU . 37.2 t-20 -179.15 92.01 0.21 Allowed Pre-proline 0 N--CA 1.49 1.554 0 O-C-N 121.225 -0.922 . . . . 0.0 109.931 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -72.27 -13.86 28.27 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 123.966 1.508 . . . . 0.0 110.441 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -82.49 -14.36 55.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.21 -0.931 . . . . 0.0 109.973 179.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.46 ' HB2' ' OD1' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -116.57 -156.44 0.62 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.349 -0.844 . . . . 0.0 109.882 179.815 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.456 ' HB2' ' HG2' ' A' ' 33' ' ' GLU . 2.1 m -99.57 147.98 24.78 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.247 -0.908 . . . . 0.0 110.333 179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.73 HG12 HG22 ' A' ' 54' ' ' THR . 21.9 t -68.92 -27.58 36.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.556 0 O-C-N 121.233 -0.917 . . . . 0.0 109.435 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.538 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.55 -40.8 89.23 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.332 -0.855 . . . . 0.0 109.067 179.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.456 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 43.0 mm-40 -67.59 -33.0 74.13 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.499 -0.75 . . . . 0.0 109.325 179.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.905 HD13 ' HB3' ' A' ' 25' ' ' LEU . 20.2 mt -66.01 -37.85 86.97 Favored 'General case' 0 C--N 1.306 -1.311 0 O-C-N 121.417 -0.802 . . . . 0.0 109.017 179.229 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.422 ' CG ' ' HB ' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -60.83 -50.16 74.57 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 179.01 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 32' ' ' ALA . 10.5 t -60.83 -35.12 62.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.526 -0.734 . . . . 0.0 109.247 178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.714 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -59.68 -31.98 70.07 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 179.164 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.849 ' CD1' HD13 ' A' ' 87' ' ' ILE . 29.1 mm -80.71 -31.78 12.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.41 0 O-C-N 121.616 -0.677 . . . . 0.0 109.367 178.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.689 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.5 OUTLIER -78.55 -23.59 46.08 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.149 -0.97 . . . . 0.0 108.914 179.268 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.81 -38.38 18.22 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.448 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.939 HD21 ' HB3' ' A' ' 80' ' ' LEU . 6.3 tp -66.7 -32.98 74.64 Favored 'General case' 0 C--N 1.302 -1.479 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.617 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 10.4 m-85 -87.72 -20.75 25.8 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.689 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -80.98 -29.16 35.35 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.492 -0.755 . . . . 0.0 109.211 179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HG3' ' OE1' ' A' ' 40' ' ' GLU . 17.2 mttt -87.34 -17.72 31.75 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.561 -0.712 . . . . 0.0 109.387 179.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.627 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.2 m-80 -92.27 -20.34 21.24 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.497 -0.752 . . . . 0.0 109.925 179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.627 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.2 t0 90.21 29.71 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.093 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.939 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -74.8 -137.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.449 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.76 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -173.63 58.34 0.02 OUTLIER 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.188 -0.945 . . . . 0.0 109.604 179.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.553 ' CG1' ' CD2' ' A' ' 42' ' ' PHE . 12.8 m -58.42 117.51 1.78 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 CA-C-O 121.942 0.877 . . . . 0.0 110.141 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.911 ' HB ' HG21 ' A' ' 16' ' ' THR . 1.9 t -96.64 -33.54 4.6 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.869 0 O-C-N 121.909 -0.494 . . . . 0.0 109.866 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.536 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 6.9 t70 -144.27 149.34 36.13 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.067 -1.02 . . . . 0.0 110.884 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.6 HG12 HG23 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -138.16 150.66 24.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.609 -0.682 . . . . 0.0 109.776 179.936 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.491 ' HB2' ' HB3' ' A' ' 62' ' ' TYR . 0.2 OUTLIER -154.96 164.26 39.14 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.198 -0.938 . . . . 0.0 110.405 179.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.73 HG22 HG12 ' A' ' 31' ' ' VAL . 63.0 p -94.86 167.13 11.61 Favored 'General case' 0 C--N 1.303 -1.431 0 O-C-N 121.384 -0.822 . . . . 0.0 110.571 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.516 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -126.5 117.33 2.77 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.647 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.1 m 55.43 -161.51 0.17 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.287 -1.125 . . . . 0.0 110.209 179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.647 ' H ' HG22 ' A' ' 56' ' ' THR . 35.9 m120 -42.43 -77.67 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.569 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 2.3 ptp180 -162.93 49.17 0.16 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.279 -0.888 . . . . 0.0 110.327 -179.989 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.7 mttt -124.5 -23.13 4.49 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.231 -0.918 . . . . 0.0 110.398 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.516 ' O ' ' N ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER -128.14 -179.8 5.19 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.183 -0.948 . . . . 0.0 109.611 179.838 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.493 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -163.87 164.59 36.52 Favored Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.543 -1.313 . . . . 0.0 110.398 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.56 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 2.6 t80 -120.74 166.27 13.96 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.539 -0.977 . . . . 0.0 109.291 179.531 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.606 HG12 HD11 ' A' ' 20' ' ' LEU . 0.3 OUTLIER -165.48 168.52 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.571 0 O-C-N 120.818 -1.176 . . . . 0.0 111.543 -179.592 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.536 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 76.5 m-20 -137.13 142.4 42.26 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 179.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.772 ' CE2' ' HB2' ' A' ' 74' ' ' ALA . 28.2 m-85 -104.6 -178.43 3.65 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.732 -0.605 . . . . 0.0 110.721 -179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.579 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.69 17.99 13.48 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.35 -0.844 . . . . 0.0 111.05 -179.082 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 18.9 p 177.95 176.63 0.43 Allowed 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 122.463 1.125 . . . . 0.0 112.135 179.801 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.99 -24.26 55.32 Favored 'General case' 0 C--N 1.297 -1.685 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 177.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -77.93 -28.6 49.68 Favored 'General case' 0 C--N 1.296 -1.719 0 CA-C-N 115.107 -0.951 . . . . 0.0 109.363 179.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.76 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 88.3 m-20 -79.22 -28.02 42.51 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 177.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 18.6 tp -76.54 -36.88 57.43 Favored 'General case' 0 C--N 1.305 -1.353 0 C-N-CA 119.861 -0.736 . . . . 0.0 109.064 178.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -68.65 -32.78 72.86 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.419 -0.801 . . . . 0.0 109.576 179.329 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.939 ' HB2' HD21 ' A' ' 47' ' ' LEU . 5.3 mmtp -76.8 -29.4 55.98 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 178.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.772 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -64.83 -29.94 70.92 Favored 'General case' 0 C--N 1.304 -1.376 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 178.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.483 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -73.1 -44.03 60.96 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 178.548 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -72.14 -7.2 47.75 Favored 'General case' 0 N--CA 1.485 1.289 0 O-C-N 121.501 -0.75 . . . . 0.0 109.404 178.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.81 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -73.07 4.93 3.77 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.357 -0.839 . . . . 0.0 110.63 179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.542 HG22 ' O ' ' A' ' 78' ' ' THR . 89.5 m -78.13 6.95 6.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.006 -1.059 . . . . 0.0 110.541 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.437 ' C ' ' OE1' ' A' ' 86' ' ' GLU . . . -118.32 19.55 10.74 Favored Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.585 -1.406 . . . . 0.0 109.585 179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.939 ' HB3' HD21 ' A' ' 41' ' ' LEU . 2.8 mt -124.61 122.57 37.93 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.141 -1.211 . . . . 0.0 111.395 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.529 ' O ' ' O ' ' A' ' 82' ' ' VAL . 2.7 mttm -92.69 89.24 6.58 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 122.372 1.082 . . . . 0.0 108.517 178.182 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.989 HG21 HG23 ' A' ' 87' ' ' ILE . 3.0 m -36.93 -104.69 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.271 -2.83 0 CA-C-N 114.502 -1.226 . . . . 0.0 111.542 -179.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.714 ' CD1' ' HB2' ' A' ' 37' ' ' ALA . 0.1 OUTLIER -82.43 20.08 1.14 Allowed 'General case' 0 C--N 1.292 -1.93 0 O-C-N 121.063 -1.023 . . . . 0.0 110.647 -179.441 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.458 ' C ' ' ND2' ' A' ' 85' ' ' ASN . . . 122.71 10.33 5.94 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.677 ' O ' HG22 ' A' ' 82' ' ' VAL . 1.5 m-80 -145.25 117.45 8.39 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.236 -1.155 . . . . 0.0 109.726 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.503 ' OE2' ' N ' ' A' ' 80' ' ' LEU . 7.4 tp10 -56.68 83.56 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.454 0 O-C-N 121.419 -0.8 . . . . 0.0 109.982 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.989 HG23 HG21 ' A' ' 82' ' ' VAL . 1.7 pt -43.57 126.82 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.432 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.5 OUTLIER -102.22 131.86 48.5 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.515 -0.74 . . . . 0.0 109.746 179.715 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.485 ' HA ' ' O ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -108.44 173.07 6.48 Favored 'General case' 0 C--N 1.298 -1.652 0 O-C-N 120.926 -1.108 . . . . 0.0 110.531 -179.867 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 3.8 mt-10 -166.94 174.15 8.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.378 -0.826 . . . . 0.0 110.138 179.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.7 ttpt -100.41 102.53 18.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.196 -0.94 . . . . 0.0 110.088 179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' CG ' ' OH ' ' A' ' 62' ' ' TYR . 48.2 Cg_endo -74.57 169.33 22.77 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.023 1.539 . . . . 0.0 110.383 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.521 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 166.66 -78.26 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.548 -0.72 . . . . 0.0 110.05 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -174.34 40.2 0.13 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.4 ' O ' ' C ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER 52.63 -172.17 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 0.0 110.154 -179.96 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.4 ' C ' ' O ' ' A' ' 95' ' ' ARG . 0.5 OUTLIER 42.56 85.02 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.32 -0.862 . . . . 0.0 110.251 179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -175.08 68.63 0.09 OUTLIER Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.444 ' O ' ' HB2' ' A' ' 99' ' ' ARG . 2.7 p -112.23 -33.63 6.16 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.242 -1.152 . . . . 0.0 110.204 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 98' ' ' THR . 0.0 OUTLIER 178.06 110.36 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.275 -0.89 . . . . 0.0 110.164 179.997 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 139.79 128.66 2.52 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 2.0 t . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.255 -1.144 . . . . 0.0 110.246 -179.996 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.281 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.416 ' O ' ' CB ' ' A' ' 3' ' ' HIS . 10.3 t -93.75 23.3 4.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.229 -1.16 . . . . 0.0 110.146 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.46 ' O ' ' O ' ' A' ' 4' ' ' MET . 5.1 t-160 64.73 -156.18 0.3 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.204 -0.935 . . . . 0.0 110.142 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.46 ' O ' ' O ' ' A' ' 3' ' ' HIS . 32.0 mtm 53.25 170.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.29 -0.881 . . . . 0.0 110.225 -179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.453 ' HA ' HD13 ' A' ' 5' ' ' LEU . 0.2 OUTLIER -122.63 -34.1 3.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.263 -0.898 . . . . 0.0 110.187 -179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.448 ' O ' ' CB ' ' A' ' 7' ' ' ASP . 1.5 mt-10 -178.64 -164.53 0.08 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.192 -0.943 . . . . 0.0 110.23 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.562 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.0 OUTLIER 172.89 -59.3 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.254 -0.903 . . . . 0.0 110.142 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.562 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 43.6 Cg_endo -71.03 80.98 1.19 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.01 1.531 . . . . 0.0 110.29 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.551 HG23 ' N ' ' A' ' 10' ' ' GLU . 4.0 m -64.61 -151.32 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.295 -1.781 0 CA-C-O 121.611 0.72 . . . . 0.0 110.331 179.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.551 ' N ' HG23 ' A' ' 9' ' ' VAL . 10.6 pt-20 -132.03 -153.66 0.57 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.579 -0.701 . . . . 0.0 110.294 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.447 ' O ' ' OG ' ' A' ' 12' ' ' SER . . . -91.74 48.33 2.79 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.791 -1.323 . . . . 0.0 109.791 -179.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 11' ' ' GLY . 2.6 m -176.1 -98.46 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.185 -1.186 . . . . 0.0 109.936 179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 12' ' ' SER . 0.2 OUTLIER 173.69 31.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.086 -1.009 . . . . 0.0 110.517 -179.87 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.673 ' O ' HG22 ' A' ' 15' ' ' THR . 15.2 m -61.89 -115.89 0.0 OUTLIER 'General case' 0 C--N 1.289 -2.029 0 O-C-N 121.895 -0.503 . . . . 0.0 110.39 179.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.673 HG22 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER 80.59 -7.31 1.6 Allowed 'General case' 0 N--CA 1.5 2.072 0 CA-C-O 121.326 0.584 . . . . 0.0 109.917 -179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.972 ' CG2' HG11 ' A' ' 50' ' ' VAL . 45.9 p -130.24 153.4 81.2 Favored Pre-proline 0 N--CA 1.491 1.576 0 O-C-N 121.393 -0.817 . . . . 0.0 110.309 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_endo -80.56 -22.08 6.91 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.127 1.593 . . . . 0.0 110.742 -179.682 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.545 ' CE2' ' C ' ' A' ' 67' ' ' SER . 75.3 m-85 -113.57 108.78 17.62 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.975 -1.078 . . . . 0.0 111.027 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.517 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.1 m120 -137.91 149.0 45.83 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.513 -0.742 . . . . 0.0 109.041 179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.706 HD21 HD11 ' A' ' 22' ' ' ILE . 0.8 OUTLIER -164.27 171.61 14.66 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.168 -0.958 . . . . 0.0 110.261 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.651 ' C ' HD12 ' A' ' 22' ' ' ILE . 0.2 OUTLIER -89.99 160.14 16.53 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.47 -0.769 . . . . 0.0 109.207 -179.872 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.778 HD13 HG23 ' A' ' 63' ' ' VAL . 1.6 mp -147.61 161.92 7.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 O-C-N 120.975 -1.078 . . . . 0.0 109.673 -179.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.582 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -160.28 -160.07 10.32 Favored Glycine 0 N--CA 1.486 2.016 0 C-N-CA 119.477 -1.344 . . . . 0.0 110.084 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.49 ' HB3' ' HA ' ' A' ' 87' ' ' ILE . 2.3 t30 67.16 55.09 0.7 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.415 -1.05 . . . . 0.0 110.141 -179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.648 ' HB3' HD22 ' A' ' 34' ' ' LEU . 3.7 mt -104.12 -133.67 0.32 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.321 -0.862 . . . . 0.0 110.066 -179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.435 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 36.4 t-20 -143.0 109.78 5.49 Favored Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.111 -0.993 . . . . 0.0 110.235 -179.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.59 2.66 6.14 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 123.993 1.522 . . . . 0.0 110.698 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.435 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 34.7 m-80 -113.59 18.3 17.67 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.15 -0.968 . . . . 0.0 109.169 179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.6 ' HG2' ' CE1' ' A' ' 83' ' ' PHE . 2.0 tptt -138.64 -158.34 0.85 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.717 -0.614 . . . . 0.0 109.771 -179.66 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.53 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -107.29 142.59 36.83 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.21 -0.931 . . . . 0.0 109.735 179.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.778 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.6 t -69.29 -32.07 52.14 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 C-N-CA 119.052 -1.059 . . . . 0.0 109.386 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.551 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -62.83 -27.81 69.58 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.313 -0.867 . . . . 0.0 109.003 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.599 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 11.3 mm-40 -77.59 -42.3 35.6 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.553 -0.717 . . . . 0.0 109.537 179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.716 HD12 ' HA ' ' A' ' 31' ' ' VAL . 3.8 mt -61.89 -37.93 86.43 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.259 -0.901 . . . . 0.0 109.092 179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.744 ' HG3' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -63.17 -52.07 63.85 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 120.091 -0.644 . . . . 0.0 109.618 179.67 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 32' ' ' ALA . 48.7 t -63.41 -28.14 44.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.333 -0.855 . . . . 0.0 109.252 179.071 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.52 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.43 -34.14 77.5 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.225 -0.922 . . . . 0.0 108.587 179.287 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.655 HD11 HG21 ' A' ' 87' ' ' ILE . 6.5 mt -83.89 -25.48 7.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.589 ' HA ' HG21 ' A' ' 49' ' ' VAL . 13.1 m -80.3 -28.86 38.18 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.498 -0.881 . . . . 0.0 109.145 179.24 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.513 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 0.6 OUTLIER -82.43 -37.34 25.62 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.533 -0.73 . . . . 0.0 109.238 179.396 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.646 HD23 ' CD2' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -70.23 -30.44 67.51 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.555 -0.716 . . . . 0.0 109.18 179.237 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.844 ' CE1' HD22 ' A' ' 77' ' ' LEU . 3.2 m-85 -91.99 -14.63 29.13 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.388 -0.82 . . . . 0.0 109.363 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -92.19 -28.57 16.96 Favored 'General case' 0 C--N 1.301 -1.528 0 O-C-N 121.113 -0.992 . . . . 0.0 109.697 179.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.513 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -91.51 -21.23 21.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.41 -0.806 . . . . 0.0 109.089 179.302 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.609 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -79.25 -60.01 2.54 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.569 -0.707 . . . . 0.0 109.388 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.609 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 147.37 31.48 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.994 0 CA-C-O 121.186 0.517 . . . . 0.0 109.802 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.885 HD21 ' HB3' ' A' ' 73' ' ' LYS . 3.8 mm? -98.35 -157.72 0.62 Allowed 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.2 -0.938 . . . . 0.0 109.677 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.558 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -156.93 63.82 0.51 Allowed 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.272 -0.893 . . . . 0.0 110.122 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.589 HG21 ' HA ' ' A' ' 39' ' ' SER . 12.7 m -58.28 117.66 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.929 0.871 . . . . 0.0 109.789 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.972 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -90.31 -44.26 14.78 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 O-C-N 121.735 -0.603 . . . . 0.0 110.188 -179.489 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.501 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 34.3 t0 -141.04 152.74 45.1 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.07 -1.019 . . . . 0.0 110.829 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.809 HG22 HG13 ' A' ' 63' ' ' VAL . 2.8 t -152.36 105.25 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.38 -0.825 . . . . 0.0 109.44 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.3 167.45 10.01 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.181 -0.949 . . . . 0.0 110.409 -179.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.778 HG22 ' CG1' ' A' ' 31' ' ' VAL . 47.3 p -85.16 163.65 18.6 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.4 -0.812 . . . . 0.0 110.416 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.497 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -137.76 137.32 8.79 Favored Glycine 0 N--CA 1.488 2.136 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.553 HG22 ' N ' ' A' ' 57' ' ' ASN . 28.8 m 60.36 176.43 0.09 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.304 -1.115 . . . . 0.0 109.961 -179.627 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.553 ' N ' HG22 ' A' ' 56' ' ' THR . 20.0 m120 -40.98 -59.68 1.39 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.317 -0.864 . . . . 0.0 110.581 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -168.08 35.25 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.157 -0.965 . . . . 0.0 110.193 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.623 ' C ' HD12 ' A' ' 25' ' ' LEU . 12.0 tttt -127.14 -11.04 5.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.204 -0.935 . . . . 0.0 110.448 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.582 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.3 t80 -122.18 179.41 4.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.18 -0.95 . . . . 0.0 110.26 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.64 163.79 31.33 Favored Glycine 0 N--CA 1.493 2.48 0 N-CA-C 110.252 -1.139 . . . . 0.0 110.252 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.604 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 11.5 t80 -126.25 157.24 38.81 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.467 -1.019 . . . . 0.0 109.727 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.809 HG13 HG22 ' A' ' 52' ' ' VAL . 4.2 t -151.72 145.2 16.14 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 C-N-CA 119.403 -0.919 . . . . 0.0 110.813 -178.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.506 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -116.35 144.01 44.81 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.405 -0.81 . . . . 0.0 109.705 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.838 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 19.6 m-85 -107.05 176.71 5.08 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.215 -0.928 . . . . 0.0 110.571 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.622 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -112.28 13.62 20.42 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.249 -0.907 . . . . 0.0 111.609 -178.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 25.0 p 177.66 178.16 0.33 Allowed 'General case' 0 N--CA 1.494 1.773 0 CA-C-O 122.401 1.096 . . . . 0.0 112.1 179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.68 -22.65 53.69 Favored 'General case' 0 C--N 1.298 -1.666 0 N-CA-C 107.405 -1.332 . . . . 0.0 107.405 177.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.455 ' OE2' ' HE2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.59 -25.84 38.23 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 115.095 -0.957 . . . . 0.0 109.493 -179.849 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.759 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 85.4 m-20 -83.3 -27.81 29.54 Favored 'General case' 0 C--N 1.307 -1.267 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.777 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.0 tm? -78.7 -34.06 46.37 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 120.024 -0.67 . . . . 0.0 109.772 179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -75.03 -38.51 61.47 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.343 -0.848 . . . . 0.0 109.804 179.595 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.885 ' HB3' HD21 ' A' ' 47' ' ' LEU . 14.7 mtmt -79.55 -18.21 52.3 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 178.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.838 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -79.26 -28.1 42.38 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-O 121.583 0.706 . . . . 0.0 109.379 179.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.45 HD23 ' C ' ' A' ' 75' ' ' LEU . 5.6 tt -79.12 -44.32 22.27 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.435 -0.791 . . . . 0.0 109.105 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.401 ' N ' HD23 ' A' ' 75' ' ' LEU . 2.0 mt-10 -71.34 -24.26 62.07 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.308 -0.87 . . . . 0.0 109.29 179.135 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.884 HD12 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -64.45 -15.05 60.01 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.625 -0.672 . . . . 0.0 109.972 179.712 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.436 ' C ' ' O ' ' A' ' 77' ' ' LEU . 0.7 OUTLIER -37.93 -28.11 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.878 0.847 . . . . 0.0 110.891 -179.668 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.522 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -51.73 -26.17 16.62 Favored Glycine 0 C--N 1.286 -2.231 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.723 HD21 HD11 ' A' ' 87' ' ' ILE . 1.6 pt? -65.52 131.91 47.59 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.194 -1.18 . . . . 0.0 110.896 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 3.5 mttm -109.9 80.76 1.35 Allowed 'General case' 0 C--N 1.3 -1.544 0 CA-C-O 122.08 0.943 . . . . 0.0 109.964 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -39.71 122.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.275 -2.656 0 CA-C-N 115.33 -0.85 . . . . 0.0 109.421 179.86 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.6 ' CE1' ' HG2' ' A' ' 29' ' ' LYS . 7.9 m-85 43.33 24.48 0.05 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.252 -0.905 . . . . 0.0 110.654 -179.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 93.38 19.16 36.31 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.56 ' O ' HG12 ' A' ' 82' ' ' VAL . 1.3 m-80 -133.31 91.7 2.9 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.245 -1.15 . . . . 0.0 110.173 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.55 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 9.2 tt0 -41.1 91.86 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.424 -0.798 . . . . 0.0 110.733 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -47.64 141.33 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 C-N-CA 119.748 -0.781 . . . . 0.0 109.771 179.699 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.518 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.1 OUTLIER -116.32 157.89 24.28 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.567 -0.708 . . . . 0.0 109.975 -179.942 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.584 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -125.86 174.68 8.2 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.163 -179.66 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -173.87 113.87 0.2 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.384 -0.822 . . . . 0.0 110.166 179.799 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.1 tmtm? -55.2 121.19 35.22 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.198 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.507 ' HD3' ' HA ' ' A' ' 20' ' ' LEU . 45.2 Cg_endo -73.47 -179.94 4.94 Favored 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.961 1.506 . . . . 0.0 110.286 179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HB2' ' O ' ' A' ' 92' ' ' PRO . 0.5 OUTLIER 177.23 31.71 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.414 -0.804 . . . . 0.0 110.254 -179.992 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 95' ' ' ARG . . . -60.88 -28.79 69.07 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.424 ' C ' ' O ' ' A' ' 94' ' ' GLY . 5.1 mtp180 41.94 42.59 2.34 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.337 -1.096 . . . . 0.0 110.339 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -77.49 160.0 28.96 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.223 -0.923 . . . . 0.0 110.28 -179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -75.36 138.53 23.46 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 -179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -172.72 165.85 5.37 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.26 -1.141 . . . . 0.0 110.407 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -79.34 -85.4 0.08 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.238 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 46.85 -134.27 11.47 Favored Glycine 0 N--CA 1.49 2.265 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.665 0 O-C-N 121.268 -1.136 . . . . 0.0 110.177 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.569 -1.412 . . . . 0.0 109.569 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -116.47 175.23 5.65 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -1.186 . . . . 0.0 110.188 179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.3 m170 46.97 64.18 1.65 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.214 179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 7.7 ttm -104.51 -40.78 5.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.222 -0.924 . . . . 0.0 110.233 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.552 HD13 ' HB3' ' A' ' 8' ' ' PRO . 2.0 mt -142.87 -169.77 3.09 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.224 -0.923 . . . . 0.0 110.211 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.4 ' C ' ' HD3' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -157.3 117.56 3.49 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.213 -0.929 . . . . 0.0 110.245 -179.965 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.54 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 23.1 t70 44.64 49.49 5.9 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.284 -0.885 . . . . 0.0 110.233 -179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.552 ' HB3' HD13 ' A' ' 5' ' ' LEU . 49.7 Cg_endo -71.51 -157.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.026 1.54 . . . . 0.0 110.158 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.67 HG13 ' O ' ' A' ' 9' ' ' VAL . 9.3 p -140.57 77.19 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 CA-C-O 121.242 0.544 . . . . 0.0 110.144 179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.473 ' OE2' ' HB2' ' A' ' 13' ' ' GLU . 0.0 OUTLIER 64.55 149.79 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.291 -0.881 . . . . 0.0 110.234 -179.974 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -143.96 58.99 0.52 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.598 -1.401 . . . . 0.0 109.598 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m 62.41 77.53 0.33 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.287 -1.125 . . . . 0.0 110.145 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.473 ' HB2' ' OE2' ' A' ' 10' ' ' GLU . 1.3 mt-10 -91.65 28.44 1.76 Allowed 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.25 -0.906 . . . . 0.0 110.271 -179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.563 ' CB ' ' ND2' ' A' ' 19' ' ' ASN . 0.5 OUTLIER -41.19 164.07 0.01 OUTLIER 'General case' 0 C--N 1.291 -1.944 0 CA-C-O 121.36 0.6 . . . . 0.0 110.199 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 1.015 HG23 HG23 ' A' ' 16' ' ' THR . 5.3 t -75.82 -22.44 56.3 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.354 -0.842 . . . . 0.0 110.173 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 1.015 HG23 HG23 ' A' ' 15' ' ' THR . 32.0 p -119.64 163.29 28.19 Favored Pre-proline 0 C--N 1.299 -1.628 0 O-C-N 121.579 -0.7 . . . . 0.0 110.417 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.5 Cg_endo -74.67 -27.65 10.49 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.015 1.534 . . . . 0.0 110.661 -179.759 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.54 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 97.7 m-85 -102.63 112.52 25.32 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.122 -0.987 . . . . 0.0 110.374 -179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.563 ' ND2' ' CB ' ' A' ' 14' ' ' SER . 3.7 m120 -143.05 151.97 41.37 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.312 -0.867 . . . . 0.0 109.748 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.749 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.0 pp -161.3 -176.41 5.39 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.254 -0.904 . . . . 0.0 110.408 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.544 ' CD1' ' N ' ' A' ' 22' ' ' ILE . 16.3 t80 -108.75 161.5 15.04 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.342 -0.849 . . . . 0.0 110.431 -179.807 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.897 HD12 HG21 ' A' ' 63' ' ' VAL . 5.1 mt -140.19 159.08 25.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.314 -0.866 . . . . 0.0 109.808 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' A' ' 88' ' ' LYS . . . -143.5 170.82 25.45 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.679 -1.368 . . . . 0.0 109.679 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.659 ' C ' HD22 ' A' ' 25' ' ' LEU . 28.2 t30 67.81 71.76 0.33 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -1.118 . . . . 0.0 109.944 -179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.773 HD13 HD12 ' A' ' 34' ' ' LEU . 4.2 mm? -106.15 19.68 20.15 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.332 -0.855 . . . . 0.0 110.352 -179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.483 ' ND2' ' O ' ' A' ' 83' ' ' PHE . 2.8 t30 55.94 99.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.282 -0.886 . . . . 0.0 110.249 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 47.2 Cg_endo -73.39 -19.57 21.92 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.02 1.537 . . . . 0.0 110.289 179.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -77.2 -19.83 56.19 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.232 -0.917 . . . . 0.0 110.111 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' HG3' ' HB3' ' A' ' 83' ' ' PHE . 5.6 tmtt? -98.54 -154.29 0.46 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.417 -0.802 . . . . 0.0 109.855 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.724 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -113.56 139.56 48.89 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.354 -0.841 . . . . 0.0 110.384 179.814 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.897 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.6 t -67.98 -29.64 45.49 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 C-N-CA 119.074 -1.05 . . . . 0.0 109.003 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.502 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.45 -37.35 87.21 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.582 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 69.3 mm-40 -70.68 -27.53 64.08 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 178.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.773 HD12 HD13 ' A' ' 25' ' ' LEU . 3.2 mm? -64.43 -42.58 95.94 Favored 'General case' 0 C--N 1.307 -1.281 0 O-C-N 121.404 -0.81 . . . . 0.0 109.106 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.829 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -64.89 -54.65 27.55 Favored 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.981 -0.687 . . . . 0.0 109.8 179.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 32' ' ' ALA . 4.9 t -62.66 -30.21 48.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.314 -0.866 . . . . 0.0 109.373 179.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.747 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -65.97 -40.01 90.9 Favored 'General case' 0 C--N 1.304 -1.41 0 C-N-CA 119.415 -0.914 . . . . 0.0 108.758 179.434 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 34' ' ' LEU . 10.8 mm -78.58 -24.24 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 119.69 -0.804 . . . . 0.0 109.109 178.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.861 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.4 p -79.78 -32.94 40.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.346 -0.846 . . . . 0.0 109.26 179.268 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -80.34 -37.9 31.58 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.534 -0.729 . . . . 0.0 109.572 179.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.148 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -69.35 -30.91 69.04 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.515 -0.741 . . . . 0.0 109.167 179.162 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 5.5 m-85 -89.03 -16.0 32.7 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.499 -0.751 . . . . 0.0 109.328 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -90.8 -27.37 18.91 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.131 -0.981 . . . . 0.0 109.67 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.474 ' HD3' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -92.02 -21.1 20.69 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.694 0.759 . . . . 0.0 109.305 179.507 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -81.25 -59.16 2.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.58 -0.7 . . . . 0.0 109.554 179.546 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.2 m-20 144.61 32.21 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.16 0 C-N-CA 123.204 0.601 . . . . 0.0 109.64 179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.866 HD12 ' OD1' ' A' ' 70' ' ' ASP . 2.7 mm? -99.26 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.498 0 O-C-N 121.205 -0.935 . . . . 0.0 109.842 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.82 61.87 0.47 Allowed 'General case' 0 C--N 1.299 -1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.142 179.781 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.861 HG21 ' HA ' ' A' ' 39' ' ' SER . 11.7 m -58.28 116.14 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.46 0 CA-C-O 121.814 0.816 . . . . 0.0 109.843 179.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.853 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.0 OUTLIER -88.95 -45.55 15.5 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-O 121.209 0.528 . . . . 0.0 109.779 -179.684 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.478 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 12.6 t0 -143.37 159.22 42.77 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.271 -0.893 . . . . 0.0 110.637 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.73 HG22 ' HG3' ' A' ' 35' ' ' LYS . 6.2 p -158.81 100.98 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.291 -0.88 . . . . 0.0 110.068 179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 27.9 mtp180 -96.58 164.72 12.48 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -0.9 . . . . 0.0 110.283 -179.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.897 ' HB ' HG11 ' A' ' 31' ' ' VAL . 1.3 p -87.32 159.15 18.87 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.167 -0.958 . . . . 0.0 110.14 -179.636 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.513 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -121.04 120.37 4.45 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.583 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 10.0 m 50.42 102.57 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.289 -1.124 . . . . 0.0 110.544 179.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.415 ' C ' ' O ' ' A' ' 56' ' ' THR . 90.5 m-20 41.26 -92.72 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.441 -0.787 . . . . 0.0 110.675 179.67 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.583 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -149.0 52.45 0.97 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.16 -0.962 . . . . 0.0 110.454 -179.701 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.591 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 4.2 tmtt? -123.74 -24.31 4.52 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.219 -0.926 . . . . 0.0 110.34 179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.762 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.6 m-85 -138.15 -158.07 0.83 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.371 -0.831 . . . . 0.0 109.37 179.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.513 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 168.83 165.77 26.77 Favored Glycine 0 N--CA 1.489 2.212 0 C-N-CA 119.396 -1.383 . . . . 0.0 110.267 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.569 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 10.2 t80 -122.84 158.53 30.09 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.564 -0.962 . . . . 0.0 109.38 179.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.897 HG21 HD12 ' A' ' 22' ' ' ILE . 3.7 t -149.72 144.44 17.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 C-N-CA 119.24 -0.984 . . . . 0.0 111.112 -178.553 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 2.9 m-20 -114.31 139.18 49.65 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.458 -0.776 . . . . 0.0 109.788 179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.696 ' HE2' HD21 ' A' ' 20' ' ' LEU . 17.8 m-85 -104.15 173.81 6.14 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.442 -0.786 . . . . 0.0 110.291 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.695 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.16 13.48 15.75 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.301 -0.874 . . . . 0.0 111.577 -178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.535 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.7 p -171.82 173.87 4.39 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 118.954 -1.098 . . . . 0.0 112.207 179.758 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.539 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.51 -24.32 42.32 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 177.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.98 -25.2 32.5 Favored 'General case' 0 C--N 1.298 -1.645 0 CA-C-N 115.316 -0.856 . . . . 0.0 108.989 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.866 ' OD1' HD12 ' A' ' 47' ' ' LEU . 4.8 t0 -83.12 -25.55 31.83 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 107.485 -1.302 . . . . 0.0 107.485 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.784 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.7 tm? -82.73 -31.24 28.56 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 178.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -74.69 -34.68 62.69 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.581 -0.699 . . . . 0.0 109.529 179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.833 ' HG2' HD21 ' A' ' 47' ' ' LEU . 1.5 tppt? -78.56 -28.4 45.94 Favored 'General case' 0 C--N 1.308 -1.203 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.686 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -70.06 -25.99 63.8 Favored 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 178.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.473 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.5 OUTLIER -72.96 -48.65 34.82 Favored 'General case' 0 C--N 1.307 -1.248 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.604 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.72 -5.77 45.12 Favored 'General case' 0 C--N 1.306 -1.283 0 C-N-CA 119.596 -0.842 . . . . 0.0 109.176 178.497 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.751 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -75.85 6.31 5.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.491 -0.755 . . . . 0.0 110.446 179.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.452 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -65.27 -8.42 17.72 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.074 -1.016 . . . . 0.0 110.312 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -93.24 29.55 8.1 Favored Glycine 0 N--CA 1.491 2.305 0 N-CA-C 108.843 -1.703 . . . . 0.0 108.843 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.148 HD22 HD22 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -114.31 117.1 30.16 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.403 -1.057 . . . . 0.0 110.198 -179.554 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.55 ' O ' ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -112.47 93.39 4.42 Favored 'General case' 0 C--N 1.293 -1.873 0 CA-C-O 122.944 1.354 . . . . 0.0 109.381 178.597 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.747 HG13 ' HB1' ' A' ' 37' ' ' ALA . 23.5 t -46.66 -113.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.269 -2.93 0 CA-C-N 113.267 -1.788 . . . . 0.0 110.29 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.582 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 21.9 m-85 -80.31 47.57 0.93 Allowed 'General case' 0 C--N 1.291 -1.949 0 O-C-N 120.705 -1.247 . . . . 0.0 109.673 179.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.477 ' HA2' ' HD3' ' A' ' 81' ' ' LYS . . . 81.29 26.34 52.22 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.154 -1.578 . . . . 0.0 109.154 -179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.517 ' ND2' ' O ' ' A' ' 85' ' ' ASN . 7.9 p-10 -137.63 74.94 1.5 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.326 -1.102 . . . . 0.0 110.125 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.544 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.5 tm-20 -43.05 96.85 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.173 -0.955 . . . . 0.0 110.106 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.666 HD13 ' N ' ' A' ' 87' ' ' ILE . 0.1 OUTLIER -54.13 127.19 12.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.512 0.673 . . . . 0.0 110.402 -179.633 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.49 ' O ' ' N ' ' A' ' 23' ' ' GLY . 4.4 mttt -102.54 129.84 49.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.418 -0.802 . . . . 0.0 109.577 179.698 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.487 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -111.18 172.99 6.55 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.964 -1.085 . . . . 0.0 110.685 -179.689 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.469 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -168.23 166.81 12.56 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.499 -0.751 . . . . 0.0 109.995 -179.978 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 20.5 mtmt -86.51 110.23 30.12 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.288 -0.883 . . . . 0.0 110.28 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' HG3' ' OH ' ' A' ' 62' ' ' TYR . 46.6 Cg_endo -73.33 -172.27 1.0 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.975 1.513 . . . . 0.0 110.471 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 24.1 tttt -84.48 168.17 15.71 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.184 -0.947 . . . . 0.0 110.176 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.55 -67.9 0.58 Allowed Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.568 -1.413 . . . . 0.0 109.568 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.439 ' HD3' ' O ' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -75.45 -17.95 60.01 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.22 -1.165 . . . . 0.0 110.235 179.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.439 ' O ' ' HD3' ' A' ' 95' ' ' ARG . 1.6 m-20 49.13 -170.24 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.285 -0.885 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 98' ' ' THR . . . -71.57 97.96 0.73 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.498 HG23 ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -41.99 -93.76 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.238 -1.154 . . . . 0.0 110.459 -179.903 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.498 ' H ' HG23 ' A' ' 98' ' ' THR . 0.0 OUTLIER -89.42 -46.11 8.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.1 -1.0 . . . . 0.0 110.229 -179.945 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 100.25 177.89 30.22 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.5 t . . . . . 0 N--CA 1.492 1.651 0 O-C-N 121.394 -1.063 . . . . 0.0 110.219 179.917 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.304 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.12 64.77 1.35 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.281 -1.129 . . . . 0.0 110.167 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.463 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 13.6 t-160 -151.84 44.46 0.75 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.195 -0.941 . . . . 0.0 110.192 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.6 tpp -122.15 11.92 10.24 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.201 -0.937 . . . . 0.0 110.186 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 3.0 tp -84.44 137.84 33.15 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.308 -0.87 . . . . 0.0 110.213 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.506 ' N ' ' OE1' ' A' ' 6' ' ' GLU . 3.0 pm0 -129.13 63.37 1.49 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.183 -0.948 . . . . 0.0 110.252 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.16 93.69 40.83 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.261 -0.9 . . . . 0.0 110.205 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -71.92 79.77 1.6 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.002 1.528 . . . . 0.0 110.398 -179.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.598 HG22 ' O ' ' A' ' 9' ' ' VAL . 7.0 p -144.44 63.95 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 CA-C-O 121.253 0.549 . . . . 0.0 110.197 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 60.96 155.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.218 -0.926 . . . . 0.0 110.213 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -162.55 52.95 0.31 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 42.1 m -141.75 83.74 1.86 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.128 -1.219 . . . . 0.0 110.239 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.461 ' O ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -170.72 29.25 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.282 -0.886 . . . . 0.0 110.126 -179.964 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.461 ' O ' ' O ' ' A' ' 13' ' ' GLU . 8.1 t 46.55 -175.14 0.01 OUTLIER 'General case' 0 C--N 1.289 -2.038 0 CA-C-O 121.23 0.538 . . . . 0.0 110.358 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.2 t -74.69 -14.56 60.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.34 -0.85 . . . . 0.0 109.867 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.819 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -135.34 164.95 40.03 Favored Pre-proline 0 N--CA 1.492 1.647 0 C-N-CA 120.053 -0.659 . . . . 0.0 110.531 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.497 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 51.1 Cg_endo -77.24 -38.49 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 124.167 1.614 . . . . 0.0 110.53 179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.645 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.3 m-85 -94.24 107.14 19.1 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.192 -0.942 . . . . 0.0 110.572 -179.56 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 18' ' ' PHE . 6.8 m120 -136.41 154.3 50.83 Favored 'General case' 0 C--N 1.304 -1.374 0 O-C-N 121.375 -0.828 . . . . 0.0 109.356 179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.866 HD22 ' N ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -170.51 -176.71 2.2 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.312 -0.867 . . . . 0.0 110.809 -179.196 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.866 ' N ' HD22 ' A' ' 20' ' ' LEU . 4.5 t80 -105.04 146.74 28.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.442 -0.786 . . . . 0.0 110.507 -179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.696 ' CD1' HD21 ' A' ' 20' ' ' LEU . 1.5 mt -141.09 149.76 20.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 O-C-N 121.307 -0.871 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -149.36 -156.22 7.1 Favored Glycine 0 N--CA 1.487 2.052 0 C-N-CA 119.331 -1.414 . . . . 0.0 109.868 179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.489 ' O ' ' HB3' ' A' ' 85' ' ' ASN . 2.1 t30 67.52 41.59 2.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.463 -1.022 . . . . 0.0 110.027 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 34' ' ' LEU . 3.6 mm? -84.73 -167.82 1.96 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.286 -0.884 . . . . 0.0 110.114 -179.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 t30 -119.98 107.3 40.09 Favored Pre-proline 0 N--CA 1.489 1.498 0 O-C-N 121.353 -0.842 . . . . 0.0 110.147 -179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HA ' ' HG3' ' A' ' 58' ' ' ARG . 44.9 Cg_endo -73.25 -5.0 16.41 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.082 1.569 . . . . 0.0 110.324 -179.833 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 29.0 m120 -79.78 -18.69 50.4 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 109.735 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.38 -155.51 0.58 Allowed 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.554 -0.716 . . . . 0.0 109.709 179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.607 ' O ' HD23 ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.21 141.28 32.18 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.102 -0.999 . . . . 0.0 110.51 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.656 HG22 ' HB2' ' A' ' 58' ' ' ARG . 3.3 t -65.48 -29.86 48.42 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.214 -0.995 . . . . 0.0 109.178 179.351 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.416 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -65.84 -38.67 89.51 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.341 -0.849 . . . . 0.0 109.047 178.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.56 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 63.6 mm-40 -67.12 -30.73 70.83 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.855 HD12 HD12 ' A' ' 25' ' ' LEU . 3.9 mm? -66.53 -40.61 89.2 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 121.382 -0.824 . . . . 0.0 108.917 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.614 ' HG2' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -58.4 -53.3 59.83 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.362 -0.836 . . . . 0.0 108.911 178.822 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 4.8 t -65.27 -30.37 50.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.344 -0.848 . . . . 0.0 108.89 178.432 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.53 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.45 -29.63 70.88 Favored 'General case' 0 C--N 1.303 -1.427 0 C-N-CA 119.41 -0.916 . . . . 0.0 108.534 179.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.658 HD11 HG21 ' A' ' 87' ' ' ILE . 12.9 mm -84.04 -28.55 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.893 -0.723 . . . . 0.0 109.198 178.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.966 ' HA ' HG21 ' A' ' 49' ' ' VAL . 31.0 t -80.05 -27.83 39.34 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.277 -0.889 . . . . 0.0 108.893 179.134 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.526 ' OE2' ' CE ' ' A' ' 44' ' ' LYS . 2.8 tm-20 -81.88 -36.32 28.3 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-O 121.539 0.685 . . . . 0.0 109.377 179.396 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.107 ' CD2' HD13 ' A' ' 80' ' ' LEU . 5.0 tp -70.96 -31.08 67.54 Favored 'General case' 0 C--N 1.302 -1.465 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.077 ' CE1' HD13 ' A' ' 77' ' ' LEU . 3.5 m-30 -90.98 -14.88 30.62 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.481 -0.762 . . . . 0.0 109.393 179.713 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.56 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -90.02 -27.27 19.85 Favored 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.123 -0.986 . . . . 0.0 109.405 179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.526 ' CE ' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -91.43 -22.22 20.56 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.403 -0.811 . . . . 0.0 109.225 179.414 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.613 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.4 m-80 -79.59 -58.99 2.92 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.596 -0.69 . . . . 0.0 109.684 179.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.2 m-20 148.03 29.51 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 CA-C-O 121.143 0.497 . . . . 0.0 110.153 179.151 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.901 HD11 ' HB3' ' A' ' 73' ' ' LYS . 6.3 mp -103.4 -158.17 0.65 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.146 -0.971 . . . . 0.0 109.69 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.87 64.28 0.46 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.314 -0.866 . . . . 0.0 110.277 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.966 HG21 ' HA ' ' A' ' 39' ' ' SER . 9.5 m -53.08 118.01 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 CA-C-O 121.995 0.903 . . . . 0.0 109.761 179.742 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.819 HG11 ' CG2' ' A' ' 16' ' ' THR . 1.8 t -89.54 -39.12 12.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.924 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.064 -179.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.488 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -150.22 158.12 43.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.186 -0.946 . . . . 0.0 110.698 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.739 HG23 HG22 ' A' ' 63' ' ' VAL . 9.8 p -144.07 159.97 15.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.43 -0.794 . . . . 0.0 109.594 179.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.497 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.3 OUTLIER -155.55 164.08 39.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.057 -1.027 . . . . 0.0 110.104 179.913 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.549 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 0.2 OUTLIER -116.83 154.89 29.94 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.27 -0.894 . . . . 0.0 110.513 -179.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.501 ' O ' ' CB ' ' A' ' 56' ' ' THR . . . -123.71 127.84 6.69 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.411 -1.476 . . . . 0.0 109.411 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.696 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.9 m 71.31 -171.75 0.16 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.384 -1.068 . . . . 0.0 110.319 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.696 ' H ' HG22 ' A' ' 56' ' ' THR . 3.7 p30 -48.67 -53.0 20.41 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.247 -0.908 . . . . 0.0 110.556 -179.669 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.656 ' HB2' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -179.41 53.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.115 -0.991 . . . . 0.0 110.565 -179.764 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.529 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 1.0 OUTLIER -126.73 -22.87 3.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.169 -0.957 . . . . 0.0 110.561 179.965 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.576 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 1.6 m-85 -122.57 -177.18 3.56 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.2 -0.937 . . . . 0.0 109.909 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.549 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . 176.54 135.43 2.16 Favored Glycine 0 N--CA 1.49 2.259 0 C-N-CA 119.797 -1.192 . . . . 0.0 110.235 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.731 ' O ' HG23 ' A' ' 63' ' ' VAL . 0.7 OUTLIER -98.09 169.53 9.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 121.519 -0.989 . . . . 0.0 109.423 179.572 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.739 HG22 HG23 ' A' ' 52' ' ' VAL . 17.6 t -158.82 162.14 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 C-N-CA 119.057 -1.057 . . . . 0.0 111.139 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -130.99 140.6 50.16 Favored 'General case' 0 C--N 1.303 -1.425 0 O-C-N 121.697 -0.627 . . . . 0.0 109.479 179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.789 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 16.8 m-85 -110.87 174.64 5.76 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.289 -0.882 . . . . 0.0 110.845 -179.637 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.668 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.84 11.53 19.28 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.498 -0.751 . . . . 0.0 111.309 -178.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.645 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.6 p -173.08 173.51 3.65 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 122.26 1.029 . . . . 0.0 112.185 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.519 ' N ' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.64 -23.56 45.74 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 177.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.466 ' O ' ' HB2' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -84.44 -23.69 29.86 Favored 'General case' 0 C--N 1.3 -1.571 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.277 179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.579 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 4.4 t0 -83.69 -26.94 29.39 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 178.455 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.555 HD23 ' C ' ' A' ' 71' ' ' LEU . 9.8 tt -81.4 -33.98 31.91 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.962 -0.695 . . . . 0.0 109.266 179.022 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -74.96 -32.96 61.84 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.456 -0.777 . . . . 0.0 109.621 179.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.901 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -81.47 -23.19 37.57 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 107.421 -1.325 . . . . 0.0 107.421 178.403 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.789 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.99 -29.94 63.42 Favored 'General case' 0 C--N 1.304 -1.38 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.66 ' C ' HD13 ' A' ' 75' ' ' LEU . 3.1 tm? -75.96 -45.53 34.42 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -66.94 -23.39 65.96 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.665 -0.814 . . . . 0.0 109.435 179.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.077 HD13 ' CE1' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -67.57 -8.05 31.16 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-O 121.55 0.691 . . . . 0.0 110.391 179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.635 HG23 ' O ' ' A' ' 87' ' ' ILE . 22.2 m -67.4 0.37 3.0 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.646 -0.659 . . . . 0.0 111.556 -179.427 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -89.1 16.93 54.41 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.896 -1.682 . . . . 0.0 108.896 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.107 HD13 ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -103.09 -159.12 0.71 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.521 -0.988 . . . . 0.0 110.541 -179.661 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.586 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -164.76 49.67 0.11 Allowed 'General case' 0 N--CA 1.494 1.736 0 CA-C-O 122.344 1.068 . . . . 0.0 108.914 -179.851 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.749 HG21 HG23 ' A' ' 87' ' ' ILE . 17.0 t 0.35 -115.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.37 0 CA-C-N 113.444 -1.707 . . . . 0.0 111.769 -179.609 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.56 ' CE2' ' HB3' ' A' ' 33' ' ' GLU . 4.0 m-30 -76.81 9.32 2.93 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.076 -1.015 . . . . 0.0 109.962 179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.512 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 128.51 35.34 0.5 Allowed Glycine 0 N--CA 1.485 1.967 0 N-CA-C 108.836 -1.705 . . . . 0.0 108.836 -179.781 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.522 ' CA ' ' HG3' ' A' ' 81' ' ' LYS . 12.2 m120 -161.73 100.9 1.16 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.265 -1.138 . . . . 0.0 109.565 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.586 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -49.55 90.85 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.308 -0.87 . . . . 0.0 110.406 -179.212 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.749 HG23 HG21 ' A' ' 82' ' ' VAL . 0.5 OUTLIER -42.71 143.13 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 CA-C-O 121.625 0.726 . . . . 0.0 109.88 179.895 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.51 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 5.5 mtpp -119.26 159.68 23.63 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.596 -0.69 . . . . 0.0 109.99 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.649 HD23 ' CD2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -112.82 -179.2 3.58 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.322 -0.861 . . . . 0.0 110.226 -179.843 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 1.3 tt0 -168.89 148.56 4.22 Favored 'General case' 0 C--N 1.299 -1.63 0 C-N-CA 120.017 -0.673 . . . . 0.0 109.744 -179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.502 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 17.3 mttm -99.8 102.19 16.38 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.23 -0.919 . . . . 0.0 110.311 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.4 Cg_endo -73.19 -171.92 0.9 Allowed 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.98 1.516 . . . . 0.0 110.352 179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -158.54 -63.48 0.08 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.203 -0.936 . . . . 0.0 110.206 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -80.43 67.47 3.5 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.531 -1.428 . . . . 0.0 109.531 -179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -50.48 99.8 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.232 -1.158 . . . . 0.0 110.118 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 17.6 t0 -68.99 157.26 37.1 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.278 -0.889 . . . . 0.0 110.227 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 162.86 -155.61 27.02 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 p -118.07 -147.67 0.41 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.348 -1.089 . . . . 0.0 110.191 -179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -106.45 -16.3 14.58 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.276 -0.89 . . . . 0.0 110.194 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -140.99 98.88 0.23 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.605 0 O-C-N 121.23 -1.159 . . . . 0.0 110.214 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.209 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -141.41 103.07 4.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.221 -1.164 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -110.95 38.53 2.49 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.206 179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -134.45 112.46 10.96 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.218 -0.927 . . . . 0.0 110.208 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.704 HD12 ' N ' ' A' ' 6' ' ' GLU . 2.3 pp -62.81 -170.54 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.93 . . . . 0.0 110.16 179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.704 ' N ' HD12 ' A' ' 5' ' ' LEU . 2.6 pt-20 -150.53 -164.51 2.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.287 -0.883 . . . . 0.0 110.218 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 48.8 58.45 17.86 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.311 -0.868 . . . . 0.0 110.181 -179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.91 79.78 1.59 Allowed 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.987 1.52 . . . . 0.0 110.428 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.464 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.6 p -153.69 128.7 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.821 0 CA-C-O 121.263 0.554 . . . . 0.0 110.177 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -63.97 -172.61 0.07 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.227 -0.92 . . . . 0.0 110.219 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -116.47 62.7 0.38 Allowed Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -106.39 37.06 2.4 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.287 -1.125 . . . . 0.0 110.196 179.929 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -145.74 95.79 2.7 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.267 -0.896 . . . . 0.0 109.785 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.505 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 0.6 OUTLIER -65.91 169.63 6.44 Favored 'General case' 0 C--N 1.283 -2.289 0 CA-C-O 121.204 0.526 . . . . 0.0 110.222 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.705 HG23 HG23 ' A' ' 16' ' ' THR . 5.7 t -115.95 -23.73 8.43 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.292 -0.88 . . . . 0.0 110.115 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.928 ' CG2' HG11 ' A' ' 50' ' ' VAL . 39.1 p -105.6 161.85 21.53 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.219 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.566 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 47.4 Cg_endo -74.85 -25.45 12.18 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.083 1.57 . . . . 0.0 110.762 -179.825 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.711 ' CD1' HD22 ' A' ' 71' ' ' LEU . 97.6 m-85 -102.2 110.16 22.05 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.973 -1.079 . . . . 0.0 110.567 -179.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.505 ' ND2' ' HB3' ' A' ' 14' ' ' SER . 2.0 m120 -140.88 149.75 42.33 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.405 -0.809 . . . . 0.0 109.656 -179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.712 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -163.72 -175.97 4.39 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.254 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.684 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 8.2 t80 -118.4 144.53 45.86 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.317 -0.864 . . . . 0.0 110.319 -179.895 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.542 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 3.0 mt -127.46 157.83 39.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 O-C-N 121.368 -0.833 . . . . 0.0 109.196 179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.528 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.96 -169.68 11.98 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.714 ' C ' HD22 ' A' ' 25' ' ' LEU . 42.1 t30 72.67 71.8 0.14 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.562 -0.963 . . . . 0.0 110.132 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.983 HD13 HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -110.59 157.78 19.29 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.352 -0.842 . . . . 0.0 110.268 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.519 ' ND2' ' OD1' ' A' ' 28' ' ' ASN . 39.4 t-20 -87.88 109.69 29.27 Favored Pre-proline 0 C--N 1.301 -1.502 0 O-C-N 121.401 -0.812 . . . . 0.0 110.206 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 46.5 Cg_endo -73.07 -28.33 12.98 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.967 1.509 . . . . 0.0 110.687 -179.823 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.519 ' OD1' ' ND2' ' A' ' 26' ' ' ASN . 32.7 p30 -75.0 -13.68 60.53 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.104 -0.997 . . . . 0.0 109.713 179.831 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.484 ' N ' ' OD1' ' A' ' 28' ' ' ASN . 0.0 OUTLIER -110.49 -154.94 0.55 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.514 -0.741 . . . . 0.0 109.681 179.727 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.555 ' O ' HD12 ' A' ' 34' ' ' LEU . 1.4 m -109.98 145.64 36.61 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.192 -0.942 . . . . 0.0 110.496 179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.655 HG12 ' HE3' ' A' ' 35' ' ' LYS . 2.9 t -69.97 -30.95 46.13 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.2 -0.937 . . . . 0.0 109.389 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.598 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -67.1 -37.19 83.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.331 -0.856 . . . . 0.0 109.26 179.063 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.484 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 63.2 mm-40 -68.71 -34.28 75.37 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 109.41 179.249 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.983 HD22 HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -65.03 -35.57 81.59 Favored 'General case' 0 N--CA 1.485 1.309 0 O-C-N 121.403 -0.811 . . . . 0.0 109.104 179.3 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.707 ' HG3' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -64.38 -48.2 76.35 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.472 -0.767 . . . . 0.0 109.25 179.226 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.598 HG23 ' O ' ' A' ' 32' ' ' ALA . 9.9 t -61.26 -34.61 61.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.451 -0.781 . . . . 0.0 109.598 179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.703 ' CB ' HG23 ' A' ' 82' ' ' VAL . . . -62.89 -34.05 76.6 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.214 -0.929 . . . . 0.0 108.703 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.791 ' CD1' HD13 ' A' ' 87' ' ' ILE . 22.4 mm -81.86 -28.04 9.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 N-CA-C 109.071 -0.714 . . . . 0.0 109.071 178.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.736 ' HA ' HG21 ' A' ' 49' ' ' VAL . 11.5 t -79.02 -27.68 43.27 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.229 -0.92 . . . . 0.0 109.049 179.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.502 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.16 -39.15 23.64 Favored 'General case' 0 C--N 1.302 -1.465 0 CA-C-O 121.601 0.715 . . . . 0.0 109.125 179.294 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.714 HD22 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.08 -32.73 74.36 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.923 ' CD2' HD23 ' A' ' 47' ' ' LEU . 9.3 m-85 -86.31 -19.16 30.26 Favored 'General case' 0 C--N 1.304 -1.375 0 O-C-N 121.393 -0.817 . . . . 0.0 109.212 178.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.438 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.48 -26.37 20.97 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.15 -0.969 . . . . 0.0 109.766 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 tttm -91.8 -19.14 22.87 Favored 'General case' 0 C--N 1.302 -1.464 0 O-C-N 121.485 -0.76 . . . . 0.0 109.051 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.617 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -81.89 -59.48 2.57 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.601 -0.687 . . . . 0.0 109.483 179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.617 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.4 m-20 147.41 30.61 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.15 0.5 . . . . 0.0 110.002 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.923 HD23 ' CD2' ' A' ' 42' ' ' PHE . 3.4 mp -103.59 -157.06 0.59 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.25 -0.906 . . . . 0.0 109.848 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -158.41 65.29 0.44 Allowed 'General case' 0 C--N 1.3 -1.586 0 O-C-N 121.27 -0.894 . . . . 0.0 110.285 -179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.736 HG21 ' HA ' ' A' ' 39' ' ' SER . 5.8 m -53.17 117.92 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 CA-C-O 121.935 0.874 . . . . 0.0 109.904 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.928 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.24 -44.14 15.59 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-O 121.164 0.506 . . . . 0.0 109.943 -179.489 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.5 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 13.2 t70 -138.78 149.53 45.1 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.293 -0.879 . . . . 0.0 110.588 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.707 HG12 ' HG3' ' A' ' 35' ' ' LYS . 2.4 t -152.3 102.67 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.453 -0.78 . . . . 0.0 109.466 179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.463 ' O ' ' N ' ' A' ' 62' ' ' TYR . 64.1 mtm180 -114.37 168.83 9.51 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.089 -1.007 . . . . 0.0 110.466 -179.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.629 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.3 p -76.35 179.02 6.08 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.245 -0.909 . . . . 0.0 110.211 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -138.73 131.63 5.41 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 -179.92 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.9 HG22 ' OD1' ' A' ' 57' ' ' ASN . 53.5 m 57.32 -86.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.397 -1.061 . . . . 0.0 110.335 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.9 ' OD1' HG22 ' A' ' 56' ' ' THR . 23.0 p-10 -161.0 90.54 0.84 Allowed 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.196 -0.94 . . . . 0.0 110.489 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.482 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.3 ttp180 53.27 19.84 1.68 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.284 -0.885 . . . . 0.0 110.473 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB3' ' CZ ' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -113.01 -30.0 7.15 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.262 -0.899 . . . . 0.0 110.206 179.941 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.689 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.0 m-85 -138.6 -177.74 5.0 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.267 -0.896 . . . . 0.0 109.518 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.497 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -159.83 135.47 4.13 Favored Glycine 0 N--CA 1.492 2.375 0 C-N-CA 119.471 -1.347 . . . . 0.0 110.193 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.684 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 2.6 m-85 -91.47 154.78 18.89 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.246 -1.15 . . . . 0.0 109.635 179.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.539 HG13 HG22 ' A' ' 52' ' ' VAL . 3.7 t -151.78 143.7 16.07 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 C-N-CA 119.462 -0.895 . . . . 0.0 110.843 -178.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.513 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.7 OUTLIER -119.79 143.51 47.81 Favored 'General case' 0 C--N 1.304 -1.385 0 O-C-N 121.428 -0.795 . . . . 0.0 109.58 179.45 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.946 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 53.8 m-85 -108.2 173.48 6.3 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.187 -0.946 . . . . 0.0 110.391 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.722 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.25 16.68 14.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.346 -0.846 . . . . 0.0 111.622 -178.031 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 2.4 t -165.18 175.68 9.1 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 122.729 1.252 . . . . 0.0 112.216 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.544 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -88.23 -25.41 22.88 Favored 'General case' 0 C--N 1.293 -1.877 0 N-CA-C 107.126 -1.435 . . . . 0.0 107.126 177.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.451 ' OE1' ' CD ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -86.86 -21.65 26.24 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.537 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 9.4 t0 -84.0 -31.01 25.71 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 107.398 -1.334 . . . . 0.0 107.398 178.031 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.711 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.7 tp -75.16 -35.57 61.59 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.482 0.658 . . . . 0.0 109.336 179.067 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.1 tt0 -72.86 -37.87 67.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.395 -0.816 . . . . 0.0 109.698 179.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 1.039 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.05 -26.74 56.85 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 178.33 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.946 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.05 -26.77 61.4 Favored 'General case' 0 C--N 1.303 -1.439 0 C-N-CA 119.792 -0.763 . . . . 0.0 108.949 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 5.1 tt -70.94 -47.16 60.53 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 178.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.73 -15.78 63.21 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.55 -0.86 . . . . 0.0 108.748 178.287 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.039 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.2 mm? -73.22 1.37 9.46 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.586 -0.696 . . . . 0.0 110.246 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.99 ' OG1' HD13 ' A' ' 89' ' ' LEU . 38.7 m -76.29 4.13 9.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.584 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -107.97 19.22 33.07 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.373 -1.491 . . . . 0.0 109.373 179.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.006 HD21 HD11 ' A' ' 87' ' ' ILE . 2.5 pp -100.33 122.65 43.45 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.217 -1.167 . . . . 0.0 110.56 -179.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.584 ' CG ' ' N ' ' A' ' 85' ' ' ASN . 2.2 ttmt -82.9 81.55 8.56 Favored 'General case' 0 C--N 1.3 -1.57 0 CA-C-O 122.905 1.336 . . . . 0.0 110.147 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.774 HG22 ' N ' ' A' ' 83' ' ' PHE . 1.7 p -36.32 -98.84 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.27 -2.851 0 CA-C-N 113.973 -1.467 . . . . 0.0 110.952 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.774 ' N ' HG22 ' A' ' 82' ' ' VAL . 2.2 m-30 -91.29 20.67 4.96 Favored 'General case' 0 C--N 1.29 -1.998 0 O-C-N 121.026 -1.046 . . . . 0.0 110.533 -179.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.554 ' CA ' ' HG2' ' A' ' 81' ' ' LYS . . . 120.77 23.16 2.84 Favored Glycine 0 N--CA 1.492 2.391 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.767 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.584 ' N ' ' CG ' ' A' ' 81' ' ' LYS . 1.9 m-20 -155.58 100.04 2.07 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -1.135 . . . . 0.0 109.745 179.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -42.69 93.56 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.333 -0.854 . . . . 0.0 110.085 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.006 HD11 HD21 ' A' ' 80' ' ' LEU . 6.1 pt -42.89 154.9 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.388 0 O-C-N 121.278 -0.889 . . . . 0.0 110.575 -179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.506 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.0 OUTLIER -121.66 157.92 29.8 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.76 -0.588 . . . . 0.0 109.457 179.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.99 HD13 ' OG1' ' A' ' 78' ' ' THR . 7.7 mp -112.0 -179.04 3.58 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.058 -1.026 . . . . 0.0 110.488 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 2.2 tt0 -166.25 153.52 9.78 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.659 -0.651 . . . . 0.0 110.159 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.28 97.6 10.4 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.218 -0.926 . . . . 0.0 110.227 -179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.9 Cg_endo -72.84 -171.57 0.79 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.931 1.49 . . . . 0.0 110.459 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 34.4 mtpt 44.74 27.73 0.28 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.283 -0.885 . . . . 0.0 110.166 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -177.99 -154.06 11.98 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.42 ' O ' ' HB2' ' A' ' 96' ' ' ASP . 0.0 OUTLIER -135.07 -81.82 0.43 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.248 -1.148 . . . . 0.0 110.2 179.98 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 95' ' ' ARG . 8.9 m-20 56.76 -163.63 0.17 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.228 -0.92 . . . . 0.0 110.248 -179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 123.01 -162.12 16.96 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.64 -34.71 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.269 -1.136 . . . . 0.0 110.464 -179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 38.2 ttp180 -66.0 99.49 0.5 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.351 -0.843 . . . . 0.0 110.214 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -129.36 -70.42 0.12 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.222 -1.164 . . . . 0.0 110.215 -179.999 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.337 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.4 p -121.64 20.31 11.05 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.295 -1.121 . . . . 0.0 110.18 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.419 ' O ' ' HB2' ' A' ' 4' ' ' MET . 0.3 OUTLIER -175.0 164.08 3.33 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.267 -0.896 . . . . 0.0 110.19 -179.984 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.451 ' O ' ' N ' ' A' ' 6' ' ' GLU . 0.0 OUTLIER 59.21 55.04 4.51 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.23 -0.919 . . . . 0.0 110.163 179.954 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.541 ' N ' HD22 ' A' ' 5' ' ' LEU . 4.1 mm? -57.8 87.09 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.198 -0.939 . . . . 0.0 110.208 179.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' N ' ' O ' ' A' ' 4' ' ' MET . 15.5 pt-20 -174.95 124.61 0.26 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.177 -0.952 . . . . 0.0 110.222 179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -118.64 147.06 41.29 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.273 -0.892 . . . . 0.0 110.202 -180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_endo -71.93 79.62 1.62 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.959 1.505 . . . . 0.0 110.299 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 9.9 p -170.63 140.87 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.824 0 CA-C-O 121.221 0.534 . . . . 0.0 110.17 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -77.91 159.52 28.83 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.229 -0.92 . . . . 0.0 110.266 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.57 -24.14 11.4 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.469 -1.453 . . . . 0.0 109.469 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -96.76 38.71 1.2 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.267 -1.137 . . . . 0.0 110.184 179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.45 29.16 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.223 -0.923 . . . . 0.0 110.208 -179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.34 -174.6 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.037 0 CA-C-O 121.211 0.529 . . . . 0.0 110.239 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.557 HG22 ' O ' ' A' ' 15' ' ' THR . 7.9 m -111.55 1.54 16.92 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.262 -0.899 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.785 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -171.15 164.32 4.99 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.249 -0.907 . . . . 0.0 110.357 -179.931 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.41 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.7 Cg_endo -77.98 -27.21 5.93 Favored 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.201 1.632 . . . . 0.0 110.715 -179.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.536 ' CE2' ' C ' ' A' ' 67' ' ' SER . 87.3 m-85 -110.24 116.73 32.02 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.086 -1.009 . . . . 0.0 110.6 -179.744 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 5.9 m120 -142.8 157.01 45.04 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.405 -0.809 . . . . 0.0 109.73 179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.824 HD23 ' HB2' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -164.3 168.33 18.84 Favored 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.478 -0.763 . . . . 0.0 110.192 -179.708 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.565 ' N ' HD22 ' A' ' 20' ' ' LEU . 45.6 t80 -102.6 157.24 17.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.268 -0.895 . . . . 0.0 110.26 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.516 ' O ' ' HB3' ' A' ' 60' ' ' PHE . 11.4 mt -126.68 165.89 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.469 -0.769 . . . . 0.0 109.464 179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.625 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -160.01 106.59 0.29 Allowed Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.625 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 7.9 t-20 147.5 66.96 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.092 HD13 HD22 ' A' ' 34' ' ' LEU . 4.6 mm? -98.44 133.54 42.68 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.17 -0.957 . . . . 0.0 110.958 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.585 ' HB2' HD11 ' A' ' 34' ' ' LEU . 9.6 t-20 -58.36 113.11 5.9 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.706 -0.621 . . . . 0.0 109.946 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.76 -36.91 5.72 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.901 1.474 . . . . 0.0 110.448 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -74.87 -16.27 60.68 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.164 -0.96 . . . . 0.0 109.623 179.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.574 ' HG3' ' CD1' ' A' ' 83' ' ' PHE . 4.1 mmtt -110.4 -155.2 0.56 Allowed 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.546 -0.721 . . . . 0.0 109.694 179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.1 m -122.01 148.52 44.72 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.237 -0.914 . . . . 0.0 110.297 179.868 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.986 HG13 ' CD1' ' A' ' 25' ' ' LEU . 2.5 t -69.62 -35.52 66.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.458 0 O-C-N 121.137 -0.977 . . . . 0.0 109.244 179.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.487 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -54.98 -44.7 74.69 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.233 -0.917 . . . . 0.0 108.906 178.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.613 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 20.8 mm-40 -61.88 -44.77 96.13 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 178.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.092 HD22 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -57.26 -31.29 65.42 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 108.156 -1.054 . . . . 0.0 108.156 178.321 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.828 ' HD2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.87 -60.71 3.41 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.701 -0.852 . . . . 0.0 108.701 178.777 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.483 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 83.7 t -58.47 -40.48 78.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.54 -0.725 . . . . 0.0 109.07 178.586 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.69 -33.03 73.28 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.469 -0.937 . . . . 0.0 108.469 178.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.64 HD12 ' O ' ' A' ' 34' ' ' LEU . 23.8 mt -80.32 -30.23 12.54 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 121.562 -0.711 . . . . 0.0 109.138 178.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.585 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 1.4 t -77.42 -27.28 52.27 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.393 -0.923 . . . . 0.0 108.634 179.057 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -84.02 -40.92 17.81 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-O 121.534 0.683 . . . . 0.0 109.414 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.109 HD21 HD22 ' A' ' 80' ' ' LEU . 6.2 tp -61.75 -35.29 77.67 Favored 'General case' 0 C--N 1.302 -1.473 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.142 ' CE2' HD13 ' A' ' 77' ' ' LEU . 7.3 m-85 -84.62 -22.63 29.88 Favored 'General case' 0 C--N 1.302 -1.488 0 N-CA-C 108.495 -0.928 . . . . 0.0 108.495 178.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.585 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -72.23 -34.81 68.6 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-O 121.556 0.694 . . . . 0.0 109.285 179.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.448 ' HE2' ' OE1' ' A' ' 40' ' ' GLU . 9.6 mtmt -78.08 -17.81 56.53 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.442 -0.787 . . . . 0.0 109.242 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.614 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -88.46 -16.26 33.25 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.518 -0.739 . . . . 0.0 109.583 179.519 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.614 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 0.6 OUTLIER 88.86 30.31 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -179.355 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.884 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -82.1 -138.3 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 179.523 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.605 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -178.95 57.39 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.378 -0.826 . . . . 0.0 109.906 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 49' ' ' VAL . 21.0 m -50.96 117.8 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.563 0 CA-C-O 121.834 0.826 . . . . 0.0 110.033 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.785 HG21 HG21 ' A' ' 16' ' ' THR . 0.5 OUTLIER -89.22 -45.31 15.41 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 CA-C-O 121.226 0.536 . . . . 0.0 109.94 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 0.3 OUTLIER -143.69 160.22 41.09 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.781 -179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.828 HG12 ' HD2' ' A' ' 35' ' ' LYS . 2.5 t -152.4 157.49 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.344 -0.848 . . . . 0.0 109.494 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.09 164.25 33.22 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.195 -0.941 . . . . 0.0 110.206 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.474 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.9 p -91.83 156.18 17.69 Favored 'General case' 0 C--N 1.305 -1.369 0 O-C-N 121.241 -0.912 . . . . 0.0 110.847 -179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.579 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.57 129.51 9.34 Favored Glycine 0 N--CA 1.484 1.884 0 N-CA-C 108.143 -1.983 . . . . 0.0 108.143 179.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.752 HG21 ' HD2' ' A' ' 59' ' ' LYS . 2.6 m 59.61 13.59 3.46 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.518 -0.99 . . . . 0.0 109.39 -178.592 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 0.1 OUTLIER 70.66 15.75 6.96 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.194 -0.941 . . . . 0.0 111.328 179.252 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 0.2 OUTLIER 168.19 -21.81 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 O-C-N 120.807 -1.183 . . . . 0.0 111.543 179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.752 ' HD2' HG21 ' A' ' 56' ' ' THR . 0.0 OUTLIER -89.06 -65.34 1.03 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.929 -1.107 . . . . 0.0 111.728 -178.603 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 60' ' ' PHE . 1.2 m-85 -103.66 -148.53 0.39 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.043 -1.035 . . . . 0.0 110.617 -178.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.579 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 178.62 -179.85 48.63 Favored Glycine 0 N--CA 1.494 2.506 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 -179.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.583 ' CZ ' ' OD1' ' A' ' 64' ' ' ASP . 40.9 t80 -151.96 150.44 30.01 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.26 -1.141 . . . . 0.0 110.206 -179.522 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.801 HG22 HG13 ' A' ' 52' ' ' VAL . 4.0 t -150.69 153.94 9.45 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 C-N-CA 119.355 -0.938 . . . . 0.0 111.219 -178.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.583 ' OD1' ' CZ ' ' A' ' 62' ' ' TYR . 3.6 m-20 -122.27 138.03 54.64 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.589 -0.695 . . . . 0.0 110.202 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.636 ' CE2' ' CB ' ' A' ' 74' ' ' ALA . 66.4 m-85 -104.66 172.32 6.86 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.512 -0.743 . . . . 0.0 109.912 179.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.765 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.8 OUTLIER -117.52 17.11 14.59 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.23 -0.919 . . . . 0.0 111.254 -178.657 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.536 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 14.8 p -167.6 173.4 8.6 Favored 'General case' 0 N--CA 1.495 1.805 0 CA-C-O 122.563 1.173 . . . . 0.0 112.314 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.434 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -76.33 -25.31 54.61 Favored 'General case' 0 C--N 1.296 -1.721 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 177.555 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.514 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -76.55 -27.73 56.01 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.03 -0.986 . . . . 0.0 109.518 179.843 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.605 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 87.8 m-20 -79.92 -30.35 39.97 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 178.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.417 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 12.6 tp -71.82 -38.73 70.15 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.835 -0.746 . . . . 0.0 109.297 179.071 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -71.48 -30.88 66.49 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.515 -0.741 . . . . 0.0 109.621 179.51 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.831 ' O ' HD12 ' A' ' 77' ' ' LEU . 33.7 mmtt -83.49 -27.2 29.59 Favored 'General case' 0 C--N 1.306 -1.299 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 178.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.636 ' CB ' ' CE2' ' A' ' 65' ' ' PHE . . . -65.8 -30.93 71.64 Favored 'General case' 0 C--N 1.305 -1.342 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.507 HD13 ' O ' ' A' ' 75' ' ' LEU . 0.7 OUTLIER -78.06 -44.28 26.8 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 179.178 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.5 -21.64 59.46 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.363 -0.836 . . . . 0.0 109.494 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.142 HD13 ' CE2' ' A' ' 42' ' ' PHE . 2.9 mt -72.19 -4.9 32.01 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.483 -0.761 . . . . 0.0 110.163 179.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 1.027 ' OG1' HD11 ' A' ' 89' ' ' LEU . 32.3 m -71.47 2.27 5.24 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.637 -0.664 . . . . 0.0 110.956 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.94 -3.15 56.0 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.286 -1.525 . . . . 0.0 109.286 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.109 HD22 HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -91.34 135.59 33.71 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.268 -1.136 . . . . 0.0 110.346 -179.939 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.514 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -89.51 76.06 7.47 Favored 'General case' 0 N--CA 1.492 1.659 0 CA-C-O 121.998 0.904 . . . . 0.0 110.573 -179.928 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.885 ' HB ' HG23 ' A' ' 87' ' ' ILE . 3.4 t -43.17 129.28 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.272 -2.761 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.613 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.3 OUTLIER 46.34 22.99 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.904 . . . . 0.0 110.518 -179.016 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 92.95 17.62 43.24 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 2.1 m-80 -133.89 110.35 9.67 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.412 -1.052 . . . . 0.0 110.034 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.528 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 29.2 tt0 -58.05 81.19 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.319 -0.863 . . . . 0.0 110.099 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.885 HG23 ' HB ' ' A' ' 82' ' ' VAL . 2.7 pt -43.84 123.69 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.454 -0.779 . . . . 0.0 110.406 -179.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 23' ' ' GLY . 1.6 mtpm? -106.72 132.75 52.35 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.195 -0.941 . . . . 0.0 109.46 179.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.027 HD11 ' OG1' ' A' ' 78' ' ' THR . 0.0 OUTLIER -121.69 179.25 4.54 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 120.944 -1.098 . . . . 0.0 111.329 -179.638 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 0.2 OUTLIER -176.89 148.82 0.68 Allowed 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.641 -0.662 . . . . 0.0 109.616 -179.363 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.499 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 1.5 mttp -59.27 112.98 5.91 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.23 -0.919 . . . . 0.0 110.277 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.421 ' HB3' ' HB2' ' A' ' 21' ' ' PHE . 46.1 Cg_endo -73.07 -174.31 1.53 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.988 1.52 . . . . 0.0 110.4 -179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' C ' ' O ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER 42.78 77.69 0.06 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.253 -0.905 . . . . 0.0 110.168 179.968 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -130.17 7.96 6.01 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.479 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 21.7 ttt180 -114.57 56.26 0.73 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.283 -1.128 . . . . 0.0 110.257 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -54.81 154.38 5.2 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.236 -0.915 . . . . 0.0 110.217 179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.424 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -146.2 63.21 0.45 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.424 ' C ' ' O ' ' A' ' 97' ' ' GLY . 2.7 p 42.43 -155.03 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.31 -1.112 . . . . 0.0 110.243 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.7 ptt180 -134.33 34.7 3.26 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.266 -0.896 . . . . 0.0 110.2 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 105.94 156.92 22.02 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 80.1 m . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.231 -1.158 . . . . 0.0 110.175 179.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 28.2 p -76.08 -45.08 35.81 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.316 -1.108 . . . . 0.0 110.217 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 2.8 t-160 -139.87 128.0 22.38 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.93 8.57 30.62 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.215 -0.928 . . . . 0.0 110.203 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.611 HD23 ' H ' ' A' ' 6' ' ' GLU . 0.6 OUTLIER -70.86 159.3 34.88 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.273 -0.892 . . . . 0.0 110.194 -179.997 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.611 ' H ' HD23 ' A' ' 5' ' ' LEU . 1.5 mm-40 -135.49 -178.34 5.07 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.242 -0.911 . . . . 0.0 110.236 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.449 ' O ' ' OD1' ' A' ' 7' ' ' ASP . 31.7 p30 -144.14 138.58 15.04 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.229 -0.919 . . . . 0.0 110.18 -179.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.1 79.8 1.65 Allowed 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.975 1.513 . . . . 0.0 110.394 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.663 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.1 p -91.89 54.44 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.286 0.565 . . . . 0.0 110.226 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -104.48 173.5 6.27 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.272 -0.893 . . . . 0.0 110.19 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -102.27 81.28 0.4 Allowed Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.49 51.75 1.35 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.26 -1.141 . . . . 0.0 110.247 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -91.81 28.14 1.88 Allowed 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.97 0.891 . . . . 0.0 110.325 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -118.09 -170.29 1.85 Allowed 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.828 -0.545 . . . . 0.0 110.208 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.838 ' O ' HG23 ' A' ' 16' ' ' THR . 3.4 m -80.59 -10.85 59.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.226 -0.921 . . . . 0.0 110.138 -179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.838 HG23 ' O ' ' A' ' 15' ' ' THR . 1.1 p -164.79 154.6 11.99 Favored Pre-proline 0 N--CA 1.491 1.6 0 O-C-N 121.325 -0.86 . . . . 0.0 110.734 -179.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.439 ' HD2' ' O ' ' A' ' 65' ' ' PHE . 51.3 Cg_endo -76.78 -39.82 0.62 Allowed 'Trans proline' 0 C--N 1.302 -1.894 0 O-C-N 124.205 1.634 . . . . 0.0 110.585 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.568 ' CE2' ' CA ' ' A' ' 68' ' ' ALA . 94.4 m-85 -121.57 119.92 33.33 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.234 -0.916 . . . . 0.0 110.796 -179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.448 ' OD1' ' O ' ' A' ' 18' ' ' PHE . 15.5 m-20 -139.94 152.39 46.32 Favored 'General case' 0 C--N 1.304 -1.386 0 O-C-N 121.33 -0.856 . . . . 0.0 109.411 179.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.735 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.0 pp -164.09 -175.0 3.8 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.143 -0.973 . . . . 0.0 110.767 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.503 ' C ' ' CD1' ' A' ' 21' ' ' PHE . 6.1 t80 -109.34 141.91 41.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.492 -0.755 . . . . 0.0 110.035 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.562 HG23 ' O ' ' A' ' 88' ' ' LYS . 1.0 OUTLIER -122.05 160.32 24.04 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.258 -0.901 . . . . 0.0 109.851 179.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.521 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.82 -175.87 14.08 Favored Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.616 -1.393 . . . . 0.0 109.616 -179.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.58 ' C ' HD22 ' A' ' 25' ' ' LEU . 11.9 t30 71.52 54.02 0.22 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.437 -1.037 . . . . 0.0 110.506 179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.925 HD23 ' HA ' ' A' ' 60' ' ' PHE . 4.3 mm? -105.35 129.05 53.77 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.22 -0.925 . . . . 0.0 109.958 179.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 34.5 t-20 -40.54 100.6 0.22 Allowed Pre-proline 0 C--N 1.3 -1.577 0 O-C-N 121.72 -0.612 . . . . 0.0 110.502 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.433 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -73.73 -17.22 23.22 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 124.074 1.565 . . . . 0.0 110.415 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 21.3 m120 -86.92 -14.8 40.81 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.174 -0.954 . . . . 0.0 109.721 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.455 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 8.5 mmtt -106.27 -157.79 0.63 Allowed 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.496 -0.753 . . . . 0.0 109.554 179.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.468 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.0 OUTLIER -106.25 142.88 35.19 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.071 -1.018 . . . . 0.0 110.765 -179.821 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.908 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.7 t -66.1 -22.85 30.98 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.053 -1.059 . . . . 0.0 108.639 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.469 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -67.58 -38.96 84.81 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' OE2' ' CD1' ' A' ' 83' ' ' PHE . 1.8 pt-20 -65.67 -38.3 88.91 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 178.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.834 HD12 ' HA ' ' A' ' 31' ' ' VAL . 50.9 mt -60.98 -36.09 78.51 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.593 ' CG ' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -58.43 -60.49 3.71 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.7 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.495 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 28.7 t -60.51 -32.74 52.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.575 -0.703 . . . . 0.0 109.344 178.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.622 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -64.8 -38.07 89.74 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.32 -0.862 . . . . 0.0 108.774 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.572 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 24.5 mt -80.07 -24.46 11.73 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 O-C-N 121.413 -0.804 . . . . 0.0 108.995 178.871 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.801 ' HA ' HG21 ' A' ' 49' ' ' VAL . 7.8 p -80.13 -30.74 39.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.255 -0.903 . . . . 0.0 109.053 179.171 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.93 -40.73 21.87 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-O 121.562 0.696 . . . . 0.0 109.609 179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.87 HD22 HD22 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -65.53 -35.05 79.71 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.505 -0.747 . . . . 0.0 109.178 179.264 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.733 ' HD2' HD22 ' A' ' 47' ' ' LEU . 9.2 m-85 -83.0 -21.64 33.84 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 179.143 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.43 -24.7 57.1 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 109.039 -0.726 . . . . 0.0 109.039 179.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.494 ' NZ ' ' OE1' ' A' ' 40' ' ' GLU . 9.5 mttp -104.17 -17.23 14.97 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.587 -0.695 . . . . 0.0 109.519 179.505 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.674 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.7 m-80 -81.3 -21.87 38.99 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.369 -0.832 . . . . 0.0 109.934 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.674 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 17.5 t0 99.34 29.67 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.733 HD22 ' HD2' ' A' ' 42' ' ' PHE . 0.1 OUTLIER -100.93 -149.85 0.38 Allowed 'General case' 0 C--N 1.298 -1.638 0 N-CA-C 109.317 -0.623 . . . . 0.0 109.317 179.644 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -175.44 61.23 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.228 -0.92 . . . . 0.0 109.598 179.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.801 HG21 ' HA ' ' A' ' 39' ' ' SER . 6.5 m -50.9 117.74 0.69 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 CA-C-O 122.001 0.905 . . . . 0.0 110.133 -179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.692 ' HB ' HG21 ' A' ' 16' ' ' THR . 2.8 t -89.04 -35.68 7.98 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.881 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.264 -179.61 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 8.4 t0 -146.85 156.18 42.9 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.116 -0.99 . . . . 0.0 111.229 -179.663 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.593 ' CG1' ' CG ' ' A' ' 35' ' ' LYS . 14.8 p -153.17 146.59 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.599 -0.688 . . . . 0.0 109.701 179.535 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.436 ' O ' ' CA ' ' A' ' 61' ' ' GLY . 0.0 OUTLIER -149.59 166.54 28.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.172 -0.955 . . . . 0.0 110.201 -179.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.908 HG22 ' CG1' ' A' ' 31' ' ' VAL . 15.7 p -87.75 160.45 18.06 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.37 -0.831 . . . . 0.0 110.528 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.499 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -125.63 126.0 5.75 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.228 -1.549 . . . . 0.0 109.228 179.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.706 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.8 m 59.34 -166.81 0.17 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.368 -1.078 . . . . 0.0 110.073 -179.841 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.706 ' H ' HG22 ' A' ' 56' ' ' THR . 0.7 OUTLIER -41.76 -65.78 0.41 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.228 -0.92 . . . . 0.0 110.402 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.642 ' HG3' HG21 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -173.89 51.96 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.232 -0.917 . . . . 0.0 110.168 -179.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.433 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.3 OUTLIER -124.47 -23.34 4.46 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.205 -0.935 . . . . 0.0 110.414 179.956 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.925 ' HA ' HD23 ' A' ' 25' ' ' LEU . 1.0 OUTLIER -124.6 -177.05 3.69 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.183 -0.948 . . . . 0.0 109.909 179.919 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -168.0 141.75 7.03 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.866 ' O ' HG23 ' A' ' 63' ' ' VAL . 48.2 t80 -94.62 169.07 10.44 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.243 -1.151 . . . . 0.0 109.973 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.866 HG23 ' O ' ' A' ' 62' ' ' TYR . 2.4 t -163.64 163.17 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.135 -0.978 . . . . 0.0 110.836 -179.292 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.482 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.5 m-20 -137.07 144.63 43.25 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 179.481 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.802 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 31.8 m-85 -108.25 176.58 5.08 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.561 -0.712 . . . . 0.0 110.983 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.608 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -109.77 16.37 22.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.373 -0.829 . . . . 0.0 111.584 -178.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.525 ' O ' ' CD2' ' A' ' 18' ' ' PHE . 26.0 p 178.17 178.17 0.38 Allowed 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.877 -1.139 . . . . 0.0 112.224 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.568 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.05 -23.28 52.04 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.67 -26.2 41.06 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-N 115.099 -0.955 . . . . 0.0 109.361 -179.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.693 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 85.9 m-20 -83.01 -28.0 29.97 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 178.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.6 tm? -77.96 -34.19 51.19 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 120.1 -0.64 . . . . 0.0 109.827 179.542 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -74.49 -40.05 62.06 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -0.809 . . . . 0.0 109.849 179.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.788 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.03 -30.63 61.12 Favored 'General case' 0 C--N 1.306 -1.308 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 178.413 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.802 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.16 -28.48 67.33 Favored 'General case' 0 C--N 1.301 -1.528 0 C-N-CA 119.708 -0.797 . . . . 0.0 108.997 178.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.53 ' HA ' HD11 ' A' ' 89' ' ' LEU . 5.7 tt -69.79 -45.18 68.54 Favored 'General case' 0 C--N 1.307 -1.275 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 178.66 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -73.87 -12.47 60.68 Favored 'General case' 0 C--N 1.306 -1.321 0 C-N-CA 119.466 -0.894 . . . . 0.0 109.164 178.495 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.993 HD12 ' CD2' ' A' ' 80' ' ' LEU . 0.3 OUTLIER -76.07 4.62 8.09 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.54 -0.725 . . . . 0.0 109.939 179.827 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 1.025 ' OG1' HD21 ' A' ' 89' ' ' LEU . 11.1 m -72.89 1.18 9.21 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.115 -0.991 . . . . 0.0 110.552 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.421 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -106.2 1.42 37.79 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.394 -1.483 . . . . 0.0 109.394 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.039 HD21 HD11 ' A' ' 87' ' ' ILE . 0.9 OUTLIER -84.8 124.0 31.07 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 121.151 -1.205 . . . . 0.0 111.257 -179.417 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.481 ' O ' ' O ' ' A' ' 82' ' ' VAL . 32.2 mtpt -83.38 84.33 7.55 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.908 0.861 . . . . 0.0 109.189 178.879 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.972 ' CG1' HG23 ' A' ' 87' ' ' ILE . 1.2 p -34.76 -94.81 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.276 -2.587 0 CA-C-N 115.27 -0.877 . . . . 0.0 110.437 -179.873 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.798 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -98.56 31.89 2.73 Favored 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.138 -0.976 . . . . 0.0 109.427 179.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.454 ' C ' ' HE3' ' A' ' 81' ' ' LYS . . . 108.35 15.51 13.87 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 108.973 -1.651 . . . . 0.0 108.973 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.647 ' O ' HG12 ' A' ' 82' ' ' VAL . 5.1 m120 -143.42 98.18 3.21 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.434 -1.039 . . . . 0.0 109.528 179.849 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.525 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 35.1 tt0 -41.72 92.14 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.476 -0.765 . . . . 0.0 110.548 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.039 HD11 HD21 ' A' ' 80' ' ' LEU . 0.5 OUTLIER -51.25 145.39 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.369 -0.832 . . . . 0.0 110.149 -179.992 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.697 ' HA ' HG23 ' A' ' 78' ' ' THR . 18.5 tttt -120.87 155.77 33.42 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.566 -0.708 . . . . 0.0 109.904 179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.025 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.1 OUTLIER -120.38 171.35 8.59 Favored 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.236 -0.915 . . . . 0.0 110.281 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.461 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -171.95 127.82 0.6 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.319 -0.863 . . . . 0.0 110.108 -179.949 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 21.3 ttmt -61.33 110.58 3.2 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.318 -0.864 . . . . 0.0 110.351 -179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.461 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 49.4 Cg_endo -78.84 -170.05 0.92 Allowed 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.927 1.488 . . . . 0.0 110.451 -179.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 18.4 tptp 48.78 52.83 13.38 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.217 -0.927 . . . . 0.0 110.288 179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . -94.21 -66.58 1.03 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.407 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.0 OUTLIER 48.77 -174.71 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.276 -1.132 . . . . 0.0 110.241 -179.972 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 41.8 p-10 -78.52 -157.34 0.11 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.262 -0.899 . . . . 0.0 110.24 179.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.418 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -131.38 63.44 0.63 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.418 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -42.63 -32.72 0.61 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.255 -1.144 . . . . 0.0 110.406 -179.97 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 6.0 ttt180 -172.02 81.43 0.06 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.288 -0.882 . . . . 0.0 110.248 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 73.64 -171.13 52.11 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.632 0 O-C-N 121.247 -1.149 . . . . 0.0 110.231 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.35 0 N-CA-C 109.547 -1.421 . . . . 0.0 109.547 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.489 ' O ' ' N ' ' A' ' 4' ' ' MET . 1.4 p 59.57 -163.34 0.23 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.224 -1.163 . . . . 0.0 110.217 179.901 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.451 ' O ' ' HB3' ' A' ' 4' ' ' MET . 47.8 m170 53.49 -88.87 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.27 -0.894 . . . . 0.0 110.183 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 2' ' ' SER . 5.0 ptp -177.66 136.88 0.19 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.212 -0.93 . . . . 0.0 110.139 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -179.43 108.34 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.232 -0.918 . . . . 0.0 110.224 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -89.05 62.98 6.5 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.346 -0.846 . . . . 0.0 110.177 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.578 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.4 OUTLIER -69.12 -60.52 4.15 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.356 -0.84 . . . . 0.0 110.166 -179.947 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.578 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 49.4 Cg_endo -71.43 -157.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.996 1.524 . . . . 0.0 110.067 -179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.464 ' O ' ' O ' ' A' ' 8' ' ' PRO . 95.9 t 51.7 104.03 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.781 -0.575 . . . . 0.0 110.196 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 54.59 -165.77 0.1 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.227 -0.921 . . . . 0.0 110.207 179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 79.78 -4.97 63.02 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.527 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 1.1 p -117.76 5.58 12.29 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.164 -1.198 . . . . 0.0 110.28 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.527 ' HB3' ' O ' ' A' ' 12' ' ' SER . 72.2 tt0 68.36 122.11 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.279 0 CA-C-O 122.767 1.27 . . . . 0.0 110.386 -179.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.62 178.6 6.46 Favored 'General case' 0 C--N 1.276 -2.603 0 CA-C-N 114.456 -1.247 . . . . 0.0 110.177 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.798 ' O ' HG23 ' A' ' 16' ' ' THR . 4.3 m -88.42 -6.9 57.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.248 -0.908 . . . . 0.0 110.118 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.812 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.1 OUTLIER -172.2 162.53 4.35 Favored Pre-proline 0 N--CA 1.491 1.592 0 O-C-N 121.221 -0.924 . . . . 0.0 110.525 -179.864 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.54 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.0 Cg_endo -79.95 -25.96 4.77 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.187 1.625 . . . . 0.0 110.957 -179.55 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.653 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 97.4 m-85 -116.25 119.7 36.58 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.927 -1.108 . . . . 0.0 110.951 -179.523 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.486 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 30.2 m-20 -135.42 171.0 15.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.439 -0.788 . . . . 0.0 109.211 179.385 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.655 HD12 ' CE2' ' A' ' 65' ' ' PHE . 11.2 mt -156.44 165.89 35.02 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.21 -0.931 . . . . 0.0 111.137 -179.51 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.604 ' CZ ' ' CE2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER -97.96 157.59 16.02 Favored 'General case' 0 C--N 1.302 -1.48 0 N-CA-C 108.958 -0.756 . . . . 0.0 108.958 179.177 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.977 HG22 HD21 ' A' ' 25' ' ' LEU . 65.2 mt -149.39 146.83 16.91 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.323 -0.861 . . . . 0.0 110.121 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.92 179.91 22.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.489 -1.444 . . . . 0.0 109.489 179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 48.1 t30 71.15 23.35 4.15 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.495 -1.003 . . . . 0.0 110.332 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.005 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.1 mm? -68.37 122.93 19.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.264 -0.897 . . . . 0.0 109.957 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.567 ' O ' HD11 ' A' ' 34' ' ' LEU . 28.1 t-20 -41.09 100.85 0.23 Allowed Pre-proline 0 C--N 1.3 -1.552 0 O-C-N 121.654 -0.653 . . . . 0.0 110.421 -179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.8 Cg_endo -75.69 -26.51 9.79 Favored 'Trans proline' 0 C--N 1.306 -1.679 0 O-C-N 124.071 1.564 . . . . 0.0 110.188 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m120 -74.69 -24.1 58.72 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.284 -0.885 . . . . 0.0 109.966 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.514 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.7 mmtt -90.9 -154.45 0.35 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.603 -0.686 . . . . 0.0 109.72 179.532 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.531 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.1 m -101.9 143.83 31.29 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.342 -0.849 . . . . 0.0 110.1 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.764 ' CG1' HG21 ' A' ' 54' ' ' THR . 3.7 t -69.0 -31.02 48.73 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.577 0 O-C-N 121.22 -0.925 . . . . 0.0 109.418 179.485 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.7 -33.7 76.21 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.366 -0.834 . . . . 0.0 109.118 178.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.589 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . 66.0 mm-40 -70.66 -36.58 73.45 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.488 -0.757 . . . . 0.0 109.359 179.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.005 HD13 ' HB3' ' A' ' 25' ' ' LEU . 42.3 mt -63.24 -34.57 77.95 Favored 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.442 -0.786 . . . . 0.0 109.061 179.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.715 ' HZ2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -64.94 -55.84 16.78 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 119.795 -0.762 . . . . 0.0 109.213 179.194 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.5 t -58.3 -40.78 79.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.431 -0.793 . . . . 0.0 109.385 178.749 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.727 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -59.32 -29.07 67.37 Favored 'General case' 0 C--N 1.301 -1.521 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.97 179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.474 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 47.0 mt -83.95 -32.1 8.38 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.405 0 O-C-N 121.458 -0.776 . . . . 0.0 109.385 179.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.625 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 2.7 t -79.27 -23.14 43.82 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.223 -0.923 . . . . 0.0 108.967 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -85.97 -39.31 17.04 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.999 -0.741 . . . . 0.0 108.999 179.392 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.947 HD21 ' HB3' ' A' ' 80' ' ' LEU . 4.9 tp -63.45 -36.89 85.24 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 178.672 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.56 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 10.2 m-85 -83.56 -22.02 32.5 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.625 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.43 -21.76 45.12 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 108.907 -0.775 . . . . 0.0 108.907 178.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.97 -20.43 14.83 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.633 -0.667 . . . . 0.0 109.441 179.356 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.675 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -82.48 -21.12 35.66 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.459 -0.776 . . . . 0.0 109.788 179.713 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.675 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.3 t70 98.61 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.209 0 CA-C-O 121.868 0.842 . . . . 0.0 108.891 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.937 HD21 ' HB3' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -91.33 -145.28 0.19 Allowed 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.329 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.612 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -177.33 61.01 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.245 -0.909 . . . . 0.0 109.506 179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.622 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.9 m -63.24 115.44 2.3 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 CA-C-O 122.012 0.91 . . . . 0.0 110.317 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.812 ' CB ' HG21 ' A' ' 16' ' ' THR . 19.6 t -82.0 -23.01 9.67 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.871 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.509 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.783 ' CG ' HG21 ' A' ' 15' ' ' THR . 0.2 OUTLIER -155.79 155.67 33.43 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.065 -1.022 . . . . 0.0 110.673 179.764 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.715 HG12 ' HZ2' ' A' ' 35' ' ' LYS . 3.4 t -152.87 128.01 1.54 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.411 -0.805 . . . . 0.0 109.963 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 5.6 ttp180 -128.51 178.64 6.16 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.17 -0.956 . . . . 0.0 110.164 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.764 HG21 ' CG1' ' A' ' 31' ' ' VAL . 0.2 OUTLIER -149.98 151.49 33.41 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.126 -0.984 . . . . 0.0 110.691 -179.997 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.474 ' O ' ' HB ' ' A' ' 56' ' ' THR . . . -173.0 -160.86 22.38 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.617 HG22 ' O ' ' A' ' 56' ' ' THR . 5.7 m 57.07 85.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.429 -1.042 . . . . 0.0 110.788 179.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.53 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.3 m-20 39.58 48.59 1.86 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.446 -0.784 . . . . 0.0 110.936 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 10.1 ptm180 37.44 35.51 0.06 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.577 -0.702 . . . . 0.0 111.004 179.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' N ' ' A' ' 25' ' ' LEU . 20.0 tttt -121.92 -19.26 6.75 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.128 -0.983 . . . . 0.0 110.193 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.604 ' CE2' ' CZ ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -124.53 170.36 10.98 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.265 -0.897 . . . . 0.0 109.22 179.671 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.552 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -163.35 172.8 39.39 Favored Glycine 0 N--CA 1.49 2.255 0 C-N-CA 119.263 -1.446 . . . . 0.0 110.905 -179.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.528 ' OH ' ' CB ' ' A' ' 92' ' ' PRO . 1.3 t80 -121.88 162.56 20.77 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.828 -0.807 . . . . 0.0 109.976 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.559 HG23 HG13 ' A' ' 52' ' ' VAL . 0.9 OUTLIER -145.29 167.4 9.79 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 O-C-N 121.117 -0.989 . . . . 0.0 110.834 -179.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.545 ' HB2' ' CB ' ' A' ' 51' ' ' ASP . 2.8 m-20 -141.69 144.1 33.92 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.56 -0.712 . . . . 0.0 110.136 -179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.843 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 61.5 m-85 -118.3 -178.55 3.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.368 -0.832 . . . . 0.0 110.639 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 7.5 pt-20 -113.96 8.93 17.32 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.477 -0.764 . . . . 0.0 111.016 -179.086 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.653 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 32.1 p -167.81 176.1 6.49 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 122.572 1.177 . . . . 0.0 112.423 -179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.529 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.34 -24.32 50.77 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.415 -1.328 . . . . 0.0 107.415 177.727 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.05 -28.69 57.75 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.04 -0.982 . . . . 0.0 109.364 -179.922 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.697 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.0 m-20 -82.54 -27.78 31.43 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 178.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.469 ' HB2' ' HB3' ' A' ' 18' ' ' PHE . 0.3 OUTLIER -72.56 -37.34 68.25 Favored 'General case' 0 C--N 1.304 -1.373 0 C-N-CA 119.991 -0.684 . . . . 0.0 109.876 179.46 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -75.02 -38.47 61.5 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.346 -0.846 . . . . 0.0 109.979 179.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.955 ' O ' HD23 ' A' ' 77' ' ' LEU . 11.2 ttmm -76.68 -25.75 54.01 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 178.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.843 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -69.77 -31.75 69.87 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 108.85 -0.796 . . . . 0.0 108.85 178.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.461 HD23 ' C ' ' A' ' 75' ' ' LEU . 5.6 tt -70.86 -43.11 69.15 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 178.553 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -73.08 -10.58 59.94 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.703 -0.799 . . . . 0.0 109.163 178.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.955 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.6 OUTLIER -72.48 1.82 7.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.549 -0.72 . . . . 0.0 110.658 179.964 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.565 ' CA ' HD21 ' A' ' 89' ' ' LEU . 15.4 m -78.52 6.07 9.42 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.071 -1.018 . . . . 0.0 110.841 -179.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -101.36 24.18 32.64 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.947 ' HB3' HD21 ' A' ' 41' ' ' LEU . 4.7 mt -127.11 128.14 45.73 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.18 -1.188 . . . . 0.0 110.837 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.493 ' O ' ' O ' ' A' ' 82' ' ' VAL . 21.3 mtmt -84.82 83.24 8.11 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.851 0.834 . . . . 0.0 109.768 179.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.82 HG21 HG21 ' A' ' 87' ' ' ILE . 74.3 t -32.2 -98.62 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.518 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.063 179.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.667 ' N ' HG12 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -85.38 23.06 1.38 Allowed 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.268 -0.895 . . . . 0.0 110.665 -179.786 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.434 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.94 20.44 5.28 Favored Glycine 0 N--CA 1.492 2.376 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.531 ' O ' ' N ' ' A' ' 87' ' ' ILE . 66.6 m-80 -154.71 116.12 4.08 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.327 -1.102 . . . . 0.0 109.363 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.516 ' O ' ' CG ' ' A' ' 86' ' ' GLU . 1.1 pt-20 -55.56 84.93 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.309 -0.869 . . . . 0.0 110.14 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.82 HG21 HG21 ' A' ' 82' ' ' VAL . 24.4 pt -41.01 130.46 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.444 0 O-C-N 121.508 -0.745 . . . . 0.0 110.091 -179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.504 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 3.4 mttt -98.15 122.58 41.48 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.373 -0.829 . . . . 0.0 109.774 -179.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.582 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -118.87 172.49 7.5 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 121.39 -0.819 . . . . 0.0 110.386 -179.812 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.489 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 11.3 pt-20 -173.03 147.81 1.66 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.348 -0.845 . . . . 0.0 110.469 179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.6 mtmm -51.05 109.5 1.38 Allowed Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.312 -0.867 . . . . 0.0 109.999 179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.528 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 45.1 Cg_endo -72.18 -174.13 1.3 Allowed 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 124.024 1.539 . . . . 0.0 110.603 -179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -168.41 -150.07 0.09 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.342 -0.849 . . . . 0.0 110.166 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -129.38 48.79 0.95 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.422 ' O ' ' C ' ' A' ' 96' ' ' ASP . 0.9 OUTLIER 48.23 -144.48 0.38 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.271 -1.135 . . . . 0.0 110.281 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -43.14 117.91 1.19 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.239 -0.913 . . . . 0.0 110.241 179.989 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 110.91 75.09 0.78 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.9 p -84.31 166.14 17.7 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -1.168 . . . . 0.0 110.272 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 14.4 ptt180 -127.57 34.26 4.7 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.256 -0.903 . . . . 0.0 110.194 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -93.25 18.37 56.39 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.628 0 O-C-N 121.243 -1.151 . . . . 0.0 110.205 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.314 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 20.8 p -114.13 137.01 52.31 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -1.142 . . . . 0.0 110.195 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER 49.67 52.19 15.03 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.209 -0.932 . . . . 0.0 110.183 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.413 ' O ' ' HG ' ' A' ' 5' ' ' LEU . 26.5 mtm -64.05 -51.77 62.54 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.212 -0.93 . . . . 0.0 110.302 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.413 ' HG ' ' O ' ' A' ' 4' ' ' MET . 0.2 OUTLIER -166.89 -171.26 1.77 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.241 -0.912 . . . . 0.0 110.195 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -106.85 -88.82 0.45 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.267 -0.896 . . . . 0.0 110.161 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.559 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 1.5 m-20 -74.88 -58.86 1.53 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.309 -0.87 . . . . 0.0 110.148 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.559 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 44.1 Cg_endo -72.56 79.75 1.81 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.931 1.49 . . . . 0.0 110.427 -179.89 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.74 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.9 p -101.37 57.04 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 O-C-N 121.821 -0.55 . . . . 0.0 110.168 179.913 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 9.8 mt-10 -128.41 135.2 49.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.331 -0.856 . . . . 0.0 110.236 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.99 57.13 0.92 Allowed Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.529 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 27.2 m -123.76 -80.8 0.63 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -1.161 . . . . 0.0 110.213 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.529 ' HB2' ' O ' ' A' ' 12' ' ' SER . 12.2 tp10 170.87 124.41 0.02 OUTLIER 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.08 0.943 . . . . 0.0 109.377 179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.487 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER 28.8 -148.12 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.393 0 CA-C-N 114.893 -1.049 . . . . 0.0 111.383 179.453 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.545 ' O ' HG22 ' A' ' 15' ' ' THR . 4.6 m -82.4 0.65 41.05 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.311 -0.868 . . . . 0.0 110.082 179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.815 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.63 166.27 1.86 Allowed Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.282 -0.886 . . . . 0.0 110.064 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD2' HG22 ' A' ' 16' ' ' THR . 48.0 Cg_endo -76.15 -31.95 4.47 Favored 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.95 1.5 . . . . 0.0 110.798 -179.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.543 ' CE2' ' C ' ' A' ' 67' ' ' SER . 93.6 m-85 -111.62 106.93 15.9 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.026 -1.046 . . . . 0.0 110.614 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 16' ' ' THR . 43.7 m-20 -139.79 156.06 46.95 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.352 -0.843 . . . . 0.0 109.814 179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.627 HD12 ' N ' ' A' ' 21' ' ' PHE . 3.5 pp -169.78 -168.55 0.78 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.288 179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.627 ' N ' HD12 ' A' ' 20' ' ' LEU . 22.0 t80 -111.95 158.46 19.47 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.359 -0.838 . . . . 0.0 110.265 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.966 HD12 HG21 ' A' ' 63' ' ' VAL . 2.5 mt -140.73 160.11 24.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.292 -0.88 . . . . 0.0 109.104 179.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.542 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -141.76 -170.66 12.53 Favored Glycine 0 N--CA 1.488 2.136 0 C-N-CA 119.517 -1.325 . . . . 0.0 109.923 -179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 4.6 t30 73.85 34.31 0.91 Allowed 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.622 -0.928 . . . . 0.0 110.617 179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.049 HD22 ' O ' ' A' ' 60' ' ' PHE . 7.9 mp -85.57 134.73 34.0 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.162 -0.961 . . . . 0.0 109.788 179.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.436 ' CG ' ' HB2' ' A' ' 29' ' ' LYS . 35.0 t-20 -60.2 109.89 2.39 Favored Pre-proline 0 C--N 1.3 -1.563 0 O-C-N 121.485 -0.76 . . . . 0.0 110.464 -179.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.0 Cg_endo -74.55 -26.26 12.06 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 124.062 1.559 . . . . 0.0 110.307 -179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -75.44 -25.11 57.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.17 -0.957 . . . . 0.0 109.897 -179.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HE3' ' CE1' ' A' ' 83' ' ' PHE . 6.6 mmtt -91.23 -154.41 0.36 Allowed 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.533 -0.729 . . . . 0.0 109.665 179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.537 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.8 OUTLIER -110.61 140.79 44.62 Favored 'General case' 0 C--N 1.298 -1.65 0 O-C-N 121.348 -0.845 . . . . 0.0 110.148 179.629 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.682 HG12 ' HE2' ' A' ' 35' ' ' LYS . 3.0 t -67.48 -35.36 73.1 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.62 0 C-N-CA 119.173 -1.011 . . . . 0.0 109.096 179.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.484 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -61.08 -32.23 71.89 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.294 -0.879 . . . . 0.0 109.181 178.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 65.7 mm-40 -73.45 -34.34 65.35 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.481 -0.762 . . . . 0.0 109.229 179.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.966 HD22 ' HG ' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -66.3 -30.37 70.77 Favored 'General case' 0 N--CA 1.486 1.334 0 O-C-N 121.375 -0.828 . . . . 0.0 109.068 179.085 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.682 ' HE2' HG12 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -68.74 -56.27 8.61 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 179.15 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.489 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -62.91 -37.44 79.27 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.565 -0.709 . . . . 0.0 109.376 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.517 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.55 -32.77 74.34 Favored 'General case' 0 C--N 1.303 -1.425 0 C-N-CA 119.417 -0.913 . . . . 0.0 108.844 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.87 HD12 ' O ' ' A' ' 34' ' ' LEU . 13.5 mt -81.46 -28.96 10.47 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.411 0 O-C-N 121.475 -0.765 . . . . 0.0 109.107 178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 1.024 ' HA ' HG21 ' A' ' 49' ' ' VAL . 3.6 m -77.82 -30.94 51.38 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.283 -0.885 . . . . 0.0 109.16 179.217 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.489 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.99 -37.63 33.87 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.658 -0.651 . . . . 0.0 109.564 179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.986 HD22 HD21 ' A' ' 80' ' ' LEU . 1.1 tt -67.74 -32.35 72.9 Favored 'General case' 0 C--N 1.3 -1.551 0 C-N-CA 119.797 -0.761 . . . . 0.0 109.228 179.168 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.635 ' CD2' HD13 ' A' ' 47' ' ' LEU . 15.3 m-85 -87.55 -17.18 32.6 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.361 -0.837 . . . . 0.0 109.363 179.251 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.404 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -88.44 -28.97 20.54 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.063 -1.023 . . . . 0.0 109.799 179.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.427 ' HD2' ' OE2' ' A' ' 40' ' ' GLU . 11.2 mttt -91.44 -20.93 21.24 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.472 -0.768 . . . . 0.0 109.395 179.556 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.592 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.1 m-80 -79.08 -58.89 3.0 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.53 -0.731 . . . . 0.0 109.633 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.592 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 1.8 m-20 148.47 29.94 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 CA-C-O 121.267 0.556 . . . . 0.0 110.056 179.295 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.635 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -108.74 -158.86 0.66 Allowed 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.207 -0.933 . . . . 0.0 109.593 179.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.589 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . -160.33 65.37 0.33 Allowed 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.292 -0.88 . . . . 0.0 110.018 179.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.024 HG21 ' HA ' ' A' ' 39' ' ' SER . 11.0 m -54.59 115.44 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 CA-C-O 121.811 0.815 . . . . 0.0 110.052 179.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.815 HG11 ' CG2' ' A' ' 16' ' ' THR . 11.5 t -82.51 -35.9 13.11 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.872 0 O-C-N 121.88 -0.513 . . . . 0.0 110.482 -179.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -152.84 164.02 38.64 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.034 -1.041 . . . . 0.0 110.723 -179.835 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.61 HG22 ' HG3' ' A' ' 35' ' ' LYS . 5.4 p -159.0 102.32 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.433 -0.792 . . . . 0.0 109.723 179.595 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.494 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -93.87 163.34 13.55 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.269 -179.578 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.626 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.1 p -85.05 161.68 19.62 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.313 -0.867 . . . . 0.0 110.715 -179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.541 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -115.33 121.8 5.4 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.536 ' O ' ' CB ' ' A' ' 57' ' ' ASN . 9.1 m -21.54 142.39 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.152 0 CA-C-O 121.605 0.717 . . . . 0.0 112.445 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 56' ' ' THR . 0.1 OUTLIER 72.4 18.78 4.46 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.476 -0.765 . . . . 0.0 109.959 179.864 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.589 ' HD2' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER 42.46 27.2 0.08 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.379 -0.826 . . . . 0.0 109.788 -179.86 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.456 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -110.92 -17.93 13.19 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.359 -0.838 . . . . 0.0 110.12 -179.806 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 1.049 ' O ' HD22 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -130.08 -168.4 1.96 Allowed 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.042 -1.036 . . . . 0.0 109.601 179.634 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 177.88 155.79 14.94 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.563 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.0 m-85 -108.9 162.18 14.44 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.395 -1.062 . . . . 0.0 109.834 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.966 HG21 HD12 ' A' ' 22' ' ' ILE . 3.2 t -150.13 143.17 17.52 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.497 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.891 -178.746 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.501 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.13 144.97 42.28 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.547 -0.721 . . . . 0.0 109.717 179.73 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.648 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 13.1 m-85 -109.68 177.79 4.62 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.245 -0.91 . . . . 0.0 110.323 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.589 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 2.3 pp20? -114.21 8.4 16.83 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.136 -0.978 . . . . 0.0 111.285 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 10.0 p -175.41 177.15 1.87 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.278 1.037 . . . . 0.0 111.972 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.429 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -79.04 -22.87 44.75 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 107.484 -1.302 . . . . 0.0 107.484 177.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.515 ' OE2' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -82.22 -26.51 33.21 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 115.227 -0.897 . . . . 0.0 109.264 179.857 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.595 ' OD1' HD23 ' A' ' 47' ' ' LEU . 2.9 t0 -82.42 -26.61 32.6 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.08 -1.452 . . . . 0.0 107.08 178.078 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.422 HD22 ' CD1' ' A' ' 18' ' ' PHE . 3.1 tp -80.6 -33.71 35.7 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -71.62 -34.53 69.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.514 -0.741 . . . . 0.0 109.357 179.248 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.916 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -75.17 -29.08 60.32 Favored 'General case' 0 C--N 1.307 -1.256 0 N-CA-C 106.641 -1.615 . . . . 0.0 106.641 178.149 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.648 ' CB ' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.51 -26.68 65.57 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.49 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.0 tt -72.98 -46.61 51.3 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.69 -10.72 60.05 Favored 'General case' 0 C--N 1.306 -1.304 0 C-N-CA 119.651 -0.82 . . . . 0.0 108.999 178.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.916 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.5 OUTLIER -73.14 4.26 4.62 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.573 -0.705 . . . . 0.0 110.379 179.741 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 9.9 m -58.01 -14.27 6.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.1 -1.0 . . . . 0.0 110.295 179.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.54 37.69 3.33 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 108.652 -1.779 . . . . 0.0 108.652 179.01 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.011 HD13 HD11 ' A' ' 87' ' ' ILE . 4.2 mt -90.03 -168.56 2.16 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.535 -0.979 . . . . 0.0 111.159 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.587 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 17.7 mttt 170.89 53.59 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 121.857 0.837 . . . . 0.0 108.927 179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.787 HG11 HD23 ' A' ' 34' ' ' LEU . 90.7 t -24.96 -100.03 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.726 -1.124 . . . . 0.0 110.991 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.626 ' N ' HG12 ' A' ' 82' ' ' VAL . 12.7 m-85 -89.64 39.99 0.97 Allowed 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.477 -0.935 . . . . 0.0 108.477 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 90.24 24.65 28.52 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 108.694 -1.762 . . . . 0.0 108.694 -178.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 7.3 p-10 -138.52 86.21 2.14 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.538 -0.978 . . . . 0.0 109.016 179.833 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.587 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 1.1 pt-20 -41.74 94.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.471 -0.768 . . . . 0.0 110.686 -178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.011 HD11 HD13 ' A' ' 80' ' ' LEU . 3.6 pt -51.27 146.11 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 CA-C-O 121.554 0.692 . . . . 0.0 109.942 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.567 ' O ' HG23 ' A' ' 22' ' ' ILE . 20.9 tptt -119.43 156.29 30.43 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.586 -0.696 . . . . 0.0 109.845 179.902 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.577 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -119.87 171.95 8.06 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.069 -1.019 . . . . 0.0 110.304 -179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.491 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.7 OUTLIER -165.01 163.86 20.63 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.365 -0.835 . . . . 0.0 110.127 -179.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.83 98.96 12.35 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.221 -0.925 . . . . 0.0 110.207 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.491 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.0 Cg_endo -73.54 -177.48 3.1 Favored 'Trans proline' 0 C--N 1.305 -1.723 0 O-C-N 124.048 1.552 . . . . 0.0 110.456 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.43 ' C ' ' O ' ' A' ' 92' ' ' PRO . 17.2 ttpt 42.15 63.59 1.33 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.379 -0.825 . . . . 0.0 110.29 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 95' ' ' ARG . . . 156.5 -104.16 0.25 Allowed Glycine 0 N--CA 1.49 2.251 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.403 ' C ' ' O ' ' A' ' 94' ' ' GLY . 2.1 mtt180 -42.91 155.35 0.05 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.294 -1.121 . . . . 0.0 110.259 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -113.03 -157.62 0.63 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.236 -0.915 . . . . 0.0 110.229 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.413 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -54.02 -91.7 0.01 OUTLIER Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.605 -1.398 . . . . 0.0 109.605 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.413 ' C ' ' O ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER -42.34 144.58 0.48 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.275 -1.132 . . . . 0.0 110.456 -179.99 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -64.87 -84.4 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.252 -0.905 . . . . 0.0 110.239 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 107.93 53.76 0.65 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 29.8 p . . . . . 0 N--CA 1.491 1.601 0 O-C-N 121.225 -1.162 . . . . 0.0 110.206 -179.963 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.529 -1.428 . . . . 0.0 109.529 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 14.7 m -82.23 -30.11 30.97 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -1.152 . . . . 0.0 110.211 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 6.7 m-70 -100.27 136.66 39.82 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.279 -0.888 . . . . 0.0 110.207 -179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.505 ' O ' ' N ' ' A' ' 6' ' ' GLU . 2.4 mtm -64.38 -17.15 63.47 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.213 -0.93 . . . . 0.0 110.154 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.447 ' O ' ' HB3' ' A' ' 6' ' ' GLU . 1.1 mt 51.41 -89.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.198 -0.939 . . . . 0.0 110.18 179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.505 ' N ' ' O ' ' A' ' 4' ' ' MET . 8.4 pt-20 176.52 50.33 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.285 -0.885 . . . . 0.0 110.238 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 34.3 t0 -131.71 69.98 81.24 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.306 -0.871 . . . . 0.0 110.179 179.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.96 79.64 1.63 Allowed 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.955 1.502 . . . . 0.0 110.361 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.709 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.1 p -122.15 92.1 2.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 121.311 0.576 . . . . 0.0 110.257 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.417 ' CG ' ' OE2' ' A' ' 13' ' ' GLU . 1.0 OUTLIER -94.44 -169.75 2.11 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.18 -0.95 . . . . 0.0 110.208 179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.457 ' O ' ' CB ' ' A' ' 12' ' ' SER . . . -90.47 -26.63 22.58 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.57 -1.412 . . . . 0.0 109.57 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 11' ' ' GLY . 2.1 p 171.33 106.69 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.25 -1.147 . . . . 0.0 110.147 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.417 ' OE2' ' CG ' ' A' ' 10' ' ' GLU . 15.4 mt-10 -115.4 -129.5 0.3 Allowed 'General case' 0 C--N 1.305 -1.338 0 O-C-N 121.246 -0.909 . . . . 0.0 109.632 -179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.511 ' OG ' ' ND2' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -107.23 -170.43 1.7 Allowed 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.695 -0.628 . . . . 0.0 110.259 -179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.569 HG22 HG23 ' A' ' 16' ' ' THR . 3.3 m -56.49 -18.99 13.26 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.074 179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.919 ' CG2' HG11 ' A' ' 50' ' ' VAL . 69.5 p -139.78 164.28 39.04 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.476 -0.765 . . . . 0.0 110.066 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.583 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.3 Cg_endo -74.99 -21.65 15.66 Favored 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.088 1.573 . . . . 0.0 110.721 -179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.583 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 96.9 m-85 -106.67 113.44 26.94 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.037 -1.04 . . . . 0.0 110.56 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.531 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -144.76 140.59 28.61 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.489 179.806 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.815 ' N ' HD12 ' A' ' 20' ' ' LEU . 0.0 OUTLIER -149.53 -166.88 2.67 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.043 -1.036 . . . . 0.0 110.837 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.685 ' CE2' ' CE1' ' A' ' 60' ' ' PHE . 6.7 t80 -118.69 157.54 27.25 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.179 -179.814 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.799 HG13 HD23 ' A' ' 89' ' ' LEU . 5.5 mt -145.85 151.26 14.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.282 -0.886 . . . . 0.0 109.761 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.508 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.44 -174.4 13.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.508 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 27.2 t30 69.84 55.28 0.35 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.163 -1.199 . . . . 0.0 109.998 -179.863 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.789 HD23 ' HA ' ' A' ' 60' ' ' PHE . 3.9 mm? -93.78 123.75 37.33 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.37 -0.831 . . . . 0.0 110.317 -179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.924 ' N ' HD21 ' A' ' 34' ' ' LEU . 58.5 t30 -42.25 101.71 0.25 Allowed Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.573 -0.704 . . . . 0.0 110.132 179.734 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.47 ' HA ' ' HG2' ' A' ' 58' ' ' ARG . 48.2 Cg_endo -75.39 -11.47 20.79 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.065 1.561 . . . . 0.0 110.498 -179.716 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 94.4 m-20 -81.96 -8.5 59.68 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.251 -0.906 . . . . 0.0 109.926 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.522 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 13.4 mttt -124.95 -154.86 0.64 Allowed 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.38 -0.825 . . . . 0.0 109.971 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.877 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.9 m -100.09 147.59 25.49 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.164 -0.96 . . . . 0.0 109.99 -179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.876 HG11 ' HB ' ' A' ' 54' ' ' THR . 2.6 t -64.53 -35.16 73.78 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.567 0 C-N-CA 119.071 -1.052 . . . . 0.0 109.535 179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -61.09 -51.51 68.82 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.288 -0.883 . . . . 0.0 109.778 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.49 ' HG2' ' HB2' ' A' ' 30' ' ' SER . 38.5 mm-40 -56.74 -31.61 64.73 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.373 -0.83 . . . . 0.0 109.015 179.248 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.924 HD21 ' N ' ' A' ' 26' ' ' ASN . 6.7 mp -66.27 -33.17 75.14 Favored 'General case' 0 C--N 1.305 -1.364 0 O-C-N 121.384 -0.822 . . . . 0.0 109.069 179.157 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.939 ' HD2' HG12 ' A' ' 52' ' ' VAL . 29.1 mmtt -64.72 -55.47 19.73 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.628 -0.829 . . . . 0.0 108.974 178.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 15.8 t -57.26 -32.87 41.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.592 -0.693 . . . . 0.0 109.552 179.029 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.536 ' CB ' HG23 ' A' ' 82' ' ' VAL . . . -63.79 -35.62 81.21 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.153 -0.967 . . . . 0.0 108.822 179.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.707 HD11 ' HB ' ' A' ' 82' ' ' VAL . 15.6 mm -80.05 -26.75 12.01 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 121.535 -0.728 . . . . 0.0 109.311 178.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.823 ' HA ' HG21 ' A' ' 49' ' ' VAL . 52.5 m -79.58 -30.72 41.66 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.248 -0.908 . . . . 0.0 108.921 179.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.496 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.2 tm-20 -80.53 -39.69 27.36 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.583 0.706 . . . . 0.0 109.572 179.483 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.713 HD21 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -66.83 -33.54 75.84 Favored 'General case' 0 C--N 1.303 -1.453 0 C-N-CA 119.788 -0.765 . . . . 0.0 109.132 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.733 ' HE1' HD12 ' A' ' 77' ' ' LEU . 5.5 m-30 -81.82 -23.17 36.63 Favored 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.405 -0.81 . . . . 0.0 109.18 179.352 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -78.85 -27.53 44.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.236 -0.915 . . . . 0.0 110.027 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.483 ' CD ' ' OE2' ' A' ' 40' ' ' GLU . 6.4 mtpt -87.8 -19.47 27.45 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.448 -0.783 . . . . 0.0 109.284 179.498 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.607 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.5 m-80 -80.64 -60.04 2.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.562 -0.711 . . . . 0.0 109.423 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.607 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.0 m-20 149.68 33.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.914 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.571 179.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.906 HD11 ' HB3' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -106.58 -157.69 0.62 Allowed 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.182 -0.949 . . . . 0.0 109.871 -179.87 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -159.47 61.22 0.38 Allowed 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.325 -0.859 . . . . 0.0 110.019 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.823 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.6 m -48.32 117.25 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-O 121.98 0.895 . . . . 0.0 110.068 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.919 HG11 ' CG2' ' A' ' 16' ' ' THR . 0.5 OUTLIER -88.94 -41.55 14.05 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.817 0 CA-C-O 121.297 0.57 . . . . 0.0 109.588 -179.686 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.581 ' C ' HG23 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -146.57 159.26 43.66 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -0.931 . . . . 0.0 110.519 179.961 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.939 HG12 ' HD2' ' A' ' 35' ' ' LYS . 40.9 t -157.57 114.94 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.387 -0.821 . . . . 0.0 109.427 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.418 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.3 OUTLIER -113.83 163.81 14.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.084 -1.01 . . . . 0.0 110.496 -179.629 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.876 ' HB ' HG11 ' A' ' 31' ' ' VAL . 21.7 p -83.45 171.53 13.34 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.311 -0.868 . . . . 0.0 110.204 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.63 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -135.29 130.77 5.54 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.461 -1.456 . . . . 0.0 109.461 -179.755 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.4 m 50.45 -140.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.228 -1.16 . . . . 0.0 109.902 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.485 ' H ' HG22 ' A' ' 56' ' ' THR . 41.0 p30 -100.75 79.82 2.11 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.24 -0.913 . . . . 0.0 110.075 179.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.577 ' HA ' HG22 ' A' ' 31' ' ' VAL . 7.7 ttp180 56.65 28.98 14.92 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.251 -0.906 . . . . 0.0 110.482 179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -101.94 -31.23 10.79 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.217 -0.927 . . . . 0.0 109.889 179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.789 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.9 OUTLIER -150.93 177.52 10.06 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.403 -0.811 . . . . 0.0 109.265 179.358 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.566 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -154.2 150.52 22.16 Favored Glycine 0 N--CA 1.491 2.357 0 C-N-CA 119.364 -1.398 . . . . 0.0 110.298 -179.696 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.626 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 20.7 t80 -103.85 160.6 14.66 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.365 -1.079 . . . . 0.0 109.393 179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.924 HG22 HG13 ' A' ' 52' ' ' VAL . 88.7 t -154.5 154.42 7.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 C-N-CA 118.715 -1.194 . . . . 0.0 111.435 -178.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.1 m-20 -124.13 139.88 53.5 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.708 -0.62 . . . . 0.0 109.865 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.861 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 21.7 m-85 -109.71 173.45 6.32 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.457 -0.777 . . . . 0.0 110.431 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.718 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -115.08 15.19 17.16 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.353 -0.842 . . . . 0.0 111.212 -178.454 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.56 ' CA ' ' CE2' ' A' ' 18' ' ' PHE . 2.3 t -166.24 175.49 8.28 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-O 122.718 1.247 . . . . 0.0 112.063 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.497 ' N ' ' OG ' ' A' ' 67' ' ' SER . . . -88.15 -25.39 22.98 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 177.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.21 -20.95 26.21 Favored 'General case' 0 C--N 1.3 -1.548 0 N-CA-C 107.961 -1.126 . . . . 0.0 107.961 178.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.45 ' OD2' ' HB3' ' A' ' 65' ' ' PHE . 8.7 t0 -84.14 -31.68 25.07 Favored 'General case' 0 C--N 1.306 -1.289 0 N-CA-C 107.377 -1.342 . . . . 0.0 107.377 178.087 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.647 HD23 ' C ' ' A' ' 71' ' ' LEU . 8.4 tt -75.77 -34.59 60.24 Favored 'General case' 0 C--N 1.305 -1.336 0 CA-C-O 121.485 0.66 . . . . 0.0 109.59 179.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -75.5 -35.19 60.85 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.345 -0.847 . . . . 0.0 109.992 179.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 1.018 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.5 OUTLIER -76.65 -27.38 55.62 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 178.526 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.861 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -71.09 -28.7 64.52 Favored 'General case' 0 C--N 1.301 -1.524 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 178.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.728 HD22 HD13 ' A' ' 89' ' ' LEU . 0.7 OUTLIER -68.95 -45.76 69.92 Favored 'General case' 0 C--N 1.308 -1.229 0 N-CA-C 107.852 -1.166 . . . . 0.0 107.852 178.443 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -69.55 -15.55 63.25 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.563 -0.855 . . . . 0.0 108.963 178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.018 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.2 mm? -72.86 0.01 12.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.652 -0.655 . . . . 0.0 110.225 179.76 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.854 HG23 ' HA ' ' A' ' 88' ' ' LYS . 5.8 m -78.23 5.59 9.96 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.242 -0.911 . . . . 0.0 110.672 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.408 ' HA2' ' CD ' ' A' ' 86' ' ' GLU . . . -103.72 14.15 53.38 Favored Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.713 HD22 HD21 ' A' ' 41' ' ' LEU . 0.5 OUTLIER -115.3 131.21 57.0 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.254 -1.145 . . . . 0.0 110.843 -179.795 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.495 ' O ' ' C ' ' A' ' 82' ' ' VAL . 14.1 mttt -75.95 83.85 2.86 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-O 122.133 0.968 . . . . 0.0 109.62 179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.106 HG11 HG23 ' A' ' 87' ' ' ILE . 1.2 p -31.34 -94.77 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.279 -2.463 0 CA-C-N 115.007 -0.997 . . . . 0.0 110.81 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.811 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -100.84 28.79 4.94 Favored 'General case' 0 C--N 1.288 -2.101 0 O-C-N 121.177 -0.952 . . . . 0.0 110.278 179.807 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 122.61 15.93 3.89 Favored Glycine 0 N--CA 1.491 2.332 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 179.71 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.762 ' O ' HG12 ' A' ' 82' ' ' VAL . 6.7 m-20 -158.64 116.62 2.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.16 -1.2 . . . . 0.0 109.478 179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.529 ' CG ' ' O ' ' A' ' 78' ' ' THR . 24.9 tt0 -52.72 83.94 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.44 -0.787 . . . . 0.0 110.465 -179.518 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.106 HG23 HG11 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -42.77 154.43 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.351 -0.843 . . . . 0.0 110.215 -179.756 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.854 ' HA ' HG23 ' A' ' 78' ' ' THR . 7.1 mtpp -129.7 157.15 42.94 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.682 -0.636 . . . . 0.0 109.836 179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.799 HD23 HG13 ' A' ' 22' ' ' ILE . 3.7 mt -106.68 -179.54 3.97 Favored 'General case' 0 C--N 1.302 -1.472 0 O-C-N 121.11 -0.993 . . . . 0.0 110.119 -179.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 175.18 -168.41 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.585 -0.697 . . . . 0.0 110.219 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.0 mtpm? -100.74 122.12 50.33 Favored Pre-proline 0 N--CA 1.49 1.525 0 O-C-N 121.246 -0.908 . . . . 0.0 110.373 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.482 ' CA ' ' HB2' ' A' ' 21' ' ' PHE . 43.4 Cg_endo -70.89 -160.57 0.08 OUTLIER 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.938 1.494 . . . . 0.0 110.535 179.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.474 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 20.3 pttt -35.9 139.31 0.15 Allowed 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.769 -0.582 . . . . 0.0 110.827 -179.672 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . 151.74 -46.85 0.58 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.427 ' O ' ' O ' ' A' ' 94' ' ' GLY . 0.1 OUTLIER 42.55 -164.22 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.275 -1.132 . . . . 0.0 110.317 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 34.9 t0 59.98 47.09 10.21 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.406 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -129.87 -167.54 12.1 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.406 ' C ' ' O ' ' A' ' 97' ' ' GLY . 2.4 p 42.48 -162.07 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.258 -1.142 . . . . 0.0 110.243 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.91 -38.13 3.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.272 -0.892 . . . . 0.0 110.207 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 104.57 138.83 9.74 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.556 -1.418 . . . . 0.0 109.556 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.491 1.589 0 O-C-N 121.212 -1.169 . . . . 0.0 110.277 179.991 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.328 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.442 ' O ' ' O ' ' A' ' 3' ' ' HIS . 24.3 m -134.1 143.55 48.06 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.299 -1.118 . . . . 0.0 110.26 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.442 ' O ' ' O ' ' A' ' 2' ' ' SER . 92.9 m-70 47.61 95.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.195 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.412 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 0.0 OUTLIER -142.73 152.28 42.17 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.29 -0.881 . . . . 0.0 110.24 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.428 ' HA ' HD22 ' A' ' 5' ' ' LEU . 0.2 OUTLIER 63.29 29.28 15.83 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.214 -0.929 . . . . 0.0 110.231 179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.417 ' O ' ' O ' ' A' ' 5' ' ' LEU . 0.4 OUTLIER 59.03 157.06 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.304 -0.873 . . . . 0.0 110.167 -180.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -120.73 135.49 24.73 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.297 -0.877 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -71.47 -157.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.994 1.523 . . . . 0.0 110.059 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.525 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.7 p -111.98 46.63 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 CA-C-O 121.269 0.557 . . . . 0.0 110.228 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.444 ' O ' ' O ' ' A' ' 9' ' ' VAL . 0.3 OUTLIER 60.58 127.25 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.244 -0.91 . . . . 0.0 110.217 179.962 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -64.13 -59.76 8.06 Favored Glycine 0 N--CA 1.491 2.361 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.1 t -155.42 -84.23 0.06 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.21 -1.171 . . . . 0.0 110.135 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -134.47 -130.1 0.16 Allowed 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.266 -0.896 . . . . 0.0 109.352 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -134.65 163.93 28.66 Favored 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.698 -0.626 . . . . 0.0 110.211 -179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 16' ' ' THR . 5.6 m -118.81 -8.77 10.27 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.277 -0.889 . . . . 0.0 110.146 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.882 ' CG2' HG11 ' A' ' 50' ' ' VAL . 16.2 p -159.89 159.11 27.38 Favored Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.36 -0.838 . . . . 0.0 110.207 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -77.18 -18.2 14.46 Favored 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.149 1.605 . . . . 0.0 110.913 -179.75 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.61 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 79.9 m-85 -122.34 115.78 22.9 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.931 -1.106 . . . . 0.0 111.14 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.488 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 2.2 m120 -143.49 151.39 40.24 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.532 -0.73 . . . . 0.0 109.067 179.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.806 HD21 ' HE2' ' A' ' 65' ' ' PHE . 1.7 pp -160.22 179.59 8.56 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.142 -0.974 . . . . 0.0 110.544 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -103.66 158.12 16.59 Favored 'General case' 0 C--N 1.296 -1.756 0 C-N-CA 120.243 -0.583 . . . . 0.0 109.631 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 88' ' ' LYS . 6.6 mt -148.33 154.21 10.64 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 O-C-N 121.355 -0.841 . . . . 0.0 109.414 -179.651 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.601 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -144.68 -164.87 10.79 Favored Glycine 0 N--CA 1.486 2.018 0 C-N-CA 119.259 -1.448 . . . . 0.0 109.89 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.7 t30 71.68 35.03 1.49 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.444 -1.033 . . . . 0.0 109.83 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.749 ' CD1' HD22 ' A' ' 34' ' ' LEU . 4.1 mm? -85.3 129.5 34.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.362 -0.836 . . . . 0.0 110.19 -179.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.704 ' H ' HD21 ' A' ' 34' ' ' LEU . 28.4 t-20 -50.06 106.17 0.6 Allowed Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.417 -0.802 . . . . 0.0 110.297 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.475 ' HG3' ' HE3' ' A' ' 59' ' ' LYS . 47.9 Cg_endo -74.42 -18.88 19.91 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 123.996 1.524 . . . . 0.0 110.486 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 11.8 m-80 -79.45 -16.21 56.5 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.244 -0.91 . . . . 0.0 110.162 -179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.476 ' N ' ' OD1' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -106.18 -155.88 0.56 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.372 -0.83 . . . . 0.0 109.817 179.807 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.528 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 2.6 m -103.6 149.39 24.95 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.345 -0.847 . . . . 0.0 110.181 179.753 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.777 ' CG1' HG22 ' A' ' 54' ' ' THR . 3.0 t -69.85 -42.66 79.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.229 -0.919 . . . . 0.0 109.821 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 35' ' ' LYS . . . -56.96 -34.81 68.42 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.309 -0.869 . . . . 0.0 109.503 179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.598 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.93 -46.47 71.41 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.435 -0.79 . . . . 0.0 109.581 179.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.749 HD22 ' CD1' ' A' ' 25' ' ' LEU . 2.0 mt -54.55 -32.44 58.35 Favored 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.177 -0.952 . . . . 0.0 108.837 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.51 ' HD3' ' HB ' ' A' ' 52' ' ' VAL . 13.2 mmtt -64.77 -58.43 6.27 Favored 'General case' 0 C--N 1.304 -1.409 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.131 179.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.487 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 21.9 t -53.24 -35.64 24.21 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.497 -0.752 . . . . 0.0 109.369 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.519 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.4 -39.01 93.35 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.574 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 70.8 mt -77.92 -26.72 14.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 178.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.615 ' HA ' HG21 ' A' ' 49' ' ' VAL . 41.0 m -79.16 -29.21 42.9 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.238 -0.914 . . . . 0.0 109.085 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -82.84 -38.56 22.85 Favored 'General case' 0 C--N 1.301 -1.501 0 CA-C-O 121.586 0.708 . . . . 0.0 109.456 179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.862 ' HG ' HD13 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.84 -31.49 71.36 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 179.098 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.735 ' CE1' HD12 ' A' ' 77' ' ' LEU . 6.9 m-85 -85.37 -22.22 28.52 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 108.646 -0.872 . . . . 0.0 108.646 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.486 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.97 -31.85 59.22 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.547 -0.721 . . . . 0.0 109.131 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mttm -91.92 -15.41 28.09 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.59 -0.694 . . . . 0.0 109.134 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.671 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -82.71 -29.04 30.12 Favored 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.501 -0.75 . . . . 0.0 109.58 179.503 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.671 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 36.6 t0 103.85 29.74 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.011 HD11 ' CB ' ' A' ' 73' ' ' LYS . 3.3 mp -97.73 -151.78 0.38 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.594 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -167.86 61.9 0.07 Allowed 'General case' 0 C--N 1.297 -1.717 0 O-C-N 121.093 -1.004 . . . . 0.0 110.43 -179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.615 HG21 ' HA ' ' A' ' 39' ' ' SER . 5.9 m -50.07 119.03 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 CA-C-O 121.878 0.847 . . . . 0.0 109.396 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.882 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.5 t -89.28 -48.14 14.73 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 O-C-N 121.86 -0.525 . . . . 0.0 110.968 -178.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB2' ' OD1' ' A' ' 64' ' ' ASP . 5.1 m-20 -141.48 115.68 9.37 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.868 -1.145 . . . . 0.0 111.311 -179.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.753 HG12 HG13 ' A' ' 63' ' ' VAL . 16.0 m -103.64 143.49 15.51 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.471 0 O-C-N 121.437 -0.789 . . . . 0.0 109.679 179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 9.7 ttp180 -150.32 167.79 25.99 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.202 -0.936 . . . . 0.0 110.532 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.777 HG22 ' CG1' ' A' ' 31' ' ' VAL . 13.7 p -88.9 164.31 15.22 Favored 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.472 -0.767 . . . . 0.0 110.578 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.55 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -132.63 127.35 4.8 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.104 -1.598 . . . . 0.0 109.104 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.482 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 0.2 OUTLIER 68.19 -143.75 0.11 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.309 -1.112 . . . . 0.0 110.069 -179.684 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 7.9 m120 -70.94 -89.59 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.204 -0.935 . . . . 0.0 110.158 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.489 ' C ' ' CD ' ' A' ' 58' ' ' ARG . 0.0 OUTLIER -140.9 31.18 1.81 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.195 -0.941 . . . . 0.0 110.06 -179.993 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.475 ' HE3' ' HG3' ' A' ' 27' ' ' PRO . 19.3 tttt -123.76 -17.34 6.4 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.271 -0.893 . . . . 0.0 110.423 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.601 ' HA ' ' HA2' ' A' ' 23' ' ' GLY . 0.2 OUTLIER -109.49 -176.57 3.05 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.092 -1.005 . . . . 0.0 110.156 -179.99 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -179.4 152.26 10.9 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 110.346 -1.101 . . . . 0.0 110.346 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.61 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.5 t80 -125.12 158.85 32.86 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.417 -1.049 . . . . 0.0 109.521 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.753 HG13 HG12 ' A' ' 52' ' ' VAL . 3.4 t -151.95 147.88 14.84 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 C-N-CA 119.217 -0.993 . . . . 0.0 110.852 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.515 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -114.47 137.31 52.0 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.429 -0.794 . . . . 0.0 109.472 179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.806 ' HE2' HD21 ' A' ' 20' ' ' LEU . 25.7 m-85 -100.04 177.46 5.08 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.665 -0.647 . . . . 0.0 111.101 -179.224 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.64 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -116.19 12.02 15.35 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.289 -0.882 . . . . 0.0 111.611 -178.53 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.543 ' C ' ' CD2' ' A' ' 18' ' ' PHE . 5.2 p -173.71 172.11 3.64 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 120.932 -1.105 . . . . 0.0 112.2 179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.61 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -78.61 -25.76 45.19 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 107.352 -1.351 . . . . 0.0 107.352 177.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.508 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -80.25 -28.16 38.5 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-N 115.151 -0.931 . . . . 0.0 108.793 179.338 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.495 ' HB3' ' OG ' ' A' ' 67' ' ' SER . 5.5 t0 -79.77 -24.27 41.62 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 177.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.788 HD13 ' C ' ' A' ' 71' ' ' LEU . 2.3 tm? -77.22 -35.65 55.37 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 178.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -70.48 -35.45 73.28 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.422 -0.799 . . . . 0.0 109.042 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 1.011 ' CB ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -75.35 -25.36 57.69 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 106.947 -1.501 . . . . 0.0 106.947 178.027 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.65 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -68.7 -30.7 69.41 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.457 ' C ' HD23 ' A' ' 75' ' ' LEU . 7.9 tt -71.83 -45.54 61.11 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.544 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -77.79 -2.13 34.9 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 119.655 -0.818 . . . . 0.0 109.151 178.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.924 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -76.74 7.65 4.45 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.507 -0.746 . . . . 0.0 110.483 -179.964 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 1.8 m -73.65 0.55 12.48 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.014 -1.054 . . . . 0.0 110.357 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -86.19 12.02 61.47 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.044 -1.622 . . . . 0.0 109.044 179.214 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.862 HD13 ' HG ' ' A' ' 41' ' ' LEU . 0.7 OUTLIER -102.37 131.83 48.76 Favored 'General case' 0 N--CA 1.486 1.339 0 O-C-N 121.289 -1.124 . . . . 0.0 109.678 179.987 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.742 ' N ' HD12 ' A' ' 80' ' ' LEU . 0.7 OUTLIER -114.37 80.15 1.36 Allowed 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 122.489 1.137 . . . . 0.0 110.11 179.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.036 ' CG2' HG23 ' A' ' 87' ' ' ILE . 3.5 m -51.17 127.59 7.6 Favored 'Isoleucine or valine' 0 C--N 1.268 -2.963 0 CA-C-N 114.925 -1.034 . . . . 0.0 109.68 179.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 8.2 m-30 38.17 28.98 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.477 -0.765 . . . . 0.0 111.331 -179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 85.44 26.88 34.54 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.92 -1.272 . . . . 0.0 109.92 179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.541 ' HB2' HG23 ' A' ' 82' ' ' VAL . 10.1 m120 -134.74 78.58 1.75 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -1.162 . . . . 0.0 109.739 179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.3 tm-20 -37.19 93.43 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.748 0 CA-C-O 121.729 0.776 . . . . 0.0 110.747 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.036 HG23 ' CG2' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -47.7 144.29 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 CA-C-O 121.71 0.767 . . . . 0.0 110.462 -179.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.6 ' O ' HG23 ' A' ' 22' ' ' ILE . 25.7 tttt -119.3 156.54 29.81 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.705 -0.622 . . . . 0.0 109.592 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.53 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.6 172.34 7.28 Favored 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.021 -1.05 . . . . 0.0 110.38 -179.924 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.473 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.5 tm-20 -161.02 146.05 14.05 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.498 -0.751 . . . . 0.0 110.133 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.96 111.33 25.97 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.346 -0.846 . . . . 0.0 110.192 -179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.4 Cg_endo -72.97 -170.85 0.67 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.038 1.546 . . . . 0.0 110.435 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.499 ' O ' ' N ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER 63.91 16.72 10.06 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.291 -0.881 . . . . 0.0 110.242 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.425 ' O ' ' O ' ' A' ' 95' ' ' ARG . . . 63.78 -75.56 0.05 OUTLIER Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.535 -1.426 . . . . 0.0 109.535 -179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.499 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER 46.81 94.86 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.265 -1.138 . . . . 0.0 110.229 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 95' ' ' ARG . 31.9 t70 -42.82 141.93 0.99 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 110.197 -179.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -179.83 96.4 0.1 Allowed Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -134.89 -92.86 0.3 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.295 -1.121 . . . . 0.0 110.449 -179.93 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.494 ' H ' HG23 ' A' ' 98' ' ' THR . 3.7 ttt180 -172.03 124.45 0.53 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.162 -0.961 . . . . 0.0 110.264 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -155.82 146.66 14.52 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.27 -1.136 . . . . 0.0 110.29 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -125.08 35.06 4.84 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.198 -1.178 . . . . 0.0 110.204 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -140.21 126.24 19.66 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.236 -0.915 . . . . 0.0 110.196 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -108.07 175.4 5.49 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.248 -0.908 . . . . 0.0 110.273 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.403 ' O ' ' CB ' ' A' ' 6' ' ' GLU . 2.2 mp -63.79 -84.26 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.227 -0.92 . . . . 0.0 110.249 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.403 ' CB ' ' O ' ' A' ' 5' ' ' LEU . 26.2 tt0 62.39 161.82 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.291 -0.881 . . . . 0.0 110.271 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 51.04 79.8 0.33 Allowed Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.221 -0.924 . . . . 0.0 110.215 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -71.66 -157.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 124.036 1.545 . . . . 0.0 110.024 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.535 HG22 ' O ' ' A' ' 9' ' ' VAL . 10.9 p -164.73 58.11 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.291 -1.976 0 CA-C-O 121.212 0.53 . . . . 0.0 110.226 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -78.75 130.74 36.11 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.335 -0.853 . . . . 0.0 110.204 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.76 53.7 0.8 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.519 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 3.0 t -105.68 25.4 10.84 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.294 -1.121 . . . . 0.0 110.188 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.519 ' HB2' ' O ' ' A' ' 12' ' ' SER . 46.5 tt0 169.89 125.6 0.01 OUTLIER 'General case' 0 C--N 1.307 -1.241 0 CA-C-O 122.423 1.106 . . . . 0.0 109.203 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.0 OUTLIER -42.19 166.63 0.0 OUTLIER 'General case' 0 C--N 1.275 -2.643 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.221 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 16' ' ' THR . 5.8 t -105.58 -24.6 12.55 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.364 -0.835 . . . . 0.0 110.069 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 1.055 HG23 HG23 ' A' ' 15' ' ' THR . 74.6 p -139.27 164.76 36.66 Favored Pre-proline 0 C--N 1.298 -1.644 0 O-C-N 121.565 -0.71 . . . . 0.0 110.265 179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD2' ' HB ' ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.72 -22.62 11.77 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 124.022 1.538 . . . . 0.0 111.073 -179.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.541 ' CE2' ' C ' ' A' ' 67' ' ' SER . 91.5 m-85 -104.19 85.5 2.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.928 -1.107 . . . . 0.0 110.939 -179.393 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.521 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.7 m-20 -122.61 146.87 47.05 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.09 -1.006 . . . . 0.0 109.374 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.831 HD21 ' HE2' ' A' ' 65' ' ' PHE . 1.8 pp -154.36 -176.97 6.14 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.338 -0.851 . . . . 0.0 110.496 -179.858 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -103.18 166.46 10.42 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.487 -0.758 . . . . 0.0 110.617 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.774 HD12 ' CG2' ' A' ' 63' ' ' VAL . 9.0 mt -144.49 158.79 14.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.525 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -149.19 -178.67 24.41 Favored Glycine 0 N--CA 1.489 2.173 0 C-N-CA 119.478 -1.344 . . . . 0.0 110.031 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.525 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 20.5 t30 72.67 54.66 0.14 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.636 -0.92 . . . . 0.0 110.233 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.923 ' HB3' HD13 ' A' ' 34' ' ' LEU . 21.0 mt -102.23 125.93 49.07 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.042 179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.512 ' HB2' ' HB2' ' A' ' 83' ' ' PHE . 26.4 t-20 -41.25 110.08 0.7 Allowed Pre-proline 0 N--CA 1.489 1.508 0 O-C-N 121.526 -0.733 . . . . 0.0 110.412 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.01 -19.94 22.49 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.997 1.525 . . . . 0.0 110.289 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 72.9 m-20 -85.54 -7.56 58.8 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.256 -0.902 . . . . 0.0 109.953 179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.583 ' HD3' ' CG ' ' A' ' 83' ' ' PHE . 10.1 mttt -114.15 -157.24 0.62 Allowed 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.371 -0.83 . . . . 0.0 109.904 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.454 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 3.5 m -110.51 150.09 29.4 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.165 -0.96 . . . . 0.0 110.572 -179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.911 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.6 t -69.56 -38.47 76.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.272 -0.893 . . . . 0.0 109.337 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.675 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.4 -34.66 69.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.312 -0.867 . . . . 0.0 109.422 179.321 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.454 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 5.6 mm-40 -74.82 -32.67 62.03 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.375 -0.828 . . . . 0.0 109.159 179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.923 HD13 ' HB3' ' A' ' 25' ' ' LEU . 7.4 mt -66.21 -35.18 79.77 Favored 'General case' 0 C--N 1.307 -1.282 0 O-C-N 121.392 -0.818 . . . . 0.0 109.03 179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.755 ' HE2' HG12 ' A' ' 31' ' ' VAL . 2.7 mptp? -67.11 -54.08 24.74 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.583 -0.698 . . . . 0.0 109.615 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.675 HG23 ' O ' ' A' ' 32' ' ' ALA . 16.7 t -52.17 -35.97 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.353 -0.842 . . . . 0.0 109.581 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.742 ' CB ' HG13 ' A' ' 82' ' ' VAL . . . -64.34 -38.37 90.78 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.236 -0.915 . . . . 0.0 108.647 179.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.841 HD11 ' CG2' ' A' ' 82' ' ' VAL . 20.2 mm -78.02 -26.66 14.63 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.369 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.559 ' HA ' HG21 ' A' ' 49' ' ' VAL . 37.6 m -78.97 -31.92 45.12 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.122 -0.986 . . . . 0.0 109.148 179.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.51 ' OE2' ' NZ ' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -79.8 -39.27 31.22 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.46 -0.775 . . . . 0.0 109.537 179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.859 HD22 HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.6 -33.55 75.92 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 119.814 -0.754 . . . . 0.0 109.132 179.269 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.586 ' CZ ' ' HG ' ' A' ' 77' ' ' LEU . 7.8 m-85 -82.17 -21.95 36.3 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.554 -0.716 . . . . 0.0 109.211 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -80.31 -20.52 44.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.409 -0.807 . . . . 0.0 109.726 179.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.51 ' NZ ' ' OE2' ' A' ' 40' ' ' GLU . 14.4 mtmm -104.67 -22.81 13.17 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.354 -0.841 . . . . 0.0 109.993 179.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.708 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -79.31 -30.92 43.08 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.27 -0.894 . . . . 0.0 109.959 179.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.708 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 35.7 t70 112.62 29.03 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.478 0 N-CA-C 108.538 -0.912 . . . . 0.0 108.538 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.583 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 1.7 mm? -88.93 -153.16 0.25 Allowed 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.923 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -165.87 64.09 0.11 Allowed 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.202 -0.936 . . . . 0.0 109.978 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.559 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.6 m -62.98 117.87 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 CA-C-O 121.917 0.865 . . . . 0.0 110.079 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.92 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.3 t -92.36 -42.2 13.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-O 121.137 0.494 . . . . 0.0 110.187 -179.388 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.49 ' HB3' ' OD1' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -144.4 158.22 43.86 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.122 -0.986 . . . . 0.0 110.667 -179.969 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.949 HG13 HG13 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -144.96 156.19 14.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.428 -0.795 . . . . 0.0 109.569 -179.917 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.449 ' C ' ' HE3' ' A' ' 35' ' ' LYS . 0.0 OUTLIER -162.51 170.23 19.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.152 -0.968 . . . . 0.0 110.24 179.924 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.586 HG22 ' CG1' ' A' ' 31' ' ' VAL . 13.8 p -90.48 164.62 14.19 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.229 -0.919 . . . . 0.0 110.243 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -120.5 131.78 8.95 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.619 -1.393 . . . . 0.0 109.619 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.494 ' HB ' ' CD2' ' A' ' 60' ' ' PHE . 99.0 m 58.72 -81.81 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.606 -0.937 . . . . 0.0 110.371 -179.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.47 ' O ' ' CB ' ' A' ' 58' ' ' ARG . 27.6 t-20 -173.25 84.54 0.05 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.143 -0.973 . . . . 0.0 110.627 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.554 ' HA ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER 66.25 22.18 10.96 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.198 -0.939 . . . . 0.0 110.729 179.43 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.566 ' HB3' ' CE2' ' A' ' 60' ' ' PHE . 4.0 tttm -120.59 -35.84 3.31 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 109.919 179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.852 ' O ' HD12 ' A' ' 25' ' ' LEU . 1.2 m-85 -135.27 -164.3 1.51 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.324 -0.86 . . . . 0.0 109.192 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -169.08 165.3 38.81 Favored Glycine 0 N--CA 1.49 2.29 0 C-N-CA 119.328 -1.415 . . . . 0.0 110.272 179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.55 ' CD2' ' O ' ' A' ' 20' ' ' LEU . 36.8 t80 -128.73 153.1 47.69 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.467 -1.02 . . . . 0.0 109.524 179.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.949 HG13 HG13 ' A' ' 52' ' ' VAL . 3.1 t -150.43 144.15 17.23 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.211 -0.995 . . . . 0.0 111.079 -178.38 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.516 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 1.0 OUTLIER -107.5 141.07 39.51 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.406 -0.809 . . . . 0.0 109.663 179.34 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.831 ' HE2' HD21 ' A' ' 20' ' ' LEU . 30.8 m-85 -104.3 177.79 4.75 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.299 -0.876 . . . . 0.0 110.551 -179.619 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.626 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -117.12 15.91 14.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.429 -0.794 . . . . 0.0 111.02 -178.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.541 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.7 p -179.38 178.28 0.7 Allowed 'General case' 0 N--CA 1.494 1.761 0 CA-C-O 122.368 1.08 . . . . 0.0 111.954 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.54 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.51 -22.57 50.99 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -80.19 -27.99 38.77 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.229 -0.896 . . . . 0.0 109.43 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.923 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 85.8 m-20 -80.22 -29.27 38.5 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 178.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.838 ' O ' HD13 ' A' ' 71' ' ' LEU . 3.4 tm? -81.41 -32.81 32.57 Favored 'General case' 0 C--N 1.304 -1.374 0 CA-C-O 121.501 0.667 . . . . 0.0 109.314 178.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -69.68 -36.05 75.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.445 -0.784 . . . . 0.0 109.748 179.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.633 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.98 -30.14 50.09 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 107.34 -1.356 . . . . 0.0 107.34 178.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.794 ' HB2' ' CZ ' ' A' ' 65' ' ' PHE . . . -63.82 -28.99 70.24 Favored 'General case' 0 C--N 1.303 -1.429 0 C-N-CA 119.631 -0.828 . . . . 0.0 108.799 178.742 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.486 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -74.95 -47.15 31.0 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 108.575 -0.898 . . . . 0.0 108.575 178.843 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -80.41 5.01 16.21 Favored 'General case' 0 C--N 1.305 -1.367 0 C-N-CA 119.811 -0.756 . . . . 0.0 109.612 178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -79.39 11.66 2.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.356 -0.84 . . . . 0.0 110.422 -179.873 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.45 -6.44 19.4 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.095 -1.003 . . . . 0.0 110.251 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -91.41 25.03 16.6 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 108.894 -1.682 . . . . 0.0 108.894 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.984 HD12 HD12 ' A' ' 77' ' ' LEU . 1.3 mt -92.76 -171.16 2.65 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.468 -1.019 . . . . 0.0 110.9 -179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.578 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 1.4 mttt 176.55 53.99 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 121.869 0.842 . . . . 0.0 108.978 179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.841 ' CG2' HD11 ' A' ' 38' ' ' ILE . 99.3 t -24.34 -101.16 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.2 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.169 -179.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.625 ' N ' HG12 ' A' ' 82' ' ' VAL . 10.2 m-85 -87.86 42.32 1.05 Allowed 'General case' 0 C--N 1.288 -2.108 0 O-C-N 121.337 -0.852 . . . . 0.0 108.728 178.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 86.69 29.78 22.98 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 108.863 -1.695 . . . . 0.0 108.863 -179.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' OD1' ' ND2' ' A' ' 24' ' ' ASN . 1.1 t-20 -145.91 88.12 1.8 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.449 -1.03 . . . . 0.0 109.078 179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.578 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -42.95 96.06 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.331 -0.856 . . . . 0.0 110.625 -178.746 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.647 HD11 ' CD1' ' A' ' 80' ' ' LEU . 0.8 OUTLIER -48.56 125.73 2.81 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.606 -0.684 . . . . 0.0 110.144 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.0 OUTLIER -100.89 129.9 46.82 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.363 -0.836 . . . . 0.0 109.733 179.826 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.754 ' H ' HD13 ' A' ' 89' ' ' LEU . 0.0 OUTLIER -113.58 176.34 5.07 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.013 -1.054 . . . . 0.0 111.222 -179.795 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.408 ' HB3' ' O ' ' A' ' 89' ' ' LEU . 3.2 pt-20 -178.39 131.41 0.13 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.459 -0.776 . . . . 0.0 110.23 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.46 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 1.9 ptpt -60.22 115.34 12.82 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.171 -0.956 . . . . 0.0 110.233 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.499 ' CD ' ' HA ' ' A' ' 20' ' ' LEU . 46.1 Cg_endo -72.95 -171.6 0.81 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.84 1.442 . . . . 0.0 110.363 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -150.11 119.34 6.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.275 -0.891 . . . . 0.0 110.179 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 45.04 60.61 3.88 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -43.86 110.25 0.2 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.29 -1.123 . . . . 0.0 110.293 179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.01 133.83 33.89 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 110.246 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.505 ' C ' HG22 ' A' ' 98' ' ' THR . . . -67.34 -160.0 1.15 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.505 HG22 ' C ' ' A' ' 97' ' ' GLY . 0.0 OUTLIER 177.73 -33.27 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.263 -1.14 . . . . 0.0 110.47 179.977 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -116.37 9.2 14.35 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.289 -0.882 . . . . 0.0 110.215 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 112.52 -60.04 0.35 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.566 -1.413 . . . . 0.0 109.566 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.281 -1.129 . . . . 0.0 110.237 179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.226 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 m -152.72 179.83 8.28 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.268 -1.136 . . . . 0.0 110.266 -179.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -131.61 17.62 4.79 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.23 -0.919 . . . . 0.0 110.144 179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.448 ' HA ' ' HE3' ' A' ' 4' ' ' MET . 0.0 OUTLIER 61.39 112.73 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.236 -0.915 . . . . 0.0 110.202 179.942 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.3 mt 62.44 55.76 2.22 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.236 -0.915 . . . . 0.0 110.274 -179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -55.75 -44.37 77.56 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.217 -0.927 . . . . 0.0 110.199 179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -136.24 107.49 9.48 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.259 -0.901 . . . . 0.0 110.216 -179.989 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -73.17 79.37 2.08 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.051 1.553 . . . . 0.0 110.416 -179.981 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.692 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.4 p -142.18 109.02 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.812 0 CA-C-O 121.239 0.543 . . . . 0.0 110.207 -179.98 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.512 ' OE1' ' N ' ' A' ' 10' ' ' GLU . 36.5 mp0 -93.3 163.26 13.67 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.272 -0.893 . . . . 0.0 110.216 -179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.19 71.7 1.0 Allowed Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.896 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -133.06 -71.07 0.53 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.243 -1.151 . . . . 0.0 110.16 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -107.29 27.75 8.77 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.26 -0.9 . . . . 0.0 110.066 179.943 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -59.39 -173.66 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.953 0 CA-C-O 121.256 0.55 . . . . 0.0 110.229 179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.669 ' O ' HG23 ' A' ' 16' ' ' THR . 4.6 m -78.65 -2.15 37.76 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.241 -0.912 . . . . 0.0 110.16 179.938 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 1.026 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -178.83 165.19 1.03 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.233 -0.917 . . . . 0.0 110.39 -179.928 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.561 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.8 Cg_endo -75.43 -44.16 0.32 Allowed 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.101 1.579 . . . . 0.0 110.651 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.587 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 90.6 m-85 -96.15 106.33 18.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.119 -0.988 . . . . 0.0 110.594 -179.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' ND2' ' C ' ' A' ' 18' ' ' PHE . 2.0 m120 -135.66 146.31 47.68 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.354 -0.841 . . . . 0.0 109.525 179.689 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.607 HD23 ' N ' ' A' ' 20' ' ' LEU . 0.9 OUTLIER -164.71 169.15 17.21 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.176 -0.953 . . . . 0.0 110.547 179.79 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.69 ' CD1' ' CE1' ' A' ' 62' ' ' TYR . 3.5 t80 -101.73 145.97 28.39 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.364 -0.835 . . . . 0.0 109.732 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' LYS . 1.4 mt -127.78 158.53 39.34 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.119 -0.988 . . . . 0.0 110.201 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.499 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -134.68 179.84 17.21 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 109.728 -1.349 . . . . 0.0 109.728 -179.896 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.834 ' C ' HD22 ' A' ' 25' ' ' LEU . 45.8 t30 71.35 76.74 0.18 Allowed 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.413 -1.051 . . . . 0.0 110.464 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.834 HD22 ' C ' ' A' ' 24' ' ' ASN . 4.4 mm? -118.88 126.44 51.8 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.28 -0.888 . . . . 0.0 110.021 179.637 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.515 ' HB3' HD21 ' A' ' 34' ' ' LEU . 46.0 t30 -40.43 100.36 0.22 Allowed Pre-proline 0 C--N 1.301 -1.516 0 O-C-N 121.613 -0.68 . . . . 0.0 110.525 179.995 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.7 Cg_endo -75.75 -13.81 19.77 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.997 1.525 . . . . 0.0 110.411 -179.871 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -82.17 -18.26 43.37 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.04 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.563 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -108.28 -156.52 0.58 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.415 -0.803 . . . . 0.0 109.753 179.773 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.525 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -101.63 147.19 26.72 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.225 -0.922 . . . . 0.0 110.292 179.942 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.987 ' HA ' HD12 ' A' ' 34' ' ' LEU . 3.3 t -69.67 -32.11 51.18 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 C-N-CA 119.475 -0.89 . . . . 0.0 109.486 179.565 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -64.21 -36.74 85.04 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.362 -0.836 . . . . 0.0 109.183 179.004 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.608 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 9.3 mm-40 -67.72 -40.15 84.27 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.542 -0.724 . . . . 0.0 109.33 179.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.987 HD12 ' HA ' ' A' ' 31' ' ' VAL . 40.2 mt -57.3 -37.04 71.84 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.537 ' HG3' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -61.45 -58.19 9.18 Favored 'General case' 0 C--N 1.304 -1.406 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.32 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.492 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 11.8 t -58.54 -33.7 49.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.419 -0.801 . . . . 0.0 109.414 178.988 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.61 -36.49 83.98 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.189 -0.945 . . . . 0.0 108.609 179.25 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.604 HG13 HG22 ' A' ' 82' ' ' VAL . 17.0 mt -79.66 -26.14 12.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 O-C-N 121.584 -0.697 . . . . 0.0 109.224 178.908 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 5.3 m -79.79 -30.35 40.58 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.07 -1.019 . . . . 0.0 108.93 179.09 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.492 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -81.12 -38.06 27.86 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.514 0.673 . . . . 0.0 109.669 179.464 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.066 HD22 ' CD2' ' A' ' 80' ' ' LEU . 1.1 tt -69.9 -31.19 68.85 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.458 -0.776 . . . . 0.0 109.248 179.215 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.888 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 5.5 m-85 -82.87 -23.92 33.43 Favored 'General case' 0 C--N 1.301 -1.507 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.394 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -75.11 -32.01 61.3 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.542 -0.724 . . . . 0.0 109.429 179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.467 ' HD3' ' N ' ' A' ' 44' ' ' LYS . 0.1 OUTLIER -90.02 -18.95 25.02 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.446 -0.784 . . . . 0.0 109.437 179.353 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.623 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.3 m-80 -85.49 -20.16 30.13 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.406 -0.809 . . . . 0.0 109.786 179.653 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.623 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 18.0 t0 89.42 30.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 2.002 0 CA-C-O 122.044 0.926 . . . . 0.0 108.577 -179.19 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.773 HD21 ' HB2' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -80.14 -138.33 0.03 OUTLIER 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 109.357 -0.609 . . . . 0.0 109.357 179.576 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.412 ' HB2' ' O ' ' A' ' 47' ' ' LEU . . . -176.52 57.44 0.01 OUTLIER 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.194 -0.941 . . . . 0.0 109.953 179.723 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.681 ' O ' HG23 ' A' ' 49' ' ' VAL . 9.9 m -63.32 117.45 4.14 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-O 122.047 0.927 . . . . 0.0 110.766 -179.818 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 1.026 HG21 HG21 ' A' ' 16' ' ' THR . 0.0 OUTLIER -98.2 -34.39 4.61 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.864 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 179.524 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.51 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 56.7 t0 -144.78 148.49 34.15 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.41 -0.806 . . . . 0.0 110.543 179.999 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.894 HG22 HG13 ' A' ' 63' ' ' VAL . 3.8 t -152.87 100.28 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.247 -0.908 . . . . 0.0 109.996 179.777 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -104.82 169.23 8.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.124 -0.985 . . . . 0.0 110.388 -179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.482 ' HB ' HG11 ' A' ' 31' ' ' VAL . 17.4 p -83.52 168.21 16.66 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.286 -0.884 . . . . 0.0 110.449 -179.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -122.04 122.02 4.93 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 -179.634 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.574 ' OG1' ' CD1' ' A' ' 60' ' ' PHE . 4.3 m 67.87 -57.88 0.45 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.755 -0.85 . . . . 0.0 110.368 179.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.504 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER 179.81 -43.05 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.219 -0.925 . . . . 0.0 109.69 179.936 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.4 ptt180 -168.39 25.43 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.546 -0.721 . . . . 0.0 110.123 179.784 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.633 ' CB ' ' CE1' ' A' ' 60' ' ' PHE . 2.8 mttt -119.65 -24.83 6.11 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.321 -0.862 . . . . 0.0 109.803 179.829 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.827 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -138.51 -172.38 3.28 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.195 -0.941 . . . . 0.0 109.449 179.517 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.505 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -172.93 151.69 14.55 Favored Glycine 0 N--CA 1.49 2.279 0 C-N-CA 119.549 -1.31 . . . . 0.0 110.147 179.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.69 ' CE1' ' CD1' ' A' ' 21' ' ' PHE . 38.0 m-85 -108.05 150.62 26.92 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.415 -1.05 . . . . 0.0 109.525 179.367 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.894 HG13 HG22 ' A' ' 52' ' ' VAL . 3.9 t -151.36 146.1 16.08 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 C-N-CA 119.363 -0.935 . . . . 0.0 111.264 -178.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.551 ' O ' HG23 ' A' ' 50' ' ' VAL . 1.2 m-20 -122.56 146.6 47.27 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 178.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.646 ' O ' HG21 ' A' ' 50' ' ' VAL . 26.2 m-85 -114.86 -175.21 2.64 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 119.583 -0.847 . . . . 0.0 109.861 179.74 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.709 ' HG3' HG13 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -129.44 31.34 4.82 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.661 -1.274 . . . . 0.0 113.673 -176.623 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.776 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 22.6 p -172.88 172.76 3.96 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 119.902 -1.749 . . . . 0.0 113.167 179.828 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -75.77 -27.81 58.2 Favored 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.819 -1.549 . . . . 0.0 106.819 177.23 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.503 ' O ' ' CG ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -27.1 61.76 Favored 'General case' 0 C--N 1.298 -1.644 0 CA-C-N 114.832 -1.076 . . . . 0.0 108.983 179.459 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.776 ' OD2' ' N ' ' A' ' 67' ' ' SER . 0.5 OUTLIER -78.23 -32.29 49.71 Favored 'General case' 0 C--N 1.307 -1.244 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 178.083 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.587 ' HB2' ' CD1' ' A' ' 18' ' ' PHE . 0.1 OUTLIER -65.95 -41.55 91.14 Favored 'General case' 0 C--N 1.302 -1.498 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.284 -179.917 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.482 ' N ' HD23 ' A' ' 71' ' ' LEU . 2.4 tt0 -70.09 -33.11 71.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.364 -0.835 . . . . 0.0 109.193 178.931 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.773 ' HB2' HD21 ' A' ' 47' ' ' LEU . 15.9 mmtt -81.49 -23.02 37.64 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 178.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.564 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -69.19 -29.91 67.98 Favored 'General case' 0 C--N 1.306 -1.301 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 178.53 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.456 ' HA ' HD22 ' A' ' 75' ' ' LEU . 0.3 OUTLIER -74.45 -48.13 29.38 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 108.14 -1.059 . . . . 0.0 108.14 178.261 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.07 8.51 15.21 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.941 -0.704 . . . . 0.0 109.269 178.567 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.897 HD23 ' O ' ' A' ' 77' ' ' LEU . 3.0 tt -66.32 -8.81 27.54 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.611 -0.681 . . . . 0.0 110.837 -179.713 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.533 HG22 ' O ' ' A' ' 78' ' ' THR . 84.9 m -70.92 5.41 2.01 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.353 -0.842 . . . . 0.0 111.692 -179.279 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -98.44 -6.48 56.52 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.066 ' CD2' HD22 ' A' ' 41' ' ' LEU . 6.8 mp -92.61 120.79 33.4 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.218 -1.166 . . . . 0.0 110.723 -179.704 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.508 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -95.07 80.69 3.63 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.965 0.888 . . . . 0.0 110.139 179.36 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.859 ' HB ' HG23 ' A' ' 87' ' ' ILE . 2.5 t -43.22 120.99 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.71 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.611 ' HB2' HD23 ' A' ' 34' ' ' LEU . 0.6 OUTLIER 48.73 20.54 0.34 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.323 -0.861 . . . . 0.0 110.965 -179.122 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.87 11.67 39.51 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.71 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.545 ' O ' ' N ' ' A' ' 87' ' ' ILE . 4.7 m120 -128.28 110.43 12.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.301 -1.117 . . . . 0.0 109.686 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.508 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.0 OUTLIER -59.35 76.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.529 -0.732 . . . . 0.0 110.123 -179.93 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.859 HG23 ' HB ' ' A' ' 82' ' ' VAL . 4.9 pt -42.99 140.33 0.55 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 O-C-N 121.457 -0.777 . . . . 0.0 110.042 -179.957 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.565 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.8 mttm -108.61 158.72 17.32 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.58 -0.7 . . . . 0.0 109.205 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.557 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -120.69 170.99 8.91 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.259 -0.9 . . . . 0.0 110.494 -179.567 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.452 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -167.93 122.29 0.96 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.372 -0.83 . . . . 0.0 110.083 179.944 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 3.4 mmmt -57.44 109.21 1.59 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.28 -0.888 . . . . 0.0 110.376 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 49.7 Cg_endo -81.17 -169.79 0.86 Allowed 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 123.978 1.515 . . . . 0.0 110.339 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.6 mttp -58.3 -178.3 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.248 -0.908 . . . . 0.0 110.08 179.926 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 95.57 -46.99 1.92 Allowed Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -123.9 11.22 8.97 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.231 -1.158 . . . . 0.0 110.173 -179.93 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -71.15 131.05 42.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 -179.973 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.403 ' C ' HG22 ' A' ' 98' ' ' THR . . . -126.74 14.49 6.73 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.558 -1.417 . . . . 0.0 109.558 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.404 ' O ' ' O ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -176.58 135.45 0.24 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.198 -1.178 . . . . 0.0 110.428 179.959 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.404 ' O ' ' O ' ' A' ' 98' ' ' THR . 0.6 OUTLIER 51.2 97.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.298 -0.876 . . . . 0.0 110.149 179.984 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 101' ' ' CYS . . . -75.15 81.48 0.92 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 179.952 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . 0.407 ' O ' ' O ' ' A' ' 100' ' ' GLY . 1.8 t . . . . . 0 N--CA 1.491 1.608 0 O-C-N 121.277 -1.131 . . . . 0.0 110.241 179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.453 ' O ' ' N ' ' A' ' 3' ' ' HIS . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 65.26 -73.67 0.06 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.269 -1.136 . . . . 0.0 110.272 -179.983 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.453 ' N ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER 48.37 93.52 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.241 -0.912 . . . . 0.0 110.205 179.966 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -111.03 111.17 22.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.167 -0.958 . . . . 0.0 110.181 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.3 tp -139.59 -59.77 0.56 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.227 -0.921 . . . . 0.0 110.255 179.999 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -96.39 -166.41 1.42 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.177 -0.952 . . . . 0.0 110.269 -179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.442 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 17.0 t70 -176.06 55.78 0.13 Allowed Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.313 -0.867 . . . . 0.0 110.143 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.607 ' O ' HG12 ' A' ' 9' ' ' VAL . 48.4 Cg_endo -71.56 -157.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 124.054 1.555 . . . . 0.0 110.02 -179.9 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.607 HG12 ' O ' ' A' ' 8' ' ' PRO . 11.9 p 37.51 46.41 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.83 0 CA-C-O 121.233 0.539 . . . . 0.0 110.597 -179.979 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.443 ' O ' ' O ' ' A' ' 9' ' ' VAL . 16.3 mt-10 -42.93 165.99 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.299 -0.876 . . . . 0.0 110.171 -179.99 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 122.58 9.36 6.46 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.614 -1.394 . . . . 0.0 109.614 -179.959 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 7.4 m -167.42 97.17 0.49 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.306 -1.114 . . . . 0.0 110.247 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -126.87 -130.47 0.23 Allowed 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.287 -0.883 . . . . 0.0 109.285 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.27 -167.72 1.83 Allowed 'General case' 0 C--N 1.286 -2.173 0 O-C-N 121.679 -0.638 . . . . 0.0 110.204 179.931 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.497 HG21 ' OD2' ' A' ' 51' ' ' ASP . 4.2 m -89.51 -4.41 57.93 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.206 -0.934 . . . . 0.0 110.222 179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.831 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -170.52 165.4 5.31 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.189 -0.944 . . . . 0.0 110.33 -179.962 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.465 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.95 -34.06 2.46 Favored 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.097 1.577 . . . . 0.0 111.052 -179.624 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.546 ' CE2' ' C ' ' A' ' 67' ' ' SER . 94.2 m-85 -109.78 115.62 30.18 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.061 -1.025 . . . . 0.0 110.737 -179.51 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.492 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 3.5 m-80 -142.88 152.36 42.03 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 121.412 -0.805 . . . . 0.0 109.567 179.697 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.735 ' N ' HD23 ' A' ' 20' ' ' LEU . 2.0 pt? -162.91 170.88 17.46 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.248 -0.908 . . . . 0.0 110.416 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -97.93 167.79 10.7 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.413 -0.804 . . . . 0.0 110.3 -179.903 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.512 ' N ' ' O ' ' A' ' 61' ' ' GLY . 14.2 mt -142.69 161.65 18.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.428 -0.795 . . . . 0.0 109.831 179.827 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -148.11 177.61 26.25 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 -179.877 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.515 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 16.9 t30 71.73 43.75 0.55 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.339 -1.095 . . . . 0.0 110.257 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.933 ' CD1' HD22 ' A' ' 34' ' ' LEU . 4.2 mm? -92.73 127.63 38.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.264 -0.898 . . . . 0.0 109.932 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.783 ' H ' HD21 ' A' ' 34' ' ' LEU . 63.8 t-20 -40.8 106.61 0.43 Allowed Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.54 -0.725 . . . . 0.0 110.447 -179.898 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.53 -24.4 16.18 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.085 1.571 . . . . 0.0 110.389 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.0 m-80 -76.44 -10.93 59.76 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.275 -0.89 . . . . 0.0 109.902 179.858 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.575 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.8 mmtp -114.68 -155.6 0.58 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.397 -0.814 . . . . 0.0 109.959 179.774 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.823 ' O ' HD12 ' A' ' 34' ' ' LEU . 6.8 m -115.22 153.39 30.95 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.274 -0.891 . . . . 0.0 110.369 179.885 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.082 HG11 HG22 ' A' ' 54' ' ' THR . 2.8 t -69.52 -21.03 24.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.452 0 O-C-N 121.224 -0.922 . . . . 0.0 109.422 179.554 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -66.53 -40.27 89.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.338 -0.851 . . . . 0.0 109.308 179.134 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.552 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 5.1 mm-40 -71.49 -45.35 62.74 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.532 -0.73 . . . . 0.0 109.354 179.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.933 HD22 ' CD1' ' A' ' 25' ' ' LEU . 0.4 OUTLIER -57.91 -31.07 66.42 Favored 'General case' 0 C--N 1.306 -1.325 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 178.841 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.575 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.6 OUTLIER -64.53 -62.09 1.81 Allowed 'General case' 0 C--N 1.305 -1.358 0 CA-C-O 121.513 0.673 . . . . 0.0 109.238 179.092 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.537 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 44.2 t -51.93 -38.99 24.27 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.555 -0.716 . . . . 0.0 109.684 178.91 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.82 -28.54 70.08 Favored 'General case' 0 C--N 1.301 -1.527 0 C-N-CA 119.177 -1.009 . . . . 0.0 109.036 179.628 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 34' ' ' LEU . 39.9 mt -88.08 -27.63 5.54 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 O-C-N 121.35 -0.844 . . . . 0.0 109.006 178.799 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.588 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 8.9 m -79.97 -26.94 39.79 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.288 -0.883 . . . . 0.0 109.101 179.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.1 OUTLIER -84.0 -38.99 20.23 Favored 'General case' 0 C--N 1.302 -1.474 0 O-C-N 121.513 -0.742 . . . . 0.0 109.25 179.445 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.809 HD22 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -65.99 -34.49 78.22 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.793 -0.818 . . . . 0.0 108.793 178.929 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.697 ' CD1' HD13 ' A' ' 77' ' ' LEU . 8.1 m-30 -86.45 -19.14 30.04 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.501 -0.749 . . . . 0.0 109.224 179.258 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.588 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -87.69 -28.12 21.99 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.337 -0.852 . . . . 0.0 109.831 179.778 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.459 ' HB2' ' O ' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -90.41 -20.23 23.02 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.409 -0.807 . . . . 0.0 109.247 179.377 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.877 ' OD1' HD21 ' A' ' 77' ' ' LEU . 1.9 m-80 -79.2 -59.63 2.69 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.658 -0.651 . . . . 0.0 109.56 179.443 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.605 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 5.8 m-20 149.01 30.79 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.008 0 CA-C-O 121.275 0.56 . . . . 0.0 109.925 179.3 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.769 HD11 ' HB3' ' A' ' 73' ' ' LYS . 1.9 mp -99.94 -157.35 0.6 Allowed 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.165 -0.959 . . . . 0.0 109.836 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -157.6 63.15 0.48 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.249 -0.907 . . . . 0.0 110.25 179.926 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 49' ' ' VAL . 7.8 m -49.89 117.4 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 CA-C-O 121.909 0.862 . . . . 0.0 109.975 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.831 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.4 t -93.6 -44.63 13.74 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 CA-C-O 121.165 0.507 . . . . 0.0 110.403 -179.423 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.497 ' OD2' HG21 ' A' ' 15' ' ' THR . 1.5 t70 -139.28 155.71 47.55 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.098 -1.001 . . . . 0.0 110.783 -179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.728 HG12 HG22 ' A' ' 63' ' ' VAL . 0.5 OUTLIER -136.86 174.44 11.95 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.366 0 O-C-N 121.318 -0.864 . . . . 0.0 110.101 -179.822 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.457 ' HB3' ' HB3' ' A' ' 62' ' ' TYR . 0.0 OUTLIER 175.17 178.14 0.15 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.168 -0.957 . . . . 0.0 110.057 179.896 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 1.082 HG22 HG11 ' A' ' 31' ' ' VAL . 18.5 p -103.14 170.18 8.12 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.111 -0.993 . . . . 0.0 110.515 -179.536 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.626 ' HA3' ' CB ' ' A' ' 60' ' ' PHE . . . -121.95 132.32 8.86 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.178 -1.569 . . . . 0.0 109.178 179.702 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.485 HG22 ' N ' ' A' ' 57' ' ' ASN . 53.3 m 57.46 -92.36 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.469 -1.018 . . . . 0.0 110.448 179.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.485 ' N ' HG22 ' A' ' 56' ' ' THR . 1.1 t-20 -154.53 99.32 2.17 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.058 -1.026 . . . . 0.0 110.744 -179.813 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.525 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 42.1 mtm180 45.12 23.75 0.11 Allowed 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.429 -0.794 . . . . 0.0 110.902 179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.431 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -121.26 -32.88 3.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.138 -0.976 . . . . 0.0 109.799 179.579 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.771 ' HA ' HD23 ' A' ' 25' ' ' LEU . 8.6 m-85 -119.88 -161.08 0.85 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.515 -0.74 . . . . 0.0 109.407 179.54 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.61 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -167.92 167.65 40.22 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.636 ' O ' HG23 ' A' ' 63' ' ' VAL . 14.6 t80 -142.01 153.58 44.37 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.394 -1.062 . . . . 0.0 109.546 -179.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.728 HG22 HG12 ' A' ' 52' ' ' VAL . 43.7 t -157.56 158.81 2.83 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 C-N-CA 119.07 -1.052 . . . . 0.0 111.192 -178.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.58 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 11.4 m-20 -123.85 142.35 51.2 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.679 -0.638 . . . . 0.0 109.286 179.302 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.836 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 49.6 m-85 -104.73 175.32 5.53 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.38 -0.825 . . . . 0.0 111.049 -179.215 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.635 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.37 11.76 20.05 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.416 -0.802 . . . . 0.0 111.524 -178.585 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.546 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 6.3 p -172.7 172.91 4.05 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.985 -1.072 . . . . 0.0 112.178 179.6 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -79.14 -23.96 43.65 Favored 'General case' 0 C--N 1.298 -1.64 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 178.033 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -84.43 -24.1 29.71 Favored 'General case' 0 C--N 1.298 -1.656 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.11 179.742 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.524 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 5.6 t0 -82.94 -26.58 31.28 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.65 -1.241 . . . . 0.0 107.65 178.281 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.774 ' C ' HD13 ' A' ' 71' ' ' LEU . 2.8 tm? -79.58 -34.47 40.82 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 121.461 0.648 . . . . 0.0 109.287 179.019 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -74.8 -33.86 62.29 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.467 -0.77 . . . . 0.0 109.779 179.6 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.769 ' HB3' HD11 ' A' ' 47' ' ' LEU . 0.1 OUTLIER -80.62 -21.94 41.05 Favored 'General case' 0 C--N 1.307 -1.239 0 N-CA-C 107.561 -1.274 . . . . 0.0 107.561 178.589 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.836 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -77.8 -28.23 50.33 Favored 'General case' 0 C--N 1.303 -1.45 0 C-N-CA 119.96 -0.696 . . . . 0.0 109.198 179.059 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.979 HD23 HD11 ' A' ' 89' ' ' LEU . 2.0 tm? -75.72 -46.23 32.27 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 179.236 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.478 ' N ' HD13 ' A' ' 75' ' ' LEU . 1.8 mt-10 -66.68 -26.31 66.97 Favored 'General case' 0 C--N 1.306 -1.313 0 C-N-CA 119.523 -0.871 . . . . 0.0 109.218 179.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.877 HD21 ' OD1' ' A' ' 45' ' ' ASN . 6.9 mt -70.7 -20.58 62.65 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.564 -0.71 . . . . 0.0 109.839 179.663 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.479 ' HB ' ' O ' ' A' ' 75' ' ' LEU . 1.5 t -39.66 -31.01 0.09 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 122.306 1.05 . . . . 0.0 110.212 -179.852 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.452 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.27 -20.31 9.75 Favored Glycine 0 C--N 1.281 -2.489 0 N-CA-C 109.196 -1.562 . . . . 0.0 109.196 179.572 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.017 ' CD1' HG23 ' A' ' 82' ' ' VAL . 2.9 pp -66.99 125.84 27.26 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.319 -1.106 . . . . 0.0 110.655 -179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.538 ' HG3' ' N ' ' A' ' 86' ' ' GLU . 11.0 mttt -93.88 78.67 4.16 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 122.301 1.048 . . . . 0.0 110.26 179.653 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.017 HG23 ' CD1' ' A' ' 80' ' ' LEU . 21.7 t -43.8 131.09 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.271 -2.838 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.146 179.562 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.575 ' CE1' ' HG3' ' A' ' 29' ' ' LYS . 3.0 m-85 44.32 24.25 0.08 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.178 -0.951 . . . . 0.0 110.467 -179.249 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 91.21 25.03 25.2 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.762 -1.335 . . . . 0.0 109.762 179.636 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.525 ' O ' ' N ' ' A' ' 87' ' ' ILE . 39.4 m-20 -140.35 104.8 4.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.188 -1.184 . . . . 0.0 110.343 179.977 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.538 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 5.9 tt0 -56.35 84.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.289 -0.882 . . . . 0.0 109.933 179.724 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.798 ' O ' HD12 ' A' ' 87' ' ' ILE . 2.7 pp -40.09 129.38 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 CA-C-O 121.523 0.678 . . . . 0.0 110.731 -179.679 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.499 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.2 OUTLIER -104.78 132.75 50.65 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.507 -0.745 . . . . 0.0 109.376 179.393 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.979 HD11 HD23 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -105.64 174.07 6.04 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.888 -1.133 . . . . 0.0 110.737 -179.45 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.41 135.91 0.58 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.505 -0.747 . . . . 0.0 110.109 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.27 113.29 5.6 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 121.233 -0.917 . . . . 0.0 110.167 -179.994 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.473 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 46.0 Cg_endo -73.13 -169.64 0.54 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 O-C-N 124.017 1.535 . . . . 0.0 110.432 -179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.473 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 1.7 ttmt 67.55 105.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.275 -0.891 . . . . 0.0 110.226 -179.982 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 126.62 -9.97 7.21 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.606 -1.398 . . . . 0.0 109.606 -179.975 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.41 ' O ' ' HG2' ' A' ' 95' ' ' ARG . 2.0 tmt_? -101.42 5.6 42.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -1.15 . . . . 0.0 110.224 -179.968 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.29 157.92 32.76 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.175 -0.953 . . . . 0.0 110.235 -179.955 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 163.12 57.49 0.02 OUTLIER Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.436 -1.465 . . . . 0.0 109.436 -180.0 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.7 p -123.44 115.94 22.41 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.242 -1.152 . . . . 0.0 110.315 179.934 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.04 -23.72 9.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.227 -0.92 . . . . 0.0 110.202 -179.933 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.74 87.75 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.552 -1.419 . . . . 0.0 109.552 -179.994 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 O-C-N 121.258 -1.142 . . . . 0.0 110.242 179.908 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.3 p 56.15 -161.31 0.19 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.198 -1.178 . . . . 0.0 110.197 179.979 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -115.63 -177.76 3.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.247 -0.908 . . . . 0.0 110.212 179.973 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.447 ' O ' ' CB ' ' A' ' 5' ' ' LEU . 30.2 ttp -85.39 -2.98 58.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.31 -0.869 . . . . 0.0 110.248 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.447 ' CB ' ' O ' ' A' ' 4' ' ' MET . 4.7 tp 65.58 137.09 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.261 -0.899 . . . . 0.0 110.204 179.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.18 59.55 4.51 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.164 -0.96 . . . . 0.0 110.242 -179.961 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 32.5 t0 -146.18 100.53 4.18 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.269 -0.894 . . . . 0.0 110.211 -179.963 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -72.51 79.42 1.84 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.99 1.521 . . . . 0.0 110.403 179.978 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' O ' ' N ' ' A' ' 11' ' ' GLY . 52.6 t -144.05 128.16 13.43 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 C-N-CA 120.364 -0.534 . . . . 0.0 110.18 -179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.475 ' O ' ' N ' ' A' ' 12' ' ' SER . 0.7 OUTLIER -58.18 84.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.0 110.193 179.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.486 ' N ' ' O ' ' A' ' 9' ' ' VAL . . . 43.48 -97.49 0.01 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.561 -1.415 . . . . 0.0 109.561 179.997 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.475 ' N ' ' O ' ' A' ' 10' ' ' GLU . 2.5 m 42.06 87.98 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.42 -1.047 . . . . 0.0 110.267 179.936 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -167.34 27.97 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.226 -0.921 . . . . 0.0 110.313 -179.96 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -49.46 156.43 0.63 Allowed 'General case' 0 C--N 1.291 -1.965 0 O-C-N 121.798 -0.564 . . . . 0.0 109.718 179.749 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 27.2 m -124.29 -25.42 4.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.215 -0.928 . . . . 0.0 110.676 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.976 ' CG2' HG11 ' A' ' 50' ' ' VAL . 65.2 p -139.57 164.48 38.04 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.448 -0.782 . . . . 0.0 110.579 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.559 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 50.9 Cg_endo -78.21 -31.6 2.8 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.127 1.593 . . . . 0.0 110.695 -179.89 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.657 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 89.9 m-85 -92.82 93.05 8.22 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.103 -0.998 . . . . 0.0 110.607 -179.582 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 1.5 m120 -137.38 150.63 47.83 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 121.252 -0.905 . . . . 0.0 109.317 179.689 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.029 HD11 HD23 ' A' ' 89' ' ' LEU . 2.1 pt? -158.94 -176.63 5.98 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.714 -179.823 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.576 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.2 t80 -101.37 156.61 17.35 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.4 -0.813 . . . . 0.0 109.664 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.646 HG22 HD21 ' A' ' 25' ' ' LEU . 2.4 mt -147.41 155.77 10.55 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 O-C-N 121.078 -1.014 . . . . 0.0 109.572 -179.652 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.545 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -143.13 -162.7 9.42 Favored Glycine 0 N--CA 1.488 2.124 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.981 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.498 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.5 t30 71.38 14.09 6.48 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.319 -1.107 . . . . 0.0 110.025 -179.72 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.938 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.4 mm? -66.5 124.81 23.8 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.199 -0.938 . . . . 0.0 109.704 179.635 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.508 ' ND2' ' HB2' ' A' ' 29' ' ' LYS . 32.6 t-20 -40.96 101.09 0.23 Allowed Pre-proline 0 C--N 1.299 -1.594 0 O-C-N 121.623 -0.673 . . . . 0.0 110.436 -179.963 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.44 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 45.8 Cg_endo -72.37 -31.62 11.23 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.079 1.568 . . . . 0.0 110.433 -179.923 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.467 ' OD1' ' OD1' ' A' ' 26' ' ' ASN . 28.4 p30 -72.68 -14.8 61.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.198 -0.939 . . . . 0.0 109.671 179.825 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.508 ' HB2' ' ND2' ' A' ' 26' ' ' ASN . 1.2 tmtt? -96.79 -153.78 0.43 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.473 -0.767 . . . . 0.0 109.79 179.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 2.3 m -112.45 148.58 34.08 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.372 -0.83 . . . . 0.0 110.279 179.806 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.56 HG12 ' NZ ' ' A' ' 35' ' ' LYS . 3.7 t -68.75 -25.25 30.08 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 121.238 -0.914 . . . . 0.0 109.514 179.514 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.507 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -66.97 -38.88 86.88 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.291 -0.881 . . . . 0.0 109.397 179.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.542 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 29.9 mm-40 -72.96 -31.67 64.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.41 -0.806 . . . . 0.0 109.539 179.325 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.938 HD13 ' HB3' ' A' ' 25' ' ' LEU . 23.5 mt -65.89 -31.83 72.99 Favored 'General case' 0 C--N 1.306 -1.296 0 O-C-N 121.379 -0.826 . . . . 0.0 109.198 179.302 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.56 ' NZ ' HG12 ' A' ' 31' ' ' VAL . 0.2 OUTLIER -72.1 -56.48 5.52 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.558 -0.714 . . . . 0.0 109.553 179.484 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.507 HG23 ' O ' ' A' ' 32' ' ' ALA . 5.6 t -61.02 -33.69 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.275 -0.891 . . . . 0.0 109.276 179.134 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.625 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.72 -38.4 90.3 Favored 'General case' 0 C--N 1.303 -1.423 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 179.182 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.587 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 65.8 mt -75.52 -29.07 20.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 O-C-N 121.544 -0.722 . . . . 0.0 109.584 178.983 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.855 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.5 OUTLIER -77.46 -31.94 54.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.0 -1.063 . . . . 0.0 108.819 179.084 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.6 tm-20 -81.7 -42.23 20.18 Favored 'General case' 0 C--N 1.3 -1.58 0 CA-C-O 121.507 0.67 . . . . 0.0 109.556 179.379 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.067 HD21 ' CD1' ' A' ' 80' ' ' LEU . 0.4 OUTLIER -59.54 -37.58 78.76 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.748 -0.781 . . . . 0.0 108.966 179.167 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.79 ' CD2' HG13 ' A' ' 49' ' ' VAL . 9.7 m-85 -82.12 -22.65 36.07 Favored 'General case' 0 C--N 1.302 -1.469 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 179.326 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.68 -17.2 54.21 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 179.052 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 6.4 mmtt -109.24 -16.98 13.94 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 109.741 179.595 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.713 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -84.4 -31.29 24.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.332 -0.855 . . . . 0.0 110.025 179.858 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.713 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 31.9 t0 112.62 28.68 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 CA-C-O 121.971 0.891 . . . . 0.0 108.765 -179.557 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.761 HD11 ' CG ' ' A' ' 73' ' ' LYS . 0.3 OUTLIER -105.59 -155.01 0.53 Allowed 'General case' 0 C--N 1.297 -1.677 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 179.769 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -168.98 63.53 0.06 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.142 -0.974 . . . . 0.0 110.282 179.893 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 39' ' ' SER . 4.9 m -49.62 116.75 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 CA-C-O 121.85 0.833 . . . . 0.0 109.829 179.647 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.976 HG11 ' CG2' ' A' ' 16' ' ' THR . 10.5 t -81.25 -38.0 16.18 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.838 0 O-C-N 121.787 -0.571 . . . . 0.0 110.616 -179.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.497 ' HB3' ' HB2' ' A' ' 64' ' ' ASP . 8.7 t0 -153.6 152.66 31.13 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 121.087 -1.008 . . . . 0.0 110.55 179.892 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.648 HG13 HG23 ' A' ' 63' ' ' VAL . 13.4 t -134.92 161.22 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.19 -0.944 . . . . 0.0 110.264 179.931 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.453 ' CG ' ' O ' ' A' ' 52' ' ' VAL . 26.5 mtp180 -155.61 154.87 32.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.295 -0.878 . . . . 0.0 110.009 179.954 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.462 ' C ' ' HA2' ' A' ' 61' ' ' GLY . 14.3 p -78.66 166.82 22.08 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.141 -0.975 . . . . 0.0 110.398 -179.785 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.533 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -141.06 122.3 2.07 Favored Glycine 0 N--CA 1.491 2.322 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.757 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.476 ' O ' ' O ' ' A' ' 55' ' ' GLY . 32.1 m 40.4 96.22 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.337 -1.096 . . . . 0.0 111.008 179.617 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 56' ' ' THR . 21.4 m120 60.11 -141.17 0.59 Allowed 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.274 -0.891 . . . . 0.0 110.73 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.538 ' CB ' ' CG2' ' A' ' 31' ' ' VAL . 3.6 ptt85 -114.5 34.32 4.81 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.244 -0.91 . . . . 0.0 110.437 -179.563 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 25' ' ' LEU . 11.1 pttt -118.47 -19.14 8.94 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.176 -0.952 . . . . 0.0 109.959 179.71 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.594 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -119.89 174.16 6.62 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.45 -0.781 . . . . 0.0 109.547 179.637 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -176.59 148.66 9.19 Favored Glycine 0 N--CA 1.491 2.361 0 C-N-CA 119.503 -1.332 . . . . 0.0 110.815 -179.909 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.625 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 8.4 t80 -111.51 157.57 20.18 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.699 -0.883 . . . . 0.0 109.016 179.481 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.648 HG23 HG13 ' A' ' 52' ' ' VAL . 0.4 OUTLIER -141.28 172.34 10.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.773 -1.204 . . . . 0.0 111.3 -179.478 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.504 ' HB3' ' ND2' ' A' ' 19' ' ' ASN . 2.6 m-20 -136.43 135.94 39.1 Favored 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.769 -0.582 . . . . 0.0 109.457 179.897 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' CZ ' ' CB ' ' A' ' 74' ' ' ALA . 16.8 m-85 -106.47 -178.66 3.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.562 -0.711 . . . . 0.0 110.988 -179.455 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.576 ' HB3' ' CG2' ' A' ' 50' ' ' VAL . 2.1 pp20? -117.45 5.55 12.51 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.407 -0.808 . . . . 0.0 111.044 -179.091 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.657 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 6.4 p -168.96 175.2 5.95 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-O 122.301 1.048 . . . . 0.0 112.21 -179.498 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.528 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -79.99 -23.56 41.48 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 107.554 -1.276 . . . . 0.0 107.554 177.899 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -82.74 -26.46 31.9 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.344 -0.843 . . . . 0.0 109.013 179.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.75 ' OD1' HD23 ' A' ' 47' ' ' LEU . 3.4 t0 -81.05 -27.76 35.63 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.103 -1.443 . . . . 0.0 107.103 178.088 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.444 ' O ' ' HB3' ' A' ' 74' ' ' ALA . 0.4 OUTLIER -75.5 -37.16 60.34 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 178.667 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 59.4 tt0 -69.99 -33.9 72.63 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.494 -0.753 . . . . 0.0 109.426 179.222 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.761 ' CG ' HD11 ' A' ' 47' ' ' LEU . 2.7 tppt? -73.4 -25.71 60.66 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 106.805 -1.554 . . . . 0.0 106.805 178.193 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 1.014 ' HA ' HD23 ' A' ' 77' ' ' LEU . . . -72.68 -26.99 61.82 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.943 0.878 . . . . 0.0 108.641 178.599 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.757 HD13 ' O ' ' A' ' 75' ' ' LEU . 1.7 tm? -76.22 -34.47 59.23 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.281 -0.887 . . . . 0.0 109.352 179.261 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -82.28 -16.76 48.3 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.398 -0.814 . . . . 0.0 110.729 -179.926 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.014 HD23 ' HA ' ' A' ' 74' ' ' ALA . 1.1 pp -66.38 -17.83 65.0 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.98 -1.075 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.435 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 0.2 OUTLIER -47.72 -16.87 0.08 Allowed 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.569 -0.707 . . . . 0.0 111.751 -179.359 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.405 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -82.72 14.78 34.64 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.844 -1.302 . . . . 0.0 109.844 179.549 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.067 ' CD1' HD21 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -101.4 -163.71 1.04 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.169 -1.195 . . . . 0.0 110.507 179.996 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.611 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -168.35 49.76 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.746 0.784 . . . . 0.0 109.627 -179.758 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.848 ' CG2' HG23 ' A' ' 87' ' ' ILE . 5.0 t 5.67 -122.86 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.565 0 CA-C-N 114.218 -1.356 . . . . 0.0 111.708 -179.886 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.625 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 3.3 m-85 -72.31 -2.9 20.85 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 120.985 -1.072 . . . . 0.0 109.355 179.045 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 145.99 35.24 0.06 OUTLIER Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 179.877 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.508 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.1 m-20 -157.87 101.93 1.81 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.134 -1.215 . . . . 0.0 109.996 179.991 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.611 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 2.8 pt-20 -52.58 90.59 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.174 -0.954 . . . . 0.0 110.1 -179.357 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.848 HG23 ' CG2' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -37.92 148.26 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.693 0.758 . . . . 0.0 110.75 -179.645 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 16.3 ttpt -121.87 156.81 32.51 Favored 'General case' 0 C--N 1.295 -1.796 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.204 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 1.029 HD23 HD11 ' A' ' 20' ' ' LEU . 1.8 mp -112.88 173.41 6.39 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.047 -1.033 . . . . 0.0 110.415 -179.47 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -165.23 120.18 1.31 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.311 -0.868 . . . . 0.0 110.065 179.945 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.3 110.42 2.85 Favored Pre-proline 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 0.0 110.097 -179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 46.9 Cg_endo -75.71 -170.0 0.76 Allowed 'Trans proline' 0 C--N 1.304 -1.802 0 O-C-N 124.028 1.541 . . . . 0.0 110.235 -179.867 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -127.52 21.93 6.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.217 -0.927 . . . . 0.0 110.095 179.938 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -106.94 15.97 39.85 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 179.954 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -57.53 97.51 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.259 -1.142 . . . . 0.0 110.227 -179.933 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 43.9 m-20 -114.23 -179.01 3.51 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.242 -0.911 . . . . 0.0 110.196 -179.985 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -151.65 -91.4 0.08 OUTLIER Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.531 -1.427 . . . . 0.0 109.531 -179.969 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.46 167.05 23.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.244 -1.151 . . . . 0.0 110.522 -179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 5.3 ptm180 -126.62 -176.04 3.57 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.236 -0.915 . . . . 0.0 110.216 -179.897 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 110.27 45.07 0.95 Allowed Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 179.944 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.8 m . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.203 -1.175 . . . . 0.0 110.225 179.962 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 3' ' ' HIS . 2.5 m -148.03 31.14 0.86 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.283 -1.127 . . . . 0.0 110.171 179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 2' ' ' SER . 35.5 m170 54.62 68.47 0.86 Allowed 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.297 -0.877 . . . . 0.0 110.231 179.975 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.5 ttp -106.13 110.54 22.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.313 -0.867 . . . . 0.0 110.219 179.979 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.406 HD12 ' C ' ' A' ' 5' ' ' LEU . 2.8 pp -162.22 158.17 24.04 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.333 -0.854 . . . . 0.0 110.194 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -121.71 -67.25 0.98 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.253 -0.905 . . . . 0.0 110.247 -179.986 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 37.7 t0 -159.7 70.39 3.21 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.23 -0.919 . . . . 0.0 110.193 -179.977 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.431 ' C ' HG23 ' A' ' 9' ' ' VAL . 49.5 Cg_endo -71.44 -157.04 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.696 0 O-C-N 123.959 1.505 . . . . 0.0 110.095 -179.974 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.431 HG23 ' C ' ' A' ' 8' ' ' PRO . 41.1 t -146.35 101.44 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.93 0 O-C-N 121.762 -0.586 . . . . 0.0 110.176 -179.959 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.45 ' N ' ' CD ' ' A' ' 10' ' ' GLU . 1.1 pm0 -148.41 39.92 0.91 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.161 -0.962 . . . . 0.0 110.24 179.977 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -95.57 20.81 47.9 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 -179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.537 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 93.0 p -102.5 -22.14 14.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -1.201 . . . . 0.0 110.191 -179.991 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.537 ' HB3' ' O ' ' A' ' 12' ' ' SER . 33.3 tt0 68.46 122.71 0.03 OUTLIER 'General case' 0 C--N 1.307 -1.263 0 CA-C-O 122.85 1.31 . . . . 0.0 110.367 -179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.429 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -39.25 142.35 0.26 Allowed 'General case' 0 C--N 1.279 -2.473 0 CA-C-N 114.361 -1.29 . . . . 0.0 110.208 -179.985 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 16' ' ' THR . 7.2 m -103.27 -5.18 23.33 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.305 -0.872 . . . . 0.0 110.282 -179.94 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.764 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -166.68 162.89 11.28 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.23 -0.919 . . . . 0.0 110.325 -179.913 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -74.76 -32.87 5.4 Favored 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 124.115 1.587 . . . . 0.0 110.489 179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.577 ' CD1' ' HB2' ' A' ' 71' ' ' LEU . 84.9 m-85 -108.47 107.36 17.86 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.927 . . . . 0.0 110.432 -179.72 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.514 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 0.8 OUTLIER -139.25 146.72 40.78 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.312 -0.868 . . . . 0.0 109.339 179.782 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.622 HD23 ' H ' ' A' ' 20' ' ' LEU . 1.0 OUTLIER -163.17 175.1 11.34 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.12 -0.987 . . . . 0.0 110.924 -179.842 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 60' ' ' PHE . 2.4 t80 -97.37 147.75 23.86 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.713 -0.617 . . . . 0.0 110.103 -179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.841 HD13 HG23 ' A' ' 63' ' ' VAL . 1.1 mp -133.85 148.05 30.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.32 -0.862 . . . . 0.0 109.946 -179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.46 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -135.56 -166.05 10.89 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.711 -1.356 . . . . 0.0 109.711 -179.852 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' C ' HD23 ' A' ' 25' ' ' LEU . 28.1 t30 67.15 58.16 0.57 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.284 -1.127 . . . . 0.0 110.099 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.878 HD11 ' N ' ' A' ' 61' ' ' GLY . 8.1 mt -105.95 123.99 48.87 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.205 -0.934 . . . . 0.0 110.366 -179.841 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' C ' ' O ' ' A' ' 25' ' ' LEU . 53.3 t-20 -41.45 104.13 0.33 Allowed Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.461 -0.774 . . . . 0.0 110.213 179.742 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.75 -15.48 26.85 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 123.955 1.503 . . . . 0.0 110.437 -179.941 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 26.8 m120 -78.13 -17.15 57.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.292 -0.88 . . . . 0.0 109.844 179.727 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.19 -156.02 0.58 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.543 -0.723 . . . . 0.0 109.742 179.632 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.526 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.5 m -100.33 146.85 26.45 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.239 -0.913 . . . . 0.0 110.074 179.766 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.736 HG22 ' CB ' ' A' ' 58' ' ' ARG . 0.8 OUTLIER -70.85 -33.27 51.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.51 0 C-N-CA 119.044 -1.063 . . . . 0.0 108.622 179.364 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -62.96 -39.35 94.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.464 -0.773 . . . . 0.0 108.956 178.819 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.526 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 12.8 mm-40 -66.56 -33.54 75.91 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.902 -0.777 . . . . 0.0 108.902 178.902 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.894 ' O ' HD12 ' A' ' 38' ' ' ILE . 0.2 OUTLIER -64.26 -33.8 76.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.49 -0.756 . . . . 0.0 109.186 179.231 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 1.045 ' HD3' HG12 ' A' ' 52' ' ' VAL . 5.2 mmtt -66.29 -53.79 32.5 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.474 -0.766 . . . . 0.0 109.119 179.318 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.548 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 10.9 t -60.84 -40.94 86.83 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.477 -0.764 . . . . 0.0 109.376 178.829 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.507 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -61.8 -29.16 69.96 Favored 'General case' 0 C--N 1.303 -1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 108.951 179.442 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.894 HD12 ' O ' ' A' ' 34' ' ' LEU . 10.3 mt -85.86 -30.28 6.33 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.549 -0.719 . . . . 0.0 109.101 178.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.684 ' HA ' HG11 ' A' ' 49' ' ' VAL . 34.2 p -78.65 -25.77 45.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.333 -0.854 . . . . 0.0 109.283 179.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.548 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -84.43 -39.89 18.43 Favored 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.47 -0.768 . . . . 0.0 109.137 179.39 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.063 HD21 HD22 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -62.65 -36.83 84.1 Favored 'General case' 0 C--N 1.302 -1.499 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.739 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.071 ' CE2' HD21 ' A' ' 77' ' ' LEU . 9.1 m-30 -80.01 -25.19 40.35 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 178.801 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -68.67 -40.15 80.29 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.629 -0.669 . . . . 0.0 109.488 179.379 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.51 -17.57 53.82 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.45 -0.781 . . . . 0.0 109.506 179.359 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 2.0 m-80 -85.11 -8.73 58.52 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.521 -0.737 . . . . 0.0 110.009 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 9.1 t0 84.52 30.26 0.06 Allowed 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 121.954 0.883 . . . . 0.0 108.848 -179.299 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.846 HD21 ' CE1' ' A' ' 65' ' ' PHE . 0.4 OUTLIER -83.72 -132.34 0.04 OUTLIER 'General case' 0 C--N 1.299 -1.617 0 CA-C-O 121.321 0.581 . . . . 0.0 109.544 179.479 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 1.022 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 174.5 57.39 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.361 -0.837 . . . . 0.0 109.837 179.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.684 HG11 ' HA ' ' A' ' 39' ' ' SER . 10.1 m -56.19 117.33 1.2 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 121.907 0.86 . . . . 0.0 110.472 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.765 HG22 ' HB3' ' A' ' 66' ' ' GLU . 0.2 OUTLIER -92.42 -44.22 14.02 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 CA-C-O 121.289 0.566 . . . . 0.0 109.651 -179.917 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.515 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 35.2 t70 -136.76 145.8 45.02 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.256 -0.902 . . . . 0.0 110.615 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.045 HG12 ' HD3' ' A' ' 35' ' ' LYS . 1.8 t -153.96 119.85 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 O-C-N 121.374 -0.829 . . . . 0.0 109.132 179.71 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.72 160.04 40.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.891 -1.13 . . . . 0.0 111.266 -179.43 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.578 ' HB ' HG11 ' A' ' 31' ' ' VAL . 39.2 p -92.21 152.29 19.93 Favored 'General case' 0 C--N 1.305 -1.34 0 O-C-N 121.5 -0.75 . . . . 0.0 110.027 179.958 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -125.95 124.29 5.14 Favored Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.708 -1.357 . . . . 0.0 109.708 -179.925 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.625 HG22 ' H ' ' A' ' 57' ' ' ASN . 0.8 OUTLIER 67.97 -158.86 0.21 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.363 -1.081 . . . . 0.0 110.482 179.751 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.625 ' H ' HG22 ' A' ' 56' ' ' THR . 10.3 t-20 -82.57 74.1 9.56 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.33 -0.856 . . . . 0.0 110.456 -179.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.736 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.4 OUTLIER 60.64 14.54 5.05 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.272 -0.893 . . . . 0.0 110.113 179.663 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 3.6 ttpp -69.27 -50.51 46.2 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.148 -0.97 . . . . 0.0 110.223 -179.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 21' ' ' PHE . 5.3 p90 -156.8 152.24 26.65 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.299 -0.876 . . . . 0.0 109.884 179.882 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.878 ' N ' HD11 ' A' ' 25' ' ' LEU . . . -124.04 167.95 16.27 Favored Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.027 -1.229 . . . . 0.0 110.027 -179.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.59 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 12.1 t80 -119.75 155.3 32.75 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.406 -1.055 . . . . 0.0 109.721 179.6 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.841 HG23 HD13 ' A' ' 22' ' ' ILE . 3.2 t -151.2 143.43 16.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 C-N-CA 119.236 -0.986 . . . . 0.0 110.746 -178.613 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.519 ' OD1' ' N ' ' A' ' 64' ' ' ASP . 0.9 OUTLIER -117.83 143.96 45.81 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.332 -0.855 . . . . 0.0 109.705 179.676 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.846 ' CE1' HD21 ' A' ' 47' ' ' LEU . 37.6 m-85 -107.92 171.76 7.22 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.307 -0.871 . . . . 0.0 110.168 -179.883 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.838 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 1.2 pp20? -118.55 16.38 13.74 Favored 'General case' 0 C--N 1.302 -1.487 0 C-N-CA 119.555 -0.858 . . . . 0.0 111.29 -178.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.505 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 17.0 p -164.37 176.13 9.37 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-O 122.466 1.127 . . . . 0.0 112.207 179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -78.91 -25.09 43.74 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.537 -1.282 . . . . 0.0 107.537 177.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.57 -31.07 59.88 Favored 'General case' 0 C--N 1.296 -1.758 0 CA-C-N 115.085 -0.961 . . . . 0.0 109.093 179.833 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 1.022 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 91.3 m-20 -78.7 -28.4 45.12 Favored 'General case' 0 C--N 1.305 -1.327 0 N-CA-C 106.897 -1.519 . . . . 0.0 106.897 177.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.77 ' C ' HD13 ' A' ' 71' ' ' LEU . 1.8 tm? -74.64 -37.84 62.66 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.645 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 30.1 tp10 -65.81 -34.53 78.38 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.451 -0.78 . . . . 0.0 109.025 178.948 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.707 ' C ' HD13 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -76.02 -32.35 59.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 177.976 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB2' ' CE2' ' A' ' 65' ' ' PHE . . . -56.14 -33.57 65.32 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.459 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.588 ' C ' HD13 ' A' ' 75' ' ' LEU . 2.5 tm? -72.47 -46.13 56.31 Favored 'General case' 0 C--N 1.305 -1.352 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 178.486 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -82.52 6.71 16.6 Favored 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 119.821 -0.752 . . . . 0.0 109.346 178.58 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.071 HD21 ' CE2' ' A' ' 42' ' ' PHE . 1.0 OUTLIER -77.15 -12.61 59.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.462 -0.773 . . . . 0.0 110.367 -179.896 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.932 ' OG1' HD21 ' A' ' 89' ' ' LEU . 26.1 m -73.68 7.63 2.35 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.513 -0.742 . . . . 0.0 111.558 -179.382 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.474 ' HA2' ' HG3' ' A' ' 86' ' ' GLU . . . -124.39 18.34 7.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 179.792 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.063 HD22 HD21 ' A' ' 41' ' ' LEU . 27.3 mt -107.66 111.16 23.24 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.257 -1.143 . . . . 0.0 110.809 -179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.473 ' O ' ' O ' ' A' ' 82' ' ' VAL . 38.1 mttm -76.91 84.02 3.46 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-O 122.07 0.938 . . . . 0.0 109.741 179.261 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.886 ' CG1' HG23 ' A' ' 87' ' ' ILE . 1.2 p -36.96 -94.55 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.277 -2.565 0 CA-C-N 115.35 -0.841 . . . . 0.0 110.415 179.81 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.792 ' N ' HG22 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -96.81 29.05 3.17 Favored 'General case' 0 C--N 1.288 -2.102 0 O-C-N 121.159 -0.963 . . . . 0.0 109.681 179.498 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.459 ' O ' ' OD1' ' A' ' 85' ' ' ASN . . . 115.46 9.54 12.78 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.121 -1.592 . . . . 0.0 109.121 -179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.722 ' O ' HG12 ' A' ' 82' ' ' VAL . 3.4 m-20 -139.95 106.28 5.28 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.356 -1.085 . . . . 0.0 109.608 179.876 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.531 ' CG ' ' O ' ' A' ' 78' ' ' THR . 1.6 tm-20 -47.67 88.67 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.505 -0.747 . . . . 0.0 110.692 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.886 HG23 ' CG1' ' A' ' 82' ' ' VAL . 0.6 OUTLIER -45.73 145.09 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.305 -0.872 . . . . 0.0 110.104 179.777 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.536 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 10.0 ttmt -117.58 155.7 29.36 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.647 -0.658 . . . . 0.0 109.837 179.725 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.932 HD21 ' OG1' ' A' ' 78' ' ' THR . 0.2 OUTLIER -120.66 175.02 6.22 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 121.417 -0.802 . . . . 0.0 110.327 -179.769 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.531 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 0.8 OUTLIER -163.54 161.61 24.07 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.542 -0.724 . . . . 0.0 109.663 -179.592 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.531 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 7.3 mtpp -103.43 95.63 7.39 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.314 -0.866 . . . . 0.0 110.288 -179.869 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 45.1 Cg_endo -72.24 -173.34 1.08 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 124.082 1.569 . . . . 0.0 110.5 179.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.488 ' O ' ' N ' ' A' ' 95' ' ' ARG . 4.0 tttm 63.61 48.2 3.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.25 -0.906 . . . . 0.0 109.947 -179.918 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.61 59.77 0.31 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 -179.982 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.488 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.5 OUTLIER 52.17 -141.8 0.8 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.189 -1.183 . . . . 0.0 110.167 179.955 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -140.58 120.63 13.71 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.204 -0.935 . . . . 0.0 110.177 -179.952 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -111.45 -167.01 18.44 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 p -114.48 109.63 18.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.263 -1.139 . . . . 0.0 110.296 179.94 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 10.9 ttt-85 -117.97 -46.78 2.62 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.293 -0.879 . . . . 0.0 110.137 -179.968 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 62.49 158.55 0.13 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.54 -1.424 . . . . 0.0 109.54 -179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.8 p . . . . . 0 N--CA 1.491 1.617 0 O-C-N 121.289 -1.124 . . . . 0.0 110.209 -179.963 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -114.37 20.34 15.54 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.273 -1.134 . . . . 0.0 110.206 -179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -111.44 -171.32 1.81 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.238 -0.914 . . . . 0.0 110.136 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -132.47 139.24 47.89 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.258 -0.901 . . . . 0.0 110.215 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.6 tp -131.32 130.55 42.87 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.19 -0.944 . . . . 0.0 110.262 179.993 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -91.31 150.14 21.44 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.222 -0.924 . . . . 0.0 110.234 179.991 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.408 ' OD1' ' HD2' ' A' ' 8' ' ' PRO . 9.5 t0 -68.24 136.16 91.35 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.332 -0.855 . . . . 0.0 110.189 -179.982 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' O ' ' N ' ' A' ' 10' ' ' GLU . 49.6 Cg_endo -71.52 -156.95 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.073 1.564 . . . . 0.0 110.148 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.428 ' C ' ' O ' ' A' ' 8' ' ' PRO . 66.7 t -41.77 94.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.99 0 O-C-N 121.764 -0.585 . . . . 0.0 110.169 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.513 ' O ' ' N ' ' A' ' 12' ' ' SER . 2.2 mt-10 -50.57 103.24 0.05 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.217 -0.927 . . . . 0.0 110.297 179.977 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.417 ' C ' ' O ' ' A' ' 10' ' ' GLU . . . 44.28 -94.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.531 ' O ' ' HB3' ' A' ' 13' ' ' GLU . 92.7 p -133.69 -66.19 0.65 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.164 -1.198 . . . . 0.0 110.249 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' HB3' ' O ' ' A' ' 12' ' ' SER . 15.1 tt0 67.54 122.25 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 CA-C-O 122.76 1.267 . . . . 0.0 110.28 -179.436 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.462 ' HB3' ' OD1' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -77.27 0.3 22.6 Favored 'General case' 0 C--N 1.276 -2.615 0 CA-C-N 114.489 -1.232 . . . . 0.0 110.552 -179.859 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.759 HG22 ' O ' ' A' ' 15' ' ' THR . 23.8 m 47.79 19.74 0.18 Allowed 'General case' 0 C--N 1.294 -1.815 0 O-C-N 121.564 -0.71 . . . . 0.0 110.873 179.649 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.967 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -175.42 168.78 1.59 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 120.817 -1.177 . . . . 0.0 110.854 -179.88 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.609 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.6 Cg_endo -79.33 -48.06 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.75 0 O-C-N 124.218 1.641 . . . . 0.0 110.638 -179.9 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.63 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 98.3 m-85 -85.84 110.03 19.11 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.116 -0.99 . . . . 0.0 110.226 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.462 ' OD1' ' HB3' ' A' ' 14' ' ' SER . 5.6 m-80 -139.23 152.04 47.01 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.307 -0.87 . . . . 0.0 110.141 -179.892 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.766 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.4 pp -162.54 -177.71 5.78 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.408 -0.808 . . . . 0.0 110.065 179.918 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.716 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.8 t80 -117.78 144.64 45.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.318 -0.864 . . . . 0.0 110.446 -179.812 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.63 HG22 HD21 ' A' ' 25' ' ' LEU . 1.1 mt -133.49 155.4 40.37 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 121.333 -0.854 . . . . 0.0 109.132 179.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.54 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -128.18 -174.86 13.87 Favored Glycine 0 N--CA 1.49 2.262 0 C-N-CA 119.505 -1.331 . . . . 0.0 110.194 -179.417 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.54 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 3.3 t30 74.86 13.69 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.66 -0.906 . . . . 0.0 110.667 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.63 HD21 HG22 ' A' ' 22' ' ' ILE . 4.3 mm? -62.59 123.5 18.53 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.024 -1.048 . . . . 0.0 109.823 179.415 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.476 ' OD1' ' HB3' ' A' ' 83' ' ' PHE . 0.6 OUTLIER -39.57 99.41 0.19 Allowed Pre-proline 0 C--N 1.297 -1.704 0 O-C-N 121.876 -0.515 . . . . 0.0 110.496 179.984 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.8 Cg_endo -78.16 -17.2 13.53 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.979 1.515 . . . . 0.0 110.619 -179.766 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -83.11 -17.78 41.84 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.195 -0.94 . . . . 0.0 110.071 -179.853 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.566 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.3 OUTLIER -110.5 -157.07 0.6 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.4 -0.813 . . . . 0.0 109.613 179.626 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.483 ' O ' ' HG ' ' A' ' 34' ' ' LEU . 0.8 OUTLIER -99.05 140.89 32.53 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 121.229 -0.92 . . . . 0.0 110.365 179.895 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.008 HG11 HG22 ' A' ' 54' ' ' THR . 2.6 t -67.24 -34.15 67.4 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 118.99 -1.084 . . . . 0.0 108.732 179.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.897 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.86 -34.53 69.84 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 178.454 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 44.6 mm-40 -68.23 -43.71 77.35 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.909 -0.775 . . . . 0.0 108.909 178.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.882 HD22 HG12 ' A' ' 82' ' ' VAL . 9.1 mt -61.15 -46.07 92.04 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 178.609 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.68 ' HG2' HG22 ' A' ' 52' ' ' VAL . 90.7 mttt -53.54 -51.05 64.14 Favored 'General case' 0 C--N 1.3 -1.581 0 CA-C-O 121.314 0.578 . . . . 0.0 109.495 179.383 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.897 HG23 ' O ' ' A' ' 32' ' ' ALA . 11.3 t -63.64 -38.56 82.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.323 -0.86 . . . . 0.0 109.474 179.234 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.527 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.89 -35.64 81.31 Favored 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 119.365 -0.934 . . . . 0.0 108.733 179.345 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.593 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 93.4 mt -79.24 -28.14 13.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.49 -0.756 . . . . 0.0 109.171 178.846 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 1.046 ' HA ' HG21 ' A' ' 49' ' ' VAL . 6.9 t -78.0 -31.71 50.77 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.159 -0.963 . . . . 0.0 108.972 179.2 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -79.75 -38.85 32.33 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.603 -0.686 . . . . 0.0 109.765 179.589 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.55 HD22 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -67.67 -31.74 71.93 Favored 'General case' 0 C--N 1.302 -1.484 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.315 179.335 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.593 ' CD1' ' O ' ' A' ' 38' ' ' ILE . 7.2 m-85 -82.18 -23.71 35.36 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.374 -0.829 . . . . 0.0 108.928 178.905 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -72.42 -31.42 65.48 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.491 -0.756 . . . . 0.0 109.471 179.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.4 mttt -94.14 -17.26 22.95 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.524 -0.735 . . . . 0.0 109.684 179.546 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.665 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -81.77 -24.57 35.93 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.385 -0.822 . . . . 0.0 109.982 179.862 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.665 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 23.6 t70 101.57 28.89 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.299 0 N-CA-C 108.466 -0.939 . . . . 0.0 108.466 -179.351 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.124 HD11 HD21 ' A' ' 77' ' ' LEU . 0.7 OUTLIER -97.5 -151.04 0.36 Allowed 'General case' 0 C--N 1.299 -1.623 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.505 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.54 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -168.88 62.34 0.06 Allowed 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.081 -1.012 . . . . 0.0 109.841 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.046 HG21 ' HA ' ' A' ' 39' ' ' SER . 7.3 m -54.23 117.77 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 CA-C-O 121.918 0.866 . . . . 0.0 110.043 -179.881 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.967 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -93.41 -39.13 10.61 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.944 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.981 -179.604 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.494 ' HB2' ' HB2' ' A' ' 64' ' ' ASP . 0.1 OUTLIER -146.75 163.65 35.29 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.072 -1.017 . . . . 0.0 110.572 179.864 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.68 HG22 ' HG2' ' A' ' 35' ' ' LYS . 14.4 p -165.61 114.72 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.406 -0.809 . . . . 0.0 109.909 179.895 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.485 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.1 OUTLIER -119.59 165.3 14.63 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.505 -179.66 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 1.008 HG22 HG11 ' A' ' 31' ' ' VAL . 3.8 p -79.56 171.24 15.41 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.43 -0.794 . . . . 0.0 110.008 -179.953 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.491 ' O ' ' CD2' ' A' ' 60' ' ' PHE . . . -140.45 98.48 0.23 Allowed Glycine 0 N--CA 1.491 2.36 0 C-N-CA 119.634 -1.269 . . . . 0.0 110.479 -179.803 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.462 ' HB ' ' O ' ' A' ' 55' ' ' GLY . 85.6 m 58.78 130.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.349 -1.089 . . . . 0.0 111.779 178.845 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.45 ' C ' ' O ' ' A' ' 56' ' ' THR . 1.3 m-80 33.18 40.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.858 -0.526 . . . . 0.0 111.586 178.944 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.517 ' HB3' ' CG2' ' A' ' 31' ' ' VAL . 3.6 mtp-105 43.5 25.34 0.08 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.074 -1.016 . . . . 0.0 110.313 179.794 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.517 ' O ' ' N ' ' A' ' 25' ' ' LEU . 0.0 OUTLIER -88.37 -33.27 18.0 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.201 -0.937 . . . . 0.0 109.679 179.733 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 55' ' ' GLY . 3.0 m-85 -112.68 -160.73 0.73 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.467 -0.771 . . . . 0.0 109.167 179.295 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.495 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . 179.24 125.99 0.98 Allowed Glycine 0 N--CA 1.489 2.168 0 C-N-CA 119.452 -1.356 . . . . 0.0 110.066 179.736 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.68 ' CE2' ' CD1' ' A' ' 21' ' ' PHE . 61.1 m-85 -90.2 158.57 17.16 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.29 -1.124 . . . . 0.0 109.598 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.68 HG22 HG23 ' A' ' 52' ' ' VAL . 2.8 t -149.86 141.4 17.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.323 -0.951 . . . . 0.0 110.906 -178.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.502 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 52.0 m-20 -112.67 146.46 38.64 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.53 -0.731 . . . . 0.0 109.53 179.371 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.73 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 50.3 m-85 -112.38 177.22 4.71 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.257 -0.902 . . . . 0.0 110.878 -179.422 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.597 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -113.79 18.86 17.12 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.424 -0.798 . . . . 0.0 111.475 -178.354 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.63 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 23.4 p -178.83 -179.3 0.6 Allowed 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.643 1.211 . . . . 0.0 112.325 179.884 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . 0.259 . . -81.0 -28.58 35.43 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 106.437 -1.69 . . . . 0.0 106.437 177.484 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -74.13 -24.92 59.5 Favored 'General case' 0 C--N 1.29 -2.006 0 CA-C-N 113.613 -1.63 . . . . 0.0 109.229 -179.889 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.709 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 79.1 m-20 -83.33 -33.34 25.91 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.265 -1.383 . . . . 0.0 107.265 177.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.513 ' O ' HD12 ' A' ' 71' ' ' LEU . 9.5 tp -70.67 -36.93 73.59 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.981 -0.688 . . . . 0.0 109.741 179.263 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 -71.81 -41.17 68.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.305 -0.872 . . . . 0.0 109.689 179.581 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.885 ' HB3' HD21 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -74.25 -32.62 63.04 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.611 -1.626 . . . . 0.0 106.611 178.134 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.73 ' HB1' ' CE2' ' A' ' 65' ' ' PHE . . . -60.26 -29.92 69.1 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 178.747 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.492 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.3 OUTLIER -72.18 -49.03 38.8 Favored 'General case' 0 C--N 1.307 -1.242 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 178.724 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -78.09 -0.46 28.2 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.61 -0.836 . . . . 0.0 109.31 178.419 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.124 HD21 HD11 ' A' ' 47' ' ' LEU . 0.3 OUTLIER -82.56 17.08 1.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.388 -0.82 . . . . 0.0 110.367 -179.725 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.514 ' OG1' ' CD1' ' A' ' 89' ' ' LEU . 86.3 m -87.73 5.62 39.0 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.184 -0.948 . . . . 0.0 109.806 179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.09 20.92 33.76 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.782 -1.327 . . . . 0.0 109.782 -179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.879 ' CD2' HD12 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -118.12 124.74 48.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.25 -1.147 . . . . 0.0 110.602 -179.711 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.471 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 14.9 mttt -87.98 82.54 7.21 Favored 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 119.55 -0.86 . . . . 0.0 109.613 179.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.882 HG12 HD22 ' A' ' 34' ' ' LEU . 76.5 t -42.99 106.69 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.283 -2.309 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 179.646 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 0.5 OUTLIER 60.09 22.67 11.89 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 110.397 -179.17 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 100.84 14.72 30.86 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.759 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.513 ' O ' ' N ' ' A' ' 87' ' ' ILE . 19.5 m-20 -133.3 103.26 5.89 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.136 -1.214 . . . . 0.0 110.207 179.959 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.505 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.7 tt0 -57.52 83.23 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.245 -0.91 . . . . 0.0 110.124 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.864 HG21 HG21 ' A' ' 82' ' ' VAL . 13.0 pt -41.71 137.31 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 O-C-N 121.382 -0.824 . . . . 0.0 110.586 -179.813 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.545 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 0.2 OUTLIER -104.48 167.86 9.47 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 179.164 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.54 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 1.4 mp -109.7 179.0 4.25 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.04 -1.038 . . . . 0.0 110.641 -179.556 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 179.42 137.62 0.1 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.637 -0.664 . . . . 0.0 109.949 179.957 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.1 112.07 22.88 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.164 -0.96 . . . . 0.0 110.325 -179.818 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.475 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 47.5 Cg_endo -74.18 -170.26 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.618 0 O-C-N 123.997 1.525 . . . . 0.0 110.416 -179.996 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 93' ' ' LYS . 1.9 pttt -168.22 35.03 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.257 -0.902 . . . . 0.0 110.181 179.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 69.03 90.23 0.07 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.982 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 124.95 3.15 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -1.176 . . . . 0.0 110.219 179.981 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.7 p30 -175.14 -177.37 1.05 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.246 -0.909 . . . . 0.0 110.154 -179.965 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -113.09 112.23 2.89 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -143.15 142.91 31.6 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.299 -1.118 . . . . 0.0 110.404 179.975 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -172.73 -36.65 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.229 -0.919 . . . . 0.0 110.233 -179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -115.99 -37.45 1.04 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 -179.976 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.236 -1.155 . . . . 0.0 110.182 -179.976 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.331 0 N-CA-C 109.505 -1.438 . . . . 0.0 109.505 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -157.7 70.49 0.58 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.275 -1.132 . . . . 0.0 110.192 179.947 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 36.2 p-80 -86.09 47.57 1.48 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.247 -0.908 . . . . 0.0 110.202 -179.986 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 12.0 mtm -82.43 121.7 27.08 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.256 -0.902 . . . . 0.0 110.197 179.991 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 mt -92.83 60.42 3.38 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.226 -0.921 . . . . 0.0 110.252 -179.995 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.471 ' O ' ' HD3' ' A' ' 8' ' ' PRO . 2.7 tp10 -90.51 117.54 29.28 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.205 -0.935 . . . . 0.0 110.2 -179.988 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 -97.99 104.71 23.55 Favored Pre-proline 0 N--CA 1.49 1.569 0 O-C-N 121.241 -0.912 . . . . 0.0 110.163 179.954 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.471 ' HD3' ' O ' ' A' ' 6' ' ' GLU . 44.1 Cg_endo -73.55 79.61 2.16 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.072 1.564 . . . . 0.0 110.36 -179.889 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.693 HG22 ' H ' ' A' ' 10' ' ' GLU . 1.6 p -122.11 -159.17 0.2 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 O-C-N 121.758 -0.589 . . . . 0.0 109.925 179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.693 ' H ' HG22 ' A' ' 9' ' ' VAL . 0.3 OUTLIER 42.96 47.86 5.0 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.17 -0.956 . . . . 0.0 110.26 -179.978 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 75.37 -80.57 1.0 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.456 ' OG ' ' N ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -156.04 -74.46 0.1 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.211 -1.17 . . . . 0.0 110.035 179.994 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.456 ' N ' ' OG ' ' A' ' 12' ' ' SER . 2.4 mt-10 -175.17 30.16 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 110.352 -179.936 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.65 137.67 57.41 Favored 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.764 -0.585 . . . . 0.0 110.107 179.997 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.66 ' O ' HG23 ' A' ' 16' ' ' THR . 5.1 m -123.79 8.14 8.78 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.249 -0.907 . . . . 0.0 110.243 -179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.8 HG21 ' CB ' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -173.52 161.98 3.3 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.225 -0.922 . . . . 0.0 110.516 -179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -76.77 -40.51 0.51 Allowed 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 124.249 1.657 . . . . 0.0 110.675 -179.791 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.508 ' O ' ' N ' ' A' ' 65' ' ' PHE . 81.6 m-85 -95.51 111.16 23.12 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.187 -0.945 . . . . 0.0 110.46 -179.618 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.519 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 m120 -135.64 151.87 50.66 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.379 -0.825 . . . . 0.0 109.687 179.631 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -160.01 166.89 29.12 Favored 'General case' 0 C--N 1.297 -1.684 0 O-C-N 121.558 -0.713 . . . . 0.0 110.512 -179.651 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.698 ' CE2' ' CD1' ' A' ' 60' ' ' PHE . 1.1 t80 -99.05 151.24 21.16 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.564 -0.71 . . . . 0.0 110.002 -179.637 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.663 HD12 ' CG2' ' A' ' 63' ' ' VAL . 7.8 mt -126.19 162.56 29.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.32 -0.862 . . . . 0.0 109.659 179.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.52 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -147.81 175.73 26.99 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.675 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.52 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 30.9 t30 72.71 64.01 0.11 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.582 -0.952 . . . . 0.0 110.07 -179.932 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.938 HD13 HG13 ' A' ' 31' ' ' VAL . 18.9 mt -95.4 -167.06 1.55 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.414 -0.804 . . . . 0.0 110.376 180.0 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.507 ' H ' HD11 ' A' ' 34' ' ' LEU . 54.0 t-20 -114.61 107.03 51.5 Favored Pre-proline 0 C--N 1.3 -1.575 0 O-C-N 121.622 -0.674 . . . . 0.0 109.825 -179.846 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.485 ' HA ' ' CD ' ' A' ' 58' ' ' ARG . 44.4 Cg_endo -72.27 -1.82 10.72 Favored 'Trans proline' 0 C--N 1.305 -1.753 0 O-C-N 124.064 1.56 . . . . 0.0 110.579 -179.664 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 34.3 m-20 -113.97 20.52 15.66 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.293 -0.879 . . . . 0.0 108.671 179.11 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.507 ' CG ' ' OE2' ' A' ' 33' ' ' GLU . 2.2 tptm -148.12 -157.98 0.87 Allowed 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 -179.327 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.467 ' HB2' ' HB3' ' A' ' 33' ' ' GLU . 0.7 OUTLIER -110.78 139.9 45.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.109 -0.994 . . . . 0.0 109.685 179.217 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.938 HG13 HD13 ' A' ' 25' ' ' LEU . 20.7 t -66.8 -28.42 43.05 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 118.999 -1.08 . . . . 0.0 109.08 179.504 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -67.5 -40.79 85.18 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 108.828 -0.805 . . . . 0.0 108.828 178.679 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.568 ' OE2' ' CE2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -64.4 -30.29 71.34 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 178.811 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.885 HD22 ' CD2' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.63 -37.42 84.81 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.362 -0.836 . . . . 0.0 108.932 178.921 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.921 ' HD3' HG12 ' A' ' 52' ' ' VAL . 13.3 mmtt -61.71 -54.07 47.52 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.459 -0.775 . . . . 0.0 109.306 179.251 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 42.7 t -49.21 -41.29 14.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.381 -0.824 . . . . 0.0 109.88 179.277 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.035 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -62.39 -33.18 74.24 Favored 'General case' 0 C--N 1.304 -1.376 0 O-C-N 121.17 -0.956 . . . . 0.0 108.724 179.363 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 42' ' ' PHE . 32.6 mt -82.03 -26.01 9.36 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.408 0 O-C-N 121.586 -0.696 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.689 ' HA ' HG21 ' A' ' 49' ' ' VAL . 0.1 OUTLIER -80.75 -28.34 36.5 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.147 -0.971 . . . . 0.0 108.574 178.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.468 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.8 tm-20 -81.45 -41.13 22.27 Favored 'General case' 0 C--N 1.302 -1.487 0 CA-C-O 121.57 0.7 . . . . 0.0 109.381 179.393 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.12 HD22 ' CD2' ' A' ' 80' ' ' LEU . 0.2 OUTLIER -66.13 -34.43 78.02 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.096 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.129 ' CD2' HD13 ' A' ' 47' ' ' LEU . 5.9 m-85 -80.79 -23.56 39.2 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.717 -0.845 . . . . 0.0 108.717 179.331 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -73.04 -33.1 65.5 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.488 -0.758 . . . . 0.0 109.105 179.25 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -92.28 -17.3 24.95 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.43 -0.794 . . . . 0.0 109.402 179.278 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.654 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -82.17 -20.76 37.23 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.435 -0.791 . . . . 0.0 109.995 179.897 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.654 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 7.2 t70 95.76 29.17 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.237 0 CA-C-O 121.992 0.901 . . . . 0.0 108.877 -179.396 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.129 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -91.68 -143.73 0.19 Allowed 'General case' 0 C--N 1.3 -1.569 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.316 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.622 ' HB1' ' HG2' ' A' ' 66' ' ' GLU . . . -176.29 60.12 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.647 0 O-C-N 121.127 -0.983 . . . . 0.0 109.958 179.755 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.689 HG21 ' HA ' ' A' ' 39' ' ' SER . 8.3 m -55.23 118.23 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.541 0 CA-C-O 121.902 0.858 . . . . 0.0 110.214 179.901 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.8 ' CB ' HG21 ' A' ' 16' ' ' THR . 0.3 OUTLIER -92.03 -38.49 10.37 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 CA-C-O 121.158 0.504 . . . . 0.0 109.82 -179.498 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.512 ' C ' ' CG2' ' A' ' 52' ' ' VAL . 1.6 t70 -137.21 152.11 49.51 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.175 -0.953 . . . . 0.0 110.64 179.906 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.921 HG12 ' HD3' ' A' ' 35' ' ' LYS . 0.1 OUTLIER -157.82 114.42 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 121.491 -0.755 . . . . 0.0 109.62 179.967 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.482 ' HG2' ' HB3' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -134.97 175.47 9.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.169 -0.957 . . . . 0.0 110.512 -179.944 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.656 ' HB ' HG11 ' A' ' 31' ' ' VAL . 16.8 p -83.48 175.0 10.12 Favored 'General case' 0 C--N 1.306 -1.312 0 O-C-N 121.224 -0.923 . . . . 0.0 110.187 -179.888 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.639 ' CA ' ' CE2' ' A' ' 60' ' ' PHE . . . -130.5 117.11 2.17 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.361 -1.496 . . . . 0.0 109.361 -179.798 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.567 ' HG1' ' HD2' ' A' ' 60' ' ' PHE . 2.8 m 77.05 -64.81 0.31 Allowed 'General case' 0 N--CA 1.498 1.937 0 O-C-N 122.117 -0.637 . . . . 0.0 109.829 -179.436 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.475 ' HB3' ' O ' ' A' ' 56' ' ' THR . 18.9 p-10 179.91 -32.94 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.437 -0.79 . . . . 0.0 109.448 179.778 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.531 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 1.0 OUTLIER -177.57 28.21 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.52 -0.737 . . . . 0.0 110.018 -179.789 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 tptm -115.0 -33.61 5.35 Favored 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.205 -0.934 . . . . 0.0 109.394 179.549 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.698 ' CD1' ' CE2' ' A' ' 21' ' ' PHE . 0.8 OUTLIER -146.91 -179.28 6.69 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.372 -0.83 . . . . 0.0 109.346 179.175 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.623 ' N ' ' CD1' ' A' ' 60' ' ' PHE . . . -148.9 168.18 29.38 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 -179.797 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.52 ' C ' ' CG2' ' A' ' 63' ' ' VAL . 5.9 t80 -127.11 154.66 44.45 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.224 -1.162 . . . . 0.0 110.193 179.954 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.817 HG13 HG13 ' A' ' 52' ' ' VAL . 3.7 t -151.63 158.35 4.67 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.495 0 C-N-CA 119.648 -0.821 . . . . 0.0 110.531 -178.922 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.496 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 28.4 m-20 -130.96 142.68 50.37 Favored 'General case' 0 N--CA 1.485 1.325 0 O-C-N 121.111 -0.993 . . . . 0.0 109.951 179.796 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 74' ' ' ALA . 64.3 m-85 -106.96 172.42 6.83 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.42 -0.8 . . . . 0.0 110.004 179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.742 ' HB3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -118.11 17.75 13.97 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -0.987 . . . . 0.0 111.462 -178.32 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.472 ' OG ' ' OD2' ' A' ' 70' ' ' ASP . 26.7 p -168.17 175.81 6.36 Favored 'General case' 0 N--CA 1.494 1.744 0 CA-C-O 122.525 1.155 . . . . 0.0 112.437 179.823 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.83 -24.82 48.56 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 177.698 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -77.23 -26.6 52.83 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.035 -0.984 . . . . 0.0 109.576 -179.969 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.617 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 90.2 m-20 -82.9 -30.04 28.78 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 178.241 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 1.2 tt -72.6 -36.87 68.21 Favored 'General case' 0 C--N 1.306 -1.315 0 C-N-CA 119.944 -0.702 . . . . 0.0 109.786 179.353 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.53 -36.91 63.17 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.381 -0.824 . . . . 0.0 109.973 179.771 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.971 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.0 OUTLIER -77.22 -26.59 52.85 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 107.171 -1.418 . . . . 0.0 107.171 178.654 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 65' ' ' PHE . . . -70.67 -29.37 65.68 Favored 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.637 -0.825 . . . . 0.0 108.912 178.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.462 ' O ' HD23 ' A' ' 75' ' ' LEU . 4.7 tt -71.74 -46.96 56.87 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 108.166 -1.049 . . . . 0.0 108.166 178.711 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.36 -4.22 44.05 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 119.617 -0.833 . . . . 0.0 109.257 178.55 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.971 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.4 OUTLIER -76.38 6.81 5.07 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.538 -0.726 . . . . 0.0 110.547 -179.876 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.537 HG22 ' O ' ' A' ' 78' ' ' THR . 54.3 m -76.65 3.11 12.29 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 120.999 -1.063 . . . . 0.0 110.299 179.744 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -108.72 28.85 10.65 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 179.487 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.12 ' CD2' HD22 ' A' ' 41' ' ' LEU . 0.3 OUTLIER -116.0 120.57 39.55 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.394 -1.062 . . . . 0.0 110.236 -179.579 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.629 ' N ' HD12 ' A' ' 80' ' ' LEU . 2.1 ttmt -91.58 87.97 6.57 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 123.017 1.389 . . . . 0.0 109.385 178.804 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.764 HG13 ' HB3' ' A' ' 37' ' ' ALA . 98.5 t -43.24 -105.34 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.265 -3.071 0 CA-C-N 113.447 -1.706 . . . . 0.0 110.686 -179.649 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 1.035 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 6.3 m-85 -90.13 40.37 1.0 Allowed 'General case' 0 C--N 1.291 -1.961 0 O-C-N 121.014 -1.054 . . . . 0.0 109.964 -179.923 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.416 ' O ' ' HE2' ' A' ' 81' ' ' LYS . . . 97.54 19.57 24.8 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.488 -1.445 . . . . 0.0 109.488 179.929 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.547 ' N ' ' HG3' ' A' ' 81' ' ' LYS . 12.4 m-80 -147.01 92.58 2.15 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.224 -1.162 . . . . 0.0 110.105 179.855 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' HA ' ' A' ' 81' ' ' LYS . 1.6 mt-10 -43.27 94.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.35 -0.844 . . . . 0.0 110.144 -179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.75 HG21 HG21 ' A' ' 82' ' ' VAL . 2.2 pp -58.67 129.21 20.48 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 O-C-N 121.538 -0.726 . . . . 0.0 110.203 -179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 23' ' ' GLY . 0.4 OUTLIER -104.63 133.22 49.85 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.461 -0.774 . . . . 0.0 109.466 179.701 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.554 ' HB2' HD23 ' A' ' 20' ' ' LEU . 0.2 OUTLIER -110.72 174.16 5.99 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 120.936 -1.102 . . . . 0.0 111.122 -179.38 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.45 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.6 OUTLIER -173.22 132.18 0.49 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.635 -0.666 . . . . 0.0 109.634 -179.7 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 7.8 mttp -59.33 110.1 2.45 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.245 -0.909 . . . . 0.0 110.15 -179.968 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' CD ' ' HA ' ' A' ' 20' ' ' LEU . 48.5 Cg_endo -79.22 -169.85 0.88 Allowed 'Trans proline' 0 C--N 1.306 -1.684 0 O-C-N 123.991 1.522 . . . . 0.0 110.451 -179.799 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 55.69 47.34 20.76 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.92 . . . . 0.0 110.196 179.946 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -88.54 22.94 18.05 Favored Glycine 0 N--CA 1.491 2.362 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -68.78 140.06 55.3 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.278 -1.131 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -165.03 158.02 16.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.359 -0.838 . . . . 0.0 110.151 -179.979 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -88.4 -14.35 62.03 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -153.76 146.25 24.06 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.227 -1.161 . . . . 0.0 110.375 179.989 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -79.9 168.99 18.53 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.264 -0.897 . . . . 0.0 110.221 179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 126.17 60.77 0.15 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.6 -1.4 . . . . 0.0 109.6 -179.957 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.492 1.626 0 O-C-N 121.298 -1.119 . . . . 0.0 110.18 -179.925 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.355 0 N-CA-C 109.523 -1.431 . . . . 0.0 109.523 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.444 ' O ' ' OG ' ' A' ' 2' ' ' SER . 1.0 OUTLIER -120.79 111.88 18.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.256 -1.144 . . . . 0.0 110.25 -179.988 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.9 t60 -102.78 82.23 2.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.276 -179.99 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 1.8 ttm -151.03 66.56 0.91 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.9 . . . . 0.0 110.166 -179.876 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -65.92 118.61 9.98 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.289 -0.882 . . . . 0.0 110.12 179.998 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.426 ' O ' ' C ' ' A' ' 7' ' ' ASP . 0.4 OUTLIER -101.99 16.04 27.2 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.164 -0.96 . . . . 0.0 110.198 179.977 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.566 ' CB ' ' CD ' ' A' ' 8' ' ' PRO . 0.2 OUTLIER -43.35 -60.05 2.8 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.225 -0.922 . . . . 0.0 110.191 179.921 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.566 ' CD ' ' CB ' ' A' ' 7' ' ' ASP . 49.8 Cg_endo -71.47 -157.03 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.089 1.573 . . . . 0.0 110.028 179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.545 HG23 ' C ' ' A' ' 8' ' ' PRO . 88.9 t -155.5 125.14 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.95 0 O-C-N 121.847 -0.533 . . . . 0.0 110.275 179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.418 ' C ' ' O ' ' A' ' 9' ' ' VAL . 12.2 pt-20 -42.91 162.04 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.0 110.21 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -134.14 80.59 0.32 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -179.949 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.3 m -69.81 -6.15 30.35 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.172 -1.193 . . . . 0.0 110.068 179.839 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' O ' ' O ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -170.69 29.24 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.25 -0.906 . . . . 0.0 109.987 179.978 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.509 ' O ' ' O ' ' A' ' 13' ' ' GLU . 0.8 OUTLIER 41.42 -173.0 0.0 OUTLIER 'General case' 0 C--N 1.293 -1.878 0 CA-C-O 121.634 0.731 . . . . 0.0 111.399 179.205 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.1 t -124.53 -16.44 6.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.273 -0.892 . . . . 0.0 110.08 -179.589 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.974 HG21 HG21 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -119.04 163.9 23.97 Favored Pre-proline 0 C--N 1.3 -1.586 0 O-C-N 121.553 -0.717 . . . . 0.0 110.567 -179.632 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD2' HG22 ' A' ' 16' ' ' THR . 49.4 Cg_endo -76.4 -29.56 6.0 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.201 1.632 . . . . 0.0 110.47 179.974 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.573 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 86.9 m-85 -108.54 113.2 26.03 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.192 -0.942 . . . . 0.0 110.667 -179.759 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.441 ' OD1' ' N ' ' A' ' 19' ' ' ASN . 2.0 m120 -141.8 149.15 40.0 Favored 'General case' 0 C--N 1.304 -1.371 0 O-C-N 121.388 -0.82 . . . . 0.0 109.317 179.757 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.769 ' C ' HD12 ' A' ' 20' ' ' LEU . 4.5 pp -164.62 -176.9 4.52 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.199 -0.938 . . . . 0.0 110.451 -179.857 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.579 ' N ' HD12 ' A' ' 20' ' ' LEU . 7.7 t80 -108.94 153.35 23.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.367 -0.833 . . . . 0.0 110.169 -179.941 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.643 HG23 ' O ' ' A' ' 88' ' ' LYS . 1.6 mt -138.92 155.27 26.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.237 -0.915 . . . . 0.0 109.394 179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -135.24 -169.89 11.99 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 -179.7 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.0 t30 72.0 51.32 0.22 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.498 -1.001 . . . . 0.0 110.422 179.935 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.777 HD12 ' O ' ' A' ' 60' ' ' PHE . 13.8 mt -102.51 120.97 41.44 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.223 -0.923 . . . . 0.0 109.915 179.542 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.556 ' N ' HD21 ' A' ' 34' ' ' LEU . 34.6 t30 -47.13 104.53 0.42 Allowed Pre-proline 0 C--N 1.301 -1.543 0 O-C-N 121.581 -0.699 . . . . 0.0 110.416 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 48.6 Cg_endo -75.44 -5.02 16.1 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.045 1.55 . . . . 0.0 110.433 179.931 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -80.11 -20.35 45.23 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.215 -0.928 . . . . 0.0 109.99 179.969 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.576 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -107.95 -156.63 0.59 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.46 -0.775 . . . . 0.0 109.705 179.789 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.737 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.5 m -98.5 146.75 25.46 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 121.194 -0.941 . . . . 0.0 109.949 179.674 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.767 HG11 ' HB ' ' A' ' 54' ' ' THR . 4.5 t -67.98 -34.1 65.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 C-N-CA 119.318 -0.953 . . . . 0.0 109.722 179.716 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -64.52 -34.6 78.61 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.257 -0.902 . . . . 0.0 109.741 179.41 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.522 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 59.0 mm-40 -71.44 -34.98 70.74 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.291 -0.88 . . . . 0.0 109.336 179.367 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.737 HD13 ' O ' ' A' ' 30' ' ' SER . 6.7 mp -66.54 -29.02 69.0 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.409 -0.807 . . . . 0.0 109.16 179.376 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 1.076 ' HZ2' HG12 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -70.94 -54.98 9.4 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 121.461 -0.775 . . . . 0.0 109.1 179.158 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 32' ' ' ALA . 12.2 t -60.15 -35.03 59.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 O-C-N 121.392 -0.817 . . . . 0.0 109.379 178.916 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.533 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -62.45 -38.03 88.18 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 179.262 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 63.9 mt -76.03 -29.37 19.63 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.073 -0.651 . . . . 0.0 109.493 179.042 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 1.012 ' HA ' HG21 ' A' ' 49' ' ' VAL . 1.9 t -78.66 -29.75 45.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.191 -0.943 . . . . 0.0 109.084 179.377 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.488 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.3 tm-20 -81.48 -36.95 28.7 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-O 121.488 0.661 . . . . 0.0 109.516 179.413 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 80' ' ' LEU . 1.1 tt -69.73 -30.2 67.75 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.502 -0.748 . . . . 0.0 109.093 179.038 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.576 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 3.9 m-85 -90.02 -16.71 29.23 Favored 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.492 -0.755 . . . . 0.0 109.388 179.278 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.465 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -89.88 -28.83 18.97 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.11 -0.994 . . . . 0.0 109.761 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.415 ' HE3' ' OE2' ' A' ' 40' ' ' GLU . 47.6 mttt -89.4 -24.6 21.87 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.408 -0.807 . . . . 0.0 109.203 179.431 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.6 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.6 m-80 -77.41 -59.3 2.84 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.552 -0.717 . . . . 0.0 109.493 179.398 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.6 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 8.2 p30 148.02 25.64 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.014 0 CA-C-O 121.489 0.661 . . . . 0.0 110.828 179.419 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.847 HD11 ' O ' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -91.76 -154.35 0.37 Allowed 'General case' 0 C--N 1.289 -2.061 0 O-C-N 121.381 -0.824 . . . . 0.0 109.96 -179.97 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -160.86 63.53 0.3 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.374 -0.829 . . . . 0.0 110.266 179.912 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 1.012 HG21 ' HA ' ' A' ' 39' ' ' SER . 15.8 m -67.2 115.65 5.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.463 0 O-C-N 121.433 -0.792 . . . . 0.0 109.732 179.791 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.974 HG21 HG21 ' A' ' 16' ' ' THR . 0.6 OUTLIER -90.09 -39.89 12.46 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.845 0 CA-C-O 121.223 0.535 . . . . 0.0 109.972 -179.602 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.521 ' CB ' ' OD2' ' A' ' 64' ' ' ASP . 0.2 OUTLIER -140.78 156.31 46.2 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.215 -0.928 . . . . 0.0 110.566 179.924 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.076 HG12 ' HZ2' ' A' ' 35' ' ' LYS . 3.9 t -152.9 100.9 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.382 -0.823 . . . . 0.0 110.017 179.862 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.512 ' O ' ' NZ ' ' A' ' 35' ' ' LYS . 2.3 ttp180 -99.69 167.44 10.56 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.151 -0.968 . . . . 0.0 110.264 179.989 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.767 ' HB ' HG11 ' A' ' 31' ' ' VAL . 12.7 p -88.25 169.7 11.64 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.243 -0.911 . . . . 0.0 110.475 -179.822 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.518 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -128.75 115.46 2.01 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.34 -1.504 . . . . 0.0 109.34 179.856 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.575 HG22 ' H ' ' A' ' 57' ' ' ASN . 1.0 OUTLIER 65.83 -150.58 0.23 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.391 -1.064 . . . . 0.0 110.075 -179.85 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.575 ' H ' HG22 ' A' ' 56' ' ' THR . 73.5 m-20 -63.76 -55.37 23.68 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.204 -0.935 . . . . 0.0 110.321 -179.944 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.7 ptt-85 -176.39 49.56 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.191 -0.943 . . . . 0.0 110.254 -179.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.525 ' HB2' ' CE1' ' A' ' 60' ' ' PHE . 16.5 mtpt -123.68 -23.93 4.62 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.235 -0.915 . . . . 0.0 110.293 -179.979 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.777 ' O ' HD12 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -132.48 178.37 6.88 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.285 -0.884 . . . . 0.0 109.731 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.514 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -164.63 142.99 8.15 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.976 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.581 ' CZ ' ' O ' ' A' ' 20' ' ' LEU . 13.5 t80 -97.03 157.77 15.75 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.196 -1.179 . . . . 0.0 109.763 179.579 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.816 HG13 HG22 ' A' ' 52' ' ' VAL . 3.1 t -151.71 140.66 14.85 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 119.448 -0.901 . . . . 0.0 110.959 -178.628 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.523 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 2.3 m-20 -108.09 140.82 40.72 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.473 -0.767 . . . . 0.0 109.056 178.991 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.806 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 8.5 m-85 -103.94 178.34 4.59 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.284 -0.885 . . . . 0.0 110.446 -179.026 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.634 ' HG3' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -108.15 -9.64 15.54 Favored 'General case' 0 C--N 1.301 -1.529 0 C-N-CA 119.5 -0.88 . . . . 0.0 111.799 -178.447 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.573 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 17.3 p -168.12 -176.58 3.01 Favored 'General case' 0 N--CA 1.5 2.049 0 CA-C-O 122.812 1.291 . . . . 0.0 113.061 179.943 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -83.79 -18.63 37.04 Favored 'General case' 0 C--N 1.298 -1.653 0 N-CA-C 107.98 -1.118 . . . . 0.0 107.98 178.567 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.437 ' OE2' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -87.72 -27.09 22.6 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.069 -179.922 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.847 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -82.5 -29.75 30.31 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.794 -1.558 . . . . 0.0 106.794 177.947 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.706 ' C ' HD23 ' A' ' 71' ' ' LEU . 2.0 tt -72.56 -37.65 68.17 Favored 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 178.649 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.593 ' N ' HD23 ' A' ' 71' ' ' LEU . 0.5 OUTLIER -67.47 -40.84 85.34 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.575 -0.703 . . . . 0.0 109.328 179.205 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 1.044 ' O ' HD23 ' A' ' 77' ' ' LEU . 9.9 mttm -75.61 -27.33 58.45 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 178.289 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.806 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -72.03 -28.11 63.15 Favored 'General case' 0 C--N 1.303 -1.428 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 178.737 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.739 HD22 HD11 ' A' ' 89' ' ' LEU . 1.5 tm? -69.55 -46.3 66.76 Favored 'General case' 0 C--N 1.309 -1.172 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 178.673 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -71.88 -13.75 61.75 Favored 'General case' 0 C--N 1.305 -1.364 0 C-N-CA 119.663 -0.815 . . . . 0.0 108.939 178.398 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.044 HD23 ' O ' ' A' ' 73' ' ' LYS . 1.0 OUTLIER -73.12 2.6 6.85 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.634 -0.666 . . . . 0.0 110.396 179.804 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.678 ' OG1' HD21 ' A' ' 89' ' ' LEU . 99.7 m -75.1 2.66 10.16 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.058 -1.026 . . . . 0.0 110.592 -179.969 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -88.14 11.99 65.72 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.913 -1.675 . . . . 0.0 108.913 179.262 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.002 HD13 HD13 ' A' ' 41' ' ' LEU . 75.4 mt -89.55 -165.18 1.28 Allowed 'General case' 0 C--N 1.307 -1.248 0 O-C-N 121.307 -1.113 . . . . 0.0 110.591 -179.736 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.617 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.4 OUTLIER -169.27 48.9 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 CA-C-O 121.703 0.763 . . . . 0.0 109.867 179.796 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.046 HG21 HG23 ' A' ' 87' ' ' ILE . 3.9 t 6.44 -123.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.465 0 CA-C-N 114.265 -1.334 . . . . 0.0 111.636 179.721 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CD2' ' HG3' ' A' ' 29' ' ' LYS . 16.6 m-85 -73.03 -3.16 24.43 Favored 'General case' 0 C--N 1.298 -1.633 0 O-C-N 120.99 -1.069 . . . . 0.0 109.149 178.743 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.465 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 146.89 35.32 0.06 OUTLIER Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.203 -1.559 . . . . 0.0 109.203 179.99 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.511 ' O ' ' N ' ' A' ' 87' ' ' ILE . 1.9 t30 -158.1 101.45 1.75 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -1.215 . . . . 0.0 109.775 -179.971 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.617 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.5 OUTLIER -50.44 90.54 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.0 110.489 -178.99 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.046 HG23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -39.84 137.27 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 121.568 0.699 . . . . 0.0 110.211 179.881 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.643 ' O ' HG23 ' A' ' 22' ' ' ILE . 28.4 ttmt -112.78 156.44 22.85 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.522 -0.736 . . . . 0.0 109.364 179.621 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.739 HD11 HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -117.01 175.12 5.73 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.249 -0.907 . . . . 0.0 110.643 -179.591 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 91' ' ' LYS . 2.4 tt0 -169.04 159.3 9.13 Favored 'General case' 0 C--N 1.301 -1.527 0 O-C-N 121.592 -0.692 . . . . 0.0 109.541 -179.503 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.521 ' N ' ' HG3' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -92.0 108.65 31.81 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.156 -0.965 . . . . 0.0 110.442 -179.78 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.489 ' HG3' ' HA ' ' A' ' 20' ' ' LEU . 48.2 Cg_endo -75.3 -169.12 0.6 Allowed 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.001 1.527 . . . . 0.0 110.388 179.985 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.7 tttt 46.75 -150.64 0.1 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.263 -0.898 . . . . 0.0 110.172 179.874 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.45 ' O ' ' HB3' ' A' ' 95' ' ' ARG . . . 101.03 -48.55 1.13 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.45 ' HB3' ' O ' ' A' ' 94' ' ' GLY . 16.6 ptt85 -177.82 -139.37 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.23 -1.159 . . . . 0.0 110.129 -179.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 59.0 m-20 -143.42 116.85 9.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.135 -0.978 . . . . 0.0 110.235 179.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.452 ' O ' ' O ' ' A' ' 98' ' ' THR . . . -116.62 -85.99 1.2 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.924 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.452 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.4 p 42.82 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.275 -1.132 . . . . 0.0 110.265 179.949 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 44.64 81.45 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.24 -0.913 . . . . 0.0 110.328 -179.962 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.81 -88.28 0.06 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 179.967 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 24.6 p . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.295 -1.121 . . . . 0.0 110.262 179.951 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.341 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.9 p -101.41 107.58 18.94 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.26 -1.141 . . . . 0.0 110.195 -179.94 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.493 ' O ' ' CD2' ' A' ' 3' ' ' HIS . 0.5 OUTLIER -179.31 81.97 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.206 -0.934 . . . . 0.0 110.233 -179.938 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 2.3 ppp? -82.01 137.8 35.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.247 -0.908 . . . . 0.0 110.164 -179.971 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.0 mt -82.03 177.99 8.53 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.295 -0.878 . . . . 0.0 110.19 -179.967 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -99.69 102.7 14.25 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.211 -0.931 . . . . 0.0 110.188 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . 0.412 ' N ' ' CD ' ' A' ' 8' ' ' PRO . 0.3 OUTLIER -174.98 56.7 0.17 Allowed Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.21 -0.931 . . . . 0.0 110.204 179.936 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' CD ' ' N ' ' A' ' 7' ' ' ASP . 49.4 Cg_endo -71.45 -157.02 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 124.114 1.586 . . . . 0.0 110.118 179.942 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.615 HG13 ' O ' ' A' ' 9' ' ' VAL . 6.0 p -62.67 85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.29 -1.981 0 O-C-N 121.774 -0.579 . . . . 0.0 110.23 179.957 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -90.59 -158.16 0.53 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.226 -0.921 . . . . 0.0 110.205 179.951 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 138.13 -11.91 3.59 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.648 -1.381 . . . . 0.0 109.648 179.925 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.509 ' N ' ' OE2' ' A' ' 13' ' ' GLU . 5.2 p -170.1 94.22 0.24 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.236 -1.155 . . . . 0.0 110.287 179.967 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.509 ' OE2' ' N ' ' A' ' 12' ' ' SER . 3.4 mp0 -141.52 93.65 2.59 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.159 -0.963 . . . . 0.0 109.687 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -124.82 164.94 18.93 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-O 121.361 0.601 . . . . 0.0 110.215 -179.962 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.729 HG22 ' O ' ' A' ' 15' ' ' THR . 19.6 m -151.01 16.05 0.75 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.268 -0.895 . . . . 0.0 110.166 179.987 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.754 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -176.65 166.16 1.52 Allowed Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.15 -0.969 . . . . 0.0 110.312 -179.876 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.446 ' HD2' HG22 ' A' ' 16' ' ' THR . 51.2 Cg_endo -79.66 -25.93 5.07 Favored 'Trans proline' 0 C--N 1.303 -1.853 0 O-C-N 124.107 1.583 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.963 ' CZ ' ' HB2' ' A' ' 68' ' ' ALA . 79.1 m-85 -111.89 108.81 18.31 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.233 -0.917 . . . . 0.0 110.815 -179.665 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 23.0 m-20 -142.15 152.06 42.84 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.441 -0.787 . . . . 0.0 108.999 179.602 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.752 ' C ' HD12 ' A' ' 20' ' ' LEU . 3.7 pp -162.65 -176.19 4.86 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.101 -0.999 . . . . 0.0 110.791 -179.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.631 ' CE2' ' CE2' ' A' ' 60' ' ' PHE . 2.3 t80 -104.39 154.48 19.79 Favored 'General case' 0 C--N 1.302 -1.463 0 O-C-N 121.548 -0.72 . . . . 0.0 109.562 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.625 HD12 ' CG2' ' A' ' 63' ' ' VAL . 6.2 mt -143.83 152.73 15.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.54 -179.712 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.558 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -140.7 -167.11 10.94 Favored Glycine 0 N--CA 1.488 2.128 0 C-N-CA 119.462 -1.351 . . . . 0.0 109.869 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.526 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.9 t30 70.7 38.29 1.27 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.339 -1.095 . . . . 0.0 109.888 -179.574 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.944 ' HB3' HD13 ' A' ' 34' ' ' LEU . 3.8 mm? -88.97 127.97 35.68 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.408 -0.808 . . . . 0.0 110.297 -179.856 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.741 ' H ' HD21 ' A' ' 34' ' ' LEU . 34.5 t-20 -39.96 100.22 0.21 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.651 -0.656 . . . . 0.0 110.528 179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.473 ' HB3' ' CG ' ' A' ' 59' ' ' LYS . 47.9 Cg_endo -74.87 -13.14 21.79 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 124.046 1.551 . . . . 0.0 110.505 -179.934 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -87.68 -10.01 52.51 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 109.974 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.569 ' HZ3' ' HD1' ' A' ' 83' ' ' PHE . 18.2 mttt -112.98 -159.0 0.67 Allowed 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.45 -0.781 . . . . 0.0 109.772 179.958 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.447 ' O ' ' HG2' ' A' ' 33' ' ' GLU . 1.5 m -97.2 146.0 25.5 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.239 -0.913 . . . . 0.0 110.389 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.668 ' HA ' HD12 ' A' ' 34' ' ' LEU . 3.4 t -65.15 -38.37 82.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.247 -0.981 . . . . 0.0 109.185 179.38 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.425 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -59.6 -37.71 79.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.282 -0.886 . . . . 0.0 109.224 178.989 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.602 ' HG3' ' CD2' ' A' ' 83' ' ' PHE . 0.0 OUTLIER -68.0 -29.86 68.97 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 108.752 -0.832 . . . . 0.0 108.752 179.116 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.944 HD13 ' HB3' ' A' ' 25' ' ' LEU . 7.7 mt -68.94 -31.56 70.52 Favored 'General case' 0 C--N 1.306 -1.306 0 O-C-N 121.328 -0.857 . . . . 0.0 109.437 179.285 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.556 ' HD3' ' CG1' ' A' ' 52' ' ' VAL . 9.7 mmpt? -69.13 -51.56 37.08 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.328 -0.857 . . . . 0.0 109.296 179.155 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 12.7 t -60.58 -39.53 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.566 -0.708 . . . . 0.0 109.892 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.984 ' HB2' ' CD2' ' A' ' 83' ' ' PHE . . . -62.26 -34.84 77.31 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.155 -0.965 . . . . 0.0 108.764 179.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.611 HD12 ' O ' ' A' ' 34' ' ' LEU . 44.7 mt -79.45 -29.79 13.56 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 121.597 -0.689 . . . . 0.0 109.193 178.999 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 22.6 t -77.81 -28.45 50.33 Favored 'General case' 0 N--CA 1.491 1.597 0 C-N-CA 119.453 -0.899 . . . . 0.0 109.133 179.196 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.1 tm-20 -81.74 -39.03 24.79 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-O 121.534 0.683 . . . . 0.0 109.446 179.402 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.692 HD21 ' CB ' ' A' ' 80' ' ' LEU . 6.0 tp -66.08 -32.8 74.48 Favored 'General case' 0 C--N 1.301 -1.523 0 C-N-CA 119.851 -0.74 . . . . 0.0 109.024 179.152 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.579 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 7.7 m-85 -85.52 -20.64 29.36 Favored 'General case' 0 C--N 1.303 -1.413 0 O-C-N 121.418 -0.801 . . . . 0.0 108.898 179.034 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.36 -31.66 48.65 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.514 -0.741 . . . . 0.0 109.508 179.482 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.477 ' HD3' ' OE1' ' A' ' 40' ' ' GLU . 8.9 mtpt -89.17 -23.39 22.44 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.41 -0.806 . . . . 0.0 109.502 179.288 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.77 ' OD1' HD11 ' A' ' 77' ' ' LEU . 1.7 m-80 -81.73 -22.0 37.59 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.503 -0.748 . . . . 0.0 109.829 179.698 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.639 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.7 t70 90.89 31.01 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 CA-C-O 122.011 0.91 . . . . 0.0 108.851 -179.329 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.986 HD11 ' O ' ' A' ' 70' ' ' ASP . 0.0 OUTLIER -77.96 -137.84 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 109.178 -0.675 . . . . 0.0 109.178 179.434 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.772 ' HB1' ' HB2' ' A' ' 66' ' ' GLU . . . -171.16 58.05 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.211 -0.931 . . . . 0.0 109.912 179.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.567 HG11 ' HD2' ' A' ' 42' ' ' PHE . 15.6 m -66.82 113.14 2.7 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 CA-C-O 121.772 0.796 . . . . 0.0 109.831 179.746 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.754 HG11 ' CG2' ' A' ' 16' ' ' THR . 71.3 t -91.07 -24.38 5.64 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.941 0 O-C-N 121.814 -0.554 . . . . 0.0 110.291 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.529 ' CB ' ' HB2' ' A' ' 64' ' ' ASP . 0.5 OUTLIER -162.49 163.66 27.39 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.169 -0.957 . . . . 0.0 110.387 179.741 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.556 ' CG1' ' HD3' ' A' ' 35' ' ' LYS . 2.3 t -150.93 156.94 5.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.242 -0.911 . . . . 0.0 109.797 179.843 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 2.9 ttp85 -155.61 165.57 36.14 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.288 -0.883 . . . . 0.0 110.119 -179.928 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.641 ' HB ' HG11 ' A' ' 31' ' ' VAL . 25.8 p -86.83 161.13 18.51 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 121.227 -0.92 . . . . 0.0 110.759 -179.65 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -137.35 127.13 3.87 Favored Glycine 0 N--CA 1.489 2.219 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.679 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.432 ' O ' ' O ' ' A' ' 55' ' ' GLY . 6.3 m 49.77 100.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.212 -1.169 . . . . 0.0 110.713 179.645 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.417 ' C ' ' O ' ' A' ' 56' ' ' THR . 3.6 m-80 39.56 -98.41 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.404 -0.81 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.41 ' N ' ' O ' ' A' ' 56' ' ' THR . 0.3 OUTLIER -141.13 30.53 1.79 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.007 -1.058 . . . . 0.0 110.636 -179.594 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.473 ' CG ' ' HB3' ' A' ' 27' ' ' PRO . 0.1 OUTLIER -121.2 14.17 11.3 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.185 -0.947 . . . . 0.0 109.995 179.761 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.697 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -156.51 178.51 10.24 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.417 -0.802 . . . . 0.0 109.69 -179.864 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.512 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . -178.58 150.95 10.0 Favored Glycine 0 N--CA 1.492 2.369 0 C-N-CA 119.599 -1.286 . . . . 0.0 110.724 -179.905 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.565 ' CE1' ' O ' ' A' ' 20' ' ' LEU . 10.6 t80 -113.5 158.53 20.6 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 121.55 -0.971 . . . . 0.0 109.013 179.292 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.625 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.4 t -151.09 144.36 16.69 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 C-N-CA 118.594 -1.242 . . . . 0.0 111.881 -178.249 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.537 ' HB3' ' HG1' ' A' ' 16' ' ' THR . 1.0 OUTLIER -102.75 146.56 28.06 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.527 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.7 ' O ' HG21 ' A' ' 16' ' ' THR . 3.7 m-85 -112.38 -172.23 2.01 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 120.937 -1.102 . . . . 0.0 111.165 -178.869 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.772 ' HB2' ' HB1' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -115.21 -7.09 12.43 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.409 -0.807 . . . . 0.0 110.958 -179.421 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.645 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 24.1 p -176.18 175.62 1.84 Allowed 'General case' 0 N--CA 1.497 1.915 0 CA-C-O 122.58 1.181 . . . . 0.0 112.502 179.608 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.963 ' HB2' ' CZ ' ' A' ' 18' ' ' PHE . . . -76.4 -25.81 54.9 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 178.108 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.99 -29.47 58.22 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.097 -0.956 . . . . 0.0 108.964 179.737 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.986 ' O ' HD11 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -76.6 -29.7 56.64 Favored 'General case' 0 C--N 1.306 -1.316 0 N-CA-C 106.783 -1.562 . . . . 0.0 106.783 177.938 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.546 ' N ' ' OD1' ' A' ' 70' ' ' ASP . 0.3 OUTLIER -71.78 -38.78 70.25 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 109.225 -0.657 . . . . 0.0 109.225 179.606 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.2 tm-20 -66.19 -38.04 87.03 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.514 -0.741 . . . . 0.0 109.525 179.409 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.796 ' O ' HD23 ' A' ' 77' ' ' LEU . 2.5 mttp -81.56 -30.51 33.03 Favored 'General case' 0 C--N 1.307 -1.252 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 178.615 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' A' ' 47' ' ' LEU . . . -74.95 -25.18 58.69 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.605 -0.838 . . . . 0.0 109.118 178.944 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.538 HD23 ' C ' ' A' ' 75' ' ' LEU . 6.1 tt -73.35 -46.75 47.41 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 178.517 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -71.46 -14.81 62.25 Favored 'General case' 0 C--N 1.306 -1.32 0 C-N-CA 119.666 -0.814 . . . . 0.0 108.875 178.218 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.796 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -71.82 -0.28 10.8 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.598 -0.689 . . . . 0.0 110.265 179.707 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.54 ' OG1' HD21 ' A' ' 89' ' ' LEU . 24.9 m -76.65 4.42 9.47 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.17 -0.956 . . . . 0.0 110.841 -179.573 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -82.05 -8.66 86.27 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 179.297 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.692 ' CB ' HD21 ' A' ' 41' ' ' LEU . 3.5 mm? -80.46 -164.89 0.77 Allowed 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.429 -1.042 . . . . 0.0 110.955 -179.668 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.579 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.0 OUTLIER -148.45 51.41 1.0 Allowed 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.624 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.868 ' HB ' HG23 ' A' ' 87' ' ' ILE . 8.7 p 17.04 -132.3 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.529 0 CA-C-N 114.895 -1.048 . . . . 0.0 110.344 -179.711 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.984 ' CD2' ' HB2' ' A' ' 37' ' ' ALA . 0.3 OUTLIER -78.6 11.47 2.52 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.447 -1.408 . . . . 0.0 109.666 178.579 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.485 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 143.57 36.54 0.08 OUTLIER Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 179.89 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.696 ' O ' HG12 ' A' ' 82' ' ' VAL . 4.6 t30 -174.07 115.76 0.21 Allowed 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.178 -1.19 . . . . 0.0 109.661 179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 tt0 -52.5 88.62 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.104 -0.997 . . . . 0.0 110.346 -179.552 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.868 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -44.75 143.97 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 119.924 -0.71 . . . . 0.0 109.802 179.668 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.547 ' O ' HG23 ' A' ' 22' ' ' ILE . 9.3 mtmt -119.85 155.09 33.31 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.516 -0.74 . . . . 0.0 109.777 179.938 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.57 ' N ' HD23 ' A' ' 89' ' ' LEU . 0.2 OUTLIER -116.83 172.59 7.15 Favored 'General case' 0 C--N 1.302 -1.494 0 O-C-N 121.275 -0.891 . . . . 0.0 110.182 -179.941 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.454 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.2 OUTLIER -163.74 105.16 0.93 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.315 -0.866 . . . . 0.0 110.316 179.988 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.459 ' O ' ' HG3' ' A' ' 91' ' ' LYS . 6.4 ptpt -57.78 109.61 1.91 Allowed Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.275 -0.89 . . . . 0.0 110.219 179.834 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.0 Cg_endo -74.9 -175.56 2.4 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 124.001 1.527 . . . . 0.0 110.445 -179.948 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 92' ' ' PRO . 1.0 OUTLIER 42.59 37.49 1.02 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.947 . . . . 0.0 110.214 179.906 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.427 ' O ' ' HG3' ' A' ' 95' ' ' ARG . . . -144.1 -156.58 6.86 Favored Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.985 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 96' ' ' ASP . 0.1 OUTLIER -156.65 159.75 38.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.214 -1.168 . . . . 0.0 110.242 -179.962 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.457 ' HB3' ' O ' ' A' ' 95' ' ' ARG . 19.1 t70 64.08 79.8 0.25 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.274 -0.891 . . . . 0.0 110.201 179.977 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -137.94 111.41 0.82 Allowed Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.512 -1.435 . . . . 0.0 109.512 179.941 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -169.2 134.11 1.5 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.26 -1.141 . . . . 0.0 110.469 179.953 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -164.38 43.78 0.09 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.233 -0.917 . . . . 0.0 110.252 179.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -60.25 -157.47 0.04 OUTLIER Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.564 -1.415 . . . . 0.0 109.564 -179.99 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.261 -1.141 . . . . 0.0 110.192 179.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.1 p -116.76 119.7 36.26 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.26 -1.141 . . . . 0.0 110.185 179.962 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.444 ' ND1' ' O ' ' A' ' 3' ' ' HIS . 0.9 OUTLIER -128.52 28.05 5.47 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.258 -0.901 . . . . 0.0 110.216 -179.944 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.451 ' O ' ' HG2' ' A' ' 6' ' ' GLU . 1.5 mtp -77.27 -71.3 0.42 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.18 -0.95 . . . . 0.0 110.105 -179.988 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.462 ' HA ' HD23 ' A' ' 5' ' ' LEU . 10.0 mt 47.83 36.45 5.93 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.22 -179.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.451 ' HG2' ' O ' ' A' ' 4' ' ' MET . 11.1 pt-20 -154.64 19.4 0.46 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 110.22 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 40.1 t0 -96.46 118.26 65.46 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.239 -0.913 . . . . 0.0 110.173 -179.965 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -72.16 79.71 1.68 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 123.895 1.471 . . . . 0.0 110.371 179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.751 HG22 ' O ' ' A' ' 9' ' ' VAL . 5.6 p -118.82 45.87 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.293 -1.861 0 CA-C-O 121.264 0.554 . . . . 0.0 110.299 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.455 ' O ' ' CG ' ' A' ' 10' ' ' GLU . 1.9 pt-20 -115.71 102.27 9.59 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.247 -0.908 . . . . 0.0 110.208 179.903 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 12' ' ' SER . . . -44.36 -64.27 2.09 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.965 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.567 ' O ' ' CB ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER 71.96 107.09 0.07 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.31 -1.112 . . . . 0.0 109.199 -179.571 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.567 ' CB ' ' O ' ' A' ' 12' ' ' SER . 27.7 tt0 78.6 127.41 0.05 OUTLIER 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 122.525 1.155 . . . . 0.0 110.309 -179.47 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.693 ' O ' HG22 ' A' ' 15' ' ' THR . 0.8 OUTLIER 34.15 -136.14 0.03 OUTLIER 'General case' 0 C--N 1.282 -2.349 0 CA-C-N 114.526 -1.215 . . . . 0.0 111.01 179.326 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.693 HG22 ' O ' ' A' ' 14' ' ' SER . 0.5 OUTLIER 78.99 -5.47 2.0 Allowed 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.632 -0.667 . . . . 0.0 109.934 -179.417 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.984 ' CG2' HG11 ' A' ' 50' ' ' VAL . 20.3 p -140.64 160.99 56.88 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.417 -0.802 . . . . 0.0 110.128 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -76.43 -22.53 12.32 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.013 1.533 . . . . 0.0 110.959 -179.537 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.706 ' HD1' HD13 ' A' ' 71' ' ' LEU . 85.5 m-85 -123.36 115.38 21.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.991 -1.068 . . . . 0.0 111.159 -179.436 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.52 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.5 m120 -138.72 150.84 46.59 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.477 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.647 HD21 ' HE2' ' A' ' 65' ' ' PHE . 3.1 pp -165.22 -167.15 1.11 Allowed 'General case' 0 C--N 1.3 -1.582 0 O-C-N 121.125 -0.984 . . . . 0.0 110.647 -179.82 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.651 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 31.3 t80 -125.07 142.72 51.31 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.323 -0.86 . . . . 0.0 110.019 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.511 ' HB ' ' O ' ' A' ' 61' ' ' GLY . 3.4 mt -119.99 170.12 10.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.276 -0.89 . . . . 0.0 109.266 179.806 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -145.03 -172.91 15.82 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 -179.695 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.531 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 1.3 t-20 73.26 48.55 0.16 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.61 -0.935 . . . . 0.0 110.177 179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 1.061 HD13 HD22 ' A' ' 34' ' ' LEU . 3.7 mm? -93.3 123.04 36.31 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.309 -0.869 . . . . 0.0 109.944 179.74 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.557 ' N ' HD11 ' A' ' 34' ' ' LEU . 22.5 t-20 -43.67 107.31 0.57 Allowed Pre-proline 0 C--N 1.298 -1.635 0 O-C-N 121.563 -0.711 . . . . 0.0 110.337 -179.976 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 26' ' ' ASN . 45.8 Cg_endo -72.3 -27.94 15.79 Favored 'Trans proline' 0 C--N 1.305 -1.739 0 O-C-N 124.104 1.581 . . . . 0.0 110.31 179.814 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 8.2 m-80 -78.84 -17.03 56.33 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.301 -0.874 . . . . 0.0 109.687 179.758 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.565 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 0.8 OUTLIER -106.19 -155.94 0.56 Allowed 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.54 -0.725 . . . . 0.0 109.673 179.727 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 3.1 m -114.2 150.29 34.49 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.28 -0.888 . . . . 0.0 110.164 179.791 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.816 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.8 t -69.38 -26.22 30.96 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.167 -0.958 . . . . 0.0 109.331 179.458 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -63.46 -38.79 92.49 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.371 -0.831 . . . . 0.0 109.135 179.187 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.604 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 1.6 mm-40 -69.78 -46.17 66.37 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.458 -0.776 . . . . 0.0 109.148 179.062 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.061 HD22 HD13 ' A' ' 25' ' ' LEU . 0.7 OUTLIER -55.37 -37.3 67.35 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.55 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.423 ' NZ ' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -56.85 -63.12 1.31 Allowed 'General case' 0 C--N 1.305 -1.362 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 179.076 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.498 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 47.9 t -49.4 -35.16 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 178.513 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.617 ' HB3' ' O ' ' A' ' 34' ' ' LEU . . . -62.49 -42.26 99.37 Favored 'General case' 0 C--N 1.305 -1.369 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 178.827 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.767 HD11 HG21 ' A' ' 87' ' ' ILE . 16.0 mm -73.11 -28.68 26.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 C-N-CA 120.008 -0.677 . . . . 0.0 109.428 178.863 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.727 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.1 OUTLIER -77.8 -29.44 50.73 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.103 -0.998 . . . . 0.0 109.044 179.351 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -84.46 -41.24 16.8 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.6 -0.687 . . . . 0.0 109.759 179.643 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.73 HD11 HD21 ' A' ' 80' ' ' LEU . 0.2 OUTLIER -63.13 -34.91 78.63 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.49 -0.756 . . . . 0.0 109.187 179.177 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.133 ' CD2' HD13 ' A' ' 47' ' ' LEU . 8.6 m-85 -87.13 -21.15 26.15 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 179.079 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -77.19 -31.53 55.45 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 120.005 -0.678 . . . . 0.0 109.266 179.546 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.461 ' CD ' ' OE1' ' A' ' 40' ' ' GLU . 0.1 OUTLIER -84.1 -19.46 34.25 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.52 -0.738 . . . . 0.0 109.138 179.25 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.618 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -87.31 -18.73 29.47 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.552 -0.717 . . . . 0.0 109.593 179.649 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.618 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 6.4 t70 87.84 29.62 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 -179.158 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 1.133 HD13 ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -76.89 -137.96 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.593 0 CA-C-N 115.821 -0.627 . . . . 0.0 109.357 179.585 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.663 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . -176.27 57.55 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.251 -0.906 . . . . 0.0 109.819 179.868 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.414 ' O ' HG23 ' A' ' 49' ' ' VAL . 10.5 m -55.02 117.69 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.9 0.857 . . . . 0.0 109.87 179.885 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.984 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.2 t -90.95 -44.07 14.48 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.346 -179.382 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.523 ' O ' ' HA ' ' A' ' 63' ' ' VAL . 17.5 t70 -143.9 148.03 34.84 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.105 -0.997 . . . . 0.0 110.926 -179.76 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.94 HG12 HG22 ' A' ' 63' ' ' VAL . 0.0 OUTLIER -136.13 158.31 38.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 O-C-N 121.427 -0.796 . . . . 0.0 109.577 179.907 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.51 ' O ' ' N ' ' A' ' 62' ' ' TYR . 3.8 mtp180 -165.75 161.43 18.02 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.137 -0.977 . . . . 0.0 110.42 -179.946 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.816 HG22 ' CG1' ' A' ' 31' ' ' VAL . 9.6 p -88.02 170.8 10.79 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.209 -0.932 . . . . 0.0 110.249 -179.862 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.487 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -133.95 127.02 4.44 Favored Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.47 -1.452 . . . . 0.0 109.47 179.921 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.475 HG22 ' H ' ' A' ' 57' ' ' ASN . 2.0 m 60.03 -135.94 0.73 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.265 -1.138 . . . . 0.0 110.146 -179.953 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.528 ' O ' ' CG ' ' A' ' 59' ' ' LYS . 14.8 t-20 -102.06 90.09 3.84 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.019 -1.051 . . . . 0.0 110.594 -179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.415 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 3.2 mtt180 43.34 45.57 5.2 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.359 -0.838 . . . . 0.0 110.61 179.798 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.594 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 18.9 mttt -124.32 -28.42 3.67 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.195 -0.941 . . . . 0.0 110.028 179.691 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.737 ' HA ' HD23 ' A' ' 25' ' ' LEU . 2.0 m-85 -138.82 -174.44 3.84 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.374 -0.829 . . . . 0.0 109.369 179.6 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.511 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -162.15 136.85 4.55 Favored Glycine 0 N--CA 1.489 2.215 0 C-N-CA 119.499 -1.334 . . . . 0.0 110.231 179.956 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.689 ' O ' HG23 ' A' ' 63' ' ' VAL . 48.3 m-85 -94.48 159.98 14.86 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.268 -1.137 . . . . 0.0 109.577 179.253 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.94 HG22 HG12 ' A' ' 52' ' ' VAL . 24.6 t -158.63 161.19 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 C-N-CA 119.44 -0.904 . . . . 0.0 110.584 -178.876 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.499 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -134.64 139.72 45.51 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.484 -0.76 . . . . 0.0 109.511 179.795 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.647 ' HE2' HD21 ' A' ' 20' ' ' LEU . 55.6 m-85 -103.66 175.34 5.51 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.502 -0.749 . . . . 0.0 110.905 -179.478 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.638 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -112.66 16.42 19.68 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.462 -0.774 . . . . 0.0 111.388 -178.543 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.539 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 20.7 p -178.38 176.71 1.03 Allowed 'General case' 0 N--CA 1.495 1.794 0 CA-C-O 122.434 1.111 . . . . 0.0 112.044 179.807 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.467 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -77.18 -23.52 51.53 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 177.802 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.447 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -78.91 -27.52 43.81 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 115.104 -0.953 . . . . 0.0 109.369 179.999 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.663 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 89.6 m-20 -80.37 -29.98 37.9 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 178.119 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.706 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -75.66 -36.78 60.05 Favored 'General case' 0 C--N 1.304 -1.393 0 C-N-CA 119.95 -0.7 . . . . 0.0 109.323 179.165 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -69.33 -34.37 74.54 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.397 -0.814 . . . . 0.0 109.308 179.298 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.481 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 0.2 OUTLIER -81.0 -26.29 36.57 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 178.326 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.837 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -64.77 -29.88 70.87 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 178.675 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.501 HD22 ' HA ' ' A' ' 75' ' ' LEU . 0.4 OUTLIER -78.52 -45.11 22.71 Favored 'General case' 0 C--N 1.306 -1.32 0 CA-C-O 121.505 0.669 . . . . 0.0 109.246 179.12 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -66.07 -23.28 66.5 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.534 -0.729 . . . . 0.0 110.019 179.719 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.926 HD11 ' CD1' ' A' ' 47' ' ' LEU . 20.8 mt -69.69 -5.17 23.16 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.449 -0.782 . . . . 0.0 110.501 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.466 ' OG1' HD12 ' A' ' 89' ' ' LEU . 25.9 m -67.39 -2.02 5.62 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.525 -0.734 . . . . 0.0 111.205 -179.668 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -99.27 10.68 61.63 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.184 -1.566 . . . . 0.0 109.184 179.231 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.73 HD21 HD11 ' A' ' 41' ' ' LEU . 6.1 mt -84.8 -161.64 0.6 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.414 -1.051 . . . . 0.0 111.272 -179.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.575 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 9.6 tttm -159.66 52.4 0.35 Allowed 'General case' 0 N--CA 1.493 1.716 0 CA-C-O 122.345 1.069 . . . . 0.0 109.821 -179.168 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.739 ' HB ' HG23 ' A' ' 87' ' ' ILE . 0.5 OUTLIER -38.45 133.26 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 CA-C-N 114.625 -1.17 . . . . 0.0 109.737 -179.958 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.604 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 1.0 OUTLIER 40.97 34.74 0.3 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.409 -0.807 . . . . 0.0 110.313 -179.228 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 77.68 28.42 57.17 Favored Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.877 -1.289 . . . . 0.0 109.877 179.8 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.518 ' N ' ' O ' ' A' ' 82' ' ' VAL . 9.5 m-20 -144.42 107.77 4.59 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.229 -1.16 . . . . 0.0 109.291 179.643 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.575 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 4.4 mt-10 -59.03 92.68 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.005 -1.059 . . . . 0.0 110.3 -179.161 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.767 HG21 HD11 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -41.16 142.72 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 CA-C-O 121.712 0.768 . . . . 0.0 110.505 -179.846 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.473 ' HG3' ' HB2' ' A' ' 24' ' ' ASN . 0.1 OUTLIER -121.44 125.15 46.19 Favored 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.516 -0.74 . . . . 0.0 109.217 179.513 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.605 HD23 ' CD1' ' A' ' 20' ' ' LEU . 1.3 mt -85.24 176.64 8.22 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 121.139 -0.975 . . . . 0.0 110.855 -179.22 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.457 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 1.1 tt0 -176.42 110.68 0.09 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.701 -0.624 . . . . 0.0 109.715 -179.704 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 2.7 tptm -63.97 111.15 4.77 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.211 -0.931 . . . . 0.0 110.314 -179.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.0 Cg_endo -74.71 -179.31 4.76 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.936 1.493 . . . . 0.0 110.385 -179.933 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 92' ' ' PRO . 1.5 mttp 41.07 44.5 2.1 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.4 -0.813 . . . . 0.0 110.403 179.925 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -173.04 -157.39 14.69 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 -179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.6 mtt180 -109.55 -86.98 0.52 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.271 -1.135 . . . . 0.0 110.219 -179.988 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.494 ' OD1' ' N ' ' A' ' 96' ' ' ASP . 5.1 p-10 -174.17 59.37 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.239 -0.913 . . . . 0.0 110.187 -179.986 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -163.92 158.94 31.63 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 179.976 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.494 HG23 ' H ' ' A' ' 99' ' ' ARG . 0.0 OUTLIER -137.8 -93.25 0.21 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.282 -1.128 . . . . 0.0 110.416 179.988 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . 0.494 ' H ' HG23 ' A' ' 98' ' ' THR . 1.0 OUTLIER -78.06 167.37 21.55 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.176 -0.953 . . . . 0.0 110.233 179.946 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -136.79 -175.54 13.86 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.563 -1.415 . . . . 0.0 109.563 -179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 97.9 m . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.231 -1.158 . . . . 0.0 110.105 -179.983 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.38 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -141.59 -166.74 2.27 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.193 -1.18 . . . . 0.0 110.117 -179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 9.5 p80 -132.12 73.11 1.51 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 179.971 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 19.2 mtm -117.74 33.12 5.78 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.205 -0.934 . . . . 0.0 110.224 179.918 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -108.26 30.78 6.09 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.314 -0.866 . . . . 0.0 110.201 179.99 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -137.94 -155.31 0.59 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.254 -0.904 . . . . 0.0 110.18 179.96 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -65.54 128.94 94.21 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.23 -0.919 . . . . 0.0 110.191 179.958 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -71.55 -157.0 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.661 0 O-C-N 123.973 1.512 . . . . 0.0 110.166 -179.994 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.418 HG13 ' O ' ' A' ' 9' ' ' VAL . 7.1 p -152.5 133.16 4.34 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.953 0 O-C-N 121.814 -0.554 . . . . 0.0 110.118 -179.957 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.497 ' O ' ' N ' ' A' ' 12' ' ' SER . 2.3 tt0 -43.16 134.53 3.58 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.14 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -67.73 61.5 0.32 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.594 -1.403 . . . . 0.0 109.594 179.985 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 10' ' ' GLU . 57.9 m -108.41 -6.11 16.36 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.226 -1.161 . . . . 0.0 110.135 -179.984 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 16.1 mt-10 -144.55 95.14 2.66 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.216 -0.927 . . . . 0.0 109.799 179.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.34 172.06 0.51 Allowed 'General case' 0 C--N 1.284 -2.278 0 CA-C-O 121.265 0.555 . . . . 0.0 110.136 -179.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.778 HG21 ' CG ' ' A' ' 51' ' ' ASP . 3.8 m -87.83 -9.23 54.44 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.309 -0.869 . . . . 0.0 110.227 179.891 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.957 ' CG2' HG11 ' A' ' 50' ' ' VAL . 0.0 OUTLIER -172.45 165.02 3.78 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.258 -0.901 . . . . 0.0 110.551 -179.876 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.489 ' HD2' HG22 ' A' ' 16' ' ' THR . 50.5 Cg_endo -77.0 -40.49 0.47 Allowed 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.175 1.619 . . . . 0.0 110.5 -179.894 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.672 ' HD1' HD13 ' A' ' 71' ' ' LEU . 95.5 m-85 -100.03 108.98 21.3 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.111 -0.993 . . . . 0.0 110.531 -179.664 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.493 ' HB3' ' OH ' ' A' ' 62' ' ' TYR . 2.8 m120 -138.41 153.28 48.89 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.436 -0.79 . . . . 0.0 109.524 179.764 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.792 HD12 HD23 ' A' ' 89' ' ' LEU . 2.5 pt? -165.3 174.6 9.98 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.419 -0.8 . . . . 0.0 110.267 -179.766 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.416 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.5 OUTLIER -109.17 159.17 17.12 Favored 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.679 -0.638 . . . . 0.0 109.921 -179.662 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.635 HG23 ' O ' ' A' ' 88' ' ' LYS . 4.5 mt -142.61 149.11 19.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.559 0 O-C-N 121.356 -0.84 . . . . 0.0 109.403 -179.887 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.6 ' HA3' ' CE1' ' A' ' 60' ' ' PHE . . . -132.1 -172.74 13.13 Favored Glycine 0 N--CA 1.487 2.094 0 C-N-CA 119.565 -1.303 . . . . 0.0 110.027 -179.532 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.514 ' C ' HD22 ' A' ' 25' ' ' LEU . 32.3 t30 72.1 49.88 0.23 Allowed 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.527 -0.984 . . . . 0.0 109.858 -179.622 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.784 ' CD1' HD22 ' A' ' 34' ' ' LEU . 3.9 mm? -95.46 123.54 39.05 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.369 -0.832 . . . . 0.0 110.082 -179.965 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.654 ' N ' HD21 ' A' ' 34' ' ' LEU . 30.5 t-20 -42.47 101.78 0.25 Allowed Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.49 -0.756 . . . . 0.0 110.287 -179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.456 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 47.3 Cg_endo -74.52 -16.68 21.4 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.973 1.512 . . . . 0.0 110.338 -179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -77.48 -15.97 59.0 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.262 -0.899 . . . . 0.0 110.032 179.934 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -106.68 -155.66 0.55 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.406 -0.809 . . . . 0.0 109.803 179.817 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.71 ' O ' HD12 ' A' ' 34' ' ' LEU . 3.5 m -100.18 149.87 23.1 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.209 -0.932 . . . . 0.0 110.116 179.811 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.502 ' O ' ' HE2' ' A' ' 35' ' ' LYS . 3.5 t -66.61 -45.87 87.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 O-C-N 121.191 -0.943 . . . . 0.0 109.817 179.685 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -57.64 -42.54 83.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.265 -0.897 . . . . 0.0 109.446 179.322 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 80.6 mm-40 -58.84 -35.86 73.62 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.437 -0.79 . . . . 0.0 109.278 179.251 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.942 HD23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -65.68 -31.3 72.24 Favored 'General case' 0 C--N 1.305 -1.333 0 O-C-N 121.404 -0.81 . . . . 0.0 108.978 179.176 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.502 ' HE2' ' O ' ' A' ' 31' ' ' VAL . 0.0 OUTLIER -66.76 -50.84 61.43 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.538 -0.727 . . . . 0.0 109.335 179.228 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.482 ' O ' ' HB2' ' A' ' 40' ' ' GLU . 22.0 t -59.66 -39.19 78.94 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.474 -0.766 . . . . 0.0 109.937 179.469 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.931 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -61.45 -33.45 73.76 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.135 -0.978 . . . . 0.0 108.682 179.434 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.665 HG12 HD13 ' A' ' 87' ' ' ILE . 42.5 mt -81.04 -30.82 11.75 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.45 0 N-CA-C 109.07 -0.715 . . . . 0.0 109.07 178.835 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.61 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 46.4 t -77.22 -26.4 52.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.252 -0.905 . . . . 0.0 109.063 179.299 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -82.87 -43.26 16.78 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.707 0.765 . . . . 0.0 109.247 179.302 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 80' ' ' LEU . 1.1 tp -60.13 -36.5 77.64 Favored 'General case' 0 C--N 1.301 -1.54 0 C-N-CA 119.833 -0.747 . . . . 0.0 109.153 179.281 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.568 ' CD2' ' HG ' ' A' ' 47' ' ' LEU . 8.9 m-85 -83.71 -22.13 32.11 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.647 -0.871 . . . . 0.0 108.647 178.661 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.61 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -78.57 -32.04 47.54 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.621 0.725 . . . . 0.0 109.286 179.518 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.47 ' HE2' ' OE2' ' A' ' 40' ' ' GLU . 0.0 OUTLIER -89.73 -14.89 33.68 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.423 -0.798 . . . . 0.0 109.328 179.188 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.626 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.4 m-80 -89.02 -18.09 28.06 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.431 -0.793 . . . . 0.0 109.656 179.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.626 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 4.1 t0 89.52 29.4 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.996 0 CA-C-O 122.004 0.907 . . . . 0.0 108.765 -179.234 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.568 ' HG ' ' CD2' ' A' ' 42' ' ' PHE . 0.2 OUTLIER -79.25 -137.41 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.337 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.655 ' HB3' ' HG2' ' A' ' 66' ' ' GLU . . . 178.94 58.26 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.796 0 O-C-N 121.14 -0.975 . . . . 0.0 109.517 179.706 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.43 ' O ' HG23 ' A' ' 49' ' ' VAL . 13.0 m -60.17 116.04 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-O 121.987 0.899 . . . . 0.0 110.148 -179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.957 HG11 ' CG2' ' A' ' 16' ' ' THR . 17.1 t -81.44 -36.19 14.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.822 0 O-C-N 121.894 -0.504 . . . . 0.0 110.561 -179.702 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.778 ' CG ' HG21 ' A' ' 15' ' ' THR . 0.3 OUTLIER -149.98 154.39 38.15 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.107 -0.996 . . . . 0.0 110.673 179.873 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.808 HG12 HG22 ' A' ' 63' ' ' VAL . 0.1 OUTLIER -133.51 173.14 15.21 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.149 -0.97 . . . . 0.0 109.732 179.981 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 178.38 170.12 0.79 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.197 -0.939 . . . . 0.0 110.47 179.949 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.523 ' HA ' ' HA2' ' A' ' 61' ' ' GLY . 28.5 p -100.7 164.74 11.73 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.395 -0.816 . . . . 0.0 110.225 -179.679 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.565 ' HA3' ' HB3' ' A' ' 60' ' ' PHE . . . -134.53 136.6 8.69 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 108.961 -1.656 . . . . 0.0 108.961 179.692 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.467 ' OG1' ' HB2' ' A' ' 60' ' ' PHE . 0.2 OUTLIER 63.47 -138.51 0.35 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.306 -1.114 . . . . 0.0 110.293 179.918 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.532 ' O ' ' CG ' ' A' ' 58' ' ' ARG . 9.0 m-20 -111.82 99.98 8.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.17 -0.956 . . . . 0.0 110.529 -179.8 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 57' ' ' ASN . 3.2 ptt85 38.37 27.94 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.586 -0.696 . . . . 0.0 111.02 179.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.492 ' N ' ' O ' ' A' ' 57' ' ' ASN . 1.3 ttpt -129.51 -5.33 4.74 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.124 -0.985 . . . . 0.0 110.268 179.791 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.736 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -138.58 -168.39 2.39 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.363 -0.836 . . . . 0.0 109.38 -179.991 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.523 ' HA2' ' HA ' ' A' ' 54' ' ' THR . . . -173.26 179.4 44.7 Favored Glycine 0 N--CA 1.493 2.476 0 C-N-CA 119.46 -1.352 . . . . 0.0 110.524 179.869 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.687 ' O ' HG23 ' A' ' 63' ' ' VAL . 12.3 t80 -154.88 156.43 36.14 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.568 -0.96 . . . . 0.0 109.365 179.979 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.808 HG22 HG12 ' A' ' 52' ' ' VAL . 25.5 t -158.66 164.28 1.04 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.413 0 C-N-CA 119.248 -0.981 . . . . 0.0 111.009 -178.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.579 ' OD1' ' CE1' ' A' ' 62' ' ' TYR . 7.9 m-20 -130.08 140.16 50.86 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.554 -0.716 . . . . 0.0 109.47 179.595 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.67 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 22.3 m-85 -103.09 179.56 4.24 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.286 -179.808 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.655 ' HG2' ' HB3' ' A' ' 48' ' ' ALA . 10.9 pt-20 -113.11 2.54 15.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.171 -0.955 . . . . 0.0 110.954 -179.288 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.545 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 56.8 p -165.44 177.68 7.31 Favored 'General case' 0 N--CA 1.495 1.784 0 CA-C-O 122.585 1.183 . . . . 0.0 112.348 179.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.46 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -78.27 -24.05 46.98 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 107.474 -1.306 . . . . 0.0 107.474 177.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.475 ' OE1' ' NZ ' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -76.52 -26.85 55.67 Favored 'General case' 0 C--N 1.298 -1.674 0 CA-C-N 115.031 -0.986 . . . . 0.0 109.562 -179.885 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.593 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 77.6 m-20 -86.02 -27.37 24.85 Favored 'General case' 0 C--N 1.305 -1.33 0 N-CA-C 107.861 -1.163 . . . . 0.0 107.861 178.308 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.672 HD13 ' HD1' ' A' ' 18' ' ' PHE . 0.4 OUTLIER -77.13 -35.47 56.2 Favored 'General case' 0 C--N 1.304 -1.388 0 C-N-CA 120.013 -0.675 . . . . 0.0 109.659 179.288 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -79.93 -32.43 40.1 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.396 -0.815 . . . . 0.0 109.962 179.764 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.755 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.4 OUTLIER -80.85 -25.1 37.94 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 178.708 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.67 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.65 -26.74 45.17 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 119.808 -0.757 . . . . 0.0 108.998 178.936 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.597 HD23 ' C ' ' A' ' 75' ' ' LEU . 6.9 tt -72.97 -46.05 54.51 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 178.735 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -72.39 -19.22 61.65 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.723 -0.843 . . . . 0.0 108.723 178.496 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.755 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -62.6 -11.06 14.45 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.761 -0.587 . . . . 0.0 109.949 179.569 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.525 HG22 ' OE2' ' A' ' 86' ' ' GLU . 18.7 m -39.23 -28.53 0.03 OUTLIER 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 121.806 0.812 . . . . 0.0 110.966 -179.463 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 77' ' ' LEU . . . -53.62 -20.55 12.25 Favored Glycine 0 C--N 1.285 -2.298 0 N-CA-C 108.926 -1.67 . . . . 0.0 108.926 179.431 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.839 HD13 HG12 ' A' ' 87' ' ' ILE . 1.5 pp -48.04 -178.22 0.0 OUTLIER 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.441 -1.035 . . . . 0.0 111.82 -179.584 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.569 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.7 OUTLIER -167.7 51.41 0.06 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 -179.979 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.942 HG21 HD23 ' A' ' 34' ' ' LEU . 11.0 p 5.73 -122.99 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.512 2.654 0 CA-C-N 114.462 -1.245 . . . . 0.0 111.091 -179.233 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.931 ' CE1' ' HB2' ' A' ' 37' ' ' ALA . 3.4 m-85 -81.58 13.79 2.91 Favored 'General case' 0 C--N 1.296 -1.757 0 O-C-N 120.437 -1.414 . . . . 0.0 108.985 178.447 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 133.73 34.77 0.29 Allowed Glycine 0 N--CA 1.489 2.209 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 -179.774 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.632 ' O ' HG12 ' A' ' 82' ' ' VAL . 24.8 m-80 -158.86 103.5 1.7 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.462 -1.022 . . . . 0.0 109.224 -179.923 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.728 ' HA ' HD12 ' A' ' 80' ' ' LEU . 3.5 tt0 -49.91 90.52 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.092 -1.005 . . . . 0.0 110.371 -179.393 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.839 HG12 HD13 ' A' ' 80' ' ' LEU . 16.7 pt -49.45 138.73 4.6 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 O-C-N 121.474 -0.766 . . . . 0.0 109.767 179.819 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.635 ' O ' HG23 ' A' ' 22' ' ' ILE . 0.0 OUTLIER -97.21 175.19 6.37 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.507 -0.745 . . . . 0.0 109.432 179.86 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.792 HD23 HD12 ' A' ' 20' ' ' LEU . 7.1 mp -121.45 -176.66 3.35 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.428 -0.795 . . . . 0.0 110.372 -179.708 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.72 96.43 0.13 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.648 -0.658 . . . . 0.0 110.184 179.971 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -59.33 115.49 12.53 Favored Pre-proline 0 N--CA 1.492 1.66 0 O-C-N 121.232 -0.918 . . . . 0.0 110.152 179.978 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.496 ' HD3' ' HA ' ' A' ' 20' ' ' LEU . 46.4 Cg_endo -72.94 -174.15 1.45 Allowed 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.943 1.497 . . . . 0.0 110.441 179.938 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.508 ' O ' ' N ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER 50.58 73.6 0.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -0.907 . . . . 0.0 110.15 179.998 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.15 72.76 0.05 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.541 -1.423 . . . . 0.0 109.541 -179.992 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.508 ' N ' ' O ' ' A' ' 93' ' ' LYS . 0.2 OUTLIER -128.18 73.75 1.5 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.29 -1.124 . . . . 0.0 110.252 -179.926 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -68.29 169.14 11.06 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.271 -0.893 . . . . 0.0 110.164 -179.99 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.458 ' O ' ' O ' ' A' ' 98' ' ' THR . . . 98.3 -18.62 56.79 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.519 -1.432 . . . . 0.0 109.519 179.964 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.458 ' O ' ' O ' ' A' ' 97' ' ' GLY . 3.6 p 42.44 94.08 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.312 -1.11 . . . . 0.0 110.327 179.944 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -79.32 52.54 1.36 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.23 -0.919 . . . . 0.0 110.25 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -90.91 -40.59 5.53 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.997 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 33.9 t . . . . . 0 N--CA 1.491 1.61 0 O-C-N 121.183 -1.186 . . . . 0.0 110.236 -179.995 . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.326 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 031 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.1 p -156.18 77.65 0.94 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.23 -1.159 . . . . 0.0 110.211 -179.981 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -127.87 55.55 1.63 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.291 -0.881 . . . . 0.0 110.206 -179.974 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.95 59.95 1.25 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.235 -0.916 . . . . 0.0 110.178 -179.983 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 5.0 mt -55.64 94.99 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.262 -0.899 . . . . 0.0 110.161 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -97.76 85.37 3.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.301 -0.874 . . . . 0.0 110.209 179.965 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 1.1 p30 -150.71 75.92 8.32 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.291 -0.88 . . . . 0.0 110.256 179.992 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -71.74 80.5 1.44 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 124.022 1.538 . . . . 0.0 110.421 179.983 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.565 HG13 ' O ' ' A' ' 9' ' ' VAL . 11.8 p -136.8 124.18 31.92 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.801 0 O-C-N 121.78 -0.575 . . . . 0.0 110.267 -179.966 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.457 ' O ' ' O ' ' A' ' 9' ' ' VAL . 0.7 OUTLIER -57.95 -154.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.322 -0.862 . . . . 0.0 110.212 179.903 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -171.07 73.14 0.11 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.745 -1.342 . . . . 0.0 109.745 -179.987 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.493 ' O ' ' O ' ' A' ' 13' ' ' GLU . 20.8 m -76.2 -91.98 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -1.147 . . . . 0.0 110.029 179.915 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.493 ' O ' ' O ' ' A' ' 12' ' ' SER . 4.7 mt-10 38.0 97.92 0.0 OUTLIER 'General case' 0 C--N 1.308 -1.207 0 CA-C-O 121.992 0.901 . . . . 0.0 110.883 179.463 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.455 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.1 OUTLIER -38.21 146.48 0.06 Allowed 'General case' 0 C--N 1.289 -2.04 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.242 179.728 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.63 ' O ' HG23 ' A' ' 16' ' ' THR . 30.2 m -89.37 -12.14 41.26 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.348 -0.845 . . . . 0.0 110.666 -179.557 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.941 ' CG2' HG11 ' A' ' 50' ' ' VAL . 24.8 p -158.93 153.36 20.4 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.158 -0.964 . . . . 0.0 110.793 -179.941 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.591 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.8 Cg_endo -78.94 -30.36 2.85 Favored 'Trans proline' 0 C--N 1.304 -1.806 0 O-C-N 124.262 1.664 . . . . 0.0 110.339 179.71 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.62 ' HD1' HD22 ' A' ' 71' ' ' LEU . 96.4 m-85 -92.75 106.07 18.1 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.122 -0.986 . . . . 0.0 110.358 -179.799 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.443 ' CB ' ' OH ' ' A' ' 62' ' ' TYR . 4.8 m120 -139.52 152.69 47.14 Favored 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.323 -0.861 . . . . 0.0 109.682 179.969 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.616 ' N ' HD23 ' A' ' 20' ' ' LEU . 1.6 pt? -165.33 164.73 19.78 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.393 -0.817 . . . . 0.0 110.291 -179.908 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.461 ' HA ' ' CD2' ' A' ' 62' ' ' TYR . 0.4 OUTLIER -91.08 160.75 15.43 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.552 -0.718 . . . . 0.0 109.379 -179.967 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 1.05 HD12 ' CG2' ' A' ' 63' ' ' VAL . 5.4 mt -150.03 146.93 16.52 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 O-C-N 121.112 -0.992 . . . . 0.0 109.951 -179.669 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.589 ' HA2' ' HA ' ' A' ' 60' ' ' PHE . . . -129.91 -171.47 12.94 Favored Glycine 0 N--CA 1.487 2.048 0 N-CA-C 109.774 -1.33 . . . . 0.0 109.774 179.909 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.536 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 26.2 t30 73.08 35.27 0.97 Allowed 'General case' 0 N--CA 1.496 1.825 0 O-C-N 121.501 -0.999 . . . . 0.0 110.561 179.96 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.792 ' HB3' HD13 ' A' ' 34' ' ' LEU . 4.1 mm? -84.13 128.21 34.42 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.158 -0.964 . . . . 0.0 109.824 179.358 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.79 ' H ' HD21 ' A' ' 34' ' ' LEU . 57.6 t-20 -39.8 102.89 0.27 Allowed Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.663 -0.648 . . . . 0.0 110.61 -179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -77.02 7.0 3.84 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 124.045 1.55 . . . . 0.0 110.733 -179.729 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -106.07 -14.63 15.11 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.097 -1.002 . . . . 0.0 109.304 179.593 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 6.6 mptt -111.23 -156.3 0.58 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.624 -0.673 . . . . 0.0 109.629 179.702 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.477 ' HB2' ' HG3' ' A' ' 33' ' ' GLU . 2.3 m -105.49 148.53 27.11 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.301 -0.874 . . . . 0.0 109.735 179.283 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 1.018 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.8 t -63.97 -15.6 17.22 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.558 0 C-N-CA 118.873 -1.131 . . . . 0.0 109.038 179.525 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.849 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -75.34 -38.38 60.2 Favored 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.432 -0.792 . . . . 0.0 109.05 178.828 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.573 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . 3.8 mt-10 -72.13 -28.02 62.99 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.502 -0.749 . . . . 0.0 109.046 178.955 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.968 HD23 HG11 ' A' ' 82' ' ' VAL . 4.8 mt -70.79 -43.11 69.37 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.415 -0.803 . . . . 0.0 109.155 179.091 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.718 ' HG2' HG22 ' A' ' 52' ' ' VAL . 53.1 mttt -60.65 -43.81 97.16 Favored 'General case' 0 C--N 1.302 -1.459 0 O-C-N 121.66 -0.65 . . . . 0.0 110.018 179.599 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.849 HG23 ' O ' ' A' ' 32' ' ' ALA . 8.5 t -63.67 -41.1 91.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.259 -0.901 . . . . 0.0 109.869 179.583 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.717 ' HB2' ' HE1' ' A' ' 83' ' ' PHE . . . -63.05 -38.16 90.09 Favored 'General case' 0 C--N 1.305 -1.359 0 O-C-N 121.146 -0.971 . . . . 0.0 108.93 179.635 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.895 HD11 HG22 ' A' ' 82' ' ' VAL . 17.6 mm -77.7 -28.87 15.92 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 C-N-CA 119.841 -0.743 . . . . 0.0 109.234 178.973 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 14.9 t -76.96 -30.23 55.92 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.317 -0.864 . . . . 0.0 108.951 179.245 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.482 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 2.9 tm-20 -81.27 -45.92 15.53 Favored 'General case' 0 C--N 1.301 -1.505 0 CA-C-O 121.567 0.699 . . . . 0.0 109.585 179.42 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.043 ' HG ' HD13 ' A' ' 80' ' ' LEU . 0.3 OUTLIER -56.76 -39.97 74.99 Favored 'General case' 0 C--N 1.3 -1.548 0 C-N-CA 119.744 -0.782 . . . . 0.0 109.302 179.402 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 1.029 ' CE1' HD13 ' A' ' 77' ' ' LEU . 16.2 m-30 -78.43 -25.16 45.92 Favored 'General case' 0 C--N 1.302 -1.462 0 N-CA-C 108.628 -0.879 . . . . 0.0 108.628 178.755 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -79.71 -33.12 41.21 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 179.327 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.472 ' HG3' ' OE2' ' A' ' 40' ' ' GLU . 2.8 mttt -88.43 -13.07 41.34 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.534 -0.729 . . . . 0.0 109.432 179.296 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.603 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.9 OUTLIER -92.36 -14.48 28.63 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.299 -0.876 . . . . 0.0 109.751 179.659 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.603 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.9 t0 86.38 28.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.905 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 -178.936 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.923 HD13 HD11 ' A' ' 77' ' ' LEU . 2.5 tp -76.97 -136.39 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.572 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 179.401 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.78 ' HB3' ' HB2' ' A' ' 70' ' ' ASP . . . -165.35 46.09 0.08 Allowed 'General case' 0 C--N 1.294 -1.808 0 CA-C-O 122.093 0.949 . . . . 0.0 108.67 178.923 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 49' ' ' VAL . 0.5 OUTLIER -55.29 150.93 2.11 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.784 0 CA-C-O 122.241 1.02 . . . . 0.0 109.447 -179.961 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.941 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.5 t -136.18 -34.63 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.356 -178.984 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' O ' ' HB ' ' A' ' 52' ' ' VAL . 1.9 m-20 -152.61 -179.91 8.02 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.068 -1.02 . . . . 0.0 111.034 -179.864 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.718 HG22 ' HG2' ' A' ' 35' ' ' LYS . 14.6 p 179.84 113.67 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.764 -0.585 . . . . 0.0 109.8 179.887 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -114.02 172.18 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.163 -0.961 . . . . 0.0 110.332 -179.698 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 1.018 HG22 ' CG1' ' A' ' 31' ' ' VAL . 18.9 p -82.34 162.4 22.24 Favored 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.268 -0.895 . . . . 0.0 110.368 -179.839 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.541 ' O ' ' CB ' ' A' ' 60' ' ' PHE . . . -134.21 122.58 3.01 Favored Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.664 -1.374 . . . . 0.0 109.664 -179.734 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.545 HG22 ' OD1' ' A' ' 57' ' ' ASN . 28.8 m 38.95 96.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.392 -1.064 . . . . 0.0 111.119 179.626 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.545 ' OD1' HG22 ' A' ' 56' ' ' THR . 9.5 m120 64.13 -146.3 0.29 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.266 -0.896 . . . . 0.0 110.622 179.474 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -112.91 31.71 6.21 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.292 -0.88 . . . . 0.0 110.572 -179.714 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.442 ' C ' ' HB2' ' A' ' 25' ' ' LEU . 12.0 tttm -115.54 -20.25 10.27 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.046 -1.034 . . . . 0.0 110.07 179.833 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.597 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -115.52 -170.16 1.72 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.243 -0.911 . . . . 0.0 109.687 179.73 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.504 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 169.62 154.57 9.31 Favored Glycine 0 N--CA 1.492 2.401 0 C-N-CA 119.416 -1.373 . . . . 0.0 110.711 -179.876 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.618 ' CD1' ' N ' ' A' ' 63' ' ' VAL . 21.6 t80 -115.13 163.04 16.2 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.555 -0.968 . . . . 0.0 109.514 179.537 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 1.05 ' CG2' HD12 ' A' ' 22' ' ' ILE . 3.4 t -148.88 148.22 16.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.533 0 C-N-CA 119.21 -0.996 . . . . 0.0 111.019 -178.601 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.497 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.4 m-20 -119.71 142.71 48.26 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 121.425 -0.797 . . . . 0.0 109.993 179.795 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.755 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 31.0 m-85 -110.91 178.97 4.18 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.496 -0.753 . . . . 0.0 109.718 179.789 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.549 ' CG ' ' CG2' ' A' ' 50' ' ' VAL . 0.0 OUTLIER -123.99 15.73 9.26 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.012 -1.055 . . . . 0.0 110.865 -179.124 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.547 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 1.9 t -165.81 174.94 9.12 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-O 122.835 1.302 . . . . 0.0 112.505 -179.934 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.538 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -87.44 -25.73 23.62 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 177.484 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.484 ' OE1' ' HE3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -83.72 -22.83 31.87 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.908 -1.145 . . . . 0.0 107.908 178.783 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.78 ' HB2' ' HB3' ' A' ' 48' ' ' ALA . 4.8 t0 -81.45 -33.91 31.76 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 177.809 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.62 HD22 ' HD1' ' A' ' 18' ' ' PHE . 48.5 tp -69.41 -39.4 77.93 Favored 'General case' 0 C--N 1.304 -1.379 0 C-N-CA 119.707 -0.797 . . . . 0.0 109.01 178.634 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -69.04 -32.86 72.66 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.409 -0.807 . . . . 0.0 109.398 179.195 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.558 ' HB3' ' CD1' ' A' ' 47' ' ' LEU . 38.0 mttm -80.79 -24.21 38.73 Favored 'General case' 0 C--N 1.305 -1.35 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.22 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.987 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -67.34 -29.81 69.47 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.488 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.743 HD22 HD11 ' A' ' 89' ' ' LEU . 0.4 OUTLIER -77.59 -45.44 25.19 Favored 'General case' 0 C--N 1.306 -1.324 0 N-CA-C 109.078 -0.712 . . . . 0.0 109.078 179.152 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -67.89 -17.43 64.48 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.451 -0.781 . . . . 0.0 109.676 179.46 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 1.029 HD13 ' CE1' ' A' ' 42' ' ' PHE . 11.7 mt -67.43 -7.02 21.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.534 -0.729 . . . . 0.0 110.294 179.745 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . . . . . . . . . 91.2 m -49.68 -15.9 0.2 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.432 -0.792 . . . . 0.0 111.217 -179.956 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -83.31 18.19 19.53 Favored Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.929 -1.268 . . . . 0.0 109.929 179.487 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.043 HD13 ' HG ' ' A' ' 41' ' ' LEU . 0.1 OUTLIER -97.28 179.08 5.02 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.144 -1.21 . . . . 0.0 109.146 179.843 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.672 ' H ' HD12 ' A' ' 80' ' ' LEU . 0.1 OUTLIER -162.22 53.62 0.22 Allowed 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.317 -0.864 . . . . 0.0 109.752 179.942 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.019 HG21 HG23 ' A' ' 87' ' ' ILE . 3.5 t 8.5 -125.36 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.506 0 CA-C-N 114.469 -1.241 . . . . 0.0 111.441 179.841 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.717 ' HE1' ' HB2' ' A' ' 37' ' ' ALA . 4.0 m-30 -75.04 -2.11 25.87 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.001 -1.062 . . . . 0.0 108.82 178.719 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.436 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 149.51 35.0 0.04 OUTLIER Glycine 0 N--CA 1.487 2.073 0 N-CA-C 109.319 -1.512 . . . . 0.0 109.319 179.865 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.515 ' O ' ' N ' ' A' ' 87' ' ' ILE . 58.1 m-20 -158.94 104.16 1.72 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.11 -1.229 . . . . 0.0 110.041 179.958 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.581 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.4 OUTLIER -54.03 88.62 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.234 -0.916 . . . . 0.0 110.309 -179.616 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 1.019 HG23 HG21 ' A' ' 82' ' ' VAL . 0.4 OUTLIER -40.43 147.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.58 0 CA-C-O 121.577 0.703 . . . . 0.0 110.186 179.722 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.557 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 4.6 mmmt -116.31 152.94 32.84 Favored 'General case' 0 C--N 1.296 -1.741 0 O-C-N 121.643 -0.661 . . . . 0.0 109.503 179.763 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.743 HD11 HD22 ' A' ' 75' ' ' LEU . 0.2 OUTLIER -115.82 173.91 6.31 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.311 -0.868 . . . . 0.0 110.304 -179.852 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -165.36 145.25 6.8 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.368 -0.832 . . . . 0.0 110.213 179.961 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 10.7 mtmt -76.29 115.23 45.35 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.311 -0.868 . . . . 0.0 110.2 -179.968 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.432 ' HD2' ' HG3' ' A' ' 95' ' ' ARG . 46.2 Cg_endo -73.15 -173.17 1.18 Allowed 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.906 1.477 . . . . 0.0 110.398 179.896 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.31 121.33 22.05 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.25 -0.906 . . . . 0.0 110.252 179.989 . . . . . . . . 2 2 . 1 . 031 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 99.29 32.73 5.67 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.967 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.432 ' HG3' ' HD2' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -119.0 133.29 55.92 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.342 -1.093 . . . . 0.0 110.233 -179.966 . . . . . . . . 3 3 . 1 . 031 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -118.45 -156.44 0.64 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.218 -0.926 . . . . 0.0 110.266 179.931 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 82.22 97.73 0.48 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 179.965 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 2.8 p -97.05 106.76 19.16 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.19 -1.182 . . . . 0.0 110.287 179.969 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 2.3 ptp180 -140.83 -155.66 0.61 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.25 -0.906 . . . . 0.0 110.189 -179.92 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 106.54 153.26 19.9 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.481 -1.447 . . . . 0.0 109.481 179.998 . . . . . . . . 1 1 . 1 . 031 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 8.2 t . . . . . 0 N--CA 1.492 1.625 0 O-C-N 121.231 -1.159 . . . . 0.0 110.216 179.931 . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.329 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 032 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 5.0 p -117.31 41.05 2.88 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.294 -1.121 . . . . 0.0 110.203 -179.995 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -133.94 -81.78 0.46 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.0 110.177 179.997 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.517 ' HE2' HD13 ' A' ' 5' ' ' LEU . 8.4 ptm -134.12 -166.82 1.85 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.286 -0.883 . . . . 0.0 110.208 -179.95 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.517 HD13 ' HE2' ' A' ' 4' ' ' MET . 1.0 OUTLIER 63.04 -153.67 0.34 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.282 -0.886 . . . . 0.0 110.16 -179.985 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . 0.443 ' CB ' ' O ' ' A' ' 5' ' ' LEU . 3.1 tt0 64.97 47.03 2.67 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.265 -0.897 . . . . 0.0 110.24 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 14.3 m-20 -66.88 144.74 98.71 Favored Pre-proline 0 N--CA 1.491 1.602 0 O-C-N 121.306 -0.871 . . . . 0.0 110.172 -179.978 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -72.08 79.92 1.63 Allowed 'Trans proline' 0 C--N 1.305 -1.72 0 O-C-N 123.995 1.524 . . . . 0.0 110.4 -179.977 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 48.9 t -58.32 93.8 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 CA-C-O 121.305 0.574 . . . . 0.0 110.223 -179.969 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 4.9 pt-20 -99.71 -168.97 1.68 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.26 -0.9 . . . . 0.0 110.215 179.96 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 119.07 -14.72 11.11 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 179.951 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 75.4 m -101.95 49.61 0.86 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.281 -1.129 . . . . 0.0 110.168 179.968 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -91.54 27.73 1.92 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.256 -0.902 . . . . 0.0 110.21 -179.881 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -58.93 173.79 0.41 Allowed 'General case' 0 C--N 1.29 -1.979 0 CA-C-O 121.223 0.535 . . . . 0.0 110.075 179.938 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 1.042 HG23 HG23 ' A' ' 16' ' ' THR . 5.0 t -121.41 -24.18 5.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.231 -0.918 . . . . 0.0 110.265 -179.923 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 1.042 HG23 HG23 ' A' ' 15' ' ' THR . 73.0 p -137.27 159.54 69.21 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.441 -0.787 . . . . 0.0 110.361 -179.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 49.3 Cg_endo -76.51 -15.98 17.23 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.06 1.558 . . . . 0.0 110.896 -179.576 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.643 ' CE2' ' HA ' ' A' ' 67' ' ' SER . 92.1 m-85 -115.62 122.94 47.11 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.996 -1.065 . . . . 0.0 110.645 -179.562 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.478 ' HA ' ' HA ' ' A' ' 64' ' ' ASP . 97.9 m-20 -139.43 170.21 16.35 Favored 'General case' 0 C--N 1.3 -1.551 0 O-C-N 121.644 -0.66 . . . . 0.0 109.271 179.603 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.809 HD22 ' C ' ' A' ' 20' ' ' LEU . 0.0 OUTLIER -169.25 163.55 10.87 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 121.29 -0.882 . . . . 0.0 110.47 -179.775 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.596 ' O ' ' HA ' ' A' ' 89' ' ' LEU . 0.0 OUTLIER -97.72 177.25 5.54 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 121.683 -0.636 . . . . 0.0 111.366 -177.72 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.523 ' CG1' ' O ' ' A' ' 21' ' ' PHE . 15.2 mt -157.28 133.29 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.288 -0.883 . . . . 0.0 109.564 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -132.98 166.61 23.61 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.96 -1.256 . . . . 0.0 109.96 -179.6 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.909 ' C ' HD22 ' A' ' 25' ' ' LEU . 35.8 t30 72.48 81.02 0.14 Allowed 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.505 -0.997 . . . . 0.0 110.472 179.823 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.909 HD22 ' C ' ' A' ' 24' ' ' ASN . 4.2 mm? -119.92 128.79 53.94 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.295 -0.878 . . . . 0.0 110.005 179.637 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.532 ' CB ' HD21 ' A' ' 34' ' ' LEU . 31.1 t-20 -41.25 101.89 0.25 Allowed Pre-proline 0 C--N 1.301 -1.534 0 O-C-N 121.556 -0.715 . . . . 0.0 110.429 -179.883 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.564 ' HA ' ' HD3' ' A' ' 58' ' ' ARG . 45.8 Cg_endo -72.48 -23.7 19.9 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.036 1.545 . . . . 0.0 110.264 179.845 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . 0.474 ' OD1' ' N ' ' A' ' 28' ' ' ASN . 1.7 m-20 -78.46 -16.16 57.86 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.27 -0.893 . . . . 0.0 110.048 179.866 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.558 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 1.2 mmtt -107.86 -155.4 0.55 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.378 -0.826 . . . . 0.0 109.889 179.741 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.536 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 1.3 m -102.97 145.03 30.48 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.253 -0.904 . . . . 0.0 110.464 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.918 ' HA ' HD12 ' A' ' 34' ' ' LEU . 2.6 t -68.18 -42.5 84.84 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.465 -0.894 . . . . 0.0 109.431 179.43 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.682 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -56.44 -36.08 68.6 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.267 -0.896 . . . . 0.0 109.185 179.063 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.597 ' HB3' ' CZ ' ' A' ' 83' ' ' PHE . 25.8 mm-40 -64.72 -43.54 93.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.461 -0.774 . . . . 0.0 109.092 179.109 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.918 HD12 ' HA ' ' A' ' 31' ' ' VAL . 18.6 mt -59.72 -38.88 82.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.365 -0.835 . . . . 0.0 108.802 179.033 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.789 ' HA ' HD12 ' A' ' 38' ' ' ILE . 9.8 mmpt? -59.98 -54.22 48.63 Favored 'General case' 0 C--N 1.302 -1.466 0 CA-C-O 121.537 0.684 . . . . 0.0 109.366 179.379 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.682 HG23 ' O ' ' A' ' 32' ' ' ALA . 18.3 t -54.21 -35.49 29.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.452 -0.78 . . . . 0.0 109.675 179.258 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.493 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -63.77 -32.3 73.76 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.169 -0.957 . . . . 0.0 108.798 179.403 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.789 HD12 ' HA ' ' A' ' 35' ' ' LYS . 14.1 mt -82.53 -28.84 8.76 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 178.853 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . . . . . . . . . 3.4 m -78.75 -28.78 44.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.339 -0.85 . . . . 0.0 109.072 179.164 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 3.3 tm-20 -80.83 -41.12 23.77 Favored 'General case' 0 C--N 1.301 -1.506 0 CA-C-O 121.626 0.727 . . . . 0.0 109.162 179.38 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.073 ' CD2' HD22 ' A' ' 80' ' ' LEU . 1.1 tp -63.45 -34.42 77.72 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.919 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.607 ' CD1' ' HG ' ' A' ' 47' ' ' LEU . 4.7 m-85 -79.9 -23.99 41.44 Favored 'General case' 0 C--N 1.303 -1.426 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 178.782 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -74.7 -32.69 62.24 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.535 -0.728 . . . . 0.0 109.499 179.631 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 48.1 mttt -89.14 -17.97 28.13 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.726 . . . . 0.0 109.411 179.465 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.602 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.5 m-80 -87.85 -14.68 38.82 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.461 -0.774 . . . . 0.0 109.937 179.822 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.602 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 3.1 t70 83.96 30.91 0.06 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-O 121.916 0.865 . . . . 0.0 108.784 -179.257 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.618 ' O ' ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -74.82 -129.33 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 179.464 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.81 ' HB3' ' OD2' ' A' ' 70' ' ' ASP . . . 173.34 54.28 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.736 0 O-C-N 121.196 -0.94 . . . . 0.0 109.066 179.642 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 49' ' ' VAL . 10.7 m -57.43 116.88 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.642 0 CA-C-O 122.111 0.958 . . . . 0.0 110.392 -179.616 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.95 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.1 t -91.54 -39.14 11.36 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.948 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.788 -179.896 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.758 ' CG ' HG21 ' A' ' 15' ' ' THR . 4.0 m-20 -152.65 125.35 8.35 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.162 -0.961 . . . . 0.0 111.101 -179.91 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.946 HG12 HG22 ' A' ' 63' ' ' VAL . 3.2 m -115.09 153.8 16.54 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.303 0 O-C-N 121.256 -0.903 . . . . 0.0 110.001 179.526 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.447 ' O ' ' HD2' ' A' ' 35' ' ' LYS . 1.4 tpt180 -148.98 168.78 22.17 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.266 -0.896 . . . . 0.0 110.431 179.974 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.706 ' HB ' HG11 ' A' ' 31' ' ' VAL . 75.6 p -99.51 159.61 14.9 Favored 'General case' 0 C--N 1.304 -1.372 0 O-C-N 121.327 -0.858 . . . . 0.0 110.67 -179.572 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.559 ' N ' ' HA2' ' A' ' 61' ' ' GLY . . . -110.28 115.74 4.19 Favored Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.902 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.498 HG22 ' H ' ' A' ' 57' ' ' ASN . 0.3 OUTLIER 58.66 -154.51 0.36 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.219 -1.165 . . . . 0.0 110.172 179.953 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.498 ' H ' HG22 ' A' ' 56' ' ' THR . 81.5 m-20 -60.55 -51.94 67.29 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.214 -0.929 . . . . 0.0 110.09 179.966 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.582 ' CB ' HG22 ' A' ' 31' ' ' VAL . 2.1 ptp180 -177.3 51.85 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.339 -0.851 . . . . 0.0 110.138 -179.969 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.548 ' HB3' ' CE1' ' A' ' 60' ' ' PHE . 0.1 OUTLIER -125.12 -21.58 4.61 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -0.9 . . . . 0.0 110.424 -179.831 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.878 ' HA ' HD23 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -140.69 -154.15 0.5 Allowed 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.105 -0.997 . . . . 0.0 109.995 179.941 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.559 ' HA2' ' N ' ' A' ' 55' ' ' GLY . . . 172.23 175.61 40.45 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.784 -1.198 . . . . 0.0 110.195 179.903 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.743 ' O ' HG23 ' A' ' 63' ' ' VAL . 25.7 t80 -143.9 168.4 20.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.493 -1.004 . . . . 0.0 109.732 179.679 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.946 HG22 HG12 ' A' ' 52' ' ' VAL . 13.7 t -160.01 163.56 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 119.465 -0.894 . . . . 0.0 110.491 -178.89 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.478 ' HB3' ' OG1' ' A' ' 16' ' ' THR . 1.3 m-20 -130.92 136.77 48.89 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.417 -0.802 . . . . 0.0 109.16 179.53 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.677 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 19.0 m-85 -103.24 176.81 5.03 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 121.495 0.664 . . . . 0.0 111.168 -179.247 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.612 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -115.26 17.1 16.75 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.556 -0.715 . . . . 0.0 111.247 -178.813 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.643 ' HA ' ' CE2' ' A' ' 18' ' ' PHE . 35.5 p 179.38 178.32 0.52 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-O 122.465 1.126 . . . . 0.0 112.338 179.869 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.547 ' HA ' ' CE1' ' A' ' 18' ' ' PHE . . . -77.95 -23.43 48.51 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 177.811 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.96 -25.96 43.51 Favored 'General case' 0 C--N 1.297 -1.708 0 CA-C-N 115.106 -0.952 . . . . 0.0 109.248 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.81 ' OD2' ' HB3' ' A' ' 48' ' ' ALA . 87.1 m-20 -83.42 -29.02 28.44 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 178.314 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -80.58 -29.42 36.98 Favored 'General case' 0 C--N 1.304 -1.4 0 C-N-CA 119.901 -0.719 . . . . 0.0 109.821 179.655 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 3.6 mt-10 -79.89 -36.59 36.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.464 -0.773 . . . . 0.0 110.36 -179.942 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.753 ' O ' HD23 ' A' ' 77' ' ' LEU . 0.2 OUTLIER -78.31 -29.58 47.82 Favored 'General case' 0 C--N 1.305 -1.328 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 178.91 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.677 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -73.0 -27.88 62.05 Favored 'General case' 0 C--N 1.3 -1.57 0 C-N-CA 119.723 -0.791 . . . . 0.0 108.963 178.895 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . . . . . . . . . 4.1 tt -70.73 -43.35 69.08 Favored 'General case' 0 N--CA 1.485 1.287 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 178.542 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -74.41 -13.54 60.73 Favored 'General case' 0 C--N 1.306 -1.323 0 C-N-CA 119.639 -0.824 . . . . 0.0 109.083 178.472 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.753 HD23 ' O ' ' A' ' 73' ' ' LYS . 0.2 OUTLIER -72.73 5.03 3.42 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.604 -0.685 . . . . 0.0 110.7 179.898 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.801 ' HA ' HD21 ' A' ' 89' ' ' LEU . 8.3 m -66.31 -5.64 11.28 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.94 -1.1 . . . . 0.0 110.56 179.939 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -90.06 32.26 4.98 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.114 -1.595 . . . . 0.0 109.114 179.131 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.073 HD22 ' CD2' ' A' ' 41' ' ' LEU . 0.4 OUTLIER -114.78 132.56 56.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.308 -1.113 . . . . 0.0 110.127 -179.732 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.614 ' N ' HD12 ' A' ' 80' ' ' LEU . 1.5 mtmt -104.94 78.35 1.41 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.554 1.169 . . . . 0.0 109.976 179.522 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.796 HG12 HD23 ' A' ' 34' ' ' LEU . 47.8 t -48.45 132.38 5.98 Favored 'Isoleucine or valine' 0 C--N 1.269 -2.923 0 CA-C-N 114.942 -1.026 . . . . 0.0 109.754 -179.978 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.597 ' CZ ' ' HB3' ' A' ' 33' ' ' GLU . 3.0 m-85 40.82 25.95 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.422 -0.799 . . . . 0.0 110.869 -179.757 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 86.72 28.78 25.63 Favored Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.878 -1.289 . . . . 0.0 109.878 179.561 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.51 ' O ' ' N ' ' A' ' 87' ' ' ILE . 88.1 m-20 -143.12 91.77 2.32 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.202 -1.175 . . . . 0.0 110.282 179.824 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.53 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 19.1 tt0 -42.27 94.38 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.351 -0.843 . . . . 0.0 110.171 179.821 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.737 HG21 HG21 ' A' ' 82' ' ' VAL . 2.2 pp -68.74 125.89 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.503 -0.748 . . . . 0.0 110.696 -179.806 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.514 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 1.8 mttt -83.85 118.49 23.99 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.645 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.801 HD21 ' HA ' ' A' ' 78' ' ' THR . 0.4 OUTLIER -106.06 -171.19 1.85 Allowed 'General case' 0 C--N 1.295 -1.78 0 O-C-N 121.156 -0.965 . . . . 0.0 111.988 -178.258 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.594 ' O ' ' HB2' ' A' ' 21' ' ' PHE . 3.4 mt-10 78.51 177.73 0.14 Allowed 'General case' 0 N--CA 1.501 2.119 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.385 179.813 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.595 ' N ' ' CD ' ' A' ' 92' ' ' PRO . 0.0 OUTLIER 67.95 43.89 0.29 Allowed Pre-proline 0 N--CA 1.493 1.691 0 CA-C-O 121.294 0.569 . . . . 0.0 112.02 178.771 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.595 ' CD ' ' N ' ' A' ' 91' ' ' LYS . 49.7 Cg_endo -68.78 -162.12 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.755 0 O-C-N 123.608 1.32 . . . . 0.0 110.425 178.421 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.45 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.9 OUTLIER 172.21 -60.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.603 -0.686 . . . . 0.0 109.671 179.809 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.439 ' C ' ' O ' ' A' ' 93' ' ' LYS . . . 43.13 26.41 0.52 Allowed Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.052 -1.619 . . . . 0.0 109.052 -179.831 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.441 ' N ' ' O ' ' A' ' 93' ' ' LYS . 72.7 ttt180 -146.67 120.67 9.39 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.333 -1.098 . . . . 0.0 110.436 -179.577 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.416 ' C ' ' O ' ' A' ' 95' ' ' ARG . 0.3 OUTLIER 42.39 -156.12 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.277 -0.889 . . . . 0.0 110.313 179.868 . . . . . . . . 3 3 . 1 . 032 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 98' ' ' THR . . . -135.65 -98.03 0.54 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.548 -1.421 . . . . 0.0 109.548 179.946 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.427 ' C ' ' O ' ' A' ' 97' ' ' GLY . 2.5 p 42.44 -147.87 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.252 -1.146 . . . . 0.0 110.261 179.876 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.06 39.27 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.36 -0.837 . . . . 0.0 110.244 -179.961 . . . . . . . . 2 2 . 1 . 032 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 150.73 125.53 1.27 Allowed Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 -179.974 . . . . . . . . 1 1 . 1 . 032 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 53.0 t . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.315 -1.109 . . . . 0.0 110.205 179.982 . . . . . . . . 0 0 . 1 . 033 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 . . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 1' ' ' GLY . 1.1 p 179.73 -179.55 0.45 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.247 -1.149 . . . . 0.0 110.19 -179.965 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.549 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 51.3 p-80 -175.53 107.32 0.09 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.31 -0.869 . . . . 0.0 110.141 -179.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER 46.9 -157.59 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.325 -0.859 . . . . 0.0 110.201 179.896 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -67.89 -165.93 0.05 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.262 -0.899 . . . . 0.0 110.22 179.967 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -93.0 -87.09 0.24 Allowed 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.264 -0.898 . . . . 0.0 110.203 180.0 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -155.53 113.16 2.23 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.266 -0.896 . . . . 0.0 110.084 -179.983 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -71.41 -157.13 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.668 0 O-C-N 123.945 1.497 . . . . 0.0 110.053 -179.986 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.544 HG13 ' O ' ' A' ' 9' ' ' VAL . 3.8 p -151.96 112.79 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 121.248 0.547 . . . . 0.0 110.199 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.446 ' O ' ' N ' ' A' ' 12' ' ' SER . 3.8 mt-10 53.34 179.39 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.198 -0.939 . . . . 0.0 110.168 -179.937 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -61.3 83.86 0.02 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.479 -1.449 . . . . 0.0 109.479 179.948 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.446 ' N ' ' O ' ' A' ' 10' ' ' GLU . 60.5 p -158.37 93.7 1.23 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.284 -1.127 . . . . 0.0 110.248 -179.96 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.434 ' O ' ' C ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -120.84 -128.8 0.27 Allowed 'General case' 0 C--N 1.305 -1.362 0 O-C-N 121.232 -0.917 . . . . 0.0 109.495 179.994 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.434 ' C ' ' O ' ' A' ' 13' ' ' GLU . 0.5 OUTLIER -41.42 132.44 2.71 Favored 'General case' 0 C--N 1.287 -2.121 0 CA-C-O 121.238 0.542 . . . . 0.0 110.128 179.95 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.493 ' C ' ' CG2' ' A' ' 16' ' ' THR . 20.7 m -81.0 -11.62 59.52 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.224 -0.923 . . . . 0.0 110.33 -179.76 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.759 ' CG2' HG11 ' A' ' 50' ' ' VAL . 14.0 p -151.25 164.23 20.95 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.238 -0.914 . . . . 0.0 110.408 -179.993 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.458 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 46.8 Cg_endo -75.17 -34.49 3.64 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.052 1.554 . . . . 0.0 110.768 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.549 ' CE2' ' C ' ' A' ' 67' ' ' SER . 97.4 m-85 -100.64 102.39 13.52 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.067 -1.021 . . . . 0.0 110.489 -179.815 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.503 ' N ' ' OD1' ' A' ' 19' ' ' ASN . 2.0 m120 -137.99 153.2 49.43 Favored 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.321 -0.862 . . . . 0.0 109.527 179.895 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.786 HD22 HD23 ' A' ' 89' ' ' LEU . 4.6 pp -163.57 -171.78 2.67 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.315 -0.866 . . . . 0.0 110.462 -179.873 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.678 ' CD1' ' CZ ' ' A' ' 62' ' ' TYR . 11.5 t80 -116.54 151.22 36.59 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.0 110.087 179.934 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.519 HG22 HD11 ' A' ' 25' ' ' LEU . 2.8 mt -131.27 159.9 42.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.233 -0.917 . . . . 0.0 109.902 179.93 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.507 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -142.49 -176.24 16.45 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.806 -1.318 . . . . 0.0 109.806 -179.628 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.507 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 47.8 t30 71.34 49.3 0.32 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.407 -1.055 . . . . 0.0 110.215 179.998 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.996 HD13 ' HA ' ' A' ' 60' ' ' PHE . 10.8 mp -97.26 132.94 42.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.346 -0.846 . . . . 0.0 110.145 179.875 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.658 ' H ' HD21 ' A' ' 34' ' ' LEU . 39.1 t-20 -41.41 102.06 0.26 Allowed Pre-proline 0 C--N 1.3 -1.544 0 O-C-N 121.609 -0.682 . . . . 0.0 110.287 179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' HD3' ' O ' ' A' ' 25' ' ' LEU . 49.9 Cg_endo -77.06 8.06 3.37 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.046 1.55 . . . . 0.0 110.852 -179.759 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 22.0 m-80 -111.81 -17.67 12.89 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.986 -1.071 . . . . 0.0 108.948 179.55 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.43 ' HB2' ' CG ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -96.72 -155.52 0.49 Allowed 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.731 -0.605 . . . . 0.0 109.513 179.483 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.529 ' HB2' ' CG ' ' A' ' 33' ' ' GLU . 0.9 OUTLIER -100.54 142.09 32.5 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.327 -0.858 . . . . 0.0 109.597 179.109 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.929 HG12 ' HE3' ' A' ' 35' ' ' LYS . 3.0 t -63.46 -42.88 97.79 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.814 -1.154 . . . . 0.0 109.114 179.582 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.559 ' O ' HG23 ' A' ' 36' ' ' VAL . . . -57.49 -37.26 72.67 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.334 -0.854 . . . . 0.0 109.575 178.959 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.529 ' CG ' ' HB2' ' A' ' 30' ' ' SER . 16.0 mm-40 -67.15 -30.22 70.14 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.296 -0.877 . . . . 0.0 109.62 179.529 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.111 HD23 HG21 ' A' ' 82' ' ' VAL . 3.0 mt -67.56 -38.4 84.06 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.33 -0.856 . . . . 0.0 109.505 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.929 ' HE3' HG12 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -65.3 -47.31 77.03 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.357 -0.839 . . . . 0.0 109.943 179.776 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 32' ' ' ALA . 7.3 t -65.09 -34.57 71.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.249 -0.907 . . . . 0.0 109.394 179.131 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.509 ' O ' ' HB2' ' A' ' 41' ' ' LEU . . . -64.53 -43.98 92.28 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.298 -0.876 . . . . 0.0 109.068 179.647 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.555 HG23 ' CE2' ' A' ' 42' ' ' PHE . 19.5 mm -76.96 -27.95 16.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 C-N-CA 119.474 -0.891 . . . . 0.0 108.929 178.832 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.725 ' O ' ' HB2' ' A' ' 43' ' ' ALA . 0.3 OUTLIER -73.82 -32.75 63.87 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.437 -0.79 . . . . 0.0 109.395 179.478 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.9 tt0 -85.24 -43.11 14.05 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.402 -0.811 . . . . 0.0 110.009 179.672 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.567 ' O ' ' HB3' ' A' ' 45' ' ' ASN . 3.7 tt -55.67 -40.8 72.78 Favored 'General case' 0 C--N 1.298 -1.67 0 C-N-CA 119.486 -0.886 . . . . 0.0 109.569 -179.64 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.555 ' CE2' HG23 ' A' ' 38' ' ' ILE . 11.6 m-30 -87.06 -23.62 24.88 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.425 -0.91 . . . . 0.0 109.447 179.542 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.725 ' HB2' ' O ' ' A' ' 39' ' ' SER . . . -75.93 -18.32 59.4 Favored 'General case' 0 C--N 1.299 -1.621 0 C-N-CA 119.228 -0.989 . . . . 0.0 108.802 179.688 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttmp? -102.28 -39.27 7.28 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 119.958 -0.697 . . . . 0.0 109.588 179.632 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.615 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 0.0 OUTLIER -51.03 -43.17 60.85 Favored 'General case' 0 C--N 1.3 -1.583 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 178.619 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.615 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 13.1 m-20 143.22 34.19 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 123.561 0.744 . . . . 0.0 110.151 179.587 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.703 HD12 ' HB3' ' A' ' 73' ' ' LYS . 0.1 OUTLIER -112.0 -152.45 0.5 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.8 -1.187 . . . . 0.0 110.624 -179.926 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.419 ' O ' ' C ' ' A' ' 49' ' ' VAL . . . -164.31 55.83 0.15 Allowed 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.674 0.749 . . . . 0.0 109.153 179.447 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.654 HG21 ' HA ' ' A' ' 39' ' ' SER . 0.9 OUTLIER -41.11 118.31 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 CA-C-O 122.045 0.926 . . . . 0.0 110.151 -179.794 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.759 HG11 ' CG2' ' A' ' 16' ' ' THR . 2.8 t -84.24 -44.11 17.8 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.803 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.283 -179.397 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.471 ' HB3' ' OD2' ' A' ' 64' ' ' ASP . 5.4 t70 -147.72 160.73 42.39 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.083 -1.011 . . . . 0.0 110.873 -179.861 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.813 HG22 ' CG ' ' A' ' 35' ' ' LYS . 7.6 p -150.96 111.15 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 121.338 -0.851 . . . . 0.0 110.094 179.639 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.495 ' HB2' ' HB2' ' A' ' 62' ' ' TYR . 2.2 mpp_? -99.71 165.53 11.55 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.154 -0.966 . . . . 0.0 110.261 179.944 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.472 HG22 ' HD3' ' A' ' 35' ' ' LYS . 69.0 p -87.96 163.73 16.18 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.267 -0.896 . . . . 0.0 110.647 -179.644 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.52 ' N ' ' O ' ' A' ' 60' ' ' PHE . . . -119.19 105.57 1.17 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.289 -1.524 . . . . 0.0 109.289 179.732 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.473 ' CB ' ' O ' ' A' ' 55' ' ' GLY . 2.2 m 67.57 -134.99 0.12 Allowed 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.254 -1.145 . . . . 0.0 110.016 -179.836 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.509 ' O ' HG21 ' A' ' 31' ' ' VAL . 1.0 OUTLIER -80.47 -48.58 12.61 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.991 -1.068 . . . . 0.0 110.482 -179.832 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.823 ' CB ' HG22 ' A' ' 31' ' ' VAL . 0.0 OUTLIER -177.76 37.8 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.137 -0.977 . . . . 0.0 110.444 -179.877 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.487 ' HB2' ' CE2' ' A' ' 60' ' ' PHE . 21.5 mttt -113.93 -24.33 9.14 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.158 -0.964 . . . . 0.0 110.259 179.966 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.996 ' HA ' HD13 ' A' ' 25' ' ' LEU . 1.2 m-85 -137.57 -174.99 3.92 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.264 -0.898 . . . . 0.0 109.665 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.508 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.04 154.01 18.37 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.743 -1.343 . . . . 0.0 109.743 179.898 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.678 ' CZ ' ' CD1' ' A' ' 21' ' ' PHE . 13.7 m-85 -107.84 167.23 10.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.188 -1.183 . . . . 0.0 110.031 179.683 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.628 HG23 ' O ' ' A' ' 62' ' ' TYR . 50.2 t -157.25 155.44 5.06 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.555 -0.858 . . . . 0.0 110.939 -178.99 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.471 ' OD2' ' HB3' ' A' ' 51' ' ' ASP . 8.6 m-20 -125.22 139.5 53.67 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.703 -0.623 . . . . 0.0 109.498 179.768 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.873 ' CZ ' ' HB1' ' A' ' 74' ' ' ALA . 17.7 m-85 -103.83 176.61 5.09 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.508 -0.745 . . . . 0.0 110.407 -179.764 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.645 ' CG ' HG22 ' A' ' 50' ' ' VAL . 0.1 OUTLIER -113.98 14.65 18.47 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.208 -0.932 . . . . 0.0 111.479 -178.395 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.549 ' C ' ' CE2' ' A' ' 18' ' ' PHE . 19.9 p 176.94 178.39 0.25 Allowed 'General case' 0 N--CA 1.495 1.776 0 CA-C-O 122.371 1.081 . . . . 0.0 112.089 179.862 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.47 ' N ' ' CE2' ' A' ' 18' ' ' PHE . . . -76.5 -22.71 54.11 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 177.553 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.06 -25.47 37.06 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.132 -0.94 . . . . 0.0 109.521 -179.903 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.758 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 88.6 m-20 -82.79 -28.16 30.47 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 178.164 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.78 ' C ' HD13 ' A' ' 71' ' ' LEU . 3.0 tm? -79.13 -33.7 43.97 Favored 'General case' 0 C--N 1.304 -1.389 0 C-N-CA 120.111 -0.636 . . . . 0.0 109.566 179.389 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.42 ' HB2' ' O ' ' A' ' 68' ' ' ALA . 1.4 tp10 -73.46 -39.22 65.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.413 -0.805 . . . . 0.0 109.733 179.606 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.703 ' HB3' HD12 ' A' ' 47' ' ' LEU . 0.0 OUTLIER -80.19 -18.04 50.74 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 178.524 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.873 ' HB1' ' CZ ' ' A' ' 65' ' ' PHE . . . -78.47 -28.13 46.46 Favored 'General case' 0 C--N 1.306 -1.325 0 C-N-CA 119.922 -0.711 . . . . 0.0 109.178 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.62 HD23 ' C ' ' A' ' 75' ' ' LEU . 7.2 tt -79.69 -44.19 21.31 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 109.112 -0.699 . . . . 0.0 109.112 179.251 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.55 -27.8 67.26 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 121.269 -0.894 . . . . 0.0 109.096 178.9 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.803 ' O ' HD23 ' A' ' 80' ' ' LEU . 15.4 mt -68.8 -7.97 39.08 Favored 'General case' 0 N--CA 1.488 1.465 0 CA-C-O 121.536 0.684 . . . . 0.0 109.826 179.394 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.418 ' OG1' ' O ' ' A' ' 75' ' ' LEU . 87.7 m -57.01 -9.14 0.76 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.658 -0.651 . . . . 0.0 111.506 -179.667 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -85.98 26.97 5.7 Favored Glycine 0 N--CA 1.492 2.367 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.283 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.958 HD11 HG12 ' A' ' 87' ' ' ILE . 0.6 OUTLIER -94.14 -161.95 0.9 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.218 -1.166 . . . . 0.0 110.695 -179.762 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.62 ' HA ' ' N ' ' A' ' 86' ' ' GLU . 0.3 OUTLIER -164.1 48.05 0.12 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-O 121.56 0.695 . . . . 0.0 109.817 179.643 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 1.111 HG21 HD23 ' A' ' 34' ' ' LEU . 7.9 p 8.49 -126.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.456 0 CA-C-N 114.511 -1.222 . . . . 0.0 111.203 179.708 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.708 ' N ' HG13 ' A' ' 82' ' ' VAL . 2.8 m-85 -72.44 -1.75 16.9 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 120.408 -1.432 . . . . 0.0 109.508 179.14 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.469 ' N ' ' O ' ' A' ' 81' ' ' LYS . . . 147.89 36.42 0.05 OUTLIER Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.269 -1.532 . . . . 0.0 109.269 179.88 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.6 ' O ' HG12 ' A' ' 82' ' ' VAL . 15.3 m-20 -163.4 108.02 1.06 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.234 -1.156 . . . . 0.0 109.418 179.997 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.62 ' N ' ' HA ' ' A' ' 81' ' ' LYS . 0.1 OUTLIER -51.27 88.02 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.349 -0.844 . . . . 0.0 110.61 -178.837 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.958 HG12 HD11 ' A' ' 80' ' ' LEU . 2.3 pp -46.38 144.1 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 C-N-CA 119.854 -0.738 . . . . 0.0 109.651 179.691 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.517 ' O ' ' HA ' ' A' ' 22' ' ' ILE . 8.1 mtmt -112.03 169.78 8.61 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.56 -0.712 . . . . 0.0 109.649 179.924 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.786 HD23 HD22 ' A' ' 20' ' ' LEU . 7.7 mp -113.31 -177.56 3.16 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.302 -0.874 . . . . 0.0 110.399 -179.923 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.501 ' N ' ' O ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -174.64 -174.67 0.85 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.585 -0.697 . . . . 0.0 110.243 179.974 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 1.8 mptt -116.29 106.12 49.5 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.283 -0.886 . . . . 0.0 110.226 -179.959 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.484 ' O ' ' CB ' ' A' ' 93' ' ' LYS . 45.5 Cg_endo -73.41 -170.44 0.66 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.997 1.525 . . . . 0.0 110.43 179.988 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.484 ' CB ' ' O ' ' A' ' 92' ' ' PRO . 0.4 OUTLIER 67.66 94.14 0.07 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.249 -0.907 . . . . 0.0 110.26 -179.89 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 138.79 -56.12 0.65 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.995 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.446 ' O ' ' CG ' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -102.52 113.4 26.72 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.275 -1.132 . . . . 0.0 110.239 -179.983 . . . . . . . . 3 3 . 1 . 033 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -128.5 134.17 48.64 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.238 -0.914 . . . . 0.0 110.194 179.94 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . -138.52 162.03 25.76 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.544 -1.422 . . . . 0.0 109.544 -179.993 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -138.92 135.79 34.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.321 -1.105 . . . . 0.0 110.366 -179.987 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.1 46.09 0.75 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.314 -0.866 . . . . 0.0 110.166 179.973 . . . . . . . . 2 2 . 1 . 033 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . -66.12 -125.37 0.02 OUTLIER Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.543 -1.423 . . . . 0.0 109.543 179.992 . . . . . . . . 1 1 . 1 . 033 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 O-C-N 121.222 -1.164 . . . . 0.0 110.195 -179.963 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.509 -1.436 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 034 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.481 ' O ' ' CG ' ' A' ' 3' ' ' HIS . 0.1 OUTLIER -112.5 -16.54 12.85 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.268 -1.136 . . . . 0.0 110.183 179.981 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 2' ' ' SER . 98.9 m-70 -153.65 175.39 13.3 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.237 -0.914 . . . . 0.0 110.215 179.976 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -153.26 39.48 0.51 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.274 -0.891 . . . . 0.0 110.275 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.81 153.43 49.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.0 110.235 179.968 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.5 tp10 57.63 24.1 10.11 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.249 -0.907 . . . . 0.0 110.228 179.973 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -99.68 146.69 32.27 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.29 -0.881 . . . . 0.0 110.141 179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -71.4 -157.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.077 1.567 . . . . 0.0 110.099 179.948 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.766 ' O ' HG12 ' A' ' 9' ' ' VAL . 77.6 t 50.41 51.04 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.291 -1.958 0 CA-C-O 121.223 0.535 . . . . 0.0 110.147 179.965 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . . . . . . . . . 36.3 mm-40 -64.88 121.54 14.86 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.258 -0.901 . . . . 0.0 110.293 179.971 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.03 46.45 2.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.521 -1.431 . . . . 0.0 109.521 179.927 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.523 ' O ' ' HB2' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -70.31 -6.07 32.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.334 -1.098 . . . . 0.0 110.156 179.985 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.523 ' HB2' ' O ' ' A' ' 12' ' ' SER . 0.4 OUTLIER 170.12 125.06 0.01 OUTLIER 'General case' 0 C--N 1.306 -1.287 0 CA-C-O 122.451 1.119 . . . . 0.0 109.276 179.593 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.73 178.04 0.66 Allowed 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 115.08 -0.963 . . . . 0.0 110.135 179.981 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.921 HG23 HG23 ' A' ' 16' ' ' THR . 1.8 t -109.59 -17.46 13.72 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.248 -0.907 . . . . 0.0 110.11 -179.99 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.973 HG21 HG21 ' A' ' 50' ' ' VAL . 17.6 p -138.6 158.08 70.96 Favored Pre-proline 0 C--N 1.299 -1.609 0 O-C-N 121.535 -0.728 . . . . 0.0 110.689 -179.789 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.571 ' HG2' ' CD2' ' A' ' 18' ' ' PHE . 48.7 Cg_endo -75.71 -29.07 7.51 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.136 1.598 . . . . 0.0 110.559 179.904 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . 0.571 ' CD2' ' HG2' ' A' ' 17' ' ' PRO . 88.0 m-85 -106.35 101.89 11.33 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.157 -0.964 . . . . 0.0 110.774 -179.55 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.516 ' ND2' ' OG1' ' A' ' 16' ' ' THR . 1.7 m120 -134.71 150.9 50.66 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.501 -0.749 . . . . 0.0 109.131 179.413 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.716 HD12 ' N ' ' A' ' 21' ' ' PHE . 4.3 pp -172.93 -175.69 1.29 Allowed 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.099 -1.001 . . . . 0.0 110.861 -179.85 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.716 ' N ' HD12 ' A' ' 20' ' ' LEU . 3.2 t80 -110.29 154.65 23.15 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.337 -0.852 . . . . 0.0 110.024 -179.932 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.548 ' CG1' ' HG ' ' A' ' 89' ' ' LEU . 1.7 mt -140.15 153.55 22.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 O-C-N 121.338 -0.851 . . . . 0.0 109.453 179.751 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . 0.511 ' O ' ' CB ' ' A' ' 24' ' ' ASN . . . -121.04 -177.03 15.55 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 -179.882 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 23' ' ' GLY . 2.9 t30 70.46 71.41 0.21 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.297 -1.12 . . . . 0.0 110.012 -179.861 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.91 HD13 HD22 ' A' ' 34' ' ' LEU . 0.3 OUTLIER -114.1 27.43 9.51 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.248 -0.907 . . . . 0.0 110.307 -179.823 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.537 ' HB2' HD21 ' A' ' 34' ' ' LEU . 0.7 OUTLIER 53.13 98.04 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.275 -0.891 . . . . 0.0 110.335 -179.994 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.73 -9.9 22.93 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.96 1.505 . . . . 0.0 110.519 -179.837 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 28' ' ' ASN . . . . . . . . . . . . . 35.6 m120 -94.75 -12.94 26.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.17 -0.956 . . . . 0.0 109.83 179.917 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.457 ' HG3' ' OE2' ' A' ' 33' ' ' GLU . 12.4 mmtt -115.12 -160.01 0.72 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.449 -0.782 . . . . 0.0 109.536 179.791 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.728 ' O ' HD12 ' A' ' 34' ' ' LEU . 2.0 m -112.69 148.09 35.42 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.08 -1.012 . . . . 0.0 110.306 179.935 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.795 ' CG1' HG22 ' A' ' 54' ' ' THR . 2.6 t -67.44 -18.96 24.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 O-C-N 121.066 -1.021 . . . . 0.0 108.879 179.328 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -68.3 -41.98 80.11 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.444 -0.785 . . . . 0.0 109.033 178.861 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . 0.576 ' HG3' ' CE1' ' A' ' 83' ' ' PHE . 3.8 pt-20 -66.88 -45.96 76.42 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 179.041 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.91 HD22 HD13 ' A' ' 25' ' ' LEU . 0.5 OUTLIER -62.7 -34.21 76.67 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.322 -0.861 . . . . 0.0 108.72 178.957 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . 0.94 ' HD2' HG12 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -57.79 -49.55 76.25 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 108.68 -0.859 . . . . 0.0 108.68 178.773 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.511 ' HA ' ' HB3' ' A' ' 39' ' ' SER . 91.1 t -64.39 -32.18 56.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 121.594 -0.691 . . . . 0.0 109.141 178.584 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.561 ' HB2' ' CD1' ' A' ' 83' ' ' PHE . . . -65.7 -43.0 90.51 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 178.854 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.821 ' CD1' HG23 ' A' ' 82' ' ' VAL . 24.7 mm -75.63 -24.62 17.11 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 N-CA-C 109.017 -0.735 . . . . 0.0 109.017 178.568 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 39' ' ' SER . . . . . 0.511 ' HB3' ' HA ' ' A' ' 36' ' ' VAL . 2.5 t -77.66 -35.2 52.65 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.95 -1.094 . . . . 0.0 108.873 179.095 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -81.07 -38.76 26.82 Favored 'General case' 0 C--N 1.3 -1.573 0 CA-C-O 121.491 0.662 . . . . 0.0 109.724 179.528 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 1.044 HD21 HD22 ' A' ' 80' ' ' LEU . 10.4 tp -65.52 -32.43 74.02 Favored 'General case' 0 C--N 1.3 -1.547 0 C-N-CA 119.765 -0.774 . . . . 0.0 109.406 179.356 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 42' ' ' PHE . . . . . 0.899 ' CZ ' HD11 ' A' ' 77' ' ' LEU . 7.3 m-85 -87.51 -19.99 27.16 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.516 -0.74 . . . . 0.0 109.103 179.619 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . . . . . . . . . . . -89.27 -26.96 20.88 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.248 -0.908 . . . . 0.0 109.668 179.839 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.9 ttpt -92.39 -17.44 24.62 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.477 -0.764 . . . . 0.0 109.212 179.491 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 45' ' ' ASN . . . . . 0.608 ' O ' ' CB ' ' A' ' 46' ' ' ASP . 1.9 m-80 -83.23 -59.07 2.58 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.621 -0.674 . . . . 0.0 109.534 179.469 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . 0.608 ' CB ' ' O ' ' A' ' 45' ' ' ASN . 2.6 m-20 146.65 31.17 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.741 179.476 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.799 HD23 ' HB2' ' A' ' 70' ' ' ASP . 0.2 OUTLIER -102.27 -156.27 0.55 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.192 -0.942 . . . . 0.0 109.874 -179.836 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.579 ' HB1' ' HG2' ' A' ' 66' ' ' GLU . . . -162.39 56.51 0.23 Allowed 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.381 -0.824 . . . . 0.0 109.784 179.73 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 39' ' ' SER . 10.4 m -45.53 118.79 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.588 0 CA-C-O 122.036 0.922 . . . . 0.0 110.372 179.959 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 50' ' ' VAL . . . . . 0.973 HG21 HG21 ' A' ' 16' ' ' THR . 0.0 OUTLIER -93.45 -33.89 5.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.873 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.586 ' C ' HG23 ' A' ' 52' ' ' VAL . 11.5 m-20 -149.35 148.24 29.26 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.322 -0.861 . . . . 0.0 110.686 -179.886 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.94 HG12 ' HD2' ' A' ' 35' ' ' LYS . 57.1 t -156.85 102.9 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.283 -0.886 . . . . 0.0 110.01 179.672 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.518 ' O ' ' N ' ' A' ' 62' ' ' TYR . 0.7 OUTLIER -113.17 173.27 6.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.18 -0.95 . . . . 0.0 110.332 -179.814 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.795 HG22 ' CG1' ' A' ' 31' ' ' VAL . 2.0 p -82.33 -179.32 7.37 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.238 -0.914 . . . . 0.0 110.171 -179.665 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.475 ' HA3' ' HB2' ' A' ' 60' ' ' PHE . . . -140.91 132.5 5.42 Favored Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.947 -1.261 . . . . 0.0 109.947 -179.833 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.809 HG22 ' ND2' ' A' ' 57' ' ' ASN . 63.4 m 58.34 -106.09 0.29 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.371 -1.076 . . . . 0.0 110.586 179.71 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.809 ' ND2' HG22 ' A' ' 56' ' ' THR . 7.9 p30 -130.17 90.56 2.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.861 -1.149 . . . . 0.0 110.48 -179.701 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.543 ' HA ' ' CG2' ' A' ' 31' ' ' VAL . 19.2 mtt85 41.77 29.7 0.13 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.279 -0.888 . . . . 0.0 110.533 179.683 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.438 ' C ' ' CD1' ' A' ' 60' ' ' PHE . 0.0 OUTLIER -112.39 -32.96 6.33 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.237 -0.915 . . . . 0.0 110.177 179.943 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 60' ' ' PHE . . . . . 0.606 ' C ' HD23 ' A' ' 25' ' ' LEU . 2.3 m-85 -126.71 -162.59 1.16 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.353 -0.842 . . . . 0.0 109.361 179.733 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.498 ' O ' ' HB ' ' A' ' 22' ' ' ILE . . . -174.58 132.12 2.15 Favored Glycine 0 N--CA 1.488 2.113 0 C-N-CA 119.481 -1.342 . . . . 0.0 110.575 179.986 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.712 ' O ' HG23 ' A' ' 63' ' ' VAL . 2.9 m-85 -86.33 158.35 19.68 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.404 -1.057 . . . . 0.0 109.116 178.963 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 63' ' ' VAL . . . . . 0.929 HG22 HG13 ' A' ' 52' ' ' VAL . 25.2 t -158.68 156.32 3.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.628 0 C-N-CA 119.209 -0.996 . . . . 0.0 110.947 -179.155 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 64' ' ' ASP . . . . . 0.581 ' O ' HG23 ' A' ' 50' ' ' VAL . 80.3 m-20 -142.39 144.88 33.33 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 179.912 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 65' ' ' PHE . . . . . 0.638 ' O ' HG21 ' A' ' 50' ' ' VAL . 23.0 m-85 -114.97 -174.87 2.57 Favored 'General case' 0 C--N 1.302 -1.499 0 O-C-N 121.483 -0.761 . . . . 0.0 109.001 178.951 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.579 ' HG2' ' HB1' ' A' ' 48' ' ' ALA . 0.5 OUTLIER -132.67 29.61 4.17 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.494 -1.379 . . . . 0.0 113.44 -176.6 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.777 ' N ' ' OD2' ' A' ' 70' ' ' ASP . 18.4 p -169.09 173.5 6.8 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.319 -1.488 . . . . 0.0 113.119 179.94 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -77.3 -27.42 52.99 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 177.393 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 69' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 73' ' ' LYS . 0.0 OUTLIER -72.82 -28.89 62.83 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 114.926 -1.034 . . . . 0.0 108.912 179.41 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.799 ' HB2' HD23 ' A' ' 47' ' ' LEU . 0.5 OUTLIER -76.5 -33.26 58.65 Favored 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 177.851 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.567 ' HB2' ' CE1' ' A' ' 18' ' ' PHE . 0.0 OUTLIER -62.28 -43.89 97.79 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.447 -0.797 . . . . 0.0 108.997 179.794 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.485 ' N ' HD23 ' A' ' 71' ' ' LEU . 3.9 tt0 -66.26 -35.52 80.63 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.307 -0.871 . . . . 0.0 109.034 178.806 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.729 ' HB3' HD11 ' A' ' 47' ' ' LEU . 4.8 mttm -78.59 -21.19 48.94 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.329 -1.36 . . . . 0.0 107.329 178.13 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.771 ' HA ' HD12 ' A' ' 77' ' ' LEU . . . -69.33 -29.4 67.22 Favored 'General case' 0 C--N 1.307 -1.279 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 178.767 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 75' ' ' LEU . . . . . 0.67 HD23 ' C ' ' A' ' 75' ' ' LEU . 4.3 tt -77.22 -45.74 25.52 Favored 'General case' 0 N--CA 1.485 1.316 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.496 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.582 ' N ' HD23 ' A' ' 75' ' ' LEU . 8.5 tt0 -71.66 -7.15 46.13 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 119.716 -0.794 . . . . 0.0 109.642 178.93 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.899 HD11 ' CZ ' ' A' ' 42' ' ' PHE . 0.3 OUTLIER -57.63 -13.52 4.06 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 121.525 -0.734 . . . . 0.0 111.09 -179.996 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 78' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 78' ' ' THR . 45.8 m -69.2 3.76 2.0 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.242 -0.912 . . . . 0.0 111.801 -179.186 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 79' ' ' GLY . . . . . . . . . . . . . . . -116.61 10.95 16.17 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.477 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 1.044 HD22 HD21 ' A' ' 41' ' ' LEU . 45.6 mt -97.74 112.38 24.29 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.321 -1.105 . . . . 0.0 110.688 -179.635 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 81' ' ' LYS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 86' ' ' GLU . 1.1 mttp -88.62 80.59 7.27 Favored 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 122.105 0.955 . . . . 0.0 110.295 179.589 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.821 HG23 ' CD1' ' A' ' 38' ' ' ILE . 1.1 p -46.16 126.84 1.84 Allowed 'Isoleucine or valine' 0 C--N 1.273 -2.745 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 179.697 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.576 ' CE1' ' HG3' ' A' ' 33' ' ' GLU . 1.2 m-85 42.21 25.33 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.174 -0.953 . . . . 0.0 110.653 -179.561 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.449 ' N ' ' O ' ' A' ' 82' ' ' VAL . . . 97.18 17.68 31.22 Favored Glycine 0 N--CA 1.492 2.381 0 N-CA-C 109.689 -1.364 . . . . 0.0 109.689 179.731 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 85' ' ' ASN . . . . . 0.524 ' O ' ' N ' ' A' ' 87' ' ' ILE . 84.7 m-20 -133.54 110.52 9.99 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.258 -1.142 . . . . 0.0 110.084 179.856 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.526 ' HA ' ' O ' ' A' ' 80' ' ' LEU . 1.5 tm-20 -56.65 83.68 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.219 -0.926 . . . . 0.0 110.071 179.941 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 87' ' ' ILE . . . . . 0.792 HG23 ' HB ' ' A' ' 82' ' ' VAL . 0.5 OUTLIER -39.3 151.41 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 CA-C-O 121.891 0.853 . . . . 0.0 110.771 -179.479 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 88' ' ' LYS . . . . . 0.52 ' O ' HG23 ' A' ' 22' ' ' ILE . 31.9 ttpt -119.26 157.36 28.2 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.684 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.548 ' HG ' ' CG1' ' A' ' 22' ' ' ILE . 5.1 mp -112.36 179.07 4.09 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.232 -0.917 . . . . 0.0 110.419 -179.597 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.502 ' O ' ' HD3' ' A' ' 92' ' ' PRO . 0.0 OUTLIER -170.48 161.34 7.82 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.662 -0.649 . . . . 0.0 109.924 179.856 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.5 ' N ' ' OE1' ' A' ' 90' ' ' GLU . 0.0 OUTLIER -102.12 100.36 15.0 Favored Pre-proline 0 N--CA 1.491 1.589 0 O-C-N 121.219 -0.925 . . . . 0.0 110.462 -179.708 . . . . . . . . 3 3 . 1 . 034 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . 0.502 ' HD3' ' O ' ' A' ' 90' ' ' GLU . 48.1 Cg_endo -75.07 -169.16 0.6 Allowed 'Trans proline' 0 C--N 1.307 -1.653 0 O-C-N 124.081 1.569 . . . . 0.0 110.408 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.424 ' C ' ' O ' ' A' ' 92' ' ' PRO . 13.2 tttm 42.38 45.42 3.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.323 -0.861 . . . . 0.0 110.217 179.95 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 143.23 139.5 3.56 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.96 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.15 -178.19 2.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.25 -1.147 . . . . 0.0 110.221 -179.903 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.511 ' O ' HG23 ' A' ' 98' ' ' THR . 17.0 t70 -84.28 61.37 6.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.269 -0.894 . . . . 0.0 110.201 -179.972 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 98' ' ' THR . . . 74.5 -110.75 3.17 Favored Glycine 0 N--CA 1.491 2.324 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 -179.92 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 98' ' ' THR . . . . . 0.511 HG23 ' O ' ' A' ' 96' ' ' ASP . 3.4 p 42.31 94.01 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.221 -1.164 . . . . 0.0 110.354 179.971 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 99' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.89 166.55 13.64 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.254 -0.903 . . . . 0.0 110.148 -179.994 . . . . . . . . 2 2 . 1 . 034 nuclear nobuild full ' A' A ' 100' ' ' GLY . . . . . . . . . . . . . . . 53.24 65.34 3.46 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.964 . . . . . . . . 1 1 . 1 . 034 nuclear nobuild full ' A' A ' 101' ' ' CYS . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.492 1.64 0 O-C-N 121.268 -1.137 . . . . 0.0 110.249 -179.98 . . . . . . . . 0 0 . 1 stop_ save_